data_1fa4_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1fa4 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 28' ' ' THR . 11.9 t . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.265 0.555 . . . . 0.0 109.585 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -93.88 153.75 18.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 0.0 109.28 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.5 m -142.85 135.92 28.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 109.736 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.577 ' CG1' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -117.39 100.33 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.239 -0.913 . . . . 0.0 109.338 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -69.46 79.21 0.4 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.257 -0.902 . . . . 0.0 109.497 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.497 ' CD2' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -52.33 136.55 30.81 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.193 -0.942 . . . . 0.0 109.243 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.54 115.56 3.95 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.51 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 97.4 p -69.86 -82.45 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -1.129 . . . . 0.0 109.608 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 9' ' ' SER . 2.8 p30 163.45 -50.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.885 . . . . 0.0 109.049 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.459 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 4.0 mttt -120.59 -5.72 9.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.349 -0.845 . . . . 0.0 109.252 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -100.38 -103.78 2.59 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.65 -156.51 0.69 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -1.152 . . . . 0.0 109.562 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.637 ' CD1' ' CD2' ' A' ' 92' ' ' HIS . 30.9 mt -99.86 120.57 39.98 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.18 -0.95 . . . . 0.0 109.873 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.509 ' CG1' ' O ' ' A' ' 14' ' ' LEU . 16.1 m -160.53 126.68 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.921 . . . . 0.0 109.621 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.428 ' O ' ' O ' ' A' ' 15' ' ' VAL . 6.0 m-85 -44.47 165.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.055 -1.028 . . . . 0.0 109.301 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 22.9 mt-10 -148.16 104.62 3.58 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.195 -0.94 . . . . 0.0 109.405 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.2 Cg_endo -77.59 -176.03 17.92 Favored 'Cis proline' 0 C--N 1.311 -1.426 0 C-N-CA 123.736 -1.36 . . . . 0.0 110.563 0.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.12 -47.56 50.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.622 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.81 178.04 5.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 109.331 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.577 ' CD1' ' CG1' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -153.04 141.73 20.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.967 . . . . 0.0 109.87 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.2 m -120.21 115.3 23.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.336 -0.852 . . . . 0.0 109.213 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.53 HD13 ' CG2' ' A' ' 103' ' ' VAL . 1.0 OUTLIER -132.36 -176.75 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.209 -0.932 . . . . 0.0 109.738 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.53 ' CG ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -104.63 177.39 1.41 Allowed Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.188 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.53 ' HD2' ' CG ' ' A' ' 24' ' ' LYS . 34.3 Cg_endo -77.18 76.69 4.09 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.213 1.942 . . . . 0.0 110.349 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 132.6 -11.78 5.19 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 26' ' ' GLY . 9.2 m-20 -53.3 -176.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.165 -1.197 . . . . 0.0 109.407 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.46 HG22 HG21 ' A' ' 75' ' ' THR . 26.8 m -123.39 146.62 47.83 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.163 -0.96 . . . . 0.0 109.461 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.46 HG22 ' CD1' ' A' ' 101' ' ' ILE . 3.4 t -137.5 124.23 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.202 -0.937 . . . . 0.0 109.24 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.533 ' OE1' ' CA ' ' A' ' 73' ' ' SER . 21.8 tp10 -100.99 130.85 47.05 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.25 -0.906 . . . . 0.0 110.109 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.485 ' O ' ' OG ' ' A' ' 71' ' ' SER . 0.4 OUTLIER -113.59 151.27 31.89 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.032 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.497 ' O ' ' CD2' ' A' ' 7' ' ' LEU . 2.4 pp -142.09 -177.6 5.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.816 -1.178 . . . . 0.0 110.635 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 2.5 p-10 -116.55 152.96 33.05 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -101.5 -109.01 0.23 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.815 -1.178 . . . . 0.0 109.601 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.458 ' O ' HG21 ' A' ' 36' ' ' VAL . 0.9 OUTLIER -128.98 36.58 4.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.805 -1.185 . . . . 0.0 109.412 -179.824 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.546 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 2.5 t -153.02 61.98 4.0 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.502 -0.749 . . . . 0.0 109.141 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.567 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.9 Cg_endo -80.24 175.9 9.82 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.811 2.341 . . . . 0.0 110.55 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.567 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.3 Cg_endo -85.78 159.46 59.65 Favored 'Cis proline' 0 C--N 1.31 -1.449 0 C-N-CA 123.525 -1.448 . . . . 0.0 110.483 -1.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.715 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 74.6 m-70 -116.46 141.64 47.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.472 -0.767 . . . . 0.0 109.435 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.51 126.71 53.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 109.45 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.8 t -116.37 126.27 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -0.936 . . . . 0.0 109.445 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -160.12 166.39 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.38 -0.825 . . . . 0.0 109.322 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.607 ' CE2' HD21 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -116.74 109.65 17.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 109.382 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.443 ' HB3' HD13 ' A' ' 47' ' ' LEU . 30.7 t0 -53.06 144.43 15.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.874 . . . . 0.0 109.682 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.57 19.21 3.47 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.183 -0.948 . . . . 0.0 109.479 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -121.31 -30.31 4.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.083 -1.011 . . . . 0.0 109.724 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.443 HD13 ' HB3' ' A' ' 44' ' ' ASP . 6.2 mp -96.33 61.16 2.0 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.037 -1.039 . . . . 0.0 109.518 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.481 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 10.2 p30 -141.6 162.51 46.45 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.286 -0.884 . . . . 0.0 109.49 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 33.5 Cg_endo -75.6 -16.54 18.86 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.446 2.098 . . . . 0.0 109.904 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 52' ' ' SER . . . -133.54 68.55 1.49 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -40.37 92.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.607 -0.683 . . . . 0.0 109.987 -179.519 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 50' ' ' ALA . 19.5 m -140.71 -159.21 0.93 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.341 -0.849 . . . . 0.0 109.191 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -155.81 56.95 0.61 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.245 -0.909 . . . . 0.0 109.535 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -138.78 -60.99 0.58 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.219 -0.925 . . . . 0.0 109.378 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.466 ' HG ' ' N ' ' A' ' 56' ' ' ALA . 1.6 pp -54.28 -28.16 40.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.93 . . . . 0.0 109.044 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.466 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -72.41 -39.3 68.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.324 -0.86 . . . . 0.0 109.243 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 56' ' ' ALA . 65.9 tttt -44.3 -45.8 8.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.316 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -98.01 25.45 6.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.292 -0.88 . . . . 0.0 109.421 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.607 HD21 ' CE2' ' A' ' 43' ' ' PHE . 8.2 tp -127.0 -54.88 1.38 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.869 . . . . 0.0 109.267 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.49 147.24 33.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.307 -0.871 . . . . 0.0 110.082 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -122.18 174.81 6.73 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -125.06 -160.2 0.94 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.196 -0.94 . . . . 0.0 109.226 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 65.87 135.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.202 -0.936 . . . . 0.0 109.802 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.6 mt -64.76 158.63 24.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.392 -0.818 . . . . 0.0 109.576 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.547 ' CD2' ' HB2' ' A' ' 39' ' ' HIS . 3.5 mp -79.31 87.26 5.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.079 -1.013 . . . . 0.0 109.155 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -83.32 4.59 26.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 109.759 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.467 ' HB3' ' O ' ' A' ' 70' ' ' GLN . 12.0 t -102.81 115.79 63.65 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.144 -0.973 . . . . 0.0 109.009 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.467 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.4 Cg_endo -78.51 95.23 1.07 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.4 2.067 . . . . 0.0 111.004 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.504 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 127.45 -17.12 6.2 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.595 -1.288 . . . . 0.0 110.125 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.475 ' HA ' ' CB ' ' A' ' 32' ' ' LEU . 8.0 pt20 -149.99 149.69 30.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.111 -1.229 . . . . 0.0 109.602 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.537 ' OG ' ' N ' ' A' ' 72' ' ' THR . 81.1 p -120.01 -78.46 0.59 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.122 -0.986 . . . . 0.0 109.5 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.537 ' N ' ' OG ' ' A' ' 71' ' ' SER . 22.8 m -160.14 119.0 2.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.327 -0.858 . . . . 0.0 109.424 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.533 ' CA ' ' OE1' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -79.53 99.75 7.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.0 109.228 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.527 ' CG2' ' CD1' ' A' ' 59' ' ' LEU . 26.3 m -82.54 108.4 15.91 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.337 -0.852 . . . . 0.0 109.665 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.46 HG21 HG22 ' A' ' 28' ' ' THR . 0.0 OUTLIER -79.36 85.77 5.15 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.476 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.583 ' CE2' HD23 ' A' ' 59' ' ' LEU . 23.7 m-85 -40.45 137.02 1.37 Allowed Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.486 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 35.3 Cg_endo -77.74 174.49 12.52 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.605 2.203 . . . . 0.0 111.719 -178.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.29 4.03 11.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.583 -0.698 . . . . 0.0 109.211 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.466 ' O ' ' C ' ' A' ' 80' ' ' ALA . 0.5 OUTLIER -98.13 -10.77 23.66 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.24 -0.912 . . . . 0.0 108.591 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.47 ' HB2' ' OH ' ' A' ' 85' ' ' TYR . . . -39.95 110.88 0.68 Allowed Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -75.19 130.97 13.57 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.263 1.975 . . . . 0.0 110.68 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -56.42 162.03 2.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.463 -0.773 . . . . 0.0 109.374 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 125.92 -117.78 2.97 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -160.51 122.5 3.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -1.152 . . . . 0.0 109.718 -179.792 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.632 ' CD2' ' CG2' ' A' ' 101' ' ' ILE . 4.1 m-30 -85.88 -165.43 1.24 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.14 -0.975 . . . . 0.0 108.726 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.442 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 20.7 m -165.18 101.23 0.74 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.839 -1.163 . . . . 0.0 110.678 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.497 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -107.18 165.9 11.03 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.517 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 3.9 p90 -157.07 -171.41 3.63 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.823 -1.173 . . . . 0.0 110.442 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.58 143.76 47.46 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.56 -0.713 . . . . 0.0 109.332 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.617 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 31.5 tt0 -77.6 -45.14 2.54 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.323 -0.861 . . . . 0.0 109.846 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.3 Cg_endo -79.53 -65.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 122.008 1.805 . . . . 0.0 110.197 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.715 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 3.3 m80 -73.39 63.25 0.76 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 109.375 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.1 tpp85 -90.42 -26.91 19.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.332 -0.855 . . . . 0.0 109.174 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -95.33 35.53 4.24 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 14' ' ' LEU . . . -135.73 34.42 2.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -1.145 . . . . 0.0 109.573 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 48.45 25.44 4.45 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.502 ' HE1' ' N ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -78.53 54.42 1.46 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.066 -1.255 . . . . 0.0 109.354 179.742 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.1 t -125.74 104.24 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.442 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.93 174.76 22.69 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.442 ' HG2' ' HA ' ' A' ' 86' ' ' THR . 11.2 mttm -150.56 131.41 14.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -1.144 . . . . 0.0 109.788 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.632 ' CG2' ' CD2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -83.29 126.58 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 21' ' ' LEU . 3.5 m -104.25 102.26 11.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.183 -0.948 . . . . 0.0 109.443 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.53 ' CG2' HD13 ' A' ' 23' ' ' ILE . 2.4 t -99.76 92.95 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.185 -0.947 . . . . 0.0 109.466 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.923 . . . . 0.0 109.561 -179.977 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 19.0 m-85 -112.3 150.51 30.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.237 -0.914 . . . . 0.0 109.536 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.407 HG21 ' HB3' ' A' ' 30' ' ' GLU . 45.3 m -145.58 114.06 6.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.894 . . . . 0.0 109.413 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.461 ' O ' HD23 ' A' ' 7' ' ' LEU . 4.4 m -91.77 80.99 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.187 -0.946 . . . . 0.0 109.58 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 5' ' ' VAL . 9.3 mtmt -44.26 110.51 0.22 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.157 -0.964 . . . . 0.0 109.393 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.534 ' CG ' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -91.14 83.94 5.62 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.224 -0.923 . . . . 0.0 109.362 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 14' ' ' LEU . . . 144.3 102.6 0.39 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.51 ' OG ' ' N ' ' A' ' 10' ' ' ASP . 89.8 p -50.47 -82.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -1.13 . . . . 0.0 109.492 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.51 ' N ' ' OG ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -176.88 -93.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.227 -0.921 . . . . 0.0 109.508 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -100.06 54.28 0.91 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.14 -0.975 . . . . 0.0 109.625 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.59 -82.38 0.04 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.6 tp -144.89 -159.32 0.98 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.395 -1.062 . . . . 0.0 109.134 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.529 ' CD1' ' HB ' ' A' ' 36' ' ' VAL . 49.8 mt -119.58 124.16 45.68 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.164 -0.96 . . . . 0.0 109.425 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 14' ' ' LEU . 25.6 m -156.63 155.44 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.869 . . . . 0.0 109.338 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 7' ' ' LEU . 6.2 m-85 -68.45 156.57 37.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.224 -0.922 . . . . 0.0 109.674 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 16.1 mt-10 -157.39 101.07 1.88 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.462 -0.774 . . . . 0.0 109.243 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 35.3 Cg_endo -77.9 179.8 29.71 Favored 'Cis proline' 0 C--N 1.311 -1.42 0 C-N-CA 123.67 -1.388 . . . . 0.0 110.584 0.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.17 -54.69 3.61 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.267 -0.896 . . . . 0.0 109.413 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.08 153.77 24.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -0.877 . . . . 0.0 109.495 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.465 HD21 ' CG2' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -158.48 108.12 2.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.091 -1.006 . . . . 0.0 110.046 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.408 HG21 ' O ' ' A' ' 102' ' ' THR . 54.9 m -91.14 102.82 15.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 108.836 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 1.0 OUTLIER -103.24 -179.72 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.256 -0.903 . . . . 0.0 110.49 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.583 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 5.3 mttm -94.5 -175.81 0.51 Allowed Pre-proline 0 N--CA 1.488 1.443 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 33.6 Cg_endo -78.48 76.52 4.41 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.002 1.801 . . . . 0.0 110.607 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 121.23 43.99 0.41 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.473 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 5.0 m-20 -94.11 -178.06 4.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.253 -1.145 . . . . 0.0 108.876 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.9 m -117.7 126.1 51.87 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.203 -0.936 . . . . 0.0 109.534 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.554 ' HB ' ' CZ ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER -119.44 134.14 63.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.284 -0.885 . . . . 0.0 109.398 -179.832 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.407 ' HB3' HG21 ' A' ' 4' ' ' THR . 4.6 tt0 -105.69 141.24 37.48 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.231 -0.918 . . . . 0.0 109.813 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.561 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -134.19 96.57 3.65 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.613 ' HA ' ' HB3' ' A' ' 71' ' ' SER . 0.5 OUTLIER -98.59 168.81 9.94 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.283 -0.886 . . . . 0.0 110.491 -178.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.538 ' HB2' ' CD2' ' A' ' 39' ' ' HIS . 3.5 p-10 -94.66 153.72 17.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.547 -0.721 . . . . 0.0 109.572 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.454 ' HB2' ' HA3' ' A' ' 8' ' ' GLY . 38.5 t30 -97.1 -129.63 0.17 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.027 -1.045 . . . . 0.0 108.915 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.443 ' O ' HG21 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -108.86 36.55 2.83 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.757 -1.214 . . . . 0.0 109.364 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.529 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 4.3 t -154.96 67.89 5.35 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 109.421 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.544 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.5 Cg_endo -80.41 173.95 11.82 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.6 2.2 . . . . 0.0 110.788 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.544 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 39.1 Cg_endo -85.83 165.06 54.78 Favored 'Cis proline' 0 C--N 1.312 -1.378 0 C-N-CA 123.494 -1.461 . . . . 0.0 110.305 -1.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.709 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 57.4 m-70 -119.58 140.24 50.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.934 . . . . 0.0 109.762 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.472 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 1.3 t-20 -121.92 125.96 47.55 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.356 -0.84 . . . . 0.0 109.544 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.457 ' C ' ' CG2' ' A' ' 42' ' ' VAL . 24.8 t -114.13 134.22 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.92 . . . . 0.0 109.17 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.513 ' HA ' ' HB3' ' A' ' 60' ' ' SER . 0.2 OUTLIER -156.84 166.82 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.071 -1.018 . . . . 0.0 109.855 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.517 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 4.5 m-85 -119.39 112.04 18.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.836 . . . . 0.0 109.183 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.476 ' HB3' ' HB2' ' A' ' 47' ' ' LEU . 7.5 t70 -43.74 143.21 1.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.305 -0.872 . . . . 0.0 109.733 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.459 ' HB1' ' HB2' ' A' ' 53' ' ' ALA . . . -90.54 -3.43 57.6 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.39 -0.819 . . . . 0.0 109.737 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.36 9.56 21.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.621 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 0.5 OUTLIER -122.29 39.35 3.92 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.135 -0.978 . . . . 0.0 109.735 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.523 ' OD1' ' CA ' ' A' ' 51' ' ' LYS . 0.6 OUTLIER -112.31 165.3 13.28 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 109.419 179.756 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 35.0 Cg_endo -76.59 -10.06 18.63 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.606 2.204 . . . . 0.0 110.826 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -125.0 26.18 7.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.11 -0.994 . . . . 0.0 109.493 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.523 ' CA ' ' OD1' ' A' ' 48' ' ' ASN . 0.6 OUTLIER 34.28 35.58 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.134 0.492 . . . . 0.0 110.325 179.66 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 50' ' ' ALA . 19.1 m -110.85 164.03 13.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.151 -0.968 . . . . 0.0 109.74 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.459 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . . . -132.51 45.8 2.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.305 -0.872 . . . . 0.0 109.295 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.41 ' C ' ' OD1' ' A' ' 54' ' ' ASP . 7.5 t0 -111.94 -56.4 2.39 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.311 -0.868 . . . . 0.0 109.58 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 3.3 pp -55.34 -29.87 59.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.917 . . . . 0.0 109.556 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.11 -43.5 78.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.62 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -57.7 -39.82 78.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.367 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.4 m -87.84 16.36 5.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.227 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.502 HD23 ' CE2' ' A' ' 43' ' ' PHE . 9.7 tp -122.93 -45.25 2.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.346 -0.846 . . . . 0.0 109.375 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.513 ' HB3' ' HA ' ' A' ' 42' ' ' VAL . 37.0 p -82.16 159.35 23.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.491 -0.756 . . . . 0.0 110.247 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -110.38 174.53 5.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.563 -0.711 . . . . 0.0 109.496 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -121.25 -163.07 1.01 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.367 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 59.19 -165.82 0.18 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.916 . . . . 0.0 109.386 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.462 ' HB3' ' HB2' ' A' ' 38' ' ' PRO . 4.5 mp -128.55 165.08 21.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 109.327 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.53 ' N ' ' CD1' ' A' ' 65' ' ' LEU . 7.4 mp -103.05 107.35 18.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.179 -0.95 . . . . 0.0 109.48 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -98.19 -18.83 18.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 0.0 109.443 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.498 ' OG ' ' HB2' ' A' ' 70' ' ' GLN . 46.0 t -85.67 142.91 37.53 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.915 . . . . 0.0 109.24 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 67' ' ' SER . 36.6 Cg_endo -79.14 107.06 2.15 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.81 2.34 . . . . 0.0 111.3 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.437 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 93.61 -18.35 56.65 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.498 ' HB2' ' OG ' ' A' ' 67' ' ' SER . 0.0 OUTLIER -80.2 103.15 9.88 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.063 -1.257 . . . . 0.0 109.266 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.613 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -124.62 -168.87 1.88 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.378 -0.826 . . . . 0.0 110.22 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.456 ' CG2' ' O ' ' A' ' 72' ' ' THR . 9.0 t -122.01 110.33 15.69 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.7 p -78.44 111.22 14.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 108.932 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.481 HG21 ' HA ' ' A' ' 59' ' ' LEU . 1.7 m -88.03 108.96 19.48 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.475 -0.766 . . . . 0.0 109.846 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.517 ' CG2' ' O ' ' A' ' 75' ' ' THR . 10.2 t -78.86 94.73 5.24 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.58 ' CE2' HD12 ' A' ' 101' ' ' ILE . 4.5 m-30 -39.79 160.03 0.11 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.698 -0.626 . . . . 0.0 109.693 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.503 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 33.8 Cg_endo -75.51 163.83 33.5 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.749 2.299 . . . . 0.0 111.417 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.31 1.65 7.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.379 -0.825 . . . . 0.0 110.294 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.495 ' O ' ' O ' ' A' ' 80' ' ' ALA . 0.7 OUTLIER -98.85 -61.41 1.37 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.005 -1.059 . . . . 0.0 109.065 179.766 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 79' ' ' ASP . . . 42.88 94.7 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.447 -0.783 . . . . 0.0 109.679 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.473 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 34.3 Cg_endo -75.7 121.64 6.43 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.312 2.008 . . . . 0.0 110.155 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 81' ' ' PRO . . . -42.58 133.49 3.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.47 -0.769 . . . . 0.0 109.612 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 85' ' ' TYR . . . 160.57 158.29 9.18 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.38 125.45 29.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.196 -1.179 . . . . 0.0 109.747 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.571 ' O ' ' CD2' ' A' ' 87' ' ' PHE . 9.6 m-85 -100.71 70.76 1.44 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.451 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 57.0 m -62.83 97.53 0.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.42 -0.8 . . . . 0.0 110.464 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.571 ' CD2' ' O ' ' A' ' 85' ' ' TYR . 1.5 p90 -99.91 162.97 12.66 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.154 -0.966 . . . . 0.0 108.635 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -149.99 -173.97 4.58 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.98 -1.075 . . . . 0.0 109.954 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 0.1 OUTLIER -116.34 132.27 56.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.503 -0.748 . . . . 0.0 109.562 -179.651 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.612 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 25.8 tt0 -65.92 -45.0 63.97 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.207 -0.933 . . . . 0.0 109.975 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.5 Cg_endo -79.23 -45.37 0.11 Allowed 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 121.93 1.753 . . . . 0.0 110.18 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.709 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 4.7 m80 -106.84 67.25 0.7 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 109.316 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.74 133.99 37.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 109.521 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 82.27 -4.99 74.48 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 14' ' ' LEU . . . -93.43 39.08 1.05 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.213 -1.169 . . . . 0.0 109.503 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.427 ' HA3' HG11 ' A' ' 15' ' ' VAL . . . 79.84 -3.88 67.99 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.528 ' CE ' ' HB2' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -86.59 47.17 1.44 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.178 -1.189 . . . . 0.0 109.34 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.5 t -124.23 76.15 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 0.0 109.498 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.542 ' C ' ' CE1' ' A' ' 87' ' ' PHE . . . -96.92 162.94 22.17 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.451 ' HG2' ' HA ' ' A' ' 86' ' ' THR . 15.0 mtmt -139.38 135.15 33.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -1.138 . . . . 0.0 109.199 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.58 HD12 ' CE2' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -84.01 139.08 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.169 -0.957 . . . . 0.0 109.462 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.408 ' O ' HG21 ' A' ' 22' ' ' THR . 0.1 OUTLIER -112.58 99.43 7.95 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.356 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.539 ' CG1' ' HA ' ' A' ' 25' ' ' PRO . 21.8 t -99.01 95.46 4.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.196 -0.94 . . . . 0.0 110.014 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.488 0 O-C-N 121.52 -0.737 . . . . 0.0 109.329 179.854 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.378 0.609 . . . . 0.0 109.832 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.561 ' CD1' HG23 ' A' ' 23' ' ' ILE . 10.6 m-85 -126.13 170.9 11.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.329 -0.857 . . . . 0.0 108.871 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 30' ' ' GLU . 87.1 m -157.46 116.94 3.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.07 -1.018 . . . . 0.0 110.167 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.493 ' CG1' ' CD1' ' A' ' 21' ' ' LEU . 10.4 m -98.57 170.78 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 121.345 -0.847 . . . . 0.0 109.032 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -143.56 87.2 1.92 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.06 -1.025 . . . . 0.0 109.874 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.526 ' HB2' ' CE ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -50.86 100.12 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.183 -0.948 . . . . 0.0 109.254 179.63 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 14' ' ' LEU . . . 129.1 98.87 0.9 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 2.3 p -48.0 -95.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -1.161 . . . . 0.0 109.371 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 9' ' ' SER . 48.5 t0 176.86 33.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.946 . . . . 0.0 109.508 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.08 -43.05 0.64 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.159 -0.963 . . . . 0.0 109.603 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.13 44.29 0.02 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.6 mt -151.32 160.94 43.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -1.141 . . . . 0.0 109.458 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.57 HD23 ' CE1' ' A' ' 39' ' ' HIS . 12.9 mt -120.48 103.21 8.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.308 -0.87 . . . . 0.0 109.501 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.421 HG13 ' HA3' ' A' ' 96' ' ' GLY . 26.7 m -149.8 138.6 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.718 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -56.49 153.73 9.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.15 -0.969 . . . . 0.0 108.85 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 4.6 mm-40 -143.51 103.61 5.02 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 120.995 -1.066 . . . . 0.0 109.81 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.463 ' HD2' HD11 ' A' ' 21' ' ' LEU . 35.6 Cg_endo -79.29 178.54 33.46 Favored 'Cis proline' 0 C--N 1.314 -1.286 0 C-N-CA 123.796 -1.335 . . . . 0.0 110.452 -0.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.03 -51.42 18.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.223 -0.923 . . . . 0.0 109.255 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? -99.15 146.45 26.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 0.0 109.237 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.493 ' CD1' ' CG1' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -140.46 142.36 35.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.113 -0.992 . . . . 0.0 109.826 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.429 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 32.1 m -106.52 126.22 51.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.344 -0.847 . . . . 0.0 109.096 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.561 HG23 ' CD1' ' A' ' 3' ' ' TYR . 1.0 OUTLIER -136.76 174.94 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.138 -0.976 . . . . 0.0 109.969 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.501 ' CB ' ' OD1' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -96.6 173.15 4.37 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.531 ' HA ' ' CB ' ' A' ' 80' ' ' ALA . 35.2 Cg_endo -77.58 91.66 1.17 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.346 2.03 . . . . 0.0 110.39 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 123.27 -11.35 8.6 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.501 ' OD1' ' CB ' ' A' ' 24' ' ' LYS . 5.8 m-20 -55.81 -178.69 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.287 -1.125 . . . . 0.0 109.096 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 97.3 m -124.09 140.99 52.44 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.205 -0.934 . . . . 0.0 109.43 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.478 HG21 HD13 ' A' ' 101' ' ' ILE . 1.3 t -130.93 119.28 44.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.278 -0.889 . . . . 0.0 109.364 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 4' ' ' THR . 30.9 tt0 -99.51 135.88 40.26 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.263 -0.898 . . . . 0.0 109.514 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.489 ' O ' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -127.28 152.0 48.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.126 -0.984 . . . . 0.0 108.856 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.542 ' HB3' ' N ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -140.49 -170.07 2.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.018 -1.052 . . . . 0.0 109.772 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 8.6 p-10 -114.05 169.81 8.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.429 -0.795 . . . . 0.0 109.002 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -110.02 -95.49 0.41 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.078 -1.014 . . . . 0.0 109.517 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.455 ' O ' HG21 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -143.05 33.14 1.36 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.009 -1.057 . . . . 0.0 109.376 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.552 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 37.6 t -151.49 59.58 3.32 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.519 -0.738 . . . . 0.0 109.063 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.552 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 36.4 Cg_endo -77.66 173.43 14.16 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.744 2.296 . . . . 0.0 110.943 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.58 ' O ' ' CG ' ' A' ' 39' ' ' HIS . 37.5 Cg_endo -82.42 -158.57 1.69 Allowed 'Cis proline' 0 C--N 1.31 -1.467 0 C-N-CA 123.292 -1.545 . . . . 0.0 110.175 -0.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.58 ' CG ' ' O ' ' A' ' 38' ' ' PRO . 86.9 m-70 -160.85 129.52 4.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.238 -0.914 . . . . 0.0 109.431 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.07 106.04 17.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.208 -0.933 . . . . 0.0 109.379 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.422 ' N ' ' NE2' ' A' ' 61' ' ' HIS . 41.2 t -99.7 120.64 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.098 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.538 ' CG1' ' HB2' ' A' ' 60' ' ' SER . 0.8 OUTLIER -159.5 158.01 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.146 -0.972 . . . . 0.0 109.899 -179.521 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.652 ' CE2' ' CG ' ' A' ' 59' ' ' LEU . 3.4 m-85 -94.9 116.35 28.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.396 -0.815 . . . . 0.0 109.498 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -52.9 130.09 32.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.357 -0.839 . . . . 0.0 109.709 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.97 -1.9 53.7 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.214 -0.929 . . . . 0.0 109.605 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.68 12.99 34.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.156 -0.965 . . . . 0.0 109.609 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.1 mt -139.84 52.81 1.69 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.178 -0.951 . . . . 0.0 109.45 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -105.07 164.36 15.29 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.935 . . . . 0.0 109.504 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 35.1 Cg_endo -78.12 -20.63 11.28 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.675 2.25 . . . . 0.0 110.956 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.486 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -126.32 26.32 6.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.041 -1.037 . . . . 0.0 109.919 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.495 ' HA ' ' OD1' ' A' ' 48' ' ' ASN . 15.6 mmtt 34.53 36.79 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.16 0.505 . . . . 0.0 110.284 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 50' ' ' ALA . 41.0 m -99.75 -162.32 0.94 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.206 -0.934 . . . . 0.0 109.584 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -166.12 80.31 0.27 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.346 -0.846 . . . . 0.0 109.268 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -155.92 -48.96 0.08 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.252 -0.905 . . . . 0.0 109.469 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 1.5 pp -62.23 -17.14 57.49 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.163 -0.961 . . . . 0.0 109.222 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.411 ' O ' ' C ' ' A' ' 57' ' ' LYS . . . -90.33 -30.43 17.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.332 -0.855 . . . . 0.0 109.539 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -43.86 -62.73 1.02 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.913 . . . . 0.0 109.503 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.9 m -94.39 49.57 1.3 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 0.0 109.417 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.652 ' CG ' ' CE2' ' A' ' 43' ' ' PHE . 7.3 tp -136.27 -60.89 0.71 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.347 -0.846 . . . . 0.0 109.34 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.538 ' HB2' ' CG1' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -77.48 152.17 34.31 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.462 -0.774 . . . . 0.0 110.159 -178.432 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.422 ' NE2' ' N ' ' A' ' 41' ' ' VAL . 27.4 p80 -97.17 -168.59 1.72 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.547 -0.721 . . . . 0.0 109.327 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.11 -46.17 0.34 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.178 -0.951 . . . . 0.0 109.391 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -65.72 132.82 49.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.2 -0.938 . . . . 0.0 109.402 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.428 HD23 ' HG2' ' A' ' 38' ' ' PRO . 5.7 mp -58.86 169.76 0.95 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.18 -0.95 . . . . 0.0 109.356 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.465 ' N ' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -115.6 127.04 54.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.19 -0.944 . . . . 0.0 109.262 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.9 mtt -120.29 9.78 11.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.266 -0.896 . . . . 0.0 109.599 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.422 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 32.3 t -94.07 138.44 22.62 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 109.322 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.443 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.5 Cg_endo -79.92 95.65 1.03 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.579 2.186 . . . . 0.0 110.62 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.463 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 99.76 48.63 1.61 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.542 ' N ' ' HB3' ' A' ' 32' ' ' LEU . 6.4 tt0 -179.22 100.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.14 -1.212 . . . . 0.0 109.334 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.572 ' OG ' ' N ' ' A' ' 72' ' ' THR . 24.1 p -103.8 -79.63 0.54 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.145 -0.972 . . . . 0.0 109.723 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.572 ' N ' ' OG ' ' A' ' 71' ' ' SER . 0.4 OUTLIER -160.72 107.95 1.53 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.925 -1.109 . . . . 0.0 109.751 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.22 99.38 7.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.047 -1.033 . . . . 0.0 108.818 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.519 HG22 ' CD1' ' A' ' 59' ' ' LEU . 6.9 m -102.97 124.99 49.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.343 -0.848 . . . . 0.0 110.047 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.462 ' O ' ' C ' ' A' ' 76' ' ' PHE . 0.8 OUTLIER -89.9 93.69 9.52 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.168 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.536 ' CE1' HD13 ' A' ' 101' ' ' ILE . 32.5 m-85 -39.95 157.15 0.15 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.475 -0.766 . . . . 0.0 109.64 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.5 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.1 Cg_endo -75.5 161.58 37.09 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.703 2.269 . . . . 0.0 111.238 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 25' ' ' PRO . . . -74.54 5.11 5.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.557 -0.715 . . . . 0.0 109.964 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.474 ' O ' ' C ' ' A' ' 80' ' ' ALA . 0.4 OUTLIER -98.6 -67.22 0.86 Allowed 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.015 -1.053 . . . . 0.0 109.202 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.531 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . . . 40.65 76.49 0.5 Allowed Pre-proline 0 N--CA 1.493 1.687 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 82' ' ' ALA . 35.3 Cg_endo -76.73 119.91 5.33 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.866 2.378 . . . . 0.0 111.697 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 81' ' ' PRO . . . 50.89 106.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.597 -0.689 . . . . 0.0 110.482 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 103' ' ' VAL . . . -49.0 103.71 0.08 OUTLIER Glycine 0 N--CA 1.48 1.626 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 49' ' ' PRO . 1.1 tp10 -160.32 53.33 0.32 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.273 -1.134 . . . . 0.0 109.744 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.564 ' CE2' HG21 ' A' ' 103' ' ' VAL . 1.1 m-85 -111.45 128.45 56.0 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.468 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 59.3 m -124.72 114.85 19.85 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.143 -0.973 . . . . 0.0 110.09 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.552 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.6 OUTLIER -99.98 164.45 11.99 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 89' ' ' CYS . 55.2 p90 -155.36 -162.37 1.33 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.013 -1.054 . . . . 0.0 109.662 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.436 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 0.1 OUTLIER -133.27 124.38 27.23 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.568 -0.707 . . . . 0.0 109.52 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.616 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 6.3 tt0 -61.47 -43.85 90.37 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.313 -0.867 . . . . 0.0 110.739 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.2 Cg_endo -79.42 -66.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 122.09 1.86 . . . . 0.0 110.729 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.56 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 10.1 m80 -75.68 55.61 0.86 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.159 -0.963 . . . . 0.0 109.256 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -82.19 109.86 16.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.34 -0.85 . . . . 0.0 109.631 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.7 -1.19 28.99 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.473 ' O ' ' O ' ' A' ' 14' ' ' LEU . . . -101.1 35.12 2.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.176 -1.191 . . . . 0.0 109.467 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.421 ' HA3' HG13 ' A' ' 15' ' ' VAL . . . 70.12 19.69 75.84 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.526 ' CE ' ' HB2' ' A' ' 7' ' ' LEU . 1.0 OUTLIER -92.04 37.25 0.98 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.082 -1.246 . . . . 0.0 109.329 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 89.4 t -125.59 110.27 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.187 -0.946 . . . . 0.0 109.686 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.552 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -118.34 173.27 14.79 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.468 ' HG2' ' HA ' ' A' ' 86' ' ' THR . 7.6 mtmm -148.15 129.8 15.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.099 -1.236 . . . . 0.0 109.823 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.536 HD13 ' CE1' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -83.49 129.02 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.286 -0.884 . . . . 0.0 108.669 179.409 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.429 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 2.8 m -99.66 95.1 6.73 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.173 -0.954 . . . . 0.0 108.988 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.564 HG21 ' CE2' ' A' ' 85' ' ' TYR . 60.1 t -98.5 99.4 8.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.464 -0.773 . . . . 0.0 109.664 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.375 -0.828 . . . . 0.0 109.587 -179.944 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 55.6 m . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.279 0.561 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -92.7 150.21 20.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 109.39 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 30' ' ' GLU . 1.4 t -157.22 135.39 11.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.215 -0.928 . . . . 0.0 109.591 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.523 ' CG1' HD12 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -109.12 102.36 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.295 -0.878 . . . . 0.0 109.37 179.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -68.43 127.66 33.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.407 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.511 ' CD2' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -97.79 177.26 5.52 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.118 -0.989 . . . . 0.0 109.09 179.53 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 9' ' ' SER . . . 59.03 86.72 0.03 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.473 ' OG ' ' N ' ' A' ' 10' ' ' ASP . 93.6 p -45.27 -88.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.301 -1.117 . . . . 0.0 109.587 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.473 ' N ' ' OG ' ' A' ' 9' ' ' SER . 6.8 t70 179.6 -47.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 109.157 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.58 30.71 5.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.332 -0.855 . . . . 0.0 109.146 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.409 ' C ' ' HG ' ' A' ' 13' ' ' LEU . . . -138.96 -108.78 0.82 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.409 ' HG ' ' C ' ' A' ' 12' ' ' GLY . 0.5 OUTLIER -130.87 -155.24 0.68 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.24 -1.153 . . . . 0.0 109.61 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.442 ' HB3' ' HE1' ' A' ' 97' ' ' MET . 5.3 mt -107.7 118.12 35.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.298 -0.876 . . . . 0.0 109.38 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 95' ' ' ALA . 2.4 m -146.07 159.25 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.528 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -82.05 138.26 34.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.319 -0.863 . . . . 0.0 109.248 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 83.3 mt-10 -126.17 111.86 23.96 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 109.368 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.448 ' HG2' ' HG ' ' A' ' 21' ' ' LEU . 35.2 Cg_endo -78.88 -178.2 23.17 Favored 'Cis proline' 0 C--N 1.311 -1.429 0 C-N-CA 123.841 -1.316 . . . . 0.0 110.517 -0.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.61 -59.27 2.93 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.315 -0.865 . . . . 0.0 109.086 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.28 160.71 14.08 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.355 -0.84 . . . . 0.0 108.861 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.523 HD12 ' CG1' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -155.24 121.02 5.07 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.961 -1.087 . . . . 0.0 110.314 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.461 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 34.0 m -92.81 107.64 19.38 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.541 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -105.74 171.44 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.19 -0.944 . . . . 0.0 110.42 -178.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.48 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -89.58 171.34 8.94 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.017 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 34.7 Cg_endo -76.6 79.39 3.04 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.219 1.946 . . . . 0.0 110.728 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 136.91 -22.6 3.27 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.394 -1.384 . . . . 0.0 110.424 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 26' ' ' GLY . 16.4 m-20 -46.66 172.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.031 -1.276 . . . . 0.0 109.533 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.461 HG21 ' OG1' ' A' ' 75' ' ' THR . 1.3 m -115.96 119.6 36.44 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.337 -0.852 . . . . 0.0 109.406 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.549 HG22 ' CD1' ' A' ' 76' ' ' PHE . 2.5 t -99.48 132.31 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 121.222 -0.924 . . . . 0.0 109.518 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 4' ' ' THR . 10.6 tt0 -113.47 142.68 45.63 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.197 -0.939 . . . . 0.0 109.53 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.589 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -138.55 95.02 2.91 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.55 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 1.1 pp -98.77 160.4 14.3 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.228 -0.92 . . . . 0.0 110.456 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.49 ' HA ' ' CD1' ' A' ' 7' ' ' LEU . 2.3 p-10 -79.0 -173.82 3.75 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.629 -0.67 . . . . 0.0 109.271 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.47 ' ND2' ' HG2' ' A' ' 35' ' ' LYS . 25.3 t30 -134.73 -93.27 0.3 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.138 -0.976 . . . . 0.0 109.291 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.47 ' HG2' ' ND2' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -138.45 36.17 2.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.1 -1.0 . . . . 0.0 109.412 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.548 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -157.11 61.11 2.29 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.44 -0.788 . . . . 0.0 109.011 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.548 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 36.0 Cg_endo -79.42 173.39 13.23 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.632 2.221 . . . . 0.0 111.007 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.581 ' O ' ' CD2' ' A' ' 39' ' ' HIS . 37.9 Cg_endo -84.47 -157.1 1.26 Allowed 'Cis proline' 0 C--N 1.31 -1.482 0 C-N-CA 123.298 -1.543 . . . . 0.0 110.163 -1.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.581 ' CD2' ' O ' ' A' ' 38' ' ' PRO . 81.6 m-70 -161.46 142.46 11.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.46 -0.775 . . . . 0.0 109.754 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -116.63 123.47 47.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 109.31 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.428 ' C ' ' CG2' ' A' ' 42' ' ' VAL . 70.4 t -110.17 128.55 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.326 -0.859 . . . . 0.0 109.425 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 87' ' ' PHE . 1.2 t -151.64 178.1 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.931 . . . . 0.0 109.489 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.58 ' CE2' HD22 ' A' ' 59' ' ' LEU . 12.1 m-85 -130.14 121.47 26.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.235 -0.915 . . . . 0.0 109.533 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.455 ' O ' ' O ' ' A' ' 43' ' ' PHE . 8.5 t0 -50.77 -177.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.355 -0.84 . . . . 0.0 109.455 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.84 14.3 2.9 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.247 -0.908 . . . . 0.0 109.501 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.71 15.37 2.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.899 . . . . 0.0 109.607 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 mp -117.29 35.72 4.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.101 -1.0 . . . . 0.0 109.601 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.531 ' OD1' ' CA ' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -130.13 156.39 79.33 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.319 -0.863 . . . . 0.0 109.071 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.545 ' HG2' ' CB ' ' A' ' 82' ' ' ALA . 35.5 Cg_endo -77.93 2.67 7.69 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.611 2.207 . . . . 0.0 111.145 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.505 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -140.2 29.64 2.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.88 -1.138 . . . . 0.0 110.103 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.531 ' CA ' ' OD1' ' A' ' 48' ' ' ASN . 0.3 OUTLIER 30.54 96.35 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 121.234 0.54 . . . . 0.0 110.577 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.517 ' N ' ' OD1' ' A' ' 48' ' ' ASN . 1.7 m -99.23 -177.68 3.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.008 -1.057 . . . . 0.0 109.904 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 170.59 -33.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.434 -0.791 . . . . 0.0 109.21 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -89.15 -17.63 28.8 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.332 -0.855 . . . . 0.0 109.51 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.483 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 0.7 OUTLIER -106.26 -28.17 10.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.121 -0.987 . . . . 0.0 109.508 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.471 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -87.45 -7.07 58.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.339 -0.851 . . . . 0.0 109.85 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -79.72 -49.77 11.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.155 -0.966 . . . . 0.0 109.347 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 t -82.53 -22.06 35.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 109.559 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.58 HD22 ' CE2' ' A' ' 43' ' ' PHE . 9.1 tp -53.0 -32.25 45.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.937 . . . . 0.0 108.83 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.495 ' HB3' ' HA ' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -78.8 127.92 32.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.336 -0.852 . . . . 0.0 109.74 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.518 ' ND1' ' N ' ' A' ' 62' ' ' LYS . 9.7 p80 -73.38 -28.58 62.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.149 -0.969 . . . . 0.0 109.048 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 1.3 mtpt 56.65 118.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.497 -0.752 . . . . 0.0 110.011 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.52 ' CB ' ' O ' ' A' ' 62' ' ' LYS . 0.5 OUTLIER 160.46 169.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.466 -0.771 . . . . 0.0 109.438 179.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 mp -102.68 123.56 46.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.172 -0.955 . . . . 0.0 109.218 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 70' ' ' GLN . 9.1 mp -84.47 81.9 8.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.581 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.43 ' HE1' ' HB3' ' A' ' 66' ' ' MET . 30.9 mtp -93.98 2.69 56.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.164 -0.96 . . . . 0.0 109.822 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.484 ' OG ' ' HD2' ' A' ' 68' ' ' PRO . 1.0 OUTLIER -115.81 152.42 47.41 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.121 -0.987 . . . . 0.0 109.089 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.484 ' HD2' ' OG ' ' A' ' 67' ' ' SER . 33.8 Cg_endo -76.13 102.18 1.58 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.407 2.071 . . . . 0.0 110.151 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.98 -26.31 14.28 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.486 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.5 108.73 0.19 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.277 -1.131 . . . . 0.0 108.991 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.55 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . 5.2 p -140.42 -159.57 0.97 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.097 -1.002 . . . . 0.0 110.083 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.502 ' CG2' ' HB3' ' A' ' 61' ' ' HIS . 4.2 m -157.06 112.39 2.84 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.5 p -79.41 76.2 5.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.121 -0.987 . . . . 0.0 109.293 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.543 ' CG2' HD11 ' A' ' 59' ' ' LEU . 60.9 m -51.1 111.0 0.49 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.538 -0.726 . . . . 0.0 109.939 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.461 ' OG1' HG21 ' A' ' 28' ' ' THR . 96.0 m -80.39 92.25 5.8 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.339 -0.85 . . . . 0.0 109.047 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.572 ' CE2' HD11 ' A' ' 101' ' ' ILE . 11.6 m-85 -44.74 165.11 0.16 Allowed Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.374 -0.829 . . . . 0.0 109.399 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 76' ' ' PHE . 32.6 Cg_endo -75.64 155.38 40.01 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.552 2.168 . . . . 0.0 111.362 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.26 -6.5 24.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.61 -0.681 . . . . 0.0 109.801 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -99.96 -66.31 0.91 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.2 -0.937 . . . . 0.0 109.2 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.481 ' O ' HG13 ' A' ' 103' ' ' VAL . . . 42.59 65.75 4.88 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.407 -0.808 . . . . 0.0 109.59 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.465 ' O ' ' HB2' ' A' ' 82' ' ' ALA . 33.5 Cg_endo -76.27 -159.81 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.374 2.049 . . . . 0.0 109.907 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.545 ' CB ' ' HG2' ' A' ' 49' ' ' PRO . . . 69.62 -84.84 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.076 -1.015 . . . . 0.0 109.189 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.424 ' HA2' ' C ' ' A' ' 103' ' ' VAL . . . 116.22 19.64 5.43 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -160.02 96.67 1.23 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.153 -1.204 . . . . 0.0 110.243 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.526 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 5.5 m-85 -111.85 125.46 54.04 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.401 ' OG1' ' HG2' ' A' ' 100' ' ' LYS . 24.3 m -112.69 118.3 34.64 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.0 -1.063 . . . . 0.0 110.946 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.556 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.7 OUTLIER -103.77 175.17 5.57 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.272 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -160.53 -177.61 6.32 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.662 -1.273 . . . . 0.0 110.427 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.0 137.08 54.82 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -77.24 -46.98 2.65 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.888 . . . . 0.0 110.905 -179.49 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 33.3 Cg_endo -77.49 -47.83 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.331 2.02 . . . . 0.0 112.145 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.597 ' CE1' ' HG2' ' A' ' 91' ' ' PRO . 3.3 m80 -101.32 65.42 1.06 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.736 -1.227 . . . . 0.0 110.142 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -90.12 4.83 49.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 109.163 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.31 -14.73 23.38 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.483 ' O ' HG12 ' A' ' 15' ' ' VAL . . . -95.91 35.01 1.45 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -1.162 . . . . 0.0 109.181 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 98' ' ' VAL . . . 48.93 27.29 6.45 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.453 ' SD ' ' HB2' ' A' ' 92' ' ' HIS . 4.1 mtp -68.39 60.73 0.09 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.976 -1.308 . . . . 0.0 109.138 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.463 ' N ' ' O ' ' A' ' 96' ' ' GLY . 96.7 t -139.14 110.18 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.88 . . . . 0.0 109.761 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.556 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -103.69 -171.55 25.59 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 18.2 mttt -155.1 123.63 6.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.162 -1.199 . . . . 0.0 109.758 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.572 HD11 ' CE2' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -90.97 124.43 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.233 -0.917 . . . . 0.0 108.795 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.461 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 18.2 m -105.26 97.65 7.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.252 -0.905 . . . . 0.0 108.856 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 80' ' ' ALA . 4.0 t -99.8 73.37 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.013 -1.055 . . . . 0.0 109.512 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.893 . . . . 0.0 109.526 179.967 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.4 m . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.442 ' HB2' HG12 ' A' ' 29' ' ' VAL . 58.8 m-85 -105.77 130.82 53.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -0.893 . . . . 0.0 109.328 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.442 ' O ' ' CG2' ' A' ' 4' ' ' THR . 10.1 t -127.61 108.76 11.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.714 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.5 m -92.83 159.5 2.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.23 -0.919 . . . . 0.0 109.537 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.407 ' HG2' HD12 ' A' ' 32' ' ' LEU . 25.4 mttt -128.26 84.26 2.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.426 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.544 ' HB2' ' CE ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -45.15 100.7 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.25 -0.906 . . . . 0.0 109.536 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 14' ' ' LEU . . . 104.46 114.22 3.93 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 1.8 p -76.21 -81.3 0.08 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -1.121 . . . . 0.0 109.254 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 9' ' ' SER . 7.5 t70 167.83 -30.19 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.335 -0.853 . . . . 0.0 109.483 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . 0.417 ' HB2' ' HE2' ' A' ' 11' ' ' LYS . 3.3 ttmm -114.85 -14.9 11.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 109.588 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.68 -85.92 1.77 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -164.34 -148.73 0.12 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -1.135 . . . . 0.0 109.296 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.545 HD13 ' CD2' ' A' ' 92' ' ' HIS . 83.9 mt -106.11 94.92 5.43 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.257 -0.902 . . . . 0.0 109.432 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.459 HG11 ' O ' ' A' ' 14' ' ' LEU . 3.5 m -144.57 155.41 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.199 -0.938 . . . . 0.0 109.591 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -70.06 142.99 52.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 109.764 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 2.8 mt-10 -134.44 105.18 11.03 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.235 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.476 ' HG2' HD23 ' A' ' 21' ' ' LEU . 33.9 Cg_endo -76.34 -175.71 17.06 Favored 'Cis proline' 0 C--N 1.311 -1.403 0 C-N-CA 123.664 -1.39 . . . . 0.0 110.639 0.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.29 -9.61 54.52 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.242 -0.911 . . . . 0.0 109.89 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.469 ' O ' HD23 ' A' ' 21' ' ' LEU . 30.2 mtmt -139.02 137.34 36.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.095 -1.003 . . . . 0.0 109.492 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.476 ' N ' HD22 ' A' ' 21' ' ' LEU . 4.6 mm? -123.54 127.77 48.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.33 -0.856 . . . . 0.0 109.887 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.4 m -99.67 97.98 8.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 108.705 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.53 ' CD1' HG23 ' A' ' 103' ' ' VAL . 1.1 pt -104.16 -175.87 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.227 -0.92 . . . . 0.0 110.4 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.545 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -113.85 179.72 0.74 Allowed Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.075 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 34.1 Cg_endo -76.93 76.47 4.12 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.009 1.806 . . . . 0.0 110.571 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 134.31 -2.02 4.18 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.5 -1.334 . . . . 0.0 110.101 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.91 -170.86 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.092 -1.24 . . . . 0.0 109.249 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.4 HG23 ' HA ' ' A' ' 75' ' ' THR . 52.2 m -137.85 112.93 9.16 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.135 -0.978 . . . . 0.0 109.675 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.519 ' O ' ' CZ ' ' A' ' 31' ' ' PHE . 0.8 OUTLIER -99.89 128.43 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.214 -0.929 . . . . 0.0 109.422 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.436 ' C ' ' CG ' ' A' ' 31' ' ' PHE . 46.3 mt-10 -99.48 163.49 12.49 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.232 -0.917 . . . . 0.0 109.205 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.519 ' CZ ' ' O ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -149.44 152.87 36.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.209 -0.932 . . . . 0.0 109.391 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.53 ' HB3' ' N ' ' A' ' 70' ' ' GLN . 2.3 mp -141.73 -162.59 1.42 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.146 -0.971 . . . . 0.0 109.953 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 3.3 p-10 -123.97 172.99 8.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.446 -0.784 . . . . 0.0 109.011 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 26.0 t-20 -111.64 -96.36 0.43 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.939 -1.1 . . . . 0.0 109.193 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.469 ' HE2' HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -147.13 30.91 0.93 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.18 -0.95 . . . . 0.0 108.862 179.523 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.564 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -151.1 59.42 3.34 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.694 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 36.6 Cg_endo -78.49 174.86 11.75 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.761 2.307 . . . . 0.0 110.617 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.556 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 37.9 Cg_endo -84.15 172.62 44.03 Favored 'Cis proline' 0 C--N 1.31 -1.461 0 C-N-CA 123.518 -1.451 . . . . 0.0 110.37 -1.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.687 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 91.9 m-70 -132.04 142.01 49.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.141 -0.974 . . . . 0.0 109.729 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.509 ' ND2' ' HB3' ' A' ' 63' ' ' GLN . 4.9 t-20 -112.47 119.29 37.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.335 -0.853 . . . . 0.0 109.604 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.9 t -108.03 112.94 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.519 ' HA ' ' HB3' ' A' ' 60' ' ' SER . 2.4 t -139.19 170.8 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.979 -1.075 . . . . 0.0 110.566 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.526 ' CE2' HD23 ' A' ' 59' ' ' LEU . 4.4 m-85 -118.45 110.58 17.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.491 -0.756 . . . . 0.0 109.345 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.494 ' HB3' ' CD2' ' A' ' 47' ' ' LEU . 6.1 t0 -48.83 139.3 10.1 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.192 -0.942 . . . . 0.0 109.278 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.29 12.84 6.0 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.251 -0.906 . . . . 0.0 109.888 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -119.8 23.99 10.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.069 -1.019 . . . . 0.0 109.668 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.494 ' CD2' ' HB3' ' A' ' 44' ' ' ASP . 0.7 OUTLIER -131.03 46.33 2.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.226 -0.921 . . . . 0.0 109.474 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 48' ' ' ASN . 0.5 OUTLIER -119.47 156.38 53.31 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.214 -0.929 . . . . 0.0 109.603 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.36 -21.56 11.65 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.676 2.251 . . . . 0.0 110.305 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.451 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -123.89 28.06 7.0 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.264 -0.898 . . . . 0.0 109.424 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.462 ' HA ' ' OD1' ' A' ' 48' ' ' ASN . 0.1 OUTLIER 38.55 48.17 1.22 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.295 0.569 . . . . 0.0 110.025 179.711 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.435 ' N ' ' ND2' ' A' ' 48' ' ' ASN . 22.3 m -112.02 139.22 47.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.165 -0.959 . . . . 0.0 109.434 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.442 ' O ' ' HD2' ' A' ' 57' ' ' LYS . . . -121.54 21.82 10.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.802 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.86 -32.85 34.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.203 -0.936 . . . . 0.0 109.568 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 0.5 OUTLIER -97.39 21.42 10.14 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.215 -0.928 . . . . 0.0 109.415 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -113.35 -33.88 5.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.328 -0.858 . . . . 0.0 109.294 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.442 ' HD2' ' O ' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -71.34 -48.66 48.93 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.275 -0.891 . . . . 0.0 109.028 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.1 t -77.83 -2.12 34.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 0.0 109.44 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.578 HD22 ' CE2' ' A' ' 76' ' ' PHE . 9.7 tp -89.05 -48.41 7.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.109 -0.994 . . . . 0.0 109.097 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.519 ' HB3' ' HA ' ' A' ' 42' ' ' VAL . 10.1 p -79.78 164.65 23.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.527 -0.733 . . . . 0.0 110.507 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.466 ' CG ' ' N ' ' A' ' 62' ' ' LYS . 3.5 p80 -125.0 -164.74 1.31 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.526 -0.734 . . . . 0.0 109.217 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.466 ' N ' ' CG ' ' A' ' 61' ' ' HIS . 2.2 mttp -65.43 -162.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.119 -0.988 . . . . 0.0 109.353 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.509 ' HB3' ' ND2' ' A' ' 40' ' ' ASN . 5.4 pt20 -137.07 42.44 2.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.102 -0.999 . . . . 0.0 109.876 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.61 76.53 1.64 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.182 -0.948 . . . . 0.0 109.938 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.582 ' N ' ' CD1' ' A' ' 65' ' ' LEU . 4.9 mp -85.58 105.0 15.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.131 -0.981 . . . . 0.0 109.21 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.1 ttt -109.04 3.82 22.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 0.0 109.578 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.428 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 2.6 t -98.28 133.63 22.74 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 109.123 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.86 78.92 3.53 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.413 2.076 . . . . 0.0 110.512 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.533 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 112.63 50.36 0.56 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.53 ' N ' ' HB3' ' A' ' 32' ' ' LEU . 0.0 OUTLIER 172.3 111.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -1.103 . . . . 0.0 109.385 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' A' ' 72' ' ' THR . 77.8 p -111.14 -78.89 0.58 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.209 -0.932 . . . . 0.0 109.199 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.531 ' N ' ' OG ' ' A' ' 71' ' ' SER . 14.7 t -160.4 164.28 32.47 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.387 -0.821 . . . . 0.0 108.945 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.2 t -115.44 126.47 54.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.156 -0.965 . . . . 0.0 109.226 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.536 ' CG2' HD12 ' A' ' 59' ' ' LEU . 56.0 m -108.3 101.74 10.91 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.303 -0.873 . . . . 0.0 109.716 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.469 ' O ' ' C ' ' A' ' 76' ' ' PHE . 25.1 m -79.14 80.13 5.51 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.578 ' CE2' HD22 ' A' ' 59' ' ' LEU . 9.1 m-85 -36.83 146.54 0.23 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.964 -0.46 . . . . 0.0 109.886 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.451 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.0 Cg_endo -75.63 168.81 23.61 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.625 2.217 . . . . 0.0 110.895 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.75 11.82 8.4 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.493 -0.754 . . . . 0.0 109.424 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.507 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 0.9 OUTLIER -99.55 -24.36 14.78 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.285 -0.885 . . . . 0.0 109.329 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 25' ' ' PRO . . . -37.04 96.58 0.11 Allowed Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.815 -0.553 . . . . 0.0 109.769 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 79' ' ' ASP . 35.9 Cg_endo -78.62 -177.0 3.57 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.643 2.229 . . . . 0.0 110.732 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -70.39 127.32 32.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.301 -0.874 . . . . 0.0 109.266 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 167.11 145.75 4.61 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -85.07 117.02 23.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -1.137 . . . . 0.0 109.808 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.49 ' CD1' HG22 ' A' ' 101' ' ' ILE . 26.5 m-85 -92.51 153.4 19.1 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.492 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 29.6 m -138.81 114.33 9.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.837 -1.164 . . . . 0.0 110.762 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.598 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.4 OUTLIER -108.33 154.75 21.38 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.282 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.524 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 5.0 p90 -143.49 -156.77 0.72 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.052 -1.03 . . . . 0.0 110.11 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.459 ' SG ' ' HD2' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -133.41 139.19 46.62 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.323 -0.861 . . . . 0.0 109.491 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.629 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 63.1 tt0 -79.45 -42.64 1.6 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.349 -0.844 . . . . 0.0 111.035 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 34.2 Cg_endo -76.93 -46.04 0.16 Allowed 'Trans proline' 0 C--N 1.316 -1.148 0 C-N-CA 121.931 1.754 . . . . 0.0 111.068 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.687 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 15.2 m80 -102.3 33.32 3.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.0 -1.062 . . . . 0.0 109.6 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.9 ttt-85 -50.65 -36.9 37.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.129 -0.982 . . . . 0.0 109.718 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -96.27 40.26 2.64 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' A' ' 92' ' ' HIS . . . -133.68 33.38 3.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.231 -1.158 . . . . 0.0 109.541 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.11 24.12 54.01 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.231 -1.147 . . . . 0.0 110.231 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.544 ' CE ' ' HB2' ' A' ' 7' ' ' LEU . 2.7 mtp -87.54 71.59 9.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.039 -1.271 . . . . 0.0 109.217 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 88.6 t -137.62 127.94 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.541 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.598 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -123.66 -174.78 14.27 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.527 ' CG ' ' O ' ' A' ' 99' ' ' GLY . 22.2 mttt -162.33 122.27 2.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.175 -1.191 . . . . 0.0 110.169 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.568 HD11 ' CE2' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -88.16 121.25 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.107 -0.995 . . . . 0.0 108.406 178.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.6 101.41 12.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.021 -1.05 . . . . 0.0 109.329 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.53 HG23 ' CD1' ' A' ' 23' ' ' ILE . 2.4 t -99.77 116.47 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 109.367 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 109.385 -179.917 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.27 0.557 . . . . 0.0 109.749 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.514 ' CD2' HG21 ' A' ' 23' ' ' ILE . 23.2 m-85 -80.17 173.87 12.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.281 -0.887 . . . . 0.0 109.373 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.475 HG21 ' CB ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -156.08 113.57 3.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.149 -0.97 . . . . 0.0 109.814 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.468 HG11 ' CD1' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -101.41 114.3 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.908 . . . . 0.0 109.129 179.514 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -82.03 107.53 14.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.244 -0.91 . . . . 0.0 109.475 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.567 HD21 ' CE1' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -88.94 -169.1 2.4 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.16 -0.963 . . . . 0.0 109.108 179.565 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.517 ' O ' ' ND2' ' A' ' 34' ' ' ASN . . . 65.05 74.51 0.48 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 p -58.44 151.57 19.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -1.177 . . . . 0.0 109.531 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -89.52 -0.72 57.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.758 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.53 -0.41 8.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.1 -1.0 . . . . 0.0 109.769 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -131.78 -105.95 1.03 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.2 -91.3 0.08 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.336 -1.097 . . . . 0.0 109.462 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.643 ' CD1' ' CD2' ' A' ' 92' ' ' HIS . 74.0 mt -133.76 108.05 8.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.224 -0.923 . . . . 0.0 109.714 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.413 HG11 ' O ' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -148.48 116.68 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.33 -0.856 . . . . 0.0 109.284 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.567 ' CE1' HD21 ' A' ' 7' ' ' LEU . 37.6 m-85 -45.39 151.09 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.165 -0.959 . . . . 0.0 109.27 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 16' ' ' PHE . 7.5 mt-10 -144.69 112.91 5.0 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.159 -0.963 . . . . 0.0 109.296 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.9 Cg_endo -76.7 177.62 38.81 Favored 'Cis proline' 0 C--N 1.312 -1.387 0 C-N-CA 123.678 -1.384 . . . . 0.0 110.609 0.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.38 -1.95 35.89 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.283 -0.886 . . . . 0.0 109.675 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -134.19 161.49 34.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 109.281 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.524 HD23 ' CG2' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -156.5 118.07 3.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.001 -1.062 . . . . 0.0 110.032 -179.85 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.496 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 92.6 m -90.5 101.4 14.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.849 . . . . 0.0 108.876 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.526 ' CG1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -102.14 -172.75 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.317 -0.864 . . . . 0.0 110.317 -179.135 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.471 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -111.94 172.53 3.47 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.159 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 34.3 Cg_endo -77.41 79.83 3.07 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.364 2.043 . . . . 0.0 110.725 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 130.12 -24.56 4.48 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.577 -1.297 . . . . 0.0 109.898 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 26' ' ' GLY . 0.7 OUTLIER -51.43 -176.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.123 -1.222 . . . . 0.0 109.623 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.2 m -122.6 146.17 47.69 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.318 -0.864 . . . . 0.0 109.441 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.519 ' HB ' ' CZ ' ' A' ' 31' ' ' PHE . 2.4 t -127.17 140.36 49.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.23 -0.919 . . . . 0.0 109.451 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.475 ' CB ' HG21 ' A' ' 4' ' ' THR . 1.8 mt-10 -106.85 155.85 19.3 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.165 -0.959 . . . . 0.0 109.814 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.535 ' O ' ' OG ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -153.52 84.63 1.18 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.533 ' HA ' ' HB3' ' A' ' 71' ' ' SER . 1.7 pt? -96.55 165.3 12.23 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.98 0.895 . . . . 0.0 111.941 -177.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.609 ' HB2' ' CD2' ' A' ' 39' ' ' HIS . 3.9 p30 -87.45 154.85 20.32 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.97 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 48.4 t30 -92.98 -62.78 1.31 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.057 -1.027 . . . . 0.0 109.36 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.409 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -158.19 35.53 0.24 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.243 -0.91 . . . . 0.0 109.291 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.574 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 26.7 t -154.73 57.42 1.71 Allowed Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.411 -0.806 . . . . 0.0 109.794 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.574 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 37.0 Cg_endo -79.97 174.54 11.44 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.579 2.186 . . . . 0.0 110.515 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.532 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.1 Cg_endo -84.34 175.57 34.37 Favored 'Cis proline' 0 C--N 1.31 -1.462 0 C-N-CA 123.549 -1.438 . . . . 0.0 110.137 -1.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.689 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 51.0 m-70 -127.09 146.56 50.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.335 -0.853 . . . . 0.0 110.116 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -113.11 110.04 19.8 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.7 t -99.28 117.82 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.143 -0.973 . . . . 0.0 109.681 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.515 HG12 ' CB ' ' A' ' 60' ' ' SER . 0.8 OUTLIER -147.81 171.49 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.445 -0.785 . . . . 0.0 109.407 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.643 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.9 OUTLIER -124.66 109.59 13.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.331 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -46.96 136.46 8.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -0.884 . . . . 0.0 109.584 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.53 45.99 1.19 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.254 -0.904 . . . . 0.0 109.538 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.68 -30.52 0.82 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 110.186 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.9 mt -103.12 77.36 1.54 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.038 -1.039 . . . . 0.0 110.013 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.459 ' OD1' ' HA ' ' A' ' 51' ' ' LYS . 1.9 p30 -126.19 153.74 74.36 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.284 -0.885 . . . . 0.0 109.159 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.06 -14.31 13.58 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.562 2.175 . . . . 0.0 111.076 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -135.9 24.46 3.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.929 -1.107 . . . . 0.0 109.999 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.459 ' HA ' ' OD1' ' A' ' 48' ' ' ASN . 1.0 OUTLIER 35.75 87.39 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.115 0.483 . . . . 0.0 110.111 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.5 m -136.99 159.57 41.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.107 -0.996 . . . . 0.0 109.763 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.81 43.87 3.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 109.271 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -143.97 -41.05 0.28 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.347 -0.845 . . . . 0.0 109.648 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 1.3 pp -58.9 -18.11 30.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.044 -1.035 . . . . 0.0 109.135 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 57' ' ' LYS . . . -89.56 -38.74 13.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.342 -0.849 . . . . 0.0 109.314 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -44.15 -45.03 8.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 109.249 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.28 32.32 2.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -0.863 . . . . 0.0 109.16 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.596 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 7.1 tp -133.1 -51.37 0.89 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 0.0 109.648 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.515 ' CB ' HG12 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -78.74 121.18 24.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 109.766 -179.16 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.502 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 18.0 p80 -99.76 125.38 45.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.299 -0.876 . . . . 0.0 109.541 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 63' ' ' GLN . 2.2 mtpp -78.31 -37.22 45.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.186 -0.946 . . . . 0.0 109.591 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.436 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 2.4 tt0 -45.56 123.56 4.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.165 -0.959 . . . . 0.0 109.446 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.8 mp -75.97 170.66 15.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.478 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.59 ' N ' ' CD1' ' A' ' 65' ' ' LEU . 3.5 mp -93.1 -179.72 5.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -0.955 . . . . 0.0 109.429 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.43 ' HG3' ' C ' ' A' ' 65' ' ' LEU . 3.9 mtt -145.45 -48.52 0.23 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.065 -1.022 . . . . 0.0 110.151 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.503 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 47.2 t -80.58 144.96 57.69 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.058 -1.026 . . . . 0.0 110.224 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.16 95.02 1.0 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 123.024 2.482 . . . . 0.0 110.454 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 33' ' ' ASN . . . 116.96 49.79 0.41 Allowed Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.228 -1.463 . . . . 0.0 109.83 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.528 ' N ' ' HB2' ' A' ' 32' ' ' LEU . 1.7 pt20 167.7 108.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -1.129 . . . . 0.0 109.457 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.535 ' OG ' ' O ' ' A' ' 31' ' ' PHE . 95.6 p -100.1 -100.24 0.24 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.228 -0.92 . . . . 0.0 109.445 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.532 ' N ' ' OG ' ' A' ' 71' ' ' SER . 36.9 p -146.32 -157.85 0.84 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 p -143.05 93.68 2.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.06 -1.025 . . . . 0.0 109.389 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.544 ' CG2' HD11 ' A' ' 59' ' ' LEU . 42.6 m -67.44 103.24 1.26 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.377 -0.827 . . . . 0.0 109.428 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 76' ' ' PHE . 1.9 m -78.65 78.73 5.09 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.223 -0.923 . . . . 0.0 108.859 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.596 ' CZ ' HD21 ' A' ' 59' ' ' LEU . 14.5 m-85 -40.79 144.02 0.65 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.651 -0.656 . . . . 0.0 109.306 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.468 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.9 Cg_endo -77.5 168.65 22.39 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.702 2.268 . . . . 0.0 111.149 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.45 9.78 8.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.429 -0.795 . . . . 0.0 109.447 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.489 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 28.0 t70 -99.15 -19.78 16.99 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.171 -0.956 . . . . 0.0 108.865 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 79' ' ' ASP . . . -40.08 99.97 0.21 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.683 -0.635 . . . . 0.0 109.573 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 79' ' ' ASP . 34.8 Cg_endo -76.29 133.99 15.26 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.312 2.008 . . . . 0.0 110.357 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -46.1 136.05 7.1 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.26 -0.9 . . . . 0.0 109.354 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 167.47 -139.37 5.68 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -135.67 120.1 18.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.29 -1.123 . . . . 0.0 109.733 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.583 ' CD1' HG21 ' A' ' 101' ' ' ILE . 4.0 m-85 -102.02 -179.41 3.99 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.4 m -163.63 115.41 1.42 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.9 -1.125 . . . . 0.0 110.38 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.563 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.5 OUTLIER -110.83 162.62 14.62 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -149.87 -162.01 1.46 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.989 -1.069 . . . . 0.0 109.954 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.12 126.28 28.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.348 -0.845 . . . . 0.0 109.838 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -59.33 -46.3 99.06 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 109.961 179.467 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.2 Cg_endo -78.85 -69.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.152 0 C-N-CA 122.182 1.921 . . . . 0.0 110.725 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.689 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 9.5 m80 -66.96 63.98 0.05 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.036 -1.04 . . . . 0.0 109.423 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 91' ' ' PRO . 5.8 ttp180 -92.62 -9.08 42.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 0.0 109.599 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.68 39.84 2.76 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.47 36.4 0.98 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.099 -1.236 . . . . 0.0 109.573 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' A' ' 98' ' ' VAL . . . 50.48 21.96 4.99 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.528 ' CE ' ' HB3' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -66.85 67.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.094 -1.239 . . . . 0.0 109.432 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' A' ' 96' ' ' GLY . 97.2 t -138.34 92.54 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.104 -0.997 . . . . 0.0 109.546 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.563 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -88.44 -173.31 47.14 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.501 ' CG ' ' O ' ' A' ' 99' ' ' GLY . 12.6 mttp -157.96 122.79 4.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -1.178 . . . . 0.0 109.541 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.583 HG21 ' CD1' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -85.15 135.26 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 109.091 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.496 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 75.7 m -115.72 112.17 21.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.962 . . . . 0.0 108.635 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.559 HG21 ' CE1' ' A' ' 85' ' ' TYR . 8.6 t -99.37 131.64 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.941 . . . . 0.0 109.64 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 0.0 109.587 -179.92 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.436 HG22 ' HB ' ' A' ' 28' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -118.47 125.42 49.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.256 -0.903 . . . . 0.0 109.499 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 30' ' ' GLU . 1.7 t -115.49 136.02 53.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 109.504 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.443 ' O ' HD23 ' A' ' 7' ' ' LEU . 0.9 OUTLIER -111.09 85.71 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.578 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -56.18 128.29 34.86 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.178 -0.951 . . . . 0.0 109.328 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.541 ' CD2' ' N ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -104.48 179.5 4.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.243 -0.911 . . . . 0.0 109.504 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 14' ' ' LEU . . . 68.36 75.63 0.49 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.466 ' O ' ' OD2' ' A' ' 10' ' ' ASP . 1.4 p -44.84 -30.28 0.95 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -1.186 . . . . 0.0 109.501 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.469 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER 77.07 -3.06 2.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.472 -0.768 . . . . 0.0 109.652 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.33 13.67 8.26 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.132 -0.98 . . . . 0.0 109.641 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.07 -82.1 0.05 OUTLIER Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.7 tp -140.38 -151.42 0.36 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.231 -1.159 . . . . 0.0 109.685 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.461 ' O ' HG13 ' A' ' 15' ' ' VAL . 87.5 mt -112.17 118.38 35.18 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.357 -0.84 . . . . 0.0 109.354 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 14' ' ' LEU . 6.1 m -152.03 156.91 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.179 -0.95 . . . . 0.0 109.381 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -71.41 156.37 39.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.211 -0.931 . . . . 0.0 109.454 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 47.6 mt-10 -143.88 112.86 5.35 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.416 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.1 Cg_endo -77.63 -178.6 24.53 Favored 'Cis proline' 0 C--N 1.312 -1.346 0 C-N-CA 123.739 -1.359 . . . . 0.0 110.462 0.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.14 -34.5 61.65 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.266 -0.896 . . . . 0.0 109.741 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.73 158.04 19.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 0.0 109.265 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.9 tp -151.83 107.45 3.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.102 -0.999 . . . . 0.0 109.891 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.0 m -81.43 95.23 7.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.152 -0.968 . . . . 0.0 109.058 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.521 ' CD1' HG21 ' A' ' 103' ' ' VAL . 1.0 OUTLIER -99.7 168.62 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.397 -0.814 . . . . 0.0 110.163 -179.3 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.527 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 37.0 mttt -88.28 168.21 17.08 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 32.5 Cg_endo -75.54 82.77 2.03 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 121.872 1.714 . . . . 0.0 110.559 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 132.05 -13.52 5.23 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.445 ' OD2' ' HG3' ' A' ' 24' ' ' LYS . 6.8 m-20 -54.8 -176.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.16 -1.2 . . . . 0.0 109.699 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.523 ' CG2' ' HA ' ' A' ' 75' ' ' THR . 0.2 OUTLIER -122.1 138.77 54.33 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.365 -0.834 . . . . 0.0 109.495 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.444 ' HB ' ' CZ ' ' A' ' 31' ' ' PHE . 2.0 t -118.09 137.2 52.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.172 -0.955 . . . . 0.0 109.598 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -115.18 125.6 53.6 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.246 -0.909 . . . . 0.0 109.861 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.597 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -124.69 101.48 7.13 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.579 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 1.5 mp -97.08 178.15 5.36 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.294 -0.879 . . . . 0.0 110.926 -178.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 2.8 p-10 -97.37 164.13 12.59 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.753 -0.592 . . . . 0.0 109.741 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 7' ' ' LEU . 23.7 t30 -109.35 -85.18 0.54 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.137 -0.977 . . . . 0.0 108.962 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.455 ' O ' HG22 ' A' ' 36' ' ' VAL . 10.5 ptmt -150.91 29.75 0.66 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.386 -0.821 . . . . 0.0 108.911 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.561 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 3.0 t -148.68 58.5 3.65 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.563 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 35.7 Cg_endo -77.65 175.06 11.7 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.564 2.176 . . . . 0.0 110.781 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.9 Cg_endo -85.45 161.96 61.32 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 123.537 -1.443 . . . . 0.0 110.614 -1.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.718 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 65.5 m-70 -120.21 142.25 49.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.357 -0.839 . . . . 0.0 109.845 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 6.6 m120 -130.83 126.4 36.18 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.521 ' HB ' ' NE2' ' A' ' 61' ' ' HIS . 1.2 t -99.57 135.7 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.209 -0.932 . . . . 0.0 109.108 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.52 ' O ' ' CB ' ' A' ' 87' ' ' PHE . 2.2 t -140.07 178.04 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.332 -0.855 . . . . 0.0 109.24 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.553 ' CE2' HD22 ' A' ' 59' ' ' LEU . 17.6 m-85 -137.56 120.85 16.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.189 -0.945 . . . . 0.0 109.479 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 43' ' ' PHE . 5.9 t0 -54.28 -166.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.423 -0.798 . . . . 0.0 109.785 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -147.69 25.8 1.05 Allowed 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.239 -0.913 . . . . 0.0 109.614 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -119.42 -10.13 9.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.407 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.7 mt -110.82 55.68 0.65 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.281 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' A' ' 48' ' ' ASN . 0.9 OUTLIER -120.01 152.96 54.91 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.258 -0.901 . . . . 0.0 109.476 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.92 -19.86 12.12 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.669 2.246 . . . . 0.0 110.644 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -126.57 29.89 5.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.065 -1.022 . . . . 0.0 109.71 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER 34.46 59.21 0.65 Allowed 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.153 0.501 . . . . 0.0 110.33 179.665 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.8 m -132.49 171.72 13.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.15 -0.969 . . . . 0.0 109.543 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.82 16.8 0.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 109.758 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 54' ' ' ASP . 2.0 p-10 -71.11 -23.13 62.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.16 -0.963 . . . . 0.0 109.444 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.518 ' HG ' ' N ' ' A' ' 56' ' ' ALA . 1.1 pp -87.63 -27.7 22.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.242 -0.911 . . . . 0.0 109.501 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.518 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -79.73 -31.33 41.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 0.0 109.959 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -58.08 -31.54 67.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.166 -0.959 . . . . 0.0 109.745 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.5 p -105.29 -8.3 18.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.95 . . . . 0.0 110.071 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.565 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 9.3 tp -80.73 -33.02 35.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.053 -1.029 . . . . 0.0 109.297 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.487 ' OG ' HG12 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -78.62 136.08 37.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.332 -0.855 . . . . 0.0 110.163 -179.009 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.521 ' NE2' ' HB ' ' A' ' 41' ' ' VAL . 0.4 OUTLIER -117.12 94.48 4.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.42 -0.8 . . . . 0.0 109.016 179.615 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.481 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.9 OUTLIER -61.32 -12.28 13.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.307 -0.871 . . . . 0.0 110.016 -179.529 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.468 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 20.8 tt0 -43.43 122.14 2.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.142 -0.974 . . . . 0.0 109.718 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.481 HD12 ' O ' ' A' ' 62' ' ' LYS . 0.3 OUTLIER -64.53 121.85 15.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.844 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.513 ' N ' ' CD1' ' A' ' 65' ' ' LEU . 8.1 mp -84.2 93.71 8.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.252 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.0 tpt -97.02 -6.56 35.07 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.268 -0.895 . . . . 0.0 109.472 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.469 ' CB ' ' HB3' ' A' ' 70' ' ' GLN . 35.1 t -84.29 138.57 39.09 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.174 -0.954 . . . . 0.0 109.325 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.29 92.35 1.14 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.558 2.172 . . . . 0.0 110.86 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 91.86 24.93 24.01 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.469 ' HB3' ' CB ' ' A' ' 67' ' ' SER . 0.6 OUTLIER -137.84 89.68 2.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.242 -1.152 . . . . 0.0 109.278 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.597 ' CB ' ' O ' ' A' ' 31' ' ' PHE . 6.4 p -105.66 -167.92 1.38 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.154 -0.966 . . . . 0.0 109.88 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.505 HG22 ' CG ' ' A' ' 61' ' ' HIS . 1.1 t -105.6 123.08 47.33 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 73' ' ' SER . 1.7 p -78.7 109.29 12.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.985 -1.072 . . . . 0.0 109.507 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.522 HG21 ' CD1' ' A' ' 59' ' ' LEU . 24.7 m -78.44 107.3 10.98 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.422 -0.799 . . . . 0.0 109.555 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.523 ' HA ' ' CG2' ' A' ' 28' ' ' THR . 18.7 m -79.55 93.57 5.47 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.248 -0.907 . . . . 0.0 109.034 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.565 ' CZ ' HD22 ' A' ' 59' ' ' LEU . 3.3 m-85 -44.08 156.74 0.31 Allowed Pre-proline 0 N--CA 1.487 1.407 0 O-C-N 121.401 -0.812 . . . . 0.0 109.268 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.433 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.0 Cg_endo -76.86 168.21 23.91 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.818 2.345 . . . . 0.0 111.788 -179.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.66 8.18 15.19 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 80' ' ' ALA . 2.8 m-20 -98.87 -8.05 26.32 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.329 -0.857 . . . . 0.0 108.957 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.504 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . . . -36.61 98.13 0.15 Allowed Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.809 -0.557 . . . . 0.0 109.702 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 79' ' ' ASP . 35.3 Cg_endo -76.68 155.42 35.31 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.536 2.157 . . . . 0.0 110.628 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.54 108.34 1.64 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 109.636 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -175.44 -177.17 44.3 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 pm0 -107.69 143.79 35.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.22 -1.165 . . . . 0.0 109.661 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.512 ' CD1' HG22 ' A' ' 101' ' ' ILE . 17.9 m-85 -118.85 165.45 14.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.306 -0.872 . . . . 0.0 109.066 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.478 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 44.7 m -146.06 109.26 4.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.139 -0.976 . . . . 0.0 110.045 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.574 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.8 OUTLIER -106.27 160.11 15.6 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.338 -0.851 . . . . 0.0 109.16 179.435 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 88' ' ' TYR . 16.0 p90 -146.17 -168.04 2.89 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.192 -0.942 . . . . 0.0 109.59 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 0.1 OUTLIER -120.51 140.89 50.8 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.339 -0.85 . . . . 0.0 109.707 -179.597 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.601 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.6 tt0 -75.64 -45.73 4.2 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.291 -0.881 . . . . 0.0 109.892 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.2 Cg_endo -78.34 -51.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.14 0 C-N-CA 121.898 1.732 . . . . 0.0 110.562 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.718 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 19.8 m80 -90.25 43.58 1.15 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.137 -0.977 . . . . 0.0 109.316 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -59.38 -57.73 11.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -0.88 . . . . 0.0 109.521 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -81.23 49.82 4.07 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -138.63 38.19 2.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -1.151 . . . . 0.0 109.431 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 47.58 30.47 6.39 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.457 ' HE3' ' HB3' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -92.32 68.56 5.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.221 -1.164 . . . . 0.0 109.203 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.2 t -136.12 112.06 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.912 . . . . 0.0 109.579 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.574 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -108.96 -171.54 20.94 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.478 ' HG2' ' HA ' ' A' ' 86' ' ' THR . 14.5 mttp -159.12 119.62 3.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -1.157 . . . . 0.0 109.855 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.512 HG22 ' CD1' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -82.96 143.34 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.089 -1.007 . . . . 0.0 108.47 179.19 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.54 95.93 4.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.149 -0.969 . . . . 0.0 109.041 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.521 HG21 ' CD1' ' A' ' 23' ' ' ILE . 2.1 t -99.86 131.81 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.272 -0.893 . . . . 0.0 109.655 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.292 -0.88 . . . . 0.0 109.305 179.929 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.27 0.557 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -94.06 136.95 33.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.242 -0.911 . . . . 0.0 109.529 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.87 102.84 7.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.885 . . . . 0.0 109.557 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.582 ' CG1' ' CD1' ' A' ' 21' ' ' LEU . 2.8 m -91.79 48.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.231 -0.918 . . . . 0.0 109.614 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -47.54 92.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 109.43 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -53.97 170.54 0.12 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.228 -0.92 . . . . 0.0 109.665 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.49 ' HA3' ' CB ' ' A' ' 34' ' ' ASN . . . 74.35 122.29 0.1 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.1 p -68.55 -70.12 0.29 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.218 -1.166 . . . . 0.0 109.545 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 179.79 -59.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 109.358 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -140.06 41.25 1.96 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.284 -0.885 . . . . 0.0 109.517 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.95 -97.17 0.34 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 mt -116.7 170.51 8.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.262 -1.14 . . . . 0.0 109.691 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.539 ' CB ' ' HE2' ' A' ' 97' ' ' MET . 46.0 mt -100.08 120.07 39.27 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.374 -0.829 . . . . 0.0 108.987 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.4 m -159.95 145.97 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.076 -1.015 . . . . 0.0 109.716 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.484 ' HA ' ' HA ' ' A' ' 7' ' ' LEU . 7.2 m-85 -56.68 154.53 8.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 109.046 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 42.5 mt-10 -145.29 109.65 4.59 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.124 -0.985 . . . . 0.0 109.448 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 35.7 Cg_endo -78.8 174.8 49.34 Favored 'Cis proline' 0 C--N 1.312 -1.354 0 C-N-CA 123.904 -1.29 . . . . 0.0 110.491 0.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.75 -62.37 1.41 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.14 -0.975 . . . . 0.0 109.053 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -89.5 154.04 20.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.35 -0.844 . . . . 0.0 108.787 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.582 ' CD1' ' CG1' ' A' ' 5' ' ' VAL . 1.2 mt -147.12 135.88 22.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.951 -1.093 . . . . 0.0 110.216 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.484 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 28.6 m -109.03 98.12 7.64 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.53 ' CD1' HG21 ' A' ' 103' ' ' VAL . 1.0 OUTLIER -102.35 177.69 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.396 -0.815 . . . . 0.0 110.156 -179.277 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.478 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -101.2 174.73 2.73 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.54 ' HA ' ' CB ' ' A' ' 80' ' ' ALA . 34.9 Cg_endo -77.15 79.19 3.21 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.262 1.975 . . . . 0.0 110.505 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 134.96 -12.49 4.46 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.434 ' OD2' ' HB2' ' A' ' 24' ' ' LYS . 64.1 m-20 -55.09 -179.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.151 -1.206 . . . . 0.0 109.294 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 90.5 m -126.64 113.64 16.99 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.149 -0.97 . . . . 0.0 109.658 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.473 ' O ' ' CZ ' ' A' ' 31' ' ' PHE . 2.0 t -104.74 131.0 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.149 -0.969 . . . . 0.0 109.53 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -101.84 155.54 18.07 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.249 -0.907 . . . . 0.0 109.696 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -148.35 85.25 1.51 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.554 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.5 OUTLIER -97.55 179.51 4.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.362 -0.836 . . . . 0.0 110.942 -178.491 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 2.1 p-10 -90.09 157.01 17.98 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.591 -0.693 . . . . 0.0 109.263 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.49 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . 3.8 t30 -97.59 -73.65 0.6 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.982 -1.074 . . . . 0.0 109.338 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.48 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -163.5 31.91 0.09 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 108.923 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.534 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 27.8 t -157.47 63.95 3.03 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.591 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 33.6 Cg_endo -77.32 177.33 8.98 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 123.097 2.531 . . . . 0.0 111.026 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.591 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 39.7 Cg_endo -87.28 158.81 48.42 Favored 'Cis proline' 0 C--N 1.313 -1.316 0 O-C-N 123.698 1.367 . . . . 0.0 111.328 -1.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.703 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 65.3 m-70 -119.55 141.52 49.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.707 -0.62 . . . . 0.0 109.388 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -117.99 119.36 34.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.872 . . . . 0.0 108.94 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.551 ' HB ' ' NE2' ' A' ' 61' ' ' HIS . 2.0 t -100.42 128.48 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.131 -0.98 . . . . 0.0 109.8 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -157.3 165.5 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.546 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.64 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.4 OUTLIER -124.03 134.61 53.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.099 -1.001 . . . . 0.0 109.284 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -66.97 133.35 49.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.348 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.37 10.63 6.7 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.27 -0.894 . . . . 0.0 109.918 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.8 19.65 13.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.129 -0.982 . . . . 0.0 109.437 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.26 49.88 2.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -0.934 . . . . 0.0 109.687 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.521 ' OD1' ' CA ' ' A' ' 51' ' ' LYS . 1.5 p30 -118.26 160.47 39.32 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.347 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.468 ' HG3' ' HA3' ' A' ' 83' ' ' GLY . 36.3 Cg_endo -77.82 -5.31 15.24 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.512 2.142 . . . . 0.0 110.662 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -125.46 27.36 6.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.115 -0.991 . . . . 0.0 109.62 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.521 ' CA ' ' OD1' ' A' ' 48' ' ' ASN . 3.6 ptmt 34.0 38.55 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.134 0.493 . . . . 0.0 110.39 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.51 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 1.8 m -115.47 170.19 8.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.083 -1.011 . . . . 0.0 109.676 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -139.68 51.9 1.73 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.958 . . . . 0.0 109.57 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -115.38 -42.07 3.2 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.311 -0.868 . . . . 0.0 109.493 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.482 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 1.8 pp -56.71 -28.18 60.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.892 . . . . 0.0 109.498 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.473 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -79.93 -35.06 38.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.929 . . . . 0.0 109.538 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -51.1 -22.92 2.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.177 -0.952 . . . . 0.0 109.373 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.1 m -123.18 18.42 9.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.626 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.615 HD23 ' CZ ' ' A' ' 76' ' ' PHE . 12.3 tp -119.69 -41.97 2.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.11 -0.994 . . . . 0.0 109.635 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.437 ' HB3' ' HA ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -78.04 127.44 32.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.384 -179.445 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.638 ' CE1' ' CG2' ' A' ' 72' ' ' THR . 0.5 OUTLIER -108.63 137.14 47.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.374 -0.829 . . . . 0.0 109.486 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -85.83 -159.74 0.48 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.227 -0.921 . . . . 0.0 109.51 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.518 ' CB ' ' O ' ' A' ' 62' ' ' LYS . 1.6 tt0 77.33 136.4 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.408 -0.807 . . . . 0.0 109.533 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.439 ' HB2' ' CE ' ' A' ' 66' ' ' MET . 5.2 mp -85.91 133.5 33.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.451 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.452 ' CD1' ' O ' ' A' ' 39' ' ' HIS . 9.9 mt -80.12 124.21 28.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 0.0 109.48 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.439 ' CE ' ' HB2' ' A' ' 64' ' ' LEU . 6.7 mtt -124.99 4.58 7.98 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.25 -0.906 . . . . 0.0 109.601 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.446 ' OG ' ' HB3' ' A' ' 70' ' ' GLN . 47.4 t -91.89 142.33 26.39 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.188 -0.945 . . . . 0.0 109.332 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.6 86.3 1.7 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.62 2.213 . . . . 0.0 110.892 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.528 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 95.23 44.41 3.27 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.475 ' HA ' ' OE1' ' A' ' 70' ' ' GLN . 3.6 tp60 -162.32 101.45 1.08 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.243 -1.151 . . . . 0.0 109.244 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.554 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . 3.2 p -112.11 -103.77 0.4 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.405 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.638 ' CG2' ' CE1' ' A' ' 61' ' ' HIS . 9.0 t -161.02 117.94 2.3 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.0 t -78.54 116.58 19.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.957 -1.089 . . . . 0.0 109.895 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.42 ' CG2' HD12 ' A' ' 59' ' ' LEU . 0.6 OUTLIER -95.52 105.05 16.98 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 76' ' ' PHE . 41.4 m -78.91 92.27 4.89 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.248 -0.907 . . . . 0.0 108.905 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.615 ' CZ ' HD23 ' A' ' 59' ' ' LEU . 7.0 m-85 -42.8 161.34 0.19 Allowed Pre-proline 0 N--CA 1.488 1.442 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.471 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 33.1 Cg_endo -75.45 159.04 40.11 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.346 2.031 . . . . 0.0 111.185 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.54 -5.64 20.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.551 -0.718 . . . . 0.0 109.644 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 80' ' ' ALA . 0.9 OUTLIER -99.41 -65.6 0.95 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.187 -0.946 . . . . 0.0 109.284 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.54 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . . . 61.26 133.09 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.337 -0.852 . . . . 0.0 109.407 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.463 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 36.1 Cg_endo -78.42 99.75 1.3 Allowed 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.345 2.03 . . . . 0.0 110.284 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 81' ' ' PRO . . . -41.42 117.82 0.96 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.378 -0.826 . . . . 0.0 109.683 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.468 ' HA3' ' HG3' ' A' ' 49' ' ' PRO . . . 156.13 -156.31 26.98 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 0.4 OUTLIER -122.0 126.1 47.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -1.167 . . . . 0.0 109.508 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.627 ' CD2' ' CG2' ' A' ' 101' ' ' ILE . 1.5 m-30 -92.89 -164.7 1.21 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.889 . . . . 0.0 108.941 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.486 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 65.4 m -167.19 111.68 0.72 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.868 -1.145 . . . . 0.0 110.505 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.7 OUTLIER -112.05 157.4 20.8 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.378 -0.826 . . . . 0.0 108.774 178.729 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -145.47 -162.93 1.61 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.013 -1.055 . . . . 0.0 109.916 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 93' ' ' ARG . 0.1 OUTLIER -126.94 129.14 47.57 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.373 -0.83 . . . . 0.0 109.829 -179.265 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.613 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.3 tt0 -65.77 -43.77 60.99 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.264 -0.898 . . . . 0.0 110.264 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.4 Cg_endo -78.35 -52.64 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 121.889 1.726 . . . . 0.0 110.446 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.703 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 9.2 m80 -90.21 34.23 0.87 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.172 -0.955 . . . . 0.0 109.24 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.501 ' HB3' ' O ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -64.52 126.53 28.13 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.237 -0.914 . . . . 0.0 109.532 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 92.31 2.33 68.35 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.23 32.97 2.29 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.117 -1.225 . . . . 0.0 109.414 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.39 7.09 37.58 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.539 ' HE2' ' CB ' ' A' ' 14' ' ' LEU . 16.7 mtm -90.75 63.28 5.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.976 -1.308 . . . . 0.0 109.598 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 84.2 t -140.52 76.24 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.387 -0.82 . . . . 0.0 109.41 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.489 ' O ' ' CG ' ' A' ' 100' ' ' LYS . . . -72.27 -167.72 10.22 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.489 ' CG ' ' O ' ' A' ' 99' ' ' GLY . 5.7 mtmt -159.25 131.37 6.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.355 -1.085 . . . . 0.0 109.484 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.627 ' CG2' ' CD2' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -82.59 133.37 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.12 -0.987 . . . . 0.0 108.925 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.484 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 7.6 m -116.31 91.75 3.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.257 -0.902 . . . . 0.0 109.038 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.53 HG21 ' CD1' ' A' ' 23' ' ' ILE . 2.1 t -99.42 135.92 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.205 -0.935 . . . . 0.0 109.6 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.259 -0.901 . . . . 0.0 109.472 -179.975 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.407 ' CD2' HG21 ' A' ' 23' ' ' ILE . 83.4 m-85 -96.93 168.78 10.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.935 . . . . 0.0 109.301 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.6 m -156.99 144.17 18.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 109.761 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.96 69.57 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.392 -0.817 . . . . 0.0 109.0 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -51.07 106.74 0.14 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.389 -0.819 . . . . 0.0 110.017 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 34' ' ' ASN . 0.2 OUTLIER -90.86 150.91 21.36 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.292 -0.88 . . . . 0.0 109.054 179.399 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.464 ' HA2' HD23 ' A' ' 14' ' ' LEU . . . 117.6 66.88 0.35 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.511 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -51.22 -23.32 3.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.162 -1.199 . . . . 0.0 109.262 179.646 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.511 ' CB ' ' O ' ' A' ' 9' ' ' SER . 10.5 t0 80.4 29.54 0.23 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.609 -0.682 . . . . 0.0 109.45 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.78 19.12 10.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -0.9 . . . . 0.0 109.209 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.18 11.11 53.47 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.88 143.87 18.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.328 -1.101 . . . . 0.0 109.419 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.534 ' CD1' ' CE1' ' A' ' 39' ' ' HIS . 1.1 mt -101.93 143.44 31.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.181 -0.949 . . . . 0.0 109.315 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 95' ' ' ALA . 1.8 m -154.57 128.78 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.92 . . . . 0.0 109.601 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -48.83 142.01 6.84 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.188 -0.945 . . . . 0.0 109.106 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -136.56 109.71 9.49 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.273 -0.892 . . . . 0.0 109.254 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.469 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 34.9 Cg_endo -77.29 -178.03 22.92 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 123.73 -1.362 . . . . 0.0 110.64 0.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.19 4.29 20.73 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.244 -0.91 . . . . 0.0 109.763 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 5.2 pttt -146.06 160.72 41.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.149 -0.969 . . . . 0.0 109.488 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.73 136.62 11.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.187 -0.946 . . . . 0.0 109.48 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.0 m -104.93 99.16 8.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.296 -0.878 . . . . 0.0 109.286 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.523 ' CD1' HD11 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -99.48 173.47 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.234 -0.916 . . . . 0.0 109.523 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.548 ' CG ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -95.33 177.54 1.76 Allowed Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.044 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.548 ' HD2' ' CG ' ' A' ' 24' ' ' LYS . 34.7 Cg_endo -76.41 72.72 5.39 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.088 1.859 . . . . 0.0 110.342 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 126.18 28.6 1.0 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.18 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.517 ' OD1' ' CB ' ' A' ' 24' ' ' LYS . 4.5 m-20 -88.13 -165.84 1.43 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.205 -1.173 . . . . 0.0 108.852 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 75' ' ' THR . 21.4 m -136.56 110.56 8.26 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.956 -1.09 . . . . 0.0 109.695 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.582 ' HB ' ' CZ ' ' A' ' 31' ' ' PHE . 1.7 t -99.36 136.13 31.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.321 -0.862 . . . . 0.0 109.102 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -104.76 142.54 34.52 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.104 -0.997 . . . . 0.0 110.198 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.582 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -139.7 142.63 36.87 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.375 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.535 ' HA ' ' N ' ' A' ' 71' ' ' SER . 0.5 OUTLIER -140.94 -169.95 2.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.894 -1.129 . . . . 0.0 110.523 -179.383 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 6.4 p-10 -114.9 154.28 28.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.467 -0.771 . . . . 0.0 109.352 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 7' ' ' LEU . 35.3 t30 -100.38 -88.09 0.36 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.024 -1.047 . . . . 0.0 109.637 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.426 ' C ' HG22 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -144.14 33.72 1.22 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.073 -1.017 . . . . 0.0 109.197 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.515 ' O ' ' NE2' ' A' ' 92' ' ' HIS . 92.3 t -153.77 64.53 4.88 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.478 -0.763 . . . . 0.0 109.135 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.571 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.5 Cg_endo -79.79 175.85 10.09 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.775 2.317 . . . . 0.0 110.455 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.571 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.8 Cg_endo -86.24 -172.93 8.84 Favored 'Cis proline' 0 C--N 1.31 -1.46 0 C-N-CA 123.655 -1.394 . . . . 0.0 110.65 -1.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.74 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 63.2 m-70 -137.91 159.23 42.55 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.38 -0.825 . . . . 0.0 109.583 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -138.71 118.33 13.04 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.455 ' C ' HG22 ' A' ' 42' ' ' VAL . 20.5 t -99.58 111.45 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.668 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.481 ' HA ' ' CB ' ' A' ' 60' ' ' SER . 13.8 t -135.91 162.64 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.338 -0.851 . . . . 0.0 109.311 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.607 ' CE2' ' CD2' ' A' ' 59' ' ' LEU . 20.1 m-85 -115.88 120.75 40.23 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.262 -0.899 . . . . 0.0 109.62 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.461 ' OD2' HD21 ' A' ' 47' ' ' LEU . 39.8 t0 -44.08 140.54 2.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.415 -0.803 . . . . 0.0 109.768 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.7 1.06 55.49 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.339 -0.851 . . . . 0.0 109.646 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.58 -26.19 13.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.551 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.512 ' N ' HD21 ' A' ' 47' ' ' LEU . 4.0 mm? -95.49 61.73 2.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 109.265 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 52' ' ' SER . 2.3 p30 -107.59 150.06 39.67 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.324 -0.86 . . . . 0.0 109.487 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.469 ' HB3' ' HA3' ' A' ' 83' ' ' GLY . 35.8 Cg_endo -77.96 -9.78 16.76 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.616 2.211 . . . . 0.0 110.331 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -134.55 31.59 3.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.27 -0.894 . . . . 0.0 109.452 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 50' ' ' ALA . 27.3 pttt 36.47 39.08 0.09 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.814 -0.554 . . . . 0.0 110.166 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.522 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 6.0 m -108.76 -157.63 0.62 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.568 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -169.07 33.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -0.859 . . . . 0.0 109.508 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.19 -42.26 3.76 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.215 -0.928 . . . . 0.0 109.826 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.455 ' CD1' ' C ' ' A' ' 55' ' ' LEU . 2.0 pp -47.35 -33.32 5.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 109.449 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.84 -37.41 24.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 109.483 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.77 -31.26 2.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 0.0 109.388 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.4 p -115.02 31.67 6.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.245 -0.909 . . . . 0.0 109.39 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.607 ' CD2' ' CE2' ' A' ' 43' ' ' PHE . 8.3 tp -131.37 -52.71 1.02 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.926 . . . . 0.0 109.613 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.51 ' OG ' ' CD2' ' A' ' 43' ' ' PHE . 10.2 m -77.37 160.37 28.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 110.29 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.546 ' CE1' ' O ' ' A' ' 63' ' ' GLN . 18.9 p80 -119.99 147.29 44.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.531 -0.731 . . . . 0.0 109.336 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.52 -55.86 3.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -0.945 . . . . 0.0 109.529 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.546 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -46.74 120.84 3.18 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.347 -0.846 . . . . 0.0 109.665 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.3 mp -66.48 162.06 21.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.091 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.525 ' CD2' ' O ' ' A' ' 39' ' ' HIS . 0.5 OUTLIER -109.06 152.07 25.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.051 -1.031 . . . . 0.0 109.692 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 3.4 mtp -136.6 7.45 3.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.314 -0.866 . . . . 0.0 109.548 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.515 ' HB3' ' CG ' ' A' ' 70' ' ' GLN . 8.4 t -79.27 134.53 58.84 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.235 -0.916 . . . . 0.0 109.347 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.428 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 35.9 Cg_endo -78.44 90.1 1.29 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.721 2.28 . . . . 0.0 111.612 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.514 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 113.17 34.76 1.74 Allowed Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.63 -1.272 . . . . 0.0 110.678 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.515 ' CG ' ' HB3' ' A' ' 67' ' ' SER . 0.7 OUTLIER 177.01 119.93 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.01 -1.288 . . . . 0.0 109.669 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.539 ' OG ' ' N ' ' A' ' 72' ' ' THR . 60.2 p -109.97 -75.14 0.63 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.284 -0.885 . . . . 0.0 109.325 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.539 ' N ' ' OG ' ' A' ' 71' ' ' SER . 1.6 t -160.75 107.84 1.52 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.186 -0.946 . . . . 0.0 109.633 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.3 t -78.78 85.01 4.81 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.026 -1.046 . . . . 0.0 108.298 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.426 HG22 ' HG ' ' A' ' 59' ' ' LEU . 22.6 m -75.63 108.37 8.42 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.523 -0.736 . . . . 0.0 110.378 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.455 ' O ' ' C ' ' A' ' 76' ' ' PHE . 3.2 t -79.13 87.99 4.86 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.564 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 30.1 m-85 -36.69 150.75 0.12 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.782 -0.574 . . . . 0.0 110.314 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.485 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 35.2 Cg_endo -76.74 161.36 33.7 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.995 2.463 . . . . 0.0 111.501 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.49 6.57 10.01 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.5 ' O ' ' C ' ' A' ' 80' ' ' ALA . 3.1 p30 -98.87 -4.84 32.11 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.286 -0.884 . . . . 0.0 109.096 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 79' ' ' ASP . . . -33.82 105.27 0.25 Allowed Pre-proline 0 N--CA 1.498 1.961 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 82' ' ' ALA . 35.9 Cg_endo -77.84 41.44 1.0 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.522 2.148 . . . . 0.0 111.407 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.494 ' HA ' ' HB ' ' A' ' 103' ' ' VAL . . . 46.87 -178.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -0.866 . . . . 0.0 110.006 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.469 ' HA3' ' HB3' ' A' ' 49' ' ' PRO . . . 94.21 -168.14 28.22 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -111.92 153.83 26.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.522 -0.987 . . . . 0.0 109.635 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.443 ' O ' ' HB ' ' A' ' 86' ' ' THR . 19.8 m-30 -113.63 -39.32 4.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.392 -0.817 . . . . 0.0 108.92 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.443 ' HB ' ' O ' ' A' ' 85' ' ' TYR . 92.4 m 61.79 100.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.313 -0.867 . . . . 0.0 110.333 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -105.05 173.17 6.42 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.203 -0.936 . . . . 0.0 108.905 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 97' ' ' MET . 16.7 p90 -155.39 -164.07 1.68 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.893 -1.13 . . . . 0.0 110.046 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 97' ' ' MET . 0.6 OUTLIER -136.75 144.75 43.96 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.424 -0.798 . . . . 0.0 109.447 -179.692 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.604 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 40.6 tt0 -83.12 -45.07 0.86 Allowed Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.264 -0.898 . . . . 0.0 110.433 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.0 Cg_endo -78.31 -46.93 0.11 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.048 1.832 . . . . 0.0 110.902 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.74 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 68.7 m80 -87.79 18.07 4.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.014 -1.054 . . . . 0.0 109.643 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -53.25 135.94 37.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.127 -0.983 . . . . 0.0 109.421 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.05 -8.25 80.29 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.47 ' O ' HG13 ' A' ' 15' ' ' VAL . . . -99.12 38.66 1.37 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.16 -1.2 . . . . 0.0 109.603 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.98 12.5 29.78 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.472 ' HB3' ' HB2' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -81.92 56.8 3.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.179 -1.189 . . . . 0.0 109.699 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.44 HG22 ' C ' ' A' ' 97' ' ' MET . 21.6 t -139.6 72.15 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.104 -0.998 . . . . 0.0 109.947 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.438 ' C ' ' CG ' ' A' ' 100' ' ' LYS . . . -80.95 -173.23 47.18 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.438 ' CG ' ' C ' ' A' ' 99' ' ' GLY . 0.1 OUTLIER -152.15 136.23 16.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.933 -1.334 . . . . 0.0 110.148 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.564 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -86.58 119.54 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.172 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.74 103.42 15.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.217 -0.927 . . . . 0.0 109.099 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.494 ' HB ' ' HA ' ' A' ' 82' ' ' ALA . 17.3 t -99.19 68.45 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.487 -0.758 . . . . 0.0 109.444 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.468 0 O-C-N 121.316 -0.865 . . . . 0.0 109.275 -179.996 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.6 m . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.285 0.564 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -84.35 108.88 17.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.47 HG22 ' O ' ' A' ' 30' ' ' GLU . 52.9 m -109.58 150.06 28.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.564 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.517 HG21 ' CD1' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -113.43 160.84 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -0.924 . . . . 0.0 109.227 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -125.75 101.1 6.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.929 . . . . 0.0 109.505 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.465 HD11 ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -89.19 170.98 10.14 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.168 -0.958 . . . . 0.0 109.252 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.532 ' HA3' ' CB ' ' A' ' 34' ' ' ASN . . . 86.52 77.39 1.23 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 13' ' ' LEU . 99.7 p -44.29 -65.65 0.49 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -1.151 . . . . 0.0 109.218 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 9' ' ' SER . 0.4 OUTLIER 168.47 -25.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.07 179.631 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -113.77 49.54 0.98 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.059 -1.025 . . . . 0.0 110.078 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.22 -37.85 3.24 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' A' ' 9' ' ' SER . 2.9 mp -69.61 118.85 13.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.124 -1.221 . . . . 0.0 109.578 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.545 ' HB2' ' CE ' ' A' ' 97' ' ' MET . 0.5 OUTLIER -116.19 110.81 19.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.349 -0.844 . . . . 0.0 109.488 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.68 133.34 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.345 -0.847 . . . . 0.0 109.516 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -49.31 153.73 0.98 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.045 -1.034 . . . . 0.0 109.097 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 5.7 mt-10 -143.0 109.06 5.44 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.156 -0.965 . . . . 0.0 109.445 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 35.0 Cg_endo -77.21 179.56 30.84 Favored 'Cis proline' 0 C--N 1.312 -1.368 0 C-N-CA 123.82 -1.325 . . . . 0.0 110.491 0.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.68 -44.08 71.18 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.214 -0.929 . . . . 0.0 108.877 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.29 139.6 40.54 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.517 ' CD1' HG21 ' A' ' 5' ' ' VAL . 1.7 mt -126.79 126.66 43.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 110.088 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 102' ' ' THR . 18.8 m -89.26 97.83 11.42 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.53 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -99.3 172.49 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.149 -0.969 . . . . 0.0 109.865 -179.387 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.489 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 0.3 OUTLIER -86.31 175.55 4.34 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.419 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' A' ' 24' ' ' LYS . 35.8 Cg_endo -78.0 72.84 5.99 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.377 2.052 . . . . 0.0 110.962 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 129.08 -9.75 6.28 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.22 -1.467 . . . . 0.0 110.603 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 26' ' ' GLY . 1.2 m-20 -50.54 -178.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.093 -1.239 . . . . 0.0 109.085 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.8 m -117.4 118.37 32.03 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.036 -1.04 . . . . 0.0 109.676 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.48 HG22 ' CD1' ' A' ' 101' ' ' ILE . 1.7 t -99.81 111.53 29.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.371 -0.83 . . . . 0.0 109.475 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.47 ' O ' HG22 ' A' ' 4' ' ' THR . 5.1 mt-10 -99.43 123.17 43.47 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.254 -0.904 . . . . 0.0 109.112 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -106.29 153.19 22.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.348 -0.845 . . . . 0.0 109.109 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.504 ' HA ' ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -140.54 177.81 7.75 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.09 -1.007 . . . . 0.0 110.033 -179.494 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 3.2 p-10 -109.45 169.64 8.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.355 -0.841 . . . . 0.0 109.268 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.532 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . 28.3 t30 -112.88 -73.68 0.66 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.01 -1.056 . . . . 0.0 109.378 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.407 ' C ' HG22 ' A' ' 36' ' ' VAL . 5.8 ttpt -162.91 28.39 0.1 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.064 -1.023 . . . . 0.0 109.266 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.574 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 11.1 t -148.05 58.61 3.96 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.574 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 36.2 Cg_endo -77.94 174.78 12.02 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.69 2.26 . . . . 0.0 110.664 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.6 Cg_endo -86.95 158.44 50.15 Favored 'Cis proline' 0 C--N 1.309 -1.547 0 C-N-CA 123.402 -1.499 . . . . 0.0 110.713 -1.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.639 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 70.4 m-70 -113.77 125.41 54.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.483 -0.761 . . . . 0.0 108.961 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.441 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 1.8 m120 -99.85 123.96 44.65 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.292 -0.88 . . . . 0.0 109.294 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.6 t -107.8 109.49 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.243 -0.91 . . . . 0.0 109.911 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.529 ' O ' ' CB ' ' A' ' 87' ' ' PHE . 1.4 t -134.74 167.11 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.383 -0.823 . . . . 0.0 108.852 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.593 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 7.8 m-85 -118.9 106.52 12.57 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.136 -0.977 . . . . 0.0 109.831 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -49.91 118.66 3.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.443 -0.786 . . . . 0.0 109.861 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.41 2.14 29.9 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.433 -0.792 . . . . 0.0 109.638 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -102.09 -15.03 16.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.139 -0.976 . . . . 0.0 109.753 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.0 mt -113.88 61.08 0.66 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.142 -0.974 . . . . 0.0 109.523 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.479 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 5.7 p30 -134.1 163.14 53.29 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.255 -0.903 . . . . 0.0 109.449 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.539 ' HG3' ' CA ' ' A' ' 83' ' ' GLY . 33.7 Cg_endo -77.31 -16.81 15.19 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.596 2.197 . . . . 0.0 109.423 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 52' ' ' SER . . . -135.0 77.08 1.66 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.47 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -35.88 95.43 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.351 0.596 . . . . 0.0 110.413 -179.459 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 50' ' ' ALA . 10.4 m -140.42 -174.49 3.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.423 -0.798 . . . . 0.0 109.271 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -159.86 23.94 0.18 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.934 . . . . 0.0 109.413 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -89.08 -66.03 0.96 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.279 -0.888 . . . . 0.0 109.794 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.51 ' HG ' ' N ' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -64.89 -25.31 67.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -0.929 . . . . 0.0 109.636 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.51 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -65.02 -58.18 6.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.115 -0.991 . . . . 0.0 109.343 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.45 -31.59 1.79 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.268 -0.895 . . . . 0.0 109.521 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.61 13.03 36.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.926 . . . . 0.0 109.973 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.574 HD21 ' CD2' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -108.0 -42.45 4.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.997 -1.064 . . . . 0.0 108.47 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.485 ' HB3' ' HA ' ' A' ' 42' ' ' VAL . 0.7 OUTLIER -78.11 174.57 11.01 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.457 -0.777 . . . . 0.0 110.347 -179.418 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.46 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 26.4 p80 -125.19 174.2 8.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.64 -0.662 . . . . 0.0 109.338 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -125.19 -12.91 6.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.156 -0.965 . . . . 0.0 109.71 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -92.59 105.66 17.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.965 . . . . 0.0 109.653 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.466 ' HB3' ' CB ' ' A' ' 38' ' ' PRO . 4.4 mp -49.26 165.01 0.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -0.896 . . . . 0.0 109.291 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.511 HD23 ' CB ' ' A' ' 71' ' ' SER . 5.9 mp -81.49 137.4 35.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.124 -0.985 . . . . 0.0 109.546 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.93 -2.56 5.22 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.368 -0.832 . . . . 0.0 109.538 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.473 ' OG ' ' OE1' ' A' ' 70' ' ' GLN . 27.3 t -116.0 144.93 33.74 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.141 -0.975 . . . . 0.0 109.247 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.489 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.6 Cg_endo -80.91 83.46 2.21 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.645 2.23 . . . . 0.0 111.608 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.542 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 124.94 45.41 0.26 Allowed Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.121 -1.514 . . . . 0.0 111.437 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.496 ' HB3' ' O ' ' A' ' 69' ' ' GLY . 4.1 pt20 170.15 117.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.014 -1.286 . . . . 0.0 109.974 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.511 ' CB ' HD23 ' A' ' 65' ' ' LEU . 2.8 p -115.51 -146.82 0.41 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.226 -0.922 . . . . 0.0 109.09 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.507 ' N ' ' OG ' ' A' ' 71' ' ' SER . 96.4 m -95.15 100.67 12.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.098 -1.001 . . . . 0.0 109.951 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.447 ' HB3' ' HB3' ' A' ' 30' ' ' GLU . 42.4 p -79.99 111.71 16.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.229 -0.919 . . . . 0.0 108.884 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.544 ' CG2' HD13 ' A' ' 59' ' ' LEU . 1.9 m -98.63 129.09 45.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 109.86 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.518 ' O ' ' OG1' ' A' ' 75' ' ' THR . 0.1 OUTLIER -82.65 96.81 8.24 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.139 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.574 ' CD2' HD21 ' A' ' 59' ' ' LEU . 26.1 m-85 -45.58 153.12 0.62 Allowed Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 121.066 -1.021 . . . . 0.0 108.862 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.49 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.3 Cg_endo -77.11 165.38 28.17 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.5 2.133 . . . . 0.0 111.421 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.93 8.0 6.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.46 -0.775 . . . . 0.0 109.535 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 81' ' ' PRO . 2.4 m-20 -99.08 -12.5 20.47 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.045 -1.034 . . . . 0.0 109.006 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 79' ' ' ASP . . . -32.85 93.58 0.06 OUTLIER Pre-proline 0 N--CA 1.5 2.041 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.534 ' N ' ' O ' ' A' ' 79' ' ' ASP . 36.3 Cg_endo -78.73 163.83 26.1 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.586 2.191 . . . . 0.0 110.786 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -64.77 113.19 3.62 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.406 -0.809 . . . . 0.0 109.302 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.539 ' CA ' ' HG3' ' A' ' 49' ' ' PRO . . . -174.54 155.83 21.89 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 84' ' ' GLU . 0.7 OUTLIER -90.47 104.69 17.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -1.098 . . . . 0.0 109.706 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.525 ' CE2' HG21 ' A' ' 103' ' ' VAL . 7.7 m-30 -81.08 167.25 19.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.204 -0.935 . . . . 0.0 108.863 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.492 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 95.4 m -151.81 115.52 4.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.935 -1.103 . . . . 0.0 110.573 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.529 ' CB ' ' O ' ' A' ' 42' ' ' VAL . 2.0 p90 -117.4 168.63 10.18 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 98' ' ' VAL . 30.4 p90 -160.47 -162.41 0.96 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.79 -1.194 . . . . 0.0 110.645 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 1.3 m -119.07 136.41 54.16 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.69 -0.631 . . . . 0.0 109.723 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.629 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -73.17 -45.09 8.08 Favored Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.287 -0.883 . . . . 0.0 109.762 178.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.4 Cg_endo -78.35 -60.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.063 0 C-N-CA 121.983 1.789 . . . . 0.0 110.524 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.639 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 10.8 m80 -72.48 57.23 0.39 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.017 -1.052 . . . . 0.0 109.179 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.54 18.59 9.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.368 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.85 -34.0 2.7 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 96' ' ' GLY . . . -91.81 34.35 1.0 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.143 -1.21 . . . . 0.0 109.642 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 95' ' ' ALA . . . 41.61 61.72 2.11 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.545 ' CE ' ' HB2' ' A' ' 14' ' ' LEU . 9.3 mtt -91.64 63.97 4.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.163 -1.198 . . . . 0.0 109.35 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 88' ' ' TYR . 4.9 p -127.63 96.48 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.2 -0.937 . . . . 0.0 109.775 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.471 ' O ' ' HG3' ' A' ' 100' ' ' LYS . . . -76.47 -164.42 18.51 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.492 ' HG2' ' HA ' ' A' ' 86' ' ' THR . 26.5 mtmt -163.44 120.53 1.82 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -1.149 . . . . 0.0 109.649 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.53 HD13 ' CD1' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -82.58 138.88 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.154 -0.966 . . . . 0.0 108.898 179.654 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 22' ' ' THR . 8.3 m -118.04 93.93 4.32 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.525 HG21 ' CE2' ' A' ' 85' ' ' TYR . 1.8 t -99.2 118.6 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.23 -0.918 . . . . 0.0 109.596 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 109.634 -179.82 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.8 m . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.44 ' CD2' ' CD2' ' A' ' 21' ' ' LEU . 40.0 m-85 -123.52 98.46 5.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.174 -0.954 . . . . 0.0 109.349 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.487 HG22 ' CD1' ' A' ' 32' ' ' LEU . 18.8 m -87.54 83.87 7.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.749 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.474 ' CG2' ' O ' ' A' ' 5' ' ' VAL . 24.7 m -82.55 107.15 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.152 -0.967 . . . . 0.0 109.454 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.457 ' HE3' ' HA2' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -92.25 100.86 13.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 109.333 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.535 ' CD2' ' O ' ' A' ' 32' ' ' LEU . 0.9 OUTLIER -59.68 172.48 0.7 Allowed 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.148 -0.97 . . . . 0.0 109.295 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.468 ' HA3' ' CB ' ' A' ' 34' ' ' ASN . . . 69.35 70.36 1.18 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.444 ' OG ' ' N ' ' A' ' 10' ' ' ASP . 86.4 p -47.67 -91.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.316 -1.108 . . . . 0.0 109.531 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.444 ' N ' ' OG ' ' A' ' 9' ' ' SER . 2.2 t0 177.36 -34.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.427 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.61 38.73 3.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.0 109.38 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.07 -106.35 0.28 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.6 -148.3 0.26 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -1.115 . . . . 0.0 109.359 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.57 HD22 ' CE1' ' A' ' 39' ' ' HIS . 20.8 mt -98.75 109.0 21.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.945 -1.097 . . . . 0.0 109.366 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 7' ' ' LEU . 21.4 m -148.51 165.73 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.906 . . . . 0.0 109.487 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -85.79 135.18 33.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 109.407 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -125.64 108.34 26.04 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.188 -0.945 . . . . 0.0 109.542 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -78.44 175.81 45.4 Favored 'Cis proline' 0 C--N 1.312 -1.358 0 C-N-CA 123.793 -1.336 . . . . 0.0 110.465 0.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.64 -39.53 31.28 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.225 -0.922 . . . . 0.0 109.474 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.78 138.15 45.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.309 -0.87 . . . . 0.0 109.294 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.46 HD12 HG11 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -135.51 110.34 8.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 109.588 -179.872 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.471 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 97.5 m -84.14 99.23 10.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.167 -0.958 . . . . 0.0 109.291 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.552 ' CD1' HD11 ' A' ' 101' ' ' ILE . 1.5 pt -99.64 -178.37 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.288 -0.882 . . . . 0.0 109.698 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.554 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -94.91 -179.16 0.9 Allowed Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.448 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.554 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 34.5 Cg_endo -77.88 66.69 8.15 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.093 1.862 . . . . 0.0 110.386 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 77' ' ' PRO . . . 121.08 73.96 0.35 Allowed Glycine 0 N--CA 1.487 2.08 0 C-N-CA 119.52 -1.324 . . . . 0.0 109.922 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 24' ' ' LYS . 7.7 m-20 -125.77 -142.66 0.29 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.32 -1.106 . . . . 0.0 108.581 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.3 m -148.04 99.49 3.07 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.944 -1.098 . . . . 0.0 109.563 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.454 ' O ' ' CE1' ' A' ' 31' ' ' PHE . 2.9 t -99.87 119.45 47.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.466 -0.771 . . . . 0.0 109.044 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.482 ' C ' ' CD1' ' A' ' 31' ' ' PHE . 56.1 tt0 -99.61 156.33 17.12 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.171 -0.956 . . . . 0.0 109.81 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.483 ' CD2' ' O ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -148.34 149.13 31.26 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.535 ' O ' ' CD2' ' A' ' 7' ' ' LEU . 3.1 mp -141.97 -170.98 3.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.127 -0.983 . . . . 0.0 109.807 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 8.0 p-10 -113.66 159.92 19.15 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.315 -0.865 . . . . 0.0 109.441 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 7' ' ' LEU . 17.5 t30 -94.97 -94.49 0.18 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.015 -1.053 . . . . 0.0 109.301 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.54 37.29 1.34 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.173 -0.954 . . . . 0.0 109.304 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.513 ' O ' ' NE2' ' A' ' 39' ' ' HIS . 0.5 OUTLIER -150.81 62.8 5.44 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.446 -0.784 . . . . 0.0 109.004 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.551 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 35.0 Cg_endo -77.54 174.68 12.29 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.693 2.262 . . . . 0.0 110.26 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.602 ' O ' ' CG ' ' A' ' 39' ' ' HIS . 37.9 Cg_endo -83.83 -163.12 2.98 Favored 'Cis proline' 0 C--N 1.308 -1.566 0 C-N-CA 123.558 -1.434 . . . . 0.0 110.571 -0.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.602 ' CG ' ' O ' ' A' ' 38' ' ' PRO . 89.4 m-70 -161.77 124.59 3.03 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.413 -0.804 . . . . 0.0 109.758 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -100.97 111.93 24.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.211 -0.931 . . . . 0.0 109.213 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.491 ' O ' HG13 ' A' ' 42' ' ' VAL . 52.4 t -102.06 128.4 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 0.0 109.719 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.556 ' CG1' ' HB2' ' A' ' 60' ' ' SER . 0.0 OUTLIER -159.85 167.12 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.29 -0.882 . . . . 0.0 109.496 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.508 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 3.2 m-85 -109.41 133.6 52.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.261 -0.899 . . . . 0.0 109.294 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -57.26 136.05 56.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.073 -1.017 . . . . 0.0 108.952 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.33 21.77 1.66 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.233 -0.917 . . . . 0.0 110.102 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.31 5.93 2.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.983 -1.073 . . . . 0.0 109.635 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.8 mp -113.49 41.44 2.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 0.0 109.556 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.46 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -114.03 165.34 13.83 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.346 -0.846 . . . . 0.0 109.232 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 35.5 Cg_endo -77.75 -32.08 2.9 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.615 2.21 . . . . 0.0 111.442 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -125.79 24.79 7.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.876 -1.14 . . . . 0.0 110.268 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.452 ' HA ' ' CG ' ' A' ' 48' ' ' ASN . 9.9 mtmm 36.48 91.13 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.865 -0.522 . . . . 0.0 110.182 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.449 ' HB3' ' OD1' ' A' ' 54' ' ' ASP . 73.7 m -139.92 136.49 33.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.071 -1.018 . . . . 0.0 109.681 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.24 -47.92 32.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.46 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 55' ' ' LEU . 6.8 p30 -46.45 -31.84 2.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.508 ' N ' ' OD1' ' A' ' 54' ' ' ASP . 39.1 tp -87.68 55.2 3.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 109.36 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 55' ' ' LEU . . . 163.88 -50.27 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.347 -0.845 . . . . 0.0 109.235 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -54.91 -37.95 66.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 109.437 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.6 t -104.38 -20.07 13.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.897 . . . . 0.0 109.526 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.579 HD23 ' CZ ' ' A' ' 76' ' ' PHE . 16.1 tp -65.04 -49.4 70.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 109.469 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.556 ' HB2' ' CG1' ' A' ' 42' ' ' VAL . 55.4 p -82.76 178.38 8.21 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.749 0.785 . . . . 0.0 110.936 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.461 ' CE1' ' O ' ' A' ' 63' ' ' GLN . 19.1 p80 -108.99 -154.23 0.53 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.446 ' N ' ' ND1' ' A' ' 61' ' ' HIS . 19.3 mmtt -148.05 -62.14 0.26 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.291 -0.881 . . . . 0.0 109.439 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.461 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 3.4 pm0 -46.1 148.18 0.91 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.647 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 mp -73.97 165.57 24.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 109.498 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.485 ' CD2' ' HB3' ' A' ' 33' ' ' ASN . 2.1 mp -82.47 126.17 31.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.368 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.01 -23.81 4.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.196 -0.94 . . . . 0.0 109.79 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.3 t -90.85 142.1 27.32 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.148 -0.97 . . . . 0.0 109.426 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.18 101.63 1.49 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.477 2.118 . . . . 0.0 110.423 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.528 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 98.93 47.41 1.91 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.414 ' N ' ' HB3' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -170.83 94.01 0.19 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.428 -1.042 . . . . 0.0 109.232 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.591 ' OG ' ' N ' ' A' ' 72' ' ' THR . 10.6 p -103.2 -79.91 0.53 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.016 -1.053 . . . . 0.0 109.336 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.591 ' N ' ' OG ' ' A' ' 71' ' ' SER . 13.5 m -160.95 110.11 1.64 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.106 -0.996 . . . . 0.0 108.761 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.4 t -79.24 78.74 5.71 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.158 -0.964 . . . . 0.0 108.757 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.555 ' CG2' ' CD1' ' A' ' 59' ' ' LEU . 84.9 m -62.4 96.77 0.08 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.45 -0.781 . . . . 0.0 109.847 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.499 ' O ' ' C ' ' A' ' 76' ' ' PHE . 1.7 t -79.23 74.3 5.82 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.579 ' CZ ' HD23 ' A' ' 59' ' ' LEU . 28.4 m-85 -33.88 146.05 0.14 Allowed Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.537 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 34.5 Cg_endo -76.22 -179.63 5.44 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.841 2.361 . . . . 0.0 111.482 -178.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.05 11.6 9.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.456 -0.777 . . . . 0.0 109.062 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' A' ' 80' ' ' ALA . 18.8 m-20 -98.88 -71.21 0.7 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.534 ' HB1' ' N ' ' A' ' 26' ' ' GLY . . . 31.51 98.05 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 122.023 -0.423 . . . . 0.0 111.06 178.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.474 ' HD2' HD21 ' A' ' 55' ' ' LEU . 34.5 Cg_endo -76.34 157.57 37.11 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.424 2.083 . . . . 0.0 110.708 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.32 139.87 52.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 0.0 109.482 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 157.55 171.87 24.06 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -88.73 129.95 35.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.344 -1.092 . . . . 0.0 109.661 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.464 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 9.3 m-85 -110.95 137.69 48.27 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.46 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 81.1 m -137.07 116.7 12.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.978 -1.076 . . . . 0.0 110.619 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.577 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.3 OUTLIER -111.13 164.43 12.86 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.791 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.457 ' CB ' HG23 ' A' ' 98' ' ' VAL . 6.6 p90 -157.1 -156.42 0.6 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.777 -1.202 . . . . 0.0 110.565 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 93' ' ' ARG . 0.5 OUTLIER -132.43 155.88 47.7 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.639 -0.663 . . . . 0.0 109.281 -179.539 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.597 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 12.3 tp10 -88.67 -44.6 0.45 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.088 -1.008 . . . . 0.0 110.715 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.8 Cg_endo -80.27 -55.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 122.157 1.905 . . . . 0.0 111.041 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.566 ' CD2' HD11 ' A' ' 14' ' ' LEU . 5.2 m80 -88.34 32.97 0.75 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.104 -0.998 . . . . 0.0 109.518 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.464 ' HB3' ' O ' ' A' ' 89' ' ' CYS . 12.8 ptt180 -63.09 -23.22 67.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.139 -0.976 . . . . 0.0 109.611 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.15 7.85 62.54 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -107.26 35.49 3.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -1.148 . . . . 0.0 109.668 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.8 35.99 84.78 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.478 ' HG2' ' O ' ' A' ' 14' ' ' LEU . 1.9 mtp -95.69 67.28 2.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.084 -1.245 . . . . 0.0 109.091 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.457 HG23 ' CB ' ' A' ' 88' ' ' TYR . 59.7 t -140.32 107.95 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 109.96 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.577 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -106.64 154.94 16.67 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 46.3 mtmt -130.74 135.53 47.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.071 -1.253 . . . . 0.0 110.08 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.552 HD11 ' CD1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -101.74 123.5 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.189 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.471 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 1.0 OUTLIER -98.91 108.47 21.16 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.103 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.545 ' CG1' ' HA ' ' A' ' 25' ' ' PRO . 20.7 t -99.15 94.51 3.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.35 -0.844 . . . . 0.0 109.491 -178.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.368 -0.833 . . . . 0.0 109.345 -179.939 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.33 0.586 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.501 ' O ' ' N ' ' A' ' 30' ' ' GLU . 16.8 m-85 -133.95 148.48 51.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.21 -0.931 . . . . 0.0 109.291 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 30' ' ' GLU . 1.7 t -137.92 103.67 5.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 109.801 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 m -87.37 67.26 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.239 -0.913 . . . . 0.0 109.292 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.446 ' CG ' ' O ' ' A' ' 6' ' ' LYS . 1.3 ptmm? -51.35 108.97 0.29 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.89 . . . . 0.0 109.725 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.585 ' CD1' ' CE1' ' A' ' 39' ' ' HIS . 0.2 OUTLIER -68.02 175.69 3.01 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.233 -0.917 . . . . 0.0 109.322 179.688 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 14' ' ' LEU . . . 67.21 110.45 0.02 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.2 p -68.14 -104.0 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.262 -1.14 . . . . 0.0 109.178 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -171.77 26.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.885 -1.135 . . . . 0.0 109.848 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -132.22 -9.44 3.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.098 -1.001 . . . . 0.0 110.283 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 129.19 3.53 5.25 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.121 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 mt -111.43 142.0 44.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.067 -1.255 . . . . 0.0 109.565 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.468 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 65.7 mt -103.19 102.43 12.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.305 -0.872 . . . . 0.0 109.705 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 14' ' ' LEU . 27.8 m -142.94 138.41 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 109.249 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.456 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 10.9 m-85 -56.46 148.9 18.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.156 -0.965 . . . . 0.0 109.538 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 16' ' ' PHE . 3.9 mm-40 -143.18 108.52 5.33 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.352 -0.842 . . . . 0.0 109.304 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 35.9 Cg_endo -78.17 174.53 51.35 Favored 'Cis proline' 0 C--N 1.312 -1.377 0 C-N-CA 123.779 -1.342 . . . . 0.0 110.638 0.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.469 ' HB3' ' HE3' ' A' ' 20' ' ' LYS . . . -72.59 -54.9 7.85 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.184 -0.948 . . . . 0.0 109.17 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.469 ' HE3' ' HB3' ' A' ' 19' ' ' ALA . 1.0 OUTLIER -100.58 138.34 37.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -0.878 . . . . 0.0 109.073 179.642 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.8 tp -126.14 113.18 16.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.165 -0.959 . . . . 0.0 110.26 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.7 m -82.42 94.93 7.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.208 -0.933 . . . . 0.0 108.526 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.524 ' CG1' HG23 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -99.14 172.42 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.241 -0.912 . . . . 0.0 110.276 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.514 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 2.8 mmtt -91.99 168.71 12.43 Favored Pre-proline 0 C--N 1.303 -1.428 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.53 ' HA ' ' CB ' ' A' ' 80' ' ' ALA . 33.7 Cg_endo -77.18 81.86 2.51 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.052 1.834 . . . . 0.0 110.576 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 129.47 -1.67 6.07 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -74.41 177.91 5.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.113 -1.228 . . . . 0.0 109.574 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 36.9 m -111.63 157.16 20.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.299 -0.876 . . . . 0.0 109.419 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.573 HG13 ' CE2' ' A' ' 31' ' ' PHE . 4.6 t -130.52 150.67 34.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.281 -0.887 . . . . 0.0 109.014 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -126.91 104.67 8.15 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.08 -1.012 . . . . 0.0 110.254 -179.467 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.573 ' CE2' HG13 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -107.9 91.45 3.65 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.24 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.585 ' HA ' ' HB3' ' A' ' 71' ' ' SER . 0.5 OUTLIER -95.87 161.9 13.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.288 -0.882 . . . . 0.0 110.728 -178.176 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 2.0 p-10 -80.36 160.29 25.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.626 -0.671 . . . . 0.0 109.404 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 7' ' ' LEU . 59.5 t30 -103.41 -76.21 0.59 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.949 -1.094 . . . . 0.0 109.211 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.452 ' O ' HG21 ' A' ' 36' ' ' VAL . 1.5 pttt -157.61 34.33 0.27 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.907 . . . . 0.0 108.897 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.496 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 14.9 t -154.17 65.05 4.91 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.572 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 35.3 Cg_endo -78.57 176.04 10.35 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 123.091 2.527 . . . . 0.0 110.934 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.572 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 39.2 Cg_endo -87.62 157.65 45.61 Favored 'Cis proline' 0 C--N 1.311 -1.428 0 O-C-N 123.818 1.43 . . . . 0.0 110.868 -1.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.713 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 73.7 m-70 -118.41 118.72 32.52 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.578 -0.701 . . . . 0.0 109.783 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 17.7 t-20 -100.32 126.0 46.61 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.884 . . . . 0.0 108.762 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.496 ' HB ' ' NE2' ' A' ' 61' ' ' HIS . 71.0 t -104.92 131.15 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.083 -1.011 . . . . 0.0 109.992 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.434 ' O ' ' HB3' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -152.62 172.86 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.716 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.605 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 3.6 m-85 -124.53 109.77 13.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.017 -1.052 . . . . 0.0 109.903 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -47.11 131.01 12.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.42 -0.8 . . . . 0.0 109.404 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.4 18.23 5.44 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.269 -0.894 . . . . 0.0 109.967 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -120.86 9.56 10.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.026 -1.046 . . . . 0.0 109.652 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 mt -131.06 60.38 1.66 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.176 -0.953 . . . . 0.0 109.464 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.499 ' ND2' ' HA ' ' A' ' 51' ' ' LYS . 0.7 OUTLIER -121.58 163.66 29.37 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.932 . . . . 0.0 109.514 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 35.1 Cg_endo -77.51 -46.21 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.627 2.218 . . . . 0.0 110.821 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.453 ' C ' ' HG2' ' A' ' 51' ' ' LYS . . . -115.76 37.34 3.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -0.981 . . . . 0.0 109.995 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.499 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.9 OUTLIER 36.21 47.22 0.45 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.664 -0.647 . . . . 0.0 110.545 179.545 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.43 ' O ' HD21 ' A' ' 55' ' ' LEU . 26.8 m -99.79 89.84 4.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.138 -0.976 . . . . 0.0 109.373 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.76 -19.61 58.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.486 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.08 -25.54 45.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.483 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 1.8 pp -75.88 -25.35 56.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.692 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 58' ' ' SER . . . -74.1 -53.99 8.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.896 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 56' ' ' ALA . 1.4 mmtt -43.57 -26.2 0.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 109.735 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 56' ' ' ALA . 2.8 m -110.97 22.18 15.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.103 -0.998 . . . . 0.0 109.859 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.602 ' HG ' ' CZ ' ' A' ' 43' ' ' PHE . 8.2 tp -128.24 -36.91 1.89 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.074 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.55 141.91 39.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.396 -0.815 . . . . 0.0 109.601 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.558 ' CE1' ' O ' ' A' ' 63' ' ' GLN . 21.1 p80 -99.91 -23.02 15.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.444 -0.785 . . . . 0.0 109.862 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 70.62 -65.67 0.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.144 -0.973 . . . . 0.0 109.236 -179.714 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.558 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 0.8 OUTLIER -45.42 127.2 7.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.453 179.732 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.0 mp -68.01 170.45 8.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.222 -0.924 . . . . 0.0 109.727 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 39' ' ' HIS . 6.2 mt -115.74 100.55 8.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.363 -0.836 . . . . 0.0 109.032 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 62.5 mtt -96.99 2.82 51.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.277 -0.889 . . . . 0.0 109.828 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 t -79.88 139.74 53.95 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.112 -0.992 . . . . 0.0 109.24 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.63 88.78 1.41 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.613 2.209 . . . . 0.0 110.918 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.544 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 88.25 49.01 3.86 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -172.74 92.36 0.11 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.333 -1.098 . . . . 0.0 109.108 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.585 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . 80.0 p -99.07 -140.37 0.32 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.2 t -123.21 127.69 48.98 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.979 -1.076 . . . . 0.0 108.337 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 73' ' ' SER . 17.9 p -79.18 96.88 6.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.137 -0.977 . . . . 0.0 109.639 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.471 HG22 ' HG ' ' A' ' 59' ' ' LEU . 1.2 m -70.3 113.63 7.64 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.402 -0.811 . . . . 0.0 109.259 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 76' ' ' PHE . 54.5 m -79.25 88.71 4.91 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.361 -0.837 . . . . 0.0 109.113 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.596 ' CZ ' ' CD1' ' A' ' 101' ' ' ILE . 10.4 m-85 -43.13 160.43 0.21 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.376 -0.828 . . . . 0.0 108.903 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.49 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 32.6 Cg_endo -76.22 150.7 33.39 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.443 2.095 . . . . 0.0 111.483 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.429 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . . . -69.47 -11.28 60.7 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.457 ' O ' ' C ' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -100.65 15.9 26.63 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.332 -0.855 . . . . 0.0 109.141 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.53 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . . . -39.65 109.86 0.59 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.605 -0.684 . . . . 0.0 109.313 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.464 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 33.7 Cg_endo -75.02 121.35 6.52 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.354 2.036 . . . . 0.0 110.514 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -43.64 136.93 3.17 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.479 -0.763 . . . . 0.0 109.382 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 164.64 -167.38 38.42 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -120.68 115.62 23.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.407 -1.055 . . . . 0.0 109.484 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.464 ' OH ' ' HD2' ' A' ' 81' ' ' PRO . 23.2 m-85 -93.88 165.27 12.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.369 -0.832 . . . . 0.0 109.07 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.481 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 0.2 OUTLIER -144.46 97.81 3.1 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.057 -1.027 . . . . 0.0 110.205 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.581 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.5 OUTLIER -101.96 157.77 16.62 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.356 -0.84 . . . . 0.0 108.842 178.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.531 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 4.5 p90 -160.24 -148.4 0.17 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.157 -0.964 . . . . 0.0 109.653 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.473 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 74.7 m -132.96 161.29 34.69 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.159 -0.963 . . . . 0.0 109.641 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.588 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 19.5 tt0 -77.71 -47.25 2.37 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.298 -0.876 . . . . 0.0 109.23 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.5 Cg_endo -79.23 -66.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.106 0 C-N-CA 122.206 1.938 . . . . 0.0 110.478 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.713 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 14.4 m80 -55.03 87.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.063 -1.023 . . . . 0.0 109.149 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 91' ' ' PRO . 3.7 mtm180 -131.05 32.73 4.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.162 -0.961 . . . . 0.0 109.592 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -149.99 16.78 1.05 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -138.69 37.32 2.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.279 -1.13 . . . . 0.0 109.479 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.71 53.65 28.41 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.457 ' SD ' ' HB3' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -102.04 56.86 0.81 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.21 -1.171 . . . . 0.0 109.423 179.807 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 2.5 p -135.6 94.72 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.244 -0.91 . . . . 0.0 109.383 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.581 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -70.99 179.24 31.89 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.481 ' HG2' ' HA ' ' A' ' 86' ' ' THR . 23.0 mtmm -154.81 131.18 10.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -1.133 . . . . 0.0 109.707 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.596 ' CD1' ' CZ ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -96.99 136.68 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.166 -0.959 . . . . 0.0 108.594 179.207 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.4 100.59 7.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.147 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 1.6 t -99.94 125.55 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.889 . . . . 0.0 109.562 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.23 179.764 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.457 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 15.8 m-85 -117.08 174.45 6.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 109.468 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.9 m -156.35 116.41 3.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.909 . . . . 0.0 109.466 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.441 ' CG1' ' HB3' ' A' ' 16' ' ' PHE . 1.4 t -104.17 82.58 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.91 . . . . 0.0 109.449 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.448 ' HG2' ' CD1' ' A' ' 32' ' ' LEU . 6.7 mttp -69.8 85.97 0.49 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.284 -0.885 . . . . 0.0 109.383 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.507 ' HB2' ' CE ' ' A' ' 97' ' ' MET . 0.2 OUTLIER -62.54 -172.58 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.239 -0.913 . . . . 0.0 109.599 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.483 ' CA ' HD22 ' A' ' 14' ' ' LEU . . . 54.92 87.4 0.02 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.8 p -60.55 -90.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -1.153 . . . . 0.0 109.422 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -175.57 29.55 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.243 -0.911 . . . . 0.0 109.718 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -123.05 -19.28 6.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.188 -0.945 . . . . 0.0 109.523 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.03 -13.83 5.74 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 mt -96.23 147.65 23.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -1.116 . . . . 0.0 109.141 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.561 HD13 ' CD2' ' A' ' 92' ' ' HIS . 16.0 mt -109.8 112.18 24.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 109.553 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.0 m -138.56 136.0 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 109.468 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.441 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 28.4 m-85 -54.57 143.4 24.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.212 -0.93 . . . . 0.0 109.363 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 27.3 mt-10 -143.0 108.76 5.42 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.26 -0.9 . . . . 0.0 108.995 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.4 Cg_endo -76.59 164.68 86.99 Favored 'Cis proline' 0 C--N 1.311 -1.408 0 C-N-CA 123.811 -1.329 . . . . 0.0 110.894 0.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.51 -60.25 2.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.435 -0.791 . . . . 0.0 109.914 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.468 ' O ' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -78.78 136.59 37.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 109.553 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 20' ' ' LYS . 0.8 OUTLIER -127.04 109.55 12.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.232 -0.918 . . . . 0.0 109.777 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.4 m -88.71 94.98 10.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.215 -0.928 . . . . 0.0 108.835 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.53 HD11 ' CG2' ' A' ' 103' ' ' VAL . 1.1 pp -106.72 165.41 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.32 -0.862 . . . . 0.0 110.197 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.56 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -88.68 -178.76 1.1 Allowed Pre-proline 0 C--N 1.302 -1.485 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.815 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.56 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 36.3 Cg_endo -80.2 86.3 1.68 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.123 1.882 . . . . 0.0 110.694 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 123.74 2.07 8.83 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.453 ' OD2' ' HG3' ' A' ' 24' ' ' LYS . 4.0 m-20 -66.22 -179.17 0.73 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.221 -1.164 . . . . 0.0 109.21 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 57.2 m -121.97 120.46 34.48 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.293 -0.88 . . . . 0.0 109.362 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.593 ' HB ' ' CZ ' ' A' ' 31' ' ' PHE . 21.8 t -99.15 123.75 52.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.345 -0.847 . . . . 0.0 108.994 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.61 123.03 43.49 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.242 -0.911 . . . . 0.0 109.9 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.593 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -122.64 142.85 50.21 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.124 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.499 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -142.43 179.2 7.09 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.977 -1.077 . . . . 0.0 110.222 -179.584 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.577 ' ND2' ' O ' ' A' ' 67' ' ' SER . 0.4 OUTLIER -105.88 130.64 53.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.641 -0.662 . . . . 0.0 109.716 179.072 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 45.6 t30 -72.16 -59.57 2.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.068 -1.02 . . . . 0.0 109.205 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.428 ' C ' HG21 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -172.72 36.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.311 -0.868 . . . . 0.0 109.42 179.716 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.594 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 32.1 t -148.65 55.79 2.25 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.303 -0.873 . . . . 0.0 109.729 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.594 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 37.0 Cg_endo -78.8 174.62 11.99 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.461 2.107 . . . . 0.0 110.443 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.552 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 37.8 Cg_endo -84.89 169.92 48.65 Favored 'Cis proline' 0 C--N 1.31 -1.477 0 C-N-CA 123.463 -1.474 . . . . 0.0 110.145 -1.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.689 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 71.9 m-70 -123.03 152.89 40.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.279 -0.888 . . . . 0.0 110.543 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.424 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 0.1 OUTLIER -124.23 103.11 8.05 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.7 t -98.92 109.35 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.71 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.527 ' HA ' ' HB3' ' A' ' 60' ' ' SER . 3.1 t -134.26 162.32 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.44 -0.788 . . . . 0.0 109.591 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.588 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 6.0 m-85 -110.13 96.76 6.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.397 -0.814 . . . . 0.0 109.666 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 43' ' ' PHE . 9.0 t70 -43.34 167.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.506 -0.746 . . . . 0.0 109.86 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -115.91 15.2 16.28 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.397 -0.815 . . . . 0.0 109.437 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -120.24 -3.71 10.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.614 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.0 mp -114.2 40.21 2.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.159 -0.963 . . . . 0.0 109.497 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 48' ' ' ASN . 0.4 OUTLIER -109.6 165.93 11.74 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 0.0 109.442 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 34.9 Cg_endo -77.11 -53.39 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.631 2.221 . . . . 0.0 110.493 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -100.61 30.37 3.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.363 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.479 ' HA ' ' OD1' ' A' ' 48' ' ' ASN . 0.3 OUTLIER 39.82 54.35 2.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.703 -0.623 . . . . 0.0 109.76 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.43 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 1.5 m -99.98 152.59 20.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 109.494 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.85 47.84 1.53 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 109.515 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 54' ' ' ASP . 4.6 m-20 -115.09 -71.78 0.73 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.235 -0.916 . . . . 0.0 109.57 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.466 ' HG ' ' N ' ' A' ' 56' ' ' ALA . 1.1 pp -53.92 -27.67 32.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 109.46 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.466 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -66.15 -38.58 88.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 109.325 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -36.33 75.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.247 -0.908 . . . . 0.0 109.39 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.7 t -101.77 30.47 4.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 0.0 109.499 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.587 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 10.2 tp -120.26 -33.49 3.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.243 -0.911 . . . . 0.0 109.293 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.527 ' HB3' ' HA ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -78.88 152.69 31.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.353 -0.842 . . . . 0.0 110.603 -178.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.558 ' CD2' HG22 ' A' ' 72' ' ' THR . 10.3 p80 -98.07 168.55 10.2 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.66 -33.02 4.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.047 -1.033 . . . . 0.0 109.784 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -73.81 108.31 6.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 109.553 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.41 HD12 ' HB2' ' A' ' 38' ' ' PRO . 1.5 mm? -44.47 157.9 0.06 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.15 -0.969 . . . . 0.0 109.566 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.542 ' CD1' ' HB2' ' A' ' 71' ' ' SER . 0.8 OUTLIER -104.82 91.56 3.88 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.479 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -89.18 -15.46 33.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.208 -0.932 . . . . 0.0 110.869 -178.703 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.577 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 22.9 t -78.75 113.06 31.81 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.857 -1.152 . . . . 0.0 108.52 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.479 ' HB3' ' HG3' ' A' ' 37' ' ' PRO . 32.1 Cg_endo -73.44 120.21 6.38 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.301 2.0 . . . . 0.0 111.007 -178.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.55 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 110.74 -15.4 29.09 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.56 ' N ' ' OD1' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -149.45 113.39 5.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.349 -1.089 . . . . 0.0 109.097 179.795 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.553 ' OG ' ' N ' ' A' ' 72' ' ' THR . 4.2 p -103.31 -135.91 0.33 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.123 -0.985 . . . . 0.0 108.931 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.558 HG22 ' CD2' ' A' ' 61' ' ' HIS . 6.9 t -114.94 157.08 23.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.746 -1.221 . . . . 0.0 109.296 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.93 -173.41 2.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.15 -0.969 . . . . 0.0 109.414 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.534 ' CG2' HD11 ' A' ' 59' ' ' LEU . 29.8 m -162.78 108.2 1.16 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.728 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.96 88.99 7.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.415 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.587 ' CZ ' HD21 ' A' ' 59' ' ' LEU . 8.9 m-85 -45.34 163.63 0.2 Allowed Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.324 -0.86 . . . . 0.0 109.286 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.49 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.6 Cg_endo -76.91 161.1 33.43 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.602 2.202 . . . . 0.0 111.159 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.45 -3.2 13.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.498 -0.751 . . . . 0.0 110.035 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -99.37 -76.16 0.55 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.09 -1.006 . . . . 0.0 109.2 179.826 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.541 ' N ' ' HD3' ' A' ' 81' ' ' PRO . . . 37.7 57.52 4.45 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.553 -0.717 . . . . 0.0 110.399 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 80' ' ' ALA . 36.1 Cg_endo -77.93 -160.37 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.373 2.049 . . . . 0.0 110.282 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 81' ' ' PRO . . . 72.7 -73.83 0.09 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.888 . . . . 0.0 109.896 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.417 ' HA2' ' N ' ' A' ' 103' ' ' VAL . . . 108.12 25.43 5.86 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -151.37 111.56 4.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.316 -1.108 . . . . 0.0 109.895 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' ' 100' ' ' LYS . 52.5 m-85 -138.54 83.85 1.99 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.447 ' OG1' ' CD ' ' A' ' 100' ' ' LYS . 18.4 m -78.29 121.29 24.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.874 . . . . 0.0 110.596 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CE1' ' C ' ' A' ' 99' ' ' GLY . 2.0 p90 -117.07 173.1 6.85 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.476 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 2.9 p90 -158.78 -157.4 0.61 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.836 -1.165 . . . . 0.0 110.228 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 0.1 OUTLIER -131.83 151.99 51.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.4 -0.813 . . . . 0.0 109.725 -179.305 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.612 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 1.8 tm-20 -82.77 -45.61 0.9 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.0 109.932 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.7 Cg_endo -80.53 -51.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.125 1.883 . . . . 0.0 110.592 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.689 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 12.9 m80 -86.01 40.61 0.87 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 109.71 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.438 ' HG2' ' N ' ' A' ' 94' ' ' GLY . 16.5 ttt180 -76.49 141.09 41.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.198 -0.939 . . . . 0.0 109.358 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.438 ' N ' ' HG2' ' A' ' 93' ' ' ARG . . . 72.63 17.66 78.16 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.88 37.68 4.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.157 -1.202 . . . . 0.0 109.513 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.65 12.09 77.65 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.507 ' CE ' ' HB2' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -95.66 64.66 2.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -1.19 . . . . 0.0 109.497 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 28.3 t -140.24 73.84 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 109.661 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.492 ' C ' ' CE1' ' A' ' 87' ' ' PHE . . . -89.05 167.73 34.78 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 14.3 mttp -144.23 138.08 27.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.152 -1.205 . . . . 0.0 109.758 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.538 HD12 ' CE2' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -89.14 126.31 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 108.876 179.683 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 99.6 m -101.91 99.6 9.81 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.53 ' CG2' HD11 ' A' ' 23' ' ' ILE . 2.5 t -98.9 73.45 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.222 -0.924 . . . . 0.0 109.672 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 103' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.369 -0.832 . . . . 0.0 109.414 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -131.07 93.08 3.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 109.322 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.449 ' CG2' ' HB3' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -92.7 103.41 15.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.922 . . . . 0.0 109.597 -179.841 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.482 HG11 ' CD1' ' A' ' 21' ' ' LEU . 8.2 m -96.05 110.86 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.212 -0.93 . . . . 0.0 109.281 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -79.82 133.55 36.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.238 -0.914 . . . . 0.0 109.454 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.637 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -110.03 73.46 0.84 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.736 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.413 ' HA3' ' CG ' ' A' ' 34' ' ' ASN . . . 165.52 77.85 0.03 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.478 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 2.0 p -47.84 -31.13 4.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -1.139 . . . . 0.0 109.186 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 9' ' ' SER . 6.4 t0 75.78 19.1 2.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.339 -0.851 . . . . 0.0 109.562 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -135.46 7.42 3.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.93 . . . . 0.0 109.722 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -173.49 -79.63 0.05 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.17 -171.48 2.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -1.155 . . . . 0.0 109.743 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.491 ' HB3' ' HE2' ' A' ' 97' ' ' MET . 8.6 mt -106.12 126.81 52.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.386 -0.821 . . . . 0.0 108.956 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -157.18 136.5 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.089 -1.007 . . . . 0.0 109.769 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -53.22 157.89 1.76 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.124 -0.985 . . . . 0.0 108.901 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 2.2 mt-10 -150.96 108.44 3.04 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 109.518 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 35.2 Cg_endo -78.95 166.62 78.82 Favored 'Cis proline' 0 C--N 1.313 -1.291 0 C-N-CA 123.898 -1.292 . . . . 0.0 110.534 -0.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.9 -54.21 14.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.094 -1.004 . . . . 0.0 108.978 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -86.06 159.42 19.57 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.361 -0.837 . . . . 0.0 108.893 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.482 ' CD1' HG11 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -157.99 129.01 6.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.012 -1.055 . . . . 0.0 109.944 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.0 m -100.0 90.14 4.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.378 -0.826 . . . . 0.0 109.213 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.53 ' CG1' HG23 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -99.56 166.1 2.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.206 -0.934 . . . . 0.0 109.995 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.474 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -89.28 173.0 6.48 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.348 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.531 ' HA ' ' CB ' ' A' ' 80' ' ' ALA . 34.7 Cg_endo -76.64 83.3 2.1 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.178 1.919 . . . . 0.0 110.497 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 137.56 -26.73 2.89 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.469 ' OD2' ' HB2' ' A' ' 24' ' ' LYS . 3.1 m-20 -43.8 165.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -1.156 . . . . 0.0 109.414 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 86.7 m -111.05 118.34 35.78 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.205 -0.934 . . . . 0.0 109.678 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.571 ' HB ' ' CZ ' ' A' ' 31' ' ' PHE . 2.7 t -99.21 123.85 52.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.199 -0.938 . . . . 0.0 109.17 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.449 ' HB3' ' CG2' ' A' ' 4' ' ' THR . 0.0 OUTLIER -100.23 128.61 46.27 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.245 -0.909 . . . . 0.0 109.975 -179.532 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.571 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -129.23 146.1 51.21 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.608 ' N ' ' CD1' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -140.63 -167.74 2.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.966 -1.084 . . . . 0.0 110.353 -179.609 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 67' ' ' SER . 2.1 p-10 -114.83 160.22 19.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.263 -0.898 . . . . 0.0 109.57 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.413 ' CG ' ' HA3' ' A' ' 8' ' ' GLY . 12.9 t30 -104.47 -154.28 0.5 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.249 -0.907 . . . . 0.0 109.417 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -92.89 28.31 2.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.13 -0.981 . . . . 0.0 109.254 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.54 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 3.0 t -141.84 61.89 13.6 Favored Pre-proline 0 C--N 1.299 -1.611 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.577 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.4 Cg_endo -77.93 177.32 8.94 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 123.05 2.5 . . . . 0.0 110.804 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.581 ' O ' ' CE1' ' A' ' 92' ' ' HIS . 39.6 Cg_endo -87.91 158.91 44.84 Favored 'Cis proline' 0 C--N 1.313 -1.315 0 O-C-N 123.723 1.381 . . . . 0.0 110.908 -1.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.716 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 72.5 m-70 -118.65 156.73 28.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.493 -0.754 . . . . 0.0 109.501 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 18.9 t30 -140.08 114.33 9.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.293 -0.879 . . . . 0.0 109.019 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.456 ' O ' HG12 ' A' ' 42' ' ' VAL . 3.8 t -99.72 122.75 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.889 . . . . 0.0 109.125 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.621 ' HA ' ' CB ' ' A' ' 60' ' ' SER . 0.2 OUTLIER -157.96 141.36 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.106 -0.996 . . . . 0.0 110.231 179.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.628 ' CE2' ' CG ' ' A' ' 59' ' ' LEU . 4.4 m-85 -85.98 121.5 28.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.737 -0.602 . . . . 0.0 109.793 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.469 ' OD2' HD23 ' A' ' 47' ' ' LEU . 24.9 t70 -45.74 169.0 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.413 -0.804 . . . . 0.0 109.419 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.86 -16.06 14.24 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.219 -0.926 . . . . 0.0 109.943 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.69 -14.01 11.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.138 -0.977 . . . . 0.0 109.682 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.469 HD23 ' OD2' ' A' ' 44' ' ' ASP . 2.8 mm? -94.1 48.83 1.27 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.182 -0.949 . . . . 0.0 109.433 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.509 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 3.5 p30 -129.48 163.83 43.82 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.254 -0.904 . . . . 0.0 109.496 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.509 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 34.0 Cg_endo -76.3 -11.57 19.15 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.486 2.124 . . . . 0.0 109.95 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 52' ' ' SER . . . -139.4 77.33 1.61 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -40.4 93.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.973 -179.417 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 50' ' ' ALA . 2.0 m -140.35 154.23 46.68 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.321 -0.862 . . . . 0.0 109.389 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.01 72.03 0.87 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.269 -0.894 . . . . 0.0 109.254 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -167.73 -38.4 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.156 -0.965 . . . . 0.0 109.699 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 0.9 OUTLIER -78.13 -8.14 57.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.112 -0.992 . . . . 0.0 109.517 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 57' ' ' LYS . . . -112.47 -43.83 3.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.901 . . . . 0.0 109.632 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 56' ' ' ALA . 47.7 tttp -43.52 -48.63 7.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.894 . . . . 0.0 109.575 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -98.15 25.55 6.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.893 . . . . 0.0 109.682 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.628 ' CG ' ' CE2' ' A' ' 43' ' ' PHE . 17.1 tp -104.1 -62.53 1.3 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.147 -0.971 . . . . 0.0 109.625 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.621 ' CB ' ' HA ' ' A' ' 42' ' ' VAL . 0.3 OUTLIER -85.8 -167.61 1.92 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.222 -0.924 . . . . 0.0 110.637 -178.778 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.441 ' CE1' HD13 ' A' ' 65' ' ' LEU . 25.3 p80 -120.68 142.0 49.88 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.29 -42.33 13.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 0.0 109.59 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.467 ' NE2' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -46.65 163.76 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.898 . . . . 0.0 109.496 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.484 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 2.3 mp -97.37 -179.01 4.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.938 . . . . 0.0 109.411 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.473 HD11 ' N ' ' A' ' 65' ' ' LEU . 7.1 mp -118.96 81.98 1.79 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -0.951 . . . . 0.0 109.407 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.13 -34.7 29.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 109.524 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.52 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 46.0 t -80.58 146.83 61.83 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.922 . . . . 0.0 109.531 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.446 ' HD2' ' OG ' ' A' ' 67' ' ' SER . 35.5 Cg_endo -77.84 102.55 1.6 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.641 2.228 . . . . 0.0 110.594 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.493 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 109.24 -26.67 14.37 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.506 ' CB ' ' HB3' ' A' ' 67' ' ' SER . 6.8 tt0 -62.22 105.63 0.63 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.132 -1.217 . . . . 0.0 108.464 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.561 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . 21.5 p -137.86 -161.48 1.18 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.165 -0.959 . . . . 0.0 110.695 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 t -153.82 124.16 7.02 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.3 p -79.27 135.93 36.9 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.141 -0.974 . . . . 0.0 109.517 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.532 ' CG2' ' HG ' ' A' ' 59' ' ' LEU . 86.3 m -98.54 114.33 26.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.377 -0.827 . . . . 0.0 109.711 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 76' ' ' PHE . 1.2 t -83.83 82.97 8.1 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -0.89 . . . . 0.0 109.452 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.634 ' CZ ' ' CD1' ' A' ' 101' ' ' ILE . 14.6 m-85 -43.34 149.1 0.59 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.094 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.478 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.6 Cg_endo -75.99 168.89 23.24 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.592 2.194 . . . . 0.0 110.842 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.34 6.59 6.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.424 -0.797 . . . . 0.0 109.783 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' A' ' 80' ' ' ALA . 30.9 t70 -99.12 -77.6 0.51 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.103 -0.998 . . . . 0.0 109.242 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.531 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . . . 56.66 109.31 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.35 -0.843 . . . . 0.0 108.856 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.43 ' HG2' ' HG2' ' A' ' 49' ' ' PRO . 33.3 Cg_endo -74.31 113.55 3.82 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.328 2.018 . . . . 0.0 110.688 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -46.41 109.3 0.18 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.365 -0.834 . . . . 0.0 109.459 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.424 ' HA3' ' HB3' ' A' ' 49' ' ' PRO . . . 179.13 -119.28 0.64 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -160.44 106.23 1.5 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.2 -1.176 . . . . 0.0 109.784 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.607 ' CD2' ' CG2' ' A' ' 101' ' ' ILE . 0.7 OUTLIER -82.35 131.58 35.22 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.244 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 92.4 m -111.92 117.25 32.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.052 -1.03 . . . . 0.0 110.669 -179.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.575 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -111.51 169.91 8.48 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.467 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 7.1 p90 -159.12 -154.11 0.4 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.856 -1.152 . . . . 0.0 110.089 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 0.5 OUTLIER -128.78 141.78 51.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.398 -0.814 . . . . 0.0 109.795 -179.205 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.619 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 7.4 tp10 -72.08 -47.02 11.33 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.201 -0.937 . . . . 0.0 109.57 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.9 Cg_endo -79.73 -68.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.157 0 C-N-CA 122.271 1.981 . . . . 0.0 110.333 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.716 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 9.9 m80 -69.98 64.44 0.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.135 -0.978 . . . . 0.0 109.048 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' ' 91' ' ' PRO . 4.2 mtm180 -84.58 -10.2 57.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.678 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -122.78 54.32 0.71 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -151.39 39.3 0.65 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -1.13 . . . . 0.0 109.549 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 48.24 22.05 2.16 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.534 ' CE ' ' HB2' ' A' ' 7' ' ' LEU . 2.5 mtp -80.5 55.71 2.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.981 -1.306 . . . . 0.0 109.116 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 39.4 t -130.63 113.57 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.635 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.562 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -96.55 -173.1 35.12 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 14.9 mttt -160.53 122.34 3.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -1.182 . . . . 0.0 109.66 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.634 ' CD1' ' CZ ' ' A' ' 76' ' ' PHE . 0.7 OUTLIER -91.06 119.03 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.149 -0.97 . . . . 0.0 109.344 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.0 m -105.17 94.98 5.53 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.517 HG23 ' CG2' ' A' ' 101' ' ' ILE . 91.3 t -99.28 129.18 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.218 -0.926 . . . . 0.0 109.825 -179.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.406 -0.809 . . . . 0.0 109.481 179.956 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 28' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -90.23 154.27 19.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.437 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.98 107.91 13.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.718 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.499 ' CG1' ' HB3' ' A' ' 16' ' ' PHE . 1.3 t -105.93 123.28 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.887 . . . . 0.0 109.324 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.436 ' HG2' HD13 ' A' ' 32' ' ' LEU . 13.8 mttm -117.75 90.3 3.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 109.41 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.445 HD13 ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -50.55 164.38 0.13 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.166 -0.959 . . . . 0.0 109.528 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.18 76.36 0.91 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 3.2 p -48.02 -60.44 2.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -1.164 . . . . 0.0 109.306 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 9' ' ' SER . 1.1 t70 174.46 -62.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.403 -0.81 . . . . 0.0 109.288 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.85 18.95 6.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.313 -0.867 . . . . 0.0 109.283 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.428 ' O ' ' HG ' ' A' ' 13' ' ' LEU . . . -105.84 -92.5 2.27 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.512 HD11 ' N ' ' A' ' 13' ' ' LEU . 1.1 mp -143.86 -165.37 2.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.262 -1.14 . . . . 0.0 109.668 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.649 ' CD1' ' CD2' ' A' ' 92' ' ' HIS . 10.8 mt -100.64 52.37 0.87 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.41 -0.806 . . . . 0.0 109.359 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.0 m -94.84 149.91 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 109.514 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.499 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 51.8 m-85 -65.16 177.35 1.06 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -0.923 . . . . 0.0 109.309 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 16' ' ' PHE . 4.7 mt-10 -160.16 108.01 1.4 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.907 . . . . 0.0 109.367 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 33.0 Cg_endo -75.13 170.14 72.64 Favored 'Cis proline' 0 C--N 1.311 -1.408 0 C-N-CA 123.602 -1.416 . . . . 0.0 110.678 0.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.66 -63.27 1.11 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.246 -0.909 . . . . 0.0 109.421 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -80.02 158.1 26.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.176 -0.952 . . . . 0.0 109.309 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -150.47 118.79 6.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.416 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 102' ' ' THR . 24.2 m -89.51 92.1 8.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.235 -0.916 . . . . 0.0 109.611 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.52 ' CG1' HG21 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -99.62 175.8 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.291 -0.881 . . . . 0.0 109.569 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.539 ' CG ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -88.69 179.2 1.71 Allowed Pre-proline 0 C--N 1.302 -1.464 0 O-C-N 121.355 -0.841 . . . . 0.0 108.818 179.613 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.539 ' HD2' ' CG ' ' A' ' 24' ' ' LYS . 35.1 Cg_endo -78.58 77.23 4.11 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.371 2.047 . . . . 0.0 110.889 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 116.4 27.4 2.87 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.442 ' CG ' ' HB2' ' A' ' 24' ' ' LYS . 6.0 m-20 -84.1 -176.68 6.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.154 -1.203 . . . . 0.0 109.097 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 2' ' ' THR . 90.2 m -112.98 129.02 56.64 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.251 -0.906 . . . . 0.0 109.583 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.522 ' HB ' ' CZ ' ' A' ' 31' ' ' PHE . 4.2 t -115.59 124.35 71.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.309 -0.87 . . . . 0.0 108.77 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -99.15 125.47 44.72 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.27 -0.894 . . . . 0.0 109.649 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.522 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.3 OUTLIER -116.3 153.78 31.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.38 -0.825 . . . . 0.0 108.941 -179.868 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.542 ' HB3' ' N ' ' A' ' 70' ' ' GLN . 0.1 OUTLIER -141.36 -171.62 3.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.981 -1.075 . . . . 0.0 109.95 -179.603 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.551 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 3.2 p-10 -123.14 167.45 13.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.382 -0.823 . . . . 0.0 109.093 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -157.31 -58.16 0.08 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.906 -1.121 . . . . 0.0 110.111 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.534 ' HB3' ' CD2' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -71.51 -150.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 0.0 110.161 -179.356 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.2 t -69.37 115.27 30.76 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.594 -0.691 . . . . 0.0 110.352 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.565 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.4 Cg_endo -79.62 178.53 7.23 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 122.915 2.41 . . . . 0.0 109.997 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.565 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 41.5 Cg_endo -88.48 163.61 41.92 Favored 'Cis proline' 0 C--N 1.313 -1.331 0 O-C-N 123.339 1.179 . . . . 0.0 110.707 -1.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.675 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 97.3 m-70 -126.01 122.59 36.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.175 -0.953 . . . . 0.0 110.018 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.448 ' OD1' ' HA ' ' A' ' 64' ' ' LEU . 2.0 t30 -99.45 142.55 30.79 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.425 -0.797 . . . . 0.0 109.163 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.475 ' C ' ' CG2' ' A' ' 42' ' ' VAL . 7.1 t -110.51 118.13 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.937 . . . . 0.0 109.422 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.61 ' HA ' ' CB ' ' A' ' 60' ' ' SER . 1.6 t -153.84 138.69 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.164 -0.96 . . . . 0.0 110.099 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.633 ' CE2' ' CG ' ' A' ' 59' ' ' LEU . 2.8 m-85 -87.33 126.22 34.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.658 -0.651 . . . . 0.0 109.643 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -51.67 137.54 24.94 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.236 -0.915 . . . . 0.0 108.924 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.41 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . . . -83.93 14.92 3.66 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.186 -0.946 . . . . 0.0 109.815 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.07 11.87 6.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.156 -0.965 . . . . 0.0 109.62 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 76.1 mt -126.66 50.4 1.94 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.93 . . . . 0.0 109.635 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 51' ' ' LYS . 5.2 p30 -119.67 159.39 46.47 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 0.0 109.122 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 36.2 Cg_endo -77.85 -2.23 12.37 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.566 2.177 . . . . 0.0 110.664 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.519 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -123.17 28.74 7.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.204 -0.935 . . . . 0.0 109.655 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.519 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER 28.49 40.88 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.108 0.48 . . . . 0.0 110.728 179.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 50' ' ' ALA . 72.9 m -135.91 -171.52 2.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.123 -0.986 . . . . 0.0 109.816 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.41 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . . . -146.34 19.58 1.37 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.305 -0.872 . . . . 0.0 109.598 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -68.96 -31.31 70.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 109.499 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 0.6 OUTLIER -102.0 22.77 12.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.546 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -117.36 -54.99 2.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -0.881 . . . . 0.0 109.351 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -56.97 -28.58 62.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.372 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.4 p -108.99 30.22 6.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.283 -0.886 . . . . 0.0 109.625 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.633 ' CG ' ' CE2' ' A' ' 43' ' ' PHE . 26.7 tp -115.87 -62.15 1.63 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.205 -0.934 . . . . 0.0 109.444 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.61 ' CB ' ' HA ' ' A' ' 42' ' ' VAL . 0.6 OUTLIER -80.15 -171.46 2.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.264 -0.898 . . . . 0.0 110.627 -178.703 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -115.11 157.36 23.68 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.627 -0.671 . . . . 0.0 109.295 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.58 -14.44 16.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 109.682 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -76.93 130.36 37.43 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.172 -0.955 . . . . 0.0 109.488 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.448 ' HA ' ' OD1' ' A' ' 40' ' ' ASN . 8.6 mp -60.86 179.98 0.15 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.267 -0.895 . . . . 0.0 109.375 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.514 ' CD2' ' CB ' ' A' ' 71' ' ' SER . 2.5 mp -98.57 135.22 40.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.232 -0.918 . . . . 0.0 109.349 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 3.1 mmt -127.11 1.56 6.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.187 -0.946 . . . . 0.0 109.413 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.3 t -111.45 129.41 24.12 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.908 . . . . 0.0 109.229 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.446 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.2 Cg_endo -78.47 87.0 1.58 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.338 2.026 . . . . 0.0 110.514 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.551 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 114.87 35.01 1.42 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.542 ' N ' ' HB3' ' A' ' 32' ' ' LEU . 1.0 OUTLIER 178.55 112.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -1.133 . . . . 0.0 109.366 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.589 ' OG ' ' N ' ' A' ' 72' ' ' THR . 21.5 p -104.85 -82.19 0.52 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.108 -0.995 . . . . 0.0 109.429 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.589 ' N ' ' OG ' ' A' ' 71' ' ' SER . 85.2 m -160.83 156.28 24.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.007 -1.058 . . . . 0.0 109.346 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 75' ' ' THR . 0.8 OUTLIER -102.68 67.31 0.98 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.158 -0.964 . . . . 0.0 109.309 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.441 ' CG2' ' O ' ' A' ' 59' ' ' LEU . 97.8 m -46.26 99.28 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.364 -0.835 . . . . 0.0 109.642 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.416 ' N ' ' O ' ' A' ' 73' ' ' SER . 19.0 m -78.89 95.87 5.54 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.449 ' HB3' ' HD2' ' A' ' 77' ' ' PRO . 8.0 m-85 -47.85 162.45 0.32 Allowed Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.526 -0.734 . . . . 0.0 109.34 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.538 ' HD3' ' CD1' ' A' ' 59' ' ' LEU . 35.0 Cg_endo -76.61 173.37 14.59 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.695 2.263 . . . . 0.0 111.12 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.75 8.51 7.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.295 -0.878 . . . . 0.0 109.629 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -99.32 -71.01 0.71 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.217 -0.927 . . . . 0.0 109.147 179.781 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 79' ' ' ASP . . . 42.76 88.26 0.1 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.336 -0.852 . . . . 0.0 109.374 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.452 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 33.4 Cg_endo -75.61 127.79 10.53 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.616 2.21 . . . . 0.0 110.654 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 104' ' ' ALA . . . -43.06 136.92 2.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.439 -0.788 . . . . 0.0 109.553 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 152.65 172.92 21.57 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -96.88 126.34 41.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -1.144 . . . . 0.0 109.519 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.493 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 12.6 m-85 -97.6 -173.7 2.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 108.853 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 99.4 m -164.83 103.58 0.79 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.922 -1.111 . . . . 0.0 110.443 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.586 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.5 OUTLIER -101.24 166.07 10.96 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.563 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 97' ' ' MET . 4.9 p90 -159.96 -153.38 0.34 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.724 -1.235 . . . . 0.0 110.547 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 97' ' ' MET . 0.5 OUTLIER -129.1 148.03 51.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.543 -0.723 . . . . 0.0 109.49 -179.406 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 0.4 OUTLIER -84.0 -43.58 0.77 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.943 . . . . 0.0 110.511 179.621 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.2 Cg_endo -78.68 -67.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.065 0 C-N-CA 122.109 1.873 . . . . 0.0 110.872 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.675 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 69.5 m80 -65.93 75.36 0.08 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.99 -1.069 . . . . 0.0 109.551 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 91' ' ' PRO . 45.5 mtm180 -91.84 110.94 22.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.126 -0.984 . . . . 0.0 109.139 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.7 1.71 30.63 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.406 ' CB ' HD12 ' A' ' 14' ' ' LEU . . . -98.03 33.59 2.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -1.16 . . . . 0.0 109.475 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 64.27 13.14 53.22 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.527 ' CE ' ' O ' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -74.13 63.1 0.95 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.824 -1.398 . . . . 0.0 109.201 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 97' ' ' MET . 17.1 t -140.72 107.99 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.891 . . . . 0.0 109.61 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.586 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -112.21 179.45 19.48 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.441 ' HG3' ' C ' ' A' ' 99' ' ' GLY . 2.7 mtmp? -152.46 134.24 14.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.115 -1.227 . . . . 0.0 109.784 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.52 HG21 ' CG1' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -95.82 132.73 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.88 . . . . 0.0 108.831 179.568 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -107.02 97.8 7.53 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.137 -0.977 . . . . 0.0 108.829 179.252 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.478 HG23 HG13 ' A' ' 23' ' ' ILE . 3.8 t -99.3 73.86 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.028 -1.045 . . . . 0.0 109.463 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.472 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.395 -0.816 . . . . 0.0 109.538 179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.24 0.543 . . . . 0.0 109.586 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -86.1 163.39 17.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.319 -0.863 . . . . 0.0 109.302 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -151.93 111.96 4.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.044 -1.035 . . . . 0.0 109.957 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.465 ' CG1' HD13 ' A' ' 21' ' ' LEU . 6.5 m -104.98 79.97 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.275 -0.89 . . . . 0.0 109.255 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -58.2 148.32 27.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.314 -0.866 . . . . 0.0 109.714 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.482 ' CD1' ' O ' ' A' ' 32' ' ' LEU . 0.4 OUTLIER -118.05 -173.79 2.52 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.236 -0.915 . . . . 0.0 109.485 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.528 ' HA3' ' CB ' ' A' ' 34' ' ' ASN . . . 65.28 88.57 0.05 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.559 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -66.55 -22.84 66.16 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.31 -1.112 . . . . 0.0 109.384 179.699 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.559 ' CB ' ' O ' ' A' ' 9' ' ' SER . 8.4 t70 83.36 20.05 0.2 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.63 9.74 15.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 109.361 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.56 5.16 45.78 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.413 ' HG ' ' OG ' ' A' ' 9' ' ' SER . 0.4 OUTLIER -134.95 154.4 51.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -1.161 . . . . 0.0 109.825 -179.792 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.618 ' CD1' ' CD2' ' A' ' 92' ' ' HIS . 95.1 mt -113.91 121.4 43.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.353 -0.842 . . . . 0.0 109.172 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 14' ' ' LEU . 15.6 m -149.07 153.6 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.111 -0.993 . . . . 0.0 109.863 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.468 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 12.0 m-85 -76.57 156.21 32.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.172 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 16' ' ' PHE . 4.1 mt-10 -141.98 109.77 5.99 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.128 -0.983 . . . . 0.0 109.393 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.5 Cg_endo -77.51 -177.7 21.92 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 123.767 -1.347 . . . . 0.0 110.698 0.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.21 -58.36 3.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 109.333 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.07 168.74 9.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.915 . . . . 0.0 109.16 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.465 HD13 ' CG1' ' A' ' 5' ' ' VAL . 0.4 OUTLIER -160.1 146.06 15.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.082 -1.011 . . . . 0.0 109.927 -179.812 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.458 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 90.5 m -114.31 112.88 23.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.843 . . . . 0.0 109.011 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.532 ' CD1' HG21 ' A' ' 103' ' ' VAL . 0.9 OUTLIER -117.59 164.05 14.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.265 -0.897 . . . . 0.0 110.073 -179.682 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.535 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 17.0 mmmt -82.16 165.48 42.66 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.535 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 32.7 Cg_endo -74.81 86.26 1.41 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 121.945 1.763 . . . . 0.0 110.306 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 126.26 4.43 6.45 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.494 ' OD2' ' CG ' ' A' ' 24' ' ' LYS . 59.0 m-20 -71.07 -176.73 1.47 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -1.158 . . . . 0.0 109.58 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.433 ' CG2' ' HA ' ' A' ' 75' ' ' THR . 0.2 OUTLIER -120.04 122.93 42.21 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.284 -0.885 . . . . 0.0 109.636 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.561 ' HB ' ' CE2' ' A' ' 31' ' ' PHE . 1.4 t -111.17 147.32 15.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.224 -0.923 . . . . 0.0 109.334 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -117.56 141.34 48.47 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.176 -0.953 . . . . 0.0 110.111 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.561 ' CE2' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -145.33 89.73 1.96 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.541 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.5 OUTLIER -97.84 179.88 4.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.44 -0.787 . . . . 0.0 111.257 -178.028 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.536 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 3.8 p-10 -93.21 165.42 12.82 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.528 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . 42.0 t30 -115.7 -84.0 0.62 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.073 -1.017 . . . . 0.0 109.477 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.497 ' HG2' ' ND2' ' A' ' 34' ' ' ASN . 0.5 OUTLIER -145.95 35.15 1.01 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.087 -1.008 . . . . 0.0 109.643 179.892 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.55 ' O ' ' NE2' ' A' ' 92' ' ' HIS . 2.0 t -156.87 60.36 2.13 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.86 . . . . 0.0 109.305 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 35.8 Cg_endo -78.26 174.08 12.94 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.661 2.24 . . . . 0.0 110.631 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.535 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.9 Cg_endo -86.38 162.18 54.53 Favored 'Cis proline' 0 C--N 1.311 -1.445 0 O-C-N 123.798 1.42 . . . . 0.0 110.297 -1.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.711 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 65.2 m-70 -118.59 146.73 44.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.187 -0.946 . . . . 0.0 110.17 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -120.04 114.47 22.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 109.237 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.468 ' O ' HG22 ' A' ' 42' ' ' VAL . 24.7 t -99.92 114.06 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.508 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.536 ' HA ' ' CB ' ' A' ' 60' ' ' SER . 1.6 t -150.59 157.4 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.928 . . . . 0.0 109.874 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.568 ' CE2' ' HB3' ' A' ' 59' ' ' LEU . 3.8 m-85 -109.14 110.99 22.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.422 -0.799 . . . . 0.0 109.41 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -47.16 158.35 0.15 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.0 109.519 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.73 31.2 5.64 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.292 -0.88 . . . . 0.0 109.532 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.99 -31.71 4.99 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.182 -0.949 . . . . 0.0 109.644 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 mp -101.43 64.5 1.01 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.94 . . . . 0.0 109.656 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -111.79 158.72 35.83 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.309 -0.869 . . . . 0.0 109.394 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -80.01 -33.7 1.07 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.78 2.32 . . . . 0.0 110.564 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.481 ' O ' ' HG3' ' A' ' 51' ' ' LYS . . . -122.6 35.7 4.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.15 -0.969 . . . . 0.0 109.845 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 0.3 OUTLIER 34.28 49.75 0.34 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.869 -0.519 . . . . 0.0 110.529 179.634 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 m -127.44 141.21 51.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.12 -0.987 . . . . 0.0 109.675 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -121.04 10.43 10.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 109.401 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -62.31 -39.65 93.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.392 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.507 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 1.7 pp -80.93 -32.27 34.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.362 -0.836 . . . . 0.0 109.57 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.499 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -69.01 -43.74 74.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.081 -1.012 . . . . 0.0 109.571 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.12 -30.91 12.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.313 -0.867 . . . . 0.0 109.748 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 59' ' ' LEU . 0.1 OUTLIER -105.74 -40.42 5.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.163 -0.961 . . . . 0.0 110.009 -179.623 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.568 ' HB3' ' CE2' ' A' ' 43' ' ' PHE . 13.2 tp -43.01 -56.56 3.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.217 -0.927 . . . . 0.0 109.917 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.536 ' CB ' ' HA ' ' A' ' 42' ' ' VAL . 64.3 p -78.83 153.05 30.95 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.487 -0.758 . . . . 0.0 110.619 -177.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.498 ' CE1' ' O ' ' A' ' 63' ' ' GLN . 12.8 p80 -93.69 176.67 6.27 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.87 -57.61 2.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.726 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.498 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 3.3 pt20 -44.09 145.48 0.75 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 109.552 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 mp -78.29 167.98 20.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 109.505 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.477 ' CD1' ' CE1' ' A' ' 61' ' ' HIS . 7.7 mp -95.32 108.96 21.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 0.0 109.38 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 4.2 ttp -117.81 -0.4 11.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 0.0 109.673 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.522 ' OG ' ' CB ' ' A' ' 70' ' ' GLN . 3.2 t -91.23 147.28 35.21 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.147 -0.971 . . . . 0.0 109.557 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.23 87.96 1.48 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.712 2.275 . . . . 0.0 110.823 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.536 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 89.22 35.37 8.12 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.522 ' CB ' ' OG ' ' A' ' 67' ' ' SER . 1.6 tt0 -147.25 94.0 2.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.128 -1.219 . . . . 0.0 109.205 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.559 ' CB ' ' O ' ' A' ' 31' ' ' PHE . 4.4 p -99.88 -105.89 0.22 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.33 -0.856 . . . . 0.0 109.676 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.9 t -160.56 123.74 3.4 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.7 m -79.26 82.31 5.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.046 -1.034 . . . . 0.0 109.341 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.526 ' CG2' HD11 ' A' ' 59' ' ' LEU . 99.6 m -59.67 101.51 0.11 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.399 -0.813 . . . . 0.0 109.504 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.458 ' O ' ' C ' ' A' ' 76' ' ' PHE . 3.1 t -78.95 86.18 4.85 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.552 ' CE2' HD12 ' A' ' 101' ' ' ILE . 3.2 m-85 -36.22 147.97 0.18 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.887 -0.508 . . . . 0.0 110.125 -178.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.427 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.7 Cg_endo -78.28 175.74 10.75 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.793 2.329 . . . . 0.0 111.52 -178.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.76 9.78 13.15 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.493 ' O ' ' C ' ' A' ' 80' ' ' ALA . 2.2 t70 -99.15 -12.99 19.97 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.411 -0.806 . . . . 0.0 108.886 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.493 ' C ' ' O ' ' A' ' 79' ' ' ASP . . . -34.6 104.54 0.25 Allowed Pre-proline 0 N--CA 1.497 1.919 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.461 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 33.9 Cg_endo -75.57 152.65 38.4 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.531 2.154 . . . . 0.0 110.899 -179.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -71.67 131.6 43.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.437 -0.79 . . . . 0.0 109.413 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 155.34 -149.61 20.83 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.48 137.83 53.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.214 -1.168 . . . . 0.0 109.664 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.565 ' CD1' HG22 ' A' ' 101' ' ' ILE . 6.4 m-85 -101.51 -170.95 1.9 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.347 -0.846 . . . . 0.0 108.723 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 85' ' ' TYR . 92.6 m -166.79 98.4 0.55 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.859 -1.151 . . . . 0.0 110.463 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.535 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.6 OUTLIER -101.95 162.27 13.04 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.243 -0.911 . . . . 0.0 108.677 178.622 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -154.31 -162.0 1.33 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.927 -1.108 . . . . 0.0 110.112 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.63 141.45 48.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.492 -0.755 . . . . 0.0 109.391 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 19.2 tt0 -77.95 -44.71 2.34 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.213 -0.929 . . . . 0.0 110.181 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.0 Cg_endo -78.68 -64.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 122.0 1.8 . . . . 0.0 110.439 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.711 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 9.2 m80 -73.86 57.14 0.59 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.22 -0.925 . . . . 0.0 109.315 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 16.8 ttt85 -102.91 -8.6 20.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.564 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -88.66 22.9 18.76 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.92 -129.62 0.14 Allowed 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.313 -1.11 . . . . 0.0 108.692 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -127.74 36.95 2.42 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.524 ' CE ' ' HB3' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -80.61 70.29 7.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.121 -1.223 . . . . 0.0 109.602 179.784 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 53.0 t -140.97 113.24 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.212 -0.93 . . . . 0.0 109.626 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.535 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -114.77 172.12 14.07 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 85' ' ' TYR . 6.7 mttm -148.88 128.54 13.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -1.151 . . . . 0.0 109.648 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.565 HG22 ' CD1' ' A' ' 85' ' ' TYR . 0.8 OUTLIER -80.27 154.96 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.885 . . . . 0.0 108.971 179.676 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.458 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 0.7 OUTLIER -129.26 90.17 2.97 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.259 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.532 HG21 ' CD1' ' A' ' 23' ' ' ILE . 28.0 t -99.89 121.81 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.259 -0.9 . . . . 0.0 109.835 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.398 -0.814 . . . . 0.0 109.392 -179.966 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.466 ' O ' ' N ' ' A' ' 30' ' ' GLU . 43.1 m-85 -89.37 116.7 27.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -0.917 . . . . 0.0 109.615 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.6 m -118.42 120.57 37.96 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.319 -0.863 . . . . 0.0 109.3 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.461 HG11 ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -107.93 102.66 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 109.387 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 7' ' ' LEU . 2.4 ttmt -80.68 83.89 6.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.325 -0.859 . . . . 0.0 109.464 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.522 ' CG ' ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -47.42 173.23 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.356 -0.84 . . . . 0.0 109.677 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.52 ' HA3' ' CB ' ' A' ' 34' ' ' ASN . . . 83.34 94.4 0.61 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.472 ' OG ' ' N ' ' A' ' 10' ' ' ASP . 95.0 p -49.92 -75.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.289 -1.124 . . . . 0.0 109.536 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.472 ' N ' ' OG ' ' A' ' 9' ' ' SER . 20.9 t0 -173.16 -71.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.567 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.17 55.51 1.85 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.277 -0.889 . . . . 0.0 109.385 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.77 -95.23 0.1 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.42 166.24 11.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.297 -1.12 . . . . 0.0 109.46 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.605 ' CD1' ' CD2' ' A' ' 92' ' ' HIS . 17.2 mt -101.69 123.65 46.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.213 -0.929 . . . . 0.0 109.392 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 14' ' ' LEU . 22.2 m -143.98 159.08 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.615 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -71.92 164.32 26.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 109.376 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -154.24 104.59 2.41 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 109.419 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.461 ' HD2' HG11 ' A' ' 5' ' ' VAL . 33.5 Cg_endo -77.09 169.22 74.89 Favored 'Cis proline' 0 C--N 1.311 -1.441 0 C-N-CA 123.693 -1.378 . . . . 0.0 110.448 0.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.79 -25.41 62.0 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.232 -0.918 . . . . 0.0 109.738 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.438 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 10.6 mmtm -112.62 160.4 17.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.113 -0.992 . . . . 0.0 109.832 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.448 HD11 HG13 ' A' ' 5' ' ' VAL . 7.0 mt -143.72 108.75 4.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -0.866 . . . . 0.0 109.291 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.497 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 5.3 m -89.05 90.32 8.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.277 -0.889 . . . . 0.0 109.752 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.521 HD13 ' CG2' ' A' ' 103' ' ' VAL . 1.2 pt -101.35 171.67 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.24 -0.912 . . . . 0.0 109.685 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.63 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 7.8 mttt -86.83 -164.23 0.06 OUTLIER Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.63 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 30.8 Cg_endo -74.95 62.35 5.8 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 N-CA-C 109.314 -1.072 . . . . 0.0 109.314 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.535 ' O ' ' HB2' ' A' ' 76' ' ' PHE . . . 142.52 -92.19 0.17 Allowed Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.431 ' CG ' ' HG3' ' A' ' 24' ' ' LYS . 1.3 m-20 49.61 -176.2 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.119 -1.224 . . . . 0.0 109.55 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.513 ' CG2' ' OG ' ' A' ' 73' ' ' SER . 64.0 m -122.68 142.49 50.62 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.309 -0.869 . . . . 0.0 109.523 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.555 ' HB ' ' CZ ' ' A' ' 31' ' ' PHE . 2.4 t -125.13 148.79 29.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.289 -0.882 . . . . 0.0 109.307 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 3' ' ' TYR . 1.9 mt-10 -127.27 132.61 50.3 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.197 -0.939 . . . . 0.0 109.746 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.578 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -138.1 105.01 5.38 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.77 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.542 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -100.33 -171.47 2.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.066 -1.021 . . . . 0.0 111.026 -178.654 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.464 ' C ' ' OD1' ' A' ' 33' ' ' ASN . 3.2 p-10 -105.55 168.33 9.16 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.706 -0.621 . . . . 0.0 109.725 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.52 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . 30.2 t30 -114.64 -142.05 0.38 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.295 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.416 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -99.36 36.11 1.81 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.997 -1.064 . . . . 0.0 109.241 179.76 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.527 ' O ' ' NE2' ' A' ' 92' ' ' HIS . 2.1 t -151.46 61.95 4.64 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.573 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.2 Cg_endo -77.42 175.63 11.06 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.694 2.263 . . . . 0.0 110.955 -178.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.573 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 40.5 Cg_endo -87.87 158.51 44.81 Favored 'Cis proline' 0 C--N 1.313 -1.338 0 C-N-CA 123.573 -1.428 . . . . 0.0 110.74 -1.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.712 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 80.6 m-70 -121.99 160.88 23.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.382 -0.824 . . . . 0.0 109.858 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.74 165.8 26.31 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.4 -0.813 . . . . 0.0 108.847 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.556 ' HB ' ' CD2' ' A' ' 61' ' ' HIS . 43.3 t -137.45 114.65 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.113 -0.992 . . . . 0.0 109.144 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.521 HG12 ' CB ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -144.37 174.74 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.244 -0.91 . . . . 0.0 109.518 -179.443 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.592 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 4.2 m-85 -131.33 112.24 12.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 0.0 109.392 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.497 ' CB ' HD11 ' A' ' 47' ' ' LEU . 8.0 t70 -54.0 136.49 41.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 109.633 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.87 -2.67 58.71 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.261 -0.9 . . . . 0.0 109.648 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . 0.434 ' O ' ' HG ' ' A' ' 47' ' ' LEU . . . -107.75 13.82 26.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.181 -0.949 . . . . 0.0 109.645 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.497 HD11 ' CB ' ' A' ' 44' ' ' ASP . 1.5 mt -140.32 46.66 1.81 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 0.0 109.424 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.489 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 1.2 p30 -123.86 165.75 22.18 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.321 -0.862 . . . . 0.0 109.287 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.489 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 33.5 Cg_endo -76.02 -23.71 11.93 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.437 2.092 . . . . 0.0 109.689 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 52' ' ' SER . . . -140.17 83.9 1.94 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -40.06 95.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.462 -0.774 . . . . 0.0 109.986 -179.369 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 50' ' ' ALA . 4.5 m -138.31 107.26 5.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.391 -0.818 . . . . 0.0 109.159 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.89 -0.85 17.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 109.719 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -75.79 -53.69 8.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.906 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 2.1 pp -63.28 -29.84 71.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.158 -0.964 . . . . 0.0 109.591 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.459 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -73.45 -37.97 65.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 0.0 109.631 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.1 mttp -52.4 -30.35 28.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -0.947 . . . . 0.0 109.714 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.3 p -115.6 38.36 3.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -0.908 . . . . 0.0 109.507 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.599 HD23 ' CZ ' ' A' ' 76' ' ' PHE . 7.3 tp -135.64 -48.64 0.7 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -0.881 . . . . 0.0 109.29 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.521 ' CB ' HG12 ' A' ' 42' ' ' VAL . 1.2 p -78.88 122.16 25.75 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.478 -0.764 . . . . 0.0 110.289 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.556 ' CD2' ' HB ' ' A' ' 41' ' ' VAL . 4.4 p80 -90.71 159.32 16.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.367 -0.833 . . . . 0.0 108.974 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.48 -161.66 0.76 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.133 -0.979 . . . . 0.0 109.654 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 66.9 106.92 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.412 -0.805 . . . . 0.0 109.609 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.408 HD23 ' CG ' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -54.31 143.33 23.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 109.609 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.503 ' CD1' ' O ' ' A' ' 39' ' ' HIS . 1.1 mt -89.01 87.24 7.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.361 -0.837 . . . . 0.0 109.151 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' MET . . . . . 0.525 ' HG3' ' N ' ' A' ' 67' ' ' SER . 0.0 OUTLIER -85.4 -24.61 27.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.108 -0.995 . . . . 0.0 109.954 -179.636 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.525 ' N ' ' HG3' ' A' ' 66' ' ' MET . 1.9 t -79.98 147.66 66.35 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.288 -0.883 . . . . 0.0 109.425 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.86 100.37 1.37 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.572 2.181 . . . . 0.0 110.156 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.71 -25.84 17.9 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.43 ' HB2' ' OG ' ' A' ' 67' ' ' SER . 50.9 tt0 -62.52 110.79 1.8 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.14 -1.212 . . . . 0.0 108.532 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.536 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . 12.0 p -132.8 -155.03 0.65 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.138 -0.976 . . . . 0.0 110.934 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.7 m -152.05 116.66 5.08 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.513 ' OG ' ' CG2' ' A' ' 28' ' ' THR . 13.7 t -79.05 104.26 9.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -0.961 . . . . 0.0 108.966 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.525 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 91.6 m -73.27 109.07 6.52 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.408 -0.808 . . . . 0.0 109.956 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.474 ' O ' ' C ' ' A' ' 76' ' ' PHE . 3.3 t -79.39 80.42 5.76 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.599 ' CZ ' HD23 ' A' ' 59' ' ' LEU . 10.3 m-85 -36.24 151.97 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.819 -0.551 . . . . 0.0 110.162 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.38 171.01 17.59 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.799 2.332 . . . . 0.0 111.016 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -86.37 9.44 17.99 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 80' ' ' ALA . 1.0 OUTLIER -101.51 -8.73 21.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.455 -0.778 . . . . 0.0 109.477 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 79' ' ' ASP . . . -38.2 105.28 0.32 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.559 -0.713 . . . . 0.0 109.66 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.426 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 35.3 Cg_endo -77.34 146.51 24.92 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.501 2.134 . . . . 0.0 110.747 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.59 132.1 50.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.297 -0.877 . . . . 0.0 109.513 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 145.9 161.9 9.43 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 3.8 mt-10 -85.24 131.91 34.35 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.214 -1.168 . . . . 0.0 109.562 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.57 ' CD1' HG23 ' A' ' 101' ' ' ILE . 29.0 m-85 -84.44 -156.12 0.22 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -163.88 87.04 0.5 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.685 -1.26 . . . . 0.0 110.551 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.459 ' O ' HG21 ' A' ' 98' ' ' VAL . 1.1 p90 -99.92 160.97 13.9 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.508 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 9.5 p90 -159.22 -163.11 1.15 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.919 -1.113 . . . . 0.0 110.396 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.439 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 0.1 OUTLIER -123.49 133.64 54.0 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.513 -0.742 . . . . 0.0 109.775 -179.615 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.631 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.7 tm-20 -74.16 -43.01 5.87 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.336 -0.853 . . . . 0.0 110.669 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.1 Cg_endo -77.63 -54.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.902 1.735 . . . . 0.0 110.833 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.712 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 42.6 m80 -85.38 60.44 6.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.052 -1.03 . . . . 0.0 109.535 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.45 -4.26 53.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.909 . . . . 0.0 109.427 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.71 14.62 17.3 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 96' ' ' GLY . . . -120.37 33.13 5.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -1.136 . . . . 0.0 109.376 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 95' ' ' ALA . . . 41.72 60.73 2.42 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.531 ' CE ' ' HB3' ' A' ' 14' ' ' LEU . 5.4 mtp -107.37 53.82 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.174 -1.192 . . . . 0.0 109.417 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.523 HG21 ' N ' ' A' ' 99' ' ' GLY . 1.4 p -139.44 143.82 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 109.694 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.523 ' N ' HG21 ' A' ' 98' ' ' VAL . . . -151.04 176.09 29.71 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.456 ' HB3' ' O ' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -127.29 141.89 51.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.178 -1.19 . . . . 0.0 109.716 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.57 HG23 ' CD1' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -85.6 155.59 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.889 . . . . 0.0 109.014 179.749 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.497 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -115.46 98.35 6.68 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.157 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.522 ' CG1' ' HA ' ' A' ' 25' ' ' PRO . 53.7 t -99.24 78.71 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.258 -0.901 . . . . 0.0 109.572 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.342 -0.849 . . . . 0.0 109.399 179.911 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.4 HG21 ' HB ' ' A' ' 28' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.345 0.593 . . . . 0.0 109.501 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.531 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 6.6 m-85 -103.29 174.14 6.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.12 -0.987 . . . . 0.0 109.285 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.73 105.04 4.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.089 -1.007 . . . . 0.0 110.062 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.474 ' CG2' ' O ' ' A' ' 5' ' ' VAL . 20.5 m -93.71 65.84 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.218 -0.926 . . . . 0.0 109.131 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.473 ' HG3' HD12 ' A' ' 32' ' ' LEU . 1.5 ttmt -49.48 98.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 110.026 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -65.49 157.96 28.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.119 -0.988 . . . . 0.0 108.983 179.466 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.18 137.07 0.22 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.459 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 1.5 p -100.72 -68.99 0.79 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.149 -1.206 . . . . 0.0 109.686 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 1.6 p30 167.24 -49.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 109.856 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.27 24.75 6.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 109.69 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.463 ' O ' HD13 ' A' ' 13' ' ' LEU . . . -126.49 -116.5 2.06 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 2.6 mm? -121.98 -169.1 1.82 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.309 -1.113 . . . . 0.0 109.254 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.639 ' CD1' ' CD2' ' A' ' 92' ' ' HIS . 47.5 mt -98.84 102.54 14.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.263 -0.898 . . . . 0.0 108.671 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.1 m -137.69 164.05 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 0.0 109.724 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.423 ' CD2' HG22 ' A' ' 5' ' ' VAL . 13.6 m-85 -80.07 137.25 36.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.372 -0.83 . . . . 0.0 109.205 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -126.13 105.64 25.28 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.202 -0.936 . . . . 0.0 109.551 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -78.25 169.51 72.79 Favored 'Cis proline' 0 C--N 1.312 -1.381 0 C-N-CA 123.817 -1.326 . . . . 0.0 110.557 0.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.42 -64.79 0.81 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.147 -0.971 . . . . 0.0 108.879 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.4 pttm -84.76 160.03 20.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.37 -0.832 . . . . 0.0 109.029 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 102' ' ' THR . 0.3 OUTLIER -152.12 149.13 28.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.081 -1.012 . . . . 0.0 110.078 -179.809 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.8 m -111.79 119.44 38.62 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.516 ' CG1' HG23 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -132.43 175.74 10.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.143 -0.973 . . . . 0.0 110.029 -179.437 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.525 ' CG ' ' HD2' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -91.69 175.99 3.07 Favored Pre-proline 0 C--N 1.303 -1.421 0 O-C-N 121.394 -0.816 . . . . 0.0 109.049 179.578 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.547 ' HA ' ' CB ' ' A' ' 80' ' ' ALA . 35.4 Cg_endo -77.26 92.17 1.14 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.331 2.021 . . . . 0.0 110.646 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.06 5.8 26.6 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.441 ' OD2' ' HB2' ' A' ' 24' ' ' LYS . 11.5 m-20 -66.4 -178.84 0.72 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.122 -1.222 . . . . 0.0 109.293 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.4 ' HB ' HG21 ' A' ' 2' ' ' THR . 3.6 m -115.38 129.28 56.54 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.349 -0.845 . . . . 0.0 109.549 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.574 ' HB ' ' CZ ' ' A' ' 31' ' ' PHE . 5.2 t -115.62 135.05 56.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.189 -0.944 . . . . 0.0 109.539 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -103.43 129.42 50.54 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.172 -0.955 . . . . 0.0 109.662 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.574 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -127.17 83.56 2.18 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.58 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.4 OUTLIER -96.11 157.56 15.84 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.757 0.789 . . . . 0.0 110.726 -178.198 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.546 ' C ' ' OD1' ' A' ' 33' ' ' ASN . 4.5 p30 -77.47 171.42 14.92 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.703 0.763 . . . . 0.0 110.895 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -150.04 -37.46 0.15 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.472 ' O ' ' HD3' ' A' ' 37' ' ' PRO . 1.9 tttt -99.4 -144.32 0.33 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.444 -0.785 . . . . 0.0 109.461 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -68.74 113.14 13.99 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.527 -0.733 . . . . 0.0 110.781 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.55 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 37.8 Cg_endo -84.13 178.41 5.29 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.999 2.466 . . . . 0.0 109.776 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.55 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 39.7 Cg_endo -88.5 168.19 37.51 Favored 'Cis proline' 0 C--N 1.314 -1.276 0 O-C-N 123.391 1.206 . . . . 0.0 109.849 -2.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.66 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 81.6 m-70 -122.89 143.47 49.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.066 -1.022 . . . . 0.0 109.999 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -103.84 144.08 31.98 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.359 -0.838 . . . . 0.0 108.983 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.451 ' HB ' ' NE2' ' A' ' 61' ' ' HIS . 54.5 t -119.17 124.48 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -0.969 . . . . 0.0 109.927 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.483 HG11 ' OG ' ' A' ' 60' ' ' SER . 1.4 t -150.24 167.31 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.389 -0.82 . . . . 0.0 108.987 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.603 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 7.0 m-85 -118.5 119.69 35.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.138 -0.976 . . . . 0.0 109.809 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.433 ' HB3' ' HB2' ' A' ' 47' ' ' LEU . 17.8 t0 -41.98 148.17 0.19 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.442 -0.786 . . . . 0.0 110.028 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.16 -14.46 17.73 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.359 -0.838 . . . . 0.0 109.234 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.91 0.32 41.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.37 -0.831 . . . . 0.0 109.544 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 1.6 mm? -117.81 46.65 1.71 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.173 -0.954 . . . . 0.0 109.215 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.459 ' OD1' ' HA ' ' A' ' 51' ' ' LYS . 1.2 p30 -105.42 162.38 19.89 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.343 -0.848 . . . . 0.0 109.488 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 36.3 Cg_endo -77.88 -31.62 3.04 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.765 2.31 . . . . 0.0 110.907 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.476 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -122.5 31.26 6.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.102 -0.999 . . . . 0.0 110.047 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.476 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.1 OUTLIER 35.32 36.79 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.88 -0.512 . . . . 0.0 110.479 179.492 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 50' ' ' ALA . 2.4 m -101.12 143.1 31.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.083 -1.011 . . . . 0.0 109.926 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -92.5 54.78 2.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.898 . . . . 0.0 109.523 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -140.63 23.22 2.3 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.2 -0.937 . . . . 0.0 109.563 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.44 9.59 12.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.246 -0.909 . . . . 0.0 109.531 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.9 -47.12 0.31 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.405 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -48.07 -25.22 1.34 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 0.0 109.344 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.8 t -118.4 -20.19 8.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.22 -0.925 . . . . 0.0 109.36 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.58 HD23 ' CE2' ' A' ' 43' ' ' PHE . 9.9 tp -79.29 -37.93 36.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 0.0 109.226 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.483 ' OG ' HG11 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -78.9 132.14 36.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.282 -0.886 . . . . 0.0 109.633 -179.735 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.451 ' NE2' ' HB ' ' A' ' 41' ' ' VAL . 12.5 p80 -83.84 -9.55 58.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.455 -0.778 . . . . 0.0 109.605 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 0.1 OUTLIER 54.65 -170.78 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 109.709 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.487 ' CB ' ' O ' ' A' ' 62' ' ' LYS . 4.0 tt0 75.45 -179.75 0.17 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.336 -0.852 . . . . 0.0 109.687 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.444 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 4.4 mp -118.52 155.75 30.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.299 -0.875 . . . . 0.0 109.473 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.458 ' N ' ' CD1' ' A' ' 65' ' ' LEU . 4.6 mp -84.09 -175.32 5.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.911 . . . . 0.0 109.482 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -160.74 -37.35 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.15 -0.969 . . . . 0.0 109.904 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.523 ' HB3' ' CB ' ' A' ' 70' ' ' GLN . 5.5 t -83.71 147.11 51.23 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.149 -0.97 . . . . 0.0 109.901 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.45 ' HD2' ' OG ' ' A' ' 67' ' ' SER . 36.0 Cg_endo -79.08 92.18 1.16 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.817 2.345 . . . . 0.0 110.398 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.488 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 103.71 6.04 44.14 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.523 ' CB ' ' HB3' ' A' ' 67' ' ' SER . 1.2 tt0 -124.91 102.78 7.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -1.154 . . . . 0.0 109.093 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.58 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . 11.5 p -104.77 -104.27 0.31 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.339 -0.851 . . . . 0.0 110.132 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 73' ' ' SER . 15.9 m -159.97 149.58 18.03 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.407 ' N ' HG22 ' A' ' 72' ' ' THR . 2.9 p -97.34 103.76 15.72 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.037 -1.04 . . . . 0.0 109.424 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 94.1 m -76.8 103.27 6.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -0.889 . . . . 0.0 109.54 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 76' ' ' PHE . 23.2 m -79.06 92.58 5.01 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.57 ' CZ ' HD23 ' A' ' 59' ' ' LEU . 5.4 m-85 -43.01 165.13 0.11 Allowed Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.47 -0.769 . . . . 0.0 109.537 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.514 ' HD2' ' HB3' ' A' ' 76' ' ' PHE . 32.3 Cg_endo -73.84 174.03 13.0 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.466 2.111 . . . . 0.0 111.282 -178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.59 8.19 8.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.545 -0.722 . . . . 0.0 109.515 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.484 ' O ' ' C ' ' A' ' 80' ' ' ALA . 10.5 m-20 -99.43 -74.61 0.59 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.25 -0.907 . . . . 0.0 109.156 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.547 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . . . 34.84 69.7 1.02 Allowed Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.723 -0.61 . . . . 0.0 110.074 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.453 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 34.2 Cg_endo -75.91 158.29 38.68 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.533 2.156 . . . . 0.0 110.819 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -49.07 98.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.352 -0.842 . . . . 0.0 109.609 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . 0.569 ' O ' ' CE1' ' A' ' 85' ' ' TYR . . . -166.92 149.92 16.16 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -81.72 140.11 34.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.214 -1.168 . . . . 0.0 109.54 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.569 ' CE1' ' O ' ' A' ' 83' ' ' GLY . 66.5 m-85 -118.71 147.74 43.52 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.458 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 95.2 m -134.14 118.43 17.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.987 -1.07 . . . . 0.0 110.718 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.589 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.2 OUTLIER -110.44 171.35 7.51 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.403 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 97' ' ' MET . 14.1 p90 -158.94 -163.84 1.31 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.77 -1.206 . . . . 0.0 110.476 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.447 ' SG ' ' HD2' ' A' ' 91' ' ' PRO . 0.5 OUTLIER -126.25 145.29 50.46 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.578 -0.701 . . . . 0.0 109.408 -179.623 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.627 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 24.2 tp10 -82.97 -42.81 0.87 Allowed Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 121.254 -0.904 . . . . 0.0 110.599 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.3 Cg_endo -78.1 -75.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 121.946 1.764 . . . . 0.0 110.82 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.66 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 13.4 m80 -65.5 69.18 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.056 -1.028 . . . . 0.0 109.531 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 91' ' ' PRO . 10.8 tpt180 -90.72 -14.94 31.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.138 -0.976 . . . . 0.0 109.179 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.57 1.64 87.22 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.442 ' CB ' ' HB2' ' A' ' 14' ' ' LEU . . . -114.14 33.42 5.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -1.163 . . . . 0.0 109.487 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.494 ' O ' ' N ' ' A' ' 98' ' ' VAL . . . 40.16 36.6 0.92 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.487 ' SD ' ' HB3' ' A' ' 14' ' ' LEU . 4.0 mtp -65.35 72.85 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.036 -1.273 . . . . 0.0 109.177 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 96' ' ' GLY . 98.5 t -132.7 112.23 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 109.732 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.589 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -100.31 -174.92 30.08 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.519 ' N ' ' CZ ' ' A' ' 87' ' ' PHE . 22.4 mtpt -158.12 144.92 17.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.052 -1.263 . . . . 0.0 109.977 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.516 HG23 ' CG1' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -110.73 135.88 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 108.677 179.446 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 21' ' ' LEU . 3.1 m -114.11 95.29 5.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.271 -0.893 . . . . 0.0 109.1 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.487 HG21 ' CE1' ' A' ' 85' ' ' TYR . 2.3 t -99.87 124.71 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.277 -0.89 . . . . 0.0 109.805 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 109.252 179.757 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -84.45 169.05 14.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 0.0 109.154 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.6 m -160.18 122.2 3.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.108 -0.995 . . . . 0.0 109.776 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.524 ' O ' ' CD2' ' A' ' 32' ' ' LEU . 0.6 OUTLIER -106.13 -155.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 109.001 179.446 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.423 ' HG3' HD12 ' A' ' 32' ' ' LEU . 10.5 tttt -175.22 127.93 0.27 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.33 -0.856 . . . . 0.0 109.507 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.541 ' N ' HD22 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -100.56 93.89 5.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 0.0 109.156 179.775 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.537 ' HA3' ' CB ' ' A' ' 34' ' ' ASN . . . 152.07 70.14 0.01 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 8' ' ' GLY . 1.4 p -46.56 150.39 0.68 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.192 -1.181 . . . . 0.0 109.021 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -88.28 36.9 0.79 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.228 -0.92 . . . . 0.0 109.625 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.5 mtmm -122.37 -29.24 4.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 109.406 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.411 ' O ' ' HG ' ' A' ' 13' ' ' LEU . . . 137.91 46.02 0.08 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 12' ' ' GLY . 1.9 mt -164.3 172.68 13.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.224 -1.162 . . . . 0.0 109.626 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.55 ' HB3' ' CE ' ' A' ' 97' ' ' MET . 88.1 mt -118.8 97.09 5.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 109.841 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.434 HG13 ' C ' ' A' ' 14' ' ' LEU . 33.2 m -140.95 154.68 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.294 -0.878 . . . . 0.0 109.398 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.462 ' HB3' HG13 ' A' ' 5' ' ' VAL . 61.7 m-85 -62.93 160.47 14.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.124 -0.985 . . . . 0.0 109.113 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER -134.15 103.55 11.65 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.933 . . . . 0.0 109.651 -179.915 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.3 Cg_endo -77.53 -163.59 3.44 Favored 'Cis proline' 0 C--N 1.311 -1.397 0 C-N-CA 123.633 -1.403 . . . . 0.0 110.499 0.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.85 -36.12 70.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.267 -0.896 . . . . 0.0 109.593 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -116.14 168.84 9.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 0.0 109.399 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.466 ' O ' ' N ' ' A' ' 102' ' ' THR . 2.7 tp -149.75 147.75 28.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.219 -0.926 . . . . 0.0 109.527 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.47 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 30.7 m -115.22 100.35 8.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 109.464 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.53 ' CD1' HD12 ' A' ' 101' ' ' ILE . 2.3 pt -100.45 178.53 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.255 -0.903 . . . . 0.0 109.739 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.593 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -95.57 -174.4 0.39 Allowed Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.536 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 35.7 Cg_endo -80.21 70.42 7.53 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.934 1.756 . . . . 0.0 110.694 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 111.08 48.31 0.72 Allowed Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.194 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.481 ' OD1' ' HB2' ' A' ' 24' ' ' LYS . 0.9 OUTLIER -108.16 -164.98 1.0 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.398 -1.06 . . . . 0.0 108.759 178.846 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 95.8 m -115.71 145.69 42.53 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.034 -1.041 . . . . 0.0 110.333 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.583 ' HB ' ' CZ ' ' A' ' 31' ' ' PHE . 1.9 t -127.28 121.88 58.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -99.53 103.3 15.03 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.085 -1.01 . . . . 0.0 110.836 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.583 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.4 OUTLIER -93.49 152.13 19.27 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.546 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.56 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -141.61 169.15 18.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.689 -1.257 . . . . 0.0 110.808 -179.37 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 6.7 p-10 -97.51 160.23 14.45 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.628 -0.67 . . . . 0.0 109.202 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.537 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . 51.9 t30 -110.07 -78.87 0.59 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.907 -1.121 . . . . 0.0 109.748 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.496 ' C ' ' CG2' ' A' ' 36' ' ' VAL . 5.7 tptt -151.25 34.71 0.58 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.026 -1.046 . . . . 0.0 109.886 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.588 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 0.9 OUTLIER -156.39 56.34 1.22 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.28 -0.887 . . . . 0.0 109.65 179.298 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.588 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 36.3 Cg_endo -78.59 176.37 9.96 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.697 2.265 . . . . 0.0 110.669 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.577 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.2 Cg_endo -86.13 162.23 56.26 Favored 'Cis proline' 0 C--N 1.312 -1.392 0 O-C-N 123.753 1.396 . . . . 0.0 110.416 -1.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.726 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 73.3 m-70 -122.28 140.73 52.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 110.215 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.469 ' HB2' ' HD3' ' A' ' 91' ' ' PRO . 1.2 m120 -115.15 134.76 54.87 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.542 ' HB ' ' CD2' ' A' ' 61' ' ' HIS . 35.5 t -100.82 135.07 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.105 -0.997 . . . . 0.0 110.03 -179.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.532 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 2.5 t -149.22 171.1 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.376 -0.828 . . . . 0.0 109.477 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.64 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 1.6 m-85 -139.21 115.33 10.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.144 -0.973 . . . . 0.0 109.668 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -47.59 142.8 4.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.179 -0.951 . . . . 0.0 109.132 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.22 19.98 16.6 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.187 -0.945 . . . . 0.0 109.819 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -108.35 -40.17 5.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.207 -0.933 . . . . 0.0 109.561 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.447 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 10.2 mp -87.17 55.9 3.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.922 . . . . 0.0 109.611 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.498 ' O ' ' NZ ' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -102.53 165.76 13.2 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.331 -0.856 . . . . 0.0 109.47 179.71 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 34.9 Cg_endo -77.78 -33.07 2.4 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.638 2.225 . . . . 0.0 110.807 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -124.06 30.72 6.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.037 -1.039 . . . . 0.0 109.719 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.498 ' NZ ' ' O ' ' A' ' 48' ' ' ASN . 12.5 mmtm 39.45 31.46 0.07 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.71 -0.619 . . . . 0.0 109.841 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 50' ' ' ALA . 28.8 m -101.62 125.01 48.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.68 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -100.35 97.53 8.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.353 -0.842 . . . . 0.0 109.368 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -163.49 -46.01 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.274 -0.891 . . . . 0.0 109.529 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 0.9 OUTLIER -68.4 -15.88 63.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.898 . . . . 0.0 109.381 -179.902 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.94 -50.5 8.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.252 -0.905 . . . . 0.0 109.637 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.29 -23.66 0.6 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.719 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.2 t -106.86 -3.52 20.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.062 -1.024 . . . . 0.0 109.902 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.61 ' CD2' ' CD2' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -95.12 -37.12 11.22 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.09 -1.006 . . . . 0.0 108.554 179.935 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.512 ' CB ' HG13 ' A' ' 42' ' ' VAL . 1.4 m -78.91 132.73 36.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.191 -0.943 . . . . 0.0 110.383 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.592 ' CD2' ' HB ' ' A' ' 72' ' ' THR . 18.9 p80 -109.61 138.49 45.89 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.46 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -127.74 119.42 25.74 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.009 -1.057 . . . . 0.0 110.114 -179.785 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.606 ' O ' ' O ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER 167.53 29.44 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.558 -0.714 . . . . 0.0 110.303 179.248 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.606 ' O ' ' O ' ' A' ' 63' ' ' GLN . 4.1 mt 47.66 123.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.734 0.778 . . . . 0.0 111.319 178.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 39' ' ' HIS . 6.3 mt -78.49 155.32 29.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.246 -1.534 . . . . 0.0 108.77 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 41.1 mtm -137.28 9.64 2.97 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -0.904 . . . . 0.0 109.595 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.417 ' HB3' ' O ' ' A' ' 70' ' ' GLN . 1.9 t -110.28 129.55 23.82 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 109.375 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.456 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.2 Cg_endo -79.18 93.31 1.1 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.362 2.041 . . . . 0.0 110.453 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.516 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 114.39 0.83 23.49 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.442 ' HG2' ' C ' ' A' ' 69' ' ' GLY . 32.5 mm-40 -144.43 112.94 6.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -1.112 . . . . 0.0 108.777 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.55 ' OG ' ' N ' ' A' ' 72' ' ' THR . 51.9 p -99.95 -80.28 0.48 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.001 -1.062 . . . . 0.0 109.671 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.592 ' HB ' ' CD2' ' A' ' 61' ' ' HIS . 4.3 m -160.33 107.8 1.61 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.077 -1.015 . . . . 0.0 109.474 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 29' ' ' VAL . 3.9 m -80.08 76.35 6.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -0.932 . . . . 0.0 109.154 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.517 ' CG2' HD13 ' A' ' 59' ' ' LEU . 1.0 OUTLIER -60.68 124.15 19.56 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.417 -0.802 . . . . 0.0 110.06 -179.61 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 76' ' ' PHE . 3.8 t -82.87 90.08 6.91 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.392 -0.818 . . . . 0.0 108.986 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.61 ' CD2' ' CD2' ' A' ' 59' ' ' LEU . 22.7 m-85 -41.41 157.11 0.2 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.464 -0.773 . . . . 0.0 109.693 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.513 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.6 Cg_endo -78.1 161.14 29.67 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.814 2.343 . . . . 0.0 111.031 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.09 5.4 8.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.22 -0.925 . . . . 0.0 110.023 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.468 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 2.0 p-10 -100.09 -11.04 20.85 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.001 -1.062 . . . . 0.0 109.616 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 79' ' ' ASP . . . -40.4 100.6 0.22 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.497 -0.752 . . . . 0.0 109.832 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.468 ' HG2' ' HG2' ' A' ' 49' ' ' PRO . 36.3 Cg_endo -78.54 -176.11 3.09 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.497 2.131 . . . . 0.0 110.442 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.72 123.33 27.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.355 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 169.1 148.28 5.74 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.437 ' O ' ' CG ' ' A' ' 84' ' ' GLU . 10.8 pt-20 -80.37 111.68 17.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.309 -1.112 . . . . 0.0 109.752 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.544 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 5.6 m-30 -86.5 98.04 10.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.934 . . . . 0.0 108.867 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 17.3 m -77.45 105.76 8.79 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.226 -0.921 . . . . 0.0 110.191 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.48 ' HB3' ' CD2' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -104.16 176.93 4.99 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.283 -0.886 . . . . 0.0 108.796 179.103 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.477 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 5.7 p90 -160.7 -147.7 0.15 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.014 -1.054 . . . . 0.0 109.722 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 93' ' ' ARG . 0.5 OUTLIER -130.93 159.02 38.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 109.746 -179.466 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.602 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.3 tt0 -91.79 -44.21 0.36 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.362 -0.836 . . . . 0.0 111.161 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.8 Cg_endo -80.58 -56.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.09 0 C-N-CA 122.117 1.878 . . . . 0.0 110.674 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.726 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 19.9 m80 -77.78 5.02 10.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.62 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . 0.494 ' HB2' ' O ' ' A' ' 89' ' ' CYS . 20.0 ttt-85 -43.26 120.0 1.74 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.17 -0.956 . . . . 0.0 109.37 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.73 11.07 33.72 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.7 39.26 3.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -1.163 . . . . 0.0 109.328 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.74 -0.16 66.44 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.55 ' CE ' ' HB3' ' A' ' 14' ' ' LEU . 0.1 OUTLIER -71.39 66.9 0.48 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.164 -1.198 . . . . 0.0 109.664 -179.865 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.0 t -135.25 120.0 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.189 -0.944 . . . . 0.0 109.444 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 86' ' ' THR . . . -133.77 -178.52 15.65 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 10.0 mttt -148.78 140.77 23.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -1.187 . . . . 0.0 109.669 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.53 HD12 ' CD1' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -96.88 133.73 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 109.111 179.718 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.47 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 0.5 OUTLIER -101.28 104.13 15.15 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.691 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.543 ' CG1' ' HA ' ' A' ' 25' ' ' PRO . 59.4 t -98.9 114.18 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.295 -0.878 . . . . 0.0 109.601 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.427 0 O-C-N 121.347 -0.846 . . . . 0.0 109.31 179.98 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 49.2 m . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.44 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 16.1 m-85 -90.69 137.61 32.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.281 -0.887 . . . . 0.0 109.361 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.531 ' CG2' ' HB3' ' A' ' 30' ' ' GLU . 2.0 m -139.19 110.62 7.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.646 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.513 HG23 ' CE2' ' A' ' 16' ' ' PHE . 26.8 m -96.49 109.14 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.244 -0.91 . . . . 0.0 109.466 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -86.75 137.9 32.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -0.949 . . . . 0.0 109.43 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.516 ' N ' HD21 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -98.47 80.27 2.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.0 109.1 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . 0.468 ' O ' ' ND2' ' A' ' 34' ' ' ASN . . . 134.48 79.94 0.13 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 p -52.58 -88.59 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.251 -1.147 . . . . 0.0 109.563 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -172.38 37.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.555 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.21 20.37 6.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 109.435 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.436 ' HA2' ' CE ' ' A' ' 35' ' ' LYS . . . 73.02 37.41 56.3 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.441 ' O ' ' HA2' ' A' ' 8' ' ' GLY . 74.7 mt -139.89 139.38 36.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -1.121 . . . . 0.0 109.442 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.536 ' CD2' ' CE1' ' A' ' 39' ' ' HIS . 17.0 mt -101.25 114.31 28.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.204 -0.935 . . . . 0.0 109.561 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.442 ' CG1' ' O ' ' A' ' 14' ' ' LEU . 15.0 m -157.59 157.65 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 0.0 109.378 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.513 ' CE2' HG23 ' A' ' 5' ' ' VAL . 12.5 m-85 -81.82 147.09 29.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 109.614 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 14.2 mm-40 -139.61 107.01 7.06 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.251 -0.905 . . . . 0.0 109.424 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.7 Cg_endo -78.1 176.19 44.15 Favored 'Cis proline' 0 C--N 1.312 -1.374 0 C-N-CA 123.761 -1.349 . . . . 0.0 110.675 0.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.07 -61.05 1.95 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.335 -0.853 . . . . 0.0 109.298 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.5 tttp -82.03 174.72 10.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.912 . . . . 0.0 109.198 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.507 HD11 ' CG1' ' A' ' 5' ' ' VAL . 5.2 tp -158.95 104.73 1.74 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.12 -0.988 . . . . 0.0 110.083 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . 0.449 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 32.1 m -87.01 90.09 8.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.188 -0.945 . . . . 0.0 108.477 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.531 HD11 ' CG2' ' A' ' 103' ' ' VAL . 1.0 OUTLIER -99.7 163.43 2.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.316 -0.865 . . . . 0.0 110.348 -178.999 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.567 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 14.1 mmtt -88.03 166.74 22.6 Favored Pre-proline 0 C--N 1.301 -1.526 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 31.4 Cg_endo -73.09 88.86 0.92 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.693 1.596 . . . . 0.0 110.017 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 125.59 -3.13 8.15 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.485 ' OD2' ' CG ' ' A' ' 24' ' ' LYS . 62.6 m-20 -62.47 -168.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -1.145 . . . . 0.0 109.566 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.2 m -129.33 130.63 46.35 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.278 -0.889 . . . . 0.0 109.369 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.562 HG12 ' CE2' ' A' ' 31' ' ' PHE . 3.3 t -121.42 115.91 48.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.251 -0.905 . . . . 0.0 109.346 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . 0.531 ' HB3' ' CG2' ' A' ' 4' ' ' THR . 2.0 mm-40 -99.58 132.92 44.6 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.27 -0.893 . . . . 0.0 109.635 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.6 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -131.7 94.41 3.51 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . 0.566 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.4 OUTLIER -96.58 179.68 4.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.343 -0.848 . . . . 0.0 110.663 -178.35 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASN . . . . . 0.545 ' ND2' ' HB3' ' A' ' 37' ' ' PRO . 1.7 p-10 -107.87 155.05 20.7 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.47 -0.768 . . . . 0.0 109.469 -178.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.468 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 53.2 t30 -151.19 -58.52 0.16 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.985 -1.072 . . . . 0.0 110.009 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.523 ' HB3' ' CD2' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -60.72 -147.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.27 -0.894 . . . . 0.0 109.124 -179.345 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.42 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 65.4 t -68.05 112.35 10.46 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.371 -0.831 . . . . 0.0 109.382 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.545 ' HB3' ' ND2' ' A' ' 33' ' ' ASN . 37.5 Cg_endo -82.01 175.33 9.32 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.807 2.338 . . . . 0.0 110.636 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.552 ' O ' ' CG ' ' A' ' 39' ' ' HIS . 37.8 Cg_endo -84.57 -156.09 1.13 Allowed 'Cis proline' 0 C--N 1.311 -1.404 0 C-N-CA 123.631 -1.404 . . . . 0.0 109.86 -1.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.592 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 86.0 m-70 -160.44 143.27 13.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.961 -1.087 . . . . 0.0 109.708 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.485 ' OD1' ' N ' ' A' ' 41' ' ' VAL . 63.7 t-20 -113.58 147.42 38.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.278 -0.889 . . . . 0.0 109.201 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.485 ' N ' ' OD1' ' A' ' 40' ' ' ASN . 18.8 t -128.6 118.58 47.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.277 -0.889 . . . . 0.0 109.182 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.46 ' CG1' ' HB3' ' A' ' 60' ' ' SER . 0.0 OUTLIER -153.04 175.59 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.294 -0.879 . . . . 0.0 109.379 -179.804 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.65 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -130.03 135.0 47.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.941 . . . . 0.0 109.538 -179.471 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -59.6 130.49 47.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 109.353 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.87 1.99 32.44 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.245 -0.909 . . . . 0.0 109.904 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.64 5.73 36.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.611 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 mp -131.21 57.1 1.77 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.137 -0.977 . . . . 0.0 109.672 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -114.44 156.18 44.87 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.274 179.744 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.444 ' HG2' ' HG2' ' A' ' 81' ' ' PRO . 36.2 Cg_endo -79.38 -40.36 0.26 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.67 2.247 . . . . 0.0 110.907 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ALA . . . . . 0.501 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -106.5 28.9 7.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.07 -1.019 . . . . 0.0 109.788 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.501 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER 32.5 45.88 0.06 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.186 0.517 . . . . 0.0 110.316 179.652 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.2 m -100.56 111.93 24.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.17 -0.957 . . . . 0.0 109.783 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.76 -28.3 64.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.94 . . . . 0.0 108.982 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . 0.465 ' HA ' ' HB2' ' A' ' 57' ' ' LYS . 2.1 t0 -68.17 -23.85 64.9 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.375 -0.828 . . . . 0.0 109.435 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 17.8 tp -56.11 -61.09 2.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 109.532 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' A' ' 59' ' ' LEU . . . -66.61 -23.98 66.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.649 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.465 ' HB2' ' HA ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -45.65 -64.58 0.7 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 109.52 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.98 -23.07 36.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.0 109.538 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.597 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 4.7 tp -72.65 -58.07 3.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 109.498 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . 0.46 ' HB3' ' CG1' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -79.67 133.52 36.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.306 -0.871 . . . . 0.0 110.021 -179.153 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.428 ' ND1' ' C ' ' A' ' 61' ' ' HIS . 16.2 p80 -107.34 149.98 27.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.384 -0.822 . . . . 0.0 108.941 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.428 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -99.59 174.5 6.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.096 -1.003 . . . . 0.0 109.461 -179.785 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . 0.428 ' CB ' ' O ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER 70.27 126.73 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.315 -0.866 . . . . 0.0 109.42 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.0 mp -70.67 163.97 25.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 109.528 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.9 mt -83.25 160.71 21.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 109.126 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -132.26 9.29 4.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.116 -0.99 . . . . 0.0 109.81 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.475 ' HB3' ' HB2' ' A' ' 70' ' ' GLN . 9.0 t -124.66 138.31 30.99 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.18 -0.95 . . . . 0.0 109.143 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.444 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.7 Cg_endo -79.3 105.72 1.93 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.538 2.159 . . . . 0.0 110.967 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 92.75 39.09 5.34 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 9.3 mt-30 -153.11 82.04 1.2 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.232 -1.158 . . . . 0.0 109.177 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.6 ' CB ' ' O ' ' A' ' 31' ' ' PHE . 3.2 p -99.08 -169.21 1.73 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.164 -0.96 . . . . 0.0 109.457 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' THR . . . . . 0.446 ' CG2' ' O ' ' A' ' 72' ' ' THR . 4.1 t -102.75 125.16 49.39 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.0 p -78.98 93.84 5.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.072 -1.018 . . . . 0.0 109.443 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' THR . . . . . 0.525 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 4.6 m -72.36 97.96 2.13 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.367 -0.833 . . . . 0.0 109.409 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.451 ' O ' ' C ' ' A' ' 76' ' ' PHE . 11.2 m -78.56 89.07 4.49 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.597 ' CZ ' HD22 ' A' ' 59' ' ' LEU . 9.9 m-85 -40.46 150.26 0.28 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.744 -0.598 . . . . 0.0 109.459 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' PRO . . . . . 0.401 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.8 Cg_endo -77.53 168.27 22.95 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.846 2.364 . . . . 0.0 111.434 -179.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 25' ' ' PRO . . . -83.46 5.45 23.75 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ASP . . . . . 0.478 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 1.8 m-20 -99.19 -7.21 26.87 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.179 -0.951 . . . . 0.0 109.113 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.49 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . . . -38.59 99.11 0.18 Allowed Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.593 -0.692 . . . . 0.0 109.462 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 79' ' ' ASP . 34.8 Cg_endo -77.25 141.47 20.55 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.425 2.083 . . . . 0.0 110.629 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 81' ' ' PRO . . . -43.5 132.01 4.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.409 -0.807 . . . . 0.0 109.358 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 158.29 148.78 5.27 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -89.46 117.7 28.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.154 -1.204 . . . . 0.0 109.893 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' TYR . . . . . 0.47 ' O ' ' HB3' ' A' ' 100' ' ' LYS . 60.9 m-85 -84.02 -166.69 1.49 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.244 -0.91 . . . . 0.0 108.934 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' THR . . . . . 0.465 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 39.2 m -166.59 105.72 0.62 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.897 -1.127 . . . . 0.0 110.836 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.575 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.4 OUTLIER -104.75 165.67 10.91 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.26 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' TYR . . . . . 0.426 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 29.7 p90 -157.22 -166.62 2.1 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.786 -1.197 . . . . 0.0 110.561 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' CYS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 97' ' ' MET . 0.5 OUTLIER -130.28 126.85 38.28 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.811 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.625 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 6.0 tp10 -67.94 -43.25 36.46 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.89 . . . . 0.0 111.514 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 34.4 Cg_endo -76.59 -53.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.968 1.779 . . . . 0.0 111.205 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' HIS . . . . . 0.592 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 34.8 m80 -89.78 30.34 1.06 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.016 -1.052 . . . . 0.0 109.614 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.6 ttt-85 -60.26 91.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.283 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 137.74 -15.82 3.56 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 14' ' ' LEU . . . -91.32 37.19 0.94 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.353 -1.086 . . . . 0.0 109.493 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.08 23.02 72.84 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' MET . . . . . 0.5 ' CE ' ' HB2' ' A' ' 7' ' ' LEU . 0.8 OUTLIER -91.26 53.57 2.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.063 -1.257 . . . . 0.0 109.299 179.791 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.3 t -137.26 118.43 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 109.445 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.575 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -127.32 172.47 18.69 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 85' ' ' TYR . 35.7 mttt -145.84 135.86 23.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -1.141 . . . . 0.0 109.649 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.543 HD13 ' CE1' ' A' ' 76' ' ' PHE . 0.3 OUTLIER -87.36 140.69 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.957 . . . . 0.0 108.878 179.661 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.449 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 0.3 OUTLIER -115.77 95.55 5.18 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.331 -0.856 . . . . 0.0 108.883 179.305 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' VAL . . . . . 0.531 ' CG2' HD11 ' A' ' 23' ' ' ILE . 12.5 t -99.77 150.42 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.146 -0.971 . . . . 0.0 109.597 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.4 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.492 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 28' ' ' THR . 11.9 t -112.07 157.69 20.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.585 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 53.1 m-85 -93.88 153.75 18.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 0.0 109.28 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.5 m -142.85 135.92 28.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 109.736 -179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.577 ' CG1' ' CD1' ' A' ' 21' ' ' LEU . 0.0 OUTLIER -117.39 100.33 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.239 -0.913 . . . . 0.0 109.338 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 8.6 tttt -69.46 79.21 0.4 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.257 -0.902 . . . . 0.0 109.497 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.497 ' CD2' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -52.33 136.55 30.81 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.193 -0.942 . . . . 0.0 109.243 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 101.54 115.56 3.95 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.51 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 97.4 p -69.86 -82.45 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -1.129 . . . . 0.0 109.608 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.51 ' CB ' ' O ' ' A' ' 9' ' ' SER . 2.8 p30 163.45 -50.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.885 . . . . 0.0 109.049 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.459 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 4.0 mttt -120.59 -5.72 9.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.349 -0.845 . . . . 0.0 109.252 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -100.38 -103.78 2.59 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.65 -156.51 0.69 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -1.152 . . . . 0.0 109.562 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.637 ' CD1' ' CD2' ' A' ' 92' ' ' HIS . 30.9 mt -99.86 120.57 39.98 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.18 -0.95 . . . . 0.0 109.873 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.509 ' CG1' ' O ' ' A' ' 14' ' ' LEU . 16.1 m -160.53 126.68 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.921 . . . . 0.0 109.621 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.428 ' O ' ' O ' ' A' ' 15' ' ' VAL . 6.0 m-85 -44.47 165.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.055 -1.028 . . . . 0.0 109.301 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 22.9 mt-10 -148.16 104.62 3.58 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.195 -0.94 . . . . 0.0 109.405 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.2 Cg_endo -77.59 -176.03 17.92 Favored 'Cis proline' 0 C--N 1.311 -1.426 0 C-N-CA 123.736 -1.36 . . . . 0.0 110.563 0.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.12 -47.56 50.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.622 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.81 178.04 5.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 109.331 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.577 ' CD1' ' CG1' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -153.04 141.73 20.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.967 . . . . 0.0 109.87 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.2 m -120.21 115.3 23.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.336 -0.852 . . . . 0.0 109.213 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.53 HD13 ' CG2' ' A' ' 103' ' ' VAL . 1.0 OUTLIER -132.36 -176.75 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.209 -0.932 . . . . 0.0 109.738 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.53 ' CG ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -104.63 177.39 1.41 Allowed Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.188 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.53 ' HD2' ' CG ' ' A' ' 24' ' ' LYS . 34.3 Cg_endo -77.18 76.69 4.09 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.213 1.942 . . . . 0.0 110.349 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 132.6 -11.78 5.19 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 26' ' ' GLY . 9.2 m-20 -53.3 -176.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.165 -1.197 . . . . 0.0 109.407 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.46 HG22 HG21 ' A' ' 75' ' ' THR . 26.8 m -123.39 146.62 47.83 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.163 -0.96 . . . . 0.0 109.461 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.46 HG22 ' CD1' ' A' ' 101' ' ' ILE . 3.4 t -137.5 124.23 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.202 -0.937 . . . . 0.0 109.24 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.533 ' OE1' ' CA ' ' A' ' 73' ' ' SER . 21.8 tp10 -100.99 130.85 47.05 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.25 -0.906 . . . . 0.0 110.109 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.485 ' O ' ' OG ' ' A' ' 71' ' ' SER . 0.4 OUTLIER -113.59 151.27 31.89 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.032 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.497 ' O ' ' CD2' ' A' ' 7' ' ' LEU . 2.4 pp -142.09 -177.6 5.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.816 -1.178 . . . . 0.0 110.635 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.504 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 2.5 p-10 -116.55 152.96 33.05 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -101.5 -109.01 0.23 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.815 -1.178 . . . . 0.0 109.601 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.458 ' O ' HG21 ' A' ' 36' ' ' VAL . 0.9 OUTLIER -128.98 36.58 4.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.805 -1.185 . . . . 0.0 109.412 -179.824 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.546 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 2.5 t -153.02 61.98 4.0 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.502 -0.749 . . . . 0.0 109.141 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.567 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.9 Cg_endo -80.24 175.9 9.82 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.811 2.341 . . . . 0.0 110.55 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.567 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.3 Cg_endo -85.78 159.46 59.65 Favored 'Cis proline' 0 C--N 1.31 -1.449 0 C-N-CA 123.525 -1.448 . . . . 0.0 110.483 -1.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.715 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 74.6 m-70 -116.46 141.64 47.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.472 -0.767 . . . . 0.0 109.435 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.51 126.71 53.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 109.45 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.8 t -116.37 126.27 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -0.936 . . . . 0.0 109.445 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.472 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -160.12 166.39 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.38 -0.825 . . . . 0.0 109.322 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.607 ' CE2' HD21 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -116.74 109.65 17.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 109.382 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.443 ' HB3' HD13 ' A' ' 47' ' ' LEU . 30.7 t0 -53.06 144.43 15.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.874 . . . . 0.0 109.682 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.57 19.21 3.47 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.183 -0.948 . . . . 0.0 109.479 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -121.31 -30.31 4.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.083 -1.011 . . . . 0.0 109.724 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.443 HD13 ' HB3' ' A' ' 44' ' ' ASP . 6.2 mp -96.33 61.16 2.0 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.037 -1.039 . . . . 0.0 109.518 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.481 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 10.2 p30 -141.6 162.51 46.45 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.286 -0.884 . . . . 0.0 109.49 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.481 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 33.5 Cg_endo -75.6 -16.54 18.86 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.446 2.098 . . . . 0.0 109.904 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 52' ' ' SER . . . -133.54 68.55 1.49 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -40.37 92.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.607 -0.683 . . . . 0.0 109.987 -179.519 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 50' ' ' ALA . 19.5 m -140.71 -159.21 0.93 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.341 -0.849 . . . . 0.0 109.191 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -155.81 56.95 0.61 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.245 -0.909 . . . . 0.0 109.535 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -138.78 -60.99 0.58 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.219 -0.925 . . . . 0.0 109.378 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.466 ' HG ' ' N ' ' A' ' 56' ' ' ALA . 1.6 pp -54.28 -28.16 40.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.93 . . . . 0.0 109.044 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.466 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -72.41 -39.3 68.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.324 -0.86 . . . . 0.0 109.243 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 56' ' ' ALA . 65.9 tttt -44.3 -45.8 8.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.316 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -98.01 25.45 6.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.292 -0.88 . . . . 0.0 109.421 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.607 HD21 ' CE2' ' A' ' 43' ' ' PHE . 8.2 tp -127.0 -54.88 1.38 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.869 . . . . 0.0 109.267 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.49 147.24 33.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.307 -0.871 . . . . 0.0 110.082 -178.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -122.18 174.81 6.73 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -125.06 -160.2 0.94 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.196 -0.94 . . . . 0.0 109.226 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 65.87 135.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.202 -0.936 . . . . 0.0 109.802 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.6 mt -64.76 158.63 24.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.392 -0.818 . . . . 0.0 109.576 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.547 ' CD2' ' HB2' ' A' ' 39' ' ' HIS . 3.5 mp -79.31 87.26 5.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.079 -1.013 . . . . 0.0 109.155 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -83.32 4.59 26.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 109.759 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.467 ' HB3' ' O ' ' A' ' 70' ' ' GLN . 12.0 t -102.81 115.79 63.65 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.144 -0.973 . . . . 0.0 109.009 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.467 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.4 Cg_endo -78.51 95.23 1.07 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.4 2.067 . . . . 0.0 111.004 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.504 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 127.45 -17.12 6.2 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.595 -1.288 . . . . 0.0 110.125 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.475 ' HA ' ' CB ' ' A' ' 32' ' ' LEU . 8.0 pt20 -149.99 149.69 30.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.111 -1.229 . . . . 0.0 109.602 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.537 ' OG ' ' N ' ' A' ' 72' ' ' THR . 81.1 p -120.01 -78.46 0.59 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.122 -0.986 . . . . 0.0 109.5 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.537 ' N ' ' OG ' ' A' ' 71' ' ' SER . 22.8 m -160.14 119.0 2.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.327 -0.858 . . . . 0.0 109.424 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.533 ' CA ' ' OE1' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -79.53 99.75 7.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.0 109.228 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.527 ' CG2' ' CD1' ' A' ' 59' ' ' LEU . 26.3 m -82.54 108.4 15.91 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.337 -0.852 . . . . 0.0 109.665 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.46 HG21 HG22 ' A' ' 28' ' ' THR . 0.0 OUTLIER -79.36 85.77 5.15 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.476 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.583 ' CE2' HD23 ' A' ' 59' ' ' LEU . 23.7 m-85 -40.45 137.02 1.37 Allowed Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.486 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 35.3 Cg_endo -77.74 174.49 12.52 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.605 2.203 . . . . 0.0 111.719 -178.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.29 4.03 11.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.583 -0.698 . . . . 0.0 109.211 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.466 ' O ' ' C ' ' A' ' 80' ' ' ALA . 0.5 OUTLIER -98.13 -10.77 23.66 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.24 -0.912 . . . . 0.0 108.591 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.47 ' HB2' ' OH ' ' A' ' 85' ' ' TYR . . . -39.95 110.88 0.68 Allowed Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -75.19 130.97 13.57 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.263 1.975 . . . . 0.0 110.68 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -56.42 162.03 2.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.463 -0.773 . . . . 0.0 109.374 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 125.92 -117.78 2.97 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -160.51 122.5 3.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -1.152 . . . . 0.0 109.718 -179.792 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.632 ' CD2' ' CG2' ' A' ' 101' ' ' ILE . 4.1 m-30 -85.88 -165.43 1.24 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.14 -0.975 . . . . 0.0 108.726 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.442 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 20.7 m -165.18 101.23 0.74 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.839 -1.163 . . . . 0.0 110.678 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.497 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 0.5 OUTLIER -107.18 165.9 11.03 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.623 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.517 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 3.9 p90 -157.07 -171.41 3.63 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.823 -1.173 . . . . 0.0 110.442 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.58 143.76 47.46 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.56 -0.713 . . . . 0.0 109.332 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.617 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 31.5 tt0 -77.6 -45.14 2.54 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.323 -0.861 . . . . 0.0 109.846 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.3 Cg_endo -79.53 -65.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 122.008 1.805 . . . . 0.0 110.197 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.715 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 3.3 m80 -73.39 63.25 0.76 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 109.375 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.1 tpp85 -90.42 -26.91 19.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.332 -0.855 . . . . 0.0 109.174 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -95.33 35.53 4.24 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.44 ' HB3' ' O ' ' A' ' 14' ' ' LEU . . . -135.73 34.42 2.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -1.145 . . . . 0.0 109.573 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 48.45 25.44 4.45 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.502 ' HE1' ' N ' ' A' ' 15' ' ' VAL . 0.0 OUTLIER -78.53 54.42 1.46 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.066 -1.255 . . . . 0.0 109.354 179.742 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.1 t -125.74 104.24 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.442 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.93 174.76 22.69 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.442 ' HG2' ' HA ' ' A' ' 86' ' ' THR . 11.2 mttm -150.56 131.41 14.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -1.144 . . . . 0.0 109.788 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.632 ' CG2' ' CD2' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -83.29 126.58 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 21' ' ' LEU . 3.5 m -104.25 102.26 11.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.183 -0.948 . . . . 0.0 109.443 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.53 ' CG2' HD13 ' A' ' 23' ' ' ILE . 2.4 t -99.76 92.95 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.185 -0.947 . . . . 0.0 109.466 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.03 161.64 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.923 . . . . 0.0 109.561 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 CA-C-O 117.96 -1.467 . . . . 0.0 109.474 179.85 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.39 138.74 51.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.915 . . . . 0.0 109.434 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 19.0 m-85 -112.3 150.51 30.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.237 -0.914 . . . . 0.0 109.536 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.407 HG21 ' HB3' ' A' ' 30' ' ' GLU . 45.3 m -145.58 114.06 6.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.894 . . . . 0.0 109.413 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.461 ' O ' HD23 ' A' ' 7' ' ' LEU . 4.4 m -91.77 80.99 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.187 -0.946 . . . . 0.0 109.58 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 5' ' ' VAL . 9.3 mtmt -44.26 110.51 0.22 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.157 -0.964 . . . . 0.0 109.393 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.534 ' CG ' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -91.14 83.94 5.62 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.224 -0.923 . . . . 0.0 109.362 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 14' ' ' LEU . . . 144.3 102.6 0.39 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.51 ' OG ' ' N ' ' A' ' 10' ' ' ASP . 89.8 p -50.47 -82.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -1.13 . . . . 0.0 109.492 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.51 ' N ' ' OG ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -176.88 -93.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.227 -0.921 . . . . 0.0 109.508 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -100.06 54.28 0.91 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.14 -0.975 . . . . 0.0 109.625 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.59 -82.38 0.04 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.6 tp -144.89 -159.32 0.98 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.395 -1.062 . . . . 0.0 109.134 179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.529 ' CD1' ' HB ' ' A' ' 36' ' ' VAL . 49.8 mt -119.58 124.16 45.68 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.164 -0.96 . . . . 0.0 109.425 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.457 HG13 ' O ' ' A' ' 14' ' ' LEU . 25.6 m -156.63 155.44 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.869 . . . . 0.0 109.338 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 7' ' ' LEU . 6.2 m-85 -68.45 156.57 37.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.224 -0.922 . . . . 0.0 109.674 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.41 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 16.1 mt-10 -157.39 101.07 1.88 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.462 -0.774 . . . . 0.0 109.243 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.41 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 35.3 Cg_endo -77.9 179.8 29.71 Favored 'Cis proline' 0 C--N 1.311 -1.42 0 C-N-CA 123.67 -1.388 . . . . 0.0 110.584 0.183 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.17 -54.69 3.61 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.267 -0.896 . . . . 0.0 109.413 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.08 153.77 24.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -0.877 . . . . 0.0 109.495 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.465 HD21 ' CG2' ' A' ' 23' ' ' ILE . 0.3 OUTLIER -158.48 108.12 2.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.091 -1.006 . . . . 0.0 110.046 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.408 HG21 ' O ' ' A' ' 102' ' ' THR . 54.9 m -91.14 102.82 15.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 108.836 179.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.48 ' O ' ' HA ' ' A' ' 103' ' ' VAL . 1.0 OUTLIER -103.24 -179.72 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.256 -0.903 . . . . 0.0 110.49 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.583 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 5.3 mttm -94.5 -175.81 0.51 Allowed Pre-proline 0 N--CA 1.488 1.443 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.583 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 33.6 Cg_endo -78.48 76.52 4.41 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.002 1.801 . . . . 0.0 110.607 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 121.23 43.99 0.41 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.473 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 5.0 m-20 -94.11 -178.06 4.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.253 -1.145 . . . . 0.0 108.876 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.9 m -117.7 126.1 51.87 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.203 -0.936 . . . . 0.0 109.534 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.554 ' HB ' ' CZ ' ' A' ' 31' ' ' PHE . 0.7 OUTLIER -119.44 134.14 63.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.284 -0.885 . . . . 0.0 109.398 -179.832 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.407 ' HB3' HG21 ' A' ' 4' ' ' THR . 4.6 tt0 -105.69 141.24 37.48 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.231 -0.918 . . . . 0.0 109.813 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.561 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -134.19 96.57 3.65 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.613 ' HA ' ' HB3' ' A' ' 71' ' ' SER . 0.5 OUTLIER -98.59 168.81 9.94 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.283 -0.886 . . . . 0.0 110.491 -178.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.538 ' HB2' ' CD2' ' A' ' 39' ' ' HIS . 3.5 p-10 -94.66 153.72 17.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.547 -0.721 . . . . 0.0 109.572 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.454 ' HB2' ' HA3' ' A' ' 8' ' ' GLY . 38.5 t30 -97.1 -129.63 0.17 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.027 -1.045 . . . . 0.0 108.915 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.443 ' O ' HG21 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -108.86 36.55 2.83 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.757 -1.214 . . . . 0.0 109.364 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.529 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 4.3 t -154.96 67.89 5.35 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 109.421 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.544 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.5 Cg_endo -80.41 173.95 11.82 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.6 2.2 . . . . 0.0 110.788 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.544 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 39.1 Cg_endo -85.83 165.06 54.78 Favored 'Cis proline' 0 C--N 1.312 -1.378 0 C-N-CA 123.494 -1.461 . . . . 0.0 110.305 -1.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.709 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 57.4 m-70 -119.58 140.24 50.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.934 . . . . 0.0 109.762 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.472 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 1.3 t-20 -121.92 125.96 47.55 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.356 -0.84 . . . . 0.0 109.544 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.457 ' C ' ' CG2' ' A' ' 42' ' ' VAL . 24.8 t -114.13 134.22 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.92 . . . . 0.0 109.17 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.513 ' HA ' ' HB3' ' A' ' 60' ' ' SER . 0.2 OUTLIER -156.84 166.82 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.071 -1.018 . . . . 0.0 109.855 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.517 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 4.5 m-85 -119.39 112.04 18.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.836 . . . . 0.0 109.183 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.476 ' HB3' ' HB2' ' A' ' 47' ' ' LEU . 7.5 t70 -43.74 143.21 1.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.305 -0.872 . . . . 0.0 109.733 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.459 ' HB1' ' HB2' ' A' ' 53' ' ' ALA . . . -90.54 -3.43 57.6 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.39 -0.819 . . . . 0.0 109.737 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.36 9.56 21.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.621 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.476 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 0.5 OUTLIER -122.29 39.35 3.92 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.135 -0.978 . . . . 0.0 109.735 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.523 ' OD1' ' CA ' ' A' ' 51' ' ' LYS . 0.6 OUTLIER -112.31 165.3 13.28 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 109.419 179.756 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 35.0 Cg_endo -76.59 -10.06 18.63 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.606 2.204 . . . . 0.0 110.826 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -125.0 26.18 7.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.11 -0.994 . . . . 0.0 109.493 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.523 ' CA ' ' OD1' ' A' ' 48' ' ' ASN . 0.6 OUTLIER 34.28 35.58 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.134 0.492 . . . . 0.0 110.325 179.66 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 50' ' ' ALA . 19.1 m -110.85 164.03 13.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.151 -0.968 . . . . 0.0 109.74 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.459 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . . . -132.51 45.8 2.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.305 -0.872 . . . . 0.0 109.295 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.41 ' C ' ' OD1' ' A' ' 54' ' ' ASP . 7.5 t0 -111.94 -56.4 2.39 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.311 -0.868 . . . . 0.0 109.58 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 3.3 pp -55.34 -29.87 59.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.917 . . . . 0.0 109.556 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -68.11 -43.5 78.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.62 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -57.7 -39.82 78.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.367 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.4 m -87.84 16.36 5.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.227 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.502 HD23 ' CE2' ' A' ' 43' ' ' PHE . 9.7 tp -122.93 -45.25 2.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.346 -0.846 . . . . 0.0 109.375 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.513 ' HB3' ' HA ' ' A' ' 42' ' ' VAL . 37.0 p -82.16 159.35 23.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.491 -0.756 . . . . 0.0 110.247 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 20.7 p80 -110.38 174.53 5.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.563 -0.711 . . . . 0.0 109.496 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -121.25 -163.07 1.01 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.367 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 59.19 -165.82 0.18 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.916 . . . . 0.0 109.386 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.462 ' HB3' ' HB2' ' A' ' 38' ' ' PRO . 4.5 mp -128.55 165.08 21.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 109.327 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.53 ' N ' ' CD1' ' A' ' 65' ' ' LEU . 7.4 mp -103.05 107.35 18.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.179 -0.95 . . . . 0.0 109.48 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -98.19 -18.83 18.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 0.0 109.443 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.498 ' OG ' ' HB2' ' A' ' 70' ' ' GLN . 46.0 t -85.67 142.91 37.53 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.915 . . . . 0.0 109.24 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 67' ' ' SER . 36.6 Cg_endo -79.14 107.06 2.15 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.81 2.34 . . . . 0.0 111.3 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.437 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 93.61 -18.35 56.65 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.498 ' HB2' ' OG ' ' A' ' 67' ' ' SER . 0.0 OUTLIER -80.2 103.15 9.88 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.063 -1.257 . . . . 0.0 109.266 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.613 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -124.62 -168.87 1.88 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.378 -0.826 . . . . 0.0 110.22 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.456 ' CG2' ' O ' ' A' ' 72' ' ' THR . 9.0 t -122.01 110.33 15.69 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.7 p -78.44 111.22 14.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 108.932 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.481 HG21 ' HA ' ' A' ' 59' ' ' LEU . 1.7 m -88.03 108.96 19.48 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.475 -0.766 . . . . 0.0 109.846 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.517 ' CG2' ' O ' ' A' ' 75' ' ' THR . 10.2 t -78.86 94.73 5.24 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.58 ' CE2' HD12 ' A' ' 101' ' ' ILE . 4.5 m-30 -39.79 160.03 0.11 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.698 -0.626 . . . . 0.0 109.693 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.503 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 33.8 Cg_endo -75.51 163.83 33.5 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.749 2.299 . . . . 0.0 111.417 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.31 1.65 7.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.379 -0.825 . . . . 0.0 110.294 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.495 ' O ' ' O ' ' A' ' 80' ' ' ALA . 0.7 OUTLIER -98.85 -61.41 1.37 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.005 -1.059 . . . . 0.0 109.065 179.766 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.495 ' O ' ' O ' ' A' ' 79' ' ' ASP . . . 42.88 94.7 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.447 -0.783 . . . . 0.0 109.679 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.473 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 34.3 Cg_endo -75.7 121.64 6.43 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.312 2.008 . . . . 0.0 110.155 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 81' ' ' PRO . . . -42.58 133.49 3.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.47 -0.769 . . . . 0.0 109.612 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 85' ' ' TYR . . . 160.57 158.29 9.18 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.38 125.45 29.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.196 -1.179 . . . . 0.0 109.747 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.571 ' O ' ' CD2' ' A' ' 87' ' ' PHE . 9.6 m-85 -100.71 70.76 1.44 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.451 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 57.0 m -62.83 97.53 0.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.42 -0.8 . . . . 0.0 110.464 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.571 ' CD2' ' O ' ' A' ' 85' ' ' TYR . 1.5 p90 -99.91 162.97 12.66 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.154 -0.966 . . . . 0.0 108.635 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 28.9 p90 -149.99 -173.97 4.58 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.98 -1.075 . . . . 0.0 109.954 -179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.472 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 0.1 OUTLIER -116.34 132.27 56.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.503 -0.748 . . . . 0.0 109.562 -179.651 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.612 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 25.8 tt0 -65.92 -45.0 63.97 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.207 -0.933 . . . . 0.0 109.975 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.5 Cg_endo -79.23 -45.37 0.11 Allowed 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 121.93 1.753 . . . . 0.0 110.18 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.709 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 4.7 m80 -106.84 67.25 0.7 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 109.316 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.74 133.99 37.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 109.521 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 82.27 -4.99 74.48 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 14' ' ' LEU . . . -93.43 39.08 1.05 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.213 -1.169 . . . . 0.0 109.503 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.427 ' HA3' HG11 ' A' ' 15' ' ' VAL . . . 79.84 -3.88 67.99 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.528 ' CE ' ' HB2' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -86.59 47.17 1.44 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.178 -1.189 . . . . 0.0 109.34 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.5 t -124.23 76.15 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 0.0 109.498 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.542 ' C ' ' CE1' ' A' ' 87' ' ' PHE . . . -96.92 162.94 22.17 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.451 ' HG2' ' HA ' ' A' ' 86' ' ' THR . 15.0 mtmt -139.38 135.15 33.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -1.138 . . . . 0.0 109.199 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.58 HD12 ' CE2' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -84.01 139.08 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.169 -0.957 . . . . 0.0 109.462 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.408 ' O ' HG21 ' A' ' 22' ' ' THR . 0.1 OUTLIER -112.58 99.43 7.95 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.356 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.539 ' CG1' ' HA ' ' A' ' 25' ' ' PRO . 21.8 t -99.01 95.46 4.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.196 -0.94 . . . . 0.0 110.014 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -119.39 -151.49 0.48 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.52 -0.737 . . . . 0.0 109.329 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.906 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.411 ' HG2' ' OD1' ' A' ' 27' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.8 123.34 17.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.938 . . . . 0.0 109.832 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.561 ' CD1' HG23 ' A' ' 23' ' ' ILE . 10.6 m-85 -126.13 170.9 11.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.329 -0.857 . . . . 0.0 108.871 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 30' ' ' GLU . 87.1 m -157.46 116.94 3.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.07 -1.018 . . . . 0.0 110.167 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.493 ' CG1' ' CD1' ' A' ' 21' ' ' LEU . 10.4 m -98.57 170.78 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 121.345 -0.847 . . . . 0.0 109.032 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -143.56 87.2 1.92 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.06 -1.025 . . . . 0.0 109.874 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.526 ' HB2' ' CE ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -50.86 100.12 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.183 -0.948 . . . . 0.0 109.254 179.63 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.491 ' HA2' ' HA ' ' A' ' 14' ' ' LEU . . . 129.1 98.87 0.9 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 2.3 p -48.0 -95.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -1.161 . . . . 0.0 109.371 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 9' ' ' SER . 48.5 t0 176.86 33.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.946 . . . . 0.0 109.508 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.08 -43.05 0.64 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.159 -0.963 . . . . 0.0 109.603 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.13 44.29 0.02 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 13.6 mt -151.32 160.94 43.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -1.141 . . . . 0.0 109.458 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.57 HD23 ' CE1' ' A' ' 39' ' ' HIS . 12.9 mt -120.48 103.21 8.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.308 -0.87 . . . . 0.0 109.501 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.421 HG13 ' HA3' ' A' ' 96' ' ' GLY . 26.7 m -149.8 138.6 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.718 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -56.49 153.73 9.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.15 -0.969 . . . . 0.0 108.85 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.462 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 4.6 mm-40 -143.51 103.61 5.02 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 120.995 -1.066 . . . . 0.0 109.81 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.463 ' HD2' HD11 ' A' ' 21' ' ' LEU . 35.6 Cg_endo -79.29 178.54 33.46 Favored 'Cis proline' 0 C--N 1.314 -1.286 0 C-N-CA 123.796 -1.335 . . . . 0.0 110.452 -0.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.03 -51.42 18.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.223 -0.923 . . . . 0.0 109.255 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? -99.15 146.45 26.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 0.0 109.237 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.493 ' CD1' ' CG1' ' A' ' 5' ' ' VAL . 0.3 OUTLIER -140.46 142.36 35.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.113 -0.992 . . . . 0.0 109.826 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.429 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 32.1 m -106.52 126.22 51.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.344 -0.847 . . . . 0.0 109.096 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.561 HG23 ' CD1' ' A' ' 3' ' ' TYR . 1.0 OUTLIER -136.76 174.94 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.138 -0.976 . . . . 0.0 109.969 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.501 ' CB ' ' OD1' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -96.6 173.15 4.37 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.531 ' HA ' ' CB ' ' A' ' 80' ' ' ALA . 35.2 Cg_endo -77.58 91.66 1.17 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.346 2.03 . . . . 0.0 110.39 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 123.27 -11.35 8.6 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.501 ' OD1' ' CB ' ' A' ' 24' ' ' LYS . 5.8 m-20 -55.81 -178.69 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.287 -1.125 . . . . 0.0 109.096 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 97.3 m -124.09 140.99 52.44 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.205 -0.934 . . . . 0.0 109.43 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.478 HG21 HD13 ' A' ' 101' ' ' ILE . 1.3 t -130.93 119.28 44.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.278 -0.889 . . . . 0.0 109.364 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.471 ' O ' ' HA ' ' A' ' 4' ' ' THR . 30.9 tt0 -99.51 135.88 40.26 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.263 -0.898 . . . . 0.0 109.514 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.489 ' O ' ' OG ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -127.28 152.0 48.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.126 -0.984 . . . . 0.0 108.856 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.542 ' HB3' ' N ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -140.49 -170.07 2.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.018 -1.052 . . . . 0.0 109.772 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.463 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 8.6 p-10 -114.05 169.81 8.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.429 -0.795 . . . . 0.0 109.002 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -110.02 -95.49 0.41 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.078 -1.014 . . . . 0.0 109.517 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.455 ' O ' HG21 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -143.05 33.14 1.36 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.009 -1.057 . . . . 0.0 109.376 179.84 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.552 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 37.6 t -151.49 59.58 3.32 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.519 -0.738 . . . . 0.0 109.063 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.552 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 36.4 Cg_endo -77.66 173.43 14.16 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.744 2.296 . . . . 0.0 110.943 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.58 ' O ' ' CG ' ' A' ' 39' ' ' HIS . 37.5 Cg_endo -82.42 -158.57 1.69 Allowed 'Cis proline' 0 C--N 1.31 -1.467 0 C-N-CA 123.292 -1.545 . . . . 0.0 110.175 -0.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.58 ' CG ' ' O ' ' A' ' 38' ' ' PRO . 86.9 m-70 -160.85 129.52 4.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.238 -0.914 . . . . 0.0 109.431 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.07 106.04 17.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.208 -0.933 . . . . 0.0 109.379 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.422 ' N ' ' NE2' ' A' ' 61' ' ' HIS . 41.2 t -99.7 120.64 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.098 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.538 ' CG1' ' HB2' ' A' ' 60' ' ' SER . 0.8 OUTLIER -159.5 158.01 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.146 -0.972 . . . . 0.0 109.899 -179.521 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.652 ' CE2' ' CG ' ' A' ' 59' ' ' LEU . 3.4 m-85 -94.9 116.35 28.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.396 -0.815 . . . . 0.0 109.498 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 38.3 t0 -52.9 130.09 32.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.357 -0.839 . . . . 0.0 109.709 -179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.97 -1.9 53.7 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.214 -0.929 . . . . 0.0 109.605 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.68 12.99 34.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.156 -0.965 . . . . 0.0 109.609 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.1 mt -139.84 52.81 1.69 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.178 -0.951 . . . . 0.0 109.45 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.529 ' OD1' ' N ' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -105.07 164.36 15.29 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.935 . . . . 0.0 109.504 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.473 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 35.1 Cg_endo -78.12 -20.63 11.28 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.675 2.25 . . . . 0.0 110.956 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.486 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -126.32 26.32 6.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.041 -1.037 . . . . 0.0 109.919 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.495 ' HA ' ' OD1' ' A' ' 48' ' ' ASN . 15.6 mmtt 34.53 36.79 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.16 0.505 . . . . 0.0 110.284 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 50' ' ' ALA . 41.0 m -99.75 -162.32 0.94 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.206 -0.934 . . . . 0.0 109.584 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -166.12 80.31 0.27 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.346 -0.846 . . . . 0.0 109.268 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -155.92 -48.96 0.08 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.252 -0.905 . . . . 0.0 109.469 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 1.5 pp -62.23 -17.14 57.49 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.163 -0.961 . . . . 0.0 109.222 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.411 ' O ' ' C ' ' A' ' 57' ' ' LYS . . . -90.33 -30.43 17.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.332 -0.855 . . . . 0.0 109.539 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -43.86 -62.73 1.02 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.913 . . . . 0.0 109.503 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.9 m -94.39 49.57 1.3 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 0.0 109.417 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.652 ' CG ' ' CE2' ' A' ' 43' ' ' PHE . 7.3 tp -136.27 -60.89 0.71 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.347 -0.846 . . . . 0.0 109.34 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.538 ' HB2' ' CG1' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -77.48 152.17 34.31 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.462 -0.774 . . . . 0.0 110.159 -178.432 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.422 ' NE2' ' N ' ' A' ' 41' ' ' VAL . 27.4 p80 -97.17 -168.59 1.72 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.547 -0.721 . . . . 0.0 109.327 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.11 -46.17 0.34 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.178 -0.951 . . . . 0.0 109.391 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -65.72 132.82 49.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.2 -0.938 . . . . 0.0 109.402 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.428 HD23 ' HG2' ' A' ' 38' ' ' PRO . 5.7 mp -58.86 169.76 0.95 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.18 -0.95 . . . . 0.0 109.356 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.465 ' N ' ' CD2' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -115.6 127.04 54.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.19 -0.944 . . . . 0.0 109.262 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.9 mtt -120.29 9.78 11.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.266 -0.896 . . . . 0.0 109.599 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.422 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 32.3 t -94.07 138.44 22.62 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 109.322 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.443 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.5 Cg_endo -79.92 95.65 1.03 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.579 2.186 . . . . 0.0 110.62 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.463 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 99.76 48.63 1.61 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.542 ' N ' ' HB3' ' A' ' 32' ' ' LEU . 6.4 tt0 -179.22 100.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.14 -1.212 . . . . 0.0 109.334 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.572 ' OG ' ' N ' ' A' ' 72' ' ' THR . 24.1 p -103.8 -79.63 0.54 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.145 -0.972 . . . . 0.0 109.723 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.572 ' N ' ' OG ' ' A' ' 71' ' ' SER . 0.4 OUTLIER -160.72 107.95 1.53 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.925 -1.109 . . . . 0.0 109.751 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.22 99.38 7.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.047 -1.033 . . . . 0.0 108.818 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.519 HG22 ' CD1' ' A' ' 59' ' ' LEU . 6.9 m -102.97 124.99 49.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.343 -0.848 . . . . 0.0 110.047 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.462 ' O ' ' C ' ' A' ' 76' ' ' PHE . 0.8 OUTLIER -89.9 93.69 9.52 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.168 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.536 ' CE1' HD13 ' A' ' 101' ' ' ILE . 32.5 m-85 -39.95 157.15 0.15 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.475 -0.766 . . . . 0.0 109.64 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.5 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.1 Cg_endo -75.5 161.58 37.09 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.703 2.269 . . . . 0.0 111.238 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.411 ' HA ' ' O ' ' A' ' 25' ' ' PRO . . . -74.54 5.11 5.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.557 -0.715 . . . . 0.0 109.964 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.474 ' O ' ' C ' ' A' ' 80' ' ' ALA . 0.4 OUTLIER -98.6 -67.22 0.86 Allowed 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.015 -1.053 . . . . 0.0 109.202 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.531 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . . . 40.65 76.49 0.5 Allowed Pre-proline 0 N--CA 1.493 1.687 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 82' ' ' ALA . 35.3 Cg_endo -76.73 119.91 5.33 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.866 2.378 . . . . 0.0 111.697 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 81' ' ' PRO . . . 50.89 106.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.597 -0.689 . . . . 0.0 110.482 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 103' ' ' VAL . . . -49.0 103.71 0.08 OUTLIER Glycine 0 N--CA 1.48 1.626 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 49' ' ' PRO . 1.1 tp10 -160.32 53.33 0.32 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.273 -1.134 . . . . 0.0 109.744 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.564 ' CE2' HG21 ' A' ' 103' ' ' VAL . 1.1 m-85 -111.45 128.45 56.0 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.468 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 59.3 m -124.72 114.85 19.85 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.143 -0.973 . . . . 0.0 110.09 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.552 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.6 OUTLIER -99.98 164.45 11.99 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.898 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 89' ' ' CYS . 55.2 p90 -155.36 -162.37 1.33 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.013 -1.054 . . . . 0.0 109.662 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.436 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 0.1 OUTLIER -133.27 124.38 27.23 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.568 -0.707 . . . . 0.0 109.52 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.616 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 6.3 tt0 -61.47 -43.85 90.37 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.313 -0.867 . . . . 0.0 110.739 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.2 Cg_endo -79.42 -66.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 122.09 1.86 . . . . 0.0 110.729 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.56 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 10.1 m80 -75.68 55.61 0.86 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.159 -0.963 . . . . 0.0 109.256 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -82.19 109.86 16.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.34 -0.85 . . . . 0.0 109.631 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.7 -1.19 28.99 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.473 ' O ' ' O ' ' A' ' 14' ' ' LEU . . . -101.1 35.12 2.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.176 -1.191 . . . . 0.0 109.467 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.421 ' HA3' HG13 ' A' ' 15' ' ' VAL . . . 70.12 19.69 75.84 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.526 ' CE ' ' HB2' ' A' ' 7' ' ' LEU . 1.0 OUTLIER -92.04 37.25 0.98 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.082 -1.246 . . . . 0.0 109.329 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 89.4 t -125.59 110.27 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.187 -0.946 . . . . 0.0 109.686 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.552 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -118.34 173.27 14.79 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.468 ' HG2' ' HA ' ' A' ' 86' ' ' THR . 7.6 mtmm -148.15 129.8 15.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.099 -1.236 . . . . 0.0 109.823 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.536 HD13 ' CE1' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -83.49 129.02 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.286 -0.884 . . . . 0.0 108.669 179.409 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.429 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 2.8 m -99.66 95.1 6.73 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.173 -0.954 . . . . 0.0 108.988 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.564 HG21 ' CE2' ' A' ' 85' ' ' TYR . 60.1 t -98.5 99.4 8.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.464 -0.773 . . . . 0.0 109.664 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.19 127.65 33.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.375 -0.828 . . . . 0.0 109.587 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.886 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 55.6 m -135.79 130.79 34.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.301 -0.874 . . . . 0.0 109.593 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -92.7 150.21 20.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 109.39 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 30' ' ' GLU . 1.4 t -157.22 135.39 11.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.215 -0.928 . . . . 0.0 109.591 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.523 ' CG1' HD12 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -109.12 102.36 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.295 -0.878 . . . . 0.0 109.37 179.823 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -68.43 127.66 33.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.407 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.511 ' CD2' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -97.79 177.26 5.52 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.118 -0.989 . . . . 0.0 109.09 179.53 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 9' ' ' SER . . . 59.03 86.72 0.03 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.473 ' OG ' ' N ' ' A' ' 10' ' ' ASP . 93.6 p -45.27 -88.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.301 -1.117 . . . . 0.0 109.587 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.473 ' N ' ' OG ' ' A' ' 9' ' ' SER . 6.8 t70 179.6 -47.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 109.157 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.58 30.71 5.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.332 -0.855 . . . . 0.0 109.146 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.409 ' C ' ' HG ' ' A' ' 13' ' ' LEU . . . -138.96 -108.78 0.82 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.409 ' HG ' ' C ' ' A' ' 12' ' ' GLY . 0.5 OUTLIER -130.87 -155.24 0.68 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.24 -1.153 . . . . 0.0 109.61 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.442 ' HB3' ' HE1' ' A' ' 97' ' ' MET . 5.3 mt -107.7 118.12 35.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.298 -0.876 . . . . 0.0 109.38 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.483 HG12 ' O ' ' A' ' 95' ' ' ALA . 2.4 m -146.07 159.25 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.528 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -82.05 138.26 34.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.319 -0.863 . . . . 0.0 109.248 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.438 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 83.3 mt-10 -126.17 111.86 23.96 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 109.368 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.448 ' HG2' ' HG ' ' A' ' 21' ' ' LEU . 35.2 Cg_endo -78.88 -178.2 23.17 Favored 'Cis proline' 0 C--N 1.311 -1.429 0 C-N-CA 123.841 -1.316 . . . . 0.0 110.517 -0.052 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.61 -59.27 2.93 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.315 -0.865 . . . . 0.0 109.086 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.28 160.71 14.08 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.355 -0.84 . . . . 0.0 108.861 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.523 HD12 ' CG1' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -155.24 121.02 5.07 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.961 -1.087 . . . . 0.0 110.314 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.461 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 34.0 m -92.81 107.64 19.38 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.541 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -105.74 171.44 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.19 -0.944 . . . . 0.0 110.42 -178.882 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.48 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -89.58 171.34 8.94 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.017 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.48 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 34.7 Cg_endo -76.6 79.39 3.04 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.219 1.946 . . . . 0.0 110.728 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 136.91 -22.6 3.27 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.394 -1.384 . . . . 0.0 110.424 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 26' ' ' GLY . 16.4 m-20 -46.66 172.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.031 -1.276 . . . . 0.0 109.533 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.461 HG21 ' OG1' ' A' ' 75' ' ' THR . 1.3 m -115.96 119.6 36.44 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.337 -0.852 . . . . 0.0 109.406 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.549 HG22 ' CD1' ' A' ' 76' ' ' PHE . 2.5 t -99.48 132.31 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 121.222 -0.924 . . . . 0.0 109.518 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.449 ' O ' ' HA ' ' A' ' 4' ' ' THR . 10.6 tt0 -113.47 142.68 45.63 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.197 -0.939 . . . . 0.0 109.53 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.589 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -138.55 95.02 2.91 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.55 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 1.1 pp -98.77 160.4 14.3 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.228 -0.92 . . . . 0.0 110.456 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.49 ' HA ' ' CD1' ' A' ' 7' ' ' LEU . 2.3 p-10 -79.0 -173.82 3.75 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.629 -0.67 . . . . 0.0 109.271 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.47 ' ND2' ' HG2' ' A' ' 35' ' ' LYS . 25.3 t30 -134.73 -93.27 0.3 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.138 -0.976 . . . . 0.0 109.291 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.47 ' HG2' ' ND2' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -138.45 36.17 2.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.1 -1.0 . . . . 0.0 109.412 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.548 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -157.11 61.11 2.29 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.44 -0.788 . . . . 0.0 109.011 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.548 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 36.0 Cg_endo -79.42 173.39 13.23 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.632 2.221 . . . . 0.0 111.007 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.581 ' O ' ' CD2' ' A' ' 39' ' ' HIS . 37.9 Cg_endo -84.47 -157.1 1.26 Allowed 'Cis proline' 0 C--N 1.31 -1.482 0 C-N-CA 123.298 -1.543 . . . . 0.0 110.163 -1.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.581 ' CD2' ' O ' ' A' ' 38' ' ' PRO . 81.6 m-70 -161.46 142.46 11.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.46 -0.775 . . . . 0.0 109.754 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -116.63 123.47 47.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 109.31 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.428 ' C ' ' CG2' ' A' ' 42' ' ' VAL . 70.4 t -110.17 128.55 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.326 -0.859 . . . . 0.0 109.425 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 87' ' ' PHE . 1.2 t -151.64 178.1 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.931 . . . . 0.0 109.489 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.58 ' CE2' HD22 ' A' ' 59' ' ' LEU . 12.1 m-85 -130.14 121.47 26.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.235 -0.915 . . . . 0.0 109.533 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.455 ' O ' ' O ' ' A' ' 43' ' ' PHE . 8.5 t0 -50.77 -177.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.355 -0.84 . . . . 0.0 109.455 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.84 14.3 2.9 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.247 -0.908 . . . . 0.0 109.501 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.71 15.37 2.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.899 . . . . 0.0 109.607 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 mp -117.29 35.72 4.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.101 -1.0 . . . . 0.0 109.601 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.531 ' OD1' ' CA ' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -130.13 156.39 79.33 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.319 -0.863 . . . . 0.0 109.071 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.545 ' HG2' ' CB ' ' A' ' 82' ' ' ALA . 35.5 Cg_endo -77.93 2.67 7.69 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.611 2.207 . . . . 0.0 111.145 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.505 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -140.2 29.64 2.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.88 -1.138 . . . . 0.0 110.103 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.531 ' CA ' ' OD1' ' A' ' 48' ' ' ASN . 0.3 OUTLIER 30.54 96.35 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 121.234 0.54 . . . . 0.0 110.577 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.517 ' N ' ' OD1' ' A' ' 48' ' ' ASN . 1.7 m -99.23 -177.68 3.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.008 -1.057 . . . . 0.0 109.904 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . 170.59 -33.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.434 -0.791 . . . . 0.0 109.21 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -89.15 -17.63 28.8 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.332 -0.855 . . . . 0.0 109.51 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.483 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 0.7 OUTLIER -106.26 -28.17 10.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.121 -0.987 . . . . 0.0 109.508 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.471 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -87.45 -7.07 58.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.339 -0.851 . . . . 0.0 109.85 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -79.72 -49.77 11.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.155 -0.966 . . . . 0.0 109.347 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 t -82.53 -22.06 35.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 109.559 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.58 HD22 ' CE2' ' A' ' 43' ' ' PHE . 9.1 tp -53.0 -32.25 45.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.937 . . . . 0.0 108.83 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.495 ' HB3' ' HA ' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -78.8 127.92 32.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.336 -0.852 . . . . 0.0 109.74 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.518 ' ND1' ' N ' ' A' ' 62' ' ' LYS . 9.7 p80 -73.38 -28.58 62.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.149 -0.969 . . . . 0.0 109.048 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 1.3 mtpt 56.65 118.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.497 -0.752 . . . . 0.0 110.011 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.52 ' CB ' ' O ' ' A' ' 62' ' ' LYS . 0.5 OUTLIER 160.46 169.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.466 -0.771 . . . . 0.0 109.438 179.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 mp -102.68 123.56 46.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.172 -0.955 . . . . 0.0 109.218 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 70' ' ' GLN . 9.1 mp -84.47 81.9 8.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.581 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.43 ' HE1' ' HB3' ' A' ' 66' ' ' MET . 30.9 mtp -93.98 2.69 56.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.164 -0.96 . . . . 0.0 109.822 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.484 ' OG ' ' HD2' ' A' ' 68' ' ' PRO . 1.0 OUTLIER -115.81 152.42 47.41 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.121 -0.987 . . . . 0.0 109.089 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.484 ' HD2' ' OG ' ' A' ' 67' ' ' SER . 33.8 Cg_endo -76.13 102.18 1.58 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.407 2.071 . . . . 0.0 110.151 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.98 -26.31 14.28 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.486 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.5 108.73 0.19 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.277 -1.131 . . . . 0.0 108.991 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.55 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . 5.2 p -140.42 -159.57 0.97 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.097 -1.002 . . . . 0.0 110.083 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.502 ' CG2' ' HB3' ' A' ' 61' ' ' HIS . 4.2 m -157.06 112.39 2.84 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.5 p -79.41 76.2 5.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.121 -0.987 . . . . 0.0 109.293 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.543 ' CG2' HD11 ' A' ' 59' ' ' LEU . 60.9 m -51.1 111.0 0.49 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.538 -0.726 . . . . 0.0 109.939 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.461 ' OG1' HG21 ' A' ' 28' ' ' THR . 96.0 m -80.39 92.25 5.8 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.339 -0.85 . . . . 0.0 109.047 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.572 ' CE2' HD11 ' A' ' 101' ' ' ILE . 11.6 m-85 -44.74 165.11 0.16 Allowed Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.374 -0.829 . . . . 0.0 109.399 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 76' ' ' PHE . 32.6 Cg_endo -75.64 155.38 40.01 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.552 2.168 . . . . 0.0 111.362 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.26 -6.5 24.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.61 -0.681 . . . . 0.0 109.801 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -99.96 -66.31 0.91 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.2 -0.937 . . . . 0.0 109.2 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.481 ' O ' HG13 ' A' ' 103' ' ' VAL . . . 42.59 65.75 4.88 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.407 -0.808 . . . . 0.0 109.59 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.465 ' O ' ' HB2' ' A' ' 82' ' ' ALA . 33.5 Cg_endo -76.27 -159.81 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.374 2.049 . . . . 0.0 109.907 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.545 ' CB ' ' HG2' ' A' ' 49' ' ' PRO . . . 69.62 -84.84 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.076 -1.015 . . . . 0.0 109.189 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.424 ' HA2' ' C ' ' A' ' 103' ' ' VAL . . . 116.22 19.64 5.43 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -160.02 96.67 1.23 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.153 -1.204 . . . . 0.0 110.243 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.526 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 5.5 m-85 -111.85 125.46 54.04 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.401 ' OG1' ' HG2' ' A' ' 100' ' ' LYS . 24.3 m -112.69 118.3 34.64 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.0 -1.063 . . . . 0.0 110.946 -178.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.556 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.7 OUTLIER -103.77 175.17 5.57 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.272 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -160.53 -177.61 6.32 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.662 -1.273 . . . . 0.0 110.427 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.0 137.08 54.82 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -77.24 -46.98 2.65 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.888 . . . . 0.0 110.905 -179.49 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 33.3 Cg_endo -77.49 -47.83 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.331 2.02 . . . . 0.0 112.145 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.597 ' CE1' ' HG2' ' A' ' 91' ' ' PRO . 3.3 m80 -101.32 65.42 1.06 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.736 -1.227 . . . . 0.0 110.142 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -90.12 4.83 49.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 109.163 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.31 -14.73 23.38 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.483 ' O ' HG12 ' A' ' 15' ' ' VAL . . . -95.91 35.01 1.45 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -1.162 . . . . 0.0 109.181 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.463 ' O ' ' N ' ' A' ' 98' ' ' VAL . . . 48.93 27.29 6.45 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.453 ' SD ' ' HB2' ' A' ' 92' ' ' HIS . 4.1 mtp -68.39 60.73 0.09 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.976 -1.308 . . . . 0.0 109.138 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.463 ' N ' ' O ' ' A' ' 96' ' ' GLY . 96.7 t -139.14 110.18 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.88 . . . . 0.0 109.761 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.556 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -103.69 -171.55 25.59 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.488 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 18.2 mttt -155.1 123.63 6.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.162 -1.199 . . . . 0.0 109.758 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.572 HD11 ' CE2' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -90.97 124.43 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.233 -0.917 . . . . 0.0 108.795 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.461 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 18.2 m -105.26 97.65 7.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.252 -0.905 . . . . 0.0 108.856 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.481 HG13 ' O ' ' A' ' 80' ' ' ALA . 4.0 t -99.8 73.37 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.013 -1.055 . . . . 0.0 109.512 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.02 109.04 0.14 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.893 . . . . 0.0 109.526 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.423 ' OXT' ' HA ' ' A' ' 81' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.309 0 CA-C-O 118.005 -1.441 . . . . 0.0 109.551 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.4 m -123.1 128.8 50.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 109.553 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.442 ' HB2' HG12 ' A' ' 29' ' ' VAL . 58.8 m-85 -105.77 130.82 53.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -0.893 . . . . 0.0 109.328 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.442 ' O ' ' CG2' ' A' ' 4' ' ' THR . 10.1 t -127.61 108.76 11.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.714 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 19.5 m -92.83 159.5 2.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.23 -0.919 . . . . 0.0 109.537 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.407 ' HG2' HD12 ' A' ' 32' ' ' LEU . 25.4 mttt -128.26 84.26 2.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.426 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.544 ' HB2' ' CE ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -45.15 100.7 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.25 -0.906 . . . . 0.0 109.536 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.481 ' HA2' ' HA ' ' A' ' 14' ' ' LEU . . . 104.46 114.22 3.93 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 1.8 p -76.21 -81.3 0.08 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -1.121 . . . . 0.0 109.254 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.47 ' HB2' ' O ' ' A' ' 9' ' ' SER . 7.5 t70 167.83 -30.19 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.335 -0.853 . . . . 0.0 109.483 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.417 ' HB2' ' HE2' ' A' ' 11' ' ' LYS . 3.3 ttmm -114.85 -14.9 11.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 109.588 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.68 -85.92 1.77 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -164.34 -148.73 0.12 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -1.135 . . . . 0.0 109.296 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.545 HD13 ' CD2' ' A' ' 92' ' ' HIS . 83.9 mt -106.11 94.92 5.43 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.257 -0.902 . . . . 0.0 109.432 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.459 HG11 ' O ' ' A' ' 14' ' ' LEU . 3.5 m -144.57 155.41 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.199 -0.938 . . . . 0.0 109.591 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -70.06 142.99 52.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 109.764 179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 2.8 mt-10 -134.44 105.18 11.03 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.235 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.476 ' HG2' HD23 ' A' ' 21' ' ' LEU . 33.9 Cg_endo -76.34 -175.71 17.06 Favored 'Cis proline' 0 C--N 1.311 -1.403 0 C-N-CA 123.664 -1.39 . . . . 0.0 110.639 0.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.29 -9.61 54.52 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.242 -0.911 . . . . 0.0 109.89 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.469 ' O ' HD23 ' A' ' 21' ' ' LEU . 30.2 mtmt -139.02 137.34 36.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.095 -1.003 . . . . 0.0 109.492 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.476 ' N ' HD22 ' A' ' 21' ' ' LEU . 4.6 mm? -123.54 127.77 48.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.33 -0.856 . . . . 0.0 109.887 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.4 m -99.67 97.98 8.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 108.705 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.53 ' CD1' HG23 ' A' ' 103' ' ' VAL . 1.1 pt -104.16 -175.87 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.227 -0.92 . . . . 0.0 110.4 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.545 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -113.85 179.72 0.74 Allowed Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.075 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.545 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 34.1 Cg_endo -76.93 76.47 4.12 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.009 1.806 . . . . 0.0 110.571 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.451 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 134.31 -2.02 4.18 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.5 -1.334 . . . . 0.0 110.101 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.91 -170.86 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.092 -1.24 . . . . 0.0 109.249 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.4 HG23 ' HA ' ' A' ' 75' ' ' THR . 52.2 m -137.85 112.93 9.16 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.135 -0.978 . . . . 0.0 109.675 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.519 ' O ' ' CZ ' ' A' ' 31' ' ' PHE . 0.8 OUTLIER -99.89 128.43 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.214 -0.929 . . . . 0.0 109.422 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.436 ' C ' ' CG ' ' A' ' 31' ' ' PHE . 46.3 mt-10 -99.48 163.49 12.49 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.232 -0.917 . . . . 0.0 109.205 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.519 ' CZ ' ' O ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -149.44 152.87 36.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.209 -0.932 . . . . 0.0 109.391 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.53 ' HB3' ' N ' ' A' ' 70' ' ' GLN . 2.3 mp -141.73 -162.59 1.42 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.146 -0.971 . . . . 0.0 109.953 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 3.3 p-10 -123.97 172.99 8.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.446 -0.784 . . . . 0.0 109.011 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.456 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 26.0 t-20 -111.64 -96.36 0.43 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.939 -1.1 . . . . 0.0 109.193 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.469 ' HE2' HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -147.13 30.91 0.93 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.18 -0.95 . . . . 0.0 108.862 179.523 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.564 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 0.2 OUTLIER -151.1 59.42 3.34 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.694 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 36.6 Cg_endo -78.49 174.86 11.75 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.761 2.307 . . . . 0.0 110.617 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.556 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 37.9 Cg_endo -84.15 172.62 44.03 Favored 'Cis proline' 0 C--N 1.31 -1.461 0 C-N-CA 123.518 -1.451 . . . . 0.0 110.37 -1.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.687 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 91.9 m-70 -132.04 142.01 49.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.141 -0.974 . . . . 0.0 109.729 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.509 ' ND2' ' HB3' ' A' ' 63' ' ' GLN . 4.9 t-20 -112.47 119.29 37.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.335 -0.853 . . . . 0.0 109.604 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.9 t -108.03 112.94 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.519 ' HA ' ' HB3' ' A' ' 60' ' ' SER . 2.4 t -139.19 170.8 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.979 -1.075 . . . . 0.0 110.566 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.526 ' CE2' HD23 ' A' ' 59' ' ' LEU . 4.4 m-85 -118.45 110.58 17.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.491 -0.756 . . . . 0.0 109.345 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.494 ' HB3' ' CD2' ' A' ' 47' ' ' LEU . 6.1 t0 -48.83 139.3 10.1 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.192 -0.942 . . . . 0.0 109.278 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.29 12.84 6.0 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.251 -0.906 . . . . 0.0 109.888 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -119.8 23.99 10.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.069 -1.019 . . . . 0.0 109.668 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.494 ' CD2' ' HB3' ' A' ' 44' ' ' ASP . 0.7 OUTLIER -131.03 46.33 2.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.226 -0.921 . . . . 0.0 109.474 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 48' ' ' ASN . 0.5 OUTLIER -119.47 156.38 53.31 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.214 -0.929 . . . . 0.0 109.603 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.36 -21.56 11.65 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.676 2.251 . . . . 0.0 110.305 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.451 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -123.89 28.06 7.0 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.264 -0.898 . . . . 0.0 109.424 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.462 ' HA ' ' OD1' ' A' ' 48' ' ' ASN . 0.1 OUTLIER 38.55 48.17 1.22 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.295 0.569 . . . . 0.0 110.025 179.711 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.435 ' N ' ' ND2' ' A' ' 48' ' ' ASN . 22.3 m -112.02 139.22 47.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.165 -0.959 . . . . 0.0 109.434 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.442 ' O ' ' HD2' ' A' ' 57' ' ' LYS . . . -121.54 21.82 10.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.802 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.86 -32.85 34.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.203 -0.936 . . . . 0.0 109.568 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 0.5 OUTLIER -97.39 21.42 10.14 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.215 -0.928 . . . . 0.0 109.415 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -113.35 -33.88 5.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.328 -0.858 . . . . 0.0 109.294 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.442 ' HD2' ' O ' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -71.34 -48.66 48.93 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.275 -0.891 . . . . 0.0 109.028 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.1 t -77.83 -2.12 34.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 0.0 109.44 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.578 HD22 ' CE2' ' A' ' 76' ' ' PHE . 9.7 tp -89.05 -48.41 7.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.109 -0.994 . . . . 0.0 109.097 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.519 ' HB3' ' HA ' ' A' ' 42' ' ' VAL . 10.1 p -79.78 164.65 23.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.527 -0.733 . . . . 0.0 110.507 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.466 ' CG ' ' N ' ' A' ' 62' ' ' LYS . 3.5 p80 -125.0 -164.74 1.31 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.526 -0.734 . . . . 0.0 109.217 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.466 ' N ' ' CG ' ' A' ' 61' ' ' HIS . 2.2 mttp -65.43 -162.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.119 -0.988 . . . . 0.0 109.353 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.509 ' HB3' ' ND2' ' A' ' 40' ' ' ASN . 5.4 pt20 -137.07 42.44 2.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.102 -0.999 . . . . 0.0 109.876 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.61 76.53 1.64 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.182 -0.948 . . . . 0.0 109.938 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.582 ' N ' ' CD1' ' A' ' 65' ' ' LEU . 4.9 mp -85.58 105.0 15.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.131 -0.981 . . . . 0.0 109.21 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.1 ttt -109.04 3.82 22.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 0.0 109.578 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.428 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 2.6 t -98.28 133.63 22.74 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 109.123 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -78.86 78.92 3.53 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.413 2.076 . . . . 0.0 110.512 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.533 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 112.63 50.36 0.56 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.53 ' N ' ' HB3' ' A' ' 32' ' ' LEU . 0.0 OUTLIER 172.3 111.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -1.103 . . . . 0.0 109.385 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' A' ' 72' ' ' THR . 77.8 p -111.14 -78.89 0.58 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.209 -0.932 . . . . 0.0 109.199 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.531 ' N ' ' OG ' ' A' ' 71' ' ' SER . 14.7 t -160.4 164.28 32.47 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.387 -0.821 . . . . 0.0 108.945 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.2 t -115.44 126.47 54.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.156 -0.965 . . . . 0.0 109.226 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.536 ' CG2' HD12 ' A' ' 59' ' ' LEU . 56.0 m -108.3 101.74 10.91 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.303 -0.873 . . . . 0.0 109.716 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.469 ' O ' ' C ' ' A' ' 76' ' ' PHE . 25.1 m -79.14 80.13 5.51 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.578 ' CE2' HD22 ' A' ' 59' ' ' LEU . 9.1 m-85 -36.83 146.54 0.23 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.964 -0.46 . . . . 0.0 109.886 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.451 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.0 Cg_endo -75.63 168.81 23.61 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.625 2.217 . . . . 0.0 110.895 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.75 11.82 8.4 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.493 -0.754 . . . . 0.0 109.424 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.507 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 0.9 OUTLIER -99.55 -24.36 14.78 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.285 -0.885 . . . . 0.0 109.329 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' A' ' 25' ' ' PRO . . . -37.04 96.58 0.11 Allowed Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.815 -0.553 . . . . 0.0 109.769 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.507 ' HD3' ' O ' ' A' ' 79' ' ' ASP . 35.9 Cg_endo -78.62 -177.0 3.57 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.643 2.229 . . . . 0.0 110.732 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.463 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -70.39 127.32 32.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.301 -0.874 . . . . 0.0 109.266 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 167.11 145.75 4.61 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -85.07 117.02 23.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -1.137 . . . . 0.0 109.808 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.49 ' CD1' HG22 ' A' ' 101' ' ' ILE . 26.5 m-85 -92.51 153.4 19.1 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.492 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 29.6 m -138.81 114.33 9.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.837 -1.164 . . . . 0.0 110.762 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.598 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.4 OUTLIER -108.33 154.75 21.38 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.282 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.524 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 5.0 p90 -143.49 -156.77 0.72 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.052 -1.03 . . . . 0.0 110.11 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.459 ' SG ' ' HD2' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -133.41 139.19 46.62 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.323 -0.861 . . . . 0.0 109.491 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.629 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 63.1 tt0 -79.45 -42.64 1.6 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.349 -0.844 . . . . 0.0 111.035 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 34.2 Cg_endo -76.93 -46.04 0.16 Allowed 'Trans proline' 0 C--N 1.316 -1.148 0 C-N-CA 121.931 1.754 . . . . 0.0 111.068 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.687 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 15.2 m80 -102.3 33.32 3.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.0 -1.062 . . . . 0.0 109.6 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.9 ttt-85 -50.65 -36.9 37.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.129 -0.982 . . . . 0.0 109.718 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -96.27 40.26 2.64 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' A' ' 92' ' ' HIS . . . -133.68 33.38 3.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.231 -1.158 . . . . 0.0 109.541 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.11 24.12 54.01 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.231 -1.147 . . . . 0.0 110.231 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.544 ' CE ' ' HB2' ' A' ' 7' ' ' LEU . 2.7 mtp -87.54 71.59 9.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.039 -1.271 . . . . 0.0 109.217 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 88.6 t -137.62 127.94 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.541 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.598 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -123.66 -174.78 14.27 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.527 ' CG ' ' O ' ' A' ' 99' ' ' GLY . 22.2 mttt -162.33 122.27 2.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.175 -1.191 . . . . 0.0 110.169 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.568 HD11 ' CE2' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -88.16 121.25 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.107 -0.995 . . . . 0.0 108.406 178.91 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.6 101.41 12.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.021 -1.05 . . . . 0.0 109.329 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.53 HG23 ' CD1' ' A' ' 23' ' ' ILE . 2.4 t -99.77 116.47 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 109.367 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.43 -172.8 0.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 109.385 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 CA-C-O 118.024 -1.431 . . . . 0.0 109.528 -179.993 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.31 142.93 50.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.749 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.514 ' CD2' HG21 ' A' ' 23' ' ' ILE . 23.2 m-85 -80.17 173.87 12.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.281 -0.887 . . . . 0.0 109.373 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.475 HG21 ' CB ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -156.08 113.57 3.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.149 -0.97 . . . . 0.0 109.814 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.468 HG11 ' CD1' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -101.41 114.3 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.908 . . . . 0.0 109.129 179.514 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -82.03 107.53 14.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.244 -0.91 . . . . 0.0 109.475 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.567 HD21 ' CE1' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -88.94 -169.1 2.4 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.16 -0.963 . . . . 0.0 109.108 179.565 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.517 ' O ' ' ND2' ' A' ' 34' ' ' ASN . . . 65.05 74.51 0.48 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 p -58.44 151.57 19.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -1.177 . . . . 0.0 109.531 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -89.52 -0.72 57.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.758 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.53 -0.41 8.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.1 -1.0 . . . . 0.0 109.769 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -131.78 -105.95 1.03 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -148.2 -91.3 0.08 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.336 -1.097 . . . . 0.0 109.462 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.643 ' CD1' ' CD2' ' A' ' 92' ' ' HIS . 74.0 mt -133.76 108.05 8.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.224 -0.923 . . . . 0.0 109.714 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.413 HG11 ' O ' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -148.48 116.68 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.33 -0.856 . . . . 0.0 109.284 179.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.567 ' CE1' HD21 ' A' ' 7' ' ' LEU . 37.6 m-85 -45.39 151.09 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.165 -0.959 . . . . 0.0 109.27 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 16' ' ' PHE . 7.5 mt-10 -144.69 112.91 5.0 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.159 -0.963 . . . . 0.0 109.296 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.9 Cg_endo -76.7 177.62 38.81 Favored 'Cis proline' 0 C--N 1.312 -1.387 0 C-N-CA 123.678 -1.384 . . . . 0.0 110.609 0.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.38 -1.95 35.89 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.283 -0.886 . . . . 0.0 109.675 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.423 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -134.19 161.49 34.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 109.281 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.524 HD23 ' CG2' ' A' ' 23' ' ' ILE . 0.5 OUTLIER -156.5 118.07 3.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.001 -1.062 . . . . 0.0 110.032 -179.85 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.496 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 92.6 m -90.5 101.4 14.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.849 . . . . 0.0 108.876 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.526 ' CG1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -102.14 -172.75 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.317 -0.864 . . . . 0.0 110.317 -179.135 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.471 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -111.94 172.53 3.47 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.159 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.471 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 34.3 Cg_endo -77.41 79.83 3.07 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.364 2.043 . . . . 0.0 110.725 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 130.12 -24.56 4.48 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.577 -1.297 . . . . 0.0 109.898 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 26' ' ' GLY . 0.7 OUTLIER -51.43 -176.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.123 -1.222 . . . . 0.0 109.623 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.2 m -122.6 146.17 47.69 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.318 -0.864 . . . . 0.0 109.441 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.519 ' HB ' ' CZ ' ' A' ' 31' ' ' PHE . 2.4 t -127.17 140.36 49.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.23 -0.919 . . . . 0.0 109.451 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.475 ' CB ' HG21 ' A' ' 4' ' ' THR . 1.8 mt-10 -106.85 155.85 19.3 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.165 -0.959 . . . . 0.0 109.814 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.535 ' O ' ' OG ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -153.52 84.63 1.18 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.533 ' HA ' ' HB3' ' A' ' 71' ' ' SER . 1.7 pt? -96.55 165.3 12.23 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.98 0.895 . . . . 0.0 111.941 -177.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.609 ' HB2' ' CD2' ' A' ' 39' ' ' HIS . 3.9 p30 -87.45 154.85 20.32 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.97 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 48.4 t30 -92.98 -62.78 1.31 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.057 -1.027 . . . . 0.0 109.36 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.409 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -158.19 35.53 0.24 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.243 -0.91 . . . . 0.0 109.291 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.574 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 26.7 t -154.73 57.42 1.71 Allowed Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.411 -0.806 . . . . 0.0 109.794 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.574 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 37.0 Cg_endo -79.97 174.54 11.44 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.579 2.186 . . . . 0.0 110.515 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.532 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.1 Cg_endo -84.34 175.57 34.37 Favored 'Cis proline' 0 C--N 1.31 -1.462 0 C-N-CA 123.549 -1.438 . . . . 0.0 110.137 -1.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.689 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 51.0 m-70 -127.09 146.56 50.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.335 -0.853 . . . . 0.0 110.116 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -113.11 110.04 19.8 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.7 t -99.28 117.82 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.143 -0.973 . . . . 0.0 109.681 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.515 HG12 ' CB ' ' A' ' 60' ' ' SER . 0.8 OUTLIER -147.81 171.49 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.445 -0.785 . . . . 0.0 109.407 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.643 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.9 OUTLIER -124.66 109.59 13.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.331 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -46.96 136.46 8.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -0.884 . . . . 0.0 109.584 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.53 45.99 1.19 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.254 -0.904 . . . . 0.0 109.538 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.68 -30.52 0.82 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 110.186 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.9 mt -103.12 77.36 1.54 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.038 -1.039 . . . . 0.0 110.013 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.459 ' OD1' ' HA ' ' A' ' 51' ' ' LYS . 1.9 p30 -126.19 153.74 74.36 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.284 -0.885 . . . . 0.0 109.159 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.06 -14.31 13.58 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.562 2.175 . . . . 0.0 111.076 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -135.9 24.46 3.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.929 -1.107 . . . . 0.0 109.999 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.459 ' HA ' ' OD1' ' A' ' 48' ' ' ASN . 1.0 OUTLIER 35.75 87.39 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.115 0.483 . . . . 0.0 110.111 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.5 m -136.99 159.57 41.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.107 -0.996 . . . . 0.0 109.763 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.81 43.87 3.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 109.271 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -143.97 -41.05 0.28 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.347 -0.845 . . . . 0.0 109.648 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 1.3 pp -58.9 -18.11 30.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.044 -1.035 . . . . 0.0 109.135 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 57' ' ' LYS . . . -89.56 -38.74 13.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.342 -0.849 . . . . 0.0 109.314 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -44.15 -45.03 8.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 109.249 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.28 32.32 2.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -0.863 . . . . 0.0 109.16 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.596 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 7.1 tp -133.1 -51.37 0.89 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 0.0 109.648 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.515 ' CB ' HG12 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -78.74 121.18 24.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 109.766 -179.16 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.502 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 18.0 p80 -99.76 125.38 45.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.299 -0.876 . . . . 0.0 109.541 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 63' ' ' GLN . 2.2 mtpp -78.31 -37.22 45.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.186 -0.946 . . . . 0.0 109.591 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.436 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 2.4 tt0 -45.56 123.56 4.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.165 -0.959 . . . . 0.0 109.446 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.8 mp -75.97 170.66 15.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.478 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.59 ' N ' ' CD1' ' A' ' 65' ' ' LEU . 3.5 mp -93.1 -179.72 5.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -0.955 . . . . 0.0 109.429 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.43 ' HG3' ' C ' ' A' ' 65' ' ' LEU . 3.9 mtt -145.45 -48.52 0.23 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.065 -1.022 . . . . 0.0 110.151 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.503 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 47.2 t -80.58 144.96 57.69 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.058 -1.026 . . . . 0.0 110.224 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.16 95.02 1.0 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 123.024 2.482 . . . . 0.0 110.454 179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 33' ' ' ASN . . . 116.96 49.79 0.41 Allowed Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.228 -1.463 . . . . 0.0 109.83 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.528 ' N ' ' HB2' ' A' ' 32' ' ' LEU . 1.7 pt20 167.7 108.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -1.129 . . . . 0.0 109.457 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.535 ' OG ' ' O ' ' A' ' 31' ' ' PHE . 95.6 p -100.1 -100.24 0.24 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.228 -0.92 . . . . 0.0 109.445 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.532 ' N ' ' OG ' ' A' ' 71' ' ' SER . 36.9 p -146.32 -157.85 0.84 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 p -143.05 93.68 2.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.06 -1.025 . . . . 0.0 109.389 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.544 ' CG2' HD11 ' A' ' 59' ' ' LEU . 42.6 m -67.44 103.24 1.26 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.377 -0.827 . . . . 0.0 109.428 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 76' ' ' PHE . 1.9 m -78.65 78.73 5.09 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.223 -0.923 . . . . 0.0 108.859 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.596 ' CZ ' HD21 ' A' ' 59' ' ' LEU . 14.5 m-85 -40.79 144.02 0.65 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.651 -0.656 . . . . 0.0 109.306 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.468 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.9 Cg_endo -77.5 168.65 22.39 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.702 2.268 . . . . 0.0 111.149 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.45 9.78 8.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.429 -0.795 . . . . 0.0 109.447 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.489 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 28.0 t70 -99.15 -19.78 16.99 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.171 -0.956 . . . . 0.0 108.865 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.447 ' C ' ' O ' ' A' ' 79' ' ' ASP . . . -40.08 99.97 0.21 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.683 -0.635 . . . . 0.0 109.573 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 79' ' ' ASP . 34.8 Cg_endo -76.29 133.99 15.26 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.312 2.008 . . . . 0.0 110.357 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -46.1 136.05 7.1 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.26 -0.9 . . . . 0.0 109.354 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 167.47 -139.37 5.68 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -135.67 120.1 18.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.29 -1.123 . . . . 0.0 109.733 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.583 ' CD1' HG21 ' A' ' 101' ' ' ILE . 4.0 m-85 -102.02 -179.41 3.99 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.4 m -163.63 115.41 1.42 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.9 -1.125 . . . . 0.0 110.38 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.563 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.5 OUTLIER -110.83 162.62 14.62 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.995 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -149.87 -162.01 1.46 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.989 -1.069 . . . . 0.0 109.954 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.12 126.28 28.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.348 -0.845 . . . . 0.0 109.838 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -59.33 -46.3 99.06 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 109.961 179.467 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.2 Cg_endo -78.85 -69.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.152 0 C-N-CA 122.182 1.921 . . . . 0.0 110.725 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.689 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 9.5 m80 -66.96 63.98 0.05 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.036 -1.04 . . . . 0.0 109.423 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 91' ' ' PRO . 5.8 ttp180 -92.62 -9.08 42.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 0.0 109.599 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.68 39.84 2.76 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.47 36.4 0.98 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.099 -1.236 . . . . 0.0 109.573 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' A' ' 98' ' ' VAL . . . 50.48 21.96 4.99 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.528 ' CE ' ' HB3' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -66.85 67.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.094 -1.239 . . . . 0.0 109.432 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' A' ' 96' ' ' GLY . 97.2 t -138.34 92.54 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.104 -0.997 . . . . 0.0 109.546 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.563 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -88.44 -173.31 47.14 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.501 ' CG ' ' O ' ' A' ' 99' ' ' GLY . 12.6 mttp -157.96 122.79 4.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -1.178 . . . . 0.0 109.541 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.583 HG21 ' CD1' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -85.15 135.26 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 109.091 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.496 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 75.7 m -115.72 112.17 21.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.962 . . . . 0.0 108.635 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.559 HG21 ' CE1' ' A' ' 85' ' ' TYR . 8.6 t -99.37 131.64 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.941 . . . . 0.0 109.64 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -179.79 -74.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 0.0 109.587 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 CA-C-O 117.977 -1.457 . . . . 0.0 109.617 -179.897 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.436 HG22 ' HB ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -102.57 147.71 26.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.169 -0.957 . . . . 0.0 109.454 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 26.3 m-85 -118.47 125.42 49.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.256 -0.903 . . . . 0.0 109.499 -179.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 30' ' ' GLU . 1.7 t -115.49 136.02 53.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 109.504 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.443 ' O ' HD23 ' A' ' 7' ' ' LEU . 0.9 OUTLIER -111.09 85.71 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.578 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -56.18 128.29 34.86 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.178 -0.951 . . . . 0.0 109.328 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.541 ' CD2' ' N ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -104.48 179.5 4.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.243 -0.911 . . . . 0.0 109.504 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.433 ' HA2' ' HA ' ' A' ' 14' ' ' LEU . . . 68.36 75.63 0.49 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.466 ' O ' ' OD2' ' A' ' 10' ' ' ASP . 1.4 p -44.84 -30.28 0.95 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -1.186 . . . . 0.0 109.501 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.469 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER 77.07 -3.06 2.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.472 -0.768 . . . . 0.0 109.652 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.33 13.67 8.26 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.132 -0.98 . . . . 0.0 109.641 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.07 -82.1 0.05 OUTLIER Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.7 tp -140.38 -151.42 0.36 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.231 -1.159 . . . . 0.0 109.685 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.461 ' O ' HG13 ' A' ' 15' ' ' VAL . 87.5 mt -112.17 118.38 35.18 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.357 -0.84 . . . . 0.0 109.354 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.461 HG13 ' O ' ' A' ' 14' ' ' LEU . 6.1 m -152.03 156.91 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.179 -0.95 . . . . 0.0 109.381 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -71.41 156.37 39.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.211 -0.931 . . . . 0.0 109.454 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.423 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 47.6 mt-10 -143.88 112.86 5.35 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.416 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.423 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.1 Cg_endo -77.63 -178.6 24.53 Favored 'Cis proline' 0 C--N 1.312 -1.346 0 C-N-CA 123.739 -1.359 . . . . 0.0 110.462 0.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.14 -34.5 61.65 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.266 -0.896 . . . . 0.0 109.741 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.73 158.04 19.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 0.0 109.265 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.9 tp -151.83 107.45 3.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.102 -0.999 . . . . 0.0 109.891 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 41.0 m -81.43 95.23 7.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.152 -0.968 . . . . 0.0 109.058 179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.521 ' CD1' HG21 ' A' ' 103' ' ' VAL . 1.0 OUTLIER -99.7 168.62 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.397 -0.814 . . . . 0.0 110.163 -179.3 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.527 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 37.0 mttt -88.28 168.21 17.08 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.527 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 32.5 Cg_endo -75.54 82.77 2.03 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 121.872 1.714 . . . . 0.0 110.559 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.433 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 132.05 -13.52 5.23 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.445 ' OD2' ' HG3' ' A' ' 24' ' ' LYS . 6.8 m-20 -54.8 -176.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.16 -1.2 . . . . 0.0 109.699 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.523 ' CG2' ' HA ' ' A' ' 75' ' ' THR . 0.2 OUTLIER -122.1 138.77 54.33 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.365 -0.834 . . . . 0.0 109.495 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.444 ' HB ' ' CZ ' ' A' ' 31' ' ' PHE . 2.0 t -118.09 137.2 52.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.172 -0.955 . . . . 0.0 109.598 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -115.18 125.6 53.6 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.246 -0.909 . . . . 0.0 109.861 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.597 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -124.69 101.48 7.13 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.579 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 1.5 mp -97.08 178.15 5.36 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.294 -0.879 . . . . 0.0 110.926 -178.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 2.8 p-10 -97.37 164.13 12.59 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.753 -0.592 . . . . 0.0 109.741 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.447 ' HB2' ' O ' ' A' ' 7' ' ' LEU . 23.7 t30 -109.35 -85.18 0.54 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.137 -0.977 . . . . 0.0 108.962 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.455 ' O ' HG22 ' A' ' 36' ' ' VAL . 10.5 ptmt -150.91 29.75 0.66 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.386 -0.821 . . . . 0.0 108.911 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.561 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 3.0 t -148.68 58.5 3.65 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.563 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 35.7 Cg_endo -77.65 175.06 11.7 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.564 2.176 . . . . 0.0 110.781 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.9 Cg_endo -85.45 161.96 61.32 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 123.537 -1.443 . . . . 0.0 110.614 -1.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.718 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 65.5 m-70 -120.21 142.25 49.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.357 -0.839 . . . . 0.0 109.845 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.417 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 6.6 m120 -130.83 126.4 36.18 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.521 ' HB ' ' NE2' ' A' ' 61' ' ' HIS . 1.2 t -99.57 135.7 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.209 -0.932 . . . . 0.0 109.108 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.52 ' O ' ' CB ' ' A' ' 87' ' ' PHE . 2.2 t -140.07 178.04 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.332 -0.855 . . . . 0.0 109.24 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.553 ' CE2' HD22 ' A' ' 59' ' ' LEU . 17.6 m-85 -137.56 120.85 16.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.189 -0.945 . . . . 0.0 109.479 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 43' ' ' PHE . 5.9 t0 -54.28 -166.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.423 -0.798 . . . . 0.0 109.785 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -147.69 25.8 1.05 Allowed 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.239 -0.913 . . . . 0.0 109.614 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -119.42 -10.13 9.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.407 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.7 mt -110.82 55.68 0.65 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.281 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' A' ' 48' ' ' ASN . 0.9 OUTLIER -120.01 152.96 54.91 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.258 -0.901 . . . . 0.0 109.476 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.92 -19.86 12.12 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.669 2.246 . . . . 0.0 110.644 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.467 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -126.57 29.89 5.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.065 -1.022 . . . . 0.0 109.71 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.467 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER 34.46 59.21 0.65 Allowed 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.153 0.501 . . . . 0.0 110.33 179.665 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.8 m -132.49 171.72 13.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.15 -0.969 . . . . 0.0 109.543 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.82 16.8 0.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 109.758 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 54' ' ' ASP . 2.0 p-10 -71.11 -23.13 62.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.16 -0.963 . . . . 0.0 109.444 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.518 ' HG ' ' N ' ' A' ' 56' ' ' ALA . 1.1 pp -87.63 -27.7 22.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.242 -0.911 . . . . 0.0 109.501 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.518 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -79.73 -31.33 41.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 0.0 109.959 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -58.08 -31.54 67.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.166 -0.959 . . . . 0.0 109.745 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.5 p -105.29 -8.3 18.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.95 . . . . 0.0 110.071 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.565 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 9.3 tp -80.73 -33.02 35.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.053 -1.029 . . . . 0.0 109.297 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.487 ' OG ' HG12 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -78.62 136.08 37.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.332 -0.855 . . . . 0.0 110.163 -179.009 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.521 ' NE2' ' HB ' ' A' ' 41' ' ' VAL . 0.4 OUTLIER -117.12 94.48 4.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.42 -0.8 . . . . 0.0 109.016 179.615 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.481 ' O ' HD12 ' A' ' 64' ' ' LEU . 0.9 OUTLIER -61.32 -12.28 13.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.307 -0.871 . . . . 0.0 110.016 -179.529 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.468 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 20.8 tt0 -43.43 122.14 2.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.142 -0.974 . . . . 0.0 109.718 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.481 HD12 ' O ' ' A' ' 62' ' ' LYS . 0.3 OUTLIER -64.53 121.85 15.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.844 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.513 ' N ' ' CD1' ' A' ' 65' ' ' LEU . 8.1 mp -84.2 93.71 8.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.252 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.0 tpt -97.02 -6.56 35.07 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.268 -0.895 . . . . 0.0 109.472 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.469 ' CB ' ' HB3' ' A' ' 70' ' ' GLN . 35.1 t -84.29 138.57 39.09 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.174 -0.954 . . . . 0.0 109.325 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.29 92.35 1.14 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.558 2.172 . . . . 0.0 110.86 -179.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 91.86 24.93 24.01 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.469 ' HB3' ' CB ' ' A' ' 67' ' ' SER . 0.6 OUTLIER -137.84 89.68 2.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.242 -1.152 . . . . 0.0 109.278 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.597 ' CB ' ' O ' ' A' ' 31' ' ' PHE . 6.4 p -105.66 -167.92 1.38 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.154 -0.966 . . . . 0.0 109.88 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.505 HG22 ' CG ' ' A' ' 61' ' ' HIS . 1.1 t -105.6 123.08 47.33 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 73' ' ' SER . 1.7 p -78.7 109.29 12.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.985 -1.072 . . . . 0.0 109.507 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.522 HG21 ' CD1' ' A' ' 59' ' ' LEU . 24.7 m -78.44 107.3 10.98 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.422 -0.799 . . . . 0.0 109.555 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.523 ' HA ' ' CG2' ' A' ' 28' ' ' THR . 18.7 m -79.55 93.57 5.47 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.248 -0.907 . . . . 0.0 109.034 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.565 ' CZ ' HD22 ' A' ' 59' ' ' LEU . 3.3 m-85 -44.08 156.74 0.31 Allowed Pre-proline 0 N--CA 1.487 1.407 0 O-C-N 121.401 -0.812 . . . . 0.0 109.268 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.433 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.0 Cg_endo -76.86 168.21 23.91 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.818 2.345 . . . . 0.0 111.788 -179.061 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.66 8.18 15.19 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 80' ' ' ALA . 2.8 m-20 -98.87 -8.05 26.32 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.329 -0.857 . . . . 0.0 108.957 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.504 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . . . -36.61 98.13 0.15 Allowed Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.809 -0.557 . . . . 0.0 109.702 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 79' ' ' ASP . 35.3 Cg_endo -76.68 155.42 35.31 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.536 2.157 . . . . 0.0 110.628 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.54 108.34 1.64 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 109.636 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -175.44 -177.17 44.3 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 pm0 -107.69 143.79 35.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.22 -1.165 . . . . 0.0 109.661 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.512 ' CD1' HG22 ' A' ' 101' ' ' ILE . 17.9 m-85 -118.85 165.45 14.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.306 -0.872 . . . . 0.0 109.066 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.478 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 44.7 m -146.06 109.26 4.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.139 -0.976 . . . . 0.0 110.045 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.574 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.8 OUTLIER -106.27 160.11 15.6 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.338 -0.851 . . . . 0.0 109.16 179.435 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 88' ' ' TYR . 16.0 p90 -146.17 -168.04 2.89 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.192 -0.942 . . . . 0.0 109.59 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 0.1 OUTLIER -120.51 140.89 50.8 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.339 -0.85 . . . . 0.0 109.707 -179.597 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.601 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.6 tt0 -75.64 -45.73 4.2 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.291 -0.881 . . . . 0.0 109.892 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.2 Cg_endo -78.34 -51.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.14 0 C-N-CA 121.898 1.732 . . . . 0.0 110.562 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.718 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 19.8 m80 -90.25 43.58 1.15 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.137 -0.977 . . . . 0.0 109.316 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -59.38 -57.73 11.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -0.88 . . . . 0.0 109.521 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -81.23 49.82 4.07 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -138.63 38.19 2.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -1.151 . . . . 0.0 109.431 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 47.58 30.47 6.39 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.457 ' HE3' ' HB3' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -92.32 68.56 5.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.221 -1.164 . . . . 0.0 109.203 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.2 t -136.12 112.06 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.912 . . . . 0.0 109.579 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.574 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -108.96 -171.54 20.94 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.478 ' HG2' ' HA ' ' A' ' 86' ' ' THR . 14.5 mttp -159.12 119.62 3.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -1.157 . . . . 0.0 109.855 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.512 HG22 ' CD1' ' A' ' 85' ' ' TYR . 0.1 OUTLIER -82.96 143.34 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.089 -1.007 . . . . 0.0 108.47 179.19 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.54 95.93 4.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.149 -0.969 . . . . 0.0 109.041 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.521 HG21 ' CD1' ' A' ' 23' ' ' ILE . 2.1 t -99.86 131.81 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.272 -0.893 . . . . 0.0 109.655 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -90.14 -174.68 4.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.292 -0.88 . . . . 0.0 109.305 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 CA-C-O 118.001 -1.444 . . . . 0.0 109.619 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.286 0.565 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.86 134.23 55.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 109.5 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -94.06 136.95 33.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.242 -0.911 . . . . 0.0 109.529 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.87 102.84 7.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.885 . . . . 0.0 109.557 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.582 ' CG1' ' CD1' ' A' ' 21' ' ' LEU . 2.8 m -91.79 48.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.231 -0.918 . . . . 0.0 109.614 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -47.54 92.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 109.43 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -53.97 170.54 0.12 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.228 -0.92 . . . . 0.0 109.665 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.49 ' HA3' ' CB ' ' A' ' 34' ' ' ASN . . . 74.35 122.29 0.1 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.1 p -68.55 -70.12 0.29 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.218 -1.166 . . . . 0.0 109.545 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 179.79 -59.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 109.358 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -140.06 41.25 1.96 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.284 -0.885 . . . . 0.0 109.517 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.95 -97.17 0.34 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 mt -116.7 170.51 8.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.262 -1.14 . . . . 0.0 109.691 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.539 ' CB ' ' HE2' ' A' ' 97' ' ' MET . 46.0 mt -100.08 120.07 39.27 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.374 -0.829 . . . . 0.0 108.987 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 1.4 m -159.95 145.97 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.076 -1.015 . . . . 0.0 109.716 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.484 ' HA ' ' HA ' ' A' ' 7' ' ' LEU . 7.2 m-85 -56.68 154.53 8.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 109.046 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.434 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 42.5 mt-10 -145.29 109.65 4.59 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.124 -0.985 . . . . 0.0 109.448 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.434 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 35.7 Cg_endo -78.8 174.8 49.34 Favored 'Cis proline' 0 C--N 1.312 -1.354 0 C-N-CA 123.904 -1.29 . . . . 0.0 110.491 0.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.75 -62.37 1.41 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.14 -0.975 . . . . 0.0 109.053 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -89.5 154.04 20.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.35 -0.844 . . . . 0.0 108.787 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.582 ' CD1' ' CG1' ' A' ' 5' ' ' VAL . 1.2 mt -147.12 135.88 22.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.951 -1.093 . . . . 0.0 110.216 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.484 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 28.6 m -109.03 98.12 7.64 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.53 ' CD1' HG21 ' A' ' 103' ' ' VAL . 1.0 OUTLIER -102.35 177.69 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.396 -0.815 . . . . 0.0 110.156 -179.277 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.478 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -101.2 174.73 2.73 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.54 ' HA ' ' CB ' ' A' ' 80' ' ' ALA . 34.9 Cg_endo -77.15 79.19 3.21 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.262 1.975 . . . . 0.0 110.505 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.471 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 134.96 -12.49 4.46 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.434 ' OD2' ' HB2' ' A' ' 24' ' ' LYS . 64.1 m-20 -55.09 -179.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.151 -1.206 . . . . 0.0 109.294 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 90.5 m -126.64 113.64 16.99 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.149 -0.97 . . . . 0.0 109.658 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.473 ' O ' ' CZ ' ' A' ' 31' ' ' PHE . 2.0 t -104.74 131.0 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.149 -0.969 . . . . 0.0 109.53 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -101.84 155.54 18.07 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.249 -0.907 . . . . 0.0 109.696 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -148.35 85.25 1.51 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.554 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.5 OUTLIER -97.55 179.51 4.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.362 -0.836 . . . . 0.0 110.942 -178.491 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 2.1 p-10 -90.09 157.01 17.98 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.591 -0.693 . . . . 0.0 109.263 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.49 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . 3.8 t30 -97.59 -73.65 0.6 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.982 -1.074 . . . . 0.0 109.338 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.48 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -163.5 31.91 0.09 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 108.923 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.534 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 27.8 t -157.47 63.95 3.03 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.591 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 33.6 Cg_endo -77.32 177.33 8.98 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 123.097 2.531 . . . . 0.0 111.026 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.591 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 39.7 Cg_endo -87.28 158.81 48.42 Favored 'Cis proline' 0 C--N 1.313 -1.316 0 O-C-N 123.698 1.367 . . . . 0.0 111.328 -1.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.703 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 65.3 m-70 -119.55 141.52 49.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.707 -0.62 . . . . 0.0 109.388 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -117.99 119.36 34.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.872 . . . . 0.0 108.94 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.551 ' HB ' ' NE2' ' A' ' 61' ' ' HIS . 2.0 t -100.42 128.48 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.131 -0.98 . . . . 0.0 109.8 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.445 ' O ' ' HA ' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -157.3 165.5 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.546 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.64 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.4 OUTLIER -124.03 134.61 53.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.099 -1.001 . . . . 0.0 109.284 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -66.97 133.35 49.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.348 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.37 10.63 6.7 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.27 -0.894 . . . . 0.0 109.918 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.8 19.65 13.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.129 -0.982 . . . . 0.0 109.437 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.26 49.88 2.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -0.934 . . . . 0.0 109.687 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.521 ' OD1' ' CA ' ' A' ' 51' ' ' LYS . 1.5 p30 -118.26 160.47 39.32 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.347 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.468 ' HG3' ' HA3' ' A' ' 83' ' ' GLY . 36.3 Cg_endo -77.82 -5.31 15.24 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.512 2.142 . . . . 0.0 110.662 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -125.46 27.36 6.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.115 -0.991 . . . . 0.0 109.62 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.521 ' CA ' ' OD1' ' A' ' 48' ' ' ASN . 3.6 ptmt 34.0 38.55 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.134 0.493 . . . . 0.0 110.39 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.51 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 1.8 m -115.47 170.19 8.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.083 -1.011 . . . . 0.0 109.676 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -139.68 51.9 1.73 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.958 . . . . 0.0 109.57 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -115.38 -42.07 3.2 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.311 -0.868 . . . . 0.0 109.493 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.482 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 1.8 pp -56.71 -28.18 60.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.892 . . . . 0.0 109.498 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.473 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -79.93 -35.06 38.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.929 . . . . 0.0 109.538 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -51.1 -22.92 2.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.177 -0.952 . . . . 0.0 109.373 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.1 m -123.18 18.42 9.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.626 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.615 HD23 ' CZ ' ' A' ' 76' ' ' PHE . 12.3 tp -119.69 -41.97 2.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.11 -0.994 . . . . 0.0 109.635 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.437 ' HB3' ' HA ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -78.04 127.44 32.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.384 -179.445 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.638 ' CE1' ' CG2' ' A' ' 72' ' ' THR . 0.5 OUTLIER -108.63 137.14 47.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.374 -0.829 . . . . 0.0 109.486 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -85.83 -159.74 0.48 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.227 -0.921 . . . . 0.0 109.51 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.518 ' CB ' ' O ' ' A' ' 62' ' ' LYS . 1.6 tt0 77.33 136.4 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.408 -0.807 . . . . 0.0 109.533 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.439 ' HB2' ' CE ' ' A' ' 66' ' ' MET . 5.2 mp -85.91 133.5 33.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.451 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.452 ' CD1' ' O ' ' A' ' 39' ' ' HIS . 9.9 mt -80.12 124.21 28.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 0.0 109.48 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.439 ' CE ' ' HB2' ' A' ' 64' ' ' LEU . 6.7 mtt -124.99 4.58 7.98 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.25 -0.906 . . . . 0.0 109.601 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.446 ' OG ' ' HB3' ' A' ' 70' ' ' GLN . 47.4 t -91.89 142.33 26.39 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.188 -0.945 . . . . 0.0 109.332 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.6 86.3 1.7 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.62 2.213 . . . . 0.0 110.892 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.528 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 95.23 44.41 3.27 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.475 ' HA ' ' OE1' ' A' ' 70' ' ' GLN . 3.6 tp60 -162.32 101.45 1.08 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.243 -1.151 . . . . 0.0 109.244 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.554 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . 3.2 p -112.11 -103.77 0.4 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.405 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.638 ' CG2' ' CE1' ' A' ' 61' ' ' HIS . 9.0 t -161.02 117.94 2.3 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.0 t -78.54 116.58 19.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.957 -1.089 . . . . 0.0 109.895 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.42 ' CG2' HD12 ' A' ' 59' ' ' LEU . 0.6 OUTLIER -95.52 105.05 16.98 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 76' ' ' PHE . 41.4 m -78.91 92.27 4.89 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.248 -0.907 . . . . 0.0 108.905 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.615 ' CZ ' HD23 ' A' ' 59' ' ' LEU . 7.0 m-85 -42.8 161.34 0.19 Allowed Pre-proline 0 N--CA 1.488 1.442 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.471 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 33.1 Cg_endo -75.45 159.04 40.11 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.346 2.031 . . . . 0.0 111.185 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.54 -5.64 20.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.551 -0.718 . . . . 0.0 109.644 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 80' ' ' ALA . 0.9 OUTLIER -99.41 -65.6 0.95 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.187 -0.946 . . . . 0.0 109.284 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.54 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . . . 61.26 133.09 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.337 -0.852 . . . . 0.0 109.407 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.463 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 36.1 Cg_endo -78.42 99.75 1.3 Allowed 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.345 2.03 . . . . 0.0 110.284 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 81' ' ' PRO . . . -41.42 117.82 0.96 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.378 -0.826 . . . . 0.0 109.683 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.468 ' HA3' ' HG3' ' A' ' 49' ' ' PRO . . . 156.13 -156.31 26.98 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.451 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 0.4 OUTLIER -122.0 126.1 47.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -1.167 . . . . 0.0 109.508 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.627 ' CD2' ' CG2' ' A' ' 101' ' ' ILE . 1.5 m-30 -92.89 -164.7 1.21 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.889 . . . . 0.0 108.941 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.486 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 65.4 m -167.19 111.68 0.72 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.868 -1.145 . . . . 0.0 110.505 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.449 ' O ' ' HA ' ' A' ' 98' ' ' VAL . 0.7 OUTLIER -112.05 157.4 20.8 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.378 -0.826 . . . . 0.0 108.774 178.729 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 24.2 p90 -145.47 -162.93 1.61 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.013 -1.055 . . . . 0.0 109.916 -179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.501 ' O ' ' HB3' ' A' ' 93' ' ' ARG . 0.1 OUTLIER -126.94 129.14 47.57 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.373 -0.83 . . . . 0.0 109.829 -179.265 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.613 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.3 tt0 -65.77 -43.77 60.99 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.264 -0.898 . . . . 0.0 110.264 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.4 Cg_endo -78.35 -52.64 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 121.889 1.726 . . . . 0.0 110.446 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.703 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 9.2 m80 -90.21 34.23 0.87 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.172 -0.955 . . . . 0.0 109.24 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.501 ' HB3' ' O ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -64.52 126.53 28.13 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.237 -0.914 . . . . 0.0 109.532 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 92.31 2.33 68.35 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.23 32.97 2.29 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.117 -1.225 . . . . 0.0 109.414 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.39 7.09 37.58 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.539 ' HE2' ' CB ' ' A' ' 14' ' ' LEU . 16.7 mtm -90.75 63.28 5.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.976 -1.308 . . . . 0.0 109.598 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 84.2 t -140.52 76.24 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.387 -0.82 . . . . 0.0 109.41 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.489 ' O ' ' CG ' ' A' ' 100' ' ' LYS . . . -72.27 -167.72 10.22 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.489 ' CG ' ' O ' ' A' ' 99' ' ' GLY . 5.7 mtmt -159.25 131.37 6.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.355 -1.085 . . . . 0.0 109.484 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.627 ' CG2' ' CD2' ' A' ' 85' ' ' TYR . 0.4 OUTLIER -82.59 133.37 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.12 -0.987 . . . . 0.0 108.925 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.484 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 7.6 m -116.31 91.75 3.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.257 -0.902 . . . . 0.0 109.038 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.53 HG21 ' CD1' ' A' ' 23' ' ' ILE . 2.1 t -99.42 135.92 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.205 -0.935 . . . . 0.0 109.6 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -82.97 -173.96 5.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.259 -0.901 . . . . 0.0 109.472 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.981 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 m -121.66 131.97 54.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.937 . . . . 0.0 109.494 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.407 ' CD2' HG21 ' A' ' 23' ' ' ILE . 83.4 m-85 -96.93 168.78 10.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.935 . . . . 0.0 109.301 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.6 m -156.99 144.17 18.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 109.761 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.5 t -128.96 69.57 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.392 -0.817 . . . . 0.0 109.0 179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -51.07 106.74 0.14 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.389 -0.819 . . . . 0.0 110.017 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 34' ' ' ASN . 0.2 OUTLIER -90.86 150.91 21.36 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.292 -0.88 . . . . 0.0 109.054 179.399 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.464 ' HA2' HD23 ' A' ' 14' ' ' LEU . . . 117.6 66.88 0.35 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.511 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -51.22 -23.32 3.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.162 -1.199 . . . . 0.0 109.262 179.646 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.511 ' CB ' ' O ' ' A' ' 9' ' ' SER . 10.5 t0 80.4 29.54 0.23 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.609 -0.682 . . . . 0.0 109.45 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.78 19.12 10.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -0.9 . . . . 0.0 109.209 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.18 11.11 53.47 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -156.88 143.87 18.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.328 -1.101 . . . . 0.0 109.419 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.534 ' CD1' ' CE1' ' A' ' 39' ' ' HIS . 1.1 mt -101.93 143.44 31.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.181 -0.949 . . . . 0.0 109.315 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.47 HG13 ' O ' ' A' ' 95' ' ' ALA . 1.8 m -154.57 128.78 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.92 . . . . 0.0 109.601 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -48.83 142.01 6.84 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.188 -0.945 . . . . 0.0 109.106 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -136.56 109.71 9.49 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.273 -0.892 . . . . 0.0 109.254 -179.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.469 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 34.9 Cg_endo -77.29 -178.03 22.92 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 123.73 -1.362 . . . . 0.0 110.64 0.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.19 4.29 20.73 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.244 -0.91 . . . . 0.0 109.763 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 5.2 pttt -146.06 160.72 41.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.149 -0.969 . . . . 0.0 109.488 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -157.73 136.62 11.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.187 -0.946 . . . . 0.0 109.48 -179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.0 m -104.93 99.16 8.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.296 -0.878 . . . . 0.0 109.286 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.523 ' CD1' HD11 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -99.48 173.47 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.234 -0.916 . . . . 0.0 109.523 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.548 ' CG ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -95.33 177.54 1.76 Allowed Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.044 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.548 ' HD2' ' CG ' ' A' ' 24' ' ' LYS . 34.7 Cg_endo -76.41 72.72 5.39 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.088 1.859 . . . . 0.0 110.342 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.485 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 126.18 28.6 1.0 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.18 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.517 ' OD1' ' CB ' ' A' ' 24' ' ' LYS . 4.5 m-20 -88.13 -165.84 1.43 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.205 -1.173 . . . . 0.0 108.852 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.414 HG22 ' HA ' ' A' ' 75' ' ' THR . 21.4 m -136.56 110.56 8.26 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.956 -1.09 . . . . 0.0 109.695 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.582 ' HB ' ' CZ ' ' A' ' 31' ' ' PHE . 1.7 t -99.36 136.13 31.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.321 -0.862 . . . . 0.0 109.102 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -104.76 142.54 34.52 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.104 -0.997 . . . . 0.0 110.198 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.582 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -139.7 142.63 36.87 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.375 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.535 ' HA ' ' N ' ' A' ' 71' ' ' SER . 0.5 OUTLIER -140.94 -169.95 2.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.894 -1.129 . . . . 0.0 110.523 -179.383 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 6.4 p-10 -114.9 154.28 28.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.467 -0.771 . . . . 0.0 109.352 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.472 ' HB2' ' O ' ' A' ' 7' ' ' LEU . 35.3 t30 -100.38 -88.09 0.36 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.024 -1.047 . . . . 0.0 109.637 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.426 ' C ' HG22 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -144.14 33.72 1.22 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.073 -1.017 . . . . 0.0 109.197 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.515 ' O ' ' NE2' ' A' ' 92' ' ' HIS . 92.3 t -153.77 64.53 4.88 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.478 -0.763 . . . . 0.0 109.135 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.571 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.5 Cg_endo -79.79 175.85 10.09 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.775 2.317 . . . . 0.0 110.455 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.571 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.8 Cg_endo -86.24 -172.93 8.84 Favored 'Cis proline' 0 C--N 1.31 -1.46 0 C-N-CA 123.655 -1.394 . . . . 0.0 110.65 -1.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.74 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 63.2 m-70 -137.91 159.23 42.55 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.38 -0.825 . . . . 0.0 109.583 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -138.71 118.33 13.04 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.455 ' C ' HG22 ' A' ' 42' ' ' VAL . 20.5 t -99.58 111.45 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.668 -179.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.481 ' HA ' ' CB ' ' A' ' 60' ' ' SER . 13.8 t -135.91 162.64 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.338 -0.851 . . . . 0.0 109.311 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.607 ' CE2' ' CD2' ' A' ' 59' ' ' LEU . 20.1 m-85 -115.88 120.75 40.23 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.262 -0.899 . . . . 0.0 109.62 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.461 ' OD2' HD21 ' A' ' 47' ' ' LEU . 39.8 t0 -44.08 140.54 2.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.415 -0.803 . . . . 0.0 109.768 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.7 1.06 55.49 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.339 -0.851 . . . . 0.0 109.646 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.58 -26.19 13.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.551 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.512 ' N ' HD21 ' A' ' 47' ' ' LEU . 4.0 mm? -95.49 61.73 2.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 109.265 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 52' ' ' SER . 2.3 p30 -107.59 150.06 39.67 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.324 -0.86 . . . . 0.0 109.487 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.469 ' HB3' ' HA3' ' A' ' 83' ' ' GLY . 35.8 Cg_endo -77.96 -9.78 16.76 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.616 2.211 . . . . 0.0 110.331 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.449 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -134.55 31.59 3.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.27 -0.894 . . . . 0.0 109.452 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.449 ' C ' ' O ' ' A' ' 50' ' ' ALA . 27.3 pttt 36.47 39.08 0.09 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.814 -0.554 . . . . 0.0 110.166 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.522 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 6.0 m -108.76 -157.63 0.62 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.568 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -169.07 33.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -0.859 . . . . 0.0 109.508 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.19 -42.26 3.76 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.215 -0.928 . . . . 0.0 109.826 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.455 ' CD1' ' C ' ' A' ' 55' ' ' LEU . 2.0 pp -47.35 -33.32 5.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 109.449 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.84 -37.41 24.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 109.483 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.77 -31.26 2.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 0.0 109.388 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.4 p -115.02 31.67 6.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.245 -0.909 . . . . 0.0 109.39 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.607 ' CD2' ' CE2' ' A' ' 43' ' ' PHE . 8.3 tp -131.37 -52.71 1.02 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.926 . . . . 0.0 109.613 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.51 ' OG ' ' CD2' ' A' ' 43' ' ' PHE . 10.2 m -77.37 160.37 28.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 110.29 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.546 ' CE1' ' O ' ' A' ' 63' ' ' GLN . 18.9 p80 -119.99 147.29 44.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.531 -0.731 . . . . 0.0 109.336 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.52 -55.86 3.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -0.945 . . . . 0.0 109.529 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.546 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -46.74 120.84 3.18 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.347 -0.846 . . . . 0.0 109.665 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 6.3 mp -66.48 162.06 21.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.091 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.525 ' CD2' ' O ' ' A' ' 39' ' ' HIS . 0.5 OUTLIER -109.06 152.07 25.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.051 -1.031 . . . . 0.0 109.692 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 3.4 mtp -136.6 7.45 3.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.314 -0.866 . . . . 0.0 109.548 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.515 ' HB3' ' CG ' ' A' ' 70' ' ' GLN . 8.4 t -79.27 134.53 58.84 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.235 -0.916 . . . . 0.0 109.347 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.428 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 35.9 Cg_endo -78.44 90.1 1.29 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.721 2.28 . . . . 0.0 111.612 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.514 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 113.17 34.76 1.74 Allowed Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.63 -1.272 . . . . 0.0 110.678 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.515 ' CG ' ' HB3' ' A' ' 67' ' ' SER . 0.7 OUTLIER 177.01 119.93 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.01 -1.288 . . . . 0.0 109.669 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.539 ' OG ' ' N ' ' A' ' 72' ' ' THR . 60.2 p -109.97 -75.14 0.63 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.284 -0.885 . . . . 0.0 109.325 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.539 ' N ' ' OG ' ' A' ' 71' ' ' SER . 1.6 t -160.75 107.84 1.52 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.186 -0.946 . . . . 0.0 109.633 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.3 t -78.78 85.01 4.81 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.026 -1.046 . . . . 0.0 108.298 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.426 HG22 ' HG ' ' A' ' 59' ' ' LEU . 22.6 m -75.63 108.37 8.42 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.523 -0.736 . . . . 0.0 110.378 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.455 ' O ' ' C ' ' A' ' 76' ' ' PHE . 3.2 t -79.13 87.99 4.86 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.564 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 30.1 m-85 -36.69 150.75 0.12 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.782 -0.574 . . . . 0.0 110.314 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.485 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 35.2 Cg_endo -76.74 161.36 33.7 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.995 2.463 . . . . 0.0 111.501 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.49 6.57 10.01 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.5 ' O ' ' C ' ' A' ' 80' ' ' ALA . 3.1 p30 -98.87 -4.84 32.11 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.286 -0.884 . . . . 0.0 109.096 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 79' ' ' ASP . . . -33.82 105.27 0.25 Allowed Pre-proline 0 N--CA 1.498 1.961 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 82' ' ' ALA . 35.9 Cg_endo -77.84 41.44 1.0 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.522 2.148 . . . . 0.0 111.407 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.494 ' HA ' ' HB ' ' A' ' 103' ' ' VAL . . . 46.87 -178.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -0.866 . . . . 0.0 110.006 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.469 ' HA3' ' HB3' ' A' ' 49' ' ' PRO . . . 94.21 -168.14 28.22 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -111.92 153.83 26.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.522 -0.987 . . . . 0.0 109.635 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.443 ' O ' ' HB ' ' A' ' 86' ' ' THR . 19.8 m-30 -113.63 -39.32 4.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.392 -0.817 . . . . 0.0 108.92 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.443 ' HB ' ' O ' ' A' ' 85' ' ' TYR . 92.4 m 61.79 100.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.313 -0.867 . . . . 0.0 110.333 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -105.05 173.17 6.42 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.203 -0.936 . . . . 0.0 108.905 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.458 ' HA ' ' O ' ' A' ' 97' ' ' MET . 16.7 p90 -155.39 -164.07 1.68 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.893 -1.13 . . . . 0.0 110.046 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.472 ' HB2' ' HB3' ' A' ' 97' ' ' MET . 0.6 OUTLIER -136.75 144.75 43.96 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.424 -0.798 . . . . 0.0 109.447 -179.692 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.604 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 40.6 tt0 -83.12 -45.07 0.86 Allowed Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.264 -0.898 . . . . 0.0 110.433 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.0 Cg_endo -78.31 -46.93 0.11 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.048 1.832 . . . . 0.0 110.902 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.74 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 68.7 m80 -87.79 18.07 4.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.014 -1.054 . . . . 0.0 109.643 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -53.25 135.94 37.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.127 -0.983 . . . . 0.0 109.421 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.05 -8.25 80.29 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.47 ' O ' HG13 ' A' ' 15' ' ' VAL . . . -99.12 38.66 1.37 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.16 -1.2 . . . . 0.0 109.603 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.98 12.5 29.78 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.472 ' HB3' ' HB2' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -81.92 56.8 3.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.179 -1.189 . . . . 0.0 109.699 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.44 HG22 ' C ' ' A' ' 97' ' ' MET . 21.6 t -139.6 72.15 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.104 -0.998 . . . . 0.0 109.947 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.438 ' C ' ' CG ' ' A' ' 100' ' ' LYS . . . -80.95 -173.23 47.18 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.438 ' CG ' ' C ' ' A' ' 99' ' ' GLY . 0.1 OUTLIER -152.15 136.23 16.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.933 -1.334 . . . . 0.0 110.148 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.564 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -86.58 119.54 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.172 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.74 103.42 15.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.217 -0.927 . . . . 0.0 109.099 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.494 ' HB ' ' HA ' ' A' ' 82' ' ' ALA . 17.3 t -99.19 68.45 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.487 -0.758 . . . . 0.0 109.444 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.406 ' O ' ' O ' ' A' ' 105' ' ' GLY . . . 53.09 -171.44 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.316 -0.865 . . . . 0.0 109.275 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 104' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.6 m -117.66 103.88 10.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.298 -0.876 . . . . 0.0 109.51 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 23.5 m-85 -84.35 108.88 17.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.47 HG22 ' O ' ' A' ' 30' ' ' GLU . 52.9 m -109.58 150.06 28.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.564 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.517 HG21 ' CD1' ' A' ' 21' ' ' LEU . 0.3 OUTLIER -113.43 160.84 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -0.924 . . . . 0.0 109.227 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -125.75 101.1 6.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.929 . . . . 0.0 109.505 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.465 HD11 ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -89.19 170.98 10.14 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.168 -0.958 . . . . 0.0 109.252 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.532 ' HA3' ' CB ' ' A' ' 34' ' ' ASN . . . 86.52 77.39 1.23 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 13' ' ' LEU . 99.7 p -44.29 -65.65 0.49 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -1.151 . . . . 0.0 109.218 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 9' ' ' SER . 0.4 OUTLIER 168.47 -25.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.07 179.631 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -113.77 49.54 0.98 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.059 -1.025 . . . . 0.0 110.078 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.22 -37.85 3.24 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' A' ' 9' ' ' SER . 2.9 mp -69.61 118.85 13.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.124 -1.221 . . . . 0.0 109.578 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.545 ' HB2' ' CE ' ' A' ' 97' ' ' MET . 0.5 OUTLIER -116.19 110.81 19.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.349 -0.844 . . . . 0.0 109.488 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.68 133.34 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.345 -0.847 . . . . 0.0 109.516 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -49.31 153.73 0.98 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.045 -1.034 . . . . 0.0 109.097 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.426 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 5.7 mt-10 -143.0 109.06 5.44 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.156 -0.965 . . . . 0.0 109.445 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 35.0 Cg_endo -77.21 179.56 30.84 Favored 'Cis proline' 0 C--N 1.312 -1.368 0 C-N-CA 123.82 -1.325 . . . . 0.0 110.491 0.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.68 -44.08 71.18 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.214 -0.929 . . . . 0.0 108.877 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.29 139.6 40.54 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.517 ' CD1' HG21 ' A' ' 5' ' ' VAL . 1.7 mt -126.79 126.66 43.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 110.088 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' A' ' 102' ' ' THR . 18.8 m -89.26 97.83 11.42 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.53 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -99.3 172.49 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.149 -0.969 . . . . 0.0 109.865 -179.387 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.489 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 0.3 OUTLIER -86.31 175.55 4.34 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.419 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' A' ' 24' ' ' LYS . 35.8 Cg_endo -78.0 72.84 5.99 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.377 2.052 . . . . 0.0 110.962 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 129.08 -9.75 6.28 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.22 -1.467 . . . . 0.0 110.603 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.479 ' O ' ' O ' ' A' ' 26' ' ' GLY . 1.2 m-20 -50.54 -178.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.093 -1.239 . . . . 0.0 109.085 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 23.8 m -117.4 118.37 32.03 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.036 -1.04 . . . . 0.0 109.676 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.48 HG22 ' CD1' ' A' ' 101' ' ' ILE . 1.7 t -99.81 111.53 29.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.371 -0.83 . . . . 0.0 109.475 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.47 ' O ' HG22 ' A' ' 4' ' ' THR . 5.1 mt-10 -99.43 123.17 43.47 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.254 -0.904 . . . . 0.0 109.112 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -106.29 153.19 22.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.348 -0.845 . . . . 0.0 109.109 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.504 ' HA ' ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -140.54 177.81 7.75 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.09 -1.007 . . . . 0.0 110.033 -179.494 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.542 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 3.2 p-10 -109.45 169.64 8.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.355 -0.841 . . . . 0.0 109.268 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.532 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . 28.3 t30 -112.88 -73.68 0.66 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.01 -1.056 . . . . 0.0 109.378 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.407 ' C ' HG22 ' A' ' 36' ' ' VAL . 5.8 ttpt -162.91 28.39 0.1 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.064 -1.023 . . . . 0.0 109.266 179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.574 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 11.1 t -148.05 58.61 3.96 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.574 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 36.2 Cg_endo -77.94 174.78 12.02 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.69 2.26 . . . . 0.0 110.664 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.6 Cg_endo -86.95 158.44 50.15 Favored 'Cis proline' 0 C--N 1.309 -1.547 0 C-N-CA 123.402 -1.499 . . . . 0.0 110.713 -1.825 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.639 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 70.4 m-70 -113.77 125.41 54.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.483 -0.761 . . . . 0.0 108.961 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.441 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 1.8 m120 -99.85 123.96 44.65 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.292 -0.88 . . . . 0.0 109.294 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.6 t -107.8 109.49 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.243 -0.91 . . . . 0.0 109.911 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.529 ' O ' ' CB ' ' A' ' 87' ' ' PHE . 1.4 t -134.74 167.11 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.383 -0.823 . . . . 0.0 108.852 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.593 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 7.8 m-85 -118.9 106.52 12.57 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.136 -0.977 . . . . 0.0 109.831 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -49.91 118.66 3.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.443 -0.786 . . . . 0.0 109.861 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.41 2.14 29.9 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.433 -0.792 . . . . 0.0 109.638 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -102.09 -15.03 16.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.139 -0.976 . . . . 0.0 109.753 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.0 mt -113.88 61.08 0.66 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.142 -0.974 . . . . 0.0 109.523 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.479 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 5.7 p30 -134.1 163.14 53.29 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.255 -0.903 . . . . 0.0 109.449 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.539 ' HG3' ' CA ' ' A' ' 83' ' ' GLY . 33.7 Cg_endo -77.31 -16.81 15.19 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.596 2.197 . . . . 0.0 109.423 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 52' ' ' SER . . . -135.0 77.08 1.66 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.47 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -35.88 95.43 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.351 0.596 . . . . 0.0 110.413 -179.459 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 50' ' ' ALA . 10.4 m -140.42 -174.49 3.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.423 -0.798 . . . . 0.0 109.271 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -159.86 23.94 0.18 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.934 . . . . 0.0 109.413 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -89.08 -66.03 0.96 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.279 -0.888 . . . . 0.0 109.794 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.51 ' HG ' ' N ' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -64.89 -25.31 67.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -0.929 . . . . 0.0 109.636 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.51 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -65.02 -58.18 6.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.115 -0.991 . . . . 0.0 109.343 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.45 -31.59 1.79 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.268 -0.895 . . . . 0.0 109.521 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.61 13.03 36.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.926 . . . . 0.0 109.973 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.574 HD21 ' CD2' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -108.0 -42.45 4.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.997 -1.064 . . . . 0.0 108.47 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.485 ' HB3' ' HA ' ' A' ' 42' ' ' VAL . 0.7 OUTLIER -78.11 174.57 11.01 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.457 -0.777 . . . . 0.0 110.347 -179.418 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.46 ' HB3' ' CG2' ' A' ' 72' ' ' THR . 26.4 p80 -125.19 174.2 8.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.64 -0.662 . . . . 0.0 109.338 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -125.19 -12.91 6.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.156 -0.965 . . . . 0.0 109.71 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -92.59 105.66 17.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.965 . . . . 0.0 109.653 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.466 ' HB3' ' CB ' ' A' ' 38' ' ' PRO . 4.4 mp -49.26 165.01 0.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -0.896 . . . . 0.0 109.291 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.511 HD23 ' CB ' ' A' ' 71' ' ' SER . 5.9 mp -81.49 137.4 35.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.124 -0.985 . . . . 0.0 109.546 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.93 -2.56 5.22 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.368 -0.832 . . . . 0.0 109.538 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.473 ' OG ' ' OE1' ' A' ' 70' ' ' GLN . 27.3 t -116.0 144.93 33.74 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.141 -0.975 . . . . 0.0 109.247 179.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.489 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.6 Cg_endo -80.91 83.46 2.21 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.645 2.23 . . . . 0.0 111.608 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.542 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 124.94 45.41 0.26 Allowed Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.121 -1.514 . . . . 0.0 111.437 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.496 ' HB3' ' O ' ' A' ' 69' ' ' GLY . 4.1 pt20 170.15 117.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.014 -1.286 . . . . 0.0 109.974 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.511 ' CB ' HD23 ' A' ' 65' ' ' LEU . 2.8 p -115.51 -146.82 0.41 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.226 -0.922 . . . . 0.0 109.09 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.507 ' N ' ' OG ' ' A' ' 71' ' ' SER . 96.4 m -95.15 100.67 12.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.098 -1.001 . . . . 0.0 109.951 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.447 ' HB3' ' HB3' ' A' ' 30' ' ' GLU . 42.4 p -79.99 111.71 16.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.229 -0.919 . . . . 0.0 108.884 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.544 ' CG2' HD13 ' A' ' 59' ' ' LEU . 1.9 m -98.63 129.09 45.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 109.86 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.518 ' O ' ' OG1' ' A' ' 75' ' ' THR . 0.1 OUTLIER -82.65 96.81 8.24 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.139 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.574 ' CD2' HD21 ' A' ' 59' ' ' LEU . 26.1 m-85 -45.58 153.12 0.62 Allowed Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 121.066 -1.021 . . . . 0.0 108.862 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.49 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.3 Cg_endo -77.11 165.38 28.17 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.5 2.133 . . . . 0.0 111.421 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.93 8.0 6.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.46 -0.775 . . . . 0.0 109.535 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 81' ' ' PRO . 2.4 m-20 -99.08 -12.5 20.47 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.045 -1.034 . . . . 0.0 109.006 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.5 ' C ' ' O ' ' A' ' 79' ' ' ASP . . . -32.85 93.58 0.06 OUTLIER Pre-proline 0 N--CA 1.5 2.041 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.534 ' N ' ' O ' ' A' ' 79' ' ' ASP . 36.3 Cg_endo -78.73 163.83 26.1 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.586 2.191 . . . . 0.0 110.786 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.465 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -64.77 113.19 3.62 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.406 -0.809 . . . . 0.0 109.302 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.539 ' CA ' ' HG3' ' A' ' 49' ' ' PRO . . . -174.54 155.83 21.89 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 84' ' ' GLU . 0.7 OUTLIER -90.47 104.69 17.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -1.098 . . . . 0.0 109.706 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.525 ' CE2' HG21 ' A' ' 103' ' ' VAL . 7.7 m-30 -81.08 167.25 19.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.204 -0.935 . . . . 0.0 108.863 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.492 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 95.4 m -151.81 115.52 4.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.935 -1.103 . . . . 0.0 110.573 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.529 ' CB ' ' O ' ' A' ' 42' ' ' VAL . 2.0 p90 -117.4 168.63 10.18 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.505 ' HA ' ' HA ' ' A' ' 98' ' ' VAL . 30.4 p90 -160.47 -162.41 0.96 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.79 -1.194 . . . . 0.0 110.645 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.441 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 1.3 m -119.07 136.41 54.16 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.69 -0.631 . . . . 0.0 109.723 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.629 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -73.17 -45.09 8.08 Favored Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.287 -0.883 . . . . 0.0 109.762 178.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.4 Cg_endo -78.35 -60.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.063 0 C-N-CA 121.983 1.789 . . . . 0.0 110.524 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.639 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 10.8 m80 -72.48 57.23 0.39 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.017 -1.052 . . . . 0.0 109.179 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.54 18.59 9.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.368 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.85 -34.0 2.7 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 96' ' ' GLY . . . -91.81 34.35 1.0 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.143 -1.21 . . . . 0.0 109.642 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 95' ' ' ALA . . . 41.61 61.72 2.11 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.545 ' CE ' ' HB2' ' A' ' 14' ' ' LEU . 9.3 mtt -91.64 63.97 4.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.163 -1.198 . . . . 0.0 109.35 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 88' ' ' TYR . 4.9 p -127.63 96.48 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.2 -0.937 . . . . 0.0 109.775 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.471 ' O ' ' HG3' ' A' ' 100' ' ' LYS . . . -76.47 -164.42 18.51 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.492 ' HG2' ' HA ' ' A' ' 86' ' ' THR . 26.5 mtmt -163.44 120.53 1.82 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -1.149 . . . . 0.0 109.649 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.53 HD13 ' CD1' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -82.58 138.88 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.154 -0.966 . . . . 0.0 108.898 179.654 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' A' ' 22' ' ' THR . 8.3 m -118.04 93.93 4.32 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.525 HG21 ' CE2' ' A' ' 85' ' ' TYR . 1.8 t -99.2 118.6 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.23 -0.918 . . . . 0.0 109.596 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -93.2 146.38 23.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 109.634 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 CA-C-O 118.032 -1.427 . . . . 0.0 109.653 179.89 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.8 m -119.88 134.14 55.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.25 -0.907 . . . . 0.0 109.427 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.44 ' CD2' ' CD2' ' A' ' 21' ' ' LEU . 40.0 m-85 -123.52 98.46 5.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.174 -0.954 . . . . 0.0 109.349 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.487 HG22 ' CD1' ' A' ' 32' ' ' LEU . 18.8 m -87.54 83.87 7.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.749 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.474 ' CG2' ' O ' ' A' ' 5' ' ' VAL . 24.7 m -82.55 107.15 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.152 -0.967 . . . . 0.0 109.454 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.457 ' HE3' ' HA2' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -92.25 100.86 13.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 109.333 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.535 ' CD2' ' O ' ' A' ' 32' ' ' LEU . 0.9 OUTLIER -59.68 172.48 0.7 Allowed 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.148 -0.97 . . . . 0.0 109.295 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.468 ' HA3' ' CB ' ' A' ' 34' ' ' ASN . . . 69.35 70.36 1.18 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.444 ' OG ' ' N ' ' A' ' 10' ' ' ASP . 86.4 p -47.67 -91.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.316 -1.108 . . . . 0.0 109.531 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.444 ' N ' ' OG ' ' A' ' 9' ' ' SER . 2.2 t0 177.36 -34.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.427 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.61 38.73 3.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.0 109.38 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -154.07 -106.35 0.28 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -149.6 -148.3 0.26 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -1.115 . . . . 0.0 109.359 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.57 HD22 ' CE1' ' A' ' 39' ' ' HIS . 20.8 mt -98.75 109.0 21.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.945 -1.097 . . . . 0.0 109.366 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 7' ' ' LEU . 21.4 m -148.51 165.73 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.906 . . . . 0.0 109.487 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -85.79 135.18 33.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 109.407 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -125.64 108.34 26.04 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.188 -0.945 . . . . 0.0 109.542 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -78.44 175.81 45.4 Favored 'Cis proline' 0 C--N 1.312 -1.358 0 C-N-CA 123.793 -1.336 . . . . 0.0 110.465 0.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.64 -39.53 31.28 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.225 -0.922 . . . . 0.0 109.474 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.78 138.15 45.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.309 -0.87 . . . . 0.0 109.294 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.46 HD12 HG11 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -135.51 110.34 8.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 109.588 -179.872 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.471 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 97.5 m -84.14 99.23 10.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.167 -0.958 . . . . 0.0 109.291 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.552 ' CD1' HD11 ' A' ' 101' ' ' ILE . 1.5 pt -99.64 -178.37 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.288 -0.882 . . . . 0.0 109.698 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.554 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -94.91 -179.16 0.9 Allowed Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.448 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.554 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 34.5 Cg_endo -77.88 66.69 8.15 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.093 1.862 . . . . 0.0 110.386 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.537 ' CA ' ' O ' ' A' ' 77' ' ' PRO . . . 121.08 73.96 0.35 Allowed Glycine 0 N--CA 1.487 2.08 0 C-N-CA 119.52 -1.324 . . . . 0.0 109.922 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.465 ' OD1' ' N ' ' A' ' 24' ' ' LYS . 7.7 m-20 -125.77 -142.66 0.29 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.32 -1.106 . . . . 0.0 108.581 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 44.3 m -148.04 99.49 3.07 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.944 -1.098 . . . . 0.0 109.563 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.454 ' O ' ' CE1' ' A' ' 31' ' ' PHE . 2.9 t -99.87 119.45 47.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.466 -0.771 . . . . 0.0 109.044 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.482 ' C ' ' CD1' ' A' ' 31' ' ' PHE . 56.1 tt0 -99.61 156.33 17.12 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.171 -0.956 . . . . 0.0 109.81 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.483 ' CD2' ' O ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -148.34 149.13 31.26 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.535 ' O ' ' CD2' ' A' ' 7' ' ' LEU . 3.1 mp -141.97 -170.98 3.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.127 -0.983 . . . . 0.0 109.807 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 8.0 p-10 -113.66 159.92 19.15 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.315 -0.865 . . . . 0.0 109.441 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.479 ' HB2' ' O ' ' A' ' 7' ' ' LEU . 17.5 t30 -94.97 -94.49 0.18 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.015 -1.053 . . . . 0.0 109.301 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.54 37.29 1.34 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.173 -0.954 . . . . 0.0 109.304 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.513 ' O ' ' NE2' ' A' ' 39' ' ' HIS . 0.5 OUTLIER -150.81 62.8 5.44 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.446 -0.784 . . . . 0.0 109.004 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.551 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 35.0 Cg_endo -77.54 174.68 12.29 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.693 2.262 . . . . 0.0 110.26 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.602 ' O ' ' CG ' ' A' ' 39' ' ' HIS . 37.9 Cg_endo -83.83 -163.12 2.98 Favored 'Cis proline' 0 C--N 1.308 -1.566 0 C-N-CA 123.558 -1.434 . . . . 0.0 110.571 -0.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.602 ' CG ' ' O ' ' A' ' 38' ' ' PRO . 89.4 m-70 -161.77 124.59 3.03 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.413 -0.804 . . . . 0.0 109.758 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -100.97 111.93 24.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.211 -0.931 . . . . 0.0 109.213 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.491 ' O ' HG13 ' A' ' 42' ' ' VAL . 52.4 t -102.06 128.4 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 0.0 109.719 -179.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.556 ' CG1' ' HB2' ' A' ' 60' ' ' SER . 0.0 OUTLIER -159.85 167.12 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.29 -0.882 . . . . 0.0 109.496 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.508 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 3.2 m-85 -109.41 133.6 52.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.261 -0.899 . . . . 0.0 109.294 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -57.26 136.05 56.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.073 -1.017 . . . . 0.0 108.952 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.33 21.77 1.66 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.233 -0.917 . . . . 0.0 110.102 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.31 5.93 2.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.983 -1.073 . . . . 0.0 109.635 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.8 mp -113.49 41.44 2.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 0.0 109.556 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.46 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -114.03 165.34 13.83 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.346 -0.846 . . . . 0.0 109.232 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.46 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 35.5 Cg_endo -77.75 -32.08 2.9 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.615 2.21 . . . . 0.0 111.442 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -125.79 24.79 7.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.876 -1.14 . . . . 0.0 110.268 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.452 ' HA ' ' CG ' ' A' ' 48' ' ' ASN . 9.9 mtmm 36.48 91.13 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.865 -0.522 . . . . 0.0 110.182 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.449 ' HB3' ' OD1' ' A' ' 54' ' ' ASP . 73.7 m -139.92 136.49 33.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.071 -1.018 . . . . 0.0 109.681 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.24 -47.92 32.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.46 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 55' ' ' LEU . 6.8 p30 -46.45 -31.84 2.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.508 ' N ' ' OD1' ' A' ' 54' ' ' ASP . 39.1 tp -87.68 55.2 3.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 109.36 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.477 ' CB ' ' O ' ' A' ' 55' ' ' LEU . . . 163.88 -50.27 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.347 -0.845 . . . . 0.0 109.235 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -54.91 -37.95 66.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 109.437 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.6 t -104.38 -20.07 13.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.897 . . . . 0.0 109.526 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.579 HD23 ' CZ ' ' A' ' 76' ' ' PHE . 16.1 tp -65.04 -49.4 70.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 109.469 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.556 ' HB2' ' CG1' ' A' ' 42' ' ' VAL . 55.4 p -82.76 178.38 8.21 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.749 0.785 . . . . 0.0 110.936 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.461 ' CE1' ' O ' ' A' ' 63' ' ' GLN . 19.1 p80 -108.99 -154.23 0.53 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.446 ' N ' ' ND1' ' A' ' 61' ' ' HIS . 19.3 mmtt -148.05 -62.14 0.26 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.291 -0.881 . . . . 0.0 109.439 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.461 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 3.4 pm0 -46.1 148.18 0.91 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.647 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 mp -73.97 165.57 24.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 109.498 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.485 ' CD2' ' HB3' ' A' ' 33' ' ' ASN . 2.1 mp -82.47 126.17 31.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.368 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.01 -23.81 4.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.196 -0.94 . . . . 0.0 109.79 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.3 t -90.85 142.1 27.32 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.148 -0.97 . . . . 0.0 109.426 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.18 101.63 1.49 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.477 2.118 . . . . 0.0 110.423 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.528 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 98.93 47.41 1.91 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.414 ' N ' ' HB3' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -170.83 94.01 0.19 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.428 -1.042 . . . . 0.0 109.232 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.591 ' OG ' ' N ' ' A' ' 72' ' ' THR . 10.6 p -103.2 -79.91 0.53 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.016 -1.053 . . . . 0.0 109.336 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.591 ' N ' ' OG ' ' A' ' 71' ' ' SER . 13.5 m -160.95 110.11 1.64 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.106 -0.996 . . . . 0.0 108.761 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.4 t -79.24 78.74 5.71 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.158 -0.964 . . . . 0.0 108.757 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.555 ' CG2' ' CD1' ' A' ' 59' ' ' LEU . 84.9 m -62.4 96.77 0.08 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.45 -0.781 . . . . 0.0 109.847 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.499 ' O ' ' C ' ' A' ' 76' ' ' PHE . 1.7 t -79.23 74.3 5.82 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.579 ' CZ ' HD23 ' A' ' 59' ' ' LEU . 28.4 m-85 -33.88 146.05 0.14 Allowed Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.537 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 34.5 Cg_endo -76.22 -179.63 5.44 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.841 2.361 . . . . 0.0 111.482 -178.438 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.05 11.6 9.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.456 -0.777 . . . . 0.0 109.062 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' A' ' 80' ' ' ALA . 18.8 m-20 -98.88 -71.21 0.7 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.534 ' HB1' ' N ' ' A' ' 26' ' ' GLY . . . 31.51 98.05 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 122.023 -0.423 . . . . 0.0 111.06 178.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.474 ' HD2' HD21 ' A' ' 55' ' ' LEU . 34.5 Cg_endo -76.34 157.57 37.11 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.424 2.083 . . . . 0.0 110.708 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.32 139.87 52.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 0.0 109.482 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 157.55 171.87 24.06 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -88.73 129.95 35.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.344 -1.092 . . . . 0.0 109.661 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.464 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 9.3 m-85 -110.95 137.69 48.27 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.46 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 81.1 m -137.07 116.7 12.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.978 -1.076 . . . . 0.0 110.619 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.577 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.3 OUTLIER -111.13 164.43 12.86 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.791 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.457 ' CB ' HG23 ' A' ' 98' ' ' VAL . 6.6 p90 -157.1 -156.42 0.6 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.777 -1.202 . . . . 0.0 110.565 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.464 ' O ' ' HB3' ' A' ' 93' ' ' ARG . 0.5 OUTLIER -132.43 155.88 47.7 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.639 -0.663 . . . . 0.0 109.281 -179.539 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.597 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 12.3 tp10 -88.67 -44.6 0.45 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.088 -1.008 . . . . 0.0 110.715 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.8 Cg_endo -80.27 -55.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 122.157 1.905 . . . . 0.0 111.041 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.566 ' CD2' HD11 ' A' ' 14' ' ' LEU . 5.2 m80 -88.34 32.97 0.75 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.104 -0.998 . . . . 0.0 109.518 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.464 ' HB3' ' O ' ' A' ' 89' ' ' CYS . 12.8 ptt180 -63.09 -23.22 67.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.139 -0.976 . . . . 0.0 109.611 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.15 7.85 62.54 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -107.26 35.49 3.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -1.148 . . . . 0.0 109.668 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.8 35.99 84.78 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.478 ' HG2' ' O ' ' A' ' 14' ' ' LEU . 1.9 mtp -95.69 67.28 2.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.084 -1.245 . . . . 0.0 109.091 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.457 HG23 ' CB ' ' A' ' 88' ' ' TYR . 59.7 t -140.32 107.95 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 109.96 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.577 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -106.64 154.94 16.67 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 46.3 mtmt -130.74 135.53 47.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.071 -1.253 . . . . 0.0 110.08 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.552 HD11 ' CD1' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -101.74 123.5 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.189 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.471 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 1.0 OUTLIER -98.91 108.47 21.16 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.103 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.545 ' CG1' ' HA ' ' A' ' 25' ' ' PRO . 20.7 t -99.15 94.51 3.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.35 -0.844 . . . . 0.0 109.491 -178.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -175.8 -157.19 0.05 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.368 -0.833 . . . . 0.0 109.345 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 CA-C-O 117.989 -1.451 . . . . 0.0 109.596 179.857 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.273 0.559 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.8 m -137.12 149.4 47.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 0.0 109.568 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.501 ' O ' ' N ' ' A' ' 30' ' ' GLU . 16.8 m-85 -133.95 148.48 51.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.21 -0.931 . . . . 0.0 109.291 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.458 ' HA ' ' O ' ' A' ' 30' ' ' GLU . 1.7 t -137.92 103.67 5.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 109.801 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 21.8 m -87.37 67.26 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.239 -0.913 . . . . 0.0 109.292 179.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.446 ' CG ' ' O ' ' A' ' 6' ' ' LYS . 1.3 ptmm? -51.35 108.97 0.29 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.89 . . . . 0.0 109.725 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.585 ' CD1' ' CE1' ' A' ' 39' ' ' HIS . 0.2 OUTLIER -68.02 175.69 3.01 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.233 -0.917 . . . . 0.0 109.322 179.688 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.468 ' HA2' ' HA ' ' A' ' 14' ' ' LEU . . . 67.21 110.45 0.02 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.2 p -68.14 -104.0 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.262 -1.14 . . . . 0.0 109.178 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -171.77 26.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.885 -1.135 . . . . 0.0 109.848 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -132.22 -9.44 3.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.098 -1.001 . . . . 0.0 110.283 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 129.19 3.53 5.25 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.121 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 mt -111.43 142.0 44.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.067 -1.255 . . . . 0.0 109.565 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.468 ' HA ' ' HA2' ' A' ' 8' ' ' GLY . 65.7 mt -103.19 102.43 12.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.305 -0.872 . . . . 0.0 109.705 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 14' ' ' LEU . 27.8 m -142.94 138.41 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 109.249 179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.456 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 10.9 m-85 -56.46 148.9 18.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.156 -0.965 . . . . 0.0 109.538 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.456 ' HG2' ' O ' ' A' ' 16' ' ' PHE . 3.9 mm-40 -143.18 108.52 5.33 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.352 -0.842 . . . . 0.0 109.304 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 35.9 Cg_endo -78.17 174.53 51.35 Favored 'Cis proline' 0 C--N 1.312 -1.377 0 C-N-CA 123.779 -1.342 . . . . 0.0 110.638 0.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.469 ' HB3' ' HE3' ' A' ' 20' ' ' LYS . . . -72.59 -54.9 7.85 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.184 -0.948 . . . . 0.0 109.17 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.469 ' HE3' ' HB3' ' A' ' 19' ' ' ALA . 1.0 OUTLIER -100.58 138.34 37.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -0.878 . . . . 0.0 109.073 179.642 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 15.8 tp -126.14 113.18 16.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.165 -0.959 . . . . 0.0 110.26 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.7 m -82.42 94.93 7.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.208 -0.933 . . . . 0.0 108.526 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.524 ' CG1' HG23 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -99.14 172.42 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.241 -0.912 . . . . 0.0 110.276 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.514 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 2.8 mmtt -91.99 168.71 12.43 Favored Pre-proline 0 C--N 1.303 -1.428 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.53 ' HA ' ' CB ' ' A' ' 80' ' ' ALA . 33.7 Cg_endo -77.18 81.86 2.51 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.052 1.834 . . . . 0.0 110.576 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 129.47 -1.67 6.07 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -74.41 177.91 5.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.113 -1.228 . . . . 0.0 109.574 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 36.9 m -111.63 157.16 20.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.299 -0.876 . . . . 0.0 109.419 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.573 HG13 ' CE2' ' A' ' 31' ' ' PHE . 4.6 t -130.52 150.67 34.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.281 -0.887 . . . . 0.0 109.014 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -126.91 104.67 8.15 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.08 -1.012 . . . . 0.0 110.254 -179.467 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.573 ' CE2' HG13 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -107.9 91.45 3.65 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.24 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.585 ' HA ' ' HB3' ' A' ' 71' ' ' SER . 0.5 OUTLIER -95.87 161.9 13.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.288 -0.882 . . . . 0.0 110.728 -178.176 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.544 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 2.0 p-10 -80.36 160.29 25.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.626 -0.671 . . . . 0.0 109.404 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.424 ' HB2' ' O ' ' A' ' 7' ' ' LEU . 59.5 t30 -103.41 -76.21 0.59 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.949 -1.094 . . . . 0.0 109.211 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.452 ' O ' HG21 ' A' ' 36' ' ' VAL . 1.5 pttt -157.61 34.33 0.27 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.907 . . . . 0.0 108.897 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.496 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 14.9 t -154.17 65.05 4.91 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.572 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 35.3 Cg_endo -78.57 176.04 10.35 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 123.091 2.527 . . . . 0.0 110.934 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.572 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 39.2 Cg_endo -87.62 157.65 45.61 Favored 'Cis proline' 0 C--N 1.311 -1.428 0 O-C-N 123.818 1.43 . . . . 0.0 110.868 -1.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.713 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 73.7 m-70 -118.41 118.72 32.52 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.578 -0.701 . . . . 0.0 109.783 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.465 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 17.7 t-20 -100.32 126.0 46.61 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.884 . . . . 0.0 108.762 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.496 ' HB ' ' NE2' ' A' ' 61' ' ' HIS . 71.0 t -104.92 131.15 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.083 -1.011 . . . . 0.0 109.992 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.434 ' O ' ' HB3' ' A' ' 87' ' ' PHE . 0.0 OUTLIER -152.62 172.86 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.716 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.605 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 3.6 m-85 -124.53 109.77 13.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.017 -1.052 . . . . 0.0 109.903 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 37.0 t0 -47.11 131.01 12.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.42 -0.8 . . . . 0.0 109.404 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.4 18.23 5.44 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.269 -0.894 . . . . 0.0 109.967 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -120.86 9.56 10.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.026 -1.046 . . . . 0.0 109.652 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.2 mt -131.06 60.38 1.66 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.176 -0.953 . . . . 0.0 109.464 -179.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.499 ' ND2' ' HA ' ' A' ' 51' ' ' LYS . 0.7 OUTLIER -121.58 163.66 29.37 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.932 . . . . 0.0 109.514 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 35.1 Cg_endo -77.51 -46.21 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.627 2.218 . . . . 0.0 110.821 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.453 ' C ' ' HG2' ' A' ' 51' ' ' LYS . . . -115.76 37.34 3.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -0.981 . . . . 0.0 109.995 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.499 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.9 OUTLIER 36.21 47.22 0.45 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.664 -0.647 . . . . 0.0 110.545 179.545 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.43 ' O ' HD21 ' A' ' 55' ' ' LEU . 26.8 m -99.79 89.84 4.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.138 -0.976 . . . . 0.0 109.373 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.76 -19.61 58.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.486 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.08 -25.54 45.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.483 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 1.8 pp -75.88 -25.35 56.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.692 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 58' ' ' SER . . . -74.1 -53.99 8.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.896 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 56' ' ' ALA . 1.4 mmtt -43.57 -26.2 0.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 109.735 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 56' ' ' ALA . 2.8 m -110.97 22.18 15.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.103 -0.998 . . . . 0.0 109.859 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.602 ' HG ' ' CZ ' ' A' ' 43' ' ' PHE . 8.2 tp -128.24 -36.91 1.89 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.074 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.55 141.91 39.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.396 -0.815 . . . . 0.0 109.601 -179.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.558 ' CE1' ' O ' ' A' ' 63' ' ' GLN . 21.1 p80 -99.91 -23.02 15.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.444 -0.785 . . . . 0.0 109.862 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 70.62 -65.67 0.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.144 -0.973 . . . . 0.0 109.236 -179.714 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.558 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 0.8 OUTLIER -45.42 127.2 7.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.453 179.732 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.0 mp -68.01 170.45 8.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.222 -0.924 . . . . 0.0 109.727 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.449 HD12 ' O ' ' A' ' 39' ' ' HIS . 6.2 mt -115.74 100.55 8.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.363 -0.836 . . . . 0.0 109.032 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 62.5 mtt -96.99 2.82 51.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.277 -0.889 . . . . 0.0 109.828 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 t -79.88 139.74 53.95 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.112 -0.992 . . . . 0.0 109.24 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.63 88.78 1.41 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.613 2.209 . . . . 0.0 110.918 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.544 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 88.25 49.01 3.86 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -172.74 92.36 0.11 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.333 -1.098 . . . . 0.0 109.108 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.585 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . 80.0 p -99.07 -140.37 0.32 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 10.2 t -123.21 127.69 48.98 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.979 -1.076 . . . . 0.0 108.337 178.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.461 ' OG ' ' O ' ' A' ' 73' ' ' SER . 17.9 p -79.18 96.88 6.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.137 -0.977 . . . . 0.0 109.639 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.471 HG22 ' HG ' ' A' ' 59' ' ' LEU . 1.2 m -70.3 113.63 7.64 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.402 -0.811 . . . . 0.0 109.259 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 76' ' ' PHE . 54.5 m -79.25 88.71 4.91 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.361 -0.837 . . . . 0.0 109.113 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.596 ' CZ ' ' CD1' ' A' ' 101' ' ' ILE . 10.4 m-85 -43.13 160.43 0.21 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.376 -0.828 . . . . 0.0 108.903 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.49 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 32.6 Cg_endo -76.22 150.7 33.39 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.443 2.095 . . . . 0.0 111.483 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.429 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . . . -69.47 -11.28 60.7 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.457 ' O ' ' C ' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -100.65 15.9 26.63 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.332 -0.855 . . . . 0.0 109.141 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.53 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . . . -39.65 109.86 0.59 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.605 -0.684 . . . . 0.0 109.313 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.464 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 33.7 Cg_endo -75.02 121.35 6.52 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.354 2.036 . . . . 0.0 110.514 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.481 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -43.64 136.93 3.17 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.479 -0.763 . . . . 0.0 109.382 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 164.64 -167.38 38.42 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -120.68 115.62 23.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.407 -1.055 . . . . 0.0 109.484 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.464 ' OH ' ' HD2' ' A' ' 81' ' ' PRO . 23.2 m-85 -93.88 165.27 12.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.369 -0.832 . . . . 0.0 109.07 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.481 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 0.2 OUTLIER -144.46 97.81 3.1 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.057 -1.027 . . . . 0.0 110.205 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.581 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.5 OUTLIER -101.96 157.77 16.62 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.356 -0.84 . . . . 0.0 108.842 178.988 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.531 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 4.5 p90 -160.24 -148.4 0.17 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.157 -0.964 . . . . 0.0 109.653 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.473 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 74.7 m -132.96 161.29 34.69 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.159 -0.963 . . . . 0.0 109.641 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.588 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 19.5 tt0 -77.71 -47.25 2.37 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.298 -0.876 . . . . 0.0 109.23 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.5 Cg_endo -79.23 -66.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.106 0 C-N-CA 122.206 1.938 . . . . 0.0 110.478 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.713 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 14.4 m80 -55.03 87.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.063 -1.023 . . . . 0.0 109.149 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 91' ' ' PRO . 3.7 mtm180 -131.05 32.73 4.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.162 -0.961 . . . . 0.0 109.592 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -149.99 16.78 1.05 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -138.69 37.32 2.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.279 -1.13 . . . . 0.0 109.479 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.71 53.65 28.41 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.457 ' SD ' ' HB3' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -102.04 56.86 0.81 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.21 -1.171 . . . . 0.0 109.423 179.807 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 87' ' ' PHE . 2.5 p -135.6 94.72 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.244 -0.91 . . . . 0.0 109.383 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.581 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -70.99 179.24 31.89 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.481 ' HG2' ' HA ' ' A' ' 86' ' ' THR . 23.0 mtmm -154.81 131.18 10.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -1.133 . . . . 0.0 109.707 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.596 ' CD1' ' CZ ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -96.99 136.68 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.166 -0.959 . . . . 0.0 108.594 179.207 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.4 100.59 7.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.147 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 82' ' ' ALA . 1.6 t -99.94 125.55 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.889 . . . . 0.0 109.562 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -105.49 -74.96 0.64 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.23 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 CA-C-O 117.938 -1.479 . . . . 0.0 109.437 179.84 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.275 0.56 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.65 139.91 42.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.282 -0.886 . . . . 0.0 109.458 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.457 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 15.8 m-85 -117.08 174.45 6.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 109.468 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.9 m -156.35 116.41 3.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.909 . . . . 0.0 109.466 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.441 ' CG1' ' HB3' ' A' ' 16' ' ' PHE . 1.4 t -104.17 82.58 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.91 . . . . 0.0 109.449 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.448 ' HG2' ' CD1' ' A' ' 32' ' ' LEU . 6.7 mttp -69.8 85.97 0.49 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.284 -0.885 . . . . 0.0 109.383 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.507 ' HB2' ' CE ' ' A' ' 97' ' ' MET . 0.2 OUTLIER -62.54 -172.58 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.239 -0.913 . . . . 0.0 109.599 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.483 ' CA ' HD22 ' A' ' 14' ' ' LEU . . . 54.92 87.4 0.02 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.8 p -60.55 -90.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -1.153 . . . . 0.0 109.422 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -175.57 29.55 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.243 -0.911 . . . . 0.0 109.718 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -123.05 -19.28 6.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.188 -0.945 . . . . 0.0 109.523 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.03 -13.83 5.74 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 mt -96.23 147.65 23.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -1.116 . . . . 0.0 109.141 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.561 HD13 ' CD2' ' A' ' 92' ' ' HIS . 16.0 mt -109.8 112.18 24.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 109.553 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 6.0 m -138.56 136.0 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 109.468 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.441 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 28.4 m-85 -54.57 143.4 24.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.212 -0.93 . . . . 0.0 109.363 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 27.3 mt-10 -143.0 108.76 5.42 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.26 -0.9 . . . . 0.0 108.995 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.441 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.4 Cg_endo -76.59 164.68 86.99 Favored 'Cis proline' 0 C--N 1.311 -1.408 0 C-N-CA 123.811 -1.329 . . . . 0.0 110.894 0.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.51 -60.25 2.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.435 -0.791 . . . . 0.0 109.914 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.468 ' O ' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -78.78 136.59 37.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 109.553 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.468 HD22 ' O ' ' A' ' 20' ' ' LYS . 0.8 OUTLIER -127.04 109.55 12.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.232 -0.918 . . . . 0.0 109.777 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.4 m -88.71 94.98 10.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.215 -0.928 . . . . 0.0 108.835 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.53 HD11 ' CG2' ' A' ' 103' ' ' VAL . 1.1 pp -106.72 165.41 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.32 -0.862 . . . . 0.0 110.197 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.56 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -88.68 -178.76 1.1 Allowed Pre-proline 0 C--N 1.302 -1.485 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.815 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.56 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 36.3 Cg_endo -80.2 86.3 1.68 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.123 1.882 . . . . 0.0 110.694 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.49 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 123.74 2.07 8.83 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.453 ' OD2' ' HG3' ' A' ' 24' ' ' LYS . 4.0 m-20 -66.22 -179.17 0.73 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.221 -1.164 . . . . 0.0 109.21 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 57.2 m -121.97 120.46 34.48 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.293 -0.88 . . . . 0.0 109.362 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.593 ' HB ' ' CZ ' ' A' ' 31' ' ' PHE . 21.8 t -99.15 123.75 52.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.345 -0.847 . . . . 0.0 108.994 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.61 123.03 43.49 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.242 -0.911 . . . . 0.0 109.9 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.593 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -122.64 142.85 50.21 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.124 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.499 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -142.43 179.2 7.09 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.977 -1.077 . . . . 0.0 110.222 -179.584 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.577 ' ND2' ' O ' ' A' ' 67' ' ' SER . 0.4 OUTLIER -105.88 130.64 53.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.641 -0.662 . . . . 0.0 109.716 179.072 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 45.6 t30 -72.16 -59.57 2.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.068 -1.02 . . . . 0.0 109.205 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.428 ' C ' HG21 ' A' ' 36' ' ' VAL . 0.1 OUTLIER -172.72 36.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.311 -0.868 . . . . 0.0 109.42 179.716 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.594 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 32.1 t -148.65 55.79 2.25 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.303 -0.873 . . . . 0.0 109.729 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.594 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 37.0 Cg_endo -78.8 174.62 11.99 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.461 2.107 . . . . 0.0 110.443 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.552 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 37.8 Cg_endo -84.89 169.92 48.65 Favored 'Cis proline' 0 C--N 1.31 -1.477 0 C-N-CA 123.463 -1.474 . . . . 0.0 110.145 -1.469 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.689 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 71.9 m-70 -123.03 152.89 40.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.279 -0.888 . . . . 0.0 110.543 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.424 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 0.1 OUTLIER -124.23 103.11 8.05 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.7 t -98.92 109.35 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.71 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.527 ' HA ' ' HB3' ' A' ' 60' ' ' SER . 3.1 t -134.26 162.32 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.44 -0.788 . . . . 0.0 109.591 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.588 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 6.0 m-85 -110.13 96.76 6.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.397 -0.814 . . . . 0.0 109.666 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 43' ' ' PHE . 9.0 t70 -43.34 167.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.506 -0.746 . . . . 0.0 109.86 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -115.91 15.2 16.28 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.397 -0.815 . . . . 0.0 109.437 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -120.24 -3.71 10.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.614 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.0 mp -114.2 40.21 2.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.159 -0.963 . . . . 0.0 109.497 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.5 ' OD1' ' N ' ' A' ' 48' ' ' ASN . 0.4 OUTLIER -109.6 165.93 11.74 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 0.0 109.442 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 34.9 Cg_endo -77.11 -53.39 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.631 2.221 . . . . 0.0 110.493 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -100.61 30.37 3.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.363 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.479 ' HA ' ' OD1' ' A' ' 48' ' ' ASN . 0.3 OUTLIER 39.82 54.35 2.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.703 -0.623 . . . . 0.0 109.76 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.43 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 1.5 m -99.98 152.59 20.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 109.494 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.85 47.84 1.53 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 109.515 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 54' ' ' ASP . 4.6 m-20 -115.09 -71.78 0.73 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.235 -0.916 . . . . 0.0 109.57 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.466 ' HG ' ' N ' ' A' ' 56' ' ' ALA . 1.1 pp -53.92 -27.67 32.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 109.46 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.466 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -66.15 -38.58 88.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 109.325 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -36.33 75.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.247 -0.908 . . . . 0.0 109.39 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.7 t -101.77 30.47 4.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 0.0 109.499 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.587 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 10.2 tp -120.26 -33.49 3.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.243 -0.911 . . . . 0.0 109.293 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.527 ' HB3' ' HA ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -78.88 152.69 31.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.353 -0.842 . . . . 0.0 110.603 -178.972 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.558 ' CD2' HG22 ' A' ' 72' ' ' THR . 10.3 p80 -98.07 168.55 10.2 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.66 -33.02 4.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.047 -1.033 . . . . 0.0 109.784 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -73.81 108.31 6.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 109.553 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.41 HD12 ' HB2' ' A' ' 38' ' ' PRO . 1.5 mm? -44.47 157.9 0.06 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.15 -0.969 . . . . 0.0 109.566 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.542 ' CD1' ' HB2' ' A' ' 71' ' ' SER . 0.8 OUTLIER -104.82 91.56 3.88 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.479 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -89.18 -15.46 33.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.208 -0.932 . . . . 0.0 110.869 -178.703 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.577 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 22.9 t -78.75 113.06 31.81 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.857 -1.152 . . . . 0.0 108.52 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.479 ' HB3' ' HG3' ' A' ' 37' ' ' PRO . 32.1 Cg_endo -73.44 120.21 6.38 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.301 2.0 . . . . 0.0 111.007 -178.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.55 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 110.74 -15.4 29.09 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.56 ' N ' ' OD1' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -149.45 113.39 5.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.349 -1.089 . . . . 0.0 109.097 179.795 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.553 ' OG ' ' N ' ' A' ' 72' ' ' THR . 4.2 p -103.31 -135.91 0.33 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.123 -0.985 . . . . 0.0 108.931 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.558 HG22 ' CD2' ' A' ' 61' ' ' HIS . 6.9 t -114.94 157.08 23.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.746 -1.221 . . . . 0.0 109.296 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.93 -173.41 2.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.15 -0.969 . . . . 0.0 109.414 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.534 ' CG2' HD11 ' A' ' 59' ' ' LEU . 29.8 m -162.78 108.2 1.16 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.728 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.96 88.99 7.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.415 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.587 ' CZ ' HD21 ' A' ' 59' ' ' LEU . 8.9 m-85 -45.34 163.63 0.2 Allowed Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.324 -0.86 . . . . 0.0 109.286 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.49 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.6 Cg_endo -76.91 161.1 33.43 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.602 2.202 . . . . 0.0 111.159 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.45 -3.2 13.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.498 -0.751 . . . . 0.0 110.035 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.49 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -99.37 -76.16 0.55 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.09 -1.006 . . . . 0.0 109.2 179.826 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.541 ' N ' ' HD3' ' A' ' 81' ' ' PRO . . . 37.7 57.52 4.45 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.553 -0.717 . . . . 0.0 110.399 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 80' ' ' ALA . 36.1 Cg_endo -77.93 -160.37 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.373 2.049 . . . . 0.0 110.282 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.459 ' HB3' ' O ' ' A' ' 81' ' ' PRO . . . 72.7 -73.83 0.09 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.888 . . . . 0.0 109.896 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.417 ' HA2' ' N ' ' A' ' 103' ' ' VAL . . . 108.12 25.43 5.86 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -151.37 111.56 4.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.316 -1.108 . . . . 0.0 109.895 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.475 ' O ' ' HA ' ' A' ' 100' ' ' LYS . 52.5 m-85 -138.54 83.85 1.99 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.447 ' OG1' ' CD ' ' A' ' 100' ' ' LYS . 18.4 m -78.29 121.29 24.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.874 . . . . 0.0 110.596 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CE1' ' C ' ' A' ' 99' ' ' GLY . 2.0 p90 -117.07 173.1 6.85 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.476 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 2.9 p90 -158.78 -157.4 0.61 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.836 -1.165 . . . . 0.0 110.228 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.424 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 0.1 OUTLIER -131.83 151.99 51.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.4 -0.813 . . . . 0.0 109.725 -179.305 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.612 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 1.8 tm-20 -82.77 -45.61 0.9 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.0 109.932 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.7 Cg_endo -80.53 -51.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.125 1.883 . . . . 0.0 110.592 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.689 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 12.9 m80 -86.01 40.61 0.87 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 109.71 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.438 ' HG2' ' N ' ' A' ' 94' ' ' GLY . 16.5 ttt180 -76.49 141.09 41.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.198 -0.939 . . . . 0.0 109.358 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.438 ' N ' ' HG2' ' A' ' 93' ' ' ARG . . . 72.63 17.66 78.16 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.88 37.68 4.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.157 -1.202 . . . . 0.0 109.513 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 72.65 12.09 77.65 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.507 ' CE ' ' HB2' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -95.66 64.66 2.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -1.19 . . . . 0.0 109.497 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 28.3 t -140.24 73.84 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 109.661 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.492 ' C ' ' CE1' ' A' ' 87' ' ' PHE . . . -89.05 167.73 34.78 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.475 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 14.3 mttp -144.23 138.08 27.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.152 -1.205 . . . . 0.0 109.758 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.538 HD12 ' CE2' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -89.14 126.31 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 108.876 179.683 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 99.6 m -101.91 99.6 9.81 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.53 ' CG2' HD11 ' A' ' 23' ' ' ILE . 2.5 t -98.9 73.45 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.222 -0.924 . . . . 0.0 109.672 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 103' ' ' VAL . . . -42.98 95.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.369 -0.832 . . . . 0.0 109.414 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 103' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.304 0 CA-C-O 117.98 -1.455 . . . . 0.0 109.469 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.19 167.57 10.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.219 -0.926 . . . . 0.0 109.482 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -131.07 93.08 3.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 109.322 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.449 ' CG2' ' HB3' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -92.7 103.41 15.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.922 . . . . 0.0 109.597 -179.841 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.482 HG11 ' CD1' ' A' ' 21' ' ' LEU . 8.2 m -96.05 110.86 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.212 -0.93 . . . . 0.0 109.281 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -79.82 133.55 36.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.238 -0.914 . . . . 0.0 109.454 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.637 ' N ' ' CD1' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -110.03 73.46 0.84 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.736 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.413 ' HA3' ' CG ' ' A' ' 34' ' ' ASN . . . 165.52 77.85 0.03 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.478 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 2.0 p -47.84 -31.13 4.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -1.139 . . . . 0.0 109.186 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 9' ' ' SER . 6.4 t0 75.78 19.1 2.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.339 -0.851 . . . . 0.0 109.562 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -135.46 7.42 3.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.93 . . . . 0.0 109.722 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -173.49 -79.63 0.05 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.17 -171.48 2.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -1.155 . . . . 0.0 109.743 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.491 ' HB3' ' HE2' ' A' ' 97' ' ' MET . 8.6 mt -106.12 126.81 52.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.386 -0.821 . . . . 0.0 108.956 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -157.18 136.5 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.089 -1.007 . . . . 0.0 109.769 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -53.22 157.89 1.76 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.124 -0.985 . . . . 0.0 108.901 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 2.2 mt-10 -150.96 108.44 3.04 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 109.518 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.467 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 35.2 Cg_endo -78.95 166.62 78.82 Favored 'Cis proline' 0 C--N 1.313 -1.291 0 C-N-CA 123.898 -1.292 . . . . 0.0 110.534 -0.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.9 -54.21 14.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.094 -1.004 . . . . 0.0 108.978 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -86.06 159.42 19.57 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.361 -0.837 . . . . 0.0 108.893 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.482 ' CD1' HG11 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -157.99 129.01 6.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.012 -1.055 . . . . 0.0 109.944 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.0 m -100.0 90.14 4.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.378 -0.826 . . . . 0.0 109.213 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.53 ' CG1' HG23 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -99.56 166.1 2.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.206 -0.934 . . . . 0.0 109.995 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.474 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -89.28 173.0 6.48 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.348 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.531 ' HA ' ' CB ' ' A' ' 80' ' ' ALA . 34.7 Cg_endo -76.64 83.3 2.1 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.178 1.919 . . . . 0.0 110.497 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 137.56 -26.73 2.89 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.469 ' OD2' ' HB2' ' A' ' 24' ' ' LYS . 3.1 m-20 -43.8 165.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -1.156 . . . . 0.0 109.414 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 86.7 m -111.05 118.34 35.78 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.205 -0.934 . . . . 0.0 109.678 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.571 ' HB ' ' CZ ' ' A' ' 31' ' ' PHE . 2.7 t -99.21 123.85 52.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.199 -0.938 . . . . 0.0 109.17 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.449 ' HB3' ' CG2' ' A' ' 4' ' ' THR . 0.0 OUTLIER -100.23 128.61 46.27 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.245 -0.909 . . . . 0.0 109.975 -179.532 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.571 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -129.23 146.1 51.21 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.608 ' N ' ' CD1' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -140.63 -167.74 2.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.966 -1.084 . . . . 0.0 110.353 -179.609 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 67' ' ' SER . 2.1 p-10 -114.83 160.22 19.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.263 -0.898 . . . . 0.0 109.57 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.413 ' CG ' ' HA3' ' A' ' 8' ' ' GLY . 12.9 t30 -104.47 -154.28 0.5 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.249 -0.907 . . . . 0.0 109.417 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -92.89 28.31 2.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.13 -0.981 . . . . 0.0 109.254 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.54 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 3.0 t -141.84 61.89 13.6 Favored Pre-proline 0 C--N 1.299 -1.611 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.577 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.4 Cg_endo -77.93 177.32 8.94 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 123.05 2.5 . . . . 0.0 110.804 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.581 ' O ' ' CE1' ' A' ' 92' ' ' HIS . 39.6 Cg_endo -87.91 158.91 44.84 Favored 'Cis proline' 0 C--N 1.313 -1.315 0 O-C-N 123.723 1.381 . . . . 0.0 110.908 -1.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.707 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 72.5 m-70 -118.65 156.73 28.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.493 -0.754 . . . . 0.0 109.501 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.429 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 18.9 t30 -140.08 114.33 9.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.293 -0.879 . . . . 0.0 109.019 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.456 ' O ' HG12 ' A' ' 42' ' ' VAL . 3.8 t -99.72 122.75 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.889 . . . . 0.0 109.125 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.621 ' HA ' ' CB ' ' A' ' 60' ' ' SER . 0.2 OUTLIER -157.96 141.36 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.106 -0.996 . . . . 0.0 110.231 179.746 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.628 ' CE2' ' CG ' ' A' ' 59' ' ' LEU . 4.4 m-85 -85.98 121.5 28.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.737 -0.602 . . . . 0.0 109.793 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.469 ' OD2' HD23 ' A' ' 47' ' ' LEU . 24.9 t70 -45.74 169.0 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.413 -0.804 . . . . 0.0 109.419 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.86 -16.06 14.24 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.219 -0.926 . . . . 0.0 109.943 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.69 -14.01 11.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.138 -0.977 . . . . 0.0 109.682 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.469 HD23 ' OD2' ' A' ' 44' ' ' ASP . 2.8 mm? -94.1 48.83 1.27 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.182 -0.949 . . . . 0.0 109.433 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.509 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 3.5 p30 -129.48 163.83 43.82 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.254 -0.904 . . . . 0.0 109.496 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.509 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 34.0 Cg_endo -76.3 -11.57 19.15 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.486 2.124 . . . . 0.0 109.95 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 52' ' ' SER . . . -139.4 77.33 1.61 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -40.4 93.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.973 -179.417 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 50' ' ' ALA . 2.0 m -140.35 154.23 46.68 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.321 -0.862 . . . . 0.0 109.389 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.01 72.03 0.87 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.269 -0.894 . . . . 0.0 109.254 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -167.73 -38.4 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.156 -0.965 . . . . 0.0 109.699 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.472 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 0.9 OUTLIER -78.13 -8.14 57.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.112 -0.992 . . . . 0.0 109.517 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 57' ' ' LYS . . . -112.47 -43.83 3.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.901 . . . . 0.0 109.632 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 56' ' ' ALA . 47.7 tttp -43.52 -48.63 7.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.894 . . . . 0.0 109.575 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -98.15 25.55 6.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.893 . . . . 0.0 109.682 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.628 ' CG ' ' CE2' ' A' ' 43' ' ' PHE . 17.1 tp -104.1 -62.53 1.3 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.147 -0.971 . . . . 0.0 109.625 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.621 ' CB ' ' HA ' ' A' ' 42' ' ' VAL . 0.3 OUTLIER -85.8 -167.61 1.92 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.222 -0.924 . . . . 0.0 110.637 -178.778 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.441 ' CE1' HD13 ' A' ' 65' ' ' LEU . 25.3 p80 -120.68 142.0 49.88 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.29 -42.33 13.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 0.0 109.59 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.467 ' NE2' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -46.65 163.76 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.898 . . . . 0.0 109.496 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.484 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 2.3 mp -97.37 -179.01 4.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.938 . . . . 0.0 109.411 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.473 HD11 ' N ' ' A' ' 65' ' ' LEU . 7.1 mp -118.96 81.98 1.79 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -0.951 . . . . 0.0 109.407 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.13 -34.7 29.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 109.524 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.52 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 46.0 t -80.58 146.83 61.83 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.922 . . . . 0.0 109.531 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.446 ' HD2' ' OG ' ' A' ' 67' ' ' SER . 35.5 Cg_endo -77.84 102.55 1.6 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.641 2.228 . . . . 0.0 110.594 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.493 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 109.24 -26.67 14.37 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.506 ' CB ' ' HB3' ' A' ' 67' ' ' SER . 6.8 tt0 -62.22 105.63 0.63 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.132 -1.217 . . . . 0.0 108.464 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.561 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . 21.5 p -137.86 -161.48 1.18 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.165 -0.959 . . . . 0.0 110.695 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.8 t -153.82 124.16 7.02 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.3 p -79.27 135.93 36.9 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.141 -0.974 . . . . 0.0 109.517 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.532 ' CG2' ' HG ' ' A' ' 59' ' ' LEU . 86.3 m -98.54 114.33 26.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.377 -0.827 . . . . 0.0 109.711 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.442 ' O ' ' C ' ' A' ' 76' ' ' PHE . 1.2 t -83.83 82.97 8.1 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -0.89 . . . . 0.0 109.452 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.634 ' CZ ' ' CD1' ' A' ' 101' ' ' ILE . 14.6 m-85 -43.34 149.1 0.59 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.094 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.478 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.6 Cg_endo -75.99 168.89 23.24 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.592 2.194 . . . . 0.0 110.842 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.34 6.59 6.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.424 -0.797 . . . . 0.0 109.783 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' A' ' 80' ' ' ALA . 30.9 t70 -99.12 -77.6 0.51 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.103 -0.998 . . . . 0.0 109.242 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.531 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . . . 56.66 109.31 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.35 -0.843 . . . . 0.0 108.856 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.43 ' HG2' ' HG2' ' A' ' 49' ' ' PRO . 33.3 Cg_endo -74.31 113.55 3.82 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.328 2.018 . . . . 0.0 110.688 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.43 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -46.41 109.3 0.18 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.365 -0.834 . . . . 0.0 109.459 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.424 ' HA3' ' HB3' ' A' ' 49' ' ' PRO . . . 179.13 -119.28 0.64 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -160.44 106.23 1.5 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.2 -1.176 . . . . 0.0 109.784 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.607 ' CD2' ' CG2' ' A' ' 101' ' ' ILE . 0.7 OUTLIER -82.35 131.58 35.22 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.244 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 92.4 m -111.92 117.25 32.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.052 -1.03 . . . . 0.0 110.669 -179.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.575 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -111.51 169.91 8.48 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.658 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.467 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 7.1 p90 -159.12 -154.11 0.4 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.856 -1.152 . . . . 0.0 110.089 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 0.5 OUTLIER -128.78 141.78 51.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.398 -0.814 . . . . 0.0 109.795 -179.205 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.619 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 7.4 tp10 -72.08 -47.02 11.33 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.201 -0.937 . . . . 0.0 109.57 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.9 Cg_endo -79.73 -68.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.157 0 C-N-CA 122.271 1.981 . . . . 0.0 110.333 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.707 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 9.9 m80 -69.98 64.44 0.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.135 -0.978 . . . . 0.0 109.048 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.416 ' N ' ' O ' ' A' ' 91' ' ' PRO . 4.2 mtm180 -84.58 -10.2 57.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.678 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -122.78 54.32 0.71 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -151.39 39.3 0.65 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -1.13 . . . . 0.0 109.549 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 48.24 22.05 2.16 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.534 ' CE ' ' HB2' ' A' ' 7' ' ' LEU . 2.5 mtp -80.5 55.71 2.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.981 -1.306 . . . . 0.0 109.116 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 39.4 t -130.63 113.57 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.635 -179.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.562 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -96.55 -173.1 35.12 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 14.9 mttt -160.53 122.34 3.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -1.182 . . . . 0.0 109.66 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.634 ' CD1' ' CZ ' ' A' ' 76' ' ' PHE . 0.7 OUTLIER -91.06 119.03 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.149 -0.97 . . . . 0.0 109.344 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.0 m -105.17 94.98 5.53 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.517 HG23 ' CG2' ' A' ' 101' ' ' ILE . 91.3 t -99.28 129.18 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.218 -0.926 . . . . 0.0 109.825 -179.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -90.41 177.2 6.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.406 -0.809 . . . . 0.0 109.481 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 CA-C-O 117.957 -1.468 . . . . 0.0 109.545 179.888 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.27 0.557 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' A' ' 28' ' ' THR . 0.3 OUTLIER -127.47 111.52 13.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.263 -0.898 . . . . 0.0 109.434 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -90.23 154.27 19.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.437 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.98 107.91 13.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.718 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.499 ' CG1' ' HB3' ' A' ' 16' ' ' PHE . 1.3 t -105.93 123.28 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.887 . . . . 0.0 109.324 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.436 ' HG2' HD13 ' A' ' 32' ' ' LEU . 13.8 mttm -117.75 90.3 3.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 109.41 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.445 HD13 ' HA ' ' A' ' 33' ' ' ASN . 0.1 OUTLIER -50.55 164.38 0.13 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.166 -0.959 . . . . 0.0 109.528 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.18 76.36 0.91 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 3.2 p -48.02 -60.44 2.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -1.164 . . . . 0.0 109.306 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 9' ' ' SER . 1.1 t70 174.46 -62.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.403 -0.81 . . . . 0.0 109.288 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.85 18.95 6.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.313 -0.867 . . . . 0.0 109.283 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.428 ' O ' ' HG ' ' A' ' 13' ' ' LEU . . . -105.84 -92.5 2.27 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.512 HD11 ' N ' ' A' ' 13' ' ' LEU . 1.1 mp -143.86 -165.37 2.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.262 -1.14 . . . . 0.0 109.668 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.649 ' CD1' ' CD2' ' A' ' 92' ' ' HIS . 10.8 mt -100.64 52.37 0.87 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.41 -0.806 . . . . 0.0 109.359 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 4.0 m -94.84 149.91 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 109.514 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.499 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 51.8 m-85 -65.16 177.35 1.06 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -0.923 . . . . 0.0 109.309 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.446 ' HG2' ' O ' ' A' ' 16' ' ' PHE . 4.7 mt-10 -160.16 108.01 1.4 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.907 . . . . 0.0 109.367 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.416 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 33.0 Cg_endo -75.13 170.14 72.64 Favored 'Cis proline' 0 C--N 1.311 -1.408 0 C-N-CA 123.602 -1.416 . . . . 0.0 110.678 0.652 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.66 -63.27 1.11 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.246 -0.909 . . . . 0.0 109.421 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.9 ptpt -80.02 158.1 26.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.176 -0.952 . . . . 0.0 109.309 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -150.47 118.79 6.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.416 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 102' ' ' THR . 24.2 m -89.51 92.1 8.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.235 -0.916 . . . . 0.0 109.611 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.52 ' CG1' HG21 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -99.62 175.8 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.291 -0.881 . . . . 0.0 109.569 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.539 ' CG ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -88.69 179.2 1.71 Allowed Pre-proline 0 C--N 1.302 -1.464 0 O-C-N 121.355 -0.841 . . . . 0.0 108.818 179.613 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.539 ' HD2' ' CG ' ' A' ' 24' ' ' LYS . 35.1 Cg_endo -78.58 77.23 4.11 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.371 2.047 . . . . 0.0 110.889 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.497 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 116.4 27.4 2.87 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.442 ' CG ' ' HB2' ' A' ' 24' ' ' LYS . 6.0 m-20 -84.1 -176.68 6.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.154 -1.203 . . . . 0.0 109.097 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' A' ' 2' ' ' THR . 90.2 m -112.98 129.02 56.64 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.251 -0.906 . . . . 0.0 109.583 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.522 ' HB ' ' CZ ' ' A' ' 31' ' ' PHE . 4.2 t -115.59 124.35 71.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.309 -0.87 . . . . 0.0 108.77 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -99.15 125.47 44.72 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.27 -0.894 . . . . 0.0 109.649 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.522 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.3 OUTLIER -116.3 153.78 31.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.38 -0.825 . . . . 0.0 108.941 -179.868 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.542 ' HB3' ' N ' ' A' ' 70' ' ' GLN . 0.1 OUTLIER -141.36 -171.62 3.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.981 -1.075 . . . . 0.0 109.95 -179.603 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.551 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 3.2 p-10 -123.14 167.45 13.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.382 -0.823 . . . . 0.0 109.093 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -157.31 -58.16 0.08 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.906 -1.121 . . . . 0.0 110.111 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.534 ' HB3' ' CD2' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -71.51 -150.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 0.0 110.161 -179.356 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.2 t -69.37 115.27 30.76 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.594 -0.691 . . . . 0.0 110.352 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.565 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.4 Cg_endo -79.62 178.53 7.23 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 122.915 2.41 . . . . 0.0 109.997 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.565 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 41.5 Cg_endo -88.48 163.61 41.92 Favored 'Cis proline' 0 C--N 1.313 -1.331 0 O-C-N 123.339 1.179 . . . . 0.0 110.707 -1.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.675 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 97.3 m-70 -126.01 122.59 36.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.175 -0.953 . . . . 0.0 110.018 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.448 ' OD1' ' HA ' ' A' ' 64' ' ' LEU . 2.0 t30 -99.45 142.55 30.79 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.425 -0.797 . . . . 0.0 109.163 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.475 ' C ' ' CG2' ' A' ' 42' ' ' VAL . 7.1 t -110.51 118.13 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.937 . . . . 0.0 109.422 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.61 ' HA ' ' CB ' ' A' ' 60' ' ' SER . 1.6 t -153.84 138.69 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.164 -0.96 . . . . 0.0 110.099 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.633 ' CE2' ' CG ' ' A' ' 59' ' ' LEU . 2.8 m-85 -87.33 126.22 34.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.658 -0.651 . . . . 0.0 109.643 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -51.67 137.54 24.94 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.236 -0.915 . . . . 0.0 108.924 179.539 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.41 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . . . -83.93 14.92 3.66 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.186 -0.946 . . . . 0.0 109.815 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -129.07 11.87 6.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.156 -0.965 . . . . 0.0 109.62 -179.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 76.1 mt -126.66 50.4 1.94 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.93 . . . . 0.0 109.635 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 51' ' ' LYS . 5.2 p30 -119.67 159.39 46.47 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 0.0 109.122 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 36.2 Cg_endo -77.85 -2.23 12.37 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.566 2.177 . . . . 0.0 110.664 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.519 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -123.17 28.74 7.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.204 -0.935 . . . . 0.0 109.655 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.519 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER 28.49 40.88 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.108 0.48 . . . . 0.0 110.728 179.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 50' ' ' ALA . 72.9 m -135.91 -171.52 2.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.123 -0.986 . . . . 0.0 109.816 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.41 ' HB2' ' HB3' ' A' ' 45' ' ' ALA . . . -146.34 19.58 1.37 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.305 -0.872 . . . . 0.0 109.598 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -68.96 -31.31 70.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 109.499 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 0.6 OUTLIER -102.0 22.77 12.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.546 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -117.36 -54.99 2.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -0.881 . . . . 0.0 109.351 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -56.97 -28.58 62.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.372 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.4 p -108.99 30.22 6.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.283 -0.886 . . . . 0.0 109.625 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.633 ' CG ' ' CE2' ' A' ' 43' ' ' PHE . 26.7 tp -115.87 -62.15 1.63 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.205 -0.934 . . . . 0.0 109.444 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.61 ' CB ' ' HA ' ' A' ' 42' ' ' VAL . 0.6 OUTLIER -80.15 -171.46 2.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.264 -0.898 . . . . 0.0 110.627 -178.703 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -115.11 157.36 23.68 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.627 -0.671 . . . . 0.0 109.295 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.58 -14.44 16.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 109.682 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -76.93 130.36 37.43 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.172 -0.955 . . . . 0.0 109.488 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.448 ' HA ' ' OD1' ' A' ' 40' ' ' ASN . 8.6 mp -60.86 179.98 0.15 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.267 -0.895 . . . . 0.0 109.375 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.514 ' CD2' ' CB ' ' A' ' 71' ' ' SER . 2.5 mp -98.57 135.22 40.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.232 -0.918 . . . . 0.0 109.349 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 3.1 mmt -127.11 1.56 6.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.187 -0.946 . . . . 0.0 109.413 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.3 t -111.45 129.41 24.12 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.908 . . . . 0.0 109.229 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.446 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.2 Cg_endo -78.47 87.0 1.58 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.338 2.026 . . . . 0.0 110.514 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.551 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 114.87 35.01 1.42 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.542 ' N ' ' HB3' ' A' ' 32' ' ' LEU . 1.0 OUTLIER 178.55 112.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -1.133 . . . . 0.0 109.366 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.589 ' OG ' ' N ' ' A' ' 72' ' ' THR . 21.5 p -104.85 -82.19 0.52 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.108 -0.995 . . . . 0.0 109.429 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.589 ' N ' ' OG ' ' A' ' 71' ' ' SER . 85.2 m -160.83 156.28 24.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.007 -1.058 . . . . 0.0 109.346 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 75' ' ' THR . 0.8 OUTLIER -102.68 67.31 0.98 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.158 -0.964 . . . . 0.0 109.309 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.441 ' CG2' ' O ' ' A' ' 59' ' ' LEU . 97.8 m -46.26 99.28 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.364 -0.835 . . . . 0.0 109.642 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.416 ' N ' ' O ' ' A' ' 73' ' ' SER . 19.0 m -78.89 95.87 5.54 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.449 ' HB3' ' HD2' ' A' ' 77' ' ' PRO . 8.0 m-85 -47.85 162.45 0.32 Allowed Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.526 -0.734 . . . . 0.0 109.34 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.538 ' HD3' ' CD1' ' A' ' 59' ' ' LEU . 35.0 Cg_endo -76.61 173.37 14.59 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.695 2.263 . . . . 0.0 111.12 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.75 8.51 7.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.295 -0.878 . . . . 0.0 109.629 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -99.32 -71.01 0.71 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.217 -0.927 . . . . 0.0 109.147 179.781 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 79' ' ' ASP . . . 42.76 88.26 0.1 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.336 -0.852 . . . . 0.0 109.374 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.452 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 33.4 Cg_endo -75.61 127.79 10.53 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.616 2.21 . . . . 0.0 110.654 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.472 ' HB1' ' O ' ' A' ' 104' ' ' ALA . . . -43.06 136.92 2.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.439 -0.788 . . . . 0.0 109.553 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.461 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . 152.65 172.92 21.57 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -96.88 126.34 41.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -1.144 . . . . 0.0 109.519 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.493 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 12.6 m-85 -97.6 -173.7 2.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 108.853 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 99.4 m -164.83 103.58 0.79 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.922 -1.111 . . . . 0.0 110.443 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.586 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.5 OUTLIER -101.24 166.07 10.96 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.563 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 97' ' ' MET . 4.9 p90 -159.96 -153.38 0.34 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.724 -1.235 . . . . 0.0 110.547 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 97' ' ' MET . 0.5 OUTLIER -129.1 148.03 51.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.543 -0.723 . . . . 0.0 109.49 -179.406 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 0.4 OUTLIER -84.0 -43.58 0.77 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.943 . . . . 0.0 110.511 179.621 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.2 Cg_endo -78.68 -67.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.065 0 C-N-CA 122.109 1.873 . . . . 0.0 110.872 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.675 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 69.5 m80 -65.93 75.36 0.08 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.99 -1.069 . . . . 0.0 109.551 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 91' ' ' PRO . 45.5 mtm180 -91.84 110.94 22.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.126 -0.984 . . . . 0.0 109.139 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.7 1.71 30.63 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.406 ' CB ' HD12 ' A' ' 14' ' ' LEU . . . -98.03 33.59 2.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -1.16 . . . . 0.0 109.475 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 64.27 13.14 53.22 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.527 ' CE ' ' O ' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -74.13 63.1 0.95 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.824 -1.398 . . . . 0.0 109.201 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.417 HG22 ' O ' ' A' ' 97' ' ' MET . 17.1 t -140.72 107.99 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.891 . . . . 0.0 109.61 -179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.586 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -112.21 179.45 19.48 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.441 ' HG3' ' C ' ' A' ' 99' ' ' GLY . 2.7 mtmp? -152.46 134.24 14.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.115 -1.227 . . . . 0.0 109.784 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.52 HG21 ' CG1' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -95.82 132.73 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.88 . . . . 0.0 108.831 179.568 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.48 ' O ' ' HA ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -107.02 97.8 7.53 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.137 -0.977 . . . . 0.0 108.829 179.252 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.478 HG23 HG13 ' A' ' 23' ' ' ILE . 3.8 t -99.3 73.86 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.028 -1.045 . . . . 0.0 109.463 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.472 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . 54.15 33.4 17.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.395 -0.816 . . . . 0.0 109.538 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.461 ' HA2' ' N ' ' A' ' 83' ' ' GLY . . . . . . . . 0 N--CA 1.492 2.403 0 CA-C-O 118.097 -1.391 . . . . 0.0 109.756 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.59 108.86 11.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.586 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 23.1 m-85 -86.1 163.39 17.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.319 -0.863 . . . . 0.0 109.302 179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -151.93 111.96 4.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.044 -1.035 . . . . 0.0 109.957 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.465 ' CG1' HD13 ' A' ' 21' ' ' LEU . 6.5 m -104.98 79.97 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.275 -0.89 . . . . 0.0 109.255 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -58.2 148.32 27.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.314 -0.866 . . . . 0.0 109.714 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.482 ' CD1' ' O ' ' A' ' 32' ' ' LEU . 0.4 OUTLIER -118.05 -173.79 2.52 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.236 -0.915 . . . . 0.0 109.485 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.528 ' HA3' ' CB ' ' A' ' 34' ' ' ASN . . . 65.28 88.57 0.05 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.559 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -66.55 -22.84 66.16 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.31 -1.112 . . . . 0.0 109.384 179.699 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.559 ' CB ' ' O ' ' A' ' 9' ' ' SER . 8.4 t70 83.36 20.05 0.2 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.63 9.74 15.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 109.361 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.56 5.16 45.78 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.413 ' HG ' ' OG ' ' A' ' 9' ' ' SER . 0.4 OUTLIER -134.95 154.4 51.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -1.161 . . . . 0.0 109.825 -179.792 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.618 ' CD1' ' CD2' ' A' ' 92' ' ' HIS . 95.1 mt -113.91 121.4 43.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.353 -0.842 . . . . 0.0 109.172 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.45 HG12 ' O ' ' A' ' 14' ' ' LEU . 15.6 m -149.07 153.6 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.111 -0.993 . . . . 0.0 109.863 -179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.468 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 12.0 m-85 -76.57 156.21 32.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.172 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.468 ' HG2' ' O ' ' A' ' 16' ' ' PHE . 4.1 mt-10 -141.98 109.77 5.99 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.128 -0.983 . . . . 0.0 109.393 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.5 Cg_endo -77.51 -177.7 21.92 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 123.767 -1.347 . . . . 0.0 110.698 0.469 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.21 -58.36 3.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 109.333 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.07 168.74 9.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.915 . . . . 0.0 109.16 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.465 HD13 ' CG1' ' A' ' 5' ' ' VAL . 0.4 OUTLIER -160.1 146.06 15.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.082 -1.011 . . . . 0.0 109.927 -179.812 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.458 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 90.5 m -114.31 112.88 23.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.843 . . . . 0.0 109.011 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.532 ' CD1' HG21 ' A' ' 103' ' ' VAL . 0.9 OUTLIER -117.59 164.05 14.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.265 -0.897 . . . . 0.0 110.073 -179.682 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.535 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 17.0 mmmt -82.16 165.48 42.66 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.535 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 32.7 Cg_endo -74.81 86.26 1.41 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 121.945 1.763 . . . . 0.0 110.306 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.427 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 126.26 4.43 6.45 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.494 ' OD2' ' CG ' ' A' ' 24' ' ' LYS . 59.0 m-20 -71.07 -176.73 1.47 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -1.158 . . . . 0.0 109.58 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.433 ' CG2' ' HA ' ' A' ' 75' ' ' THR . 0.2 OUTLIER -120.04 122.93 42.21 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.284 -0.885 . . . . 0.0 109.636 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.561 ' HB ' ' CE2' ' A' ' 31' ' ' PHE . 1.4 t -111.17 147.32 15.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.224 -0.923 . . . . 0.0 109.334 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -117.56 141.34 48.47 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.176 -0.953 . . . . 0.0 110.111 -179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.561 ' CE2' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -145.33 89.73 1.96 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.541 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.5 OUTLIER -97.84 179.88 4.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.44 -0.787 . . . . 0.0 111.257 -178.028 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.536 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 3.8 p-10 -93.21 165.42 12.82 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.528 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . 42.0 t30 -115.7 -84.0 0.62 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.073 -1.017 . . . . 0.0 109.477 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.497 ' HG2' ' ND2' ' A' ' 34' ' ' ASN . 0.5 OUTLIER -145.95 35.15 1.01 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.087 -1.008 . . . . 0.0 109.643 179.892 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.55 ' O ' ' NE2' ' A' ' 92' ' ' HIS . 2.0 t -156.87 60.36 2.13 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.86 . . . . 0.0 109.305 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 35.8 Cg_endo -78.26 174.08 12.94 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.661 2.24 . . . . 0.0 110.631 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.535 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.9 Cg_endo -86.38 162.18 54.53 Favored 'Cis proline' 0 C--N 1.311 -1.445 0 O-C-N 123.798 1.42 . . . . 0.0 110.297 -1.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.711 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 65.2 m-70 -118.59 146.73 44.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.187 -0.946 . . . . 0.0 110.17 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -120.04 114.47 22.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 109.237 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.468 ' O ' HG22 ' A' ' 42' ' ' VAL . 24.7 t -99.92 114.06 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.508 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.536 ' HA ' ' CB ' ' A' ' 60' ' ' SER . 1.6 t -150.59 157.4 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.928 . . . . 0.0 109.874 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.568 ' CE2' ' HB3' ' A' ' 59' ' ' LEU . 3.8 m-85 -109.14 110.99 22.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.422 -0.799 . . . . 0.0 109.41 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -47.16 158.35 0.15 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.0 109.519 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.73 31.2 5.64 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.292 -0.88 . . . . 0.0 109.532 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.99 -31.71 4.99 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.182 -0.949 . . . . 0.0 109.644 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 mp -101.43 64.5 1.01 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.94 . . . . 0.0 109.656 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.446 ' OD1' ' N ' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -111.79 158.72 35.83 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.309 -0.869 . . . . 0.0 109.394 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -80.01 -33.7 1.07 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.78 2.32 . . . . 0.0 110.564 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.481 ' O ' ' HG3' ' A' ' 51' ' ' LYS . . . -122.6 35.7 4.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.15 -0.969 . . . . 0.0 109.845 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.481 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 0.3 OUTLIER 34.28 49.75 0.34 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.869 -0.519 . . . . 0.0 110.529 179.634 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 m -127.44 141.21 51.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.12 -0.987 . . . . 0.0 109.675 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -121.04 10.43 10.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 109.401 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -62.31 -39.65 93.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.392 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.507 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 1.7 pp -80.93 -32.27 34.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.362 -0.836 . . . . 0.0 109.57 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.499 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -69.01 -43.74 74.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.081 -1.012 . . . . 0.0 109.571 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.12 -30.91 12.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.313 -0.867 . . . . 0.0 109.748 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 59' ' ' LEU . 0.1 OUTLIER -105.74 -40.42 5.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.163 -0.961 . . . . 0.0 110.009 -179.623 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.568 ' HB3' ' CE2' ' A' ' 43' ' ' PHE . 13.2 tp -43.01 -56.56 3.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.217 -0.927 . . . . 0.0 109.917 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.536 ' CB ' ' HA ' ' A' ' 42' ' ' VAL . 64.3 p -78.83 153.05 30.95 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.487 -0.758 . . . . 0.0 110.619 -177.989 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.498 ' CE1' ' O ' ' A' ' 63' ' ' GLN . 12.8 p80 -93.69 176.67 6.27 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.87 -57.61 2.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.726 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.498 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 3.3 pt20 -44.09 145.48 0.75 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 109.552 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 mp -78.29 167.98 20.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 109.505 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.477 ' CD1' ' CE1' ' A' ' 61' ' ' HIS . 7.7 mp -95.32 108.96 21.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 0.0 109.38 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 4.2 ttp -117.81 -0.4 11.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 0.0 109.673 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.522 ' OG ' ' CB ' ' A' ' 70' ' ' GLN . 3.2 t -91.23 147.28 35.21 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.147 -0.971 . . . . 0.0 109.557 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.23 87.96 1.48 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.712 2.275 . . . . 0.0 110.823 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.536 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 89.22 35.37 8.12 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.522 ' CB ' ' OG ' ' A' ' 67' ' ' SER . 1.6 tt0 -147.25 94.0 2.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.128 -1.219 . . . . 0.0 109.205 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.559 ' CB ' ' O ' ' A' ' 31' ' ' PHE . 4.4 p -99.88 -105.89 0.22 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.33 -0.856 . . . . 0.0 109.676 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 9.9 t -160.56 123.74 3.4 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.7 m -79.26 82.31 5.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.046 -1.034 . . . . 0.0 109.341 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.526 ' CG2' HD11 ' A' ' 59' ' ' LEU . 99.6 m -59.67 101.51 0.11 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.399 -0.813 . . . . 0.0 109.504 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.458 ' O ' ' C ' ' A' ' 76' ' ' PHE . 3.1 t -78.95 86.18 4.85 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.552 ' CE2' HD12 ' A' ' 101' ' ' ILE . 3.2 m-85 -36.22 147.97 0.18 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.887 -0.508 . . . . 0.0 110.125 -178.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.427 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.7 Cg_endo -78.28 175.74 10.75 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.793 2.329 . . . . 0.0 111.52 -178.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.76 9.78 13.15 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.493 ' O ' ' C ' ' A' ' 80' ' ' ALA . 2.2 t70 -99.15 -12.99 19.97 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.411 -0.806 . . . . 0.0 108.886 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.493 ' C ' ' O ' ' A' ' 79' ' ' ASP . . . -34.6 104.54 0.25 Allowed Pre-proline 0 N--CA 1.497 1.919 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.461 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 33.9 Cg_endo -75.57 152.65 38.4 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.531 2.154 . . . . 0.0 110.899 -179.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.458 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -71.67 131.6 43.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.437 -0.79 . . . . 0.0 109.413 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 155.34 -149.61 20.83 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.48 137.83 53.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.214 -1.168 . . . . 0.0 109.664 -179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.565 ' CD1' HG22 ' A' ' 101' ' ' ILE . 6.4 m-85 -101.51 -170.95 1.9 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.347 -0.846 . . . . 0.0 108.723 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 85' ' ' TYR . 92.6 m -166.79 98.4 0.55 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.859 -1.151 . . . . 0.0 110.463 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.535 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.6 OUTLIER -101.95 162.27 13.04 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.243 -0.911 . . . . 0.0 108.677 178.622 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -154.31 -162.0 1.33 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.927 -1.108 . . . . 0.0 110.112 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.63 141.45 48.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.492 -0.755 . . . . 0.0 109.391 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 19.2 tt0 -77.95 -44.71 2.34 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.213 -0.929 . . . . 0.0 110.181 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.0 Cg_endo -78.68 -64.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 122.0 1.8 . . . . 0.0 110.439 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.711 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 9.2 m80 -73.86 57.14 0.59 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.22 -0.925 . . . . 0.0 109.315 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 16.8 ttt85 -102.91 -8.6 20.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.564 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -88.66 22.9 18.76 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.92 -129.62 0.14 Allowed 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.313 -1.11 . . . . 0.0 108.692 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -127.74 36.95 2.42 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.524 ' CE ' ' HB3' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -80.61 70.29 7.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.121 -1.223 . . . . 0.0 109.602 179.784 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 53.0 t -140.97 113.24 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.212 -0.93 . . . . 0.0 109.626 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.535 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -114.77 172.12 14.07 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.457 ' HB3' ' O ' ' A' ' 85' ' ' TYR . 6.7 mttm -148.88 128.54 13.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -1.151 . . . . 0.0 109.648 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.565 HG22 ' CD1' ' A' ' 85' ' ' TYR . 0.8 OUTLIER -80.27 154.96 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.885 . . . . 0.0 108.971 179.676 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.458 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 0.7 OUTLIER -129.26 90.17 2.97 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.259 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.532 HG21 ' CD1' ' A' ' 23' ' ' ILE . 28.0 t -99.89 121.81 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.259 -0.9 . . . . 0.0 109.835 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -105.7 -152.31 0.47 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.398 -0.814 . . . . 0.0 109.392 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 CA-C-O 117.984 -1.453 . . . . 0.0 109.511 179.952 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.49 128.46 49.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.884 . . . . 0.0 109.344 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.466 ' O ' ' N ' ' A' ' 30' ' ' GLU . 43.1 m-85 -89.37 116.7 27.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -0.917 . . . . 0.0 109.615 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.6 m -118.42 120.57 37.96 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.319 -0.863 . . . . 0.0 109.3 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.461 HG11 ' HD2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -107.93 102.66 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 109.387 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 7' ' ' LEU . 2.4 ttmt -80.68 83.89 6.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.325 -0.859 . . . . 0.0 109.464 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.522 ' CG ' ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -47.42 173.23 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.356 -0.84 . . . . 0.0 109.677 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.52 ' HA3' ' CB ' ' A' ' 34' ' ' ASN . . . 83.34 94.4 0.61 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.472 ' OG ' ' N ' ' A' ' 10' ' ' ASP . 95.0 p -49.92 -75.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.289 -1.124 . . . . 0.0 109.536 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.472 ' N ' ' OG ' ' A' ' 9' ' ' SER . 20.9 t0 -173.16 -71.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.567 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.17 55.51 1.85 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.277 -0.889 . . . . 0.0 109.385 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.77 -95.23 0.1 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -113.42 166.24 11.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.297 -1.12 . . . . 0.0 109.46 179.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.605 ' CD1' ' CD2' ' A' ' 92' ' ' HIS . 17.2 mt -101.69 123.65 46.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.213 -0.929 . . . . 0.0 109.392 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.458 HG12 ' O ' ' A' ' 14' ' ' LEU . 22.2 m -143.98 159.08 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.615 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -71.92 164.32 26.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 109.376 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -154.24 104.59 2.41 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 109.419 -179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.461 ' HD2' HG11 ' A' ' 5' ' ' VAL . 33.5 Cg_endo -77.09 169.22 74.89 Favored 'Cis proline' 0 C--N 1.311 -1.441 0 C-N-CA 123.693 -1.378 . . . . 0.0 110.448 0.328 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.79 -25.41 62.0 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.232 -0.918 . . . . 0.0 109.738 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.438 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 10.6 mmtm -112.62 160.4 17.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.113 -0.992 . . . . 0.0 109.832 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.448 HD11 HG13 ' A' ' 5' ' ' VAL . 7.0 mt -143.72 108.75 4.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -0.866 . . . . 0.0 109.291 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.497 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 5.3 m -89.05 90.32 8.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.277 -0.889 . . . . 0.0 109.752 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.521 HD13 ' CG2' ' A' ' 103' ' ' VAL . 1.2 pt -101.35 171.67 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.24 -0.912 . . . . 0.0 109.685 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.63 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 7.8 mttt -86.83 -164.23 0.06 OUTLIER Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.63 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 30.8 Cg_endo -74.95 62.35 5.8 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 N-CA-C 109.314 -1.072 . . . . 0.0 109.314 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.535 ' O ' ' HB2' ' A' ' 76' ' ' PHE . . . 142.52 -92.19 0.17 Allowed Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.431 ' CG ' ' HG3' ' A' ' 24' ' ' LYS . 1.3 m-20 49.61 -176.2 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.119 -1.224 . . . . 0.0 109.55 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.513 ' CG2' ' OG ' ' A' ' 73' ' ' SER . 64.0 m -122.68 142.49 50.62 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.309 -0.869 . . . . 0.0 109.523 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.555 ' HB ' ' CZ ' ' A' ' 31' ' ' PHE . 2.4 t -125.13 148.79 29.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.289 -0.882 . . . . 0.0 109.307 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 3' ' ' TYR . 1.9 mt-10 -127.27 132.61 50.3 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.197 -0.939 . . . . 0.0 109.746 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.578 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -138.1 105.01 5.38 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.77 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.542 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -100.33 -171.47 2.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.066 -1.021 . . . . 0.0 111.026 -178.654 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.464 ' C ' ' OD1' ' A' ' 33' ' ' ASN . 3.2 p-10 -105.55 168.33 9.16 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.706 -0.621 . . . . 0.0 109.725 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.52 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . 30.2 t30 -114.64 -142.05 0.38 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.295 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.416 ' O ' HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -99.36 36.11 1.81 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.997 -1.064 . . . . 0.0 109.241 179.76 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.527 ' O ' ' NE2' ' A' ' 92' ' ' HIS . 2.1 t -151.46 61.95 4.64 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.573 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.2 Cg_endo -77.42 175.63 11.06 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.694 2.263 . . . . 0.0 110.955 -178.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.573 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 40.5 Cg_endo -87.87 158.51 44.81 Favored 'Cis proline' 0 C--N 1.313 -1.338 0 C-N-CA 123.573 -1.428 . . . . 0.0 110.74 -1.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.712 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 80.6 m-70 -121.99 160.88 23.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.382 -0.824 . . . . 0.0 109.858 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.74 165.8 26.31 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.4 -0.813 . . . . 0.0 108.847 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.556 ' HB ' ' CD2' ' A' ' 61' ' ' HIS . 43.3 t -137.45 114.65 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.113 -0.992 . . . . 0.0 109.144 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.521 HG12 ' CB ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -144.37 174.74 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.244 -0.91 . . . . 0.0 109.518 -179.443 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.592 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 4.2 m-85 -131.33 112.24 12.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 0.0 109.392 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.497 ' CB ' HD11 ' A' ' 47' ' ' LEU . 8.0 t70 -54.0 136.49 41.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 109.633 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.87 -2.67 58.71 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.261 -0.9 . . . . 0.0 109.648 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . 0.434 ' O ' ' HG ' ' A' ' 47' ' ' LEU . . . -107.75 13.82 26.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.181 -0.949 . . . . 0.0 109.645 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.497 HD11 ' CB ' ' A' ' 44' ' ' ASP . 1.5 mt -140.32 46.66 1.81 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 0.0 109.424 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.489 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 1.2 p30 -123.86 165.75 22.18 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.321 -0.862 . . . . 0.0 109.287 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.489 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 33.5 Cg_endo -76.02 -23.71 11.93 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.437 2.092 . . . . 0.0 109.689 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 52' ' ' SER . . . -140.17 83.9 1.94 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -40.06 95.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.462 -0.774 . . . . 0.0 109.986 -179.369 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 50' ' ' ALA . 4.5 m -138.31 107.26 5.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.391 -0.818 . . . . 0.0 109.159 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.89 -0.85 17.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 109.719 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -75.79 -53.69 8.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.906 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.463 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 2.1 pp -63.28 -29.84 71.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.158 -0.964 . . . . 0.0 109.591 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.459 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -73.45 -37.97 65.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 0.0 109.631 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.1 mttp -52.4 -30.35 28.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -0.947 . . . . 0.0 109.714 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.3 p -115.6 38.36 3.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -0.908 . . . . 0.0 109.507 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.599 HD23 ' CZ ' ' A' ' 76' ' ' PHE . 7.3 tp -135.64 -48.64 0.7 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -0.881 . . . . 0.0 109.29 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.521 ' CB ' HG12 ' A' ' 42' ' ' VAL . 1.2 p -78.88 122.16 25.75 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.478 -0.764 . . . . 0.0 110.289 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.556 ' CD2' ' HB ' ' A' ' 41' ' ' VAL . 4.4 p80 -90.71 159.32 16.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.367 -0.833 . . . . 0.0 108.974 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.48 -161.66 0.76 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.133 -0.979 . . . . 0.0 109.654 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 66.9 106.92 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.412 -0.805 . . . . 0.0 109.609 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.408 HD23 ' CG ' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -54.31 143.33 23.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 109.609 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.503 ' CD1' ' O ' ' A' ' 39' ' ' HIS . 1.1 mt -89.01 87.24 7.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.361 -0.837 . . . . 0.0 109.151 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' MET . . . . . 0.525 ' HG3' ' N ' ' A' ' 67' ' ' SER . 0.0 OUTLIER -85.4 -24.61 27.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.108 -0.995 . . . . 0.0 109.954 -179.636 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.525 ' N ' ' HG3' ' A' ' 66' ' ' MET . 1.9 t -79.98 147.66 66.35 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.288 -0.883 . . . . 0.0 109.425 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.86 100.37 1.37 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.572 2.181 . . . . 0.0 110.156 179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.71 -25.84 17.9 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.43 ' HB2' ' OG ' ' A' ' 67' ' ' SER . 50.9 tt0 -62.52 110.79 1.8 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.14 -1.212 . . . . 0.0 108.532 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.536 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . 12.0 p -132.8 -155.03 0.65 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.138 -0.976 . . . . 0.0 110.934 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.7 m -152.05 116.66 5.08 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.513 ' OG ' ' CG2' ' A' ' 28' ' ' THR . 13.7 t -79.05 104.26 9.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -0.961 . . . . 0.0 108.966 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.525 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 91.6 m -73.27 109.07 6.52 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.408 -0.808 . . . . 0.0 109.956 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.474 ' O ' ' C ' ' A' ' 76' ' ' PHE . 3.3 t -79.39 80.42 5.76 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.599 ' CZ ' HD23 ' A' ' 59' ' ' LEU . 10.3 m-85 -36.24 151.97 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.819 -0.551 . . . . 0.0 110.162 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.38 171.01 17.59 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.799 2.332 . . . . 0.0 111.016 -179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -86.37 9.44 17.99 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 80' ' ' ALA . 1.0 OUTLIER -101.51 -8.73 21.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.455 -0.778 . . . . 0.0 109.477 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.461 ' C ' ' O ' ' A' ' 79' ' ' ASP . . . -38.2 105.28 0.32 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.559 -0.713 . . . . 0.0 109.66 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.426 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 35.3 Cg_endo -77.34 146.51 24.92 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.501 2.134 . . . . 0.0 110.747 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.59 132.1 50.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.297 -0.877 . . . . 0.0 109.513 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 145.9 161.9 9.43 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.421 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 3.8 mt-10 -85.24 131.91 34.35 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.214 -1.168 . . . . 0.0 109.562 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.57 ' CD1' HG23 ' A' ' 101' ' ' ILE . 29.0 m-85 -84.44 -156.12 0.22 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.449 ' OG1' ' O ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -163.88 87.04 0.5 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.685 -1.26 . . . . 0.0 110.551 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.459 ' O ' HG21 ' A' ' 98' ' ' VAL . 1.1 p90 -99.92 160.97 13.9 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.508 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 9.5 p90 -159.22 -163.11 1.15 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.919 -1.113 . . . . 0.0 110.396 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.439 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 0.1 OUTLIER -123.49 133.64 54.0 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.513 -0.742 . . . . 0.0 109.775 -179.615 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.631 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.7 tm-20 -74.16 -43.01 5.87 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.336 -0.853 . . . . 0.0 110.669 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.1 Cg_endo -77.63 -54.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.902 1.735 . . . . 0.0 110.833 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.712 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 42.6 m80 -85.38 60.44 6.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.052 -1.03 . . . . 0.0 109.535 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.45 -4.26 53.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.909 . . . . 0.0 109.427 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.71 14.62 17.3 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 96' ' ' GLY . . . -120.37 33.13 5.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -1.136 . . . . 0.0 109.376 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 95' ' ' ALA . . . 41.72 60.73 2.42 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.531 ' CE ' ' HB3' ' A' ' 14' ' ' LEU . 5.4 mtp -107.37 53.82 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.174 -1.192 . . . . 0.0 109.417 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.523 HG21 ' N ' ' A' ' 99' ' ' GLY . 1.4 p -139.44 143.82 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 109.694 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.523 ' N ' HG21 ' A' ' 98' ' ' VAL . . . -151.04 176.09 29.71 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.456 ' HB3' ' O ' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -127.29 141.89 51.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.178 -1.19 . . . . 0.0 109.716 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.57 HG23 ' CD1' ' A' ' 85' ' ' TYR . 0.0 OUTLIER -85.6 155.59 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.889 . . . . 0.0 109.014 179.749 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.497 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -115.46 98.35 6.68 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.157 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.522 ' CG1' ' HA ' ' A' ' 25' ' ' PRO . 53.7 t -99.24 78.71 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.258 -0.901 . . . . 0.0 109.572 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.19 136.53 57.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.342 -0.849 . . . . 0.0 109.399 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 CA-C-O 118.012 -1.438 . . . . 0.0 109.555 -179.93 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.4 HG21 ' HB ' ' A' ' 28' ' ' THR . 0.2 OUTLIER -127.13 131.67 50.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 109.501 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.531 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 6.6 m-85 -103.29 174.14 6.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.12 -0.987 . . . . 0.0 109.285 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.73 105.04 4.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.089 -1.007 . . . . 0.0 110.062 -179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.474 ' CG2' ' O ' ' A' ' 5' ' ' VAL . 20.5 m -93.71 65.84 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.218 -0.926 . . . . 0.0 109.131 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.473 ' HG3' HD12 ' A' ' 32' ' ' LEU . 1.5 ttmt -49.48 98.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 110.026 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -65.49 157.96 28.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.119 -0.988 . . . . 0.0 108.983 179.466 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.18 137.07 0.22 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.459 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 1.5 p -100.72 -68.99 0.79 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.149 -1.206 . . . . 0.0 109.686 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 1.6 p30 167.24 -49.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 109.856 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.27 24.75 6.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 109.69 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.463 ' O ' HD13 ' A' ' 13' ' ' LEU . . . -126.49 -116.5 2.06 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 13' ' ' LEU . 2.6 mm? -121.98 -169.1 1.82 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.309 -1.113 . . . . 0.0 109.254 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.639 ' CD1' ' CD2' ' A' ' 92' ' ' HIS . 47.5 mt -98.84 102.54 14.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.263 -0.898 . . . . 0.0 108.671 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.1 m -137.69 164.05 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 0.0 109.724 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.423 ' CD2' HG22 ' A' ' 5' ' ' VAL . 13.6 m-85 -80.07 137.25 36.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.372 -0.83 . . . . 0.0 109.205 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 34.5 mm-40 -126.13 105.64 25.28 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.202 -0.936 . . . . 0.0 109.551 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -78.25 169.51 72.79 Favored 'Cis proline' 0 C--N 1.312 -1.381 0 C-N-CA 123.817 -1.326 . . . . 0.0 110.557 0.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.42 -64.79 0.81 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.147 -0.971 . . . . 0.0 108.879 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.4 pttm -84.76 160.03 20.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.37 -0.832 . . . . 0.0 109.029 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.4 ' O ' ' N ' ' A' ' 102' ' ' THR . 0.3 OUTLIER -152.12 149.13 28.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.081 -1.012 . . . . 0.0 110.078 -179.809 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.8 m -111.79 119.44 38.62 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.516 ' CG1' HG23 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -132.43 175.74 10.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.143 -0.973 . . . . 0.0 110.029 -179.437 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.525 ' CG ' ' HD2' ' A' ' 25' ' ' PRO . 0.1 OUTLIER -91.69 175.99 3.07 Favored Pre-proline 0 C--N 1.303 -1.421 0 O-C-N 121.394 -0.816 . . . . 0.0 109.049 179.578 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.547 ' HA ' ' CB ' ' A' ' 80' ' ' ALA . 35.4 Cg_endo -77.26 92.17 1.14 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.331 2.021 . . . . 0.0 110.646 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 111.06 5.8 26.6 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.441 ' OD2' ' HB2' ' A' ' 24' ' ' LYS . 11.5 m-20 -66.4 -178.84 0.72 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.122 -1.222 . . . . 0.0 109.293 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.4 ' HB ' HG21 ' A' ' 2' ' ' THR . 3.6 m -115.38 129.28 56.54 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.349 -0.845 . . . . 0.0 109.549 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.574 ' HB ' ' CZ ' ' A' ' 31' ' ' PHE . 5.2 t -115.62 135.05 56.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.189 -0.944 . . . . 0.0 109.539 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -103.43 129.42 50.54 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.172 -0.955 . . . . 0.0 109.662 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.574 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -127.17 83.56 2.18 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.58 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.4 OUTLIER -96.11 157.56 15.84 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.757 0.789 . . . . 0.0 110.726 -178.198 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.546 ' C ' ' OD1' ' A' ' 33' ' ' ASN . 4.5 p30 -77.47 171.42 14.92 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.703 0.763 . . . . 0.0 110.895 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -150.04 -37.46 0.15 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.472 ' O ' ' HD3' ' A' ' 37' ' ' PRO . 1.9 tttt -99.4 -144.32 0.33 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.444 -0.785 . . . . 0.0 109.461 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -68.74 113.14 13.99 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.527 -0.733 . . . . 0.0 110.781 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.55 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 37.8 Cg_endo -84.13 178.41 5.29 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.999 2.466 . . . . 0.0 109.776 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.55 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 39.7 Cg_endo -88.5 168.19 37.51 Favored 'Cis proline' 0 C--N 1.314 -1.276 0 O-C-N 123.391 1.206 . . . . 0.0 109.849 -2.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.66 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 81.6 m-70 -122.89 143.47 49.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.066 -1.022 . . . . 0.0 109.999 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -103.84 144.08 31.98 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.359 -0.838 . . . . 0.0 108.983 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.451 ' HB ' ' NE2' ' A' ' 61' ' ' HIS . 54.5 t -119.17 124.48 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -0.969 . . . . 0.0 109.927 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.483 HG11 ' OG ' ' A' ' 60' ' ' SER . 1.4 t -150.24 167.31 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.389 -0.82 . . . . 0.0 108.987 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.603 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 7.0 m-85 -118.5 119.69 35.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.138 -0.976 . . . . 0.0 109.809 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.433 ' HB3' ' HB2' ' A' ' 47' ' ' LEU . 17.8 t0 -41.98 148.17 0.19 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.442 -0.786 . . . . 0.0 110.028 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.16 -14.46 17.73 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.359 -0.838 . . . . 0.0 109.234 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -99.91 0.32 41.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.37 -0.831 . . . . 0.0 109.544 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.433 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 1.6 mm? -117.81 46.65 1.71 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.173 -0.954 . . . . 0.0 109.215 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.459 ' OD1' ' HA ' ' A' ' 51' ' ' LYS . 1.2 p30 -105.42 162.38 19.89 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.343 -0.848 . . . . 0.0 109.488 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.437 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 36.3 Cg_endo -77.88 -31.62 3.04 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.765 2.31 . . . . 0.0 110.907 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.476 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -122.5 31.26 6.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.102 -0.999 . . . . 0.0 110.047 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.476 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.1 OUTLIER 35.32 36.79 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.88 -0.512 . . . . 0.0 110.479 179.492 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 50' ' ' ALA . 2.4 m -101.12 143.1 31.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.083 -1.011 . . . . 0.0 109.926 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -92.5 54.78 2.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.898 . . . . 0.0 109.523 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -140.63 23.22 2.3 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.2 -0.937 . . . . 0.0 109.563 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -118.44 9.59 12.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.246 -0.909 . . . . 0.0 109.531 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -142.9 -47.12 0.31 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.405 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -48.07 -25.22 1.34 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 0.0 109.344 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.8 t -118.4 -20.19 8.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.22 -0.925 . . . . 0.0 109.36 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.58 HD23 ' CE2' ' A' ' 43' ' ' PHE . 9.9 tp -79.29 -37.93 36.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 0.0 109.226 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.483 ' OG ' HG11 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -78.9 132.14 36.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.282 -0.886 . . . . 0.0 109.633 -179.735 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.451 ' NE2' ' HB ' ' A' ' 41' ' ' VAL . 12.5 p80 -83.84 -9.55 58.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.455 -0.778 . . . . 0.0 109.605 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 0.1 OUTLIER 54.65 -170.78 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 109.709 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.487 ' CB ' ' O ' ' A' ' 62' ' ' LYS . 4.0 tt0 75.45 -179.75 0.17 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.336 -0.852 . . . . 0.0 109.687 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.444 ' N ' ' CD1' ' A' ' 64' ' ' LEU . 4.4 mp -118.52 155.75 30.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.299 -0.875 . . . . 0.0 109.473 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.458 ' N ' ' CD1' ' A' ' 65' ' ' LEU . 4.6 mp -84.09 -175.32 5.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.911 . . . . 0.0 109.482 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -160.74 -37.35 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.15 -0.969 . . . . 0.0 109.904 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.523 ' HB3' ' CB ' ' A' ' 70' ' ' GLN . 5.5 t -83.71 147.11 51.23 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.149 -0.97 . . . . 0.0 109.901 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.45 ' HD2' ' OG ' ' A' ' 67' ' ' SER . 36.0 Cg_endo -79.08 92.18 1.16 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.817 2.345 . . . . 0.0 110.398 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.488 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 103.71 6.04 44.14 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.523 ' CB ' ' HB3' ' A' ' 67' ' ' SER . 1.2 tt0 -124.91 102.78 7.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -1.154 . . . . 0.0 109.093 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.58 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . 11.5 p -104.77 -104.27 0.31 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.339 -0.851 . . . . 0.0 110.132 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.407 HG22 ' N ' ' A' ' 73' ' ' SER . 15.9 m -159.97 149.58 18.03 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.407 ' N ' HG22 ' A' ' 72' ' ' THR . 2.9 p -97.34 103.76 15.72 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.037 -1.04 . . . . 0.0 109.424 -179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' THR . . . . . . . . . . . . . 94.1 m -76.8 103.27 6.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -0.889 . . . . 0.0 109.54 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 76' ' ' PHE . 23.2 m -79.06 92.58 5.01 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.57 ' CZ ' HD23 ' A' ' 59' ' ' LEU . 5.4 m-85 -43.01 165.13 0.11 Allowed Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.47 -0.769 . . . . 0.0 109.537 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.514 ' HD2' ' HB3' ' A' ' 76' ' ' PHE . 32.3 Cg_endo -73.84 174.03 13.0 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.466 2.111 . . . . 0.0 111.282 -178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.59 8.19 8.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.545 -0.722 . . . . 0.0 109.515 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.484 ' O ' ' C ' ' A' ' 80' ' ' ALA . 10.5 m-20 -99.43 -74.61 0.59 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.25 -0.907 . . . . 0.0 109.156 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.547 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . . . 34.84 69.7 1.02 Allowed Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.723 -0.61 . . . . 0.0 110.074 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.453 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 34.2 Cg_endo -75.91 158.29 38.68 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.533 2.156 . . . . 0.0 110.819 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.456 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -49.07 98.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.352 -0.842 . . . . 0.0 109.609 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . 0.569 ' O ' ' CE1' ' A' ' 85' ' ' TYR . . . -166.92 149.92 16.16 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -81.72 140.11 34.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.214 -1.168 . . . . 0.0 109.54 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.569 ' CE1' ' O ' ' A' ' 83' ' ' GLY . 66.5 m-85 -118.71 147.74 43.52 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.458 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 95.2 m -134.14 118.43 17.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.987 -1.07 . . . . 0.0 110.718 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.589 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.2 OUTLIER -110.44 171.35 7.51 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.403 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.462 ' HA ' ' O ' ' A' ' 97' ' ' MET . 14.1 p90 -158.94 -163.84 1.31 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.77 -1.206 . . . . 0.0 110.476 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.447 ' SG ' ' HD2' ' A' ' 91' ' ' PRO . 0.5 OUTLIER -126.25 145.29 50.46 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.578 -0.701 . . . . 0.0 109.408 -179.623 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.627 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 24.2 tp10 -82.97 -42.81 0.87 Allowed Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 121.254 -0.904 . . . . 0.0 110.599 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.3 Cg_endo -78.1 -75.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 121.946 1.764 . . . . 0.0 110.82 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.66 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 13.4 m80 -65.5 69.18 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.056 -1.028 . . . . 0.0 109.531 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.491 ' N ' ' O ' ' A' ' 91' ' ' PRO . 10.8 tpt180 -90.72 -14.94 31.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.138 -0.976 . . . . 0.0 109.179 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.57 1.64 87.22 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.442 ' CB ' ' HB2' ' A' ' 14' ' ' LEU . . . -114.14 33.42 5.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -1.163 . . . . 0.0 109.487 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.494 ' O ' ' N ' ' A' ' 98' ' ' VAL . . . 40.16 36.6 0.92 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.487 ' SD ' ' HB3' ' A' ' 14' ' ' LEU . 4.0 mtp -65.35 72.85 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.036 -1.273 . . . . 0.0 109.177 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 96' ' ' GLY . 98.5 t -132.7 112.23 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 109.732 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.589 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -100.31 -174.92 30.08 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.519 ' N ' ' CZ ' ' A' ' 87' ' ' PHE . 22.4 mtpt -158.12 144.92 17.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.052 -1.263 . . . . 0.0 109.977 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.516 HG23 ' CG1' ' A' ' 23' ' ' ILE . 0.4 OUTLIER -110.73 135.88 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 108.677 179.446 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 21' ' ' LEU . 3.1 m -114.11 95.29 5.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.271 -0.893 . . . . 0.0 109.1 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.487 HG21 ' CE1' ' A' ' 85' ' ' TYR . 2.3 t -99.87 124.71 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.277 -0.89 . . . . 0.0 109.805 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.25 -147.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 109.252 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.407 ' OXT' ' HG3' ' A' ' 25' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.295 0 CA-C-O 117.995 -1.447 . . . . 0.0 109.538 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . 0.434 ' OE2' ' NZ ' ' A' ' 24' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.47 127.3 48.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.501 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -84.45 169.05 14.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 0.0 109.154 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.6 m -160.18 122.2 3.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.108 -0.995 . . . . 0.0 109.776 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.524 ' O ' ' CD2' ' A' ' 32' ' ' LEU . 0.6 OUTLIER -106.13 -155.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 109.001 179.446 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.423 ' HG3' HD12 ' A' ' 32' ' ' LEU . 10.5 tttt -175.22 127.93 0.27 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.33 -0.856 . . . . 0.0 109.507 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.541 ' N ' HD22 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -100.56 93.89 5.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 0.0 109.156 179.775 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.537 ' HA3' ' CB ' ' A' ' 34' ' ' ASN . . . 152.07 70.14 0.01 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 8' ' ' GLY . 1.4 p -46.56 150.39 0.68 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.192 -1.181 . . . . 0.0 109.021 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -88.28 36.9 0.79 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.228 -0.92 . . . . 0.0 109.625 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.5 mtmm -122.37 -29.24 4.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 109.406 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.411 ' O ' ' HG ' ' A' ' 13' ' ' LEU . . . 137.91 46.02 0.08 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' A' ' 12' ' ' GLY . 1.9 mt -164.3 172.68 13.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.224 -1.162 . . . . 0.0 109.626 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.55 ' HB3' ' CE ' ' A' ' 97' ' ' MET . 88.1 mt -118.8 97.09 5.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 109.841 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.434 HG13 ' C ' ' A' ' 14' ' ' LEU . 33.2 m -140.95 154.68 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.294 -0.878 . . . . 0.0 109.398 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.462 ' HB3' HG13 ' A' ' 5' ' ' VAL . 61.7 m-85 -62.93 160.47 14.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.124 -0.985 . . . . 0.0 109.113 179.733 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 0.6 OUTLIER -134.15 103.55 11.65 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.933 . . . . 0.0 109.651 -179.915 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.451 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.3 Cg_endo -77.53 -163.59 3.44 Favored 'Cis proline' 0 C--N 1.311 -1.397 0 C-N-CA 123.633 -1.403 . . . . 0.0 110.499 0.122 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.85 -36.12 70.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.267 -0.896 . . . . 0.0 109.593 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -116.14 168.84 9.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 0.0 109.399 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.466 ' O ' ' N ' ' A' ' 102' ' ' THR . 2.7 tp -149.75 147.75 28.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.219 -0.926 . . . . 0.0 109.527 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.47 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 30.7 m -115.22 100.35 8.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 109.464 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.53 ' CD1' HD12 ' A' ' 101' ' ' ILE . 2.3 pt -100.45 178.53 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.255 -0.903 . . . . 0.0 109.739 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.593 ' CB ' ' CD ' ' A' ' 25' ' ' PRO . 0.2 OUTLIER -95.57 -174.4 0.39 Allowed Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.536 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.593 ' CD ' ' CB ' ' A' ' 24' ' ' LYS . 35.7 Cg_endo -80.21 70.42 7.53 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.934 1.756 . . . . 0.0 110.694 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 111.08 48.31 0.72 Allowed Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.194 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.481 ' OD1' ' HB2' ' A' ' 24' ' ' LYS . 0.9 OUTLIER -108.16 -164.98 1.0 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.398 -1.06 . . . . 0.0 108.759 178.846 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 95.8 m -115.71 145.69 42.53 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.034 -1.041 . . . . 0.0 110.333 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.583 ' HB ' ' CZ ' ' A' ' 31' ' ' PHE . 1.9 t -127.28 121.88 58.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 25.6 mt-10 -99.53 103.3 15.03 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.085 -1.01 . . . . 0.0 110.836 -178.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.583 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.4 OUTLIER -93.49 152.13 19.27 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.546 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.56 ' CD2' ' N ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -141.61 169.15 18.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.689 -1.257 . . . . 0.0 110.808 -179.37 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.516 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 6.7 p-10 -97.51 160.23 14.45 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.628 -0.67 . . . . 0.0 109.202 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.537 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . 51.9 t30 -110.07 -78.87 0.59 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.907 -1.121 . . . . 0.0 109.748 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.496 ' C ' ' CG2' ' A' ' 36' ' ' VAL . 5.7 tptt -151.25 34.71 0.58 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.026 -1.046 . . . . 0.0 109.886 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.588 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 0.9 OUTLIER -156.39 56.34 1.22 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.28 -0.887 . . . . 0.0 109.65 179.298 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.588 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 36.3 Cg_endo -78.59 176.37 9.96 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.697 2.265 . . . . 0.0 110.669 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.577 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.2 Cg_endo -86.13 162.23 56.26 Favored 'Cis proline' 0 C--N 1.312 -1.392 0 O-C-N 123.753 1.396 . . . . 0.0 110.416 -1.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.726 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 73.3 m-70 -122.28 140.73 52.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 110.215 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.469 ' HB2' ' HD3' ' A' ' 91' ' ' PRO . 1.2 m120 -115.15 134.76 54.87 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.542 ' HB ' ' CD2' ' A' ' 61' ' ' HIS . 35.5 t -100.82 135.07 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.105 -0.997 . . . . 0.0 110.03 -179.179 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.532 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 2.5 t -149.22 171.1 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.376 -0.828 . . . . 0.0 109.477 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.64 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 1.6 m-85 -139.21 115.33 10.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.144 -0.973 . . . . 0.0 109.668 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -47.59 142.8 4.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.179 -0.951 . . . . 0.0 109.132 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.22 19.98 16.6 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.187 -0.945 . . . . 0.0 109.819 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -108.35 -40.17 5.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.207 -0.933 . . . . 0.0 109.561 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.447 ' N ' ' CD1' ' A' ' 47' ' ' LEU . 10.2 mp -87.17 55.9 3.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.922 . . . . 0.0 109.611 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.498 ' O ' ' NZ ' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -102.53 165.76 13.2 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.331 -0.856 . . . . 0.0 109.47 179.71 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 34.9 Cg_endo -77.78 -33.07 2.4 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.638 2.225 . . . . 0.0 110.807 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -124.06 30.72 6.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.037 -1.039 . . . . 0.0 109.719 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.498 ' NZ ' ' O ' ' A' ' 48' ' ' ASN . 12.5 mmtm 39.45 31.46 0.07 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.71 -0.619 . . . . 0.0 109.841 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 50' ' ' ALA . 28.8 m -101.62 125.01 48.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.68 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -100.35 97.53 8.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.353 -0.842 . . . . 0.0 109.368 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -163.49 -46.01 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.274 -0.891 . . . . 0.0 109.529 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 0.9 OUTLIER -68.4 -15.88 63.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.898 . . . . 0.0 109.381 -179.902 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.94 -50.5 8.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.252 -0.905 . . . . 0.0 109.637 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.29 -23.66 0.6 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.719 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.2 t -106.86 -3.52 20.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.062 -1.024 . . . . 0.0 109.902 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.61 ' CD2' ' CD2' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -95.12 -37.12 11.22 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.09 -1.006 . . . . 0.0 108.554 179.935 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.512 ' CB ' HG13 ' A' ' 42' ' ' VAL . 1.4 m -78.91 132.73 36.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.191 -0.943 . . . . 0.0 110.383 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.592 ' CD2' ' HB ' ' A' ' 72' ' ' THR . 18.9 p80 -109.61 138.49 45.89 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.46 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -127.74 119.42 25.74 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.009 -1.057 . . . . 0.0 110.114 -179.785 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.606 ' O ' ' O ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER 167.53 29.44 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.558 -0.714 . . . . 0.0 110.303 179.248 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.606 ' O ' ' O ' ' A' ' 63' ' ' GLN . 4.1 mt 47.66 123.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.734 0.778 . . . . 0.0 111.319 178.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 39' ' ' HIS . 6.3 mt -78.49 155.32 29.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.246 -1.534 . . . . 0.0 108.77 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 41.1 mtm -137.28 9.64 2.97 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -0.904 . . . . 0.0 109.595 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.417 ' HB3' ' O ' ' A' ' 70' ' ' GLN . 1.9 t -110.28 129.55 23.82 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 109.375 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.456 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.2 Cg_endo -79.18 93.31 1.1 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.362 2.041 . . . . 0.0 110.453 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.516 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 114.39 0.83 23.49 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.442 ' HG2' ' C ' ' A' ' 69' ' ' GLY . 32.5 mm-40 -144.43 112.94 6.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -1.112 . . . . 0.0 108.777 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.55 ' OG ' ' N ' ' A' ' 72' ' ' THR . 51.9 p -99.95 -80.28 0.48 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.001 -1.062 . . . . 0.0 109.671 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.592 ' HB ' ' CD2' ' A' ' 61' ' ' HIS . 4.3 m -160.33 107.8 1.61 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.077 -1.015 . . . . 0.0 109.474 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 29' ' ' VAL . 3.9 m -80.08 76.35 6.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -0.932 . . . . 0.0 109.154 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.517 ' CG2' HD13 ' A' ' 59' ' ' LEU . 1.0 OUTLIER -60.68 124.15 19.56 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.417 -0.802 . . . . 0.0 110.06 -179.61 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 76' ' ' PHE . 3.8 t -82.87 90.08 6.91 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.392 -0.818 . . . . 0.0 108.986 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.61 ' CD2' ' CD2' ' A' ' 59' ' ' LEU . 22.7 m-85 -41.41 157.11 0.2 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.464 -0.773 . . . . 0.0 109.693 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.513 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.6 Cg_endo -78.1 161.14 29.67 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.814 2.343 . . . . 0.0 111.031 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.09 5.4 8.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.22 -0.925 . . . . 0.0 110.023 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.468 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 2.0 p-10 -100.09 -11.04 20.85 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.001 -1.062 . . . . 0.0 109.616 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 79' ' ' ASP . . . -40.4 100.6 0.22 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.497 -0.752 . . . . 0.0 109.832 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.468 ' HG2' ' HG2' ' A' ' 49' ' ' PRO . 36.3 Cg_endo -78.54 -176.11 3.09 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.497 2.131 . . . . 0.0 110.442 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.72 123.33 27.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.355 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 169.1 148.28 5.74 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.437 ' O ' ' CG ' ' A' ' 84' ' ' GLU . 10.8 pt-20 -80.37 111.68 17.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.309 -1.112 . . . . 0.0 109.752 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.544 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 5.6 m-30 -86.5 98.04 10.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.934 . . . . 0.0 108.867 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 17.3 m -77.45 105.76 8.79 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.226 -0.921 . . . . 0.0 110.191 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.48 ' HB3' ' CD2' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -104.16 176.93 4.99 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.283 -0.886 . . . . 0.0 108.796 179.103 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.477 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 5.7 p90 -160.7 -147.7 0.15 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.014 -1.054 . . . . 0.0 109.722 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 93' ' ' ARG . 0.5 OUTLIER -130.93 159.02 38.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 109.746 -179.466 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.602 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.3 tt0 -91.79 -44.21 0.36 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.362 -0.836 . . . . 0.0 111.161 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.8 Cg_endo -80.58 -56.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.09 0 C-N-CA 122.117 1.878 . . . . 0.0 110.674 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.726 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 19.9 m80 -77.78 5.02 10.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.62 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . 0.494 ' HB2' ' O ' ' A' ' 89' ' ' CYS . 20.0 ttt-85 -43.26 120.0 1.74 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.17 -0.956 . . . . 0.0 109.37 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.73 11.07 33.72 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.7 39.26 3.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -1.163 . . . . 0.0 109.328 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.74 -0.16 66.44 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.55 ' CE ' ' HB3' ' A' ' 14' ' ' LEU . 0.1 OUTLIER -71.39 66.9 0.48 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.164 -1.198 . . . . 0.0 109.664 -179.865 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.0 t -135.25 120.0 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.189 -0.944 . . . . 0.0 109.444 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 86' ' ' THR . . . -133.77 -178.52 15.65 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.439 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 10.0 mttt -148.78 140.77 23.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -1.187 . . . . 0.0 109.669 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.53 HD12 ' CD1' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -96.88 133.73 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 109.111 179.718 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.47 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 0.5 OUTLIER -101.28 104.13 15.15 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.691 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.543 ' CG1' ' HA ' ' A' ' 25' ' ' PRO . 59.4 t -98.9 114.18 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.295 -0.878 . . . . 0.0 109.601 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 105' ' ' GLY . . . -88.04 120.72 29.67 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.347 -0.846 . . . . 0.0 109.31 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 104' ' ' ALA . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.26 0.552 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 49.2 m -133.7 127.16 32.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.304 -0.873 . . . . 0.0 109.559 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.44 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 16.1 m-85 -90.69 137.61 32.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.281 -0.887 . . . . 0.0 109.361 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.531 ' CG2' ' HB3' ' A' ' 30' ' ' GLU . 2.0 m -139.19 110.62 7.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.646 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.513 HG23 ' CE2' ' A' ' 16' ' ' PHE . 26.8 m -96.49 109.14 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.244 -0.91 . . . . 0.0 109.466 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -86.75 137.9 32.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -0.949 . . . . 0.0 109.43 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.516 ' N ' HD21 ' A' ' 7' ' ' LEU . 0.1 OUTLIER -98.47 80.27 2.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.0 109.1 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.468 ' O ' ' ND2' ' A' ' 34' ' ' ASN . . . 134.48 79.94 0.13 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 p -52.58 -88.59 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.251 -1.147 . . . . 0.0 109.563 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -172.38 37.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.555 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.21 20.37 6.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 109.435 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.436 ' HA2' ' CE ' ' A' ' 35' ' ' LYS . . . 73.02 37.41 56.3 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.441 ' O ' ' HA2' ' A' ' 8' ' ' GLY . 74.7 mt -139.89 139.38 36.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -1.121 . . . . 0.0 109.442 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.536 ' CD2' ' CE1' ' A' ' 39' ' ' HIS . 17.0 mt -101.25 114.31 28.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.204 -0.935 . . . . 0.0 109.561 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.442 ' CG1' ' O ' ' A' ' 14' ' ' LEU . 15.0 m -157.59 157.65 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 0.0 109.378 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.513 ' CE2' HG23 ' A' ' 5' ' ' VAL . 12.5 m-85 -81.82 147.09 29.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 109.614 -179.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 14.2 mm-40 -139.61 107.01 7.06 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.251 -0.905 . . . . 0.0 109.424 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.7 Cg_endo -78.1 176.19 44.15 Favored 'Cis proline' 0 C--N 1.312 -1.374 0 C-N-CA 123.761 -1.349 . . . . 0.0 110.675 0.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.07 -61.05 1.95 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.335 -0.853 . . . . 0.0 109.298 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.5 tttp -82.03 174.72 10.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.912 . . . . 0.0 109.198 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.507 HD11 ' CG1' ' A' ' 5' ' ' VAL . 5.2 tp -158.95 104.73 1.74 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.12 -0.988 . . . . 0.0 110.083 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . 0.449 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 32.1 m -87.01 90.09 8.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.188 -0.945 . . . . 0.0 108.477 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.531 HD11 ' CG2' ' A' ' 103' ' ' VAL . 1.0 OUTLIER -99.7 163.43 2.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.316 -0.865 . . . . 0.0 110.348 -178.999 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.567 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 14.1 mmtt -88.03 166.74 22.6 Favored Pre-proline 0 C--N 1.301 -1.526 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PRO . . . . . 0.567 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 31.4 Cg_endo -73.09 88.86 0.92 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.693 1.596 . . . . 0.0 110.017 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . 0.401 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 125.59 -3.13 8.15 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.485 ' OD2' ' CG ' ' A' ' 24' ' ' LYS . 62.6 m-20 -62.47 -168.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -1.145 . . . . 0.0 109.566 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.2 m -129.33 130.63 46.35 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.278 -0.889 . . . . 0.0 109.369 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.562 HG12 ' CE2' ' A' ' 31' ' ' PHE . 3.3 t -121.42 115.91 48.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.251 -0.905 . . . . 0.0 109.346 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.531 ' HB3' ' CG2' ' A' ' 4' ' ' THR . 2.0 mm-40 -99.58 132.92 44.6 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.27 -0.893 . . . . 0.0 109.635 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.6 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -131.7 94.41 3.51 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . 0.566 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.4 OUTLIER -96.58 179.68 4.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.343 -0.848 . . . . 0.0 110.663 -178.35 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASN . . . . . 0.545 ' ND2' ' HB3' ' A' ' 37' ' ' PRO . 1.7 p-10 -107.87 155.05 20.7 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.47 -0.768 . . . . 0.0 109.469 -178.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.468 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 53.2 t30 -151.19 -58.52 0.16 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.985 -1.072 . . . . 0.0 110.009 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.523 ' HB3' ' CD2' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -60.72 -147.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.27 -0.894 . . . . 0.0 109.124 -179.345 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.42 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 65.4 t -68.05 112.35 10.46 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.371 -0.831 . . . . 0.0 109.382 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.545 ' HB3' ' ND2' ' A' ' 33' ' ' ASN . 37.5 Cg_endo -82.01 175.33 9.32 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.807 2.338 . . . . 0.0 110.636 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.552 ' O ' ' CG ' ' A' ' 39' ' ' HIS . 37.8 Cg_endo -84.57 -156.09 1.13 Allowed 'Cis proline' 0 C--N 1.311 -1.404 0 C-N-CA 123.631 -1.404 . . . . 0.0 109.86 -1.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.592 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 86.0 m-70 -160.44 143.27 13.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.961 -1.087 . . . . 0.0 109.708 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.485 ' OD1' ' N ' ' A' ' 41' ' ' VAL . 63.7 t-20 -113.58 147.42 38.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.278 -0.889 . . . . 0.0 109.201 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.485 ' N ' ' OD1' ' A' ' 40' ' ' ASN . 18.8 t -128.6 118.58 47.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.277 -0.889 . . . . 0.0 109.182 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.46 ' CG1' ' HB3' ' A' ' 60' ' ' SER . 0.0 OUTLIER -153.04 175.59 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.294 -0.879 . . . . 0.0 109.379 -179.804 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.65 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -130.03 135.0 47.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.941 . . . . 0.0 109.538 -179.471 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -59.6 130.49 47.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 109.353 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.87 1.99 32.44 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.245 -0.909 . . . . 0.0 109.904 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.64 5.73 36.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.611 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 mp -131.21 57.1 1.77 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.137 -0.977 . . . . 0.0 109.672 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -114.44 156.18 44.87 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.274 179.744 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.444 ' HG2' ' HG2' ' A' ' 81' ' ' PRO . 36.2 Cg_endo -79.38 -40.36 0.26 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.67 2.247 . . . . 0.0 110.907 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ALA . . . . . 0.501 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -106.5 28.9 7.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.07 -1.019 . . . . 0.0 109.788 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.501 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER 32.5 45.88 0.06 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.186 0.517 . . . . 0.0 110.316 179.652 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.2 m -100.56 111.93 24.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.17 -0.957 . . . . 0.0 109.783 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.76 -28.3 64.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.94 . . . . 0.0 108.982 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . 0.465 ' HA ' ' HB2' ' A' ' 57' ' ' LYS . 2.1 t0 -68.17 -23.85 64.9 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.375 -0.828 . . . . 0.0 109.435 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.431 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 17.8 tp -56.11 -61.09 2.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 109.532 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.465 ' HA ' ' HB3' ' A' ' 59' ' ' LEU . . . -66.61 -23.98 66.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.649 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.465 ' HB2' ' HA ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -45.65 -64.58 0.7 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 109.52 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.98 -23.07 36.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.0 109.538 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.597 HD22 ' CZ ' ' A' ' 76' ' ' PHE . 4.7 tp -72.65 -58.07 3.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 109.498 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . 0.46 ' HB3' ' CG1' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -79.67 133.52 36.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.306 -0.871 . . . . 0.0 110.021 -179.153 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.428 ' ND1' ' C ' ' A' ' 61' ' ' HIS . 16.2 p80 -107.34 149.98 27.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.384 -0.822 . . . . 0.0 108.941 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.428 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -99.59 174.5 6.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.096 -1.003 . . . . 0.0 109.461 -179.785 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . 0.428 ' CB ' ' O ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER 70.27 126.73 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.315 -0.866 . . . . 0.0 109.42 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.0 mp -70.67 163.97 25.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 109.528 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.9 mt -83.25 160.71 21.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 109.126 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -132.26 9.29 4.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.116 -0.99 . . . . 0.0 109.81 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.475 ' HB3' ' HB2' ' A' ' 70' ' ' GLN . 9.0 t -124.66 138.31 30.99 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.18 -0.95 . . . . 0.0 109.143 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.444 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.7 Cg_endo -79.3 105.72 1.93 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.538 2.159 . . . . 0.0 110.967 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 92.75 39.09 5.34 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLN . . . . . 0.475 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 9.3 mt-30 -153.11 82.04 1.2 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.232 -1.158 . . . . 0.0 109.177 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.6 ' CB ' ' O ' ' A' ' 31' ' ' PHE . 3.2 p -99.08 -169.21 1.73 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.164 -0.96 . . . . 0.0 109.457 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . 0.446 ' CG2' ' O ' ' A' ' 72' ' ' THR . 4.1 t -102.75 125.16 49.39 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.0 p -78.98 93.84 5.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.072 -1.018 . . . . 0.0 109.443 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' THR . . . . . 0.525 ' CG2' ' HA ' ' A' ' 59' ' ' LEU . 4.6 m -72.36 97.96 2.13 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.367 -0.833 . . . . 0.0 109.409 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.451 ' O ' ' C ' ' A' ' 76' ' ' PHE . 11.2 m -78.56 89.07 4.49 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.597 ' CZ ' HD22 ' A' ' 59' ' ' LEU . 9.9 m-85 -40.46 150.26 0.28 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.744 -0.598 . . . . 0.0 109.459 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' PRO . . . . . 0.401 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.8 Cg_endo -77.53 168.27 22.95 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.846 2.364 . . . . 0.0 111.434 -179.049 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.479 ' HA ' ' O ' ' A' ' 25' ' ' PRO . . . -83.46 5.45 23.75 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASP . . . . . 0.478 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 1.8 m-20 -99.19 -7.21 26.87 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.179 -0.951 . . . . 0.0 109.113 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.49 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . . . -38.59 99.11 0.18 Allowed Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.593 -0.692 . . . . 0.0 109.462 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 79' ' ' ASP . 34.8 Cg_endo -77.25 141.47 20.55 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.425 2.083 . . . . 0.0 110.629 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' A' ' 81' ' ' PRO . . . -43.5 132.01 4.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.409 -0.807 . . . . 0.0 109.358 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 158.29 148.78 5.27 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -89.46 117.7 28.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.154 -1.204 . . . . 0.0 109.893 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' TYR . . . . . 0.47 ' O ' ' HB3' ' A' ' 100' ' ' LYS . 60.9 m-85 -84.02 -166.69 1.49 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.244 -0.91 . . . . 0.0 108.934 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' THR . . . . . 0.465 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 39.2 m -166.59 105.72 0.62 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.897 -1.127 . . . . 0.0 110.836 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.575 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.4 OUTLIER -104.75 165.67 10.91 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.26 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' TYR . . . . . 0.426 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 29.7 p90 -157.22 -166.62 2.1 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.786 -1.197 . . . . 0.0 110.561 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' CYS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 97' ' ' MET . 0.5 OUTLIER -130.28 126.85 38.28 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.811 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.625 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 6.0 tp10 -67.94 -43.25 36.46 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.89 . . . . 0.0 111.514 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 34.4 Cg_endo -76.59 -53.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.968 1.779 . . . . 0.0 111.205 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.592 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 34.8 m80 -89.78 30.34 1.06 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.016 -1.052 . . . . 0.0 109.614 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.6 ttt-85 -60.26 91.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.283 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 137.74 -15.82 3.56 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 14' ' ' LEU . . . -91.32 37.19 0.94 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.353 -1.086 . . . . 0.0 109.493 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.08 23.02 72.84 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' MET . . . . . 0.5 ' CE ' ' HB2' ' A' ' 7' ' ' LEU . 0.8 OUTLIER -91.26 53.57 2.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.063 -1.257 . . . . 0.0 109.299 179.791 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.3 t -137.26 118.43 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 109.445 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.575 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -127.32 172.47 18.69 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.47 ' HB3' ' O ' ' A' ' 85' ' ' TYR . 35.7 mttt -145.84 135.86 23.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -1.141 . . . . 0.0 109.649 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.543 HD13 ' CE1' ' A' ' 76' ' ' PHE . 0.3 OUTLIER -87.36 140.69 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.957 . . . . 0.0 108.878 179.661 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.449 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 0.3 OUTLIER -115.77 95.55 5.18 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.331 -0.856 . . . . 0.0 108.883 179.305 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' VAL . . . . . 0.531 ' CG2' HD11 ' A' ' 23' ' ' ILE . 12.5 t -99.77 150.42 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.146 -0.971 . . . . 0.0 109.597 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.4 ' O ' ' HB1' ' A' ' 82' ' ' ALA . . . -89.67 -34.27 16.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.492 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 CA-C-O 117.983 -1.454 . . . . 0.0 109.49 179.973 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 28' ' ' THR . 11.9 t . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.265 0.555 . . . . 0.0 109.585 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.477 ' CD1' HG22 ' A' ' 23' ' ' ILE . 53.1 m-85 -93.88 153.75 18.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 0.0 109.28 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.508 HG23 ' O ' ' A' ' 30' ' ' GLU . 9.5 m -142.85 135.92 28.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 109.736 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.862 HG13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -117.39 100.33 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.239 -0.913 . . . . 0.0 109.338 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.563 ' HG2' HD11 ' A' ' 32' ' ' LEU . 8.6 tttt -69.46 79.21 0.4 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.257 -0.902 . . . . 0.0 109.497 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.774 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -52.33 136.55 30.81 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.193 -0.942 . . . . 0.0 109.243 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.419 ' HA2' HD23 ' A' ' 14' ' ' LEU . . . 101.54 115.56 3.95 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.51 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 97.4 p -69.86 -82.45 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -1.129 . . . . 0.0 109.608 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 11' ' ' LYS . 2.8 p30 163.45 -50.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.885 . . . . 0.0 109.049 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.515 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 4.0 mttt -120.59 -5.72 9.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.349 -0.845 . . . . 0.0 109.252 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -100.38 -103.78 2.59 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.65 -156.51 0.69 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -1.152 . . . . 0.0 109.562 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.637 ' CD1' ' CD2' ' A' ' 92' ' ' HIS . 30.9 mt -99.86 120.57 39.98 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.18 -0.95 . . . . 0.0 109.873 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 14' ' ' LEU . 16.1 m -160.53 126.68 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.921 . . . . 0.0 109.621 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.428 ' O ' ' O ' ' A' ' 15' ' ' VAL . 6.0 m-85 -44.47 165.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.055 -1.028 . . . . 0.0 109.301 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 22.9 mt-10 -148.16 104.62 3.58 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.195 -0.94 . . . . 0.0 109.405 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.2 Cg_endo -77.59 -176.03 17.92 Favored 'Cis proline' 0 C--N 1.311 -1.426 0 C-N-CA 123.736 -1.36 . . . . 0.0 110.563 0.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.12 -47.56 50.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.622 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.81 178.04 5.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 109.331 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.862 HD11 HG13 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -153.04 141.73 20.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.967 . . . . 0.0 109.87 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.2 m -120.21 115.3 23.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.336 -0.852 . . . . 0.0 109.213 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.663 HD12 ' O ' ' A' ' 24' ' ' LYS . 1.0 OUTLIER -132.36 -176.75 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.209 -0.932 . . . . 0.0 109.738 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.663 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -104.63 177.39 1.41 Allowed Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.188 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.562 ' HD2' ' CG ' ' A' ' 24' ' ' LYS . 34.3 Cg_endo -77.18 76.69 4.09 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.213 1.942 . . . . 0.0 110.349 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 132.6 -11.78 5.19 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 26' ' ' GLY . 9.2 m-20 -53.3 -176.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.165 -1.197 . . . . 0.0 109.407 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.533 HG23 ' HA ' ' A' ' 75' ' ' THR . 26.8 m -123.39 146.62 47.83 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.163 -0.96 . . . . 0.0 109.461 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.951 HG21 HD11 ' A' ' 101' ' ' ILE . 3.4 t -137.5 124.23 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.202 -0.937 . . . . 0.0 109.24 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.533 ' OE1' ' CA ' ' A' ' 73' ' ' SER . 21.8 tp10 -100.99 130.85 47.05 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.25 -0.906 . . . . 0.0 110.109 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.484 ' O ' ' OG ' ' A' ' 71' ' ' SER . 0.4 OUTLIER -113.59 151.27 31.89 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.032 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.774 ' O ' HD21 ' A' ' 7' ' ' LEU . 2.4 pp -142.09 -177.6 5.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.816 -1.178 . . . . 0.0 110.635 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.547 ' OD1' ' HA ' ' A' ' 68' ' ' PRO . 2.5 p-10 -116.55 152.96 33.05 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -101.5 -109.01 0.23 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.815 -1.178 . . . . 0.0 109.601 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.435 ' C ' ' CG2' ' A' ' 36' ' ' VAL . 0.9 OUTLIER -128.98 36.58 4.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.805 -1.185 . . . . 0.0 109.412 -179.824 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.555 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 2.5 t -153.02 61.98 4.0 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.502 -0.749 . . . . 0.0 109.141 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.564 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.9 Cg_endo -80.24 175.9 9.82 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.811 2.341 . . . . 0.0 110.55 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.658 ' CG ' HD13 ' A' ' 64' ' ' LEU . 38.3 Cg_endo -85.78 159.46 59.65 Favored 'Cis proline' 0 C--N 1.31 -1.449 0 C-N-CA 123.525 -1.448 . . . . 0.0 110.483 -1.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.715 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 74.6 m-70 -116.46 141.64 47.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.472 -0.767 . . . . 0.0 109.435 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -117.51 126.71 53.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 109.45 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.4 ' HB ' ' NE2' ' A' ' 61' ' ' HIS . 19.8 t -116.37 126.27 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -0.936 . . . . 0.0 109.445 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.797 HG12 ' CB ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -160.12 166.39 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.38 -0.825 . . . . 0.0 109.322 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.593 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -116.74 109.65 17.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 109.382 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -53.06 144.43 15.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.874 . . . . 0.0 109.682 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.57 19.21 3.47 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.183 -0.948 . . . . 0.0 109.479 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -121.31 -30.31 4.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.083 -1.011 . . . . 0.0 109.724 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.621 HD22 HG21 ' A' ' 86' ' ' THR . 6.2 mp -96.33 61.16 2.0 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.037 -1.039 . . . . 0.0 109.518 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.503 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 10.2 p30 -141.6 162.51 46.45 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.286 -0.884 . . . . 0.0 109.49 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 33.5 Cg_endo -75.6 -16.54 18.86 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.446 2.098 . . . . 0.0 109.904 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 52' ' ' SER . . . -133.54 68.55 1.49 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -40.37 92.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.607 -0.683 . . . . 0.0 109.987 -179.519 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 50' ' ' ALA . 19.5 m -140.71 -159.21 0.93 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.341 -0.849 . . . . 0.0 109.191 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -155.81 56.95 0.61 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.245 -0.909 . . . . 0.0 109.535 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -138.78 -60.99 0.58 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.219 -0.925 . . . . 0.0 109.378 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.467 ' HG ' ' N ' ' A' ' 56' ' ' ALA . 1.6 pp -54.28 -28.16 40.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.93 . . . . 0.0 109.044 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.467 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -72.41 -39.3 68.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.324 -0.86 . . . . 0.0 109.243 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 56' ' ' ALA . 65.9 tttt -44.3 -45.8 8.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.316 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -98.01 25.45 6.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.292 -0.88 . . . . 0.0 109.421 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.716 HD21 ' CE2' ' A' ' 76' ' ' PHE . 8.2 tp -127.0 -54.88 1.38 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.869 . . . . 0.0 109.267 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.797 ' CB ' HG12 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -78.49 147.24 33.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.307 -0.871 . . . . 0.0 110.082 -178.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.4 ' NE2' ' HB ' ' A' ' 41' ' ' VAL . 30.5 p80 -122.18 174.81 6.73 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -125.06 -160.2 0.94 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.196 -0.94 . . . . 0.0 109.226 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 65.87 135.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.202 -0.936 . . . . 0.0 109.802 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.658 HD13 ' CG ' ' A' ' 38' ' ' PRO . 6.6 mt -64.76 158.63 24.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.392 -0.818 . . . . 0.0 109.576 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.697 HD22 ' HB2' ' A' ' 39' ' ' HIS . 3.5 mp -79.31 87.26 5.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.079 -1.013 . . . . 0.0 109.155 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -83.32 4.59 26.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 109.759 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.473 ' OG ' ' HG2' ' A' ' 70' ' ' GLN . 12.0 t -102.81 115.79 63.65 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.144 -0.973 . . . . 0.0 109.009 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.547 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.4 Cg_endo -78.51 95.23 1.07 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.4 2.067 . . . . 0.0 111.004 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.504 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 127.45 -17.12 6.2 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.595 -1.288 . . . . 0.0 110.125 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.502 ' HA ' ' HB3' ' A' ' 32' ' ' LEU . 8.0 pt20 -149.99 149.69 30.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.111 -1.229 . . . . 0.0 109.602 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.597 ' HG ' ' H ' ' A' ' 72' ' ' THR . 81.1 p -120.01 -78.46 0.59 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.122 -0.986 . . . . 0.0 109.5 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.597 ' H ' ' HG ' ' A' ' 71' ' ' SER . 22.8 m -160.14 119.0 2.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.327 -0.858 . . . . 0.0 109.424 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.533 ' CA ' ' OE1' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -79.53 99.75 7.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.0 109.228 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.641 HG21 ' HG ' ' A' ' 59' ' ' LEU . 26.3 m -82.54 108.4 15.91 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.337 -0.852 . . . . 0.0 109.665 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.533 ' HA ' HG23 ' A' ' 28' ' ' THR . 0.0 OUTLIER -79.36 85.77 5.15 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.476 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.931 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 23.7 m-85 -40.45 137.02 1.37 Allowed Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.5 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 35.3 Cg_endo -77.74 174.49 12.52 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.605 2.203 . . . . 0.0 111.719 -178.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.29 4.03 11.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.583 -0.698 . . . . 0.0 109.211 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.466 ' O ' ' C ' ' A' ' 80' ' ' ALA . 0.5 OUTLIER -98.13 -10.77 23.66 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.24 -0.912 . . . . 0.0 108.591 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.502 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -39.95 110.88 0.68 Allowed Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -75.19 130.97 13.57 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.263 1.975 . . . . 0.0 110.68 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -56.42 162.03 2.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.463 -0.773 . . . . 0.0 109.374 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 125.92 -117.78 2.97 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -160.51 122.5 3.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -1.152 . . . . 0.0 109.718 -179.792 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.632 ' CD2' ' CG2' ' A' ' 101' ' ' ILE . 4.1 m-30 -85.88 -165.43 1.24 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.14 -0.975 . . . . 0.0 108.726 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.621 HG21 HD22 ' A' ' 47' ' ' LEU . 20.7 m -165.18 101.23 0.74 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.839 -1.163 . . . . 0.0 110.678 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.504 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -107.18 165.9 11.03 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.623 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.517 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 3.9 p90 -157.07 -171.41 3.63 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.823 -1.173 . . . . 0.0 110.442 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.58 143.76 47.46 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.56 -0.713 . . . . 0.0 109.332 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.617 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 31.5 tt0 -77.6 -45.14 2.54 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.323 -0.861 . . . . 0.0 109.846 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.3 Cg_endo -79.53 -65.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 122.008 1.805 . . . . 0.0 110.197 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.715 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 3.3 m80 -73.39 63.25 0.76 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 109.375 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.1 tpp85 -90.42 -26.91 19.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.332 -0.855 . . . . 0.0 109.174 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -95.33 35.53 4.24 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 14' ' ' LEU . . . -135.73 34.42 2.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -1.145 . . . . 0.0 109.573 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 48.45 25.44 4.45 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.575 ' HE3' ' HB3' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -78.53 54.42 1.46 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.066 -1.255 . . . . 0.0 109.354 179.742 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.1 t -125.74 104.24 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.442 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.93 174.76 22.69 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.434 ' HG2' ' HA ' ' A' ' 86' ' ' THR . 11.2 mttm -150.56 131.41 14.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -1.144 . . . . 0.0 109.788 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.951 HD11 HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -83.29 126.58 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 21' ' ' LEU . 3.5 m -104.25 102.26 11.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.183 -0.948 . . . . 0.0 109.443 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.651 HG13 ' C ' ' A' ' 24' ' ' LYS . 2.4 t -99.76 92.95 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.185 -0.947 . . . . 0.0 109.466 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.923 . . . . 0.0 109.561 -179.977 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 19.0 m-85 -112.3 150.51 30.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.237 -0.914 . . . . 0.0 109.536 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.595 HG23 ' HB3' ' A' ' 30' ' ' GLU . 45.3 m -145.58 114.06 6.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.894 . . . . 0.0 109.413 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.449 ' O ' HD23 ' A' ' 7' ' ' LEU . 4.4 m -91.77 80.99 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.187 -0.946 . . . . 0.0 109.58 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 5' ' ' VAL . 9.3 mtmt -44.26 110.51 0.22 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.157 -0.964 . . . . 0.0 109.393 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.539 ' HB2' ' CE ' ' A' ' 97' ' ' MET . 0.1 OUTLIER -91.14 83.94 5.62 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.224 -0.923 . . . . 0.0 109.362 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 14' ' ' LEU . . . 144.3 102.6 0.39 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.51 ' OG ' ' N ' ' A' ' 10' ' ' ASP . 89.8 p -50.47 -82.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -1.13 . . . . 0.0 109.492 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.51 ' N ' ' OG ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -176.88 -93.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.227 -0.921 . . . . 0.0 109.508 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -100.06 54.28 0.91 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.14 -0.975 . . . . 0.0 109.625 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.59 -82.38 0.04 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.464 HD12 ' HA ' ' A' ' 13' ' ' LEU . 5.6 tp -144.89 -159.32 0.98 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.395 -1.062 . . . . 0.0 109.134 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.748 HD11 ' HB ' ' A' ' 36' ' ' VAL . 49.8 mt -119.58 124.16 45.68 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.164 -0.96 . . . . 0.0 109.425 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.451 HG13 ' O ' ' A' ' 14' ' ' LEU . 25.6 m -156.63 155.44 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.869 . . . . 0.0 109.338 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 7' ' ' LEU . 6.2 m-85 -68.45 156.57 37.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.224 -0.922 . . . . 0.0 109.674 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 16.1 mt-10 -157.39 101.07 1.88 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.462 -0.774 . . . . 0.0 109.243 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 35.3 Cg_endo -77.9 179.8 29.71 Favored 'Cis proline' 0 C--N 1.311 -1.42 0 C-N-CA 123.67 -1.388 . . . . 0.0 110.584 0.183 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.17 -54.69 3.61 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.267 -0.896 . . . . 0.0 109.413 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.08 153.77 24.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -0.877 . . . . 0.0 109.495 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 1.009 HD23 HG23 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -158.48 108.12 2.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.091 -1.006 . . . . 0.0 110.046 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.9 m -91.14 102.82 15.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 108.836 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 1.009 HG23 HD23 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -103.24 -179.72 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.256 -0.903 . . . . 0.0 110.49 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.734 ' O ' HG13 ' A' ' 103' ' ' VAL . 5.3 mttm -94.5 -175.81 0.51 Allowed Pre-proline 0 N--CA 1.488 1.443 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.721 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 33.6 Cg_endo -78.48 76.52 4.41 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.002 1.801 . . . . 0.0 110.607 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 121.23 43.99 0.41 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.497 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 5.0 m-20 -94.11 -178.06 4.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.253 -1.145 . . . . 0.0 108.876 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.9 m -117.7 126.1 51.87 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.203 -0.936 . . . . 0.0 109.534 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.987 HG21 HD11 ' A' ' 101' ' ' ILE . 0.7 OUTLIER -119.44 134.14 63.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.284 -0.885 . . . . 0.0 109.398 -179.832 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.595 ' HB3' HG23 ' A' ' 4' ' ' THR . 4.6 tt0 -105.69 141.24 37.48 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.231 -0.918 . . . . 0.0 109.813 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.564 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -134.19 96.57 3.65 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.647 ' HA ' ' HB3' ' A' ' 71' ' ' SER . 0.5 OUTLIER -98.59 168.81 9.94 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.283 -0.886 . . . . 0.0 110.491 -178.965 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.548 ' HB2' ' CD2' ' A' ' 39' ' ' HIS . 3.5 p-10 -94.66 153.72 17.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.547 -0.721 . . . . 0.0 109.572 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.469 ' HB2' ' HA3' ' A' ' 8' ' ' GLY . 38.5 t30 -97.1 -129.63 0.17 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.027 -1.045 . . . . 0.0 108.915 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.438 ' C ' ' CG2' ' A' ' 36' ' ' VAL . 0.5 OUTLIER -108.86 36.55 2.83 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.757 -1.214 . . . . 0.0 109.364 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.748 ' HB ' HD11 ' A' ' 14' ' ' LEU . 4.3 t -154.96 67.89 5.35 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 109.421 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.536 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.5 Cg_endo -80.41 173.95 11.82 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.6 2.2 . . . . 0.0 110.788 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 39.1 Cg_endo -85.83 165.06 54.78 Favored 'Cis proline' 0 C--N 1.312 -1.378 0 C-N-CA 123.494 -1.461 . . . . 0.0 110.305 -1.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.709 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 57.4 m-70 -119.58 140.24 50.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.934 . . . . 0.0 109.762 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 1.3 t-20 -121.92 125.96 47.55 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.356 -0.84 . . . . 0.0 109.544 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.458 ' O ' HG22 ' A' ' 42' ' ' VAL . 24.8 t -114.13 134.22 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.92 . . . . 0.0 109.17 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.775 HG13 ' HB2' ' A' ' 60' ' ' SER . 0.2 OUTLIER -156.84 166.82 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.071 -1.018 . . . . 0.0 109.855 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.517 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 4.5 m-85 -119.39 112.04 18.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.836 . . . . 0.0 109.183 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' A' ' 47' ' ' LEU . 7.5 t70 -43.74 143.21 1.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.305 -0.872 . . . . 0.0 109.733 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.876 ' HB1' ' HB2' ' A' ' 53' ' ' ALA . . . -90.54 -3.43 57.6 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.39 -0.819 . . . . 0.0 109.737 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.36 9.56 21.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.621 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.512 HD22 ' HB ' ' A' ' 86' ' ' THR . 0.5 OUTLIER -122.29 39.35 3.92 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.135 -0.978 . . . . 0.0 109.735 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.523 ' OD1' ' CA ' ' A' ' 51' ' ' LYS . 0.6 OUTLIER -112.31 165.3 13.28 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 109.419 179.756 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.494 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 35.0 Cg_endo -76.59 -10.06 18.63 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.606 2.204 . . . . 0.0 110.826 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -125.0 26.18 7.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.11 -0.994 . . . . 0.0 109.493 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.523 ' CA ' ' OD1' ' A' ' 48' ' ' ASN . 0.6 OUTLIER 34.28 35.58 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.134 0.492 . . . . 0.0 110.325 179.66 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 50' ' ' ALA . 19.1 m -110.85 164.03 13.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.151 -0.968 . . . . 0.0 109.74 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.876 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . . . -132.51 45.8 2.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.305 -0.872 . . . . 0.0 109.295 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.41 ' C ' ' OD1' ' A' ' 54' ' ' ASP . 7.5 t0 -111.94 -56.4 2.39 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.311 -0.868 . . . . 0.0 109.58 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.679 ' C ' HD12 ' A' ' 55' ' ' LEU . 3.3 pp -55.34 -29.87 59.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.917 . . . . 0.0 109.556 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.44 ' N ' HD12 ' A' ' 55' ' ' LEU . . . -68.11 -43.5 78.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.62 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -57.7 -39.82 78.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.367 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.4 m -87.84 16.36 5.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.227 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.858 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 9.7 tp -122.93 -45.25 2.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.346 -0.846 . . . . 0.0 109.375 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.775 ' HB2' HG13 ' A' ' 42' ' ' VAL . 37.0 p -82.16 159.35 23.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.491 -0.756 . . . . 0.0 110.247 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.55 ' HB3' HG21 ' A' ' 72' ' ' THR . 20.7 p80 -110.38 174.53 5.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.563 -0.711 . . . . 0.0 109.496 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -121.25 -163.07 1.01 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.367 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 59.19 -165.82 0.18 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.916 . . . . 0.0 109.386 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.584 ' C ' HD12 ' A' ' 65' ' ' LEU . 4.5 mp -128.55 165.08 21.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 109.327 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.584 HD12 ' C ' ' A' ' 64' ' ' LEU . 7.4 mp -103.05 107.35 18.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.179 -0.95 . . . . 0.0 109.48 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -98.19 -18.83 18.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 0.0 109.443 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.523 ' CB ' ' HB2' ' A' ' 70' ' ' GLN . 46.0 t -85.67 142.91 37.53 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.915 . . . . 0.0 109.24 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.472 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.6 Cg_endo -79.14 107.06 2.15 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.81 2.34 . . . . 0.0 111.3 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.497 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 93.61 -18.35 56.65 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.523 ' HB2' ' CB ' ' A' ' 67' ' ' SER . 0.0 OUTLIER -80.2 103.15 9.88 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.063 -1.257 . . . . 0.0 109.266 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.647 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -124.62 -168.87 1.88 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.378 -0.826 . . . . 0.0 110.22 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.682 HG23 ' O ' ' A' ' 72' ' ' THR . 9.0 t -122.01 110.33 15.69 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.7 p -78.44 111.22 14.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 108.932 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.74 HG21 ' O ' ' A' ' 59' ' ' LEU . 1.7 m -88.03 108.96 19.48 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.475 -0.766 . . . . 0.0 109.846 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.791 HG23 ' O ' ' A' ' 75' ' ' THR . 10.2 t -78.86 94.73 5.24 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.858 ' CZ ' HD21 ' A' ' 59' ' ' LEU . 4.5 m-30 -39.79 160.03 0.11 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.698 -0.626 . . . . 0.0 109.693 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.534 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 33.8 Cg_endo -75.51 163.83 33.5 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.749 2.299 . . . . 0.0 111.417 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.31 1.65 7.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.379 -0.825 . . . . 0.0 110.294 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.495 ' O ' ' O ' ' A' ' 80' ' ' ALA . 0.7 OUTLIER -98.85 -61.41 1.37 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.005 -1.059 . . . . 0.0 109.065 179.766 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.721 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . 42.88 94.7 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.447 -0.783 . . . . 0.0 109.679 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.49 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 34.3 Cg_endo -75.7 121.64 6.43 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.312 2.008 . . . . 0.0 110.155 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -42.58 133.49 3.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.47 -0.769 . . . . 0.0 109.612 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 85' ' ' TYR . . . 160.57 158.29 9.18 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.38 125.45 29.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.196 -1.179 . . . . 0.0 109.747 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.571 ' O ' ' CD2' ' A' ' 87' ' ' PHE . 9.6 m-85 -100.71 70.76 1.44 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.512 ' HB ' HD22 ' A' ' 47' ' ' LEU . 57.0 m -62.83 97.53 0.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.42 -0.8 . . . . 0.0 110.464 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.571 ' CD2' ' O ' ' A' ' 85' ' ' TYR . 1.5 p90 -99.91 162.97 12.66 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.154 -0.966 . . . . 0.0 108.635 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 97' ' ' MET . 28.9 p90 -149.99 -173.97 4.58 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.98 -1.075 . . . . 0.0 109.954 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 0.1 OUTLIER -116.34 132.27 56.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.503 -0.748 . . . . 0.0 109.562 -179.651 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.612 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 25.8 tt0 -65.92 -45.0 63.97 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.207 -0.933 . . . . 0.0 109.975 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.5 Cg_endo -79.23 -45.37 0.11 Allowed 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 121.93 1.753 . . . . 0.0 110.18 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.709 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 4.7 m80 -106.84 67.25 0.7 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 109.316 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.74 133.99 37.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 109.521 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 82.27 -4.99 74.48 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 14' ' ' LEU . . . -93.43 39.08 1.05 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.213 -1.169 . . . . 0.0 109.503 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.422 ' HA3' HG12 ' A' ' 15' ' ' VAL . . . 79.84 -3.88 67.99 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.539 ' CE ' ' HB2' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -86.59 47.17 1.44 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.178 -1.189 . . . . 0.0 109.34 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.5 t -124.23 76.15 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 0.0 109.498 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.542 ' C ' ' CE1' ' A' ' 87' ' ' PHE . . . -96.92 162.94 22.17 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.466 ' HD2' ' OG1' ' A' ' 86' ' ' THR . 15.0 mtmt -139.38 135.15 33.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -1.138 . . . . 0.0 109.199 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.987 HD11 HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -84.01 139.08 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.169 -0.957 . . . . 0.0 109.462 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.58 99.43 7.95 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.734 HG13 ' O ' ' A' ' 24' ' ' LYS . 21.8 t -99.01 95.46 4.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.196 -0.94 . . . . 0.0 110.014 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.488 0 O-C-N 121.52 -0.737 . . . . 0.0 109.329 179.854 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.378 0.609 . . . . 0.0 109.832 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.528 ' CE1' HG22 ' A' ' 23' ' ' ILE . 10.6 m-85 -126.13 170.9 11.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.329 -0.857 . . . . 0.0 108.871 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 30' ' ' GLU . 87.1 m -157.46 116.94 3.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.07 -1.018 . . . . 0.0 110.167 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.643 HG12 ' CD1' ' A' ' 21' ' ' LEU . 10.4 m -98.57 170.78 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 121.345 -0.847 . . . . 0.0 109.032 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -143.56 87.2 1.92 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.06 -1.025 . . . . 0.0 109.874 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.633 ' HB2' ' HE1' ' A' ' 97' ' ' MET . 0.0 OUTLIER -50.86 100.12 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.183 -0.948 . . . . 0.0 109.254 179.63 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 14' ' ' LEU . . . 129.1 98.87 0.9 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 2.3 p -48.0 -95.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -1.161 . . . . 0.0 109.371 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 9' ' ' SER . 48.5 t0 176.86 33.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.946 . . . . 0.0 109.508 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.08 -43.05 0.64 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.159 -0.963 . . . . 0.0 109.603 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.13 44.29 0.02 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 13' ' ' LEU . 13.6 mt -151.32 160.94 43.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -1.141 . . . . 0.0 109.458 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.877 HD21 ' HB ' ' A' ' 36' ' ' VAL . 12.9 mt -120.48 103.21 8.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.308 -0.87 . . . . 0.0 109.501 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.412 HG12 ' HA3' ' A' ' 96' ' ' GLY . 26.7 m -149.8 138.6 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.718 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -56.49 153.73 9.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.15 -0.969 . . . . 0.0 108.85 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 4.6 mm-40 -143.51 103.61 5.02 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 120.995 -1.066 . . . . 0.0 109.81 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 35.6 Cg_endo -79.29 178.54 33.46 Favored 'Cis proline' 0 C--N 1.314 -1.286 0 C-N-CA 123.796 -1.335 . . . . 0.0 110.452 -0.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.03 -51.42 18.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.223 -0.923 . . . . 0.0 109.255 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? -99.15 146.45 26.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 0.0 109.237 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.643 ' CD1' HG12 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -140.46 142.36 35.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.113 -0.992 . . . . 0.0 109.826 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.452 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 32.1 m -106.52 126.22 51.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.344 -0.847 . . . . 0.0 109.096 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.846 ' CD1' HG22 ' A' ' 103' ' ' VAL . 1.0 OUTLIER -136.76 174.94 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.138 -0.976 . . . . 0.0 109.969 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.57 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -96.6 173.15 4.37 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.622 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 35.2 Cg_endo -77.58 91.66 1.17 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.346 2.03 . . . . 0.0 110.39 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 123.27 -11.35 8.6 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.501 ' OD1' ' CB ' ' A' ' 24' ' ' LYS . 5.8 m-20 -55.81 -178.69 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.287 -1.125 . . . . 0.0 109.096 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 97.3 m -124.09 140.99 52.44 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.205 -0.934 . . . . 0.0 109.43 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.977 HG21 HD11 ' A' ' 101' ' ' ILE . 1.3 t -130.93 119.28 44.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.278 -0.889 . . . . 0.0 109.364 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 4' ' ' THR . 30.9 tt0 -99.51 135.88 40.26 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.263 -0.898 . . . . 0.0 109.514 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.475 ' CD1' ' O ' ' A' ' 72' ' ' THR . 0.1 OUTLIER -127.28 152.0 48.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.126 -0.984 . . . . 0.0 108.856 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.551 ' HB3' ' N ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -140.49 -170.07 2.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.018 -1.052 . . . . 0.0 109.772 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.513 ' OD1' ' HA ' ' A' ' 68' ' ' PRO . 8.6 p-10 -114.05 169.81 8.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.429 -0.795 . . . . 0.0 109.002 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -110.02 -95.49 0.41 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.078 -1.014 . . . . 0.0 109.517 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.05 33.14 1.36 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.009 -1.057 . . . . 0.0 109.376 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.877 ' HB ' HD21 ' A' ' 14' ' ' LEU . 37.6 t -151.49 59.58 3.32 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.519 -0.738 . . . . 0.0 109.063 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 36.4 Cg_endo -77.66 173.43 14.16 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.744 2.296 . . . . 0.0 110.943 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.58 ' O ' ' CG ' ' A' ' 39' ' ' HIS . 37.5 Cg_endo -82.42 -158.57 1.69 Allowed 'Cis proline' 0 C--N 1.31 -1.467 0 C-N-CA 123.292 -1.545 . . . . 0.0 110.175 -0.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.58 ' CG ' ' O ' ' A' ' 38' ' ' PRO . 86.9 m-70 -160.85 129.52 4.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.238 -0.914 . . . . 0.0 109.431 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.07 106.04 17.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.208 -0.933 . . . . 0.0 109.379 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.648 ' O ' HG13 ' A' ' 42' ' ' VAL . 41.2 t -99.7 120.64 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.098 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.951 HG12 ' HB2' ' A' ' 60' ' ' SER . 0.8 OUTLIER -159.5 158.01 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.146 -0.972 . . . . 0.0 109.899 -179.521 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.857 ' CE2' HD23 ' A' ' 59' ' ' LEU . 3.4 m-85 -94.9 116.35 28.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.396 -0.815 . . . . 0.0 109.498 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.703 ' OD2' HD12 ' A' ' 47' ' ' LEU . 38.3 t0 -52.9 130.09 32.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.357 -0.839 . . . . 0.0 109.709 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.97 -1.9 53.7 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.214 -0.929 . . . . 0.0 109.605 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.68 12.99 34.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.156 -0.965 . . . . 0.0 109.609 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.703 HD12 ' OD2' ' A' ' 44' ' ' ASP . 5.1 mt -139.84 52.81 1.69 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.178 -0.951 . . . . 0.0 109.45 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.509 ' OD1' ' HA ' ' A' ' 51' ' ' LYS . 0.7 OUTLIER -105.07 164.36 15.29 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.935 . . . . 0.0 109.504 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 35.1 Cg_endo -78.12 -20.63 11.28 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.675 2.25 . . . . 0.0 110.956 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.486 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -126.32 26.32 6.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.041 -1.037 . . . . 0.0 109.919 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.509 ' HA ' ' OD1' ' A' ' 48' ' ' ASN . 15.6 mmtt 34.53 36.79 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.16 0.505 . . . . 0.0 110.284 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 50' ' ' ALA . 41.0 m -99.75 -162.32 0.94 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.206 -0.934 . . . . 0.0 109.584 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -166.12 80.31 0.27 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.346 -0.846 . . . . 0.0 109.268 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -155.92 -48.96 0.08 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.252 -0.905 . . . . 0.0 109.469 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.516 ' O ' HD12 ' A' ' 55' ' ' LEU . 1.5 pp -62.23 -17.14 57.49 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.163 -0.961 . . . . 0.0 109.222 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.411 ' O ' ' C ' ' A' ' 57' ' ' LYS . . . -90.33 -30.43 17.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.332 -0.855 . . . . 0.0 109.539 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -43.86 -62.73 1.02 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.913 . . . . 0.0 109.503 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.9 m -94.39 49.57 1.3 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 0.0 109.417 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.857 HD23 ' CE2' ' A' ' 43' ' ' PHE . 7.3 tp -136.27 -60.89 0.71 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.347 -0.846 . . . . 0.0 109.34 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.951 ' HB2' HG12 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -77.48 152.17 34.31 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.462 -0.774 . . . . 0.0 110.159 -178.432 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.422 ' NE2' ' N ' ' A' ' 41' ' ' VAL . 27.4 p80 -97.17 -168.59 1.72 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.547 -0.721 . . . . 0.0 109.327 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.11 -46.17 0.34 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.178 -0.951 . . . . 0.0 109.391 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -65.72 132.82 49.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.2 -0.938 . . . . 0.0 109.402 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.626 ' H ' HD12 ' A' ' 64' ' ' LEU . 5.7 mp -58.86 169.76 0.95 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.18 -0.95 . . . . 0.0 109.356 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.679 HD13 ' HB2' ' A' ' 71' ' ' SER . 0.0 OUTLIER -115.6 127.04 54.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.19 -0.944 . . . . 0.0 109.262 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.9 mtt -120.29 9.78 11.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.266 -0.896 . . . . 0.0 109.599 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.44 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 32.3 t -94.07 138.44 22.62 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 109.322 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.513 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.5 Cg_endo -79.92 95.65 1.03 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.579 2.186 . . . . 0.0 110.62 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.463 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 99.76 48.63 1.61 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.551 ' N ' ' HB3' ' A' ' 32' ' ' LEU . 48.8 tt0 -179.22 100.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.14 -1.212 . . . . 0.0 109.334 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.679 ' HB2' HD13 ' A' ' 65' ' ' LEU . 24.1 p -103.8 -79.63 0.54 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.145 -0.972 . . . . 0.0 109.723 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.572 ' N ' ' OG ' ' A' ' 71' ' ' SER . 0.4 OUTLIER -160.72 107.95 1.53 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.925 -1.109 . . . . 0.0 109.751 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.22 99.38 7.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.047 -1.033 . . . . 0.0 108.818 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.42 HG21 ' HA ' ' A' ' 59' ' ' LEU . 6.9 m -102.97 124.99 49.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.343 -0.848 . . . . 0.0 110.047 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.462 ' O ' ' C ' ' A' ' 76' ' ' PHE . 0.8 OUTLIER -89.9 93.69 9.52 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.168 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.931 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 32.5 m-85 -39.95 157.15 0.15 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.475 -0.766 . . . . 0.0 109.64 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.506 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.1 Cg_endo -75.5 161.58 37.09 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.703 2.269 . . . . 0.0 111.238 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 25' ' ' PRO . . . -74.54 5.11 5.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.557 -0.715 . . . . 0.0 109.964 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.474 ' O ' ' C ' ' A' ' 80' ' ' ALA . 0.4 OUTLIER -98.6 -67.22 0.86 Allowed 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.015 -1.053 . . . . 0.0 109.202 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.976 ' CB ' HG11 ' A' ' 103' ' ' VAL . . . 40.65 76.49 0.5 Allowed Pre-proline 0 N--CA 1.493 1.687 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 82' ' ' ALA . 35.3 Cg_endo -76.73 119.91 5.33 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.866 2.378 . . . . 0.0 111.697 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 81' ' ' PRO . . . 50.89 106.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.597 -0.689 . . . . 0.0 110.482 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.533 ' CA ' ' H ' ' A' ' 103' ' ' VAL . . . -49.0 103.71 0.08 OUTLIER Glycine 0 N--CA 1.48 1.626 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 49' ' ' PRO . 1.1 tp10 -160.32 53.33 0.32 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.273 -1.134 . . . . 0.0 109.744 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.562 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 1.1 m-85 -111.45 128.45 56.0 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.495 HG23 ' HG2' ' A' ' 100' ' ' LYS . 59.3 m -124.72 114.85 19.85 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.143 -0.973 . . . . 0.0 110.09 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.54 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.6 OUTLIER -99.98 164.45 11.99 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.898 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 89' ' ' CYS . 55.2 p90 -155.36 -162.37 1.33 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.013 -1.054 . . . . 0.0 109.662 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.436 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 0.1 OUTLIER -133.27 124.38 27.23 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.568 -0.707 . . . . 0.0 109.52 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.616 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 6.3 tt0 -61.47 -43.85 90.37 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.313 -0.867 . . . . 0.0 110.739 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.2 Cg_endo -79.42 -66.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 122.09 1.86 . . . . 0.0 110.729 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.683 ' CD2' HD13 ' A' ' 14' ' ' LEU . 10.1 m80 -75.68 55.61 0.86 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.159 -0.963 . . . . 0.0 109.256 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -82.19 109.86 16.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.34 -0.85 . . . . 0.0 109.631 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.7 -1.19 28.99 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.473 ' O ' ' O ' ' A' ' 14' ' ' LEU . . . -101.1 35.12 2.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.176 -1.191 . . . . 0.0 109.467 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.412 ' HA3' HG12 ' A' ' 15' ' ' VAL . . . 70.12 19.69 75.84 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.633 ' HE1' ' HB2' ' A' ' 7' ' ' LEU . 1.0 OUTLIER -92.04 37.25 0.98 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.082 -1.246 . . . . 0.0 109.329 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 89.4 t -125.59 110.27 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.187 -0.946 . . . . 0.0 109.686 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.54 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -118.34 173.27 14.79 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.495 ' HG2' HG23 ' A' ' 86' ' ' THR . 7.6 mtmm -148.15 129.8 15.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.099 -1.236 . . . . 0.0 109.823 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.977 HD11 HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -83.49 129.02 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.286 -0.884 . . . . 0.0 108.669 179.409 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.452 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 2.8 m -99.66 95.1 6.73 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.173 -0.954 . . . . 0.0 108.988 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.976 HG11 ' CB ' ' A' ' 80' ' ' ALA . 60.1 t -98.5 99.4 8.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.464 -0.773 . . . . 0.0 109.664 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.375 -0.828 . . . . 0.0 109.587 -179.944 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 55.6 m . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.279 0.561 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -92.7 150.21 20.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 109.39 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 30' ' ' GLU . 1.4 t -157.22 135.39 11.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.215 -0.928 . . . . 0.0 109.591 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.505 ' CG1' HD12 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -109.12 102.36 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.295 -0.878 . . . . 0.0 109.37 179.823 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -68.43 127.66 33.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.407 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.595 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -97.79 177.26 5.52 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.118 -0.989 . . . . 0.0 109.09 179.53 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.483 ' CA ' HD23 ' A' ' 14' ' ' LEU . . . 59.03 86.72 0.03 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.473 ' OG ' ' N ' ' A' ' 10' ' ' ASP . 93.6 p -45.27 -88.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.301 -1.117 . . . . 0.0 109.587 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.473 ' N ' ' OG ' ' A' ' 9' ' ' SER . 6.8 t70 179.6 -47.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 109.157 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.58 30.71 5.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.332 -0.855 . . . . 0.0 109.146 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.417 ' C ' ' HG ' ' A' ' 13' ' ' LEU . . . -138.96 -108.78 0.82 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.417 ' HG ' ' C ' ' A' ' 12' ' ' GLY . 0.5 OUTLIER -130.87 -155.24 0.68 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.24 -1.153 . . . . 0.0 109.61 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.579 HD22 ' CE1' ' A' ' 39' ' ' HIS . 5.3 mt -107.7 118.12 35.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.298 -0.876 . . . . 0.0 109.38 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.4 m -146.07 159.25 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.528 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -82.05 138.26 34.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.319 -0.863 . . . . 0.0 109.248 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 83.3 mt-10 -126.17 111.86 23.96 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 109.368 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.474 ' HG2' ' HG ' ' A' ' 21' ' ' LEU . 35.2 Cg_endo -78.88 -178.2 23.17 Favored 'Cis proline' 0 C--N 1.311 -1.429 0 C-N-CA 123.841 -1.316 . . . . 0.0 110.517 -0.052 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.61 -59.27 2.93 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.315 -0.865 . . . . 0.0 109.086 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.28 160.71 14.08 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.355 -0.84 . . . . 0.0 108.861 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.505 HD12 ' CG1' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -155.24 121.02 5.07 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.961 -1.087 . . . . 0.0 110.314 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.489 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 34.0 m -92.81 107.64 19.38 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.828 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -105.74 171.44 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.19 -0.944 . . . . 0.0 110.42 -178.882 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.494 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -89.58 171.34 8.94 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.017 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.644 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 34.7 Cg_endo -76.6 79.39 3.04 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.219 1.946 . . . . 0.0 110.728 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.498 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 136.91 -22.6 3.27 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.394 -1.384 . . . . 0.0 110.424 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 26' ' ' GLY . 16.4 m-20 -46.66 172.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.031 -1.276 . . . . 0.0 109.533 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.738 HG23 ' HA ' ' A' ' 75' ' ' THR . 1.3 m -115.96 119.6 36.44 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.337 -0.852 . . . . 0.0 109.406 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.051 HG21 HD11 ' A' ' 101' ' ' ILE . 2.5 t -99.48 132.31 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 121.222 -0.924 . . . . 0.0 109.518 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.477 ' HB3' ' HB ' ' A' ' 4' ' ' THR . 10.6 tt0 -113.47 142.68 45.63 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.197 -0.939 . . . . 0.0 109.53 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.589 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -138.55 95.02 2.91 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.81 HD12 ' O ' ' A' ' 33' ' ' ASN . 1.1 pp -98.77 160.4 14.3 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.228 -0.92 . . . . 0.0 110.456 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.81 ' O ' HD12 ' A' ' 32' ' ' LEU . 2.3 p-10 -79.0 -173.82 3.75 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.629 -0.67 . . . . 0.0 109.271 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -134.73 -93.27 0.3 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.138 -0.976 . . . . 0.0 109.291 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.449 ' C ' ' CG2' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -138.45 36.17 2.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.1 -1.0 . . . . 0.0 109.412 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.557 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -157.11 61.11 2.29 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.44 -0.788 . . . . 0.0 109.011 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.557 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 36.0 Cg_endo -79.42 173.39 13.23 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.632 2.221 . . . . 0.0 111.007 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.581 ' O ' ' CD2' ' A' ' 39' ' ' HIS . 37.9 Cg_endo -84.47 -157.1 1.26 Allowed 'Cis proline' 0 C--N 1.31 -1.482 0 C-N-CA 123.298 -1.543 . . . . 0.0 110.163 -1.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.581 ' CD2' ' O ' ' A' ' 38' ' ' PRO . 81.6 m-70 -161.46 142.46 11.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.46 -0.775 . . . . 0.0 109.754 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -116.63 123.47 47.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 109.31 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.428 ' C ' ' CG2' ' A' ' 42' ' ' VAL . 70.4 t -110.17 128.55 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.326 -0.859 . . . . 0.0 109.425 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.507 ' HA ' ' HB3' ' A' ' 60' ' ' SER . 1.2 t -151.64 178.1 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.931 . . . . 0.0 109.489 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.586 ' HB2' ' HB1' ' A' ' 56' ' ' ALA . 12.1 m-85 -130.14 121.47 26.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.235 -0.915 . . . . 0.0 109.533 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.455 ' O ' ' O ' ' A' ' 43' ' ' PHE . 8.5 t0 -50.77 -177.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.355 -0.84 . . . . 0.0 109.455 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.84 14.3 2.9 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.247 -0.908 . . . . 0.0 109.501 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.71 15.37 2.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.899 . . . . 0.0 109.607 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 mp -117.29 35.72 4.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.101 -1.0 . . . . 0.0 109.601 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.531 ' OD1' ' CA ' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -130.13 156.39 79.33 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.319 -0.863 . . . . 0.0 109.071 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.761 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 35.5 Cg_endo -77.93 2.67 7.69 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.611 2.207 . . . . 0.0 111.145 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.505 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -140.2 29.64 2.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.88 -1.138 . . . . 0.0 110.103 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.531 ' CA ' ' OD1' ' A' ' 48' ' ' ASN . 0.3 OUTLIER 30.54 96.35 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 121.234 0.54 . . . . 0.0 110.577 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.579 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 1.7 m -99.23 -177.68 3.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.008 -1.057 . . . . 0.0 109.904 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.579 ' HB2' ' O ' ' A' ' 52' ' ' SER . . . 170.59 -33.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.434 -0.791 . . . . 0.0 109.21 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -89.15 -17.63 28.8 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.332 -0.855 . . . . 0.0 109.51 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 0.7 OUTLIER -106.26 -28.17 10.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.121 -0.987 . . . . 0.0 109.508 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.586 ' HB1' ' HB2' ' A' ' 43' ' ' PHE . . . -87.45 -7.07 58.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.339 -0.851 . . . . 0.0 109.85 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -79.72 -49.77 11.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.155 -0.966 . . . . 0.0 109.347 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 t -82.53 -22.06 35.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 109.559 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.922 ' HG ' HG21 ' A' ' 74' ' ' THR . 9.1 tp -53.0 -32.25 45.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.937 . . . . 0.0 108.83 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.507 ' HB3' ' HA ' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -78.8 127.92 32.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.336 -0.852 . . . . 0.0 109.74 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.891 ' HB3' HG21 ' A' ' 72' ' ' THR . 9.7 p80 -73.38 -28.58 62.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.149 -0.969 . . . . 0.0 109.048 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 1.3 mtpt 56.65 118.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.497 -0.752 . . . . 0.0 110.011 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.52 ' CB ' ' O ' ' A' ' 62' ' ' LYS . 0.5 OUTLIER 160.46 169.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.466 -0.771 . . . . 0.0 109.438 179.749 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 mp -102.68 123.56 46.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.172 -0.955 . . . . 0.0 109.218 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 70' ' ' GLN . 9.1 mp -84.47 81.9 8.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.581 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 30.9 mtp -93.98 2.69 56.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.164 -0.96 . . . . 0.0 109.822 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.505 ' OG ' ' HD2' ' A' ' 68' ' ' PRO . 1.0 OUTLIER -115.81 152.42 47.41 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.121 -0.987 . . . . 0.0 109.089 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.505 ' HD2' ' OG ' ' A' ' 67' ' ' SER . 33.8 Cg_endo -76.13 102.18 1.58 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.407 2.071 . . . . 0.0 110.151 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.98 -26.31 14.28 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.492 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.5 108.73 0.19 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.277 -1.131 . . . . 0.0 108.991 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.559 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . 5.2 p -140.42 -159.57 0.97 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.097 -1.002 . . . . 0.0 110.083 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.891 HG21 ' HB3' ' A' ' 61' ' ' HIS . 4.2 m -157.06 112.39 2.84 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.5 p -79.41 76.2 5.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.121 -0.987 . . . . 0.0 109.293 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.922 HG21 ' HG ' ' A' ' 59' ' ' LEU . 60.9 m -51.1 111.0 0.49 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.538 -0.726 . . . . 0.0 109.939 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.738 ' HA ' HG23 ' A' ' 28' ' ' THR . 96.0 m -80.39 92.25 5.8 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.339 -0.85 . . . . 0.0 109.047 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.941 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 11.6 m-85 -44.74 165.11 0.16 Allowed Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.374 -0.829 . . . . 0.0 109.399 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.498 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 32.6 Cg_endo -75.64 155.38 40.01 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.552 2.168 . . . . 0.0 111.362 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.26 -6.5 24.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.61 -0.681 . . . . 0.0 109.801 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -99.96 -66.31 0.91 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.2 -0.937 . . . . 0.0 109.2 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.695 ' HB3' HG11 ' A' ' 103' ' ' VAL . . . 42.59 65.75 4.88 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.407 -0.808 . . . . 0.0 109.59 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.622 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 33.5 Cg_endo -76.27 -159.81 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.374 2.049 . . . . 0.0 109.907 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.761 ' HB1' ' HD2' ' A' ' 49' ' ' PRO . . . 69.62 -84.84 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.076 -1.015 . . . . 0.0 109.189 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.441 ' HA2' ' C ' ' A' ' 103' ' ' VAL . . . 116.22 19.64 5.43 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -160.02 96.67 1.23 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.153 -1.204 . . . . 0.0 110.243 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.526 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 5.5 m-85 -111.85 125.46 54.04 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.3 m -112.69 118.3 34.64 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.0 -1.063 . . . . 0.0 110.946 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.54 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.7 OUTLIER -103.77 175.17 5.57 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.272 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -160.53 -177.61 6.32 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.662 -1.273 . . . . 0.0 110.427 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.0 137.08 54.82 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -77.24 -46.98 2.65 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.888 . . . . 0.0 110.905 -179.49 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 33.3 Cg_endo -77.49 -47.83 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.331 2.02 . . . . 0.0 112.145 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.608 ' CE1' ' HG2' ' A' ' 91' ' ' PRO . 3.3 m80 -101.32 65.42 1.06 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.736 -1.227 . . . . 0.0 110.142 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -90.12 4.83 49.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 109.163 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.31 -14.73 23.38 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.509 ' HB1' ' O ' ' A' ' 14' ' ' LEU . . . -95.91 35.01 1.45 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -1.162 . . . . 0.0 109.181 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 98' ' ' VAL . . . 48.93 27.29 6.45 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.473 ' SD ' ' HB2' ' A' ' 92' ' ' HIS . 4.1 mtp -68.39 60.73 0.09 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.976 -1.308 . . . . 0.0 109.138 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' A' ' 96' ' ' GLY . 96.7 t -139.14 110.18 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.88 . . . . 0.0 109.761 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.54 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -103.69 -171.55 25.59 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 18.2 mttt -155.1 123.63 6.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.162 -1.199 . . . . 0.0 109.758 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 1.051 HD11 HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -90.97 124.43 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.233 -0.917 . . . . 0.0 108.795 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.489 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 18.2 m -105.26 97.65 7.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.252 -0.905 . . . . 0.0 108.856 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.695 HG11 ' HB3' ' A' ' 80' ' ' ALA . 4.0 t -99.8 73.37 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.013 -1.055 . . . . 0.0 109.512 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.893 . . . . 0.0 109.526 179.967 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.4 m . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.694 ' HD2' HG22 ' A' ' 23' ' ' ILE . 58.8 m-85 -105.77 130.82 53.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -0.893 . . . . 0.0 109.328 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.659 HG23 ' O ' ' A' ' 4' ' ' THR . 10.1 t -127.61 108.76 11.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.714 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.491 HG21 ' CE1' ' A' ' 16' ' ' PHE . 19.5 m -92.83 159.5 2.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.23 -0.919 . . . . 0.0 109.537 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.403 ' O ' ' N ' ' A' ' 8' ' ' GLY . 25.4 mttt -128.26 84.26 2.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.426 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.572 ' HB2' ' CE ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -45.15 100.7 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.25 -0.906 . . . . 0.0 109.536 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 14' ' ' LEU . . . 104.46 114.22 3.93 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 1.8 p -76.21 -81.3 0.08 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -1.121 . . . . 0.0 109.254 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 9' ' ' SER . 7.5 t70 167.83 -30.19 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.335 -0.853 . . . . 0.0 109.483 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.422 ' HB2' ' HE2' ' A' ' 11' ' ' LYS . 3.3 ttmm -114.85 -14.9 11.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 109.588 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.68 -85.92 1.77 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -164.34 -148.73 0.12 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -1.135 . . . . 0.0 109.296 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.669 HD11 ' HB ' ' A' ' 36' ' ' VAL . 83.9 mt -106.11 94.92 5.43 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.257 -0.902 . . . . 0.0 109.432 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.5 m -144.57 155.41 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.199 -0.938 . . . . 0.0 109.591 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.491 ' CE1' HG21 ' A' ' 5' ' ' VAL . 10.0 m-85 -70.06 142.99 52.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 109.764 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 2.8 mt-10 -134.44 105.18 11.03 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.235 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 33.9 Cg_endo -76.34 -175.71 17.06 Favored 'Cis proline' 0 C--N 1.311 -1.403 0 C-N-CA 123.664 -1.39 . . . . 0.0 110.639 0.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.29 -9.61 54.52 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.242 -0.911 . . . . 0.0 109.89 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.852 ' C ' HD22 ' A' ' 21' ' ' LEU . 30.2 mtmt -139.02 137.34 36.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.095 -1.003 . . . . 0.0 109.492 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.852 HD22 ' C ' ' A' ' 20' ' ' LYS . 4.6 mm? -123.54 127.77 48.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.33 -0.856 . . . . 0.0 109.887 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.4 m -99.67 97.98 8.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 108.705 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.818 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.1 pt -104.16 -175.87 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.227 -0.92 . . . . 0.0 110.4 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.625 ' C ' HG13 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -113.85 179.72 0.74 Allowed Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.075 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.567 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 34.1 Cg_endo -76.93 76.47 4.12 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.009 1.806 . . . . 0.0 110.571 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 134.31 -2.02 4.18 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.5 -1.334 . . . . 0.0 110.101 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.91 -170.86 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.092 -1.24 . . . . 0.0 109.249 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.403 HG23 ' HA ' ' A' ' 75' ' ' THR . 52.2 m -137.85 112.93 9.16 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.135 -0.978 . . . . 0.0 109.675 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.993 HG21 HD11 ' A' ' 101' ' ' ILE . 0.8 OUTLIER -99.89 128.43 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.214 -0.929 . . . . 0.0 109.422 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 3' ' ' TYR . 46.3 mt-10 -99.48 163.49 12.49 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.232 -0.917 . . . . 0.0 109.205 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.519 ' CZ ' ' O ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -149.44 152.87 36.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.209 -0.932 . . . . 0.0 109.391 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.566 ' N ' HD12 ' A' ' 32' ' ' LEU . 2.3 mp -141.73 -162.59 1.42 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.146 -0.971 . . . . 0.0 109.953 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 3.3 p-10 -123.97 172.99 8.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.446 -0.784 . . . . 0.0 109.011 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 26.0 t-20 -111.64 -96.36 0.43 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.939 -1.1 . . . . 0.0 109.193 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.486 ' HE2' HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -147.13 30.91 0.93 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.18 -0.95 . . . . 0.0 108.862 179.523 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.669 ' HB ' HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -151.1 59.42 3.34 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.694 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.579 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 36.6 Cg_endo -78.49 174.86 11.75 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.761 2.307 . . . . 0.0 110.617 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.556 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 37.9 Cg_endo -84.15 172.62 44.03 Favored 'Cis proline' 0 C--N 1.31 -1.461 0 C-N-CA 123.518 -1.451 . . . . 0.0 110.37 -1.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.902 ' HB2' HD22 ' A' ' 65' ' ' LEU . 74.6 m80 -132.04 142.01 49.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.141 -0.974 . . . . 0.0 109.729 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.519 ' ND2' ' HB3' ' A' ' 63' ' ' GLN . 4.9 t-20 -112.47 119.29 37.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.335 -0.853 . . . . 0.0 109.604 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.9 t -108.03 112.94 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.657 HG13 ' CB ' ' A' ' 60' ' ' SER . 2.4 t -139.19 170.8 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.979 -1.075 . . . . 0.0 110.566 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.53 ' H ' HG12 ' A' ' 42' ' ' VAL . 4.4 m-85 -118.45 110.58 17.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.491 -0.756 . . . . 0.0 109.345 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.517 ' HB3' ' CD2' ' A' ' 47' ' ' LEU . 6.1 t0 -48.83 139.3 10.1 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.192 -0.942 . . . . 0.0 109.278 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.29 12.84 6.0 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.251 -0.906 . . . . 0.0 109.888 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -119.8 23.99 10.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.069 -1.019 . . . . 0.0 109.668 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.517 ' CD2' ' HB3' ' A' ' 44' ' ' ASP . 0.7 OUTLIER -131.03 46.33 2.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.226 -0.921 . . . . 0.0 109.474 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 48' ' ' ASN . 0.5 OUTLIER -119.47 156.38 53.31 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.214 -0.929 . . . . 0.0 109.603 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.36 -21.56 11.65 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.676 2.251 . . . . 0.0 110.305 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.451 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -123.89 28.06 7.0 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.264 -0.898 . . . . 0.0 109.424 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.474 ' HA ' ' OD1' ' A' ' 48' ' ' ASN . 0.1 OUTLIER 38.55 48.17 1.22 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.295 0.569 . . . . 0.0 110.025 179.711 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.435 ' N ' ' ND2' ' A' ' 48' ' ' ASN . 22.3 m -112.02 139.22 47.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.165 -0.959 . . . . 0.0 109.434 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.464 ' O ' ' HD2' ' A' ' 57' ' ' LYS . . . -121.54 21.82 10.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.802 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.86 -32.85 34.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.203 -0.936 . . . . 0.0 109.568 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.512 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 0.5 OUTLIER -97.39 21.42 10.14 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.215 -0.928 . . . . 0.0 109.415 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -113.35 -33.88 5.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.328 -0.858 . . . . 0.0 109.294 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.464 ' HD2' ' O ' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -71.34 -48.66 48.93 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.275 -0.891 . . . . 0.0 109.028 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.1 t -77.83 -2.12 34.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 0.0 109.44 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.885 HD21 ' CE2' ' A' ' 76' ' ' PHE . 9.7 tp -89.05 -48.41 7.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.109 -0.994 . . . . 0.0 109.097 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.657 ' CB ' HG13 ' A' ' 42' ' ' VAL . 10.1 p -79.78 164.65 23.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.527 -0.733 . . . . 0.0 110.507 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.535 ' CD2' HG21 ' A' ' 72' ' ' THR . 3.5 p80 -125.0 -164.74 1.31 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.526 -0.734 . . . . 0.0 109.217 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.466 ' N ' ' CG ' ' A' ' 61' ' ' HIS . 2.2 mttp -65.43 -162.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.119 -0.988 . . . . 0.0 109.353 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.519 ' HB3' ' ND2' ' A' ' 40' ' ' ASN . 5.4 pt20 -137.07 42.44 2.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.102 -0.999 . . . . 0.0 109.876 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.61 76.53 1.64 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.182 -0.948 . . . . 0.0 109.938 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.902 HD22 ' HB2' ' A' ' 39' ' ' HIS . 4.9 mp -85.58 105.0 15.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.131 -0.981 . . . . 0.0 109.21 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.1 ttt -109.04 3.82 22.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 0.0 109.578 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.428 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 2.6 t -98.28 133.63 22.74 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 109.123 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 67' ' ' SER . 36.0 Cg_endo -78.86 78.92 3.53 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.413 2.076 . . . . 0.0 110.512 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.533 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 112.63 50.36 0.56 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.531 ' N ' ' HB3' ' A' ' 32' ' ' LEU . 0.0 OUTLIER 172.3 111.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -1.103 . . . . 0.0 109.385 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' A' ' 72' ' ' THR . 77.8 p -111.14 -78.89 0.58 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.209 -0.932 . . . . 0.0 109.199 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.535 HG21 ' CD2' ' A' ' 61' ' ' HIS . 14.7 t -160.4 164.28 32.47 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.387 -0.821 . . . . 0.0 108.945 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.2 t -115.44 126.47 54.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.156 -0.965 . . . . 0.0 109.226 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.755 HG21 ' HG ' ' A' ' 59' ' ' LEU . 56.0 m -108.3 101.74 10.91 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.303 -0.873 . . . . 0.0 109.716 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.478 ' O ' HG22 ' A' ' 75' ' ' THR . 25.1 m -79.14 80.13 5.51 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.925 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 9.1 m-85 -36.83 146.54 0.23 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.964 -0.46 . . . . 0.0 109.886 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.459 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.0 Cg_endo -75.63 168.81 23.61 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.625 2.217 . . . . 0.0 110.895 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.75 11.82 8.4 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.493 -0.754 . . . . 0.0 109.424 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 81' ' ' PRO . 0.9 OUTLIER -99.55 -24.36 14.78 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.285 -0.885 . . . . 0.0 109.329 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.567 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -37.04 96.58 0.11 Allowed Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.815 -0.553 . . . . 0.0 109.769 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.488 ' N ' ' O ' ' A' ' 79' ' ' ASP . 35.9 Cg_endo -78.62 -177.0 3.57 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.643 2.229 . . . . 0.0 110.732 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -70.39 127.32 32.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.301 -0.874 . . . . 0.0 109.266 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 167.11 145.75 4.61 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -85.07 117.02 23.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -1.137 . . . . 0.0 109.808 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.489 ' CD1' HG22 ' A' ' 101' ' ' ILE . 26.5 m-85 -92.51 153.4 19.1 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.499 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 29.6 m -138.81 114.33 9.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.837 -1.164 . . . . 0.0 110.762 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.592 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.4 OUTLIER -108.33 154.75 21.38 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.282 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.524 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 5.0 p90 -143.49 -156.77 0.72 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.052 -1.03 . . . . 0.0 110.11 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.456 ' SG ' ' HD2' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -133.41 139.19 46.62 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.323 -0.861 . . . . 0.0 109.491 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.629 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 63.1 tt0 -79.45 -42.64 1.6 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.349 -0.844 . . . . 0.0 111.035 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 34.2 Cg_endo -76.93 -46.04 0.16 Allowed 'Trans proline' 0 C--N 1.316 -1.148 0 C-N-CA 121.931 1.754 . . . . 0.0 111.068 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.569 ' CD2' ' HG2' ' A' ' 91' ' ' PRO . 20.0 m-70 -102.3 33.32 3.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.0 -1.062 . . . . 0.0 109.6 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.9 ttt-85 -50.65 -36.9 37.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.129 -0.982 . . . . 0.0 109.718 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -96.27 40.26 2.64 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 92' ' ' HIS . . . -133.68 33.38 3.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.231 -1.158 . . . . 0.0 109.541 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.11 24.12 54.01 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.231 -1.147 . . . . 0.0 110.231 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.572 ' CE ' ' HB2' ' A' ' 7' ' ' LEU . 2.7 mtp -87.54 71.59 9.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.039 -1.271 . . . . 0.0 109.217 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 88.6 t -137.62 127.94 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.541 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.592 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -123.66 -174.78 14.27 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.527 ' CG ' ' O ' ' A' ' 99' ' ' GLY . 22.2 mttt -162.33 122.27 2.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.175 -1.191 . . . . 0.0 110.169 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.993 HD11 HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -88.16 121.25 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.107 -0.995 . . . . 0.0 108.406 178.91 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.6 101.41 12.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.021 -1.05 . . . . 0.0 109.329 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.705 HG22 ' CD1' ' A' ' 23' ' ' ILE . 2.4 t -99.77 116.47 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 109.367 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 109.385 -179.917 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.27 0.557 . . . . 0.0 109.749 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.707 ' CD2' HG22 ' A' ' 23' ' ' ILE . 23.2 m-85 -80.17 173.87 12.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.281 -0.887 . . . . 0.0 109.373 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.501 HG23 ' CB ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -156.08 113.57 3.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.149 -0.97 . . . . 0.0 109.814 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.768 ' CG1' HD13 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -101.41 114.3 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.908 . . . . 0.0 109.129 179.514 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -82.03 107.53 14.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.244 -0.91 . . . . 0.0 109.475 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.567 HD22 ' CE1' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -88.94 -169.1 2.4 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.16 -0.963 . . . . 0.0 109.108 179.565 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.675 ' HA2' HD23 ' A' ' 14' ' ' LEU . . . 65.05 74.51 0.48 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 p -58.44 151.57 19.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -1.177 . . . . 0.0 109.531 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -89.52 -0.72 57.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.758 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.53 -0.41 8.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.1 -1.0 . . . . 0.0 109.769 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -131.78 -105.95 1.03 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.431 ' O ' HD23 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -148.2 -91.3 0.08 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.336 -1.097 . . . . 0.0 109.462 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.675 HD23 ' HA2' ' A' ' 8' ' ' GLY . 74.0 mt -133.76 108.05 8.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.224 -0.923 . . . . 0.0 109.714 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.48 116.68 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.33 -0.856 . . . . 0.0 109.284 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.567 ' CE1' HD22 ' A' ' 7' ' ' LEU . 37.6 m-85 -45.39 151.09 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.165 -0.959 . . . . 0.0 109.27 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 7.5 mt-10 -144.69 112.91 5.0 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.159 -0.963 . . . . 0.0 109.296 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.9 Cg_endo -76.7 177.62 38.81 Favored 'Cis proline' 0 C--N 1.312 -1.387 0 C-N-CA 123.678 -1.384 . . . . 0.0 110.609 0.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.38 -1.95 35.89 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.283 -0.886 . . . . 0.0 109.675 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -134.19 161.49 34.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 109.281 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.768 HD13 ' CG1' ' A' ' 5' ' ' VAL . 0.5 OUTLIER -156.5 118.07 3.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.001 -1.062 . . . . 0.0 110.032 -179.85 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.516 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 92.6 m -90.5 101.4 14.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.849 . . . . 0.0 108.876 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.806 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -102.14 -172.75 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.317 -0.864 . . . . 0.0 110.317 -179.135 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.556 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -111.94 172.53 3.47 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.159 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.57 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 34.3 Cg_endo -77.41 79.83 3.07 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.364 2.043 . . . . 0.0 110.725 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 130.12 -24.56 4.48 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.577 -1.297 . . . . 0.0 109.898 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 26' ' ' GLY . 0.7 OUTLIER -51.43 -176.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.123 -1.222 . . . . 0.0 109.623 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.2 m -122.6 146.17 47.69 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.318 -0.864 . . . . 0.0 109.441 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.951 HG21 HD11 ' A' ' 101' ' ' ILE . 2.4 t -127.17 140.36 49.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.23 -0.919 . . . . 0.0 109.451 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.501 ' CB ' HG23 ' A' ' 4' ' ' THR . 1.8 mt-10 -106.85 155.85 19.3 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.165 -0.959 . . . . 0.0 109.814 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.529 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -153.52 84.63 1.18 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.598 ' H ' HD23 ' A' ' 32' ' ' LEU . 1.7 pt? -96.55 165.3 12.23 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.98 0.895 . . . . 0.0 111.941 -177.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.615 ' HB2' ' CD2' ' A' ' 39' ' ' HIS . 3.9 p30 -87.45 154.85 20.32 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.97 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 48.4 t30 -92.98 -62.78 1.31 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.057 -1.027 . . . . 0.0 109.36 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.472 ' C ' HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -158.19 35.53 0.24 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.243 -0.91 . . . . 0.0 109.291 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.593 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 26.7 t -154.73 57.42 1.71 Allowed Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.411 -0.806 . . . . 0.0 109.794 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.593 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 37.0 Cg_endo -79.97 174.54 11.44 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.579 2.186 . . . . 0.0 110.515 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.525 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.1 Cg_endo -84.34 175.57 34.37 Favored 'Cis proline' 0 C--N 1.31 -1.462 0 C-N-CA 123.549 -1.438 . . . . 0.0 110.137 -1.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.689 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 51.0 m-70 -127.09 146.56 50.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.335 -0.853 . . . . 0.0 110.116 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -113.11 110.04 19.8 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.423 HG21 ' HB2' ' A' ' 31' ' ' PHE . 42.7 t -99.28 117.82 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.143 -0.973 . . . . 0.0 109.681 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.003 HG12 ' HB2' ' A' ' 60' ' ' SER . 0.8 OUTLIER -147.81 171.49 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.445 -0.785 . . . . 0.0 109.407 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.643 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.9 OUTLIER -124.66 109.59 13.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.331 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -46.96 136.46 8.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -0.884 . . . . 0.0 109.584 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.53 45.99 1.19 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.254 -0.904 . . . . 0.0 109.538 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.68 -30.52 0.82 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 110.186 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.9 mt -103.12 77.36 1.54 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.038 -1.039 . . . . 0.0 110.013 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.469 ' OD1' ' HA ' ' A' ' 51' ' ' LYS . 1.9 p30 -126.19 153.74 74.36 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.284 -0.885 . . . . 0.0 109.159 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.06 -14.31 13.58 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.562 2.175 . . . . 0.0 111.076 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -135.9 24.46 3.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.929 -1.107 . . . . 0.0 109.999 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.469 ' HA ' ' OD1' ' A' ' 48' ' ' ASN . 1.0 OUTLIER 35.75 87.39 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.115 0.483 . . . . 0.0 110.111 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.5 m -136.99 159.57 41.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.107 -0.996 . . . . 0.0 109.763 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.81 43.87 3.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 109.271 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -143.97 -41.05 0.28 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.347 -0.845 . . . . 0.0 109.648 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.567 ' O ' HD12 ' A' ' 55' ' ' LEU . 1.3 pp -58.9 -18.11 30.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.044 -1.035 . . . . 0.0 109.135 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 57' ' ' LYS . . . -89.56 -38.74 13.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.342 -0.849 . . . . 0.0 109.314 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -44.15 -45.03 8.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 109.249 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.28 32.32 2.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -0.863 . . . . 0.0 109.16 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.795 HD21 ' CE2' ' A' ' 76' ' ' PHE . 7.1 tp -133.1 -51.37 0.89 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 0.0 109.648 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . 1.003 ' HB2' HG12 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -78.74 121.18 24.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 109.766 -179.16 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.502 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 18.0 p80 -99.76 125.38 45.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.299 -0.876 . . . . 0.0 109.541 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 63' ' ' GLN . 2.2 mtpp -78.31 -37.22 45.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.186 -0.946 . . . . 0.0 109.591 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.436 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 2.4 tt0 -45.56 123.56 4.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.165 -0.959 . . . . 0.0 109.446 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.8 mp -75.97 170.66 15.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.478 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.734 HD21 ' CB ' ' A' ' 71' ' ' SER . 3.5 mp -93.1 -179.72 5.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -0.955 . . . . 0.0 109.429 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.447 ' HG3' ' C ' ' A' ' 65' ' ' LEU . 3.9 mtt -145.45 -48.52 0.23 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.065 -1.022 . . . . 0.0 110.151 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.503 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 47.2 t -80.58 144.96 57.69 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.058 -1.026 . . . . 0.0 110.224 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.475 ' HA ' HD21 ' A' ' 33' ' ' ASN . 36.5 Cg_endo -80.16 95.02 1.0 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 123.024 2.482 . . . . 0.0 110.454 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 33' ' ' ASN . . . 116.96 49.79 0.41 Allowed Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.228 -1.463 . . . . 0.0 109.83 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.537 ' N ' ' HB2' ' A' ' 32' ' ' LEU . 1.7 pt20 167.7 108.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -1.129 . . . . 0.0 109.457 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.734 ' CB ' HD21 ' A' ' 65' ' ' LEU . 95.6 p -100.1 -100.24 0.24 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.228 -0.92 . . . . 0.0 109.445 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.532 ' N ' ' OG ' ' A' ' 71' ' ' SER . 36.9 p -146.32 -157.85 0.84 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 p -143.05 93.68 2.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.06 -1.025 . . . . 0.0 109.389 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.712 HG21 ' HG ' ' A' ' 59' ' ' LEU . 42.6 m -67.44 103.24 1.26 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.377 -0.827 . . . . 0.0 109.428 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 76' ' ' PHE . 1.9 m -78.65 78.73 5.09 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.223 -0.923 . . . . 0.0 108.859 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.898 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 14.5 m-85 -40.79 144.02 0.65 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.651 -0.656 . . . . 0.0 109.306 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.475 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.9 Cg_endo -77.5 168.65 22.39 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.702 2.268 . . . . 0.0 111.149 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.45 9.78 8.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.429 -0.795 . . . . 0.0 109.447 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.469 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 28.0 t70 -99.15 -19.78 16.99 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.171 -0.956 . . . . 0.0 108.865 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.57 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -40.08 99.97 0.21 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.683 -0.635 . . . . 0.0 109.573 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.48 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 34.8 Cg_endo -76.29 133.99 15.26 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.312 2.008 . . . . 0.0 110.357 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -46.1 136.05 7.1 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.26 -0.9 . . . . 0.0 109.354 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 167.47 -139.37 5.68 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -135.67 120.1 18.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.29 -1.123 . . . . 0.0 109.733 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.585 ' CD1' HG22 ' A' ' 101' ' ' ILE . 4.0 m-85 -102.02 -179.41 3.99 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.4 m -163.63 115.41 1.42 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.9 -1.125 . . . . 0.0 110.38 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.551 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.5 OUTLIER -110.83 162.62 14.62 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -149.87 -162.01 1.46 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.989 -1.069 . . . . 0.0 109.954 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.12 126.28 28.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.348 -0.845 . . . . 0.0 109.838 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -59.33 -46.3 99.06 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 109.961 179.467 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.2 Cg_endo -78.85 -69.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.152 0 C-N-CA 122.182 1.921 . . . . 0.0 110.725 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.689 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 9.5 m80 -66.96 63.98 0.05 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.036 -1.04 . . . . 0.0 109.423 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 91' ' ' PRO . 5.8 ttp180 -92.62 -9.08 42.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 0.0 109.599 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.68 39.84 2.76 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.47 36.4 0.98 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.099 -1.236 . . . . 0.0 109.573 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' A' ' 98' ' ' VAL . . . 50.48 21.96 4.99 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.537 ' CE ' ' HB3' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -66.85 67.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.094 -1.239 . . . . 0.0 109.432 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' A' ' 96' ' ' GLY . 97.2 t -138.34 92.54 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.104 -0.997 . . . . 0.0 109.546 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.551 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -88.44 -173.31 47.14 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.501 ' CG ' ' O ' ' A' ' 99' ' ' GLY . 12.6 mttp -157.96 122.79 4.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -1.178 . . . . 0.0 109.541 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.951 HD11 HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -85.15 135.26 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 109.091 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.516 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 75.7 m -115.72 112.17 21.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.962 . . . . 0.0 108.635 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.787 HG22 ' CD1' ' A' ' 23' ' ' ILE . 8.6 t -99.37 131.64 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.941 . . . . 0.0 109.64 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 0.0 109.587 -179.92 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.487 HG22 ' HB ' ' A' ' 28' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.408 ' O ' ' N ' ' A' ' 30' ' ' GLU . 26.3 m-85 -118.47 125.42 49.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.256 -0.903 . . . . 0.0 109.499 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 30' ' ' GLU . 1.7 t -115.49 136.02 53.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 109.504 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.659 ' O ' HD23 ' A' ' 7' ' ' LEU . 0.9 OUTLIER -111.09 85.71 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.578 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -56.18 128.29 34.86 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.178 -0.951 . . . . 0.0 109.328 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.745 HD23 ' N ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -104.48 179.5 4.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.243 -0.911 . . . . 0.0 109.504 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.844 ' HA2' HD23 ' A' ' 14' ' ' LEU . . . 68.36 75.63 0.49 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.466 ' O ' ' OD2' ' A' ' 10' ' ' ASP . 1.4 p -44.84 -30.28 0.95 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -1.186 . . . . 0.0 109.501 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.469 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER 77.07 -3.06 2.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.472 -0.768 . . . . 0.0 109.652 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.33 13.67 8.26 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.132 -0.98 . . . . 0.0 109.641 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.07 -82.1 0.05 OUTLIER Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.7 tp -140.38 -151.42 0.36 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.231 -1.159 . . . . 0.0 109.685 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.844 HD23 ' HA2' ' A' ' 8' ' ' GLY . 87.5 mt -112.17 118.38 35.18 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.357 -0.84 . . . . 0.0 109.354 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 96' ' ' GLY . 6.1 m -152.03 156.91 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.179 -0.95 . . . . 0.0 109.381 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -71.41 156.37 39.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.211 -0.931 . . . . 0.0 109.454 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 47.6 mt-10 -143.88 112.86 5.35 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.416 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.1 Cg_endo -77.63 -178.6 24.53 Favored 'Cis proline' 0 C--N 1.312 -1.346 0 C-N-CA 123.739 -1.359 . . . . 0.0 110.462 0.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.14 -34.5 61.65 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.266 -0.896 . . . . 0.0 109.741 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.73 158.04 19.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 0.0 109.265 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.9 tp -151.83 107.45 3.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.102 -0.999 . . . . 0.0 109.891 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.405 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 41.0 m -81.43 95.23 7.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.152 -0.968 . . . . 0.0 109.058 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.787 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -99.7 168.62 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.397 -0.814 . . . . 0.0 110.163 -179.3 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.572 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 37.0 mttt -88.28 168.21 17.08 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.727 ' HA ' HG11 ' A' ' 103' ' ' VAL . 32.5 Cg_endo -75.54 82.77 2.03 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 121.872 1.714 . . . . 0.0 110.559 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 132.05 -13.52 5.23 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.434 ' OD2' ' HG3' ' A' ' 24' ' ' LYS . 6.8 m-20 -54.8 -176.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.16 -1.2 . . . . 0.0 109.699 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.828 HG23 ' HA ' ' A' ' 75' ' ' THR . 0.2 OUTLIER -122.1 138.77 54.33 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.365 -0.834 . . . . 0.0 109.495 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.955 HG21 HD11 ' A' ' 101' ' ' ILE . 2.0 t -118.09 137.2 52.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.172 -0.955 . . . . 0.0 109.598 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -115.18 125.6 53.6 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.246 -0.909 . . . . 0.0 109.861 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.597 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -124.69 101.48 7.13 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.598 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 1.5 mp -97.08 178.15 5.36 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.294 -0.879 . . . . 0.0 110.926 -178.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 2.8 p-10 -97.37 164.13 12.59 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.753 -0.592 . . . . 0.0 109.741 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 7' ' ' LEU . 23.7 t30 -109.35 -85.18 0.54 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.137 -0.977 . . . . 0.0 108.962 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HG2' ' ND2' ' A' ' 34' ' ' ASN . 10.5 ptmt -150.91 29.75 0.66 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.386 -0.821 . . . . 0.0 108.911 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.575 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 3.0 t -148.68 58.5 3.65 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.575 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 35.7 Cg_endo -77.65 175.06 11.7 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.564 2.176 . . . . 0.0 110.781 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.566 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.9 Cg_endo -85.45 161.96 61.32 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 123.537 -1.443 . . . . 0.0 110.614 -1.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.718 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 65.5 m-70 -120.21 142.25 49.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.357 -0.839 . . . . 0.0 109.845 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 6.6 m120 -130.83 126.4 36.18 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.545 ' HB ' ' NE2' ' A' ' 61' ' ' HIS . 1.2 t -99.57 135.7 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.209 -0.932 . . . . 0.0 109.108 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.622 HG12 ' H ' ' A' ' 43' ' ' PHE . 2.2 t -140.07 178.04 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.332 -0.855 . . . . 0.0 109.24 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.622 ' H ' HG12 ' A' ' 42' ' ' VAL . 17.6 m-85 -137.56 120.85 16.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.189 -0.945 . . . . 0.0 109.479 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 43' ' ' PHE . 5.9 t0 -54.28 -166.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.423 -0.798 . . . . 0.0 109.785 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -147.69 25.8 1.05 Allowed 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.239 -0.913 . . . . 0.0 109.614 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -119.42 -10.13 9.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.407 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.597 HD13 ' OG1' ' A' ' 86' ' ' THR . 4.7 mt -110.82 55.68 0.65 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.281 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' A' ' 48' ' ' ASN . 0.9 OUTLIER -120.01 152.96 54.91 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.258 -0.901 . . . . 0.0 109.476 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.92 -19.86 12.12 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.669 2.246 . . . . 0.0 110.644 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.47 ' O ' ' HG3' ' A' ' 51' ' ' LYS . . . -126.57 29.89 5.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.065 -1.022 . . . . 0.0 109.71 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER 34.46 59.21 0.65 Allowed 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.153 0.501 . . . . 0.0 110.33 179.665 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.8 m -132.49 171.72 13.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.15 -0.969 . . . . 0.0 109.543 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.82 16.8 0.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 109.758 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 54' ' ' ASP . 2.0 p-10 -71.11 -23.13 62.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.16 -0.963 . . . . 0.0 109.444 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.525 ' HG ' ' N ' ' A' ' 56' ' ' ALA . 1.1 pp -87.63 -27.7 22.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.242 -0.911 . . . . 0.0 109.501 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.525 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -79.73 -31.33 41.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 0.0 109.959 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -58.08 -31.54 67.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.166 -0.959 . . . . 0.0 109.745 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.5 p -105.29 -8.3 18.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.95 . . . . 0.0 110.071 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.884 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 9.3 tp -80.73 -33.02 35.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.053 -1.029 . . . . 0.0 109.297 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.479 ' HB3' ' HA ' ' A' ' 42' ' ' VAL . 0.8 OUTLIER -78.62 136.08 37.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.332 -0.855 . . . . 0.0 110.163 -179.009 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.545 ' NE2' ' HB ' ' A' ' 41' ' ' VAL . 0.4 OUTLIER -117.12 94.48 4.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.42 -0.8 . . . . 0.0 109.016 179.615 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.515 ' O ' HD13 ' A' ' 64' ' ' LEU . 0.9 OUTLIER -61.32 -12.28 13.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.307 -0.871 . . . . 0.0 110.016 -179.529 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.468 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 20.8 tt0 -43.43 122.14 2.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.142 -0.974 . . . . 0.0 109.718 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.814 ' H ' HD22 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -64.53 121.85 15.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.844 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.568 HD12 ' N ' ' A' ' 65' ' ' LEU . 8.1 mp -84.2 93.71 8.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.252 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.0 tpt -97.02 -6.56 35.07 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.268 -0.895 . . . . 0.0 109.472 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.493 ' CB ' ' HB3' ' A' ' 70' ' ' GLN . 35.1 t -84.29 138.57 39.09 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.174 -0.954 . . . . 0.0 109.325 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 67' ' ' SER . 36.3 Cg_endo -79.29 92.35 1.14 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.558 2.172 . . . . 0.0 110.86 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 91.86 24.93 24.01 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.493 ' HB3' ' CB ' ' A' ' 67' ' ' SER . 0.6 OUTLIER -137.84 89.68 2.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.242 -1.152 . . . . 0.0 109.278 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.598 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . 6.4 p -105.66 -167.92 1.38 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.154 -0.966 . . . . 0.0 109.88 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.1 t -105.6 123.08 47.33 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 73' ' ' SER . 1.7 p -78.7 109.29 12.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.985 -1.072 . . . . 0.0 109.507 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.605 HG21 ' HG ' ' A' ' 59' ' ' LEU . 24.7 m -78.44 107.3 10.98 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.422 -0.799 . . . . 0.0 109.555 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.828 ' HA ' HG23 ' A' ' 28' ' ' THR . 18.7 m -79.55 93.57 5.47 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.248 -0.907 . . . . 0.0 109.034 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.884 ' CZ ' HD21 ' A' ' 59' ' ' LEU . 3.3 m-85 -44.08 156.74 0.31 Allowed Pre-proline 0 N--CA 1.487 1.407 0 O-C-N 121.401 -0.812 . . . . 0.0 109.268 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.442 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.0 Cg_endo -76.86 168.21 23.91 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.818 2.345 . . . . 0.0 111.788 -179.061 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.66 8.18 15.19 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 80' ' ' ALA . 2.8 m-20 -98.87 -8.05 26.32 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.329 -0.857 . . . . 0.0 108.957 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.689 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -36.61 98.13 0.15 Allowed Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.809 -0.557 . . . . 0.0 109.702 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.455 ' N ' ' O ' ' A' ' 79' ' ' ASP . 35.3 Cg_endo -76.68 155.42 35.31 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.536 2.157 . . . . 0.0 110.628 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.54 108.34 1.64 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 109.636 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -175.44 -177.17 44.3 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 pm0 -107.69 143.79 35.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.22 -1.165 . . . . 0.0 109.661 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.555 ' CD1' HG22 ' A' ' 101' ' ' ILE . 17.9 m-85 -118.85 165.45 14.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.306 -0.872 . . . . 0.0 109.066 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.597 ' OG1' HD13 ' A' ' 47' ' ' LEU . 44.7 m -146.06 109.26 4.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.139 -0.976 . . . . 0.0 110.045 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.564 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.8 OUTLIER -106.27 160.11 15.6 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.338 -0.851 . . . . 0.0 109.16 179.435 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 88' ' ' TYR . 16.0 p90 -146.17 -168.04 2.89 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.192 -0.942 . . . . 0.0 109.59 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 0.1 OUTLIER -120.51 140.89 50.8 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.339 -0.85 . . . . 0.0 109.707 -179.597 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.601 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.6 tt0 -75.64 -45.73 4.2 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.291 -0.881 . . . . 0.0 109.892 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.2 Cg_endo -78.34 -51.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.14 0 C-N-CA 121.898 1.732 . . . . 0.0 110.562 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.718 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 19.8 m80 -90.25 43.58 1.15 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.137 -0.977 . . . . 0.0 109.316 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.484 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -59.38 -57.73 11.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -0.88 . . . . 0.0 109.521 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -81.23 49.82 4.07 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -138.63 38.19 2.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -1.151 . . . . 0.0 109.431 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.482 ' O ' HG12 ' A' ' 15' ' ' VAL . . . 47.58 30.47 6.39 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.521 ' HE2' ' C ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -92.32 68.56 5.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.221 -1.164 . . . . 0.0 109.203 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.2 t -136.12 112.06 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.912 . . . . 0.0 109.579 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.564 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -108.96 -171.54 20.94 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.489 ' HG2' ' HA ' ' A' ' 86' ' ' THR . 14.5 mttp -159.12 119.62 3.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -1.157 . . . . 0.0 109.855 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.955 HD11 HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -82.96 143.34 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.089 -1.007 . . . . 0.0 108.47 179.19 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.405 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -119.54 95.93 4.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.149 -0.969 . . . . 0.0 109.041 179.648 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.731 HG22 ' CD1' ' A' ' 23' ' ' ILE . 2.1 t -99.86 131.81 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.272 -0.893 . . . . 0.0 109.655 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.292 -0.88 . . . . 0.0 109.305 179.929 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.27 0.557 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -94.06 136.95 33.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.242 -0.911 . . . . 0.0 109.529 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.87 102.84 7.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.885 . . . . 0.0 109.557 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.899 HG22 ' O ' ' A' ' 30' ' ' GLU . 2.8 m -91.79 48.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.231 -0.918 . . . . 0.0 109.614 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -47.54 92.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 109.43 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -53.97 170.54 0.12 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.228 -0.92 . . . . 0.0 109.665 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.496 ' HA3' ' HB2' ' A' ' 34' ' ' ASN . . . 74.35 122.29 0.1 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.1 p -68.55 -70.12 0.29 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.218 -1.166 . . . . 0.0 109.545 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 179.79 -59.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 109.358 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -140.06 41.25 1.96 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.284 -0.885 . . . . 0.0 109.517 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.95 -97.17 0.34 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 mt -116.7 170.51 8.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.262 -1.14 . . . . 0.0 109.691 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.779 HD11 ' HB ' ' A' ' 36' ' ' VAL . 46.0 mt -100.08 120.07 39.27 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.374 -0.829 . . . . 0.0 108.987 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 14' ' ' LEU . 1.4 m -159.95 145.97 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.076 -1.015 . . . . 0.0 109.716 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.497 ' HA ' ' HA ' ' A' ' 7' ' ' LEU . 7.2 m-85 -56.68 154.53 8.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 109.046 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 42.5 mt-10 -145.29 109.65 4.59 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.124 -0.985 . . . . 0.0 109.448 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 35.7 Cg_endo -78.8 174.8 49.34 Favored 'Cis proline' 0 C--N 1.312 -1.354 0 C-N-CA 123.904 -1.29 . . . . 0.0 110.491 0.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.75 -62.37 1.41 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.14 -0.975 . . . . 0.0 109.053 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -89.5 154.04 20.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.35 -0.844 . . . . 0.0 108.787 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.843 ' CD1' HG12 ' A' ' 5' ' ' VAL . 1.2 mt -147.12 135.88 22.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.951 -1.093 . . . . 0.0 110.216 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 102' ' ' THR . 28.6 m -109.03 98.12 7.64 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.755 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -102.35 177.69 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.396 -0.815 . . . . 0.0 110.156 -179.277 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.55 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -101.2 174.73 2.73 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.552 ' HA ' ' CB ' ' A' ' 80' ' ' ALA . 34.9 Cg_endo -77.15 79.19 3.21 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.262 1.975 . . . . 0.0 110.505 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 134.96 -12.49 4.46 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.445 ' OD2' ' HB2' ' A' ' 24' ' ' LYS . 64.1 m-20 -55.09 -179.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.151 -1.206 . . . . 0.0 109.294 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 90.5 m -126.64 113.64 16.99 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.149 -0.97 . . . . 0.0 109.658 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.815 HG21 HD11 ' A' ' 101' ' ' ILE . 2.0 t -104.74 131.0 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.149 -0.969 . . . . 0.0 109.53 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.899 ' O ' HG22 ' A' ' 5' ' ' VAL . 1.7 mp0 -101.84 155.54 18.07 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.249 -0.907 . . . . 0.0 109.696 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -148.35 85.25 1.51 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.572 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.5 OUTLIER -97.55 179.51 4.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.362 -0.836 . . . . 0.0 110.942 -178.491 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 2.1 p-10 -90.09 157.01 17.98 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.591 -0.693 . . . . 0.0 109.263 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.496 ' HB2' ' HA3' ' A' ' 8' ' ' GLY . 3.8 t30 -97.59 -73.65 0.6 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.982 -1.074 . . . . 0.0 109.338 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.494 ' C ' HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -163.5 31.91 0.09 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 108.923 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.779 ' HB ' HD11 ' A' ' 14' ' ' LEU . 27.8 t -157.47 63.95 3.03 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.603 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 33.6 Cg_endo -77.32 177.33 8.98 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 123.097 2.531 . . . . 0.0 111.026 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.603 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 39.7 Cg_endo -87.28 158.81 48.42 Favored 'Cis proline' 0 C--N 1.313 -1.316 0 O-C-N 123.698 1.367 . . . . 0.0 111.328 -1.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.703 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 65.3 m-70 -119.55 141.52 49.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.707 -0.62 . . . . 0.0 109.388 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -117.99 119.36 34.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.872 . . . . 0.0 108.94 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.574 ' HB ' ' NE2' ' A' ' 61' ' ' HIS . 2.0 t -100.42 128.48 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.131 -0.98 . . . . 0.0 109.8 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.916 HG12 ' CB ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -157.3 165.5 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.546 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.64 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.4 OUTLIER -124.03 134.61 53.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.099 -1.001 . . . . 0.0 109.284 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -66.97 133.35 49.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.348 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.542 ' HB1' ' CB ' ' A' ' 53' ' ' ALA . . . -82.37 10.63 6.7 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.27 -0.894 . . . . 0.0 109.918 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.8 19.65 13.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.129 -0.982 . . . . 0.0 109.437 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.26 49.88 2.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -0.934 . . . . 0.0 109.687 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.521 ' OD1' ' CA ' ' A' ' 51' ' ' LYS . 1.5 p30 -118.26 160.47 39.32 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.347 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.482 ' HG2' ' HB2' ' A' ' 81' ' ' PRO . 36.3 Cg_endo -77.82 -5.31 15.24 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.512 2.142 . . . . 0.0 110.662 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -125.46 27.36 6.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.115 -0.991 . . . . 0.0 109.62 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.521 ' CA ' ' OD1' ' A' ' 48' ' ' ASN . 3.6 ptmt 34.0 38.55 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.134 0.493 . . . . 0.0 110.39 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.51 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 1.8 m -115.47 170.19 8.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.083 -1.011 . . . . 0.0 109.676 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.542 ' CB ' ' HB1' ' A' ' 45' ' ' ALA . . . -139.68 51.9 1.73 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.958 . . . . 0.0 109.57 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -115.38 -42.07 3.2 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.311 -0.868 . . . . 0.0 109.493 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.94 HD22 ' HG3' ' A' ' 81' ' ' PRO . 1.8 pp -56.71 -28.18 60.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.892 . . . . 0.0 109.498 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.477 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -79.93 -35.06 38.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.929 . . . . 0.0 109.538 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -51.1 -22.92 2.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.177 -0.952 . . . . 0.0 109.373 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.1 m -123.18 18.42 9.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.626 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.878 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 12.3 tp -119.69 -41.97 2.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.11 -0.994 . . . . 0.0 109.635 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.916 ' CB ' HG12 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -78.04 127.44 32.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.384 -179.445 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.746 ' CG ' HG21 ' A' ' 72' ' ' THR . 0.5 OUTLIER -108.63 137.14 47.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.374 -0.829 . . . . 0.0 109.486 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -85.83 -159.74 0.48 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.227 -0.921 . . . . 0.0 109.51 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.518 ' CB ' ' O ' ' A' ' 62' ' ' LYS . 1.6 tt0 77.33 136.4 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.408 -0.807 . . . . 0.0 109.533 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.461 ' HB2' ' CE ' ' A' ' 66' ' ' MET . 5.2 mp -85.91 133.5 33.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.451 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.755 HD22 ' HA ' ' A' ' 71' ' ' SER . 9.9 mt -80.12 124.21 28.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 0.0 109.48 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.461 ' CE ' ' HB2' ' A' ' 64' ' ' LEU . 6.7 mtt -124.99 4.58 7.98 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.25 -0.906 . . . . 0.0 109.601 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.464 ' OG ' ' HB3' ' A' ' 70' ' ' GLN . 47.4 t -91.89 142.33 26.39 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.188 -0.945 . . . . 0.0 109.332 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.6 86.3 1.7 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.62 2.213 . . . . 0.0 110.892 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.528 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 95.23 44.41 3.27 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.487 ' HA ' HD23 ' A' ' 32' ' ' LEU . 3.6 tp60 -162.32 101.45 1.08 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.243 -1.151 . . . . 0.0 109.244 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.755 ' HA ' HD22 ' A' ' 65' ' ' LEU . 3.2 p -112.11 -103.77 0.4 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.405 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.746 HG21 ' CG ' ' A' ' 61' ' ' HIS . 9.0 t -161.02 117.94 2.3 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.0 t -78.54 116.58 19.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.957 -1.089 . . . . 0.0 109.895 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.436 ' HG1' ' HE1' ' A' ' 31' ' ' PHE . 0.6 OUTLIER -95.52 105.05 16.98 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 76' ' ' PHE . 41.4 m -78.91 92.27 4.89 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.248 -0.907 . . . . 0.0 108.905 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.878 ' CZ ' HD21 ' A' ' 59' ' ' LEU . 7.0 m-85 -42.8 161.34 0.19 Allowed Pre-proline 0 N--CA 1.488 1.442 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.477 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 33.1 Cg_endo -75.45 159.04 40.11 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.346 2.031 . . . . 0.0 111.185 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.54 -5.64 20.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.551 -0.718 . . . . 0.0 109.644 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 80' ' ' ALA . 0.9 OUTLIER -99.41 -65.6 0.95 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.187 -0.946 . . . . 0.0 109.284 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.552 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . . . 61.26 133.09 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.337 -0.852 . . . . 0.0 109.407 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.94 ' HG3' HD22 ' A' ' 55' ' ' LEU . 36.1 Cg_endo -78.42 99.75 1.3 Allowed 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.345 2.03 . . . . 0.0 110.284 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 81' ' ' PRO . . . -41.42 117.82 0.96 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.378 -0.826 . . . . 0.0 109.683 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.454 ' HA3' ' HG3' ' A' ' 49' ' ' PRO . . . 156.13 -156.31 26.98 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.599 ' HG3' HG23 ' A' ' 102' ' ' THR . 0.4 OUTLIER -122.0 126.1 47.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -1.167 . . . . 0.0 109.508 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.627 ' CD2' ' CG2' ' A' ' 101' ' ' ILE . 1.5 m-30 -92.89 -164.7 1.21 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.889 . . . . 0.0 108.941 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.491 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 65.4 m -167.19 111.68 0.72 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.868 -1.145 . . . . 0.0 110.505 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 0.7 OUTLIER -112.05 157.4 20.8 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.378 -0.826 . . . . 0.0 108.774 178.729 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.783 ' CB ' HG22 ' A' ' 98' ' ' VAL . 24.2 p90 -145.47 -162.93 1.61 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.013 -1.055 . . . . 0.0 109.916 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.502 ' O ' ' HB3' ' A' ' 93' ' ' ARG . 0.1 OUTLIER -126.94 129.14 47.57 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.373 -0.83 . . . . 0.0 109.829 -179.265 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.613 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.3 tt0 -65.77 -43.77 60.99 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.264 -0.898 . . . . 0.0 110.264 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.4 Cg_endo -78.35 -52.64 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 121.889 1.726 . . . . 0.0 110.446 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.703 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 9.2 m80 -90.21 34.23 0.87 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.172 -0.955 . . . . 0.0 109.24 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.502 ' HB3' ' O ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -64.52 126.53 28.13 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.237 -0.914 . . . . 0.0 109.532 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 92.31 2.33 68.35 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.538 ' HB3' ' HE3' ' A' ' 97' ' ' MET . . . -98.23 32.97 2.29 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.117 -1.225 . . . . 0.0 109.414 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.39 7.09 37.58 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.538 ' HE3' ' HB3' ' A' ' 95' ' ' ALA . 16.7 mtm -90.75 63.28 5.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.976 -1.308 . . . . 0.0 109.598 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.783 HG22 ' CB ' ' A' ' 88' ' ' TYR . 84.2 t -140.52 76.24 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.387 -0.82 . . . . 0.0 109.41 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.489 ' O ' ' CG ' ' A' ' 100' ' ' LYS . . . -72.27 -167.72 10.22 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.491 ' HG2' ' HA ' ' A' ' 86' ' ' THR . 5.7 mtmt -159.25 131.37 6.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.355 -1.085 . . . . 0.0 109.484 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.865 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 0.4 OUTLIER -82.59 133.37 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.12 -0.987 . . . . 0.0 108.925 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.599 HG23 ' HG3' ' A' ' 84' ' ' GLU . 7.6 m -116.31 91.75 3.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.257 -0.902 . . . . 0.0 109.038 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.521 HG22 HG13 ' A' ' 23' ' ' ILE . 2.1 t -99.42 135.92 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.205 -0.935 . . . . 0.0 109.6 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.259 -0.901 . . . . 0.0 109.472 -179.975 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.64 ' CD2' HG22 ' A' ' 23' ' ' ILE . 83.4 m-85 -96.93 168.78 10.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.935 . . . . 0.0 109.301 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.6 m -156.99 144.17 18.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 109.761 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.689 HG12 ' H ' ' A' ' 17' ' ' GLU . 2.5 t -128.96 69.57 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.392 -0.817 . . . . 0.0 109.0 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -51.07 106.74 0.14 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.389 -0.819 . . . . 0.0 110.017 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.624 HD11 ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -90.86 150.91 21.36 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.292 -0.88 . . . . 0.0 109.054 179.399 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.452 ' HA3' ' CB ' ' A' ' 34' ' ' ASN . . . 117.6 66.88 0.35 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.511 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -51.22 -23.32 3.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.162 -1.199 . . . . 0.0 109.262 179.646 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.511 ' CB ' ' O ' ' A' ' 9' ' ' SER . 10.5 t0 80.4 29.54 0.23 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.609 -0.682 . . . . 0.0 109.45 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.78 19.12 10.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -0.9 . . . . 0.0 109.209 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.18 11.11 53.47 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.802 ' C ' HD23 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -156.88 143.87 18.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.328 -1.101 . . . . 0.0 109.419 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.877 HD11 ' HB ' ' A' ' 36' ' ' VAL . 1.1 mt -101.93 143.44 31.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.181 -0.949 . . . . 0.0 109.315 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 14' ' ' LEU . 1.8 m -154.57 128.78 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.92 . . . . 0.0 109.601 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.639 ' HD2' HG11 ' A' ' 5' ' ' VAL . 38.2 m-85 -48.83 142.01 6.84 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.188 -0.945 . . . . 0.0 109.106 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.689 ' H ' HG12 ' A' ' 5' ' ' VAL . 19.4 mt-10 -136.56 109.71 9.49 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.273 -0.892 . . . . 0.0 109.254 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.474 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 34.9 Cg_endo -77.29 -178.03 22.92 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 123.73 -1.362 . . . . 0.0 110.64 0.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.19 4.29 20.73 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.244 -0.91 . . . . 0.0 109.763 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 5.2 pttt -146.06 160.72 41.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.149 -0.969 . . . . 0.0 109.488 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.678 HD12 HG22 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -157.73 136.62 11.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.187 -0.946 . . . . 0.0 109.48 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.0 m -104.93 99.16 8.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.296 -0.878 . . . . 0.0 109.286 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.792 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -99.48 173.47 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.234 -0.916 . . . . 0.0 109.523 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.582 ' CG ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -95.33 177.54 1.76 Allowed Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.044 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.684 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 34.7 Cg_endo -76.41 72.72 5.39 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.088 1.859 . . . . 0.0 110.342 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 126.18 28.6 1.0 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.18 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.517 ' OD1' ' CB ' ' A' ' 24' ' ' LYS . 4.5 m-20 -88.13 -165.84 1.43 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.205 -1.173 . . . . 0.0 108.852 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.731 HG23 ' HA ' ' A' ' 75' ' ' THR . 21.4 m -136.56 110.56 8.26 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.956 -1.09 . . . . 0.0 109.695 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.993 HG21 HD11 ' A' ' 101' ' ' ILE . 1.7 t -99.36 136.13 31.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.321 -0.862 . . . . 0.0 109.102 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -104.76 142.54 34.52 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.104 -0.997 . . . . 0.0 110.198 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.592 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -139.7 142.63 36.87 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.375 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.732 HD23 ' N ' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -140.94 -169.95 2.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.894 -1.129 . . . . 0.0 110.523 -179.383 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.514 ' OD1' ' HA ' ' A' ' 68' ' ' PRO . 6.4 p-10 -114.9 154.28 28.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.467 -0.771 . . . . 0.0 109.352 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 7' ' ' LEU . 35.3 t30 -100.38 -88.09 0.36 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.024 -1.047 . . . . 0.0 109.637 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.403 ' C ' HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -144.14 33.72 1.22 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.073 -1.017 . . . . 0.0 109.197 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.877 ' HB ' HD11 ' A' ' 14' ' ' LEU . 92.3 t -153.77 64.53 4.88 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.478 -0.763 . . . . 0.0 109.135 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.564 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.5 Cg_endo -79.79 175.85 10.09 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.775 2.317 . . . . 0.0 110.455 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.564 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.8 Cg_endo -86.24 -172.93 8.84 Favored 'Cis proline' 0 C--N 1.31 -1.46 0 C-N-CA 123.655 -1.394 . . . . 0.0 110.65 -1.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.803 ' NE2' HD12 ' A' ' 14' ' ' LEU . 68.3 m80 -137.91 159.23 42.55 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.38 -0.825 . . . . 0.0 109.583 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -138.71 118.33 13.04 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.5 t -99.58 111.45 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.668 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.492 ' HA ' ' CB ' ' A' ' 60' ' ' SER . 13.8 t -135.91 162.64 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.338 -0.851 . . . . 0.0 109.311 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.915 ' CE2' HD23 ' A' ' 59' ' ' LEU . 20.1 m-85 -115.88 120.75 40.23 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.262 -0.899 . . . . 0.0 109.62 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.633 ' OD2' HD23 ' A' ' 47' ' ' LEU . 39.8 t0 -44.08 140.54 2.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.415 -0.803 . . . . 0.0 109.768 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.7 1.06 55.49 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.339 -0.851 . . . . 0.0 109.646 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.58 -26.19 13.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.551 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.633 HD23 ' OD2' ' A' ' 44' ' ' ASP . 4.0 mm? -95.49 61.73 2.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 109.265 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 52' ' ' SER . 2.3 p30 -107.59 150.06 39.67 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.324 -0.86 . . . . 0.0 109.487 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.491 ' HB3' ' HA3' ' A' ' 83' ' ' GLY . 35.8 Cg_endo -77.96 -9.78 16.76 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.616 2.211 . . . . 0.0 110.331 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.452 ' C ' ' HG2' ' A' ' 51' ' ' LYS . . . -134.55 31.59 3.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.27 -0.894 . . . . 0.0 109.452 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.462 ' HA ' ' OD1' ' A' ' 48' ' ' ASN . 27.3 pttt 36.47 39.08 0.09 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.814 -0.554 . . . . 0.0 110.166 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.522 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 6.0 m -108.76 -157.63 0.62 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.568 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -169.07 33.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -0.859 . . . . 0.0 109.508 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.19 -42.26 3.76 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.215 -0.928 . . . . 0.0 109.826 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.672 ' C ' HD12 ' A' ' 55' ' ' LEU . 2.0 pp -47.35 -33.32 5.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 109.449 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.84 -37.41 24.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 109.483 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.77 -31.26 2.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 0.0 109.388 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.4 p -115.02 31.67 6.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.245 -0.909 . . . . 0.0 109.39 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.919 HD21 ' CE2' ' A' ' 76' ' ' PHE . 8.3 tp -131.37 -52.71 1.02 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.926 . . . . 0.0 109.613 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.51 ' OG ' ' CD2' ' A' ' 43' ' ' PHE . 10.2 m -77.37 160.37 28.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 110.29 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.546 ' CE1' ' O ' ' A' ' 63' ' ' GLN . 18.9 p80 -119.99 147.29 44.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.531 -0.731 . . . . 0.0 109.336 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.52 -55.86 3.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -0.945 . . . . 0.0 109.529 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.546 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -46.74 120.84 3.18 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.347 -0.846 . . . . 0.0 109.665 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.659 ' H ' HD12 ' A' ' 64' ' ' LEU . 6.3 mp -66.48 162.06 21.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.091 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.848 HD13 ' HA ' ' A' ' 71' ' ' SER . 0.5 OUTLIER -109.06 152.07 25.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.051 -1.031 . . . . 0.0 109.692 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 3.4 mtp -136.6 7.45 3.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.314 -0.866 . . . . 0.0 109.548 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.52 ' HB3' ' CG ' ' A' ' 70' ' ' GLN . 8.4 t -79.27 134.53 58.84 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.235 -0.916 . . . . 0.0 109.347 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.514 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 35.9 Cg_endo -78.44 90.1 1.29 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.721 2.28 . . . . 0.0 111.612 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.514 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 113.17 34.76 1.74 Allowed Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.63 -1.272 . . . . 0.0 110.678 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.534 ' N ' ' HB2' ' A' ' 32' ' ' LEU . 0.7 OUTLIER 177.01 119.93 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.01 -1.288 . . . . 0.0 109.669 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.848 ' HA ' HD13 ' A' ' 65' ' ' LEU . 60.2 p -109.97 -75.14 0.63 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.284 -0.885 . . . . 0.0 109.325 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.539 ' N ' ' OG ' ' A' ' 71' ' ' SER . 1.6 t -160.75 107.84 1.52 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.186 -0.946 . . . . 0.0 109.633 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.3 t -78.78 85.01 4.81 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.026 -1.046 . . . . 0.0 108.298 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.786 HG21 ' HG ' ' A' ' 59' ' ' LEU . 22.6 m -75.63 108.37 8.42 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.523 -0.736 . . . . 0.0 110.378 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.731 ' HA ' HG23 ' A' ' 28' ' ' THR . 3.2 t -79.13 87.99 4.86 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 1.004 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 30.1 m-85 -36.69 150.75 0.12 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.782 -0.574 . . . . 0.0 110.314 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.508 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 35.2 Cg_endo -76.74 161.36 33.7 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.995 2.463 . . . . 0.0 111.501 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.49 6.57 10.01 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.5 ' O ' ' C ' ' A' ' 80' ' ' ALA . 3.1 p30 -98.87 -4.84 32.11 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.286 -0.884 . . . . 0.0 109.096 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.684 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -33.82 105.27 0.25 Allowed Pre-proline 0 N--CA 1.498 1.961 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 82' ' ' ALA . 35.9 Cg_endo -77.84 41.44 1.0 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.522 2.148 . . . . 0.0 111.407 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.519 ' HA ' ' HB ' ' A' ' 103' ' ' VAL . . . 46.87 -178.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -0.866 . . . . 0.0 110.006 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.491 ' HA3' ' HB3' ' A' ' 49' ' ' PRO . . . 94.21 -168.14 28.22 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -111.92 153.83 26.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.522 -0.987 . . . . 0.0 109.635 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.448 ' O ' ' HB ' ' A' ' 86' ' ' THR . 19.8 m-30 -113.63 -39.32 4.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.392 -0.817 . . . . 0.0 108.92 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.448 ' HB ' ' O ' ' A' ' 85' ' ' TYR . 92.4 m 61.79 100.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.313 -0.867 . . . . 0.0 110.333 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -105.05 173.17 6.42 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.203 -0.936 . . . . 0.0 108.905 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 97' ' ' MET . 16.7 p90 -155.39 -164.07 1.68 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.893 -1.13 . . . . 0.0 110.046 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.516 ' HB2' ' HB3' ' A' ' 97' ' ' MET . 0.6 OUTLIER -136.75 144.75 43.96 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.424 -0.798 . . . . 0.0 109.447 -179.692 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.604 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 40.6 tt0 -83.12 -45.07 0.86 Allowed Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.264 -0.898 . . . . 0.0 110.433 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.0 Cg_endo -78.31 -46.93 0.11 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.048 1.832 . . . . 0.0 110.902 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.607 ' HE2' HG12 ' A' ' 36' ' ' VAL . 68.7 m80 -87.79 18.07 4.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.014 -1.054 . . . . 0.0 109.643 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -53.25 135.94 37.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.127 -0.983 . . . . 0.0 109.421 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.05 -8.25 80.29 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.12 38.66 1.37 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.16 -1.2 . . . . 0.0 109.603 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.98 12.5 29.78 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.516 ' HB3' ' HB2' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -81.92 56.8 3.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.179 -1.189 . . . . 0.0 109.699 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 88' ' ' TYR . 21.6 t -139.6 72.15 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.104 -0.998 . . . . 0.0 109.947 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.438 ' C ' ' CG ' ' A' ' 100' ' ' LYS . . . -80.95 -173.23 47.18 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.438 ' CG ' ' C ' ' A' ' 99' ' ' GLY . 0.1 OUTLIER -152.15 136.23 16.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.933 -1.334 . . . . 0.0 110.148 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 1.004 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -86.58 119.54 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.172 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.74 103.42 15.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.217 -0.927 . . . . 0.0 109.099 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.724 HG22 ' CD1' ' A' ' 23' ' ' ILE . 17.3 t -99.19 68.45 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.487 -0.758 . . . . 0.0 109.444 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.468 0 O-C-N 121.316 -0.865 . . . . 0.0 109.275 -179.996 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.6 m . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.285 0.564 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.518 ' CD2' HG22 ' A' ' 23' ' ' ILE . 23.5 m-85 -84.35 108.88 17.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.731 ' CG2' HD21 ' A' ' 32' ' ' LEU . 52.9 m -109.58 150.06 28.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.564 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.722 HG12 ' H ' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -113.43 160.84 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -0.924 . . . . 0.0 109.227 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -125.75 101.1 6.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.929 . . . . 0.0 109.505 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.611 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -89.19 170.98 10.14 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.168 -0.958 . . . . 0.0 109.252 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.85 ' CA ' HD23 ' A' ' 14' ' ' LEU . . . 86.52 77.39 1.23 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 13' ' ' LEU . 99.7 p -44.29 -65.65 0.49 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -1.151 . . . . 0.0 109.218 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 9' ' ' SER . 0.4 OUTLIER 168.47 -25.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.07 179.631 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -113.77 49.54 0.98 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.059 -1.025 . . . . 0.0 110.078 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.22 -37.85 3.24 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' A' ' 9' ' ' SER . 2.9 mp -69.61 118.85 13.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.124 -1.221 . . . . 0.0 109.578 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.85 HD23 ' CA ' ' A' ' 8' ' ' GLY . 0.5 OUTLIER -116.19 110.81 19.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.349 -0.844 . . . . 0.0 109.488 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.68 133.34 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.345 -0.847 . . . . 0.0 109.516 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -49.31 153.73 0.98 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.045 -1.034 . . . . 0.0 109.097 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.722 ' H ' HG12 ' A' ' 5' ' ' VAL . 5.7 mt-10 -143.0 109.06 5.44 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.156 -0.965 . . . . 0.0 109.445 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 35.0 Cg_endo -77.21 179.56 30.84 Favored 'Cis proline' 0 C--N 1.312 -1.368 0 C-N-CA 123.82 -1.325 . . . . 0.0 110.491 0.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.68 -44.08 71.18 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.214 -0.929 . . . . 0.0 108.877 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.29 139.6 40.54 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.613 ' CD1' HG22 ' A' ' 5' ' ' VAL . 1.7 mt -126.79 126.66 43.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 110.088 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 102' ' ' THR . 18.8 m -89.26 97.83 11.42 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.86 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -99.3 172.49 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.149 -0.969 . . . . 0.0 109.865 -179.387 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.503 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 0.3 OUTLIER -86.31 175.55 4.34 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.419 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.612 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 35.8 Cg_endo -78.0 72.84 5.99 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.377 2.052 . . . . 0.0 110.962 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 129.08 -9.75 6.28 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.22 -1.467 . . . . 0.0 110.603 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.487 ' OD1' ' HB2' ' A' ' 24' ' ' LYS . 1.2 m-20 -50.54 -178.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.093 -1.239 . . . . 0.0 109.085 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.579 HG23 ' HA ' ' A' ' 75' ' ' THR . 23.8 m -117.4 118.37 32.03 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.036 -1.04 . . . . 0.0 109.676 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.955 HG21 HD11 ' A' ' 101' ' ' ILE . 1.7 t -99.81 111.53 29.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.371 -0.83 . . . . 0.0 109.475 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.645 ' O ' HG23 ' A' ' 4' ' ' THR . 5.1 mt-10 -99.43 123.17 43.47 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.254 -0.904 . . . . 0.0 109.112 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -106.29 153.19 22.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.348 -0.845 . . . . 0.0 109.109 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.731 HD21 ' CG2' ' A' ' 4' ' ' THR . 0.0 OUTLIER -140.54 177.81 7.75 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.09 -1.007 . . . . 0.0 110.033 -179.494 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.645 ' HB3' HD23 ' A' ' 65' ' ' LEU . 3.2 p-10 -109.45 169.64 8.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.355 -0.841 . . . . 0.0 109.268 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.539 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . 28.3 t30 -112.88 -73.68 0.66 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.01 -1.056 . . . . 0.0 109.378 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.8 ttpt -162.91 28.39 0.1 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.064 -1.023 . . . . 0.0 109.266 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.59 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 11.1 t -148.05 58.61 3.96 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.59 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 36.2 Cg_endo -77.94 174.78 12.02 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.69 2.26 . . . . 0.0 110.664 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.557 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.6 Cg_endo -86.95 158.44 50.15 Favored 'Cis proline' 0 C--N 1.309 -1.547 0 C-N-CA 123.402 -1.499 . . . . 0.0 110.713 -1.825 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.881 ' HB2' HD22 ' A' ' 65' ' ' LEU . 70.4 m-70 -113.77 125.41 54.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.483 -0.761 . . . . 0.0 108.961 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.453 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 1.8 m120 -99.85 123.96 44.65 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.292 -0.88 . . . . 0.0 109.294 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.6 t -107.8 109.49 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.243 -0.91 . . . . 0.0 109.911 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.617 HG13 ' CB ' ' A' ' 60' ' ' SER . 1.4 t -134.74 167.11 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.383 -0.823 . . . . 0.0 108.852 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.718 ' CZ ' HD12 ' A' ' 59' ' ' LEU . 7.8 m-85 -118.9 106.52 12.57 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.136 -0.977 . . . . 0.0 109.831 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -49.91 118.66 3.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.443 -0.786 . . . . 0.0 109.861 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.41 2.14 29.9 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.433 -0.792 . . . . 0.0 109.638 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -102.09 -15.03 16.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.139 -0.976 . . . . 0.0 109.753 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.0 mt -113.88 61.08 0.66 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.142 -0.974 . . . . 0.0 109.523 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.496 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 5.7 p30 -134.1 163.14 53.29 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.255 -0.903 . . . . 0.0 109.449 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.574 ' HG3' ' CA ' ' A' ' 83' ' ' GLY . 33.7 Cg_endo -77.31 -16.81 15.19 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.596 2.197 . . . . 0.0 109.423 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 52' ' ' SER . . . -135.0 77.08 1.66 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.47 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -35.88 95.43 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.351 0.596 . . . . 0.0 110.413 -179.459 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 50' ' ' ALA . 10.4 m -140.42 -174.49 3.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.423 -0.798 . . . . 0.0 109.271 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -159.86 23.94 0.18 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.934 . . . . 0.0 109.413 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -89.08 -66.03 0.96 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.279 -0.888 . . . . 0.0 109.794 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.517 ' HG ' ' N ' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -64.89 -25.31 67.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -0.929 . . . . 0.0 109.636 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.517 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -65.02 -58.18 6.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.115 -0.991 . . . . 0.0 109.343 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.45 -31.59 1.79 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.268 -0.895 . . . . 0.0 109.521 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.61 13.03 36.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.926 . . . . 0.0 109.973 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.836 ' HA ' HG21 ' A' ' 74' ' ' THR . 0.0 OUTLIER -108.0 -42.45 4.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.997 -1.064 . . . . 0.0 108.47 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.617 ' CB ' HG13 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -78.11 174.57 11.01 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.457 -0.777 . . . . 0.0 110.347 -179.418 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.795 ' HB3' HG21 ' A' ' 72' ' ' THR . 26.4 p80 -125.19 174.2 8.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.64 -0.662 . . . . 0.0 109.338 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -125.19 -12.91 6.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.156 -0.965 . . . . 0.0 109.71 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -92.59 105.66 17.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.965 . . . . 0.0 109.653 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.614 ' H ' HD12 ' A' ' 64' ' ' LEU . 4.4 mp -49.26 165.01 0.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -0.896 . . . . 0.0 109.291 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.897 HD21 ' HB2' ' A' ' 71' ' ' SER . 5.9 mp -81.49 137.4 35.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.124 -0.985 . . . . 0.0 109.546 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.93 -2.56 5.22 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.368 -0.832 . . . . 0.0 109.538 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.3 t -116.0 144.93 33.74 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.141 -0.975 . . . . 0.0 109.247 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.58 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.6 Cg_endo -80.91 83.46 2.21 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.645 2.23 . . . . 0.0 111.608 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.542 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 124.94 45.41 0.26 Allowed Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.121 -1.514 . . . . 0.0 111.437 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.484 ' HB3' ' O ' ' A' ' 69' ' ' GLY . 4.1 pt20 170.15 117.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.014 -1.286 . . . . 0.0 109.974 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.897 ' HB2' HD21 ' A' ' 65' ' ' LEU . 2.8 p -115.51 -146.82 0.41 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.226 -0.922 . . . . 0.0 109.09 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.795 HG21 ' HB3' ' A' ' 61' ' ' HIS . 96.4 m -95.15 100.67 12.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.098 -1.001 . . . . 0.0 109.951 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' A' ' 30' ' ' GLU . 42.4 p -79.99 111.71 16.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.229 -0.919 . . . . 0.0 108.884 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.836 HG21 ' HA ' ' A' ' 59' ' ' LEU . 1.9 m -98.63 129.09 45.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 109.86 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.579 ' HA ' HG23 ' A' ' 28' ' ' THR . 0.1 OUTLIER -82.65 96.81 8.24 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.139 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.727 ' CD2' HD21 ' A' ' 59' ' ' LEU . 26.1 m-85 -45.58 153.12 0.62 Allowed Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 121.066 -1.021 . . . . 0.0 108.862 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.509 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.3 Cg_endo -77.11 165.38 28.17 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.5 2.133 . . . . 0.0 111.421 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.93 8.0 6.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.46 -0.775 . . . . 0.0 109.535 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 81' ' ' PRO . 2.4 m-20 -99.08 -12.5 20.47 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.045 -1.034 . . . . 0.0 109.006 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.612 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -32.85 93.58 0.06 OUTLIER Pre-proline 0 N--CA 1.5 2.041 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.534 ' N ' ' O ' ' A' ' 79' ' ' ASP . 36.3 Cg_endo -78.73 163.83 26.1 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.586 2.191 . . . . 0.0 110.786 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -64.77 113.19 3.62 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.406 -0.809 . . . . 0.0 109.302 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.574 ' CA ' ' HG3' ' A' ' 49' ' ' PRO . . . -174.54 155.83 21.89 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 84' ' ' GLU . 0.7 OUTLIER -90.47 104.69 17.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -1.098 . . . . 0.0 109.706 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.461 ' CD2' HG22 ' A' ' 101' ' ' ILE . 7.7 m-30 -81.08 167.25 19.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.204 -0.935 . . . . 0.0 108.863 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.506 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 95.4 m -151.81 115.52 4.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.935 -1.103 . . . . 0.0 110.573 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.627 ' O ' HG23 ' A' ' 98' ' ' VAL . 2.0 p90 -117.4 168.63 10.18 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 98' ' ' VAL . 30.4 p90 -160.47 -162.41 0.96 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.79 -1.194 . . . . 0.0 110.645 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 1.3 m -119.07 136.41 54.16 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.69 -0.631 . . . . 0.0 109.723 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.629 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -73.17 -45.09 8.08 Favored Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.287 -0.883 . . . . 0.0 109.762 178.832 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.4 Cg_endo -78.35 -60.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.063 0 C-N-CA 121.983 1.789 . . . . 0.0 110.524 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.639 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 10.8 m80 -72.48 57.23 0.39 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.017 -1.052 . . . . 0.0 109.179 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.54 18.59 9.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.368 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.85 -34.0 2.7 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 96' ' ' GLY . . . -91.81 34.35 1.0 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.143 -1.21 . . . . 0.0 109.642 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 95' ' ' ALA . . . 41.61 61.72 2.11 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.564 ' CE ' ' HB3' ' A' ' 92' ' ' HIS . 9.3 mtt -91.64 63.97 4.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.163 -1.198 . . . . 0.0 109.35 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 87' ' ' PHE . 4.9 p -127.63 96.48 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.2 -0.937 . . . . 0.0 109.775 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.495 ' O ' ' HG3' ' A' ' 100' ' ' LYS . . . -76.47 -164.42 18.51 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.506 ' HG2' ' HA ' ' A' ' 86' ' ' THR . 26.5 mtmt -163.44 120.53 1.82 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -1.149 . . . . 0.0 109.649 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.955 HD11 HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -82.58 138.88 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.154 -0.966 . . . . 0.0 108.898 179.654 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 22' ' ' THR . 8.3 m -118.04 93.93 4.32 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.613 HG22 HG13 ' A' ' 23' ' ' ILE . 1.8 t -99.2 118.6 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.23 -0.918 . . . . 0.0 109.596 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 109.634 -179.82 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.8 m . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.593 ' HB2' HG13 ' A' ' 29' ' ' VAL . 40.0 m-85 -123.52 98.46 5.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.174 -0.954 . . . . 0.0 109.349 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.727 HG23 HD11 ' A' ' 32' ' ' LEU . 18.8 m -87.54 83.87 7.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.749 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 5' ' ' VAL . 24.7 m -82.55 107.15 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.152 -0.967 . . . . 0.0 109.454 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.495 ' HE3' ' HA2' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -92.25 100.86 13.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 109.333 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.535 ' CD2' ' O ' ' A' ' 32' ' ' LEU . 0.9 OUTLIER -59.68 172.48 0.7 Allowed 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.148 -0.97 . . . . 0.0 109.295 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.484 ' HA3' ' HB3' ' A' ' 34' ' ' ASN . . . 69.35 70.36 1.18 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.467 ' OG ' ' N ' ' A' ' 10' ' ' ASP . 86.4 p -47.67 -91.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.316 -1.108 . . . . 0.0 109.531 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.467 ' N ' ' OG ' ' A' ' 9' ' ' SER . 2.2 t0 177.36 -34.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.427 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.61 38.73 3.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.0 109.38 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.407 ' O ' HD22 ' A' ' 13' ' ' LEU . . . -154.07 -106.35 0.28 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.476 HD22 ' HA ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -149.6 -148.3 0.26 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -1.115 . . . . 0.0 109.359 -179.685 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.689 HD13 ' HE1' ' A' ' 39' ' ' HIS . 20.8 mt -98.75 109.0 21.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.945 -1.097 . . . . 0.0 109.366 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 7' ' ' LEU . 21.4 m -148.51 165.73 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.906 . . . . 0.0 109.487 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -85.79 135.18 33.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 109.407 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -125.64 108.34 26.04 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.188 -0.945 . . . . 0.0 109.542 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -78.44 175.81 45.4 Favored 'Cis proline' 0 C--N 1.312 -1.358 0 C-N-CA 123.793 -1.336 . . . . 0.0 110.465 0.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.64 -39.53 31.28 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.225 -0.922 . . . . 0.0 109.474 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.78 138.15 45.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.309 -0.87 . . . . 0.0 109.294 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.465 HD11 HG11 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -135.51 110.34 8.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 109.588 -179.872 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.489 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 97.5 m -84.14 99.23 10.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.167 -0.958 . . . . 0.0 109.291 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.862 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.5 pt -99.64 -178.37 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.288 -0.882 . . . . 0.0 109.698 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.586 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -94.91 -179.16 0.9 Allowed Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.448 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.824 ' C ' ' HB3' ' A' ' 80' ' ' ALA . 34.5 Cg_endo -77.88 66.69 8.15 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.093 1.862 . . . . 0.0 110.386 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.709 ' N ' ' HB3' ' A' ' 80' ' ' ALA . . . 121.08 73.96 0.35 Allowed Glycine 0 N--CA 1.487 2.08 0 C-N-CA 119.52 -1.324 . . . . 0.0 109.922 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.48 ' OD2' ' HG2' ' A' ' 24' ' ' LYS . 7.7 m-20 -125.77 -142.66 0.29 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.32 -1.106 . . . . 0.0 108.581 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.588 HG23 ' HA ' ' A' ' 75' ' ' THR . 44.3 m -148.04 99.49 3.07 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.944 -1.098 . . . . 0.0 109.563 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.944 ' CG2' HD11 ' A' ' 101' ' ' ILE . 2.9 t -99.87 119.45 47.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.466 -0.771 . . . . 0.0 109.044 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.482 ' C ' ' CD1' ' A' ' 31' ' ' PHE . 56.1 tt0 -99.61 156.33 17.12 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.171 -0.956 . . . . 0.0 109.81 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.483 ' CD2' ' O ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -148.34 149.13 31.26 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.727 HD11 HG23 ' A' ' 4' ' ' THR . 3.1 mp -141.97 -170.98 3.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.127 -0.983 . . . . 0.0 109.807 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.915 ' HB3' HD23 ' A' ' 65' ' ' LEU . 8.0 p-10 -113.66 159.92 19.15 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.315 -0.865 . . . . 0.0 109.441 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.495 ' HB2' ' O ' ' A' ' 7' ' ' LEU . 17.5 t30 -94.97 -94.49 0.18 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.015 -1.053 . . . . 0.0 109.301 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.54 37.29 1.34 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.173 -0.954 . . . . 0.0 109.304 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.683 ' HB ' HD21 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -150.81 62.8 5.44 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.446 -0.784 . . . . 0.0 109.004 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.539 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 35.0 Cg_endo -77.54 174.68 12.29 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.693 2.262 . . . . 0.0 110.26 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.602 ' O ' ' CG ' ' A' ' 39' ' ' HIS . 37.9 Cg_endo -83.83 -163.12 2.98 Favored 'Cis proline' 0 C--N 1.308 -1.566 0 C-N-CA 123.558 -1.434 . . . . 0.0 110.571 -0.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.689 ' HE1' HD13 ' A' ' 14' ' ' LEU . 89.4 m-70 -161.77 124.59 3.03 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.413 -0.804 . . . . 0.0 109.758 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -100.97 111.93 24.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.211 -0.931 . . . . 0.0 109.213 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 52.4 t -102.06 128.4 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 0.0 109.719 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.768 HG12 ' CB ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -159.85 167.12 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.29 -0.882 . . . . 0.0 109.496 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.508 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 3.2 m-85 -109.41 133.6 52.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.261 -0.899 . . . . 0.0 109.294 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -57.26 136.05 56.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.073 -1.017 . . . . 0.0 108.952 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.33 21.77 1.66 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.233 -0.917 . . . . 0.0 110.102 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.31 5.93 2.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.983 -1.073 . . . . 0.0 109.635 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.8 mp -113.49 41.44 2.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 0.0 109.556 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.476 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -114.03 165.34 13.83 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.346 -0.846 . . . . 0.0 109.232 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 35.5 Cg_endo -77.75 -32.08 2.9 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.615 2.21 . . . . 0.0 111.442 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -125.79 24.79 7.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.876 -1.14 . . . . 0.0 110.268 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.469 ' HA ' ' CG ' ' A' ' 48' ' ' ASN . 9.9 mtmm 36.48 91.13 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.865 -0.522 . . . . 0.0 110.182 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.463 ' HB3' ' OD1' ' A' ' 54' ' ' ASP . 73.7 m -139.92 136.49 33.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.071 -1.018 . . . . 0.0 109.681 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.24 -47.92 32.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.46 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 55' ' ' LEU . 6.8 p30 -46.45 -31.84 2.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.699 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 39.1 tp -87.68 55.2 3.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 109.36 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 55' ' ' LEU . . . 163.88 -50.27 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.347 -0.845 . . . . 0.0 109.235 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -54.91 -37.95 66.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 109.437 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.6 t -104.38 -20.07 13.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.897 . . . . 0.0 109.526 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.912 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 16.1 tp -65.04 -49.4 70.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 109.469 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.768 ' CB ' HG12 ' A' ' 42' ' ' VAL . 55.4 p -82.76 178.38 8.21 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.749 0.785 . . . . 0.0 110.936 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.461 ' CE1' ' O ' ' A' ' 63' ' ' GLN . 19.1 p80 -108.99 -154.23 0.53 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.446 ' N ' ' ND1' ' A' ' 61' ' ' HIS . 19.3 mmtt -148.05 -62.14 0.26 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.291 -0.881 . . . . 0.0 109.439 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.461 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 3.4 pm0 -46.1 148.18 0.91 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.647 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 mp -73.97 165.57 24.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 109.498 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.915 HD23 ' HB3' ' A' ' 33' ' ' ASN . 2.1 mp -82.47 126.17 31.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.368 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.01 -23.81 4.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.196 -0.94 . . . . 0.0 109.79 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.3 t -90.85 142.1 27.32 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.148 -0.97 . . . . 0.0 109.426 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.445 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 35.4 Cg_endo -78.18 101.63 1.49 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.477 2.118 . . . . 0.0 110.423 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.723 ' O ' HD23 ' A' ' 32' ' ' LEU . . . 98.93 47.41 1.91 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.411 ' N ' ' HB3' ' A' ' 32' ' ' LEU . 2.5 tt0 -170.83 94.01 0.19 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.428 -1.042 . . . . 0.0 109.232 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.858 ' CB ' HD21 ' A' ' 65' ' ' LEU . 10.6 p -103.2 -79.91 0.53 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.016 -1.053 . . . . 0.0 109.336 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.591 ' H ' ' HG ' ' A' ' 71' ' ' SER . 13.5 m -160.95 110.11 1.64 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.106 -0.996 . . . . 0.0 108.761 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.4 t -79.24 78.74 5.71 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.158 -0.964 . . . . 0.0 108.757 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.806 HG21 ' HG ' ' A' ' 59' ' ' LEU . 84.9 m -62.4 96.77 0.08 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.45 -0.781 . . . . 0.0 109.847 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.588 ' HA ' HG23 ' A' ' 28' ' ' THR . 1.7 t -79.23 74.3 5.82 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.912 ' CZ ' HD21 ' A' ' 59' ' ' LEU . 28.4 m-85 -33.88 146.05 0.14 Allowed Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.537 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 34.5 Cg_endo -76.22 -179.63 5.44 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.841 2.361 . . . . 0.0 111.482 -178.438 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.05 11.6 9.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.456 -0.777 . . . . 0.0 109.062 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' A' ' 80' ' ' ALA . 18.8 m-20 -98.88 -71.21 0.7 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.824 ' HB3' ' C ' ' A' ' 25' ' ' PRO . . . 31.51 98.05 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 122.023 -0.423 . . . . 0.0 111.06 178.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.34 157.57 37.11 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.424 2.083 . . . . 0.0 110.708 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.32 139.87 52.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 0.0 109.482 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 157.55 171.87 24.06 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -88.73 129.95 35.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.344 -1.092 . . . . 0.0 109.661 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.464 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 9.3 m-85 -110.95 137.69 48.27 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.489 HG23 ' HG2' ' A' ' 100' ' ' LYS . 81.1 m -137.07 116.7 12.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.978 -1.076 . . . . 0.0 110.619 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.567 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -111.13 164.43 12.86 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.791 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.49 ' HB2' HG22 ' A' ' 98' ' ' VAL . 6.6 p90 -157.1 -156.42 0.6 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.777 -1.202 . . . . 0.0 110.565 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 93' ' ' ARG . 0.5 OUTLIER -132.43 155.88 47.7 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.639 -0.663 . . . . 0.0 109.281 -179.539 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.597 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 12.3 tp10 -88.67 -44.6 0.45 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.088 -1.008 . . . . 0.0 110.715 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.8 Cg_endo -80.27 -55.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 122.157 1.905 . . . . 0.0 111.041 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.573 ' CD2' HD13 ' A' ' 14' ' ' LEU . 5.2 m80 -88.34 32.97 0.75 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.104 -0.998 . . . . 0.0 109.518 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.478 ' HB3' ' O ' ' A' ' 89' ' ' CYS . 12.8 ptt180 -63.09 -23.22 67.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.139 -0.976 . . . . 0.0 109.611 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.15 7.85 62.54 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 92' ' ' HIS . . . -107.26 35.49 3.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -1.148 . . . . 0.0 109.668 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.8 35.99 84.78 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' A' ' 14' ' ' LEU . 1.9 mtp -95.69 67.28 2.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.084 -1.245 . . . . 0.0 109.091 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.49 HG22 ' HB2' ' A' ' 88' ' ' TYR . 59.7 t -140.32 107.95 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 109.96 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.561 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -106.64 154.94 16.67 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.489 ' HG2' HG23 ' A' ' 86' ' ' THR . 46.3 mtmt -130.74 135.53 47.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.071 -1.253 . . . . 0.0 110.08 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.944 HD11 ' CG2' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -101.74 123.5 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.189 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.489 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 1.0 OUTLIER -98.91 108.47 21.16 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.103 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.506 HG22 ' CD1' ' A' ' 23' ' ' ILE . 20.7 t -99.15 94.51 3.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.35 -0.844 . . . . 0.0 109.491 -178.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.368 -0.833 . . . . 0.0 109.345 -179.939 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.33 0.586 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.76 ' CB ' HD21 ' A' ' 21' ' ' LEU . 16.8 m-85 -133.95 148.48 51.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.21 -0.931 . . . . 0.0 109.291 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 4' ' ' THR . 1.7 t -137.92 103.67 5.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 109.801 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.706 HG12 ' HD2' ' A' ' 18' ' ' PRO . 21.8 m -87.37 67.26 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.239 -0.913 . . . . 0.0 109.292 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.59 ' HB3' HD21 ' A' ' 32' ' ' LEU . 1.3 ptmm? -51.35 108.97 0.29 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.89 . . . . 0.0 109.725 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.678 HD13 ' ND1' ' A' ' 39' ' ' HIS . 0.2 OUTLIER -68.02 175.69 3.01 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.233 -0.917 . . . . 0.0 109.322 179.688 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 14' ' ' LEU . . . 67.21 110.45 0.02 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.2 p -68.14 -104.0 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.262 -1.14 . . . . 0.0 109.178 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -171.77 26.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.885 -1.135 . . . . 0.0 109.848 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -132.22 -9.44 3.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.098 -1.001 . . . . 0.0 110.283 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 129.19 3.53 5.25 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.121 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 mt -111.43 142.0 44.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.067 -1.255 . . . . 0.0 109.565 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.636 HD11 ' CG1' ' A' ' 36' ' ' VAL . 65.7 mt -103.19 102.43 12.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.305 -0.872 . . . . 0.0 109.705 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.8 m -142.94 138.41 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 109.249 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.461 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 10.9 m-85 -56.46 148.9 18.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.156 -0.965 . . . . 0.0 109.538 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 16' ' ' PHE . 3.9 mm-40 -143.18 108.52 5.33 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.352 -0.842 . . . . 0.0 109.304 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.706 ' HD2' HG12 ' A' ' 5' ' ' VAL . 35.9 Cg_endo -78.17 174.53 51.35 Favored 'Cis proline' 0 C--N 1.312 -1.377 0 C-N-CA 123.779 -1.342 . . . . 0.0 110.638 0.116 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.59 -54.9 7.85 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.184 -0.948 . . . . 0.0 109.17 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -100.58 138.34 37.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -0.878 . . . . 0.0 109.073 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.76 HD21 ' CB ' ' A' ' 3' ' ' TYR . 15.8 tp -126.14 113.18 16.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.165 -0.959 . . . . 0.0 110.26 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.7 m -82.42 94.93 7.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.208 -0.933 . . . . 0.0 108.526 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.793 ' CD1' HD13 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -99.14 172.42 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.241 -0.912 . . . . 0.0 110.276 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.554 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 2.8 mmtt -91.99 168.71 12.43 Favored Pre-proline 0 C--N 1.303 -1.428 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.951 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 33.7 Cg_endo -77.18 81.86 2.51 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.052 1.834 . . . . 0.0 110.576 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 129.47 -1.67 6.07 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -74.41 177.91 5.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.113 -1.228 . . . . 0.0 109.574 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.459 HG22 ' N ' ' A' ' 29' ' ' VAL . 36.9 m -111.63 157.16 20.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.299 -0.876 . . . . 0.0 109.419 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.091 HG21 HD11 ' A' ' 101' ' ' ILE . 4.6 t -130.52 150.67 34.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.281 -0.887 . . . . 0.0 109.014 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -126.91 104.67 8.15 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.08 -1.012 . . . . 0.0 110.254 -179.467 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.553 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -107.9 91.45 3.65 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.24 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.713 HD12 ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -95.87 161.9 13.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.288 -0.882 . . . . 0.0 110.728 -178.176 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.561 ' HA ' HD11 ' A' ' 7' ' ' LEU . 2.0 p-10 -80.36 160.29 25.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.626 -0.671 . . . . 0.0 109.404 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 7' ' ' LEU . 59.5 t30 -103.41 -76.21 0.59 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.949 -1.094 . . . . 0.0 109.211 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.443 ' C ' HG23 ' A' ' 36' ' ' VAL . 1.5 pttt -157.61 34.33 0.27 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.907 . . . . 0.0 108.897 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.636 ' CG1' HD11 ' A' ' 14' ' ' LEU . 14.9 t -154.17 65.05 4.91 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.582 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 35.3 Cg_endo -78.57 176.04 10.35 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 123.091 2.527 . . . . 0.0 110.934 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.582 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 39.2 Cg_endo -87.62 157.65 45.61 Favored 'Cis proline' 0 C--N 1.311 -1.428 0 O-C-N 123.818 1.43 . . . . 0.0 110.868 -1.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.678 ' ND1' HD13 ' A' ' 7' ' ' LEU . 73.7 m-70 -118.41 118.72 32.52 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.578 -0.701 . . . . 0.0 109.783 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.481 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 17.7 t-20 -100.32 126.0 46.61 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.884 . . . . 0.0 108.762 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.504 ' HB ' ' NE2' ' A' ' 61' ' ' HIS . 71.0 t -104.92 131.15 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.083 -1.011 . . . . 0.0 109.992 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.653 HG12 ' HB3' ' A' ' 60' ' ' SER . 0.0 OUTLIER -152.62 172.86 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.716 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.79 ' CD2' HD23 ' A' ' 59' ' ' LEU . 3.6 m-85 -124.53 109.77 13.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.017 -1.052 . . . . 0.0 109.903 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.504 ' HB3' HD12 ' A' ' 47' ' ' LEU . 37.0 t0 -47.11 131.01 12.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.42 -0.8 . . . . 0.0 109.404 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.4 18.23 5.44 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.269 -0.894 . . . . 0.0 109.967 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -120.86 9.56 10.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.026 -1.046 . . . . 0.0 109.652 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.504 HD12 ' HB3' ' A' ' 44' ' ' ASP . 3.2 mt -131.06 60.38 1.66 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.176 -0.953 . . . . 0.0 109.464 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.519 ' ND2' ' HA ' ' A' ' 51' ' ' LYS . 0.7 OUTLIER -121.58 163.66 29.37 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.932 . . . . 0.0 109.514 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 35.1 Cg_endo -77.51 -46.21 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.627 2.218 . . . . 0.0 110.821 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.469 ' C ' ' HG2' ' A' ' 51' ' ' LYS . . . -115.76 37.34 3.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -0.981 . . . . 0.0 109.995 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.519 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.9 OUTLIER 36.21 47.22 0.45 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.664 -0.647 . . . . 0.0 110.545 179.545 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.571 ' O ' HD23 ' A' ' 55' ' ' LEU . 26.8 m -99.79 89.84 4.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.138 -0.976 . . . . 0.0 109.373 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.76 -19.61 58.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.486 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.08 -25.54 45.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.483 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 52' ' ' SER . 1.8 pp -75.88 -25.35 56.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.692 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 58' ' ' SER . . . -74.1 -53.99 8.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.896 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 56' ' ' ALA . 1.4 mmtt -43.57 -26.2 0.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 109.735 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 56' ' ' ALA . 2.8 m -110.97 22.18 15.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.103 -0.998 . . . . 0.0 109.859 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.79 HD23 ' CD2' ' A' ' 43' ' ' PHE . 8.2 tp -128.24 -36.91 1.89 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.074 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.653 ' HB3' HG12 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -77.55 141.91 39.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.396 -0.815 . . . . 0.0 109.601 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.558 ' CE1' ' O ' ' A' ' 63' ' ' GLN . 21.1 p80 -99.91 -23.02 15.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.444 -0.785 . . . . 0.0 109.862 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 70.62 -65.67 0.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.144 -0.973 . . . . 0.0 109.236 -179.714 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.558 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 0.8 OUTLIER -45.42 127.2 7.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.453 179.732 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.469 ' H ' HD12 ' A' ' 64' ' ' LEU . 5.0 mp -68.01 170.45 8.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.222 -0.924 . . . . 0.0 109.727 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.766 HD22 ' HA ' ' A' ' 71' ' ' SER . 6.2 mt -115.74 100.55 8.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.363 -0.836 . . . . 0.0 109.032 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 62.5 mtt -96.99 2.82 51.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.277 -0.889 . . . . 0.0 109.828 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 t -79.88 139.74 53.95 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.112 -0.992 . . . . 0.0 109.24 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.63 88.78 1.41 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.613 2.209 . . . . 0.0 110.918 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.713 ' HA2' HD12 ' A' ' 32' ' ' LEU . . . 88.25 49.01 3.86 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -172.74 92.36 0.11 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.333 -1.098 . . . . 0.0 109.108 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.766 ' HA ' HD22 ' A' ' 65' ' ' LEU . 80.0 p -99.07 -140.37 0.32 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 72' ' ' THR . 10.2 t -123.21 127.69 48.98 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.979 -1.076 . . . . 0.0 108.337 178.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.439 ' O ' ' OG ' ' A' ' 73' ' ' SER . 17.9 p -79.18 96.88 6.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.137 -0.977 . . . . 0.0 109.639 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.618 HG21 ' O ' ' A' ' 59' ' ' LEU . 1.2 m -70.3 113.63 7.64 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.402 -0.811 . . . . 0.0 109.259 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 76' ' ' PHE . 54.5 m -79.25 88.71 4.91 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.361 -0.837 . . . . 0.0 109.113 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 1.116 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 10.4 m-85 -43.13 160.43 0.21 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.376 -0.828 . . . . 0.0 108.903 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.501 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 32.6 Cg_endo -76.22 150.7 33.39 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.443 2.095 . . . . 0.0 111.483 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.463 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . . . -69.47 -11.28 60.7 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.457 ' O ' ' C ' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -100.65 15.9 26.63 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.332 -0.855 . . . . 0.0 109.141 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.951 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -39.65 109.86 0.59 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.605 -0.684 . . . . 0.0 109.313 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.448 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 33.7 Cg_endo -75.02 121.35 6.52 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.354 2.036 . . . . 0.0 110.514 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -43.64 136.93 3.17 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.479 -0.763 . . . . 0.0 109.382 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 164.64 -167.38 38.42 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -120.68 115.62 23.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.407 -1.055 . . . . 0.0 109.484 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.448 ' OH ' ' HD2' ' A' ' 81' ' ' PRO . 23.2 m-85 -93.88 165.27 12.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.369 -0.832 . . . . 0.0 109.07 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.776 HG22 ' CG2' ' A' ' 98' ' ' VAL . 0.2 OUTLIER -144.46 97.81 3.1 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.057 -1.027 . . . . 0.0 110.205 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.571 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.5 OUTLIER -101.96 157.77 16.62 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.356 -0.84 . . . . 0.0 108.842 178.988 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.531 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 4.5 p90 -160.24 -148.4 0.17 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.157 -0.964 . . . . 0.0 109.653 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.485 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 74.7 m -132.96 161.29 34.69 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.159 -0.963 . . . . 0.0 109.641 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.588 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 19.5 tt0 -77.71 -47.25 2.37 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.298 -0.876 . . . . 0.0 109.23 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.5 Cg_endo -79.23 -66.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.106 0 C-N-CA 122.206 1.938 . . . . 0.0 110.478 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.516 ' NE2' ' CE1' ' A' ' 39' ' ' HIS . 34.9 m-70 -55.03 87.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.063 -1.023 . . . . 0.0 109.149 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 91' ' ' PRO . 3.7 mtm180 -131.05 32.73 4.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.162 -0.961 . . . . 0.0 109.592 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -149.99 16.78 1.05 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -138.69 37.32 2.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.279 -1.13 . . . . 0.0 109.479 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.71 53.65 28.41 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.573 ' HE1' ' HB2' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -102.04 56.86 0.81 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.21 -1.171 . . . . 0.0 109.423 179.807 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.776 ' CG2' HG22 ' A' ' 86' ' ' THR . 2.5 p -135.6 94.72 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.244 -0.91 . . . . 0.0 109.383 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.571 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -70.99 179.24 31.89 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.585 ' HG2' HG23 ' A' ' 86' ' ' THR . 23.0 mtmm -154.81 131.18 10.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -1.133 . . . . 0.0 109.707 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 1.116 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -96.99 136.68 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.166 -0.959 . . . . 0.0 108.594 179.207 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.4 100.59 7.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.147 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.554 HG22 ' CD1' ' A' ' 23' ' ' ILE . 1.6 t -99.94 125.55 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.889 . . . . 0.0 109.562 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.23 179.764 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.457 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 15.8 m-85 -117.08 174.45 6.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 109.468 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.9 m -156.35 116.41 3.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.909 . . . . 0.0 109.466 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.744 HG12 ' H ' ' A' ' 17' ' ' GLU . 1.4 t -104.17 82.58 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.91 . . . . 0.0 109.449 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.979 ' HG2' HD11 ' A' ' 32' ' ' LEU . 6.7 mttp -69.8 85.97 0.49 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.284 -0.885 . . . . 0.0 109.383 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.67 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -62.54 -172.58 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.239 -0.913 . . . . 0.0 109.599 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.481 ' CA ' HD23 ' A' ' 14' ' ' LEU . . . 54.92 87.4 0.02 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.8 p -60.55 -90.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -1.153 . . . . 0.0 109.422 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -175.57 29.55 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.243 -0.911 . . . . 0.0 109.718 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -123.05 -19.28 6.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.188 -0.945 . . . . 0.0 109.523 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.03 -13.83 5.74 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 mt -96.23 147.65 23.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -1.116 . . . . 0.0 109.141 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.538 ' CD1' ' CD2' ' A' ' 92' ' ' HIS . 16.0 mt -109.8 112.18 24.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 109.553 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.56 HG12 ' HA3' ' A' ' 96' ' ' GLY . 6.0 m -138.56 136.0 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 109.468 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.634 ' HD2' HG11 ' A' ' 5' ' ' VAL . 28.4 m-85 -54.57 143.4 24.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.212 -0.93 . . . . 0.0 109.363 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.744 ' H ' HG12 ' A' ' 5' ' ' VAL . 27.3 mt-10 -143.0 108.76 5.42 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.26 -0.9 . . . . 0.0 108.995 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.4 Cg_endo -76.59 164.68 86.99 Favored 'Cis proline' 0 C--N 1.311 -1.408 0 C-N-CA 123.811 -1.329 . . . . 0.0 110.894 0.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.51 -60.25 2.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.435 -0.791 . . . . 0.0 109.914 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.474 ' O ' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -78.78 136.59 37.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 109.553 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.481 HD13 ' HA ' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -127.04 109.55 12.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.232 -0.918 . . . . 0.0 109.777 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.4 m -88.71 94.98 10.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.215 -0.928 . . . . 0.0 108.835 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.655 HD12 ' O ' ' A' ' 24' ' ' LYS . 1.1 pp -106.72 165.41 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.32 -0.862 . . . . 0.0 110.197 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.655 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -88.68 -178.76 1.1 Allowed Pre-proline 0 C--N 1.302 -1.485 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.815 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.601 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 36.3 Cg_endo -80.2 86.3 1.68 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.123 1.882 . . . . 0.0 110.694 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.498 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 123.74 2.07 8.83 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.479 ' OD2' ' HG3' ' A' ' 24' ' ' LYS . 4.0 m-20 -66.22 -179.17 0.73 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.221 -1.164 . . . . 0.0 109.21 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 57.2 m -121.97 120.46 34.48 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.293 -0.88 . . . . 0.0 109.362 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.026 ' CG2' HD11 ' A' ' 101' ' ' ILE . 21.8 t -99.15 123.75 52.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.345 -0.847 . . . . 0.0 108.994 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.61 123.03 43.49 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.242 -0.911 . . . . 0.0 109.9 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.603 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -122.64 142.85 50.21 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.124 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.979 HD11 ' HG2' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -142.43 179.2 7.09 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.977 -1.077 . . . . 0.0 110.222 -179.584 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.577 ' ND2' ' O ' ' A' ' 67' ' ' SER . 0.4 OUTLIER -105.88 130.64 53.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.641 -0.662 . . . . 0.0 109.716 179.072 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 45.6 t30 -72.16 -59.57 2.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.068 -1.02 . . . . 0.0 109.205 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.72 36.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.311 -0.868 . . . . 0.0 109.42 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.614 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 32.1 t -148.65 55.79 2.25 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.303 -0.873 . . . . 0.0 109.729 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.614 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 37.0 Cg_endo -78.8 174.62 11.99 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.461 2.107 . . . . 0.0 110.443 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 37.8 Cg_endo -84.89 169.92 48.65 Favored 'Cis proline' 0 C--N 1.31 -1.477 0 C-N-CA 123.463 -1.474 . . . . 0.0 110.145 -1.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.689 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 71.9 m-70 -123.03 152.89 40.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.279 -0.888 . . . . 0.0 110.543 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.428 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 0.1 OUTLIER -124.23 103.11 8.05 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.985 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.7 t -98.92 109.35 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.71 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.794 HG13 ' HB3' ' A' ' 60' ' ' SER . 3.1 t -134.26 162.32 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.44 -0.788 . . . . 0.0 109.591 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.588 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 6.0 m-85 -110.13 96.76 6.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.397 -0.814 . . . . 0.0 109.666 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 43' ' ' PHE . 9.0 t70 -43.34 167.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.506 -0.746 . . . . 0.0 109.86 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -115.91 15.2 16.28 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.397 -0.815 . . . . 0.0 109.437 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -120.24 -3.71 10.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.614 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.0 mp -114.2 40.21 2.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.159 -0.963 . . . . 0.0 109.497 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.49 ' OD1' ' HA ' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -109.6 165.93 11.74 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 0.0 109.442 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.649 ' CG ' ' HB1' ' A' ' 82' ' ' ALA . 34.9 Cg_endo -77.11 -53.39 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.631 2.221 . . . . 0.0 110.493 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -100.61 30.37 3.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.363 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.49 ' HA ' ' OD1' ' A' ' 48' ' ' ASN . 0.3 OUTLIER 39.82 54.35 2.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.703 -0.623 . . . . 0.0 109.76 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.43 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 1.5 m -99.98 152.59 20.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 109.494 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.85 47.84 1.53 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 109.515 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 54' ' ' ASP . 4.6 m-20 -115.09 -71.78 0.73 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.235 -0.916 . . . . 0.0 109.57 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.473 ' HG ' ' N ' ' A' ' 56' ' ' ALA . 1.1 pp -53.92 -27.67 32.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 109.46 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.473 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -66.15 -38.58 88.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 109.325 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -36.33 75.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.247 -0.908 . . . . 0.0 109.39 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.7 t -101.77 30.47 4.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 0.0 109.499 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.76 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 10.2 tp -120.26 -33.49 3.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.243 -0.911 . . . . 0.0 109.293 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.794 ' HB3' HG13 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -78.88 152.69 31.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.353 -0.842 . . . . 0.0 110.603 -178.972 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.656 ' CD2' HG21 ' A' ' 72' ' ' THR . 10.3 p80 -98.07 168.55 10.2 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.66 -33.02 4.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.047 -1.033 . . . . 0.0 109.784 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -73.81 108.31 6.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 109.553 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.437 ' HA ' HD22 ' A' ' 64' ' ' LEU . 1.5 mm? -44.47 157.9 0.06 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.15 -0.969 . . . . 0.0 109.566 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.954 HD13 ' HB2' ' A' ' 71' ' ' SER . 0.8 OUTLIER -104.82 91.56 3.88 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.479 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -89.18 -15.46 33.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.208 -0.932 . . . . 0.0 110.869 -178.703 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.577 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 22.9 t -78.75 113.06 31.81 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.857 -1.152 . . . . 0.0 108.52 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 66' ' ' MET . 32.1 Cg_endo -73.44 120.21 6.38 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.301 2.0 . . . . 0.0 111.007 -178.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.55 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 110.74 -15.4 29.09 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.56 ' N ' ' OD1' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -149.45 113.39 5.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.349 -1.089 . . . . 0.0 109.097 179.795 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.954 ' HB2' HD13 ' A' ' 65' ' ' LEU . 4.2 p -103.31 -135.91 0.33 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.123 -0.985 . . . . 0.0 108.931 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.672 ' N ' HD22 ' A' ' 65' ' ' LEU . 6.9 t -114.94 157.08 23.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.746 -1.221 . . . . 0.0 109.296 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.93 -173.41 2.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.15 -0.969 . . . . 0.0 109.414 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.58 HG21 ' HG ' ' A' ' 59' ' ' LEU . 29.8 m -162.78 108.2 1.16 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.728 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.96 88.99 7.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.415 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 1.033 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 8.9 m-85 -45.34 163.63 0.2 Allowed Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.324 -0.86 . . . . 0.0 109.286 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.498 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.6 Cg_endo -76.91 161.1 33.43 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.602 2.202 . . . . 0.0 111.159 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.45 -3.2 13.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.498 -0.751 . . . . 0.0 110.035 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.528 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -99.37 -76.16 0.55 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.09 -1.006 . . . . 0.0 109.2 179.826 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.56 ' HB1' HG21 ' A' ' 103' ' ' VAL . . . 37.7 57.52 4.45 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.553 -0.717 . . . . 0.0 110.399 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.648 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 36.1 Cg_endo -77.93 -160.37 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.373 2.049 . . . . 0.0 110.282 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.649 ' HB1' ' CG ' ' A' ' 49' ' ' PRO . . . 72.7 -73.83 0.09 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.888 . . . . 0.0 109.896 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.427 ' HA2' ' N ' ' A' ' 103' ' ' VAL . . . 108.12 25.43 5.86 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -151.37 111.56 4.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.316 -1.108 . . . . 0.0 109.895 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 100' ' ' LYS . 52.5 m-85 -138.54 83.85 1.99 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.447 ' OG1' ' CD ' ' A' ' 100' ' ' LYS . 18.4 m -78.29 121.29 24.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.874 . . . . 0.0 110.596 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CE1' ' C ' ' A' ' 99' ' ' GLY . 2.0 p90 -117.07 173.1 6.85 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.476 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 2.9 p90 -158.78 -157.4 0.61 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.836 -1.165 . . . . 0.0 110.228 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 0.1 OUTLIER -131.83 151.99 51.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.4 -0.813 . . . . 0.0 109.725 -179.305 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.612 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 1.8 tm-20 -82.77 -45.61 0.9 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.0 109.932 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.7 Cg_endo -80.53 -51.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.125 1.883 . . . . 0.0 110.592 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.689 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 12.9 m80 -86.01 40.61 0.87 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 109.71 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.443 ' HG2' ' N ' ' A' ' 94' ' ' GLY . 16.5 ttt180 -76.49 141.09 41.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.198 -0.939 . . . . 0.0 109.358 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.443 ' N ' ' HG2' ' A' ' 93' ' ' ARG . . . 72.63 17.66 78.16 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.88 37.68 4.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.157 -1.202 . . . . 0.0 109.513 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.56 ' HA3' HG12 ' A' ' 15' ' ' VAL . . . 72.65 12.09 77.65 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.535 ' CE ' ' HB2' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -95.66 64.66 2.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -1.19 . . . . 0.0 109.497 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 28.3 t -140.24 73.84 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 109.661 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.492 ' C ' ' CE1' ' A' ' 87' ' ' PHE . . . -89.05 167.73 34.78 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 14.3 mttp -144.23 138.08 27.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.152 -1.205 . . . . 0.0 109.758 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 1.033 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -89.14 126.31 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 108.876 179.683 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 99.6 m -101.91 99.6 9.81 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.56 HG21 ' HB1' ' A' ' 80' ' ' ALA . 2.5 t -98.9 73.45 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.222 -0.924 . . . . 0.0 109.672 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 103' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.369 -0.832 . . . . 0.0 109.414 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -131.07 93.08 3.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 109.322 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.734 HG23 ' HB3' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -92.7 103.41 15.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.922 . . . . 0.0 109.597 -179.841 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.449 HG11 HD13 ' A' ' 21' ' ' LEU . 8.2 m -96.05 110.86 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.212 -0.93 . . . . 0.0 109.281 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.447 ' C ' HD13 ' A' ' 7' ' ' LEU . 11.1 mttt -79.82 133.55 36.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.238 -0.914 . . . . 0.0 109.454 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.982 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -110.03 73.46 0.84 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.736 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.452 ' HA2' HD23 ' A' ' 14' ' ' LEU . . . 165.52 77.85 0.03 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.478 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 2.0 p -47.84 -31.13 4.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -1.139 . . . . 0.0 109.186 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 9' ' ' SER . 6.4 t0 75.78 19.1 2.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.339 -0.851 . . . . 0.0 109.562 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -135.46 7.42 3.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.93 . . . . 0.0 109.722 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -173.49 -79.63 0.05 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.17 -171.48 2.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -1.155 . . . . 0.0 109.743 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.596 ' HB3' ' HE1' ' A' ' 97' ' ' MET . 8.6 mt -106.12 126.81 52.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.386 -0.821 . . . . 0.0 108.956 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -157.18 136.5 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.089 -1.007 . . . . 0.0 109.769 -179.658 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -53.22 157.89 1.76 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.124 -0.985 . . . . 0.0 108.901 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 2.2 mt-10 -150.96 108.44 3.04 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 109.518 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 35.2 Cg_endo -78.95 166.62 78.82 Favored 'Cis proline' 0 C--N 1.313 -1.291 0 C-N-CA 123.898 -1.292 . . . . 0.0 110.534 -0.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.9 -54.21 14.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.094 -1.004 . . . . 0.0 108.978 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -86.06 159.42 19.57 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.361 -0.837 . . . . 0.0 108.893 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.449 HD13 HG11 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -157.99 129.01 6.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.012 -1.055 . . . . 0.0 109.944 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.0 m -100.0 90.14 4.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.378 -0.826 . . . . 0.0 109.213 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.79 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -99.56 166.1 2.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.206 -0.934 . . . . 0.0 109.995 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.476 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -89.28 173.0 6.48 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.348 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.688 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 34.7 Cg_endo -76.64 83.3 2.1 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.178 1.919 . . . . 0.0 110.497 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 137.56 -26.73 2.89 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.476 ' OD2' ' HB2' ' A' ' 24' ' ' LYS . 3.1 m-20 -43.8 165.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -1.156 . . . . 0.0 109.414 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 86.7 m -111.05 118.34 35.78 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.205 -0.934 . . . . 0.0 109.678 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.898 HG21 HD11 ' A' ' 101' ' ' ILE . 2.7 t -99.21 123.85 52.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.199 -0.938 . . . . 0.0 109.17 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.734 ' HB3' HG23 ' A' ' 4' ' ' THR . 0.0 OUTLIER -100.23 128.61 46.27 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.245 -0.909 . . . . 0.0 109.975 -179.532 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.581 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -129.23 146.1 51.21 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.982 ' O ' HD21 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -140.63 -167.74 2.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.966 -1.084 . . . . 0.0 110.353 -179.609 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 67' ' ' SER . 2.1 p-10 -114.83 160.22 19.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.263 -0.898 . . . . 0.0 109.57 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.413 ' CG ' ' HA3' ' A' ' 8' ' ' GLY . 12.9 t30 -104.47 -154.28 0.5 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.249 -0.907 . . . . 0.0 109.417 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -92.89 28.31 2.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.13 -0.981 . . . . 0.0 109.254 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.599 ' O ' ' CE1' ' A' ' 92' ' ' HIS . 3.0 t -141.84 61.89 13.6 Favored Pre-proline 0 C--N 1.299 -1.611 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.585 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.4 Cg_endo -77.93 177.32 8.94 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 123.05 2.5 . . . . 0.0 110.804 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.585 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 39.6 Cg_endo -87.91 158.91 44.84 Favored 'Cis proline' 0 C--N 1.313 -1.315 0 O-C-N 123.723 1.381 . . . . 0.0 110.908 -1.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.511 ' CE1' ' NE2' ' A' ' 92' ' ' HIS . 72.5 m-70 -118.65 156.73 28.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.493 -0.754 . . . . 0.0 109.501 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.442 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 18.9 t30 -140.08 114.33 9.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.293 -0.879 . . . . 0.0 109.019 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.558 ' O ' HG13 ' A' ' 42' ' ' VAL . 3.8 t -99.72 122.75 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.889 . . . . 0.0 109.125 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.636 ' HA ' ' CB ' ' A' ' 60' ' ' SER . 0.2 OUTLIER -157.96 141.36 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.106 -0.996 . . . . 0.0 110.231 179.746 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.628 ' CE2' ' CG ' ' A' ' 59' ' ' LEU . 4.4 m-85 -85.98 121.5 28.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.737 -0.602 . . . . 0.0 109.793 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 43' ' ' PHE . 24.9 t70 -45.74 169.0 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.413 -0.804 . . . . 0.0 109.419 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.86 -16.06 14.24 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.219 -0.926 . . . . 0.0 109.943 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.69 -14.01 11.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.138 -0.977 . . . . 0.0 109.682 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 2.8 mm? -94.1 48.83 1.27 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.182 -0.949 . . . . 0.0 109.433 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.526 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 3.5 p30 -129.48 163.83 43.82 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.254 -0.904 . . . . 0.0 109.496 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.526 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 34.0 Cg_endo -76.3 -11.57 19.15 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.486 2.124 . . . . 0.0 109.95 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 52' ' ' SER . . . -139.4 77.33 1.61 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -40.4 93.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.973 -179.417 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 50' ' ' ALA . 2.0 m -140.35 154.23 46.68 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.321 -0.862 . . . . 0.0 109.389 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.01 72.03 0.87 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.269 -0.894 . . . . 0.0 109.254 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -167.73 -38.4 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.156 -0.965 . . . . 0.0 109.699 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.856 ' O ' HD12 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -78.13 -8.14 57.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.112 -0.992 . . . . 0.0 109.517 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 57' ' ' LYS . . . -112.47 -43.83 3.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.901 . . . . 0.0 109.632 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 56' ' ' ALA . 47.7 tttp -43.52 -48.63 7.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.894 . . . . 0.0 109.575 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -98.15 25.55 6.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.893 . . . . 0.0 109.682 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.768 ' HG ' HG21 ' A' ' 74' ' ' THR . 17.1 tp -104.1 -62.53 1.3 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.147 -0.971 . . . . 0.0 109.625 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.636 ' CB ' ' HA ' ' A' ' 42' ' ' VAL . 0.3 OUTLIER -85.8 -167.61 1.92 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.222 -0.924 . . . . 0.0 110.637 -178.778 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.663 ' HB3' HG21 ' A' ' 72' ' ' THR . 25.3 p80 -120.68 142.0 49.88 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.29 -42.33 13.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 0.0 109.59 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.467 ' NE2' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -46.65 163.76 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.898 . . . . 0.0 109.496 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.741 ' H ' HD12 ' A' ' 64' ' ' LEU . 2.3 mp -97.37 -179.01 4.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.938 . . . . 0.0 109.411 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.701 HD12 ' O ' ' A' ' 64' ' ' LEU . 7.1 mp -118.96 81.98 1.79 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -0.951 . . . . 0.0 109.407 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.13 -34.7 29.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 109.524 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.52 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 46.0 t -80.58 146.83 61.83 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.922 . . . . 0.0 109.531 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.464 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 35.5 Cg_endo -77.84 102.55 1.6 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.641 2.228 . . . . 0.0 110.594 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.493 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 109.24 -26.67 14.37 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.512 ' CB ' ' HB3' ' A' ' 67' ' ' SER . 6.8 tt0 -62.22 105.63 0.63 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.132 -1.217 . . . . 0.0 108.464 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.576 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . 21.5 p -137.86 -161.48 1.18 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.165 -0.959 . . . . 0.0 110.695 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.663 HG21 ' HB3' ' A' ' 61' ' ' HIS . 1.8 t -153.82 124.16 7.02 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.3 p -79.27 135.93 36.9 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.141 -0.974 . . . . 0.0 109.517 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.768 HG21 ' HG ' ' A' ' 59' ' ' LEU . 86.3 m -98.54 114.33 26.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.377 -0.827 . . . . 0.0 109.711 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.456 HG22 ' H ' ' A' ' 75' ' ' THR . 1.2 t -83.83 82.97 8.1 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -0.89 . . . . 0.0 109.452 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 1.017 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 14.6 m-85 -43.34 149.1 0.59 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.094 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.486 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.6 Cg_endo -75.99 168.89 23.24 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.592 2.194 . . . . 0.0 110.842 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.34 6.59 6.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.424 -0.797 . . . . 0.0 109.783 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' A' ' 80' ' ' ALA . 30.9 t70 -99.12 -77.6 0.51 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.103 -0.998 . . . . 0.0 109.242 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.688 ' HB3' ' HB3' ' A' ' 25' ' ' PRO . . . 56.66 109.31 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.35 -0.843 . . . . 0.0 108.856 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.437 ' HG2' ' HG2' ' A' ' 49' ' ' PRO . 33.3 Cg_endo -74.31 113.55 3.82 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.328 2.018 . . . . 0.0 110.688 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -46.41 109.3 0.18 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.365 -0.834 . . . . 0.0 109.459 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.446 ' HA3' ' HB3' ' A' ' 49' ' ' PRO . . . 179.13 -119.28 0.64 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -160.44 106.23 1.5 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.2 -1.176 . . . . 0.0 109.784 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.607 ' CD2' ' CG2' ' A' ' 101' ' ' ILE . 0.7 OUTLIER -82.35 131.58 35.22 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.244 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 92.4 m -111.92 117.25 32.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.052 -1.03 . . . . 0.0 110.669 -179.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.591 ' O ' HG13 ' A' ' 98' ' ' VAL . 0.3 OUTLIER -111.51 169.91 8.48 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.658 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.467 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 7.1 p90 -159.12 -154.11 0.4 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.856 -1.152 . . . . 0.0 110.089 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 0.5 OUTLIER -128.78 141.78 51.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.398 -0.814 . . . . 0.0 109.795 -179.205 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.619 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 7.4 tp10 -72.08 -47.02 11.33 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.201 -0.937 . . . . 0.0 109.57 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.9 Cg_endo -79.73 -68.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.157 0 C-N-CA 122.271 1.981 . . . . 0.0 110.333 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.599 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 20.4 m-70 -69.98 64.44 0.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.135 -0.978 . . . . 0.0 109.048 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 91' ' ' PRO . 4.2 mtm180 -84.58 -10.2 57.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.678 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -122.78 54.32 0.71 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.587 ' HB3' ' HG3' ' A' ' 97' ' ' MET . . . -151.39 39.3 0.65 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -1.13 . . . . 0.0 109.549 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 48.24 22.05 2.16 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.596 ' HE1' ' HB3' ' A' ' 14' ' ' LEU . 2.5 mtp -80.5 55.71 2.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.981 -1.306 . . . . 0.0 109.116 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 87' ' ' PHE . 39.4 t -130.63 113.57 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.635 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.55 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -96.55 -173.1 35.12 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 14.9 mttt -160.53 122.34 3.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -1.182 . . . . 0.0 109.66 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 1.017 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 0.7 OUTLIER -91.06 119.03 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.149 -0.97 . . . . 0.0 109.344 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.0 m -105.17 94.98 5.53 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.608 HG23 ' CG2' ' A' ' 101' ' ' ILE . 91.3 t -99.28 129.18 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.218 -0.926 . . . . 0.0 109.825 -179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.406 -0.809 . . . . 0.0 109.481 179.956 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.461 HG23 ' HB ' ' A' ' 28' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -90.23 154.27 19.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.437 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.98 107.91 13.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.718 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.496 ' CG1' ' HB3' ' A' ' 16' ' ' PHE . 1.3 t -105.93 123.28 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.887 . . . . 0.0 109.324 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.413 ' HG2' HD12 ' A' ' 32' ' ' LEU . 13.8 mttm -117.75 90.3 3.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 109.41 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.49 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -50.55 164.38 0.13 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.166 -0.959 . . . . 0.0 109.528 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.18 76.36 0.91 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 3.2 p -48.02 -60.44 2.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -1.164 . . . . 0.0 109.306 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 9' ' ' SER . 1.1 t70 174.46 -62.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.403 -0.81 . . . . 0.0 109.288 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.85 18.95 6.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.313 -0.867 . . . . 0.0 109.283 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.435 ' O ' ' HG ' ' A' ' 13' ' ' LEU . . . -105.84 -92.5 2.27 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 13' ' ' LEU . 1.1 mp -143.86 -165.37 2.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.262 -1.14 . . . . 0.0 109.668 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.649 ' CD1' ' CD2' ' A' ' 92' ' ' HIS . 10.8 mt -100.64 52.37 0.87 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.41 -0.806 . . . . 0.0 109.359 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.438 HG12 ' O ' ' A' ' 96' ' ' GLY . 4.0 m -94.84 149.91 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 109.514 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.496 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 51.8 m-85 -65.16 177.35 1.06 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -0.923 . . . . 0.0 109.309 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 16' ' ' PHE . 4.7 mt-10 -160.16 108.01 1.4 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.907 . . . . 0.0 109.367 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 33.0 Cg_endo -75.13 170.14 72.64 Favored 'Cis proline' 0 C--N 1.311 -1.408 0 C-N-CA 123.602 -1.416 . . . . 0.0 110.678 0.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.66 -63.27 1.11 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.246 -0.909 . . . . 0.0 109.421 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.43 ' C ' HD12 ' A' ' 21' ' ' LEU . 1.9 ptpt -80.02 158.1 26.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.176 -0.952 . . . . 0.0 109.309 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.43 HD12 ' C ' ' A' ' 20' ' ' LYS . 1.0 OUTLIER -150.47 118.79 6.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.416 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 102' ' ' THR . 24.2 m -89.51 92.1 8.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.235 -0.916 . . . . 0.0 109.611 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.683 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -99.62 175.8 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.291 -0.881 . . . . 0.0 109.569 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.638 ' C ' HG13 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -88.69 179.2 1.71 Allowed Pre-proline 0 C--N 1.302 -1.464 0 O-C-N 121.355 -0.841 . . . . 0.0 108.818 179.613 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.675 ' HA ' HG11 ' A' ' 103' ' ' VAL . 35.1 Cg_endo -78.58 77.23 4.11 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.371 2.047 . . . . 0.0 110.889 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 116.4 27.4 2.87 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.465 ' CG ' ' HB2' ' A' ' 24' ' ' LYS . 6.0 m-20 -84.1 -176.68 6.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.154 -1.203 . . . . 0.0 109.097 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.461 ' HB ' HG23 ' A' ' 2' ' ' THR . 90.2 m -112.98 129.02 56.64 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.251 -0.906 . . . . 0.0 109.583 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.037 HG21 HD11 ' A' ' 101' ' ' ILE . 4.2 t -115.59 124.35 71.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.309 -0.87 . . . . 0.0 108.77 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -99.15 125.47 44.72 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.27 -0.894 . . . . 0.0 109.649 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.891 ' O ' HD23 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -116.3 153.78 31.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.38 -0.825 . . . . 0.0 108.941 -179.868 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.891 HD23 ' O ' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -141.36 -171.62 3.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.981 -1.075 . . . . 0.0 109.95 -179.603 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.68 ' HB3' HD23 ' A' ' 65' ' ' LEU . 3.2 p-10 -123.14 167.45 13.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.382 -0.823 . . . . 0.0 109.093 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -157.31 -58.16 0.08 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.906 -1.121 . . . . 0.0 110.111 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.56 ' HB3' ' CD2' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -71.51 -150.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 0.0 110.161 -179.356 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.533 ' O ' ' CE1' ' A' ' 39' ' ' HIS . 84.2 t -69.37 115.27 30.76 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.594 -0.691 . . . . 0.0 110.352 -179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.571 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.4 Cg_endo -79.62 178.53 7.23 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 122.915 2.41 . . . . 0.0 109.997 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.571 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 41.5 Cg_endo -88.48 163.61 41.92 Favored 'Cis proline' 0 C--N 1.313 -1.331 0 O-C-N 123.339 1.179 . . . . 0.0 110.707 -1.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.533 ' CE1' ' O ' ' A' ' 36' ' ' VAL . 68.6 m80 -126.01 122.59 36.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.175 -0.953 . . . . 0.0 110.018 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.456 ' OD1' ' HA ' ' A' ' 64' ' ' LEU . 2.0 t30 -99.45 142.55 30.79 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.425 -0.797 . . . . 0.0 109.163 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.494 HG12 ' OG ' ' A' ' 60' ' ' SER . 7.1 t -110.51 118.13 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.937 . . . . 0.0 109.422 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.625 ' HA ' ' CB ' ' A' ' 60' ' ' SER . 1.6 t -153.84 138.69 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.164 -0.96 . . . . 0.0 110.099 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.751 ' CE2' HD23 ' A' ' 59' ' ' LEU . 2.8 m-85 -87.33 126.22 34.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.658 -0.651 . . . . 0.0 109.643 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.469 ' OD2' ' HB3' ' A' ' 46' ' ' ALA . 38.8 t70 -51.67 137.54 24.94 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.236 -0.915 . . . . 0.0 108.924 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.93 14.92 3.66 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.186 -0.946 . . . . 0.0 109.815 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.469 ' HB3' ' OD2' ' A' ' 44' ' ' ASP . . . -129.07 11.87 6.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.156 -0.965 . . . . 0.0 109.62 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.423 HD12 ' HB3' ' A' ' 44' ' ' ASP . 76.1 mt -126.66 50.4 1.94 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.93 . . . . 0.0 109.635 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 51' ' ' LYS . 5.2 p30 -119.67 159.39 46.47 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 0.0 109.122 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 36.2 Cg_endo -77.85 -2.23 12.37 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.566 2.177 . . . . 0.0 110.664 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.519 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -123.17 28.74 7.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.204 -0.935 . . . . 0.0 109.655 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.519 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER 28.49 40.88 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.108 0.48 . . . . 0.0 110.728 179.819 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 50' ' ' ALA . 72.9 m -135.91 -171.52 2.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.123 -0.986 . . . . 0.0 109.816 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.34 19.58 1.37 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.305 -0.872 . . . . 0.0 109.598 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -68.96 -31.31 70.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 109.499 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.708 ' O ' HD12 ' A' ' 55' ' ' LEU . 0.6 OUTLIER -102.0 22.77 12.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.546 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -117.36 -54.99 2.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -0.881 . . . . 0.0 109.351 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -56.97 -28.58 62.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.372 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.4 p -108.99 30.22 6.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.283 -0.886 . . . . 0.0 109.625 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.783 ' O ' HG23 ' A' ' 74' ' ' THR . 26.7 tp -115.87 -62.15 1.63 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.205 -0.934 . . . . 0.0 109.444 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.625 ' CB ' ' HA ' ' A' ' 42' ' ' VAL . 0.6 OUTLIER -80.15 -171.46 2.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.264 -0.898 . . . . 0.0 110.627 -178.703 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -115.11 157.36 23.68 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.627 -0.671 . . . . 0.0 109.295 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.58 -14.44 16.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 109.682 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -76.93 130.36 37.43 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.172 -0.955 . . . . 0.0 109.488 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.497 HD12 ' N ' ' A' ' 64' ' ' LEU . 8.6 mp -60.86 179.98 0.15 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.267 -0.895 . . . . 0.0 109.375 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.997 HD21 ' CB ' ' A' ' 71' ' ' SER . 2.5 mp -98.57 135.22 40.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.232 -0.918 . . . . 0.0 109.349 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 3.1 mmt -127.11 1.56 6.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.187 -0.946 . . . . 0.0 109.413 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.3 t -111.45 129.41 24.12 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.908 . . . . 0.0 109.229 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.518 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.2 Cg_endo -78.47 87.0 1.58 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.338 2.026 . . . . 0.0 110.514 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.551 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 114.87 35.01 1.42 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.56 ' N ' ' HB3' ' A' ' 32' ' ' LEU . 1.0 OUTLIER 178.55 112.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -1.133 . . . . 0.0 109.366 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.997 ' CB ' HD21 ' A' ' 65' ' ' LEU . 21.5 p -104.85 -82.19 0.52 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.108 -0.995 . . . . 0.0 109.429 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.589 ' N ' ' OG ' ' A' ' 71' ' ' SER . 85.2 m -160.83 156.28 24.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.007 -1.058 . . . . 0.0 109.346 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 75' ' ' THR . 0.8 OUTLIER -102.68 67.31 0.98 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.158 -0.964 . . . . 0.0 109.309 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.783 HG23 ' O ' ' A' ' 59' ' ' LEU . 97.8 m -46.26 99.28 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.364 -0.835 . . . . 0.0 109.642 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.416 ' N ' ' O ' ' A' ' 73' ' ' SER . 19.0 m -78.89 95.87 5.54 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.654 ' CE2' HD21 ' A' ' 59' ' ' LEU . 8.0 m-85 -47.85 162.45 0.32 Allowed Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.526 -0.734 . . . . 0.0 109.34 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.563 ' HD3' ' CD1' ' A' ' 59' ' ' LEU . 35.0 Cg_endo -76.61 173.37 14.59 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.695 2.263 . . . . 0.0 111.12 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.75 8.51 7.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.295 -0.878 . . . . 0.0 109.629 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -99.32 -71.01 0.71 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.217 -0.927 . . . . 0.0 109.147 179.781 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 79' ' ' ASP . . . 42.76 88.26 0.1 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.336 -0.852 . . . . 0.0 109.374 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.435 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 33.4 Cg_endo -75.61 127.79 10.53 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.616 2.21 . . . . 0.0 110.654 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -43.06 136.92 2.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.439 -0.788 . . . . 0.0 109.553 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 152.65 172.92 21.57 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -96.88 126.34 41.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -1.144 . . . . 0.0 109.519 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.493 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 12.6 m-85 -97.6 -173.7 2.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 108.853 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 99.4 m -164.83 103.58 0.79 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.922 -1.111 . . . . 0.0 110.443 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.578 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.5 OUTLIER -101.24 166.07 10.96 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.563 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 97' ' ' MET . 4.9 p90 -159.96 -153.38 0.34 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.724 -1.235 . . . . 0.0 110.547 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 97' ' ' MET . 0.5 OUTLIER -129.1 148.03 51.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.543 -0.723 . . . . 0.0 109.49 -179.406 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 0.4 OUTLIER -84.0 -43.58 0.77 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.943 . . . . 0.0 110.511 179.621 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.2 Cg_endo -78.68 -67.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.065 0 C-N-CA 122.109 1.873 . . . . 0.0 110.872 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.649 ' CD2' ' CD1' ' A' ' 14' ' ' LEU . 69.5 m80 -65.93 75.36 0.08 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.99 -1.069 . . . . 0.0 109.551 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 91' ' ' PRO . 45.5 mtm180 -91.84 110.94 22.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.126 -0.984 . . . . 0.0 109.139 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.7 1.71 30.63 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.03 33.59 2.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -1.16 . . . . 0.0 109.475 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.438 ' O ' HG12 ' A' ' 15' ' ' VAL . . . 64.27 13.14 53.22 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.638 ' HE2' ' O ' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -74.13 63.1 0.95 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.824 -1.398 . . . . 0.0 109.201 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.1 t -140.72 107.99 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.891 . . . . 0.0 109.61 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.578 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -112.21 179.45 19.48 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.457 ' HG3' ' C ' ' A' ' 99' ' ' GLY . 2.7 mtmp? -152.46 134.24 14.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.115 -1.227 . . . . 0.0 109.784 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 1.037 HD11 HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -95.82 132.73 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.88 . . . . 0.0 108.831 179.568 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -107.02 97.8 7.53 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.137 -0.977 . . . . 0.0 108.829 179.252 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.675 HG11 ' HA ' ' A' ' 25' ' ' PRO . 3.8 t -99.3 73.86 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.028 -1.045 . . . . 0.0 109.463 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.395 -0.816 . . . . 0.0 109.538 179.942 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.24 0.543 . . . . 0.0 109.586 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.799 ' CD2' HD21 ' A' ' 21' ' ' LEU . 23.1 m-85 -86.1 163.39 17.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.319 -0.863 . . . . 0.0 109.302 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.802 HG23 ' HB3' ' A' ' 30' ' ' GLU . 0.9 OUTLIER -151.93 111.96 4.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.044 -1.035 . . . . 0.0 109.957 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.473 ' CG1' HD12 ' A' ' 21' ' ' LEU . 6.5 m -104.98 79.97 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.275 -0.89 . . . . 0.0 109.255 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -58.2 148.32 27.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.314 -0.866 . . . . 0.0 109.714 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.732 HD11 ' HA ' ' A' ' 33' ' ' ASN . 0.4 OUTLIER -118.05 -173.79 2.52 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.236 -0.915 . . . . 0.0 109.485 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.6 ' HA2' HD23 ' A' ' 14' ' ' LEU . . . 65.28 88.57 0.05 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.559 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -66.55 -22.84 66.16 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.31 -1.112 . . . . 0.0 109.384 179.699 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.559 ' CB ' ' O ' ' A' ' 9' ' ' SER . 8.4 t70 83.36 20.05 0.2 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.467 ' HB2' HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -115.63 9.74 15.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 109.361 179.774 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.56 5.16 45.78 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.513 ' N ' HD23 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -134.95 154.4 51.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -1.161 . . . . 0.0 109.825 -179.792 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.618 ' CD1' ' CD2' ' A' ' 92' ' ' HIS . 95.1 mt -113.91 121.4 43.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.353 -0.842 . . . . 0.0 109.172 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 m -149.07 153.6 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.111 -0.993 . . . . 0.0 109.863 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.477 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 12.0 m-85 -76.57 156.21 32.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.172 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 16' ' ' PHE . 4.1 mt-10 -141.98 109.77 5.99 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.128 -0.983 . . . . 0.0 109.393 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.5 Cg_endo -77.51 -177.7 21.92 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 123.767 -1.347 . . . . 0.0 110.698 0.469 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.21 -58.36 3.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 109.333 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.07 168.74 9.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.915 . . . . 0.0 109.16 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.799 HD21 ' CD2' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -160.1 146.06 15.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.082 -1.011 . . . . 0.0 109.927 -179.812 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 102' ' ' THR . 90.5 m -114.31 112.88 23.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.843 . . . . 0.0 109.011 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.737 ' CD1' HD13 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -117.59 164.05 14.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.265 -0.897 . . . . 0.0 110.073 -179.682 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.571 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 17.0 mmmt -82.16 165.48 42.66 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.615 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 32.7 Cg_endo -74.81 86.26 1.41 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 121.945 1.763 . . . . 0.0 110.306 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 126.26 4.43 6.45 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.494 ' OD2' ' CG ' ' A' ' 24' ' ' LYS . 59.0 m-20 -71.07 -176.73 1.47 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -1.158 . . . . 0.0 109.58 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.745 HG23 ' HA ' ' A' ' 75' ' ' THR . 0.2 OUTLIER -120.04 122.93 42.21 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.284 -0.885 . . . . 0.0 109.636 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.86 HG21 HD11 ' A' ' 101' ' ' ILE . 1.4 t -111.17 147.32 15.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.224 -0.923 . . . . 0.0 109.334 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.802 ' HB3' HG23 ' A' ' 4' ' ' THR . 5.3 tp10 -117.56 141.34 48.47 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.176 -0.953 . . . . 0.0 110.111 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.567 ' CE2' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -145.33 89.73 1.96 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.716 ' O ' HD11 ' A' ' 7' ' ' LEU . 0.5 OUTLIER -97.84 179.88 4.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.44 -0.787 . . . . 0.0 111.257 -178.028 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.732 ' HA ' HD11 ' A' ' 7' ' ' LEU . 3.8 p-10 -93.21 165.42 12.82 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.533 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . 13.3 t-20 -115.7 -84.0 0.62 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.073 -1.017 . . . . 0.0 109.477 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.516 ' O ' HG22 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -145.95 35.15 1.01 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.087 -1.008 . . . . 0.0 109.643 179.892 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.55 ' O ' ' NE2' ' A' ' 92' ' ' HIS . 2.0 t -156.87 60.36 2.13 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.86 . . . . 0.0 109.305 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 35.8 Cg_endo -78.26 174.08 12.94 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.661 2.24 . . . . 0.0 110.631 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.533 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.9 Cg_endo -86.38 162.18 54.53 Favored 'Cis proline' 0 C--N 1.311 -1.445 0 O-C-N 123.798 1.42 . . . . 0.0 110.297 -1.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.711 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 65.2 m-70 -118.59 146.73 44.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.187 -0.946 . . . . 0.0 110.17 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -120.04 114.47 22.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 109.237 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.497 HG21 ' HB2' ' A' ' 31' ' ' PHE . 24.7 t -99.92 114.06 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.508 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.679 HG13 ' CB ' ' A' ' 60' ' ' SER . 1.6 t -150.59 157.4 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.928 . . . . 0.0 109.874 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.573 ' CE2' HD23 ' A' ' 59' ' ' LEU . 3.8 m-85 -109.14 110.99 22.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.422 -0.799 . . . . 0.0 109.41 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -47.16 158.35 0.15 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.0 109.519 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.73 31.2 5.64 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.292 -0.88 . . . . 0.0 109.532 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.99 -31.71 4.99 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.182 -0.949 . . . . 0.0 109.644 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 mp -101.43 64.5 1.01 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.94 . . . . 0.0 109.656 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.443 ' CG ' ' HA ' ' A' ' 51' ' ' LYS . 0.7 OUTLIER -111.79 158.72 35.83 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.309 -0.869 . . . . 0.0 109.394 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -80.01 -33.7 1.07 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.78 2.32 . . . . 0.0 110.564 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.507 ' O ' ' HG3' ' A' ' 51' ' ' LYS . . . -122.6 35.7 4.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.15 -0.969 . . . . 0.0 109.845 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.507 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 0.3 OUTLIER 34.28 49.75 0.34 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.869 -0.519 . . . . 0.0 110.529 179.634 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 m -127.44 141.21 51.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.12 -0.987 . . . . 0.0 109.675 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -121.04 10.43 10.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 109.401 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -62.31 -39.65 93.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.392 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.528 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 1.7 pp -80.93 -32.27 34.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.362 -0.836 . . . . 0.0 109.57 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.506 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -69.01 -43.74 74.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.081 -1.012 . . . . 0.0 109.571 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.12 -30.91 12.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.313 -0.867 . . . . 0.0 109.748 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 59' ' ' LEU . 0.1 OUTLIER -105.74 -40.42 5.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.163 -0.961 . . . . 0.0 110.009 -179.623 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.978 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 13.2 tp -43.01 -56.56 3.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.217 -0.927 . . . . 0.0 109.917 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.679 ' CB ' HG13 ' A' ' 42' ' ' VAL . 64.3 p -78.83 153.05 30.95 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.487 -0.758 . . . . 0.0 110.619 -177.989 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.498 ' CE1' ' O ' ' A' ' 63' ' ' GLN . 12.8 p80 -93.69 176.67 6.27 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.87 -57.61 2.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.726 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.498 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 21.8 pt20 -44.09 145.48 0.75 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 109.552 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 mp -78.29 167.98 20.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 109.505 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.477 ' CD1' ' CE1' ' A' ' 61' ' ' HIS . 7.7 mp -95.32 108.96 21.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 0.0 109.38 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 4.2 ttp -117.81 -0.4 11.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 0.0 109.673 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.522 ' OG ' ' CB ' ' A' ' 70' ' ' GLN . 3.2 t -91.23 147.28 35.21 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.147 -0.971 . . . . 0.0 109.557 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.23 87.96 1.48 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.712 2.275 . . . . 0.0 110.823 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.536 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 89.22 35.37 8.12 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.522 ' CB ' ' OG ' ' A' ' 67' ' ' SER . 1.6 tt0 -147.25 94.0 2.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.128 -1.219 . . . . 0.0 109.205 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.562 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . 4.4 p -99.88 -105.89 0.22 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.33 -0.856 . . . . 0.0 109.676 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.548 HG23 ' O ' ' A' ' 72' ' ' THR . 9.9 t -160.56 123.74 3.4 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.7 m -79.26 82.31 5.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.046 -1.034 . . . . 0.0 109.341 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.521 HG21 ' HG ' ' A' ' 59' ' ' LEU . 99.6 m -59.67 101.51 0.11 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.399 -0.813 . . . . 0.0 109.504 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.745 ' HA ' HG23 ' A' ' 28' ' ' THR . 3.1 t -78.95 86.18 4.85 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.978 ' CZ ' HD21 ' A' ' 59' ' ' LEU . 3.2 m-85 -36.22 147.97 0.18 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.887 -0.508 . . . . 0.0 110.125 -178.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.442 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.7 Cg_endo -78.28 175.74 10.75 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.793 2.329 . . . . 0.0 111.52 -178.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.76 9.78 13.15 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.493 ' O ' ' C ' ' A' ' 80' ' ' ALA . 2.2 t70 -99.15 -12.99 19.97 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.411 -0.806 . . . . 0.0 108.886 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.615 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -34.6 104.54 0.25 Allowed Pre-proline 0 N--CA 1.497 1.919 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.445 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 33.9 Cg_endo -75.57 152.65 38.4 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.531 2.154 . . . . 0.0 110.899 -179.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -71.67 131.6 43.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.437 -0.79 . . . . 0.0 109.413 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 155.34 -149.61 20.83 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.454 ' CD ' HG23 ' A' ' 102' ' ' THR . 0.0 OUTLIER -126.48 137.83 53.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.214 -1.168 . . . . 0.0 109.664 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.549 ' CD1' HG22 ' A' ' 101' ' ' ILE . 6.4 m-85 -101.51 -170.95 1.9 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.347 -0.846 . . . . 0.0 108.723 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 85' ' ' TYR . 92.6 m -166.79 98.4 0.55 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.859 -1.151 . . . . 0.0 110.463 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.524 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.6 OUTLIER -101.95 162.27 13.04 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.243 -0.911 . . . . 0.0 108.677 178.622 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -154.31 -162.0 1.33 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.927 -1.108 . . . . 0.0 110.112 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.63 141.45 48.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.492 -0.755 . . . . 0.0 109.391 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 19.2 tt0 -77.95 -44.71 2.34 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.213 -0.929 . . . . 0.0 110.181 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.0 Cg_endo -78.68 -64.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 122.0 1.8 . . . . 0.0 110.439 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.711 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 9.2 m80 -73.86 57.14 0.59 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.22 -0.925 . . . . 0.0 109.315 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 16.8 ttt85 -102.91 -8.6 20.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.564 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -88.66 22.9 18.76 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.92 -129.62 0.14 Allowed 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.313 -1.11 . . . . 0.0 108.692 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -127.74 36.95 2.42 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.535 ' CE ' ' HB3' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -80.61 70.29 7.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.121 -1.223 . . . . 0.0 109.602 179.784 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 53.0 t -140.97 113.24 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.212 -0.93 . . . . 0.0 109.626 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.524 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -114.77 172.12 14.07 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.446 ' HB3' ' O ' ' A' ' 85' ' ' TYR . 6.7 mttm -148.88 128.54 13.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -1.151 . . . . 0.0 109.648 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.86 HD11 HG21 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -80.27 154.96 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.885 . . . . 0.0 108.971 179.676 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.616 ' O ' HG23 ' A' ' 22' ' ' THR . 0.7 OUTLIER -129.26 90.17 2.97 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.259 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.65 HG23 ' CG2' ' A' ' 101' ' ' ILE . 28.0 t -99.89 121.81 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.259 -0.9 . . . . 0.0 109.835 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.398 -0.814 . . . . 0.0 109.392 -179.966 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.466 ' O ' ' N ' ' A' ' 30' ' ' GLU . 43.1 m-85 -89.37 116.7 27.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -0.917 . . . . 0.0 109.615 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.6 m -118.42 120.57 37.96 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.319 -0.863 . . . . 0.0 109.3 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.539 HG12 ' C ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -107.93 102.66 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 109.387 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 7' ' ' LEU . 2.4 ttmt -80.68 83.89 6.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.325 -0.859 . . . . 0.0 109.464 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.679 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -47.42 173.23 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.356 -0.84 . . . . 0.0 109.677 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.533 ' HA3' ' CB ' ' A' ' 34' ' ' ASN . . . 83.34 94.4 0.61 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.472 ' OG ' ' N ' ' A' ' 10' ' ' ASP . 95.0 p -49.92 -75.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.289 -1.124 . . . . 0.0 109.536 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.472 ' N ' ' OG ' ' A' ' 9' ' ' SER . 20.9 t0 -173.16 -71.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.567 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.17 55.51 1.85 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.277 -0.889 . . . . 0.0 109.385 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.77 -95.23 0.1 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.458 ' HA ' HD22 ' A' ' 13' ' ' LEU . 0.8 OUTLIER -113.42 166.24 11.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.297 -1.12 . . . . 0.0 109.46 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.719 ' HB3' ' HE1' ' A' ' 97' ' ' MET . 17.2 mt -101.69 123.65 46.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.213 -0.929 . . . . 0.0 109.392 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.2 m -143.98 159.08 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.615 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.41 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 3.2 m-85 -71.92 164.32 26.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 109.376 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.539 ' C ' HG12 ' A' ' 5' ' ' VAL . 14.6 mt-10 -154.24 104.59 2.41 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 109.419 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 33.5 Cg_endo -77.09 169.22 74.89 Favored 'Cis proline' 0 C--N 1.311 -1.441 0 C-N-CA 123.693 -1.378 . . . . 0.0 110.448 0.328 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.79 -25.41 62.0 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.232 -0.918 . . . . 0.0 109.738 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.445 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 10.6 mmtm -112.62 160.4 17.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.113 -0.992 . . . . 0.0 109.832 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 20' ' ' LYS . 7.0 mt -143.72 108.75 4.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -0.866 . . . . 0.0 109.291 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.517 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 5.3 m -89.05 90.32 8.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.277 -0.889 . . . . 0.0 109.752 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.741 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.2 pt -101.35 171.67 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.24 -0.912 . . . . 0.0 109.685 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.646 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 7.8 mttt -86.83 -164.23 0.06 OUTLIER Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.646 ' HD2' ' CB ' ' A' ' 24' ' ' LYS . 30.8 Cg_endo -74.95 62.35 5.8 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 N-CA-C 109.314 -1.072 . . . . 0.0 109.314 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.568 ' O ' ' HB2' ' A' ' 76' ' ' PHE . . . 142.52 -92.19 0.17 Allowed Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.423 ' CG ' ' HG3' ' A' ' 24' ' ' LYS . 1.3 m-20 49.61 -176.2 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.119 -1.224 . . . . 0.0 109.55 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.513 ' CG2' ' OG ' ' A' ' 73' ' ' SER . 64.0 m -122.68 142.49 50.62 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.309 -0.869 . . . . 0.0 109.523 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.758 HG21 HD11 ' A' ' 101' ' ' ILE . 2.4 t -125.13 148.79 29.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.289 -0.882 . . . . 0.0 109.307 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 3' ' ' TYR . 1.9 mt-10 -127.27 132.61 50.3 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.197 -0.939 . . . . 0.0 109.746 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.578 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -138.1 105.01 5.38 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.77 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.751 HD23 ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -100.33 -171.47 2.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.066 -1.021 . . . . 0.0 111.026 -178.654 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.52 ' HA ' HD11 ' A' ' 7' ' ' LEU . 3.2 p-10 -105.55 168.33 9.16 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.706 -0.621 . . . . 0.0 109.725 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.533 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . 30.2 t30 -114.64 -142.05 0.38 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.295 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.405 ' C ' ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -99.36 36.11 1.81 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.997 -1.064 . . . . 0.0 109.241 179.76 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.595 HG21 HD21 ' A' ' 14' ' ' LEU . 2.1 t -151.46 61.95 4.64 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.579 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.2 Cg_endo -77.42 175.63 11.06 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.694 2.263 . . . . 0.0 110.955 -178.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.579 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 40.5 Cg_endo -87.87 158.51 44.81 Favored 'Cis proline' 0 C--N 1.313 -1.338 0 C-N-CA 123.573 -1.428 . . . . 0.0 110.74 -1.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.713 ' C ' HD12 ' A' ' 65' ' ' LEU . 80.6 m-70 -121.99 160.88 23.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.382 -0.824 . . . . 0.0 109.858 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -139.74 165.8 26.31 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.4 -0.813 . . . . 0.0 108.847 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.564 ' HB ' ' CD2' ' A' ' 61' ' ' HIS . 43.3 t -137.45 114.65 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.113 -0.992 . . . . 0.0 109.144 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.54 HG13 ' HB2' ' A' ' 60' ' ' SER . 0.0 OUTLIER -144.37 174.74 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.244 -0.91 . . . . 0.0 109.518 -179.443 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.669 ' CD2' HD23 ' A' ' 59' ' ' LEU . 4.2 m-85 -131.33 112.24 12.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 0.0 109.392 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.623 ' CG ' HD12 ' A' ' 47' ' ' LEU . 8.0 t70 -54.0 136.49 41.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 109.633 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.87 -2.67 58.71 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.261 -0.9 . . . . 0.0 109.648 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.443 ' O ' ' HG ' ' A' ' 47' ' ' LEU . . . -107.75 13.82 26.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.181 -0.949 . . . . 0.0 109.645 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.623 HD12 ' CG ' ' A' ' 44' ' ' ASP . 1.5 mt -140.32 46.66 1.81 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 0.0 109.424 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.502 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 1.2 p30 -123.86 165.75 22.18 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.321 -0.862 . . . . 0.0 109.287 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.502 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 33.5 Cg_endo -76.02 -23.71 11.93 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.437 2.092 . . . . 0.0 109.689 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 52' ' ' SER . . . -140.17 83.9 1.94 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -40.06 95.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.462 -0.774 . . . . 0.0 109.986 -179.369 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 50' ' ' ALA . 4.5 m -138.31 107.26 5.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.391 -0.818 . . . . 0.0 109.159 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.89 -0.85 17.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 109.719 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -75.79 -53.69 8.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.906 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.483 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 2.1 pp -63.28 -29.84 71.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.158 -0.964 . . . . 0.0 109.591 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.462 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -73.45 -37.97 65.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 0.0 109.631 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.1 mttp -52.4 -30.35 28.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -0.947 . . . . 0.0 109.714 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.3 p -115.6 38.36 3.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -0.908 . . . . 0.0 109.507 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.743 ' HG ' HG21 ' A' ' 74' ' ' THR . 7.3 tp -135.64 -48.64 0.7 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -0.881 . . . . 0.0 109.29 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.54 ' HB2' HG13 ' A' ' 42' ' ' VAL . 1.2 p -78.88 122.16 25.75 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.478 -0.764 . . . . 0.0 110.289 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.564 ' CD2' ' HB ' ' A' ' 41' ' ' VAL . 4.4 p80 -90.71 159.32 16.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.367 -0.833 . . . . 0.0 108.974 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.48 -161.66 0.76 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.133 -0.979 . . . . 0.0 109.654 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 66.9 106.92 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.412 -0.805 . . . . 0.0 109.609 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.449 HD23 ' HB2' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -54.31 143.33 23.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 109.609 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.713 HD12 ' C ' ' A' ' 39' ' ' HIS . 1.1 mt -89.01 87.24 7.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.361 -0.837 . . . . 0.0 109.151 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' MET . . . . . 0.52 ' HG3' ' N ' ' A' ' 67' ' ' SER . 0.0 OUTLIER -85.4 -24.61 27.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.108 -0.995 . . . . 0.0 109.954 -179.636 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.52 ' N ' ' HG3' ' A' ' 66' ' ' MET . 1.9 t -79.98 147.66 66.35 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.288 -0.883 . . . . 0.0 109.425 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.458 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 35.0 Cg_endo -77.86 100.37 1.37 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.572 2.181 . . . . 0.0 110.156 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.71 -25.84 17.9 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.448 ' HB2' ' OG ' ' A' ' 67' ' ' SER . 50.9 tt0 -62.52 110.79 1.8 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.14 -1.212 . . . . 0.0 108.532 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.553 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . 12.0 p -132.8 -155.03 0.65 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.138 -0.976 . . . . 0.0 110.934 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.7 m -152.05 116.66 5.08 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.513 ' OG ' ' CG2' ' A' ' 28' ' ' THR . 13.7 t -79.05 104.26 9.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -0.961 . . . . 0.0 108.966 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.743 HG21 ' HG ' ' A' ' 59' ' ' LEU . 91.6 m -73.27 109.07 6.52 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.408 -0.808 . . . . 0.0 109.956 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 75' ' ' THR . 3.3 t -79.39 80.42 5.76 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.7 ' CE2' HD21 ' A' ' 59' ' ' LEU . 10.3 m-85 -36.24 151.97 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.819 -0.551 . . . . 0.0 110.162 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.402 ' HD3' HD13 ' A' ' 59' ' ' LEU . 36.2 Cg_endo -78.38 171.01 17.59 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.799 2.332 . . . . 0.0 111.016 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -86.37 9.44 17.99 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 80' ' ' ALA . 1.0 OUTLIER -101.51 -8.73 21.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.455 -0.778 . . . . 0.0 109.477 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.492 ' HB1' HG21 ' A' ' 103' ' ' VAL . . . -38.2 105.28 0.32 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.559 -0.713 . . . . 0.0 109.66 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.421 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 35.3 Cg_endo -77.34 146.51 24.92 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.501 2.134 . . . . 0.0 110.747 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.59 132.1 50.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.297 -0.877 . . . . 0.0 109.513 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 145.9 161.9 9.43 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 3.8 mt-10 -85.24 131.91 34.35 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.214 -1.168 . . . . 0.0 109.562 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.736 ' CD1' HG22 ' A' ' 101' ' ' ILE . 29.0 m-85 -84.44 -156.12 0.22 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -163.88 87.04 0.5 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.685 -1.26 . . . . 0.0 110.551 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.787 ' O ' HG23 ' A' ' 98' ' ' VAL . 1.1 p90 -99.92 160.97 13.9 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.519 ' CB ' ' HB ' ' A' ' 98' ' ' VAL . 9.5 p90 -159.22 -163.11 1.15 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.919 -1.113 . . . . 0.0 110.396 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.489 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 0.1 OUTLIER -123.49 133.64 54.0 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.513 -0.742 . . . . 0.0 109.775 -179.615 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.631 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.7 tm-20 -74.16 -43.01 5.87 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.336 -0.853 . . . . 0.0 110.669 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.1 Cg_endo -77.63 -54.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.902 1.735 . . . . 0.0 110.833 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.712 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 42.6 m80 -85.38 60.44 6.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.052 -1.03 . . . . 0.0 109.535 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.45 -4.26 53.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.909 . . . . 0.0 109.427 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.71 14.62 17.3 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 96' ' ' GLY . . . -120.37 33.13 5.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -1.136 . . . . 0.0 109.376 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 95' ' ' ALA . . . 41.72 60.73 2.42 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.719 ' HE1' ' HB3' ' A' ' 14' ' ' LEU . 5.4 mtp -107.37 53.82 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.174 -1.192 . . . . 0.0 109.417 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 87' ' ' PHE . 1.4 p -139.44 143.82 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 109.694 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -151.04 176.09 29.71 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.444 ' HB3' ' O ' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -127.29 141.89 51.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.178 -1.19 . . . . 0.0 109.716 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.758 HD11 HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -85.6 155.59 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.889 . . . . 0.0 109.014 179.749 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.517 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -115.46 98.35 6.68 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.157 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.662 HG22 ' CD1' ' A' ' 23' ' ' ILE . 53.7 t -99.24 78.71 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.258 -0.901 . . . . 0.0 109.572 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.342 -0.849 . . . . 0.0 109.399 179.911 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.427 HG23 ' HB ' ' A' ' 28' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.345 0.593 . . . . 0.0 109.501 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.622 ' CG ' HD21 ' A' ' 21' ' ' LEU . 6.6 m-85 -103.29 174.14 6.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.12 -0.987 . . . . 0.0 109.285 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.409 HG22 HD21 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -143.73 105.04 4.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.089 -1.007 . . . . 0.0 110.062 -179.607 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 5' ' ' VAL . 20.5 m -93.71 65.84 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.218 -0.926 . . . . 0.0 109.131 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.418 ' HG3' HD11 ' A' ' 32' ' ' LEU . 1.5 ttmt -49.48 98.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 110.026 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -65.49 157.96 28.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.119 -0.988 . . . . 0.0 108.983 179.466 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 14' ' ' LEU . . . 72.18 137.07 0.22 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.459 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 1.5 p -100.72 -68.99 0.79 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.149 -1.206 . . . . 0.0 109.686 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 1.6 p30 167.24 -49.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 109.856 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LYS . . . . . 0.444 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -127.27 24.75 6.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 109.69 -179.768 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.811 ' C ' HD22 ' A' ' 13' ' ' LEU . . . -126.49 -116.5 2.06 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.825 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.6 mm? -121.98 -169.1 1.82 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.309 -1.113 . . . . 0.0 109.254 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.954 HD21 ' HB3' ' A' ' 35' ' ' LYS . 47.5 mt -98.84 102.54 14.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.263 -0.898 . . . . 0.0 108.671 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.1 m -137.69 164.05 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 0.0 109.724 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -80.07 137.25 36.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.372 -0.83 . . . . 0.0 109.205 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 34.5 mm-40 -126.13 105.64 25.28 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.202 -0.936 . . . . 0.0 109.551 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.8 Cg_endo -78.25 169.51 72.79 Favored 'Cis proline' 0 C--N 1.312 -1.381 0 C-N-CA 123.817 -1.326 . . . . 0.0 110.557 0.104 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.42 -64.79 0.81 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.147 -0.971 . . . . 0.0 108.879 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.4 pttm -84.76 160.03 20.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.37 -0.832 . . . . 0.0 109.029 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.836 HD23 HG23 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -152.12 149.13 28.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.081 -1.012 . . . . 0.0 110.078 -179.809 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.8 m -111.79 119.44 38.62 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.836 HG23 HD23 ' A' ' 21' ' ' LEU . 0.9 OUTLIER -132.43 175.74 10.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.143 -0.973 . . . . 0.0 110.029 -179.437 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.571 ' C ' HG13 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -91.69 175.99 3.07 Favored Pre-proline 0 C--N 1.303 -1.421 0 O-C-N 121.394 -0.816 . . . . 0.0 109.049 179.578 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.674 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 35.4 Cg_endo -77.26 92.17 1.14 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.331 2.021 . . . . 0.0 110.646 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 111.06 5.8 26.6 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.455 ' OD2' ' HB2' ' A' ' 24' ' ' LYS . 11.5 m-20 -66.4 -178.84 0.72 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.122 -1.222 . . . . 0.0 109.293 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.427 ' HB ' HG23 ' A' ' 2' ' ' THR . 3.6 m -115.38 129.28 56.54 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.349 -0.845 . . . . 0.0 109.549 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.032 HG21 HD11 ' A' ' 101' ' ' ILE . 5.2 t -115.62 135.05 56.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.189 -0.944 . . . . 0.0 109.539 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -103.43 129.42 50.54 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.172 -0.955 . . . . 0.0 109.662 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.582 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -127.17 83.56 2.18 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.599 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.4 OUTLIER -96.11 157.56 15.84 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.757 0.789 . . . . 0.0 110.726 -178.198 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.546 ' C ' ' OD1' ' A' ' 33' ' ' ASN . 4.5 p30 -77.47 171.42 14.92 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.703 0.763 . . . . 0.0 110.895 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' A' ' 7' ' ' LEU . 3.6 t30 -150.04 -37.46 0.15 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.954 ' HB3' HD21 ' A' ' 14' ' ' LEU . 1.9 tttt -99.4 -144.32 0.33 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.444 -0.785 . . . . 0.0 109.461 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -68.74 113.14 13.99 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.527 -0.733 . . . . 0.0 110.781 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.541 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 37.8 Cg_endo -84.13 178.41 5.29 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.999 2.466 . . . . 0.0 109.776 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 39.7 Cg_endo -88.5 168.19 37.51 Favored 'Cis proline' 0 C--N 1.314 -1.276 0 O-C-N 123.391 1.206 . . . . 0.0 109.849 -2.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.546 ' O ' HD13 ' A' ' 65' ' ' LEU . 80.7 m80 -122.89 143.47 49.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.066 -1.022 . . . . 0.0 109.999 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -103.84 144.08 31.98 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.359 -0.838 . . . . 0.0 108.983 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.459 ' HB ' ' NE2' ' A' ' 61' ' ' HIS . 54.5 t -119.17 124.48 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -0.969 . . . . 0.0 109.927 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.487 HG13 ' CB ' ' A' ' 60' ' ' SER . 1.4 t -150.24 167.31 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.389 -0.82 . . . . 0.0 108.987 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.603 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 7.0 m-85 -118.5 119.69 35.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.138 -0.976 . . . . 0.0 109.809 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.457 ' HB3' ' HB2' ' A' ' 47' ' ' LEU . 17.8 t0 -41.98 148.17 0.19 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.442 -0.786 . . . . 0.0 110.028 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.16 -14.46 17.73 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.359 -0.838 . . . . 0.0 109.234 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.466 ' O ' HD22 ' A' ' 47' ' ' LEU . . . -99.91 0.32 41.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.37 -0.831 . . . . 0.0 109.544 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.466 HD22 ' O ' ' A' ' 46' ' ' ALA . 1.6 mm? -117.81 46.65 1.71 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.173 -0.954 . . . . 0.0 109.215 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.47 ' OD1' ' HA ' ' A' ' 51' ' ' LYS . 1.2 p30 -105.42 162.38 19.89 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.343 -0.848 . . . . 0.0 109.488 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 36.3 Cg_endo -77.88 -31.62 3.04 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.765 2.31 . . . . 0.0 110.907 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.496 ' O ' ' HG3' ' A' ' 51' ' ' LYS . . . -122.5 31.26 6.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.102 -0.999 . . . . 0.0 110.047 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 0.1 OUTLIER 35.32 36.79 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.88 -0.512 . . . . 0.0 110.479 179.492 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 50' ' ' ALA . 2.4 m -101.12 143.1 31.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.083 -1.011 . . . . 0.0 109.926 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -92.5 54.78 2.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.898 . . . . 0.0 109.523 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -140.63 23.22 2.3 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.2 -0.937 . . . . 0.0 109.563 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.408 ' HA ' HD13 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -118.44 9.59 12.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.246 -0.909 . . . . 0.0 109.531 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.504 ' HB2' ' HB2' ' A' ' 43' ' ' PHE . . . -142.9 -47.12 0.31 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.405 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -48.07 -25.22 1.34 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 0.0 109.344 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.8 t -118.4 -20.19 8.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.22 -0.925 . . . . 0.0 109.36 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.965 HD21 ' CE2' ' A' ' 76' ' ' PHE . 9.9 tp -79.29 -37.93 36.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 0.0 109.226 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.487 ' CB ' HG13 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -78.9 132.14 36.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.282 -0.886 . . . . 0.0 109.633 -179.735 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.459 ' NE2' ' HB ' ' A' ' 41' ' ' VAL . 12.5 p80 -83.84 -9.55 58.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.455 -0.778 . . . . 0.0 109.605 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 0.1 OUTLIER 54.65 -170.78 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 109.709 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.487 ' CB ' ' O ' ' A' ' 62' ' ' LYS . 4.0 tt0 75.45 -179.75 0.17 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.336 -0.852 . . . . 0.0 109.687 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.703 HD12 ' N ' ' A' ' 64' ' ' LEU . 4.4 mp -118.52 155.75 30.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.299 -0.875 . . . . 0.0 109.473 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 39' ' ' HIS . 4.6 mp -84.09 -175.32 5.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.911 . . . . 0.0 109.482 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -160.74 -37.35 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.15 -0.969 . . . . 0.0 109.904 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.534 ' HB3' ' CB ' ' A' ' 70' ' ' GLN . 5.5 t -83.71 147.11 51.23 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.149 -0.97 . . . . 0.0 109.901 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.458 ' HD2' ' OG ' ' A' ' 67' ' ' SER . 36.0 Cg_endo -79.08 92.18 1.16 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.817 2.345 . . . . 0.0 110.398 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.488 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 103.71 6.04 44.14 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.534 ' CB ' ' HB3' ' A' ' 67' ' ' SER . 1.2 tt0 -124.91 102.78 7.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -1.154 . . . . 0.0 109.093 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.599 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . 11.5 p -104.77 -104.27 0.31 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.339 -0.851 . . . . 0.0 110.132 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.9 m -159.97 149.58 18.03 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.9 p -97.34 103.76 15.72 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.037 -1.04 . . . . 0.0 109.424 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.482 ' HG1' ' HE1' ' A' ' 31' ' ' PHE . 94.1 m -76.8 103.27 6.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -0.889 . . . . 0.0 109.54 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 76' ' ' PHE . 23.2 m -79.06 92.58 5.01 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.965 ' CE2' HD21 ' A' ' 59' ' ' LEU . 5.4 m-85 -43.01 165.13 0.11 Allowed Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.47 -0.769 . . . . 0.0 109.537 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.517 ' HD3' HD13 ' A' ' 59' ' ' LEU . 32.3 Cg_endo -73.84 174.03 13.0 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.466 2.111 . . . . 0.0 111.282 -178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.59 8.19 8.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.545 -0.722 . . . . 0.0 109.515 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.484 ' O ' ' C ' ' A' ' 80' ' ' ALA . 10.5 m-20 -99.43 -74.61 0.59 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.25 -0.907 . . . . 0.0 109.156 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.674 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . 34.84 69.7 1.02 Allowed Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.723 -0.61 . . . . 0.0 110.074 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.44 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 34.2 Cg_endo -75.91 158.29 38.68 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.533 2.156 . . . . 0.0 110.819 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -49.07 98.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.352 -0.842 . . . . 0.0 109.609 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.569 ' O ' ' CE1' ' A' ' 85' ' ' TYR . . . -166.92 149.92 16.16 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -81.72 140.11 34.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.214 -1.168 . . . . 0.0 109.54 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.569 ' CE1' ' O ' ' A' ' 83' ' ' GLY . 66.5 m-85 -118.71 147.74 43.52 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.465 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 95.2 m -134.14 118.43 17.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.987 -1.07 . . . . 0.0 110.718 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.582 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -110.44 171.35 7.51 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.403 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' A' ' 97' ' ' MET . 14.1 p90 -158.94 -163.84 1.31 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.77 -1.206 . . . . 0.0 110.476 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.447 ' SG ' ' HD2' ' A' ' 91' ' ' PRO . 0.5 OUTLIER -126.25 145.29 50.46 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.578 -0.701 . . . . 0.0 109.408 -179.623 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.627 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 24.2 tp10 -82.97 -42.81 0.87 Allowed Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 121.254 -0.904 . . . . 0.0 110.599 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.3 Cg_endo -78.1 -75.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 121.946 1.764 . . . . 0.0 110.82 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.639 ' CD2' ' CD1' ' A' ' 14' ' ' LEU . 13.4 m80 -65.5 69.18 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.056 -1.028 . . . . 0.0 109.531 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 91' ' ' PRO . 10.8 tpt180 -90.72 -14.94 31.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.138 -0.976 . . . . 0.0 109.179 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.57 1.64 87.22 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.449 ' CB ' ' HB2' ' A' ' 14' ' ' LEU . . . -114.14 33.42 5.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -1.163 . . . . 0.0 109.487 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.494 ' O ' ' N ' ' A' ' 98' ' ' VAL . . . 40.16 36.6 0.92 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.513 ' SD ' ' HB3' ' A' ' 14' ' ' LEU . 4.0 mtp -65.35 72.85 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.036 -1.273 . . . . 0.0 109.177 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 96' ' ' GLY . 98.5 t -132.7 112.23 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 109.732 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.581 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -100.31 -174.92 30.08 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.519 ' N ' ' CZ ' ' A' ' 87' ' ' PHE . 22.4 mtpt -158.12 144.92 17.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.052 -1.263 . . . . 0.0 109.977 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 1.032 HD11 HG21 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -110.73 135.88 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 108.677 179.446 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 21' ' ' LEU . 3.1 m -114.11 95.29 5.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.271 -0.893 . . . . 0.0 109.1 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.64 HG22 ' CD1' ' A' ' 23' ' ' ILE . 2.3 t -99.87 124.71 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.277 -0.89 . . . . 0.0 109.805 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 109.252 179.757 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.698 ' HB3' HD21 ' A' ' 21' ' ' LEU . 25.8 m-85 -84.45 169.05 14.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 0.0 109.154 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 30' ' ' GLU . 31.6 m -160.18 122.2 3.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.108 -0.995 . . . . 0.0 109.776 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.907 HG12 ' H ' ' A' ' 17' ' ' GLU . 0.6 OUTLIER -106.13 -155.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 109.001 179.446 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.472 ' H ' HG12 ' A' ' 5' ' ' VAL . 10.5 tttt -175.22 127.93 0.27 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.33 -0.856 . . . . 0.0 109.507 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.787 HD12 ' CG ' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -100.56 93.89 5.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 0.0 109.156 179.775 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.746 ' HA2' HD23 ' A' ' 14' ' ' LEU . . . 152.07 70.14 0.01 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 8' ' ' GLY . 1.4 p -46.56 150.39 0.68 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.192 -1.181 . . . . 0.0 109.021 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -88.28 36.9 0.79 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.228 -0.92 . . . . 0.0 109.625 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.5 mtmm -122.37 -29.24 4.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 109.406 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.418 ' O ' ' HG ' ' A' ' 13' ' ' LEU . . . 137.91 46.02 0.08 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 12' ' ' GLY . 1.9 mt -164.3 172.68 13.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.224 -1.162 . . . . 0.0 109.626 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.746 HD23 ' HA2' ' A' ' 8' ' ' GLY . 88.1 mt -118.8 97.09 5.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 109.841 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.2 m -140.95 154.68 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.294 -0.878 . . . . 0.0 109.398 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -62.93 160.47 14.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.124 -0.985 . . . . 0.0 109.113 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.907 ' H ' HG12 ' A' ' 5' ' ' VAL . 0.6 OUTLIER -134.15 103.55 11.65 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.933 . . . . 0.0 109.651 -179.915 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.3 Cg_endo -77.53 -163.59 3.44 Favored 'Cis proline' 0 C--N 1.311 -1.397 0 C-N-CA 123.633 -1.403 . . . . 0.0 110.499 0.122 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.85 -36.12 70.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.267 -0.896 . . . . 0.0 109.593 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -116.14 168.84 9.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 0.0 109.399 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.698 HD21 ' HB3' ' A' ' 3' ' ' TYR . 2.7 tp -149.75 147.75 28.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.219 -0.926 . . . . 0.0 109.527 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.484 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 30.7 m -115.22 100.35 8.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 109.464 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.872 ' CD1' HD13 ' A' ' 101' ' ' ILE . 2.3 pt -100.45 178.53 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.255 -0.903 . . . . 0.0 109.739 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.699 ' O ' HG13 ' A' ' 103' ' ' VAL . 0.2 OUTLIER -95.57 -174.4 0.39 Allowed Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.536 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.613 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 35.7 Cg_endo -80.21 70.42 7.53 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.934 1.756 . . . . 0.0 110.694 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.543 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 111.08 48.31 0.72 Allowed Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.194 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.507 ' OD2' ' HG3' ' A' ' 24' ' ' LYS . 0.9 OUTLIER -108.16 -164.98 1.0 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.398 -1.06 . . . . 0.0 108.759 178.846 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 95.8 m -115.71 145.69 42.53 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.034 -1.041 . . . . 0.0 110.333 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.663 HG21 HD11 ' A' ' 101' ' ' ILE . 1.9 t -127.28 121.88 58.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.528 ' O ' HG23 ' A' ' 4' ' ' THR . 25.6 mt-10 -99.53 103.3 15.03 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.085 -1.01 . . . . 0.0 110.836 -178.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.708 ' C ' HD23 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -93.49 152.13 19.27 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.546 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.878 HD21 ' O ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -141.61 169.15 18.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.689 -1.257 . . . . 0.0 110.808 -179.37 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.53 ' OD1' ' HA ' ' A' ' 68' ' ' PRO . 6.7 p-10 -97.51 160.23 14.45 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.628 -0.67 . . . . 0.0 109.202 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.542 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . 51.9 t30 -110.07 -78.87 0.59 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.907 -1.121 . . . . 0.0 109.748 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.513 ' O ' HG22 ' A' ' 36' ' ' VAL . 5.7 tptt -151.25 34.71 0.58 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.026 -1.046 . . . . 0.0 109.886 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.603 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 0.9 OUTLIER -156.39 56.34 1.22 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.28 -0.887 . . . . 0.0 109.65 179.298 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.603 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 36.3 Cg_endo -78.59 176.37 9.96 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.697 2.265 . . . . 0.0 110.669 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.2 Cg_endo -86.13 162.23 56.26 Favored 'Cis proline' 0 C--N 1.312 -1.392 0 O-C-N 123.753 1.396 . . . . 0.0 110.416 -1.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.787 ' CG ' HD12 ' A' ' 7' ' ' LEU . 73.3 m-70 -122.28 140.73 52.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 110.215 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.505 ' HB2' ' HD3' ' A' ' 91' ' ' PRO . 1.2 m120 -115.15 134.76 54.87 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.55 ' HB ' ' CD2' ' A' ' 61' ' ' HIS . 35.5 t -100.82 135.07 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.105 -0.997 . . . . 0.0 110.03 -179.179 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.532 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 2.5 t -149.22 171.1 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.376 -0.828 . . . . 0.0 109.477 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.694 ' CZ ' HD12 ' A' ' 59' ' ' LEU . 1.6 m-85 -139.21 115.33 10.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.144 -0.973 . . . . 0.0 109.668 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -47.59 142.8 4.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.179 -0.951 . . . . 0.0 109.132 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.22 19.98 16.6 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.187 -0.945 . . . . 0.0 109.819 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -108.35 -40.17 5.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.207 -0.933 . . . . 0.0 109.561 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.612 ' N ' HD12 ' A' ' 47' ' ' LEU . 10.2 mp -87.17 55.9 3.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.922 . . . . 0.0 109.611 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.493 ' OD1' ' HA ' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -102.53 165.76 13.2 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.331 -0.856 . . . . 0.0 109.47 179.71 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.516 ' HG2' ' HG2' ' A' ' 81' ' ' PRO . 34.9 Cg_endo -77.78 -33.07 2.4 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.638 2.225 . . . . 0.0 110.807 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -124.06 30.72 6.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.037 -1.039 . . . . 0.0 109.719 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.493 ' HA ' ' OD1' ' A' ' 48' ' ' ASN . 12.5 mmtm 39.45 31.46 0.07 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.71 -0.619 . . . . 0.0 109.841 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 50' ' ' ALA . 28.8 m -101.62 125.01 48.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.68 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -100.35 97.53 8.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.353 -0.842 . . . . 0.0 109.368 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -163.49 -46.01 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.274 -0.891 . . . . 0.0 109.529 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 0.9 OUTLIER -68.4 -15.88 63.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.898 . . . . 0.0 109.381 -179.902 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.94 -50.5 8.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.252 -0.905 . . . . 0.0 109.637 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.29 -23.66 0.6 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.719 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.2 t -106.86 -3.52 20.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.062 -1.024 . . . . 0.0 109.902 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.015 HD21 ' CD2' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -95.12 -37.12 11.22 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.09 -1.006 . . . . 0.0 108.554 179.935 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.498 ' CB ' ' HA ' ' A' ' 42' ' ' VAL . 1.4 m -78.91 132.73 36.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.191 -0.943 . . . . 0.0 110.383 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.683 ' CE1' HD21 ' A' ' 65' ' ' LEU . 18.9 p80 -109.61 138.49 45.89 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.46 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -127.74 119.42 25.74 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.009 -1.057 . . . . 0.0 110.114 -179.785 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.606 ' O ' ' O ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER 167.53 29.44 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.558 -0.714 . . . . 0.0 110.303 179.248 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.606 ' O ' ' O ' ' A' ' 63' ' ' GLN . 4.1 mt 47.66 123.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.734 0.778 . . . . 0.0 111.319 178.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.683 HD21 ' CE1' ' A' ' 61' ' ' HIS . 6.3 mt -78.49 155.32 29.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.246 -1.534 . . . . 0.0 108.77 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 41.1 mtm -137.28 9.64 2.97 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -0.904 . . . . 0.0 109.595 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 70' ' ' GLN . 1.9 t -110.28 129.55 23.82 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 109.375 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.53 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.2 Cg_endo -79.18 93.31 1.1 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.362 2.041 . . . . 0.0 110.453 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 114.39 0.83 23.49 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.436 ' HG2' ' C ' ' A' ' 69' ' ' GLY . 32.5 mm-40 -144.43 112.94 6.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -1.112 . . . . 0.0 108.777 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.55 ' OG ' ' N ' ' A' ' 72' ' ' THR . 51.9 p -99.95 -80.28 0.48 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.001 -1.062 . . . . 0.0 109.671 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.598 ' HB ' ' CD2' ' A' ' 61' ' ' HIS . 4.3 m -160.33 107.8 1.61 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.077 -1.015 . . . . 0.0 109.474 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 29' ' ' VAL . 3.9 m -80.08 76.35 6.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -0.932 . . . . 0.0 109.154 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.651 HG21 HD13 ' A' ' 59' ' ' LEU . 1.0 OUTLIER -60.68 124.15 19.56 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.417 -0.802 . . . . 0.0 110.06 -179.61 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 75' ' ' THR . 3.8 t -82.87 90.08 6.91 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.392 -0.818 . . . . 0.0 108.986 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 1.015 ' CD2' HD21 ' A' ' 59' ' ' LEU . 22.7 m-85 -41.41 157.11 0.2 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.464 -0.773 . . . . 0.0 109.693 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.543 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.6 Cg_endo -78.1 161.14 29.67 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.814 2.343 . . . . 0.0 111.031 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.09 5.4 8.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.22 -0.925 . . . . 0.0 110.023 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.469 ' OD1' ' HB2' ' A' ' 77' ' ' PRO . 2.0 p-10 -100.09 -11.04 20.85 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.001 -1.062 . . . . 0.0 109.616 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 79' ' ' ASP . . . -40.4 100.6 0.22 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.497 -0.752 . . . . 0.0 109.832 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.516 ' HG2' ' HG2' ' A' ' 49' ' ' PRO . 36.3 Cg_endo -78.54 -176.11 3.09 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.497 2.131 . . . . 0.0 110.442 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.72 123.33 27.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.355 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 169.1 148.28 5.74 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.437 ' O ' ' CG ' ' A' ' 84' ' ' GLU . 10.8 pt-20 -80.37 111.68 17.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.309 -1.112 . . . . 0.0 109.752 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.544 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 5.6 m-30 -86.5 98.04 10.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.934 . . . . 0.0 108.867 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 17.3 m -77.45 105.76 8.79 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.226 -0.921 . . . . 0.0 110.191 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.487 ' HB3' ' CD2' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -104.16 176.93 4.99 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.283 -0.886 . . . . 0.0 108.796 179.103 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.477 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 5.7 p90 -160.7 -147.7 0.15 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.014 -1.054 . . . . 0.0 109.722 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 93' ' ' ARG . 0.5 OUTLIER -130.93 159.02 38.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 109.746 -179.466 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.602 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.3 tt0 -91.79 -44.21 0.36 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.362 -0.836 . . . . 0.0 111.161 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.8 Cg_endo -80.58 -56.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.09 0 C-N-CA 122.117 1.878 . . . . 0.0 110.674 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.726 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 19.9 m80 -77.78 5.02 10.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.62 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 89' ' ' CYS . 20.0 ttt-85 -43.26 120.0 1.74 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.17 -0.956 . . . . 0.0 109.37 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.73 11.07 33.72 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.7 39.26 3.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -1.163 . . . . 0.0 109.328 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.74 -0.16 66.44 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.626 ' HE3' ' HB2' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -71.39 66.9 0.48 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.164 -1.198 . . . . 0.0 109.664 -179.865 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.0 t -135.25 120.0 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.189 -0.944 . . . . 0.0 109.444 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 86' ' ' THR . . . -133.77 -178.52 15.65 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 10.0 mttt -148.78 140.77 23.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -1.187 . . . . 0.0 109.669 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.872 HD13 ' CD1' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -96.88 133.73 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 109.111 179.718 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.484 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 0.5 OUTLIER -101.28 104.13 15.15 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.691 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.834 HG22 ' CD1' ' A' ' 23' ' ' ILE . 59.4 t -98.9 114.18 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.295 -0.878 . . . . 0.0 109.601 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.427 0 O-C-N 121.347 -0.846 . . . . 0.0 109.31 179.98 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 49.2 m . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.44 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 16.1 m-85 -90.69 137.61 32.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.281 -0.887 . . . . 0.0 109.361 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.962 HG23 ' HB3' ' A' ' 30' ' ' GLU . 2.0 m -139.19 110.62 7.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.646 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 5' ' ' VAL . 26.8 m -96.49 109.14 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.244 -0.91 . . . . 0.0 109.466 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -86.75 137.9 32.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -0.949 . . . . 0.0 109.43 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.734 ' HB2' ' HE3' ' A' ' 97' ' ' MET . 0.1 OUTLIER -98.47 80.27 2.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.0 109.1 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.468 ' O ' ' ND2' ' A' ' 34' ' ' ASN . . . 134.48 79.94 0.13 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 p -52.58 -88.59 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.251 -1.147 . . . . 0.0 109.563 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -172.38 37.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.555 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.21 20.37 6.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 109.435 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.432 ' HA2' ' CE ' ' A' ' 35' ' ' LYS . . . 73.02 37.41 56.3 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.455 ' O ' ' HA2' ' A' ' 8' ' ' GLY . 74.7 mt -139.89 139.38 36.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -1.121 . . . . 0.0 109.442 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.691 HD21 ' HB3' ' A' ' 35' ' ' LYS . 17.0 mt -101.25 114.31 28.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.204 -0.935 . . . . 0.0 109.561 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 14' ' ' LEU . 15.0 m -157.59 157.65 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 0.0 109.378 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -81.82 147.09 29.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 109.614 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 14.2 mm-40 -139.61 107.01 7.06 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.251 -0.905 . . . . 0.0 109.424 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.7 Cg_endo -78.1 176.19 44.15 Favored 'Cis proline' 0 C--N 1.312 -1.374 0 C-N-CA 123.761 -1.349 . . . . 0.0 110.675 0.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.07 -61.05 1.95 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.335 -0.853 . . . . 0.0 109.298 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.5 tttp -82.03 174.72 10.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.912 . . . . 0.0 109.198 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.519 ' CD2' HG13 ' A' ' 29' ' ' VAL . 5.2 tp -158.95 104.73 1.74 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.12 -0.988 . . . . 0.0 110.083 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . 0.475 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 32.1 m -87.01 90.09 8.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.188 -0.945 . . . . 0.0 108.477 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.688 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -99.7 163.43 2.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.316 -0.865 . . . . 0.0 110.348 -178.999 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.607 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 14.1 mmtt -88.03 166.74 22.6 Favored Pre-proline 0 C--N 1.301 -1.526 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PRO . . . . . 0.873 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 31.4 Cg_endo -73.09 88.86 0.92 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.693 1.596 . . . . 0.0 110.017 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 125.59 -3.13 8.15 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.485 ' OD2' ' CG ' ' A' ' 24' ' ' LYS . 62.6 m-20 -62.47 -168.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -1.145 . . . . 0.0 109.566 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.2 m -129.33 130.63 46.35 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.278 -0.889 . . . . 0.0 109.369 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.091 HG21 HD11 ' A' ' 101' ' ' ILE . 3.3 t -121.42 115.91 48.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.251 -0.905 . . . . 0.0 109.346 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . 0.962 ' HB3' HG23 ' A' ' 4' ' ' THR . 2.0 mm-40 -99.58 132.92 44.6 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.27 -0.893 . . . . 0.0 109.635 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.6 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -131.7 94.41 3.51 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . 0.582 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.4 OUTLIER -96.58 179.68 4.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.343 -0.848 . . . . 0.0 110.663 -178.35 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASN . . . . . 0.575 ' ND2' ' HB3' ' A' ' 37' ' ' PRO . 1.7 p-10 -107.87 155.05 20.7 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.47 -0.768 . . . . 0.0 109.469 -178.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.468 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 53.2 t30 -151.19 -58.52 0.16 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.985 -1.072 . . . . 0.0 110.009 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.691 ' HB3' HD21 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -60.72 -147.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.27 -0.894 . . . . 0.0 109.124 -179.345 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.566 ' O ' ' CE1' ' A' ' 39' ' ' HIS . 65.4 t -68.05 112.35 10.46 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.371 -0.831 . . . . 0.0 109.382 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.575 ' HB3' ' ND2' ' A' ' 33' ' ' ASN . 37.5 Cg_endo -82.01 175.33 9.32 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.807 2.338 . . . . 0.0 110.636 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.552 ' O ' ' CG ' ' A' ' 39' ' ' HIS . 37.8 Cg_endo -84.57 -156.09 1.13 Allowed 'Cis proline' 0 C--N 1.311 -1.404 0 C-N-CA 123.631 -1.404 . . . . 0.0 109.86 -1.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.593 ' NE2' HD22 ' A' ' 14' ' ' LEU . 58.1 m80 -160.44 143.27 13.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.961 -1.087 . . . . 0.0 109.708 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.485 ' OD1' ' N ' ' A' ' 41' ' ' VAL . 63.7 t-20 -113.58 147.42 38.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.278 -0.889 . . . . 0.0 109.201 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.485 ' N ' ' OD1' ' A' ' 40' ' ' ASN . 18.8 t -128.6 118.58 47.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.277 -0.889 . . . . 0.0 109.182 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.894 HG12 ' CB ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -153.04 175.59 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.294 -0.879 . . . . 0.0 109.379 -179.804 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.65 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -130.03 135.0 47.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.941 . . . . 0.0 109.538 -179.471 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -59.6 130.49 47.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 109.353 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.87 1.99 32.44 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.245 -0.909 . . . . 0.0 109.904 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.45 ' C ' HD12 ' A' ' 47' ' ' LEU . . . -103.64 5.73 36.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.611 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.45 HD12 ' C ' ' A' ' 46' ' ' ALA . 3.6 mp -131.21 57.1 1.77 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.137 -0.977 . . . . 0.0 109.672 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -114.44 156.18 44.87 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.274 179.744 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.464 ' HG2' ' HG2' ' A' ' 81' ' ' PRO . 36.2 Cg_endo -79.38 -40.36 0.26 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.67 2.247 . . . . 0.0 110.907 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ALA . . . . . 0.501 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -106.5 28.9 7.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.07 -1.019 . . . . 0.0 109.788 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.501 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER 32.5 45.88 0.06 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.186 0.517 . . . . 0.0 110.316 179.652 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.2 m -100.56 111.93 24.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.17 -0.957 . . . . 0.0 109.783 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.76 -28.3 64.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.94 . . . . 0.0 108.982 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . 0.478 ' HA ' ' HB2' ' A' ' 57' ' ' LYS . 2.1 t0 -68.17 -23.85 64.9 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.375 -0.828 . . . . 0.0 109.435 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 17.8 tp -56.11 -61.09 2.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 109.532 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.747 ' HB1' ' OG ' ' A' ' 60' ' ' SER . . . -66.61 -23.98 66.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.649 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.478 ' HB2' ' HA ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -45.65 -64.58 0.7 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 109.52 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.98 -23.07 36.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.0 109.538 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.686 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 4.7 tp -72.65 -58.07 3.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 109.498 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . 0.894 ' CB ' HG12 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -79.67 133.52 36.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.306 -0.871 . . . . 0.0 110.021 -179.153 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.428 ' ND1' ' C ' ' A' ' 61' ' ' HIS . 16.2 p80 -107.34 149.98 27.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.384 -0.822 . . . . 0.0 108.941 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.428 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -99.59 174.5 6.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.096 -1.003 . . . . 0.0 109.461 -179.785 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . 0.428 ' CB ' ' O ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER 70.27 126.73 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.315 -0.866 . . . . 0.0 109.42 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.0 mp -70.67 163.97 25.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 109.528 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.9 mt -83.25 160.71 21.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 109.126 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -132.26 9.29 4.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.116 -0.99 . . . . 0.0 109.81 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.503 ' HB3' ' HB2' ' A' ' 70' ' ' GLN . 9.0 t -124.66 138.31 30.99 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.18 -0.95 . . . . 0.0 109.143 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.522 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.7 Cg_endo -79.3 105.72 1.93 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.538 2.159 . . . . 0.0 110.967 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 92.75 39.09 5.34 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLN . . . . . 0.503 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 9.3 mt-30 -153.11 82.04 1.2 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.232 -1.158 . . . . 0.0 109.177 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.6 ' CB ' ' O ' ' A' ' 31' ' ' PHE . 3.2 p -99.08 -169.21 1.73 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.164 -0.96 . . . . 0.0 109.457 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 72' ' ' THR . 4.1 t -102.75 125.16 49.39 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.0 p -78.98 93.84 5.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.072 -1.018 . . . . 0.0 109.443 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' THR . . . . . 0.533 ' HG1' ' HE1' ' A' ' 31' ' ' PHE . 4.6 m -72.36 97.96 2.13 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.367 -0.833 . . . . 0.0 109.409 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.451 ' O ' ' C ' ' A' ' 76' ' ' PHE . 11.2 m -78.56 89.07 4.49 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 1.03 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 9.9 m-85 -40.46 150.26 0.28 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.744 -0.598 . . . . 0.0 109.459 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 76' ' ' PHE . 34.8 Cg_endo -77.53 168.27 22.95 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.846 2.364 . . . . 0.0 111.434 -179.049 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' A' ' 25' ' ' PRO . . . -83.46 5.45 23.75 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 81' ' ' PRO . 1.8 m-20 -99.19 -7.21 26.87 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.179 -0.951 . . . . 0.0 109.113 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.873 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -38.59 99.11 0.18 Allowed Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.593 -0.692 . . . . 0.0 109.462 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.464 ' HG2' ' HG2' ' A' ' 49' ' ' PRO . 34.8 Cg_endo -77.25 141.47 20.55 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.425 2.083 . . . . 0.0 110.629 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . 0.828 ' HB2' ' O ' ' A' ' 104' ' ' ALA . . . -43.5 132.01 4.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.409 -0.807 . . . . 0.0 109.358 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . 0.401 ' HA3' ' HB3' ' A' ' 49' ' ' PRO . . . 158.29 148.78 5.27 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -89.46 117.7 28.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.154 -1.204 . . . . 0.0 109.893 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' TYR . . . . . 0.462 ' O ' ' HB3' ' A' ' 100' ' ' LYS . 60.9 m-85 -84.02 -166.69 1.49 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.244 -0.91 . . . . 0.0 108.934 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' THR . . . . . 0.46 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 39.2 m -166.59 105.72 0.62 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.897 -1.127 . . . . 0.0 110.836 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.561 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.4 OUTLIER -104.75 165.67 10.91 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.26 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' TYR . . . . . 0.426 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 29.7 p90 -157.22 -166.62 2.1 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.786 -1.197 . . . . 0.0 110.561 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' CYS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 97' ' ' MET . 0.5 OUTLIER -130.28 126.85 38.28 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.811 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.625 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 6.0 tp10 -67.94 -43.25 36.46 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.89 . . . . 0.0 111.514 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 34.4 Cg_endo -76.59 -53.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.968 1.779 . . . . 0.0 111.205 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' HIS . . . . . 0.49 ' HB2' ' SD ' ' A' ' 97' ' ' MET . 45.0 m-70 -89.78 30.34 1.06 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.016 -1.052 . . . . 0.0 109.614 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.6 ttt-85 -60.26 91.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.283 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 137.74 -15.82 3.56 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 14' ' ' LEU . . . -91.32 37.19 0.94 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.353 -1.086 . . . . 0.0 109.493 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.08 23.02 72.84 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' MET . . . . . 0.734 ' HE3' ' HB2' ' A' ' 7' ' ' LEU . 0.8 OUTLIER -91.26 53.57 2.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.063 -1.257 . . . . 0.0 109.299 179.791 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.3 t -137.26 118.43 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 109.445 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.561 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -127.32 172.47 18.69 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 85' ' ' TYR . 35.7 mttt -145.84 135.86 23.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -1.141 . . . . 0.0 109.649 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 1.091 HD11 HG21 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -87.36 140.69 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.957 . . . . 0.0 108.878 179.661 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.475 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 0.3 OUTLIER -115.77 95.55 5.18 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.331 -0.856 . . . . 0.0 108.883 179.305 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' VAL . . . . . 0.643 HG22 ' CD1' ' A' ' 23' ' ' ILE . 12.5 t -99.77 150.42 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.146 -0.971 . . . . 0.0 109.597 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.828 ' O ' ' HB2' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.492 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 28' ' ' THR . 11.9 t -112.07 157.69 20.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.585 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.477 ' CD1' HG22 ' A' ' 23' ' ' ILE . 53.1 m-85 -93.88 153.75 18.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 0.0 109.28 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.508 HG23 ' O ' ' A' ' 30' ' ' GLU . 9.5 m -142.85 135.92 28.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 109.736 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.862 HG13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -117.39 100.33 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.239 -0.913 . . . . 0.0 109.338 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.563 ' HG2' HD11 ' A' ' 32' ' ' LEU . 8.6 tttt -69.46 79.21 0.4 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.257 -0.902 . . . . 0.0 109.497 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.774 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -52.33 136.55 30.81 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.193 -0.942 . . . . 0.0 109.243 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.419 ' HA2' HD23 ' A' ' 14' ' ' LEU . . . 101.54 115.56 3.95 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.51 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 97.4 p -69.86 -82.45 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -1.129 . . . . 0.0 109.608 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 11' ' ' LYS . 2.8 p30 163.45 -50.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.885 . . . . 0.0 109.049 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.515 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 4.0 mttt -120.59 -5.72 9.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.349 -0.845 . . . . 0.0 109.252 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -100.38 -103.78 2.59 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.65 -156.51 0.69 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -1.152 . . . . 0.0 109.562 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.637 ' CD1' ' CD2' ' A' ' 92' ' ' HIS . 30.9 mt -99.86 120.57 39.98 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.18 -0.95 . . . . 0.0 109.873 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 14' ' ' LEU . 16.1 m -160.53 126.68 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.921 . . . . 0.0 109.621 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.428 ' O ' ' O ' ' A' ' 15' ' ' VAL . 6.0 m-85 -44.47 165.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.055 -1.028 . . . . 0.0 109.301 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 22.9 mt-10 -148.16 104.62 3.58 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.195 -0.94 . . . . 0.0 109.405 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.2 Cg_endo -77.59 -176.03 17.92 Favored 'Cis proline' 0 C--N 1.311 -1.426 0 C-N-CA 123.736 -1.36 . . . . 0.0 110.563 0.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.12 -47.56 50.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.622 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.81 178.04 5.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 109.331 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.862 HD11 HG13 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -153.04 141.73 20.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.967 . . . . 0.0 109.87 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.2 m -120.21 115.3 23.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.336 -0.852 . . . . 0.0 109.213 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.663 HD12 ' O ' ' A' ' 24' ' ' LYS . 1.0 OUTLIER -132.36 -176.75 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.209 -0.932 . . . . 0.0 109.738 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.663 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -104.63 177.39 1.41 Allowed Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.188 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.562 ' HD2' ' CG ' ' A' ' 24' ' ' LYS . 34.3 Cg_endo -77.18 76.69 4.09 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.213 1.942 . . . . 0.0 110.349 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 132.6 -11.78 5.19 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 26' ' ' GLY . 9.2 m-20 -53.3 -176.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.165 -1.197 . . . . 0.0 109.407 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.533 HG23 ' HA ' ' A' ' 75' ' ' THR . 26.8 m -123.39 146.62 47.83 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.163 -0.96 . . . . 0.0 109.461 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.951 HG21 HD11 ' A' ' 101' ' ' ILE . 3.4 t -137.5 124.23 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.202 -0.937 . . . . 0.0 109.24 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.533 ' OE1' ' CA ' ' A' ' 73' ' ' SER . 21.8 tp10 -100.99 130.85 47.05 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.25 -0.906 . . . . 0.0 110.109 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.484 ' O ' ' OG ' ' A' ' 71' ' ' SER . 0.4 OUTLIER -113.59 151.27 31.89 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.032 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.774 ' O ' HD21 ' A' ' 7' ' ' LEU . 2.4 pp -142.09 -177.6 5.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.816 -1.178 . . . . 0.0 110.635 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.547 ' OD1' ' HA ' ' A' ' 68' ' ' PRO . 2.5 p-10 -116.55 152.96 33.05 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -101.5 -109.01 0.23 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.815 -1.178 . . . . 0.0 109.601 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.435 ' C ' ' CG2' ' A' ' 36' ' ' VAL . 0.9 OUTLIER -128.98 36.58 4.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.805 -1.185 . . . . 0.0 109.412 -179.824 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.555 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 2.5 t -153.02 61.98 4.0 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.502 -0.749 . . . . 0.0 109.141 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.564 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.9 Cg_endo -80.24 175.9 9.82 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.811 2.341 . . . . 0.0 110.55 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.658 ' CG ' HD13 ' A' ' 64' ' ' LEU . 38.3 Cg_endo -85.78 159.46 59.65 Favored 'Cis proline' 0 C--N 1.31 -1.449 0 C-N-CA 123.525 -1.448 . . . . 0.0 110.483 -1.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.715 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 74.6 m-70 -116.46 141.64 47.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.472 -0.767 . . . . 0.0 109.435 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -117.51 126.71 53.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 109.45 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.4 ' HB ' ' NE2' ' A' ' 61' ' ' HIS . 19.8 t -116.37 126.27 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -0.936 . . . . 0.0 109.445 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.797 HG12 ' CB ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -160.12 166.39 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.38 -0.825 . . . . 0.0 109.322 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.593 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -116.74 109.65 17.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 109.382 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -53.06 144.43 15.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.874 . . . . 0.0 109.682 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.57 19.21 3.47 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.183 -0.948 . . . . 0.0 109.479 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -121.31 -30.31 4.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.083 -1.011 . . . . 0.0 109.724 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.621 HD22 HG21 ' A' ' 86' ' ' THR . 6.2 mp -96.33 61.16 2.0 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.037 -1.039 . . . . 0.0 109.518 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.503 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 10.2 p30 -141.6 162.51 46.45 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.286 -0.884 . . . . 0.0 109.49 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 33.5 Cg_endo -75.6 -16.54 18.86 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.446 2.098 . . . . 0.0 109.904 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 52' ' ' SER . . . -133.54 68.55 1.49 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -40.37 92.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.607 -0.683 . . . . 0.0 109.987 -179.519 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 50' ' ' ALA . 19.5 m -140.71 -159.21 0.93 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.341 -0.849 . . . . 0.0 109.191 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -155.81 56.95 0.61 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.245 -0.909 . . . . 0.0 109.535 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -138.78 -60.99 0.58 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.219 -0.925 . . . . 0.0 109.378 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.467 ' HG ' ' N ' ' A' ' 56' ' ' ALA . 1.6 pp -54.28 -28.16 40.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.93 . . . . 0.0 109.044 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.467 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -72.41 -39.3 68.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.324 -0.86 . . . . 0.0 109.243 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 56' ' ' ALA . 65.9 tttt -44.3 -45.8 8.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.316 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -98.01 25.45 6.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.292 -0.88 . . . . 0.0 109.421 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.716 HD21 ' CE2' ' A' ' 76' ' ' PHE . 8.2 tp -127.0 -54.88 1.38 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.869 . . . . 0.0 109.267 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.797 ' CB ' HG12 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -78.49 147.24 33.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.307 -0.871 . . . . 0.0 110.082 -178.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.4 ' NE2' ' HB ' ' A' ' 41' ' ' VAL . 30.5 p80 -122.18 174.81 6.73 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -125.06 -160.2 0.94 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.196 -0.94 . . . . 0.0 109.226 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 65.87 135.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.202 -0.936 . . . . 0.0 109.802 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.658 HD13 ' CG ' ' A' ' 38' ' ' PRO . 6.6 mt -64.76 158.63 24.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.392 -0.818 . . . . 0.0 109.576 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.697 HD22 ' HB2' ' A' ' 39' ' ' HIS . 3.5 mp -79.31 87.26 5.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.079 -1.013 . . . . 0.0 109.155 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -83.32 4.59 26.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 109.759 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.473 ' OG ' ' HG2' ' A' ' 70' ' ' GLN . 12.0 t -102.81 115.79 63.65 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.144 -0.973 . . . . 0.0 109.009 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.547 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.4 Cg_endo -78.51 95.23 1.07 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.4 2.067 . . . . 0.0 111.004 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.504 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 127.45 -17.12 6.2 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.595 -1.288 . . . . 0.0 110.125 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.502 ' HA ' ' HB3' ' A' ' 32' ' ' LEU . 8.0 pt20 -149.99 149.69 30.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.111 -1.229 . . . . 0.0 109.602 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.597 ' HG ' ' H ' ' A' ' 72' ' ' THR . 81.1 p -120.01 -78.46 0.59 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.122 -0.986 . . . . 0.0 109.5 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.597 ' H ' ' HG ' ' A' ' 71' ' ' SER . 22.8 m -160.14 119.0 2.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.327 -0.858 . . . . 0.0 109.424 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.533 ' CA ' ' OE1' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -79.53 99.75 7.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.0 109.228 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.641 HG21 ' HG ' ' A' ' 59' ' ' LEU . 26.3 m -82.54 108.4 15.91 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.337 -0.852 . . . . 0.0 109.665 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.533 ' HA ' HG23 ' A' ' 28' ' ' THR . 0.0 OUTLIER -79.36 85.77 5.15 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.476 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.931 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 23.7 m-85 -40.45 137.02 1.37 Allowed Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.5 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 35.3 Cg_endo -77.74 174.49 12.52 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.605 2.203 . . . . 0.0 111.719 -178.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.29 4.03 11.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.583 -0.698 . . . . 0.0 109.211 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.466 ' O ' ' C ' ' A' ' 80' ' ' ALA . 0.5 OUTLIER -98.13 -10.77 23.66 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.24 -0.912 . . . . 0.0 108.591 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.502 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -39.95 110.88 0.68 Allowed Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -75.19 130.97 13.57 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.263 1.975 . . . . 0.0 110.68 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -56.42 162.03 2.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.463 -0.773 . . . . 0.0 109.374 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 125.92 -117.78 2.97 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -160.51 122.5 3.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -1.152 . . . . 0.0 109.718 -179.792 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.632 ' CD2' ' CG2' ' A' ' 101' ' ' ILE . 4.1 m-30 -85.88 -165.43 1.24 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.14 -0.975 . . . . 0.0 108.726 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.621 HG21 HD22 ' A' ' 47' ' ' LEU . 20.7 m -165.18 101.23 0.74 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.839 -1.163 . . . . 0.0 110.678 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.504 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -107.18 165.9 11.03 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.623 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.517 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 3.9 p90 -157.07 -171.41 3.63 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.823 -1.173 . . . . 0.0 110.442 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.58 143.76 47.46 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.56 -0.713 . . . . 0.0 109.332 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.617 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 31.5 tt0 -77.6 -45.14 2.54 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.323 -0.861 . . . . 0.0 109.846 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.3 Cg_endo -79.53 -65.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 122.008 1.805 . . . . 0.0 110.197 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.715 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 3.3 m80 -73.39 63.25 0.76 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 109.375 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.1 tpp85 -90.42 -26.91 19.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.332 -0.855 . . . . 0.0 109.174 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -95.33 35.53 4.24 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 14' ' ' LEU . . . -135.73 34.42 2.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -1.145 . . . . 0.0 109.573 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 48.45 25.44 4.45 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.575 ' HE3' ' HB3' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -78.53 54.42 1.46 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.066 -1.255 . . . . 0.0 109.354 179.742 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.1 t -125.74 104.24 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.442 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.93 174.76 22.69 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.434 ' HG2' ' HA ' ' A' ' 86' ' ' THR . 11.2 mttm -150.56 131.41 14.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -1.144 . . . . 0.0 109.788 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.951 HD11 HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -83.29 126.58 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 21' ' ' LEU . 3.5 m -104.25 102.26 11.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.183 -0.948 . . . . 0.0 109.443 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.651 HG13 ' C ' ' A' ' 24' ' ' LYS . 2.4 t -99.76 92.95 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.185 -0.947 . . . . 0.0 109.466 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.03 161.64 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.923 . . . . 0.0 109.561 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 CA-C-O 117.96 -1.467 . . . . 0.0 109.474 179.85 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.39 138.74 51.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.915 . . . . 0.0 109.434 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 19.0 m-85 -112.3 150.51 30.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.237 -0.914 . . . . 0.0 109.536 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.595 HG23 ' HB3' ' A' ' 30' ' ' GLU . 45.3 m -145.58 114.06 6.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.894 . . . . 0.0 109.413 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.449 ' O ' HD23 ' A' ' 7' ' ' LEU . 4.4 m -91.77 80.99 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.187 -0.946 . . . . 0.0 109.58 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 5' ' ' VAL . 9.3 mtmt -44.26 110.51 0.22 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.157 -0.964 . . . . 0.0 109.393 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.539 ' HB2' ' CE ' ' A' ' 97' ' ' MET . 0.1 OUTLIER -91.14 83.94 5.62 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.224 -0.923 . . . . 0.0 109.362 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 14' ' ' LEU . . . 144.3 102.6 0.39 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.51 ' OG ' ' N ' ' A' ' 10' ' ' ASP . 89.8 p -50.47 -82.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -1.13 . . . . 0.0 109.492 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.51 ' N ' ' OG ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -176.88 -93.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.227 -0.921 . . . . 0.0 109.508 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -100.06 54.28 0.91 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.14 -0.975 . . . . 0.0 109.625 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.59 -82.38 0.04 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.464 HD12 ' HA ' ' A' ' 13' ' ' LEU . 5.6 tp -144.89 -159.32 0.98 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.395 -1.062 . . . . 0.0 109.134 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.748 HD11 ' HB ' ' A' ' 36' ' ' VAL . 49.8 mt -119.58 124.16 45.68 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.164 -0.96 . . . . 0.0 109.425 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.451 HG13 ' O ' ' A' ' 14' ' ' LEU . 25.6 m -156.63 155.44 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.869 . . . . 0.0 109.338 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 7' ' ' LEU . 6.2 m-85 -68.45 156.57 37.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.224 -0.922 . . . . 0.0 109.674 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 16.1 mt-10 -157.39 101.07 1.88 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.462 -0.774 . . . . 0.0 109.243 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 35.3 Cg_endo -77.9 179.8 29.71 Favored 'Cis proline' 0 C--N 1.311 -1.42 0 C-N-CA 123.67 -1.388 . . . . 0.0 110.584 0.183 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.17 -54.69 3.61 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.267 -0.896 . . . . 0.0 109.413 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.08 153.77 24.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -0.877 . . . . 0.0 109.495 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 1.009 HD23 HG23 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -158.48 108.12 2.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.091 -1.006 . . . . 0.0 110.046 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.9 m -91.14 102.82 15.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 108.836 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 1.009 HG23 HD23 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -103.24 -179.72 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.256 -0.903 . . . . 0.0 110.49 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.734 ' O ' HG13 ' A' ' 103' ' ' VAL . 5.3 mttm -94.5 -175.81 0.51 Allowed Pre-proline 0 N--CA 1.488 1.443 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.721 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 33.6 Cg_endo -78.48 76.52 4.41 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.002 1.801 . . . . 0.0 110.607 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 121.23 43.99 0.41 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.497 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 5.0 m-20 -94.11 -178.06 4.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.253 -1.145 . . . . 0.0 108.876 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.9 m -117.7 126.1 51.87 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.203 -0.936 . . . . 0.0 109.534 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.987 HG21 HD11 ' A' ' 101' ' ' ILE . 0.7 OUTLIER -119.44 134.14 63.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.284 -0.885 . . . . 0.0 109.398 -179.832 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.595 ' HB3' HG23 ' A' ' 4' ' ' THR . 4.6 tt0 -105.69 141.24 37.48 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.231 -0.918 . . . . 0.0 109.813 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.564 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -134.19 96.57 3.65 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.647 ' HA ' ' HB3' ' A' ' 71' ' ' SER . 0.5 OUTLIER -98.59 168.81 9.94 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.283 -0.886 . . . . 0.0 110.491 -178.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.548 ' HB2' ' CD2' ' A' ' 39' ' ' HIS . 3.5 p-10 -94.66 153.72 17.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.547 -0.721 . . . . 0.0 109.572 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.469 ' HB2' ' HA3' ' A' ' 8' ' ' GLY . 38.5 t30 -97.1 -129.63 0.17 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.027 -1.045 . . . . 0.0 108.915 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.438 ' C ' ' CG2' ' A' ' 36' ' ' VAL . 0.5 OUTLIER -108.86 36.55 2.83 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.757 -1.214 . . . . 0.0 109.364 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.748 ' HB ' HD11 ' A' ' 14' ' ' LEU . 4.3 t -154.96 67.89 5.35 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 109.421 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.536 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.5 Cg_endo -80.41 173.95 11.82 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.6 2.2 . . . . 0.0 110.788 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 39.1 Cg_endo -85.83 165.06 54.78 Favored 'Cis proline' 0 C--N 1.312 -1.378 0 C-N-CA 123.494 -1.461 . . . . 0.0 110.305 -1.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.709 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 57.4 m-70 -119.58 140.24 50.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.934 . . . . 0.0 109.762 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 1.3 t-20 -121.92 125.96 47.55 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.356 -0.84 . . . . 0.0 109.544 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.458 ' O ' HG22 ' A' ' 42' ' ' VAL . 24.8 t -114.13 134.22 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.92 . . . . 0.0 109.17 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.775 HG13 ' HB2' ' A' ' 60' ' ' SER . 0.2 OUTLIER -156.84 166.82 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.071 -1.018 . . . . 0.0 109.855 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.517 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 4.5 m-85 -119.39 112.04 18.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.836 . . . . 0.0 109.183 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' A' ' 47' ' ' LEU . 7.5 t70 -43.74 143.21 1.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.305 -0.872 . . . . 0.0 109.733 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.876 ' HB1' ' HB2' ' A' ' 53' ' ' ALA . . . -90.54 -3.43 57.6 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.39 -0.819 . . . . 0.0 109.737 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.36 9.56 21.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.621 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.512 HD22 ' HB ' ' A' ' 86' ' ' THR . 0.5 OUTLIER -122.29 39.35 3.92 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.135 -0.978 . . . . 0.0 109.735 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.523 ' OD1' ' CA ' ' A' ' 51' ' ' LYS . 0.6 OUTLIER -112.31 165.3 13.28 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 109.419 179.756 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.494 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 35.0 Cg_endo -76.59 -10.06 18.63 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.606 2.204 . . . . 0.0 110.826 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -125.0 26.18 7.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.11 -0.994 . . . . 0.0 109.493 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.523 ' CA ' ' OD1' ' A' ' 48' ' ' ASN . 0.6 OUTLIER 34.28 35.58 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.134 0.492 . . . . 0.0 110.325 179.66 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 50' ' ' ALA . 19.1 m -110.85 164.03 13.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.151 -0.968 . . . . 0.0 109.74 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.876 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . . . -132.51 45.8 2.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.305 -0.872 . . . . 0.0 109.295 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.41 ' C ' ' OD1' ' A' ' 54' ' ' ASP . 7.5 t0 -111.94 -56.4 2.39 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.311 -0.868 . . . . 0.0 109.58 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.679 ' C ' HD12 ' A' ' 55' ' ' LEU . 3.3 pp -55.34 -29.87 59.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.917 . . . . 0.0 109.556 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.44 ' N ' HD12 ' A' ' 55' ' ' LEU . . . -68.11 -43.5 78.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.62 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -57.7 -39.82 78.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.367 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.4 m -87.84 16.36 5.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.227 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.858 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 9.7 tp -122.93 -45.25 2.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.346 -0.846 . . . . 0.0 109.375 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.775 ' HB2' HG13 ' A' ' 42' ' ' VAL . 37.0 p -82.16 159.35 23.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.491 -0.756 . . . . 0.0 110.247 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.55 ' HB3' HG21 ' A' ' 72' ' ' THR . 20.7 p80 -110.38 174.53 5.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.563 -0.711 . . . . 0.0 109.496 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -121.25 -163.07 1.01 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.367 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 59.19 -165.82 0.18 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.916 . . . . 0.0 109.386 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.584 ' C ' HD12 ' A' ' 65' ' ' LEU . 4.5 mp -128.55 165.08 21.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 109.327 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.584 HD12 ' C ' ' A' ' 64' ' ' LEU . 7.4 mp -103.05 107.35 18.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.179 -0.95 . . . . 0.0 109.48 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -98.19 -18.83 18.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 0.0 109.443 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.523 ' CB ' ' HB2' ' A' ' 70' ' ' GLN . 46.0 t -85.67 142.91 37.53 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.915 . . . . 0.0 109.24 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.472 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.6 Cg_endo -79.14 107.06 2.15 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.81 2.34 . . . . 0.0 111.3 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.497 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 93.61 -18.35 56.65 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.523 ' HB2' ' CB ' ' A' ' 67' ' ' SER . 0.0 OUTLIER -80.2 103.15 9.88 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.063 -1.257 . . . . 0.0 109.266 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.647 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -124.62 -168.87 1.88 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.378 -0.826 . . . . 0.0 110.22 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.682 HG23 ' O ' ' A' ' 72' ' ' THR . 9.0 t -122.01 110.33 15.69 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.7 p -78.44 111.22 14.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 108.932 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.74 HG21 ' O ' ' A' ' 59' ' ' LEU . 1.7 m -88.03 108.96 19.48 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.475 -0.766 . . . . 0.0 109.846 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.791 HG23 ' O ' ' A' ' 75' ' ' THR . 10.2 t -78.86 94.73 5.24 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.858 ' CZ ' HD21 ' A' ' 59' ' ' LEU . 4.5 m-30 -39.79 160.03 0.11 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.698 -0.626 . . . . 0.0 109.693 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.534 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 33.8 Cg_endo -75.51 163.83 33.5 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.749 2.299 . . . . 0.0 111.417 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.31 1.65 7.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.379 -0.825 . . . . 0.0 110.294 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.495 ' O ' ' O ' ' A' ' 80' ' ' ALA . 0.7 OUTLIER -98.85 -61.41 1.37 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.005 -1.059 . . . . 0.0 109.065 179.766 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.721 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . 42.88 94.7 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.447 -0.783 . . . . 0.0 109.679 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.49 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 34.3 Cg_endo -75.7 121.64 6.43 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.312 2.008 . . . . 0.0 110.155 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -42.58 133.49 3.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.47 -0.769 . . . . 0.0 109.612 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 85' ' ' TYR . . . 160.57 158.29 9.18 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.38 125.45 29.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.196 -1.179 . . . . 0.0 109.747 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.571 ' O ' ' CD2' ' A' ' 87' ' ' PHE . 9.6 m-85 -100.71 70.76 1.44 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.512 ' HB ' HD22 ' A' ' 47' ' ' LEU . 57.0 m -62.83 97.53 0.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.42 -0.8 . . . . 0.0 110.464 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.571 ' CD2' ' O ' ' A' ' 85' ' ' TYR . 1.5 p90 -99.91 162.97 12.66 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.154 -0.966 . . . . 0.0 108.635 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 97' ' ' MET . 28.9 p90 -149.99 -173.97 4.58 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.98 -1.075 . . . . 0.0 109.954 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 0.1 OUTLIER -116.34 132.27 56.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.503 -0.748 . . . . 0.0 109.562 -179.651 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.612 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 25.8 tt0 -65.92 -45.0 63.97 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.207 -0.933 . . . . 0.0 109.975 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.5 Cg_endo -79.23 -45.37 0.11 Allowed 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 121.93 1.753 . . . . 0.0 110.18 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.709 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 4.7 m80 -106.84 67.25 0.7 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 109.316 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.74 133.99 37.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 109.521 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 82.27 -4.99 74.48 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 14' ' ' LEU . . . -93.43 39.08 1.05 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.213 -1.169 . . . . 0.0 109.503 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.422 ' HA3' HG12 ' A' ' 15' ' ' VAL . . . 79.84 -3.88 67.99 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.539 ' CE ' ' HB2' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -86.59 47.17 1.44 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.178 -1.189 . . . . 0.0 109.34 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.5 t -124.23 76.15 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 0.0 109.498 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.542 ' C ' ' CE1' ' A' ' 87' ' ' PHE . . . -96.92 162.94 22.17 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.466 ' HD2' ' OG1' ' A' ' 86' ' ' THR . 15.0 mtmt -139.38 135.15 33.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -1.138 . . . . 0.0 109.199 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.987 HD11 HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -84.01 139.08 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.169 -0.957 . . . . 0.0 109.462 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.58 99.43 7.95 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.734 HG13 ' O ' ' A' ' 24' ' ' LYS . 21.8 t -99.01 95.46 4.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.196 -0.94 . . . . 0.0 110.014 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -119.39 -151.49 0.48 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.52 -0.737 . . . . 0.0 109.329 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.906 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLU . . . . . 0.425 ' HG2' ' OD1' ' A' ' 27' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.8 123.34 17.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.938 . . . . 0.0 109.832 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.528 ' CE1' HG22 ' A' ' 23' ' ' ILE . 10.6 m-85 -126.13 170.9 11.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.329 -0.857 . . . . 0.0 108.871 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 30' ' ' GLU . 87.1 m -157.46 116.94 3.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.07 -1.018 . . . . 0.0 110.167 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.643 HG12 ' CD1' ' A' ' 21' ' ' LEU . 10.4 m -98.57 170.78 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 121.345 -0.847 . . . . 0.0 109.032 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -143.56 87.2 1.92 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.06 -1.025 . . . . 0.0 109.874 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.633 ' HB2' ' HE1' ' A' ' 97' ' ' MET . 0.0 OUTLIER -50.86 100.12 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.183 -0.948 . . . . 0.0 109.254 179.63 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 14' ' ' LEU . . . 129.1 98.87 0.9 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 2.3 p -48.0 -95.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -1.161 . . . . 0.0 109.371 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 9' ' ' SER . 48.5 t0 176.86 33.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.946 . . . . 0.0 109.508 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.08 -43.05 0.64 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.159 -0.963 . . . . 0.0 109.603 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.13 44.29 0.02 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 13' ' ' LEU . 13.6 mt -151.32 160.94 43.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -1.141 . . . . 0.0 109.458 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.877 HD21 ' HB ' ' A' ' 36' ' ' VAL . 12.9 mt -120.48 103.21 8.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.308 -0.87 . . . . 0.0 109.501 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.412 HG12 ' HA3' ' A' ' 96' ' ' GLY . 26.7 m -149.8 138.6 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.718 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -56.49 153.73 9.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.15 -0.969 . . . . 0.0 108.85 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 4.6 mm-40 -143.51 103.61 5.02 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 120.995 -1.066 . . . . 0.0 109.81 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 35.6 Cg_endo -79.29 178.54 33.46 Favored 'Cis proline' 0 C--N 1.314 -1.286 0 C-N-CA 123.796 -1.335 . . . . 0.0 110.452 -0.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.03 -51.42 18.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.223 -0.923 . . . . 0.0 109.255 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? -99.15 146.45 26.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 0.0 109.237 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.643 ' CD1' HG12 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -140.46 142.36 35.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.113 -0.992 . . . . 0.0 109.826 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.452 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 32.1 m -106.52 126.22 51.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.344 -0.847 . . . . 0.0 109.096 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.846 ' CD1' HG22 ' A' ' 103' ' ' VAL . 1.0 OUTLIER -136.76 174.94 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.138 -0.976 . . . . 0.0 109.969 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.57 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -96.6 173.15 4.37 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.622 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 35.2 Cg_endo -77.58 91.66 1.17 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.346 2.03 . . . . 0.0 110.39 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 123.27 -11.35 8.6 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.501 ' OD1' ' CB ' ' A' ' 24' ' ' LYS . 5.8 m-20 -55.81 -178.69 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.287 -1.125 . . . . 0.0 109.096 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 97.3 m -124.09 140.99 52.44 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.205 -0.934 . . . . 0.0 109.43 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.977 HG21 HD11 ' A' ' 101' ' ' ILE . 1.3 t -130.93 119.28 44.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.278 -0.889 . . . . 0.0 109.364 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 4' ' ' THR . 30.9 tt0 -99.51 135.88 40.26 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.263 -0.898 . . . . 0.0 109.514 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.475 ' CD1' ' O ' ' A' ' 72' ' ' THR . 0.1 OUTLIER -127.28 152.0 48.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.126 -0.984 . . . . 0.0 108.856 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.551 ' HB3' ' N ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -140.49 -170.07 2.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.018 -1.052 . . . . 0.0 109.772 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.513 ' OD1' ' HA ' ' A' ' 68' ' ' PRO . 8.6 p-10 -114.05 169.81 8.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.429 -0.795 . . . . 0.0 109.002 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -110.02 -95.49 0.41 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.078 -1.014 . . . . 0.0 109.517 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.05 33.14 1.36 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.009 -1.057 . . . . 0.0 109.376 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.877 ' HB ' HD21 ' A' ' 14' ' ' LEU . 37.6 t -151.49 59.58 3.32 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.519 -0.738 . . . . 0.0 109.063 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 36.4 Cg_endo -77.66 173.43 14.16 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.744 2.296 . . . . 0.0 110.943 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.58 ' O ' ' CG ' ' A' ' 39' ' ' HIS . 37.5 Cg_endo -82.42 -158.57 1.69 Allowed 'Cis proline' 0 C--N 1.31 -1.467 0 C-N-CA 123.292 -1.545 . . . . 0.0 110.175 -0.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.58 ' CG ' ' O ' ' A' ' 38' ' ' PRO . 86.9 m-70 -160.85 129.52 4.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.238 -0.914 . . . . 0.0 109.431 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.07 106.04 17.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.208 -0.933 . . . . 0.0 109.379 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.648 ' O ' HG13 ' A' ' 42' ' ' VAL . 41.2 t -99.7 120.64 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.098 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.951 HG12 ' HB2' ' A' ' 60' ' ' SER . 0.8 OUTLIER -159.5 158.01 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.146 -0.972 . . . . 0.0 109.899 -179.521 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.857 ' CE2' HD23 ' A' ' 59' ' ' LEU . 3.4 m-85 -94.9 116.35 28.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.396 -0.815 . . . . 0.0 109.498 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.703 ' OD2' HD12 ' A' ' 47' ' ' LEU . 38.3 t0 -52.9 130.09 32.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.357 -0.839 . . . . 0.0 109.709 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.97 -1.9 53.7 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.214 -0.929 . . . . 0.0 109.605 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.68 12.99 34.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.156 -0.965 . . . . 0.0 109.609 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.703 HD12 ' OD2' ' A' ' 44' ' ' ASP . 5.1 mt -139.84 52.81 1.69 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.178 -0.951 . . . . 0.0 109.45 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.509 ' OD1' ' HA ' ' A' ' 51' ' ' LYS . 0.7 OUTLIER -105.07 164.36 15.29 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.935 . . . . 0.0 109.504 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 35.1 Cg_endo -78.12 -20.63 11.28 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.675 2.25 . . . . 0.0 110.956 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.486 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -126.32 26.32 6.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.041 -1.037 . . . . 0.0 109.919 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.509 ' HA ' ' OD1' ' A' ' 48' ' ' ASN . 15.6 mmtt 34.53 36.79 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.16 0.505 . . . . 0.0 110.284 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 50' ' ' ALA . 41.0 m -99.75 -162.32 0.94 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.206 -0.934 . . . . 0.0 109.584 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -166.12 80.31 0.27 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.346 -0.846 . . . . 0.0 109.268 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -155.92 -48.96 0.08 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.252 -0.905 . . . . 0.0 109.469 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.516 ' O ' HD12 ' A' ' 55' ' ' LEU . 1.5 pp -62.23 -17.14 57.49 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.163 -0.961 . . . . 0.0 109.222 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.411 ' O ' ' C ' ' A' ' 57' ' ' LYS . . . -90.33 -30.43 17.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.332 -0.855 . . . . 0.0 109.539 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -43.86 -62.73 1.02 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.913 . . . . 0.0 109.503 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.9 m -94.39 49.57 1.3 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 0.0 109.417 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.857 HD23 ' CE2' ' A' ' 43' ' ' PHE . 7.3 tp -136.27 -60.89 0.71 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.347 -0.846 . . . . 0.0 109.34 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.951 ' HB2' HG12 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -77.48 152.17 34.31 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.462 -0.774 . . . . 0.0 110.159 -178.432 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.422 ' NE2' ' N ' ' A' ' 41' ' ' VAL . 27.4 p80 -97.17 -168.59 1.72 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.547 -0.721 . . . . 0.0 109.327 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.11 -46.17 0.34 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.178 -0.951 . . . . 0.0 109.391 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -65.72 132.82 49.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.2 -0.938 . . . . 0.0 109.402 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.626 ' H ' HD12 ' A' ' 64' ' ' LEU . 5.7 mp -58.86 169.76 0.95 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.18 -0.95 . . . . 0.0 109.356 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.679 HD13 ' HB2' ' A' ' 71' ' ' SER . 0.0 OUTLIER -115.6 127.04 54.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.19 -0.944 . . . . 0.0 109.262 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.9 mtt -120.29 9.78 11.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.266 -0.896 . . . . 0.0 109.599 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.44 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 32.3 t -94.07 138.44 22.62 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 109.322 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.513 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.5 Cg_endo -79.92 95.65 1.03 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.579 2.186 . . . . 0.0 110.62 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.463 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 99.76 48.63 1.61 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.551 ' N ' ' HB3' ' A' ' 32' ' ' LEU . 48.8 tt0 -179.22 100.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.14 -1.212 . . . . 0.0 109.334 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.679 ' HB2' HD13 ' A' ' 65' ' ' LEU . 24.1 p -103.8 -79.63 0.54 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.145 -0.972 . . . . 0.0 109.723 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.572 ' N ' ' OG ' ' A' ' 71' ' ' SER . 0.4 OUTLIER -160.72 107.95 1.53 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.925 -1.109 . . . . 0.0 109.751 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.22 99.38 7.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.047 -1.033 . . . . 0.0 108.818 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.42 HG21 ' HA ' ' A' ' 59' ' ' LEU . 6.9 m -102.97 124.99 49.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.343 -0.848 . . . . 0.0 110.047 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.462 ' O ' ' C ' ' A' ' 76' ' ' PHE . 0.8 OUTLIER -89.9 93.69 9.52 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.168 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.931 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 32.5 m-85 -39.95 157.15 0.15 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.475 -0.766 . . . . 0.0 109.64 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.506 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.1 Cg_endo -75.5 161.58 37.09 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.703 2.269 . . . . 0.0 111.238 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 25' ' ' PRO . . . -74.54 5.11 5.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.557 -0.715 . . . . 0.0 109.964 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.474 ' O ' ' C ' ' A' ' 80' ' ' ALA . 0.4 OUTLIER -98.6 -67.22 0.86 Allowed 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.015 -1.053 . . . . 0.0 109.202 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.976 ' CB ' HG11 ' A' ' 103' ' ' VAL . . . 40.65 76.49 0.5 Allowed Pre-proline 0 N--CA 1.493 1.687 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 82' ' ' ALA . 35.3 Cg_endo -76.73 119.91 5.33 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.866 2.378 . . . . 0.0 111.697 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 81' ' ' PRO . . . 50.89 106.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.597 -0.689 . . . . 0.0 110.482 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.533 ' CA ' ' H ' ' A' ' 103' ' ' VAL . . . -49.0 103.71 0.08 OUTLIER Glycine 0 N--CA 1.48 1.626 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 49' ' ' PRO . 1.1 tp10 -160.32 53.33 0.32 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.273 -1.134 . . . . 0.0 109.744 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.562 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 1.1 m-85 -111.45 128.45 56.0 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.495 HG23 ' HG2' ' A' ' 100' ' ' LYS . 59.3 m -124.72 114.85 19.85 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.143 -0.973 . . . . 0.0 110.09 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.54 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.6 OUTLIER -99.98 164.45 11.99 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.898 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 89' ' ' CYS . 55.2 p90 -155.36 -162.37 1.33 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.013 -1.054 . . . . 0.0 109.662 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.436 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 0.1 OUTLIER -133.27 124.38 27.23 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.568 -0.707 . . . . 0.0 109.52 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.616 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 6.3 tt0 -61.47 -43.85 90.37 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.313 -0.867 . . . . 0.0 110.739 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.2 Cg_endo -79.42 -66.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 122.09 1.86 . . . . 0.0 110.729 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.683 ' CD2' HD13 ' A' ' 14' ' ' LEU . 10.1 m80 -75.68 55.61 0.86 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.159 -0.963 . . . . 0.0 109.256 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -82.19 109.86 16.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.34 -0.85 . . . . 0.0 109.631 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.7 -1.19 28.99 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.473 ' O ' ' O ' ' A' ' 14' ' ' LEU . . . -101.1 35.12 2.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.176 -1.191 . . . . 0.0 109.467 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.412 ' HA3' HG12 ' A' ' 15' ' ' VAL . . . 70.12 19.69 75.84 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.633 ' HE1' ' HB2' ' A' ' 7' ' ' LEU . 1.0 OUTLIER -92.04 37.25 0.98 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.082 -1.246 . . . . 0.0 109.329 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 89.4 t -125.59 110.27 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.187 -0.946 . . . . 0.0 109.686 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.54 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -118.34 173.27 14.79 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.495 ' HG2' HG23 ' A' ' 86' ' ' THR . 7.6 mtmm -148.15 129.8 15.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.099 -1.236 . . . . 0.0 109.823 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.977 HD11 HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -83.49 129.02 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.286 -0.884 . . . . 0.0 108.669 179.409 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.452 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 2.8 m -99.66 95.1 6.73 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.173 -0.954 . . . . 0.0 108.988 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.976 HG11 ' CB ' ' A' ' 80' ' ' ALA . 60.1 t -98.5 99.4 8.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.464 -0.773 . . . . 0.0 109.664 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.19 127.65 33.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.375 -0.828 . . . . 0.0 109.587 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.886 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 55.6 m -135.79 130.79 34.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.301 -0.874 . . . . 0.0 109.593 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -92.7 150.21 20.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 109.39 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 30' ' ' GLU . 1.4 t -157.22 135.39 11.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.215 -0.928 . . . . 0.0 109.591 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.505 ' CG1' HD12 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -109.12 102.36 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.295 -0.878 . . . . 0.0 109.37 179.823 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -68.43 127.66 33.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.407 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.595 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -97.79 177.26 5.52 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.118 -0.989 . . . . 0.0 109.09 179.53 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.483 ' CA ' HD23 ' A' ' 14' ' ' LEU . . . 59.03 86.72 0.03 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.473 ' OG ' ' N ' ' A' ' 10' ' ' ASP . 93.6 p -45.27 -88.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.301 -1.117 . . . . 0.0 109.587 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.473 ' N ' ' OG ' ' A' ' 9' ' ' SER . 6.8 t70 179.6 -47.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 109.157 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.58 30.71 5.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.332 -0.855 . . . . 0.0 109.146 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.417 ' C ' ' HG ' ' A' ' 13' ' ' LEU . . . -138.96 -108.78 0.82 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.417 ' HG ' ' C ' ' A' ' 12' ' ' GLY . 0.5 OUTLIER -130.87 -155.24 0.68 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.24 -1.153 . . . . 0.0 109.61 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.579 HD22 ' CE1' ' A' ' 39' ' ' HIS . 5.3 mt -107.7 118.12 35.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.298 -0.876 . . . . 0.0 109.38 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.4 m -146.07 159.25 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.528 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -82.05 138.26 34.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.319 -0.863 . . . . 0.0 109.248 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 83.3 mt-10 -126.17 111.86 23.96 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 109.368 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.474 ' HG2' ' HG ' ' A' ' 21' ' ' LEU . 35.2 Cg_endo -78.88 -178.2 23.17 Favored 'Cis proline' 0 C--N 1.311 -1.429 0 C-N-CA 123.841 -1.316 . . . . 0.0 110.517 -0.052 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.61 -59.27 2.93 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.315 -0.865 . . . . 0.0 109.086 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.28 160.71 14.08 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.355 -0.84 . . . . 0.0 108.861 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.505 HD12 ' CG1' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -155.24 121.02 5.07 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.961 -1.087 . . . . 0.0 110.314 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.489 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 34.0 m -92.81 107.64 19.38 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.828 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -105.74 171.44 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.19 -0.944 . . . . 0.0 110.42 -178.882 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.494 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -89.58 171.34 8.94 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.017 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.644 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 34.7 Cg_endo -76.6 79.39 3.04 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.219 1.946 . . . . 0.0 110.728 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.498 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 136.91 -22.6 3.27 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.394 -1.384 . . . . 0.0 110.424 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 26' ' ' GLY . 16.4 m-20 -46.66 172.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.031 -1.276 . . . . 0.0 109.533 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.738 HG23 ' HA ' ' A' ' 75' ' ' THR . 1.3 m -115.96 119.6 36.44 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.337 -0.852 . . . . 0.0 109.406 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.051 HG21 HD11 ' A' ' 101' ' ' ILE . 2.5 t -99.48 132.31 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 121.222 -0.924 . . . . 0.0 109.518 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.477 ' HB3' ' HB ' ' A' ' 4' ' ' THR . 10.6 tt0 -113.47 142.68 45.63 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.197 -0.939 . . . . 0.0 109.53 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.589 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -138.55 95.02 2.91 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.81 HD12 ' O ' ' A' ' 33' ' ' ASN . 1.1 pp -98.77 160.4 14.3 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.228 -0.92 . . . . 0.0 110.456 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.81 ' O ' HD12 ' A' ' 32' ' ' LEU . 2.3 p-10 -79.0 -173.82 3.75 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.629 -0.67 . . . . 0.0 109.271 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -134.73 -93.27 0.3 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.138 -0.976 . . . . 0.0 109.291 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.449 ' C ' ' CG2' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -138.45 36.17 2.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.1 -1.0 . . . . 0.0 109.412 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.557 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -157.11 61.11 2.29 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.44 -0.788 . . . . 0.0 109.011 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.557 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 36.0 Cg_endo -79.42 173.39 13.23 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.632 2.221 . . . . 0.0 111.007 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.581 ' O ' ' CD2' ' A' ' 39' ' ' HIS . 37.9 Cg_endo -84.47 -157.1 1.26 Allowed 'Cis proline' 0 C--N 1.31 -1.482 0 C-N-CA 123.298 -1.543 . . . . 0.0 110.163 -1.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.581 ' CD2' ' O ' ' A' ' 38' ' ' PRO . 81.6 m-70 -161.46 142.46 11.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.46 -0.775 . . . . 0.0 109.754 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -116.63 123.47 47.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 109.31 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.428 ' C ' ' CG2' ' A' ' 42' ' ' VAL . 70.4 t -110.17 128.55 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.326 -0.859 . . . . 0.0 109.425 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.507 ' HA ' ' HB3' ' A' ' 60' ' ' SER . 1.2 t -151.64 178.1 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.931 . . . . 0.0 109.489 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.586 ' HB2' ' HB1' ' A' ' 56' ' ' ALA . 12.1 m-85 -130.14 121.47 26.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.235 -0.915 . . . . 0.0 109.533 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.455 ' O ' ' O ' ' A' ' 43' ' ' PHE . 8.5 t0 -50.77 -177.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.355 -0.84 . . . . 0.0 109.455 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.84 14.3 2.9 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.247 -0.908 . . . . 0.0 109.501 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.71 15.37 2.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.899 . . . . 0.0 109.607 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 mp -117.29 35.72 4.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.101 -1.0 . . . . 0.0 109.601 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.531 ' OD1' ' CA ' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -130.13 156.39 79.33 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.319 -0.863 . . . . 0.0 109.071 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.761 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 35.5 Cg_endo -77.93 2.67 7.69 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.611 2.207 . . . . 0.0 111.145 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.505 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -140.2 29.64 2.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.88 -1.138 . . . . 0.0 110.103 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.531 ' CA ' ' OD1' ' A' ' 48' ' ' ASN . 0.3 OUTLIER 30.54 96.35 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 121.234 0.54 . . . . 0.0 110.577 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.579 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 1.7 m -99.23 -177.68 3.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.008 -1.057 . . . . 0.0 109.904 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.579 ' HB2' ' O ' ' A' ' 52' ' ' SER . . . 170.59 -33.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.434 -0.791 . . . . 0.0 109.21 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -89.15 -17.63 28.8 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.332 -0.855 . . . . 0.0 109.51 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 0.7 OUTLIER -106.26 -28.17 10.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.121 -0.987 . . . . 0.0 109.508 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.586 ' HB1' ' HB2' ' A' ' 43' ' ' PHE . . . -87.45 -7.07 58.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.339 -0.851 . . . . 0.0 109.85 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -79.72 -49.77 11.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.155 -0.966 . . . . 0.0 109.347 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 t -82.53 -22.06 35.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 109.559 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.922 ' HG ' HG21 ' A' ' 74' ' ' THR . 9.1 tp -53.0 -32.25 45.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.937 . . . . 0.0 108.83 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.507 ' HB3' ' HA ' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -78.8 127.92 32.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.336 -0.852 . . . . 0.0 109.74 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.891 ' HB3' HG21 ' A' ' 72' ' ' THR . 9.7 p80 -73.38 -28.58 62.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.149 -0.969 . . . . 0.0 109.048 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 1.3 mtpt 56.65 118.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.497 -0.752 . . . . 0.0 110.011 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.52 ' CB ' ' O ' ' A' ' 62' ' ' LYS . 0.5 OUTLIER 160.46 169.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.466 -0.771 . . . . 0.0 109.438 179.749 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 mp -102.68 123.56 46.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.172 -0.955 . . . . 0.0 109.218 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 70' ' ' GLN . 9.1 mp -84.47 81.9 8.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.581 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 30.9 mtp -93.98 2.69 56.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.164 -0.96 . . . . 0.0 109.822 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.505 ' OG ' ' HD2' ' A' ' 68' ' ' PRO . 1.0 OUTLIER -115.81 152.42 47.41 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.121 -0.987 . . . . 0.0 109.089 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.505 ' HD2' ' OG ' ' A' ' 67' ' ' SER . 33.8 Cg_endo -76.13 102.18 1.58 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.407 2.071 . . . . 0.0 110.151 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.98 -26.31 14.28 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.492 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.5 108.73 0.19 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.277 -1.131 . . . . 0.0 108.991 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.559 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . 5.2 p -140.42 -159.57 0.97 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.097 -1.002 . . . . 0.0 110.083 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.891 HG21 ' HB3' ' A' ' 61' ' ' HIS . 4.2 m -157.06 112.39 2.84 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.5 p -79.41 76.2 5.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.121 -0.987 . . . . 0.0 109.293 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.922 HG21 ' HG ' ' A' ' 59' ' ' LEU . 60.9 m -51.1 111.0 0.49 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.538 -0.726 . . . . 0.0 109.939 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.738 ' HA ' HG23 ' A' ' 28' ' ' THR . 96.0 m -80.39 92.25 5.8 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.339 -0.85 . . . . 0.0 109.047 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.941 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 11.6 m-85 -44.74 165.11 0.16 Allowed Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.374 -0.829 . . . . 0.0 109.399 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.498 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 32.6 Cg_endo -75.64 155.38 40.01 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.552 2.168 . . . . 0.0 111.362 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.26 -6.5 24.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.61 -0.681 . . . . 0.0 109.801 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -99.96 -66.31 0.91 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.2 -0.937 . . . . 0.0 109.2 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.695 ' HB3' HG11 ' A' ' 103' ' ' VAL . . . 42.59 65.75 4.88 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.407 -0.808 . . . . 0.0 109.59 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.622 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 33.5 Cg_endo -76.27 -159.81 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.374 2.049 . . . . 0.0 109.907 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.761 ' HB1' ' HD2' ' A' ' 49' ' ' PRO . . . 69.62 -84.84 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.076 -1.015 . . . . 0.0 109.189 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.441 ' HA2' ' C ' ' A' ' 103' ' ' VAL . . . 116.22 19.64 5.43 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -160.02 96.67 1.23 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.153 -1.204 . . . . 0.0 110.243 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.526 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 5.5 m-85 -111.85 125.46 54.04 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.3 m -112.69 118.3 34.64 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.0 -1.063 . . . . 0.0 110.946 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.54 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.7 OUTLIER -103.77 175.17 5.57 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.272 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -160.53 -177.61 6.32 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.662 -1.273 . . . . 0.0 110.427 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.0 137.08 54.82 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -77.24 -46.98 2.65 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.888 . . . . 0.0 110.905 -179.49 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 33.3 Cg_endo -77.49 -47.83 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.331 2.02 . . . . 0.0 112.145 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.608 ' CE1' ' HG2' ' A' ' 91' ' ' PRO . 3.3 m80 -101.32 65.42 1.06 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.736 -1.227 . . . . 0.0 110.142 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -90.12 4.83 49.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 109.163 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.31 -14.73 23.38 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.509 ' HB1' ' O ' ' A' ' 14' ' ' LEU . . . -95.91 35.01 1.45 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -1.162 . . . . 0.0 109.181 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 98' ' ' VAL . . . 48.93 27.29 6.45 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.473 ' SD ' ' HB2' ' A' ' 92' ' ' HIS . 4.1 mtp -68.39 60.73 0.09 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.976 -1.308 . . . . 0.0 109.138 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' A' ' 96' ' ' GLY . 96.7 t -139.14 110.18 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.88 . . . . 0.0 109.761 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.54 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -103.69 -171.55 25.59 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 18.2 mttt -155.1 123.63 6.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.162 -1.199 . . . . 0.0 109.758 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 1.051 HD11 HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -90.97 124.43 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.233 -0.917 . . . . 0.0 108.795 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.489 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 18.2 m -105.26 97.65 7.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.252 -0.905 . . . . 0.0 108.856 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.695 HG11 ' HB3' ' A' ' 80' ' ' ALA . 4.0 t -99.8 73.37 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.013 -1.055 . . . . 0.0 109.512 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.02 109.04 0.14 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.893 . . . . 0.0 109.526 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.45 ' OXT' ' HA ' ' A' ' 81' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.309 0 CA-C-O 118.005 -1.441 . . . . 0.0 109.551 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.4 m -123.1 128.8 50.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 109.553 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.694 ' HD2' HG22 ' A' ' 23' ' ' ILE . 58.8 m-85 -105.77 130.82 53.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -0.893 . . . . 0.0 109.328 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.659 HG23 ' O ' ' A' ' 4' ' ' THR . 10.1 t -127.61 108.76 11.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.714 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.491 HG21 ' CE1' ' A' ' 16' ' ' PHE . 19.5 m -92.83 159.5 2.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.23 -0.919 . . . . 0.0 109.537 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.403 ' O ' ' N ' ' A' ' 8' ' ' GLY . 25.4 mttt -128.26 84.26 2.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.426 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.572 ' HB2' ' CE ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -45.15 100.7 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.25 -0.906 . . . . 0.0 109.536 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 14' ' ' LEU . . . 104.46 114.22 3.93 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 1.8 p -76.21 -81.3 0.08 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -1.121 . . . . 0.0 109.254 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 9' ' ' SER . 7.5 t70 167.83 -30.19 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.335 -0.853 . . . . 0.0 109.483 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.422 ' HB2' ' HE2' ' A' ' 11' ' ' LYS . 3.3 ttmm -114.85 -14.9 11.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 109.588 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.68 -85.92 1.77 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -164.34 -148.73 0.12 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -1.135 . . . . 0.0 109.296 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.669 HD11 ' HB ' ' A' ' 36' ' ' VAL . 83.9 mt -106.11 94.92 5.43 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.257 -0.902 . . . . 0.0 109.432 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.5 m -144.57 155.41 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.199 -0.938 . . . . 0.0 109.591 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.491 ' CE1' HG21 ' A' ' 5' ' ' VAL . 10.0 m-85 -70.06 142.99 52.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 109.764 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 2.8 mt-10 -134.44 105.18 11.03 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.235 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 33.9 Cg_endo -76.34 -175.71 17.06 Favored 'Cis proline' 0 C--N 1.311 -1.403 0 C-N-CA 123.664 -1.39 . . . . 0.0 110.639 0.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.29 -9.61 54.52 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.242 -0.911 . . . . 0.0 109.89 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.852 ' C ' HD22 ' A' ' 21' ' ' LEU . 30.2 mtmt -139.02 137.34 36.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.095 -1.003 . . . . 0.0 109.492 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.852 HD22 ' C ' ' A' ' 20' ' ' LYS . 4.6 mm? -123.54 127.77 48.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.33 -0.856 . . . . 0.0 109.887 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.4 m -99.67 97.98 8.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 108.705 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.818 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.1 pt -104.16 -175.87 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.227 -0.92 . . . . 0.0 110.4 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.625 ' C ' HG13 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -113.85 179.72 0.74 Allowed Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.075 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.567 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 34.1 Cg_endo -76.93 76.47 4.12 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.009 1.806 . . . . 0.0 110.571 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 134.31 -2.02 4.18 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.5 -1.334 . . . . 0.0 110.101 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.91 -170.86 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.092 -1.24 . . . . 0.0 109.249 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.403 HG23 ' HA ' ' A' ' 75' ' ' THR . 52.2 m -137.85 112.93 9.16 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.135 -0.978 . . . . 0.0 109.675 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.993 HG21 HD11 ' A' ' 101' ' ' ILE . 0.8 OUTLIER -99.89 128.43 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.214 -0.929 . . . . 0.0 109.422 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 3' ' ' TYR . 46.3 mt-10 -99.48 163.49 12.49 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.232 -0.917 . . . . 0.0 109.205 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.519 ' CZ ' ' O ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -149.44 152.87 36.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.209 -0.932 . . . . 0.0 109.391 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.566 ' N ' HD12 ' A' ' 32' ' ' LEU . 2.3 mp -141.73 -162.59 1.42 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.146 -0.971 . . . . 0.0 109.953 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 3.3 p-10 -123.97 172.99 8.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.446 -0.784 . . . . 0.0 109.011 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 26.0 t-20 -111.64 -96.36 0.43 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.939 -1.1 . . . . 0.0 109.193 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.486 ' HE2' HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -147.13 30.91 0.93 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.18 -0.95 . . . . 0.0 108.862 179.523 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.669 ' HB ' HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -151.1 59.42 3.34 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.694 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.579 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 36.6 Cg_endo -78.49 174.86 11.75 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.761 2.307 . . . . 0.0 110.617 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.556 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 37.9 Cg_endo -84.15 172.62 44.03 Favored 'Cis proline' 0 C--N 1.31 -1.461 0 C-N-CA 123.518 -1.451 . . . . 0.0 110.37 -1.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.902 ' HB2' HD22 ' A' ' 65' ' ' LEU . 91.9 m-70 -132.04 142.01 49.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.141 -0.974 . . . . 0.0 109.729 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.519 ' ND2' ' HB3' ' A' ' 63' ' ' GLN . 4.9 t-20 -112.47 119.29 37.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.335 -0.853 . . . . 0.0 109.604 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.9 t -108.03 112.94 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.657 HG13 ' CB ' ' A' ' 60' ' ' SER . 2.4 t -139.19 170.8 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.979 -1.075 . . . . 0.0 110.566 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.53 ' H ' HG12 ' A' ' 42' ' ' VAL . 4.4 m-85 -118.45 110.58 17.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.491 -0.756 . . . . 0.0 109.345 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.517 ' HB3' ' CD2' ' A' ' 47' ' ' LEU . 6.1 t0 -48.83 139.3 10.1 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.192 -0.942 . . . . 0.0 109.278 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.29 12.84 6.0 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.251 -0.906 . . . . 0.0 109.888 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -119.8 23.99 10.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.069 -1.019 . . . . 0.0 109.668 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.517 ' CD2' ' HB3' ' A' ' 44' ' ' ASP . 0.7 OUTLIER -131.03 46.33 2.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.226 -0.921 . . . . 0.0 109.474 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 48' ' ' ASN . 0.5 OUTLIER -119.47 156.38 53.31 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.214 -0.929 . . . . 0.0 109.603 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.36 -21.56 11.65 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.676 2.251 . . . . 0.0 110.305 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.451 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -123.89 28.06 7.0 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.264 -0.898 . . . . 0.0 109.424 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.474 ' HA ' ' OD1' ' A' ' 48' ' ' ASN . 0.1 OUTLIER 38.55 48.17 1.22 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.295 0.569 . . . . 0.0 110.025 179.711 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.435 ' N ' ' ND2' ' A' ' 48' ' ' ASN . 22.3 m -112.02 139.22 47.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.165 -0.959 . . . . 0.0 109.434 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.464 ' O ' ' HD2' ' A' ' 57' ' ' LYS . . . -121.54 21.82 10.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.802 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.86 -32.85 34.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.203 -0.936 . . . . 0.0 109.568 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.512 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 0.5 OUTLIER -97.39 21.42 10.14 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.215 -0.928 . . . . 0.0 109.415 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -113.35 -33.88 5.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.328 -0.858 . . . . 0.0 109.294 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.464 ' HD2' ' O ' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -71.34 -48.66 48.93 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.275 -0.891 . . . . 0.0 109.028 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.1 t -77.83 -2.12 34.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 0.0 109.44 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.885 HD21 ' CE2' ' A' ' 76' ' ' PHE . 9.7 tp -89.05 -48.41 7.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.109 -0.994 . . . . 0.0 109.097 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.657 ' CB ' HG13 ' A' ' 42' ' ' VAL . 10.1 p -79.78 164.65 23.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.527 -0.733 . . . . 0.0 110.507 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.535 ' CD2' HG21 ' A' ' 72' ' ' THR . 3.5 p80 -125.0 -164.74 1.31 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.526 -0.734 . . . . 0.0 109.217 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.466 ' N ' ' CG ' ' A' ' 61' ' ' HIS . 2.2 mttp -65.43 -162.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.119 -0.988 . . . . 0.0 109.353 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.519 ' HB3' ' ND2' ' A' ' 40' ' ' ASN . 5.4 pt20 -137.07 42.44 2.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.102 -0.999 . . . . 0.0 109.876 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.61 76.53 1.64 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.182 -0.948 . . . . 0.0 109.938 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.902 HD22 ' HB2' ' A' ' 39' ' ' HIS . 4.9 mp -85.58 105.0 15.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.131 -0.981 . . . . 0.0 109.21 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.1 ttt -109.04 3.82 22.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 0.0 109.578 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.428 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 2.6 t -98.28 133.63 22.74 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 109.123 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 67' ' ' SER . 36.0 Cg_endo -78.86 78.92 3.53 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.413 2.076 . . . . 0.0 110.512 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.533 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 112.63 50.36 0.56 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.531 ' N ' ' HB3' ' A' ' 32' ' ' LEU . 0.0 OUTLIER 172.3 111.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -1.103 . . . . 0.0 109.385 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' A' ' 72' ' ' THR . 77.8 p -111.14 -78.89 0.58 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.209 -0.932 . . . . 0.0 109.199 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.535 HG21 ' CD2' ' A' ' 61' ' ' HIS . 14.7 t -160.4 164.28 32.47 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.387 -0.821 . . . . 0.0 108.945 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.2 t -115.44 126.47 54.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.156 -0.965 . . . . 0.0 109.226 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.755 HG21 ' HG ' ' A' ' 59' ' ' LEU . 56.0 m -108.3 101.74 10.91 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.303 -0.873 . . . . 0.0 109.716 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.478 ' O ' HG22 ' A' ' 75' ' ' THR . 25.1 m -79.14 80.13 5.51 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.925 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 9.1 m-85 -36.83 146.54 0.23 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.964 -0.46 . . . . 0.0 109.886 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.459 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.0 Cg_endo -75.63 168.81 23.61 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.625 2.217 . . . . 0.0 110.895 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.75 11.82 8.4 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.493 -0.754 . . . . 0.0 109.424 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 81' ' ' PRO . 0.9 OUTLIER -99.55 -24.36 14.78 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.285 -0.885 . . . . 0.0 109.329 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.567 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -37.04 96.58 0.11 Allowed Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.815 -0.553 . . . . 0.0 109.769 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.488 ' N ' ' O ' ' A' ' 79' ' ' ASP . 35.9 Cg_endo -78.62 -177.0 3.57 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.643 2.229 . . . . 0.0 110.732 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.563 ' HB2' ' HA3' ' A' ' 105' ' ' GLY . . . -70.39 127.32 32.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.301 -0.874 . . . . 0.0 109.266 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 167.11 145.75 4.61 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -85.07 117.02 23.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -1.137 . . . . 0.0 109.808 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.489 ' CD1' HG22 ' A' ' 101' ' ' ILE . 26.5 m-85 -92.51 153.4 19.1 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.499 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 29.6 m -138.81 114.33 9.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.837 -1.164 . . . . 0.0 110.762 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.592 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.4 OUTLIER -108.33 154.75 21.38 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.282 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.524 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 5.0 p90 -143.49 -156.77 0.72 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.052 -1.03 . . . . 0.0 110.11 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.456 ' SG ' ' HD2' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -133.41 139.19 46.62 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.323 -0.861 . . . . 0.0 109.491 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.629 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 63.1 tt0 -79.45 -42.64 1.6 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.349 -0.844 . . . . 0.0 111.035 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 34.2 Cg_endo -76.93 -46.04 0.16 Allowed 'Trans proline' 0 C--N 1.316 -1.148 0 C-N-CA 121.931 1.754 . . . . 0.0 111.068 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.687 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 15.2 m80 -102.3 33.32 3.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.0 -1.062 . . . . 0.0 109.6 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.9 ttt-85 -50.65 -36.9 37.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.129 -0.982 . . . . 0.0 109.718 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -96.27 40.26 2.64 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 92' ' ' HIS . . . -133.68 33.38 3.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.231 -1.158 . . . . 0.0 109.541 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.11 24.12 54.01 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.231 -1.147 . . . . 0.0 110.231 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.572 ' CE ' ' HB2' ' A' ' 7' ' ' LEU . 2.7 mtp -87.54 71.59 9.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.039 -1.271 . . . . 0.0 109.217 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 88.6 t -137.62 127.94 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.541 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.592 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -123.66 -174.78 14.27 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.527 ' CG ' ' O ' ' A' ' 99' ' ' GLY . 22.2 mttt -162.33 122.27 2.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.175 -1.191 . . . . 0.0 110.169 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.993 HD11 HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -88.16 121.25 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.107 -0.995 . . . . 0.0 108.406 178.91 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.6 101.41 12.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.021 -1.05 . . . . 0.0 109.329 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.705 HG22 ' CD1' ' A' ' 23' ' ' ILE . 2.4 t -99.77 116.47 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 109.367 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.43 -172.8 0.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 109.385 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.563 ' HA3' ' HB2' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.291 0 CA-C-O 118.024 -1.431 . . . . 0.0 109.528 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.31 142.93 50.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.749 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.707 ' CD2' HG22 ' A' ' 23' ' ' ILE . 23.2 m-85 -80.17 173.87 12.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.281 -0.887 . . . . 0.0 109.373 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.501 HG23 ' CB ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -156.08 113.57 3.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.149 -0.97 . . . . 0.0 109.814 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.768 ' CG1' HD13 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -101.41 114.3 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.908 . . . . 0.0 109.129 179.514 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -82.03 107.53 14.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.244 -0.91 . . . . 0.0 109.475 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.567 HD22 ' CE1' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -88.94 -169.1 2.4 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.16 -0.963 . . . . 0.0 109.108 179.565 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.675 ' HA2' HD23 ' A' ' 14' ' ' LEU . . . 65.05 74.51 0.48 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 p -58.44 151.57 19.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -1.177 . . . . 0.0 109.531 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -89.52 -0.72 57.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.758 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.53 -0.41 8.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.1 -1.0 . . . . 0.0 109.769 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -131.78 -105.95 1.03 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.431 ' O ' HD23 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -148.2 -91.3 0.08 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.336 -1.097 . . . . 0.0 109.462 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.675 HD23 ' HA2' ' A' ' 8' ' ' GLY . 74.0 mt -133.76 108.05 8.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.224 -0.923 . . . . 0.0 109.714 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.48 116.68 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.33 -0.856 . . . . 0.0 109.284 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.567 ' CE1' HD22 ' A' ' 7' ' ' LEU . 37.6 m-85 -45.39 151.09 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.165 -0.959 . . . . 0.0 109.27 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 7.5 mt-10 -144.69 112.91 5.0 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.159 -0.963 . . . . 0.0 109.296 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.9 Cg_endo -76.7 177.62 38.81 Favored 'Cis proline' 0 C--N 1.312 -1.387 0 C-N-CA 123.678 -1.384 . . . . 0.0 110.609 0.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.38 -1.95 35.89 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.283 -0.886 . . . . 0.0 109.675 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -134.19 161.49 34.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 109.281 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.768 HD13 ' CG1' ' A' ' 5' ' ' VAL . 0.5 OUTLIER -156.5 118.07 3.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.001 -1.062 . . . . 0.0 110.032 -179.85 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.516 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 92.6 m -90.5 101.4 14.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.849 . . . . 0.0 108.876 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.806 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -102.14 -172.75 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.317 -0.864 . . . . 0.0 110.317 -179.135 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.556 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -111.94 172.53 3.47 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.159 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.57 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 34.3 Cg_endo -77.41 79.83 3.07 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.364 2.043 . . . . 0.0 110.725 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 130.12 -24.56 4.48 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.577 -1.297 . . . . 0.0 109.898 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 26' ' ' GLY . 0.7 OUTLIER -51.43 -176.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.123 -1.222 . . . . 0.0 109.623 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.2 m -122.6 146.17 47.69 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.318 -0.864 . . . . 0.0 109.441 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.951 HG21 HD11 ' A' ' 101' ' ' ILE . 2.4 t -127.17 140.36 49.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.23 -0.919 . . . . 0.0 109.451 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.501 ' CB ' HG23 ' A' ' 4' ' ' THR . 1.8 mt-10 -106.85 155.85 19.3 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.165 -0.959 . . . . 0.0 109.814 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.529 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -153.52 84.63 1.18 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.598 ' H ' HD23 ' A' ' 32' ' ' LEU . 1.7 pt? -96.55 165.3 12.23 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.98 0.895 . . . . 0.0 111.941 -177.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.615 ' HB2' ' CD2' ' A' ' 39' ' ' HIS . 3.9 p30 -87.45 154.85 20.32 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.97 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 48.4 t30 -92.98 -62.78 1.31 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.057 -1.027 . . . . 0.0 109.36 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.472 ' C ' HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -158.19 35.53 0.24 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.243 -0.91 . . . . 0.0 109.291 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.593 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 26.7 t -154.73 57.42 1.71 Allowed Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.411 -0.806 . . . . 0.0 109.794 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.593 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 37.0 Cg_endo -79.97 174.54 11.44 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.579 2.186 . . . . 0.0 110.515 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.525 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.1 Cg_endo -84.34 175.57 34.37 Favored 'Cis proline' 0 C--N 1.31 -1.462 0 C-N-CA 123.549 -1.438 . . . . 0.0 110.137 -1.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.689 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 51.0 m-70 -127.09 146.56 50.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.335 -0.853 . . . . 0.0 110.116 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -113.11 110.04 19.8 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.423 HG21 ' HB2' ' A' ' 31' ' ' PHE . 42.7 t -99.28 117.82 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.143 -0.973 . . . . 0.0 109.681 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.003 HG12 ' HB2' ' A' ' 60' ' ' SER . 0.8 OUTLIER -147.81 171.49 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.445 -0.785 . . . . 0.0 109.407 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.643 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.9 OUTLIER -124.66 109.59 13.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.331 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -46.96 136.46 8.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -0.884 . . . . 0.0 109.584 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.53 45.99 1.19 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.254 -0.904 . . . . 0.0 109.538 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.68 -30.52 0.82 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 110.186 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.9 mt -103.12 77.36 1.54 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.038 -1.039 . . . . 0.0 110.013 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.469 ' OD1' ' HA ' ' A' ' 51' ' ' LYS . 1.9 p30 -126.19 153.74 74.36 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.284 -0.885 . . . . 0.0 109.159 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.06 -14.31 13.58 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.562 2.175 . . . . 0.0 111.076 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -135.9 24.46 3.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.929 -1.107 . . . . 0.0 109.999 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.469 ' HA ' ' OD1' ' A' ' 48' ' ' ASN . 1.0 OUTLIER 35.75 87.39 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.115 0.483 . . . . 0.0 110.111 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.5 m -136.99 159.57 41.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.107 -0.996 . . . . 0.0 109.763 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.81 43.87 3.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 109.271 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -143.97 -41.05 0.28 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.347 -0.845 . . . . 0.0 109.648 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.567 ' O ' HD12 ' A' ' 55' ' ' LEU . 1.3 pp -58.9 -18.11 30.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.044 -1.035 . . . . 0.0 109.135 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 57' ' ' LYS . . . -89.56 -38.74 13.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.342 -0.849 . . . . 0.0 109.314 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -44.15 -45.03 8.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 109.249 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.28 32.32 2.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -0.863 . . . . 0.0 109.16 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.795 HD21 ' CE2' ' A' ' 76' ' ' PHE . 7.1 tp -133.1 -51.37 0.89 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 0.0 109.648 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . 1.003 ' HB2' HG12 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -78.74 121.18 24.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 109.766 -179.16 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.502 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 18.0 p80 -99.76 125.38 45.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.299 -0.876 . . . . 0.0 109.541 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 63' ' ' GLN . 2.2 mtpp -78.31 -37.22 45.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.186 -0.946 . . . . 0.0 109.591 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.436 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 2.4 tt0 -45.56 123.56 4.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.165 -0.959 . . . . 0.0 109.446 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.8 mp -75.97 170.66 15.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.478 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.734 HD21 ' CB ' ' A' ' 71' ' ' SER . 3.5 mp -93.1 -179.72 5.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -0.955 . . . . 0.0 109.429 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.447 ' HG3' ' C ' ' A' ' 65' ' ' LEU . 3.9 mtt -145.45 -48.52 0.23 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.065 -1.022 . . . . 0.0 110.151 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.503 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 47.2 t -80.58 144.96 57.69 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.058 -1.026 . . . . 0.0 110.224 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.475 ' HA ' HD21 ' A' ' 33' ' ' ASN . 36.5 Cg_endo -80.16 95.02 1.0 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 123.024 2.482 . . . . 0.0 110.454 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 33' ' ' ASN . . . 116.96 49.79 0.41 Allowed Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.228 -1.463 . . . . 0.0 109.83 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.537 ' N ' ' HB2' ' A' ' 32' ' ' LEU . 1.7 pt20 167.7 108.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -1.129 . . . . 0.0 109.457 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.734 ' CB ' HD21 ' A' ' 65' ' ' LEU . 95.6 p -100.1 -100.24 0.24 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.228 -0.92 . . . . 0.0 109.445 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.532 ' N ' ' OG ' ' A' ' 71' ' ' SER . 36.9 p -146.32 -157.85 0.84 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 p -143.05 93.68 2.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.06 -1.025 . . . . 0.0 109.389 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.712 HG21 ' HG ' ' A' ' 59' ' ' LEU . 42.6 m -67.44 103.24 1.26 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.377 -0.827 . . . . 0.0 109.428 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 76' ' ' PHE . 1.9 m -78.65 78.73 5.09 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.223 -0.923 . . . . 0.0 108.859 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.898 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 14.5 m-85 -40.79 144.02 0.65 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.651 -0.656 . . . . 0.0 109.306 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.475 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.9 Cg_endo -77.5 168.65 22.39 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.702 2.268 . . . . 0.0 111.149 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.45 9.78 8.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.429 -0.795 . . . . 0.0 109.447 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.469 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 28.0 t70 -99.15 -19.78 16.99 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.171 -0.956 . . . . 0.0 108.865 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.57 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -40.08 99.97 0.21 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.683 -0.635 . . . . 0.0 109.573 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.48 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 34.8 Cg_endo -76.29 133.99 15.26 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.312 2.008 . . . . 0.0 110.357 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -46.1 136.05 7.1 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.26 -0.9 . . . . 0.0 109.354 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 167.47 -139.37 5.68 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -135.67 120.1 18.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.29 -1.123 . . . . 0.0 109.733 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.585 ' CD1' HG22 ' A' ' 101' ' ' ILE . 4.0 m-85 -102.02 -179.41 3.99 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.4 m -163.63 115.41 1.42 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.9 -1.125 . . . . 0.0 110.38 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.551 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.5 OUTLIER -110.83 162.62 14.62 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -149.87 -162.01 1.46 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.989 -1.069 . . . . 0.0 109.954 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.12 126.28 28.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.348 -0.845 . . . . 0.0 109.838 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -59.33 -46.3 99.06 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 109.961 179.467 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.2 Cg_endo -78.85 -69.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.152 0 C-N-CA 122.182 1.921 . . . . 0.0 110.725 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.689 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 9.5 m80 -66.96 63.98 0.05 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.036 -1.04 . . . . 0.0 109.423 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 91' ' ' PRO . 5.8 ttp180 -92.62 -9.08 42.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 0.0 109.599 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.68 39.84 2.76 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.47 36.4 0.98 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.099 -1.236 . . . . 0.0 109.573 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' A' ' 98' ' ' VAL . . . 50.48 21.96 4.99 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.537 ' CE ' ' HB3' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -66.85 67.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.094 -1.239 . . . . 0.0 109.432 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' A' ' 96' ' ' GLY . 97.2 t -138.34 92.54 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.104 -0.997 . . . . 0.0 109.546 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.551 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -88.44 -173.31 47.14 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.501 ' CG ' ' O ' ' A' ' 99' ' ' GLY . 12.6 mttp -157.96 122.79 4.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -1.178 . . . . 0.0 109.541 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.951 HD11 HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -85.15 135.26 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 109.091 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.516 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 75.7 m -115.72 112.17 21.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.962 . . . . 0.0 108.635 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.787 HG22 ' CD1' ' A' ' 23' ' ' ILE . 8.6 t -99.37 131.64 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.941 . . . . 0.0 109.64 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -179.79 -74.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 0.0 109.587 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 CA-C-O 117.977 -1.457 . . . . 0.0 109.617 -179.897 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.487 HG22 ' HB ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -102.57 147.71 26.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.169 -0.957 . . . . 0.0 109.454 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.408 ' O ' ' N ' ' A' ' 30' ' ' GLU . 26.3 m-85 -118.47 125.42 49.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.256 -0.903 . . . . 0.0 109.499 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 30' ' ' GLU . 1.7 t -115.49 136.02 53.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 109.504 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.659 ' O ' HD23 ' A' ' 7' ' ' LEU . 0.9 OUTLIER -111.09 85.71 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.578 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -56.18 128.29 34.86 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.178 -0.951 . . . . 0.0 109.328 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.745 HD23 ' N ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -104.48 179.5 4.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.243 -0.911 . . . . 0.0 109.504 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.844 ' HA2' HD23 ' A' ' 14' ' ' LEU . . . 68.36 75.63 0.49 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.466 ' O ' ' OD2' ' A' ' 10' ' ' ASP . 1.4 p -44.84 -30.28 0.95 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -1.186 . . . . 0.0 109.501 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.469 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER 77.07 -3.06 2.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.472 -0.768 . . . . 0.0 109.652 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.33 13.67 8.26 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.132 -0.98 . . . . 0.0 109.641 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.07 -82.1 0.05 OUTLIER Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.7 tp -140.38 -151.42 0.36 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.231 -1.159 . . . . 0.0 109.685 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.844 HD23 ' HA2' ' A' ' 8' ' ' GLY . 87.5 mt -112.17 118.38 35.18 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.357 -0.84 . . . . 0.0 109.354 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 96' ' ' GLY . 6.1 m -152.03 156.91 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.179 -0.95 . . . . 0.0 109.381 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -71.41 156.37 39.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.211 -0.931 . . . . 0.0 109.454 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 47.6 mt-10 -143.88 112.86 5.35 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.416 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.1 Cg_endo -77.63 -178.6 24.53 Favored 'Cis proline' 0 C--N 1.312 -1.346 0 C-N-CA 123.739 -1.359 . . . . 0.0 110.462 0.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.14 -34.5 61.65 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.266 -0.896 . . . . 0.0 109.741 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.73 158.04 19.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 0.0 109.265 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.9 tp -151.83 107.45 3.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.102 -0.999 . . . . 0.0 109.891 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.405 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 41.0 m -81.43 95.23 7.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.152 -0.968 . . . . 0.0 109.058 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.787 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -99.7 168.62 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.397 -0.814 . . . . 0.0 110.163 -179.3 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.572 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 37.0 mttt -88.28 168.21 17.08 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.727 ' HA ' HG11 ' A' ' 103' ' ' VAL . 32.5 Cg_endo -75.54 82.77 2.03 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 121.872 1.714 . . . . 0.0 110.559 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 132.05 -13.52 5.23 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.434 ' OD2' ' HG3' ' A' ' 24' ' ' LYS . 6.8 m-20 -54.8 -176.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.16 -1.2 . . . . 0.0 109.699 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.828 HG23 ' HA ' ' A' ' 75' ' ' THR . 0.2 OUTLIER -122.1 138.77 54.33 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.365 -0.834 . . . . 0.0 109.495 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.955 HG21 HD11 ' A' ' 101' ' ' ILE . 2.0 t -118.09 137.2 52.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.172 -0.955 . . . . 0.0 109.598 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -115.18 125.6 53.6 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.246 -0.909 . . . . 0.0 109.861 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.597 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -124.69 101.48 7.13 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.598 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 1.5 mp -97.08 178.15 5.36 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.294 -0.879 . . . . 0.0 110.926 -178.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 2.8 p-10 -97.37 164.13 12.59 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.753 -0.592 . . . . 0.0 109.741 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 7' ' ' LEU . 23.7 t30 -109.35 -85.18 0.54 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.137 -0.977 . . . . 0.0 108.962 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HG2' ' ND2' ' A' ' 34' ' ' ASN . 10.5 ptmt -150.91 29.75 0.66 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.386 -0.821 . . . . 0.0 108.911 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.575 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 3.0 t -148.68 58.5 3.65 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.575 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 35.7 Cg_endo -77.65 175.06 11.7 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.564 2.176 . . . . 0.0 110.781 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.566 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.9 Cg_endo -85.45 161.96 61.32 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 123.537 -1.443 . . . . 0.0 110.614 -1.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.718 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 65.5 m-70 -120.21 142.25 49.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.357 -0.839 . . . . 0.0 109.845 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 6.6 m120 -130.83 126.4 36.18 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.545 ' HB ' ' NE2' ' A' ' 61' ' ' HIS . 1.2 t -99.57 135.7 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.209 -0.932 . . . . 0.0 109.108 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.622 HG12 ' H ' ' A' ' 43' ' ' PHE . 2.2 t -140.07 178.04 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.332 -0.855 . . . . 0.0 109.24 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.622 ' H ' HG12 ' A' ' 42' ' ' VAL . 17.6 m-85 -137.56 120.85 16.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.189 -0.945 . . . . 0.0 109.479 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 43' ' ' PHE . 5.9 t0 -54.28 -166.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.423 -0.798 . . . . 0.0 109.785 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -147.69 25.8 1.05 Allowed 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.239 -0.913 . . . . 0.0 109.614 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -119.42 -10.13 9.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.407 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.597 HD13 ' OG1' ' A' ' 86' ' ' THR . 4.7 mt -110.82 55.68 0.65 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.281 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' A' ' 48' ' ' ASN . 0.9 OUTLIER -120.01 152.96 54.91 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.258 -0.901 . . . . 0.0 109.476 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.92 -19.86 12.12 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.669 2.246 . . . . 0.0 110.644 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.47 ' O ' ' HG3' ' A' ' 51' ' ' LYS . . . -126.57 29.89 5.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.065 -1.022 . . . . 0.0 109.71 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER 34.46 59.21 0.65 Allowed 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.153 0.501 . . . . 0.0 110.33 179.665 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.8 m -132.49 171.72 13.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.15 -0.969 . . . . 0.0 109.543 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.82 16.8 0.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 109.758 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 54' ' ' ASP . 2.0 p-10 -71.11 -23.13 62.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.16 -0.963 . . . . 0.0 109.444 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.525 ' HG ' ' N ' ' A' ' 56' ' ' ALA . 1.1 pp -87.63 -27.7 22.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.242 -0.911 . . . . 0.0 109.501 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.525 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -79.73 -31.33 41.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 0.0 109.959 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -58.08 -31.54 67.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.166 -0.959 . . . . 0.0 109.745 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.5 p -105.29 -8.3 18.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.95 . . . . 0.0 110.071 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.884 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 9.3 tp -80.73 -33.02 35.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.053 -1.029 . . . . 0.0 109.297 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.479 ' HB3' ' HA ' ' A' ' 42' ' ' VAL . 0.8 OUTLIER -78.62 136.08 37.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.332 -0.855 . . . . 0.0 110.163 -179.009 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.545 ' NE2' ' HB ' ' A' ' 41' ' ' VAL . 0.4 OUTLIER -117.12 94.48 4.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.42 -0.8 . . . . 0.0 109.016 179.615 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.515 ' O ' HD13 ' A' ' 64' ' ' LEU . 0.9 OUTLIER -61.32 -12.28 13.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.307 -0.871 . . . . 0.0 110.016 -179.529 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.468 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 20.8 tt0 -43.43 122.14 2.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.142 -0.974 . . . . 0.0 109.718 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.814 ' H ' HD22 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -64.53 121.85 15.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.844 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.568 HD12 ' N ' ' A' ' 65' ' ' LEU . 8.1 mp -84.2 93.71 8.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.252 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.0 tpt -97.02 -6.56 35.07 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.268 -0.895 . . . . 0.0 109.472 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.493 ' CB ' ' HB3' ' A' ' 70' ' ' GLN . 35.1 t -84.29 138.57 39.09 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.174 -0.954 . . . . 0.0 109.325 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 67' ' ' SER . 36.3 Cg_endo -79.29 92.35 1.14 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.558 2.172 . . . . 0.0 110.86 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 91.86 24.93 24.01 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.493 ' HB3' ' CB ' ' A' ' 67' ' ' SER . 0.6 OUTLIER -137.84 89.68 2.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.242 -1.152 . . . . 0.0 109.278 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.598 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . 6.4 p -105.66 -167.92 1.38 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.154 -0.966 . . . . 0.0 109.88 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.1 t -105.6 123.08 47.33 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 73' ' ' SER . 1.7 p -78.7 109.29 12.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.985 -1.072 . . . . 0.0 109.507 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.605 HG21 ' HG ' ' A' ' 59' ' ' LEU . 24.7 m -78.44 107.3 10.98 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.422 -0.799 . . . . 0.0 109.555 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.828 ' HA ' HG23 ' A' ' 28' ' ' THR . 18.7 m -79.55 93.57 5.47 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.248 -0.907 . . . . 0.0 109.034 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.884 ' CZ ' HD21 ' A' ' 59' ' ' LEU . 3.3 m-85 -44.08 156.74 0.31 Allowed Pre-proline 0 N--CA 1.487 1.407 0 O-C-N 121.401 -0.812 . . . . 0.0 109.268 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.442 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.0 Cg_endo -76.86 168.21 23.91 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.818 2.345 . . . . 0.0 111.788 -179.061 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.66 8.18 15.19 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 80' ' ' ALA . 2.8 m-20 -98.87 -8.05 26.32 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.329 -0.857 . . . . 0.0 108.957 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.689 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -36.61 98.13 0.15 Allowed Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.809 -0.557 . . . . 0.0 109.702 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.455 ' N ' ' O ' ' A' ' 79' ' ' ASP . 35.3 Cg_endo -76.68 155.42 35.31 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.536 2.157 . . . . 0.0 110.628 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.54 108.34 1.64 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 109.636 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -175.44 -177.17 44.3 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 pm0 -107.69 143.79 35.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.22 -1.165 . . . . 0.0 109.661 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.555 ' CD1' HG22 ' A' ' 101' ' ' ILE . 17.9 m-85 -118.85 165.45 14.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.306 -0.872 . . . . 0.0 109.066 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.597 ' OG1' HD13 ' A' ' 47' ' ' LEU . 44.7 m -146.06 109.26 4.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.139 -0.976 . . . . 0.0 110.045 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.564 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.8 OUTLIER -106.27 160.11 15.6 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.338 -0.851 . . . . 0.0 109.16 179.435 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 88' ' ' TYR . 16.0 p90 -146.17 -168.04 2.89 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.192 -0.942 . . . . 0.0 109.59 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 0.1 OUTLIER -120.51 140.89 50.8 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.339 -0.85 . . . . 0.0 109.707 -179.597 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.601 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.6 tt0 -75.64 -45.73 4.2 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.291 -0.881 . . . . 0.0 109.892 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.2 Cg_endo -78.34 -51.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.14 0 C-N-CA 121.898 1.732 . . . . 0.0 110.562 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.718 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 19.8 m80 -90.25 43.58 1.15 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.137 -0.977 . . . . 0.0 109.316 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.484 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -59.38 -57.73 11.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -0.88 . . . . 0.0 109.521 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -81.23 49.82 4.07 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -138.63 38.19 2.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -1.151 . . . . 0.0 109.431 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.482 ' O ' HG12 ' A' ' 15' ' ' VAL . . . 47.58 30.47 6.39 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.521 ' HE2' ' C ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -92.32 68.56 5.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.221 -1.164 . . . . 0.0 109.203 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.2 t -136.12 112.06 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.912 . . . . 0.0 109.579 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.564 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -108.96 -171.54 20.94 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.489 ' HG2' ' HA ' ' A' ' 86' ' ' THR . 14.5 mttp -159.12 119.62 3.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -1.157 . . . . 0.0 109.855 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.955 HD11 HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -82.96 143.34 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.089 -1.007 . . . . 0.0 108.47 179.19 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.405 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -119.54 95.93 4.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.149 -0.969 . . . . 0.0 109.041 179.648 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.731 HG22 ' CD1' ' A' ' 23' ' ' ILE . 2.1 t -99.86 131.81 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.272 -0.893 . . . . 0.0 109.655 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -90.14 -174.68 4.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.292 -0.88 . . . . 0.0 109.305 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 CA-C-O 118.001 -1.444 . . . . 0.0 109.619 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.286 0.565 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.86 134.23 55.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 109.5 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -94.06 136.95 33.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.242 -0.911 . . . . 0.0 109.529 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.87 102.84 7.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.885 . . . . 0.0 109.557 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.899 HG22 ' O ' ' A' ' 30' ' ' GLU . 2.8 m -91.79 48.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.231 -0.918 . . . . 0.0 109.614 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -47.54 92.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 109.43 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -53.97 170.54 0.12 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.228 -0.92 . . . . 0.0 109.665 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.496 ' HA3' ' HB2' ' A' ' 34' ' ' ASN . . . 74.35 122.29 0.1 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.1 p -68.55 -70.12 0.29 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.218 -1.166 . . . . 0.0 109.545 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 179.79 -59.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 109.358 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -140.06 41.25 1.96 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.284 -0.885 . . . . 0.0 109.517 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.95 -97.17 0.34 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 mt -116.7 170.51 8.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.262 -1.14 . . . . 0.0 109.691 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.779 HD11 ' HB ' ' A' ' 36' ' ' VAL . 46.0 mt -100.08 120.07 39.27 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.374 -0.829 . . . . 0.0 108.987 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 14' ' ' LEU . 1.4 m -159.95 145.97 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.076 -1.015 . . . . 0.0 109.716 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.497 ' HA ' ' HA ' ' A' ' 7' ' ' LEU . 7.2 m-85 -56.68 154.53 8.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 109.046 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 42.5 mt-10 -145.29 109.65 4.59 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.124 -0.985 . . . . 0.0 109.448 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 35.7 Cg_endo -78.8 174.8 49.34 Favored 'Cis proline' 0 C--N 1.312 -1.354 0 C-N-CA 123.904 -1.29 . . . . 0.0 110.491 0.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.75 -62.37 1.41 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.14 -0.975 . . . . 0.0 109.053 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -89.5 154.04 20.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.35 -0.844 . . . . 0.0 108.787 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.843 ' CD1' HG12 ' A' ' 5' ' ' VAL . 1.2 mt -147.12 135.88 22.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.951 -1.093 . . . . 0.0 110.216 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 102' ' ' THR . 28.6 m -109.03 98.12 7.64 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.755 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -102.35 177.69 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.396 -0.815 . . . . 0.0 110.156 -179.277 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.55 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -101.2 174.73 2.73 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.552 ' HA ' ' CB ' ' A' ' 80' ' ' ALA . 34.9 Cg_endo -77.15 79.19 3.21 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.262 1.975 . . . . 0.0 110.505 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 134.96 -12.49 4.46 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.445 ' OD2' ' HB2' ' A' ' 24' ' ' LYS . 64.1 m-20 -55.09 -179.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.151 -1.206 . . . . 0.0 109.294 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 90.5 m -126.64 113.64 16.99 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.149 -0.97 . . . . 0.0 109.658 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.815 HG21 HD11 ' A' ' 101' ' ' ILE . 2.0 t -104.74 131.0 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.149 -0.969 . . . . 0.0 109.53 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.899 ' O ' HG22 ' A' ' 5' ' ' VAL . 1.7 mp0 -101.84 155.54 18.07 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.249 -0.907 . . . . 0.0 109.696 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -148.35 85.25 1.51 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.572 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.5 OUTLIER -97.55 179.51 4.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.362 -0.836 . . . . 0.0 110.942 -178.491 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 2.1 p-10 -90.09 157.01 17.98 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.591 -0.693 . . . . 0.0 109.263 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.496 ' HB2' ' HA3' ' A' ' 8' ' ' GLY . 3.8 t30 -97.59 -73.65 0.6 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.982 -1.074 . . . . 0.0 109.338 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.494 ' C ' HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -163.5 31.91 0.09 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 108.923 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.779 ' HB ' HD11 ' A' ' 14' ' ' LEU . 27.8 t -157.47 63.95 3.03 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.603 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 33.6 Cg_endo -77.32 177.33 8.98 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 123.097 2.531 . . . . 0.0 111.026 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.603 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 39.7 Cg_endo -87.28 158.81 48.42 Favored 'Cis proline' 0 C--N 1.313 -1.316 0 O-C-N 123.698 1.367 . . . . 0.0 111.328 -1.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.703 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 65.3 m-70 -119.55 141.52 49.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.707 -0.62 . . . . 0.0 109.388 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -117.99 119.36 34.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.872 . . . . 0.0 108.94 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.574 ' HB ' ' NE2' ' A' ' 61' ' ' HIS . 2.0 t -100.42 128.48 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.131 -0.98 . . . . 0.0 109.8 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.916 HG12 ' CB ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -157.3 165.5 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.546 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.64 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.4 OUTLIER -124.03 134.61 53.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.099 -1.001 . . . . 0.0 109.284 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -66.97 133.35 49.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.348 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.542 ' HB1' ' CB ' ' A' ' 53' ' ' ALA . . . -82.37 10.63 6.7 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.27 -0.894 . . . . 0.0 109.918 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.8 19.65 13.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.129 -0.982 . . . . 0.0 109.437 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.26 49.88 2.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -0.934 . . . . 0.0 109.687 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.521 ' OD1' ' CA ' ' A' ' 51' ' ' LYS . 1.5 p30 -118.26 160.47 39.32 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.347 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.482 ' HG2' ' HB2' ' A' ' 81' ' ' PRO . 36.3 Cg_endo -77.82 -5.31 15.24 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.512 2.142 . . . . 0.0 110.662 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -125.46 27.36 6.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.115 -0.991 . . . . 0.0 109.62 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.521 ' CA ' ' OD1' ' A' ' 48' ' ' ASN . 3.6 ptmt 34.0 38.55 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.134 0.493 . . . . 0.0 110.39 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.51 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 1.8 m -115.47 170.19 8.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.083 -1.011 . . . . 0.0 109.676 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.542 ' CB ' ' HB1' ' A' ' 45' ' ' ALA . . . -139.68 51.9 1.73 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.958 . . . . 0.0 109.57 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -115.38 -42.07 3.2 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.311 -0.868 . . . . 0.0 109.493 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.94 HD22 ' HG3' ' A' ' 81' ' ' PRO . 1.8 pp -56.71 -28.18 60.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.892 . . . . 0.0 109.498 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.477 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -79.93 -35.06 38.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.929 . . . . 0.0 109.538 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -51.1 -22.92 2.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.177 -0.952 . . . . 0.0 109.373 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.1 m -123.18 18.42 9.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.626 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.878 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 12.3 tp -119.69 -41.97 2.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.11 -0.994 . . . . 0.0 109.635 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.916 ' CB ' HG12 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -78.04 127.44 32.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.384 -179.445 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.746 ' CG ' HG21 ' A' ' 72' ' ' THR . 0.5 OUTLIER -108.63 137.14 47.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.374 -0.829 . . . . 0.0 109.486 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -85.83 -159.74 0.48 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.227 -0.921 . . . . 0.0 109.51 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.518 ' CB ' ' O ' ' A' ' 62' ' ' LYS . 1.6 tt0 77.33 136.4 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.408 -0.807 . . . . 0.0 109.533 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.461 ' HB2' ' CE ' ' A' ' 66' ' ' MET . 5.2 mp -85.91 133.5 33.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.451 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.755 HD22 ' HA ' ' A' ' 71' ' ' SER . 9.9 mt -80.12 124.21 28.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 0.0 109.48 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.461 ' CE ' ' HB2' ' A' ' 64' ' ' LEU . 6.7 mtt -124.99 4.58 7.98 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.25 -0.906 . . . . 0.0 109.601 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.464 ' OG ' ' HB3' ' A' ' 70' ' ' GLN . 47.4 t -91.89 142.33 26.39 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.188 -0.945 . . . . 0.0 109.332 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.6 86.3 1.7 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.62 2.213 . . . . 0.0 110.892 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.528 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 95.23 44.41 3.27 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.487 ' HA ' HD23 ' A' ' 32' ' ' LEU . 3.6 tp60 -162.32 101.45 1.08 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.243 -1.151 . . . . 0.0 109.244 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.755 ' HA ' HD22 ' A' ' 65' ' ' LEU . 3.2 p -112.11 -103.77 0.4 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.405 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.746 HG21 ' CG ' ' A' ' 61' ' ' HIS . 9.0 t -161.02 117.94 2.3 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.0 t -78.54 116.58 19.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.957 -1.089 . . . . 0.0 109.895 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.436 ' HG1' ' HE1' ' A' ' 31' ' ' PHE . 0.6 OUTLIER -95.52 105.05 16.98 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 76' ' ' PHE . 41.4 m -78.91 92.27 4.89 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.248 -0.907 . . . . 0.0 108.905 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.878 ' CZ ' HD21 ' A' ' 59' ' ' LEU . 7.0 m-85 -42.8 161.34 0.19 Allowed Pre-proline 0 N--CA 1.488 1.442 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.477 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 33.1 Cg_endo -75.45 159.04 40.11 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.346 2.031 . . . . 0.0 111.185 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.54 -5.64 20.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.551 -0.718 . . . . 0.0 109.644 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 80' ' ' ALA . 0.9 OUTLIER -99.41 -65.6 0.95 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.187 -0.946 . . . . 0.0 109.284 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.552 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . . . 61.26 133.09 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.337 -0.852 . . . . 0.0 109.407 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.94 ' HG3' HD22 ' A' ' 55' ' ' LEU . 36.1 Cg_endo -78.42 99.75 1.3 Allowed 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.345 2.03 . . . . 0.0 110.284 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.46 ' HB2' ' HA3' ' A' ' 105' ' ' GLY . . . -41.42 117.82 0.96 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.378 -0.826 . . . . 0.0 109.683 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.454 ' HA3' ' HG3' ' A' ' 49' ' ' PRO . . . 156.13 -156.31 26.98 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.599 ' HG3' HG23 ' A' ' 102' ' ' THR . 0.4 OUTLIER -122.0 126.1 47.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -1.167 . . . . 0.0 109.508 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.627 ' CD2' ' CG2' ' A' ' 101' ' ' ILE . 1.5 m-30 -92.89 -164.7 1.21 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.889 . . . . 0.0 108.941 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.491 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 65.4 m -167.19 111.68 0.72 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.868 -1.145 . . . . 0.0 110.505 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 0.7 OUTLIER -112.05 157.4 20.8 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.378 -0.826 . . . . 0.0 108.774 178.729 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.783 ' CB ' HG22 ' A' ' 98' ' ' VAL . 24.2 p90 -145.47 -162.93 1.61 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.013 -1.055 . . . . 0.0 109.916 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.502 ' O ' ' HB3' ' A' ' 93' ' ' ARG . 0.1 OUTLIER -126.94 129.14 47.57 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.373 -0.83 . . . . 0.0 109.829 -179.265 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.613 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.3 tt0 -65.77 -43.77 60.99 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.264 -0.898 . . . . 0.0 110.264 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.4 Cg_endo -78.35 -52.64 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 121.889 1.726 . . . . 0.0 110.446 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.703 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 9.2 m80 -90.21 34.23 0.87 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.172 -0.955 . . . . 0.0 109.24 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.502 ' HB3' ' O ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -64.52 126.53 28.13 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.237 -0.914 . . . . 0.0 109.532 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 92.31 2.33 68.35 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.538 ' HB3' ' HE3' ' A' ' 97' ' ' MET . . . -98.23 32.97 2.29 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.117 -1.225 . . . . 0.0 109.414 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.39 7.09 37.58 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.538 ' HE3' ' HB3' ' A' ' 95' ' ' ALA . 16.7 mtm -90.75 63.28 5.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.976 -1.308 . . . . 0.0 109.598 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.783 HG22 ' CB ' ' A' ' 88' ' ' TYR . 84.2 t -140.52 76.24 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.387 -0.82 . . . . 0.0 109.41 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.489 ' O ' ' CG ' ' A' ' 100' ' ' LYS . . . -72.27 -167.72 10.22 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.491 ' HG2' ' HA ' ' A' ' 86' ' ' THR . 5.7 mtmt -159.25 131.37 6.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.355 -1.085 . . . . 0.0 109.484 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.865 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 0.4 OUTLIER -82.59 133.37 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.12 -0.987 . . . . 0.0 108.925 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.599 HG23 ' HG3' ' A' ' 84' ' ' GLU . 7.6 m -116.31 91.75 3.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.257 -0.902 . . . . 0.0 109.038 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.521 HG22 HG13 ' A' ' 23' ' ' ILE . 2.1 t -99.42 135.92 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.205 -0.935 . . . . 0.0 109.6 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -82.97 -173.96 5.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.259 -0.901 . . . . 0.0 109.472 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.46 ' HA3' ' HB2' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 m -121.66 131.97 54.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.937 . . . . 0.0 109.494 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.64 ' CD2' HG22 ' A' ' 23' ' ' ILE . 83.4 m-85 -96.93 168.78 10.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.935 . . . . 0.0 109.301 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.6 m -156.99 144.17 18.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 109.761 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.689 HG12 ' H ' ' A' ' 17' ' ' GLU . 2.5 t -128.96 69.57 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.392 -0.817 . . . . 0.0 109.0 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -51.07 106.74 0.14 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.389 -0.819 . . . . 0.0 110.017 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.624 HD11 ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -90.86 150.91 21.36 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.292 -0.88 . . . . 0.0 109.054 179.399 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.452 ' HA3' ' CB ' ' A' ' 34' ' ' ASN . . . 117.6 66.88 0.35 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.511 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -51.22 -23.32 3.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.162 -1.199 . . . . 0.0 109.262 179.646 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.511 ' CB ' ' O ' ' A' ' 9' ' ' SER . 10.5 t0 80.4 29.54 0.23 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.609 -0.682 . . . . 0.0 109.45 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.78 19.12 10.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -0.9 . . . . 0.0 109.209 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.18 11.11 53.47 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.802 ' C ' HD23 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -156.88 143.87 18.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.328 -1.101 . . . . 0.0 109.419 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 1.003 HD12 ' CE1' ' A' ' 39' ' ' HIS . 1.1 mt -101.93 143.44 31.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.181 -0.949 . . . . 0.0 109.315 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 14' ' ' LEU . 1.8 m -154.57 128.78 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.92 . . . . 0.0 109.601 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.639 ' HD2' HG11 ' A' ' 5' ' ' VAL . 38.2 m-85 -48.83 142.01 6.84 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.188 -0.945 . . . . 0.0 109.106 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.689 ' H ' HG12 ' A' ' 5' ' ' VAL . 19.4 mt-10 -136.56 109.71 9.49 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.273 -0.892 . . . . 0.0 109.254 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.474 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 34.9 Cg_endo -77.29 -178.03 22.92 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 123.73 -1.362 . . . . 0.0 110.64 0.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.19 4.29 20.73 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.244 -0.91 . . . . 0.0 109.763 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 5.2 pttt -146.06 160.72 41.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.149 -0.969 . . . . 0.0 109.488 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.678 HD12 HG22 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -157.73 136.62 11.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.187 -0.946 . . . . 0.0 109.48 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.0 m -104.93 99.16 8.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.296 -0.878 . . . . 0.0 109.286 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.792 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -99.48 173.47 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.234 -0.916 . . . . 0.0 109.523 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.582 ' CG ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -95.33 177.54 1.76 Allowed Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.044 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.684 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 34.7 Cg_endo -76.41 72.72 5.39 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.088 1.859 . . . . 0.0 110.342 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 126.18 28.6 1.0 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.18 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.517 ' OD1' ' CB ' ' A' ' 24' ' ' LYS . 4.5 m-20 -88.13 -165.84 1.43 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.205 -1.173 . . . . 0.0 108.852 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.731 HG23 ' HA ' ' A' ' 75' ' ' THR . 21.4 m -136.56 110.56 8.26 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.956 -1.09 . . . . 0.0 109.695 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.993 HG21 HD11 ' A' ' 101' ' ' ILE . 1.7 t -99.36 136.13 31.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.321 -0.862 . . . . 0.0 109.102 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -104.76 142.54 34.52 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.104 -0.997 . . . . 0.0 110.198 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.592 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -139.7 142.63 36.87 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.375 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.732 HD23 ' N ' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -140.94 -169.95 2.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.894 -1.129 . . . . 0.0 110.523 -179.383 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.514 ' OD1' ' HA ' ' A' ' 68' ' ' PRO . 6.4 p-10 -114.9 154.28 28.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.467 -0.771 . . . . 0.0 109.352 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 7' ' ' LEU . 35.3 t30 -100.38 -88.09 0.36 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.024 -1.047 . . . . 0.0 109.637 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.403 ' C ' HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -144.14 33.72 1.22 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.073 -1.017 . . . . 0.0 109.197 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.877 ' HB ' HD11 ' A' ' 14' ' ' LEU . 92.3 t -153.77 64.53 4.88 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.478 -0.763 . . . . 0.0 109.135 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.564 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.5 Cg_endo -79.79 175.85 10.09 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.775 2.317 . . . . 0.0 110.455 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.564 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.8 Cg_endo -86.24 -172.93 8.84 Favored 'Cis proline' 0 C--N 1.31 -1.46 0 C-N-CA 123.655 -1.394 . . . . 0.0 110.65 -1.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 1.003 ' CE1' HD12 ' A' ' 14' ' ' LEU . 63.2 m-70 -137.91 159.23 42.55 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.38 -0.825 . . . . 0.0 109.583 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -138.71 118.33 13.04 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.5 t -99.58 111.45 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.668 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.492 ' HA ' ' CB ' ' A' ' 60' ' ' SER . 13.8 t -135.91 162.64 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.338 -0.851 . . . . 0.0 109.311 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.915 ' CE2' HD23 ' A' ' 59' ' ' LEU . 20.1 m-85 -115.88 120.75 40.23 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.262 -0.899 . . . . 0.0 109.62 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.633 ' OD2' HD23 ' A' ' 47' ' ' LEU . 39.8 t0 -44.08 140.54 2.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.415 -0.803 . . . . 0.0 109.768 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.7 1.06 55.49 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.339 -0.851 . . . . 0.0 109.646 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.58 -26.19 13.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.551 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.633 HD23 ' OD2' ' A' ' 44' ' ' ASP . 4.0 mm? -95.49 61.73 2.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 109.265 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 52' ' ' SER . 2.3 p30 -107.59 150.06 39.67 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.324 -0.86 . . . . 0.0 109.487 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.491 ' HB3' ' HA3' ' A' ' 83' ' ' GLY . 35.8 Cg_endo -77.96 -9.78 16.76 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.616 2.211 . . . . 0.0 110.331 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.452 ' C ' ' HG2' ' A' ' 51' ' ' LYS . . . -134.55 31.59 3.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.27 -0.894 . . . . 0.0 109.452 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.462 ' HA ' ' OD1' ' A' ' 48' ' ' ASN . 27.3 pttt 36.47 39.08 0.09 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.814 -0.554 . . . . 0.0 110.166 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.522 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 6.0 m -108.76 -157.63 0.62 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.568 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -169.07 33.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -0.859 . . . . 0.0 109.508 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.19 -42.26 3.76 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.215 -0.928 . . . . 0.0 109.826 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.672 ' C ' HD12 ' A' ' 55' ' ' LEU . 2.0 pp -47.35 -33.32 5.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 109.449 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.84 -37.41 24.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 109.483 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.77 -31.26 2.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 0.0 109.388 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.4 p -115.02 31.67 6.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.245 -0.909 . . . . 0.0 109.39 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.919 HD21 ' CE2' ' A' ' 76' ' ' PHE . 8.3 tp -131.37 -52.71 1.02 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.926 . . . . 0.0 109.613 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.51 ' OG ' ' CD2' ' A' ' 43' ' ' PHE . 10.2 m -77.37 160.37 28.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 110.29 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.546 ' CE1' ' O ' ' A' ' 63' ' ' GLN . 18.9 p80 -119.99 147.29 44.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.531 -0.731 . . . . 0.0 109.336 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.52 -55.86 3.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -0.945 . . . . 0.0 109.529 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.546 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -46.74 120.84 3.18 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.347 -0.846 . . . . 0.0 109.665 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.659 ' H ' HD12 ' A' ' 64' ' ' LEU . 6.3 mp -66.48 162.06 21.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.091 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.848 HD13 ' HA ' ' A' ' 71' ' ' SER . 0.5 OUTLIER -109.06 152.07 25.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.051 -1.031 . . . . 0.0 109.692 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 3.4 mtp -136.6 7.45 3.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.314 -0.866 . . . . 0.0 109.548 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.52 ' HB3' ' CG ' ' A' ' 70' ' ' GLN . 8.4 t -79.27 134.53 58.84 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.235 -0.916 . . . . 0.0 109.347 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.514 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 35.9 Cg_endo -78.44 90.1 1.29 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.721 2.28 . . . . 0.0 111.612 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.514 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 113.17 34.76 1.74 Allowed Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.63 -1.272 . . . . 0.0 110.678 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.534 ' N ' ' HB2' ' A' ' 32' ' ' LEU . 0.7 OUTLIER 177.01 119.93 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.01 -1.288 . . . . 0.0 109.669 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.848 ' HA ' HD13 ' A' ' 65' ' ' LEU . 60.2 p -109.97 -75.14 0.63 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.284 -0.885 . . . . 0.0 109.325 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.539 ' N ' ' OG ' ' A' ' 71' ' ' SER . 1.6 t -160.75 107.84 1.52 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.186 -0.946 . . . . 0.0 109.633 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.3 t -78.78 85.01 4.81 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.026 -1.046 . . . . 0.0 108.298 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.786 HG21 ' HG ' ' A' ' 59' ' ' LEU . 22.6 m -75.63 108.37 8.42 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.523 -0.736 . . . . 0.0 110.378 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.731 ' HA ' HG23 ' A' ' 28' ' ' THR . 3.2 t -79.13 87.99 4.86 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 1.004 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 30.1 m-85 -36.69 150.75 0.12 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.782 -0.574 . . . . 0.0 110.314 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.508 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 35.2 Cg_endo -76.74 161.36 33.7 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.995 2.463 . . . . 0.0 111.501 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.49 6.57 10.01 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.5 ' O ' ' C ' ' A' ' 80' ' ' ALA . 3.1 p30 -98.87 -4.84 32.11 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.286 -0.884 . . . . 0.0 109.096 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.684 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -33.82 105.27 0.25 Allowed Pre-proline 0 N--CA 1.498 1.961 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 82' ' ' ALA . 35.9 Cg_endo -77.84 41.44 1.0 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.522 2.148 . . . . 0.0 111.407 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.519 ' HA ' ' HB ' ' A' ' 103' ' ' VAL . . . 46.87 -178.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -0.866 . . . . 0.0 110.006 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.491 ' HA3' ' HB3' ' A' ' 49' ' ' PRO . . . 94.21 -168.14 28.22 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -111.92 153.83 26.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.522 -0.987 . . . . 0.0 109.635 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.448 ' O ' ' HB ' ' A' ' 86' ' ' THR . 19.8 m-30 -113.63 -39.32 4.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.392 -0.817 . . . . 0.0 108.92 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.448 ' HB ' ' O ' ' A' ' 85' ' ' TYR . 92.4 m 61.79 100.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.313 -0.867 . . . . 0.0 110.333 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -105.05 173.17 6.42 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.203 -0.936 . . . . 0.0 108.905 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 97' ' ' MET . 16.7 p90 -155.39 -164.07 1.68 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.893 -1.13 . . . . 0.0 110.046 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.516 ' HB2' ' HB3' ' A' ' 97' ' ' MET . 0.6 OUTLIER -136.75 144.75 43.96 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.424 -0.798 . . . . 0.0 109.447 -179.692 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.604 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 40.6 tt0 -83.12 -45.07 0.86 Allowed Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.264 -0.898 . . . . 0.0 110.433 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.0 Cg_endo -78.31 -46.93 0.11 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.048 1.832 . . . . 0.0 110.902 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.74 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 68.7 m80 -87.79 18.07 4.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.014 -1.054 . . . . 0.0 109.643 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -53.25 135.94 37.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.127 -0.983 . . . . 0.0 109.421 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.05 -8.25 80.29 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.12 38.66 1.37 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.16 -1.2 . . . . 0.0 109.603 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.98 12.5 29.78 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.516 ' HB3' ' HB2' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -81.92 56.8 3.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.179 -1.189 . . . . 0.0 109.699 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 88' ' ' TYR . 21.6 t -139.6 72.15 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.104 -0.998 . . . . 0.0 109.947 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.438 ' C ' ' CG ' ' A' ' 100' ' ' LYS . . . -80.95 -173.23 47.18 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.438 ' CG ' ' C ' ' A' ' 99' ' ' GLY . 0.1 OUTLIER -152.15 136.23 16.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.933 -1.334 . . . . 0.0 110.148 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 1.004 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -86.58 119.54 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.172 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.74 103.42 15.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.217 -0.927 . . . . 0.0 109.099 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.724 HG22 ' CD1' ' A' ' 23' ' ' ILE . 17.3 t -99.19 68.45 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.487 -0.758 . . . . 0.0 109.444 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.406 ' O ' ' O ' ' A' ' 105' ' ' GLY . . . 53.09 -171.44 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.316 -0.865 . . . . 0.0 109.275 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 104' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.6 m -117.66 103.88 10.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.298 -0.876 . . . . 0.0 109.51 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.518 ' CD2' HG22 ' A' ' 23' ' ' ILE . 23.5 m-85 -84.35 108.88 17.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.731 ' CG2' HD21 ' A' ' 32' ' ' LEU . 52.9 m -109.58 150.06 28.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.564 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.722 HG12 ' H ' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -113.43 160.84 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -0.924 . . . . 0.0 109.227 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -125.75 101.1 6.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.929 . . . . 0.0 109.505 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.611 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -89.19 170.98 10.14 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.168 -0.958 . . . . 0.0 109.252 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.85 ' CA ' HD23 ' A' ' 14' ' ' LEU . . . 86.52 77.39 1.23 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 13' ' ' LEU . 99.7 p -44.29 -65.65 0.49 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -1.151 . . . . 0.0 109.218 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 9' ' ' SER . 0.4 OUTLIER 168.47 -25.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.07 179.631 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -113.77 49.54 0.98 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.059 -1.025 . . . . 0.0 110.078 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.22 -37.85 3.24 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' A' ' 9' ' ' SER . 2.9 mp -69.61 118.85 13.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.124 -1.221 . . . . 0.0 109.578 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.85 HD23 ' CA ' ' A' ' 8' ' ' GLY . 0.5 OUTLIER -116.19 110.81 19.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.349 -0.844 . . . . 0.0 109.488 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.68 133.34 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.345 -0.847 . . . . 0.0 109.516 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -49.31 153.73 0.98 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.045 -1.034 . . . . 0.0 109.097 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.722 ' H ' HG12 ' A' ' 5' ' ' VAL . 5.7 mt-10 -143.0 109.06 5.44 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.156 -0.965 . . . . 0.0 109.445 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 35.0 Cg_endo -77.21 179.56 30.84 Favored 'Cis proline' 0 C--N 1.312 -1.368 0 C-N-CA 123.82 -1.325 . . . . 0.0 110.491 0.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.68 -44.08 71.18 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.214 -0.929 . . . . 0.0 108.877 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.29 139.6 40.54 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.613 ' CD1' HG22 ' A' ' 5' ' ' VAL . 1.7 mt -126.79 126.66 43.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 110.088 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 102' ' ' THR . 18.8 m -89.26 97.83 11.42 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.86 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -99.3 172.49 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.149 -0.969 . . . . 0.0 109.865 -179.387 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.503 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 0.3 OUTLIER -86.31 175.55 4.34 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.419 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.612 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 35.8 Cg_endo -78.0 72.84 5.99 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.377 2.052 . . . . 0.0 110.962 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 129.08 -9.75 6.28 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.22 -1.467 . . . . 0.0 110.603 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.487 ' OD1' ' HB2' ' A' ' 24' ' ' LYS . 1.2 m-20 -50.54 -178.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.093 -1.239 . . . . 0.0 109.085 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.579 HG23 ' HA ' ' A' ' 75' ' ' THR . 23.8 m -117.4 118.37 32.03 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.036 -1.04 . . . . 0.0 109.676 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.955 HG21 HD11 ' A' ' 101' ' ' ILE . 1.7 t -99.81 111.53 29.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.371 -0.83 . . . . 0.0 109.475 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.645 ' O ' HG23 ' A' ' 4' ' ' THR . 5.1 mt-10 -99.43 123.17 43.47 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.254 -0.904 . . . . 0.0 109.112 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -106.29 153.19 22.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.348 -0.845 . . . . 0.0 109.109 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.731 HD21 ' CG2' ' A' ' 4' ' ' THR . 0.0 OUTLIER -140.54 177.81 7.75 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.09 -1.007 . . . . 0.0 110.033 -179.494 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.645 ' HB3' HD23 ' A' ' 65' ' ' LEU . 3.2 p-10 -109.45 169.64 8.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.355 -0.841 . . . . 0.0 109.268 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.539 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . 28.3 t30 -112.88 -73.68 0.66 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.01 -1.056 . . . . 0.0 109.378 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.8 ttpt -162.91 28.39 0.1 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.064 -1.023 . . . . 0.0 109.266 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.59 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 11.1 t -148.05 58.61 3.96 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.59 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 36.2 Cg_endo -77.94 174.78 12.02 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.69 2.26 . . . . 0.0 110.664 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.557 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.6 Cg_endo -86.95 158.44 50.15 Favored 'Cis proline' 0 C--N 1.309 -1.547 0 C-N-CA 123.402 -1.499 . . . . 0.0 110.713 -1.825 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.881 ' HB2' HD22 ' A' ' 65' ' ' LEU . 70.4 m-70 -113.77 125.41 54.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.483 -0.761 . . . . 0.0 108.961 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.453 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 1.8 m120 -99.85 123.96 44.65 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.292 -0.88 . . . . 0.0 109.294 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.6 t -107.8 109.49 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.243 -0.91 . . . . 0.0 109.911 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.617 HG13 ' CB ' ' A' ' 60' ' ' SER . 1.4 t -134.74 167.11 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.383 -0.823 . . . . 0.0 108.852 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.718 ' CZ ' HD12 ' A' ' 59' ' ' LEU . 7.8 m-85 -118.9 106.52 12.57 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.136 -0.977 . . . . 0.0 109.831 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -49.91 118.66 3.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.443 -0.786 . . . . 0.0 109.861 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.41 2.14 29.9 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.433 -0.792 . . . . 0.0 109.638 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -102.09 -15.03 16.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.139 -0.976 . . . . 0.0 109.753 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.0 mt -113.88 61.08 0.66 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.142 -0.974 . . . . 0.0 109.523 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.496 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 5.7 p30 -134.1 163.14 53.29 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.255 -0.903 . . . . 0.0 109.449 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.574 ' HG3' ' CA ' ' A' ' 83' ' ' GLY . 33.7 Cg_endo -77.31 -16.81 15.19 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.596 2.197 . . . . 0.0 109.423 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 52' ' ' SER . . . -135.0 77.08 1.66 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.47 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -35.88 95.43 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.351 0.596 . . . . 0.0 110.413 -179.459 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 50' ' ' ALA . 10.4 m -140.42 -174.49 3.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.423 -0.798 . . . . 0.0 109.271 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -159.86 23.94 0.18 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.934 . . . . 0.0 109.413 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -89.08 -66.03 0.96 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.279 -0.888 . . . . 0.0 109.794 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.517 ' HG ' ' N ' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -64.89 -25.31 67.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -0.929 . . . . 0.0 109.636 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.517 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -65.02 -58.18 6.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.115 -0.991 . . . . 0.0 109.343 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.45 -31.59 1.79 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.268 -0.895 . . . . 0.0 109.521 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.61 13.03 36.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.926 . . . . 0.0 109.973 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.836 ' HA ' HG21 ' A' ' 74' ' ' THR . 0.0 OUTLIER -108.0 -42.45 4.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.997 -1.064 . . . . 0.0 108.47 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.617 ' CB ' HG13 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -78.11 174.57 11.01 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.457 -0.777 . . . . 0.0 110.347 -179.418 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.795 ' HB3' HG21 ' A' ' 72' ' ' THR . 26.4 p80 -125.19 174.2 8.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.64 -0.662 . . . . 0.0 109.338 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -125.19 -12.91 6.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.156 -0.965 . . . . 0.0 109.71 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -92.59 105.66 17.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.965 . . . . 0.0 109.653 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.614 ' H ' HD12 ' A' ' 64' ' ' LEU . 4.4 mp -49.26 165.01 0.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -0.896 . . . . 0.0 109.291 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.897 HD21 ' HB2' ' A' ' 71' ' ' SER . 5.9 mp -81.49 137.4 35.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.124 -0.985 . . . . 0.0 109.546 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.93 -2.56 5.22 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.368 -0.832 . . . . 0.0 109.538 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.3 t -116.0 144.93 33.74 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.141 -0.975 . . . . 0.0 109.247 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.58 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.6 Cg_endo -80.91 83.46 2.21 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.645 2.23 . . . . 0.0 111.608 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.542 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 124.94 45.41 0.26 Allowed Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.121 -1.514 . . . . 0.0 111.437 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.484 ' HB3' ' O ' ' A' ' 69' ' ' GLY . 4.1 pt20 170.15 117.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.014 -1.286 . . . . 0.0 109.974 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.897 ' HB2' HD21 ' A' ' 65' ' ' LEU . 2.8 p -115.51 -146.82 0.41 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.226 -0.922 . . . . 0.0 109.09 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.795 HG21 ' HB3' ' A' ' 61' ' ' HIS . 96.4 m -95.15 100.67 12.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.098 -1.001 . . . . 0.0 109.951 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' A' ' 30' ' ' GLU . 42.4 p -79.99 111.71 16.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.229 -0.919 . . . . 0.0 108.884 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.836 HG21 ' HA ' ' A' ' 59' ' ' LEU . 1.9 m -98.63 129.09 45.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 109.86 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.579 ' HA ' HG23 ' A' ' 28' ' ' THR . 0.1 OUTLIER -82.65 96.81 8.24 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.139 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.727 ' CD2' HD21 ' A' ' 59' ' ' LEU . 26.1 m-85 -45.58 153.12 0.62 Allowed Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 121.066 -1.021 . . . . 0.0 108.862 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.509 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.3 Cg_endo -77.11 165.38 28.17 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.5 2.133 . . . . 0.0 111.421 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.93 8.0 6.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.46 -0.775 . . . . 0.0 109.535 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 81' ' ' PRO . 2.4 m-20 -99.08 -12.5 20.47 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.045 -1.034 . . . . 0.0 109.006 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.612 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -32.85 93.58 0.06 OUTLIER Pre-proline 0 N--CA 1.5 2.041 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.534 ' N ' ' O ' ' A' ' 79' ' ' ASP . 36.3 Cg_endo -78.73 163.83 26.1 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.586 2.191 . . . . 0.0 110.786 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -64.77 113.19 3.62 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.406 -0.809 . . . . 0.0 109.302 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.574 ' CA ' ' HG3' ' A' ' 49' ' ' PRO . . . -174.54 155.83 21.89 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 84' ' ' GLU . 0.7 OUTLIER -90.47 104.69 17.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -1.098 . . . . 0.0 109.706 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.461 ' CD2' HG22 ' A' ' 101' ' ' ILE . 7.7 m-30 -81.08 167.25 19.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.204 -0.935 . . . . 0.0 108.863 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.506 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 95.4 m -151.81 115.52 4.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.935 -1.103 . . . . 0.0 110.573 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.627 ' O ' HG23 ' A' ' 98' ' ' VAL . 2.0 p90 -117.4 168.63 10.18 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 98' ' ' VAL . 30.4 p90 -160.47 -162.41 0.96 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.79 -1.194 . . . . 0.0 110.645 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 1.3 m -119.07 136.41 54.16 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.69 -0.631 . . . . 0.0 109.723 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.629 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -73.17 -45.09 8.08 Favored Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.287 -0.883 . . . . 0.0 109.762 178.832 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.4 Cg_endo -78.35 -60.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.063 0 C-N-CA 121.983 1.789 . . . . 0.0 110.524 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.639 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 10.8 m80 -72.48 57.23 0.39 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.017 -1.052 . . . . 0.0 109.179 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.54 18.59 9.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.368 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.85 -34.0 2.7 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 96' ' ' GLY . . . -91.81 34.35 1.0 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.143 -1.21 . . . . 0.0 109.642 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 95' ' ' ALA . . . 41.61 61.72 2.11 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.564 ' CE ' ' HB3' ' A' ' 92' ' ' HIS . 9.3 mtt -91.64 63.97 4.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.163 -1.198 . . . . 0.0 109.35 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 87' ' ' PHE . 4.9 p -127.63 96.48 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.2 -0.937 . . . . 0.0 109.775 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.495 ' O ' ' HG3' ' A' ' 100' ' ' LYS . . . -76.47 -164.42 18.51 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.506 ' HG2' ' HA ' ' A' ' 86' ' ' THR . 26.5 mtmt -163.44 120.53 1.82 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -1.149 . . . . 0.0 109.649 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.955 HD11 HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -82.58 138.88 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.154 -0.966 . . . . 0.0 108.898 179.654 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 22' ' ' THR . 8.3 m -118.04 93.93 4.32 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.613 HG22 HG13 ' A' ' 23' ' ' ILE . 1.8 t -99.2 118.6 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.23 -0.918 . . . . 0.0 109.596 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -93.2 146.38 23.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 109.634 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 CA-C-O 118.032 -1.427 . . . . 0.0 109.653 179.89 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.8 m -119.88 134.14 55.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.25 -0.907 . . . . 0.0 109.427 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.593 ' HB2' HG13 ' A' ' 29' ' ' VAL . 40.0 m-85 -123.52 98.46 5.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.174 -0.954 . . . . 0.0 109.349 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.727 HG23 HD11 ' A' ' 32' ' ' LEU . 18.8 m -87.54 83.87 7.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.749 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 5' ' ' VAL . 24.7 m -82.55 107.15 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.152 -0.967 . . . . 0.0 109.454 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.495 ' HE3' ' HA2' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -92.25 100.86 13.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 109.333 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.535 ' CD2' ' O ' ' A' ' 32' ' ' LEU . 0.9 OUTLIER -59.68 172.48 0.7 Allowed 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.148 -0.97 . . . . 0.0 109.295 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.484 ' HA3' ' HB3' ' A' ' 34' ' ' ASN . . . 69.35 70.36 1.18 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.467 ' OG ' ' N ' ' A' ' 10' ' ' ASP . 86.4 p -47.67 -91.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.316 -1.108 . . . . 0.0 109.531 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.467 ' N ' ' OG ' ' A' ' 9' ' ' SER . 2.2 t0 177.36 -34.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.427 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.61 38.73 3.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.0 109.38 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.407 ' O ' HD22 ' A' ' 13' ' ' LEU . . . -154.07 -106.35 0.28 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.476 HD22 ' HA ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -149.6 -148.3 0.26 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -1.115 . . . . 0.0 109.359 -179.685 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.689 HD13 ' HE1' ' A' ' 39' ' ' HIS . 20.8 mt -98.75 109.0 21.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.945 -1.097 . . . . 0.0 109.366 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 7' ' ' LEU . 21.4 m -148.51 165.73 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.906 . . . . 0.0 109.487 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -85.79 135.18 33.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 109.407 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -125.64 108.34 26.04 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.188 -0.945 . . . . 0.0 109.542 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -78.44 175.81 45.4 Favored 'Cis proline' 0 C--N 1.312 -1.358 0 C-N-CA 123.793 -1.336 . . . . 0.0 110.465 0.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.64 -39.53 31.28 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.225 -0.922 . . . . 0.0 109.474 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.78 138.15 45.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.309 -0.87 . . . . 0.0 109.294 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.465 HD11 HG11 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -135.51 110.34 8.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 109.588 -179.872 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.489 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 97.5 m -84.14 99.23 10.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.167 -0.958 . . . . 0.0 109.291 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.862 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.5 pt -99.64 -178.37 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.288 -0.882 . . . . 0.0 109.698 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.586 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -94.91 -179.16 0.9 Allowed Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.448 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.824 ' C ' ' HB3' ' A' ' 80' ' ' ALA . 34.5 Cg_endo -77.88 66.69 8.15 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.093 1.862 . . . . 0.0 110.386 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.709 ' N ' ' HB3' ' A' ' 80' ' ' ALA . . . 121.08 73.96 0.35 Allowed Glycine 0 N--CA 1.487 2.08 0 C-N-CA 119.52 -1.324 . . . . 0.0 109.922 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.48 ' OD2' ' HG2' ' A' ' 24' ' ' LYS . 7.7 m-20 -125.77 -142.66 0.29 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.32 -1.106 . . . . 0.0 108.581 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.588 HG23 ' HA ' ' A' ' 75' ' ' THR . 44.3 m -148.04 99.49 3.07 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.944 -1.098 . . . . 0.0 109.563 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.944 ' CG2' HD11 ' A' ' 101' ' ' ILE . 2.9 t -99.87 119.45 47.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.466 -0.771 . . . . 0.0 109.044 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.482 ' C ' ' CD1' ' A' ' 31' ' ' PHE . 56.1 tt0 -99.61 156.33 17.12 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.171 -0.956 . . . . 0.0 109.81 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.483 ' CD2' ' O ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -148.34 149.13 31.26 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.727 HD11 HG23 ' A' ' 4' ' ' THR . 3.1 mp -141.97 -170.98 3.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.127 -0.983 . . . . 0.0 109.807 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.915 ' HB3' HD23 ' A' ' 65' ' ' LEU . 8.0 p-10 -113.66 159.92 19.15 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.315 -0.865 . . . . 0.0 109.441 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.495 ' HB2' ' O ' ' A' ' 7' ' ' LEU . 17.5 t30 -94.97 -94.49 0.18 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.015 -1.053 . . . . 0.0 109.301 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.54 37.29 1.34 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.173 -0.954 . . . . 0.0 109.304 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.683 ' HB ' HD21 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -150.81 62.8 5.44 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.446 -0.784 . . . . 0.0 109.004 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.539 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 35.0 Cg_endo -77.54 174.68 12.29 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.693 2.262 . . . . 0.0 110.26 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.602 ' O ' ' CG ' ' A' ' 39' ' ' HIS . 37.9 Cg_endo -83.83 -163.12 2.98 Favored 'Cis proline' 0 C--N 1.308 -1.566 0 C-N-CA 123.558 -1.434 . . . . 0.0 110.571 -0.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.689 ' HE1' HD13 ' A' ' 14' ' ' LEU . 89.4 m-70 -161.77 124.59 3.03 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.413 -0.804 . . . . 0.0 109.758 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -100.97 111.93 24.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.211 -0.931 . . . . 0.0 109.213 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 52.4 t -102.06 128.4 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 0.0 109.719 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.768 HG12 ' CB ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -159.85 167.12 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.29 -0.882 . . . . 0.0 109.496 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.508 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 3.2 m-85 -109.41 133.6 52.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.261 -0.899 . . . . 0.0 109.294 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -57.26 136.05 56.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.073 -1.017 . . . . 0.0 108.952 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.33 21.77 1.66 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.233 -0.917 . . . . 0.0 110.102 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.31 5.93 2.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.983 -1.073 . . . . 0.0 109.635 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.8 mp -113.49 41.44 2.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 0.0 109.556 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.476 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -114.03 165.34 13.83 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.346 -0.846 . . . . 0.0 109.232 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 35.5 Cg_endo -77.75 -32.08 2.9 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.615 2.21 . . . . 0.0 111.442 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -125.79 24.79 7.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.876 -1.14 . . . . 0.0 110.268 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.469 ' HA ' ' CG ' ' A' ' 48' ' ' ASN . 9.9 mtmm 36.48 91.13 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.865 -0.522 . . . . 0.0 110.182 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.463 ' HB3' ' OD1' ' A' ' 54' ' ' ASP . 73.7 m -139.92 136.49 33.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.071 -1.018 . . . . 0.0 109.681 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.24 -47.92 32.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.46 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 55' ' ' LEU . 6.8 p30 -46.45 -31.84 2.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.699 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 39.1 tp -87.68 55.2 3.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 109.36 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 55' ' ' LEU . . . 163.88 -50.27 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.347 -0.845 . . . . 0.0 109.235 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -54.91 -37.95 66.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 109.437 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.6 t -104.38 -20.07 13.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.897 . . . . 0.0 109.526 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.912 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 16.1 tp -65.04 -49.4 70.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 109.469 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.768 ' CB ' HG12 ' A' ' 42' ' ' VAL . 55.4 p -82.76 178.38 8.21 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.749 0.785 . . . . 0.0 110.936 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.461 ' CE1' ' O ' ' A' ' 63' ' ' GLN . 19.1 p80 -108.99 -154.23 0.53 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.446 ' N ' ' ND1' ' A' ' 61' ' ' HIS . 19.3 mmtt -148.05 -62.14 0.26 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.291 -0.881 . . . . 0.0 109.439 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.461 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 3.4 pm0 -46.1 148.18 0.91 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.647 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 mp -73.97 165.57 24.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 109.498 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.915 HD23 ' HB3' ' A' ' 33' ' ' ASN . 2.1 mp -82.47 126.17 31.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.368 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.01 -23.81 4.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.196 -0.94 . . . . 0.0 109.79 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.3 t -90.85 142.1 27.32 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.148 -0.97 . . . . 0.0 109.426 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.445 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 35.4 Cg_endo -78.18 101.63 1.49 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.477 2.118 . . . . 0.0 110.423 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.723 ' O ' HD23 ' A' ' 32' ' ' LEU . . . 98.93 47.41 1.91 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.411 ' N ' ' HB3' ' A' ' 32' ' ' LEU . 2.5 tt0 -170.83 94.01 0.19 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.428 -1.042 . . . . 0.0 109.232 -179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.858 ' CB ' HD21 ' A' ' 65' ' ' LEU . 10.6 p -103.2 -79.91 0.53 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.016 -1.053 . . . . 0.0 109.336 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.591 ' H ' ' HG ' ' A' ' 71' ' ' SER . 13.5 m -160.95 110.11 1.64 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.106 -0.996 . . . . 0.0 108.761 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.4 t -79.24 78.74 5.71 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.158 -0.964 . . . . 0.0 108.757 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.806 HG21 ' HG ' ' A' ' 59' ' ' LEU . 84.9 m -62.4 96.77 0.08 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.45 -0.781 . . . . 0.0 109.847 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.588 ' HA ' HG23 ' A' ' 28' ' ' THR . 1.7 t -79.23 74.3 5.82 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.912 ' CZ ' HD21 ' A' ' 59' ' ' LEU . 28.4 m-85 -33.88 146.05 0.14 Allowed Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.537 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 34.5 Cg_endo -76.22 -179.63 5.44 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.841 2.361 . . . . 0.0 111.482 -178.438 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.05 11.6 9.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.456 -0.777 . . . . 0.0 109.062 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' A' ' 80' ' ' ALA . 18.8 m-20 -98.88 -71.21 0.7 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.824 ' HB3' ' C ' ' A' ' 25' ' ' PRO . . . 31.51 98.05 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 122.023 -0.423 . . . . 0.0 111.06 178.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.34 157.57 37.11 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.424 2.083 . . . . 0.0 110.708 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.32 139.87 52.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 0.0 109.482 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 157.55 171.87 24.06 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -88.73 129.95 35.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.344 -1.092 . . . . 0.0 109.661 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.464 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 9.3 m-85 -110.95 137.69 48.27 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.489 HG23 ' HG2' ' A' ' 100' ' ' LYS . 81.1 m -137.07 116.7 12.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.978 -1.076 . . . . 0.0 110.619 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.567 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -111.13 164.43 12.86 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.791 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.49 ' HB2' HG22 ' A' ' 98' ' ' VAL . 6.6 p90 -157.1 -156.42 0.6 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.777 -1.202 . . . . 0.0 110.565 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 93' ' ' ARG . 0.5 OUTLIER -132.43 155.88 47.7 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.639 -0.663 . . . . 0.0 109.281 -179.539 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.597 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 12.3 tp10 -88.67 -44.6 0.45 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.088 -1.008 . . . . 0.0 110.715 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.8 Cg_endo -80.27 -55.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 122.157 1.905 . . . . 0.0 111.041 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.573 ' CD2' HD13 ' A' ' 14' ' ' LEU . 5.2 m80 -88.34 32.97 0.75 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.104 -0.998 . . . . 0.0 109.518 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.478 ' HB3' ' O ' ' A' ' 89' ' ' CYS . 12.8 ptt180 -63.09 -23.22 67.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.139 -0.976 . . . . 0.0 109.611 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.15 7.85 62.54 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 92' ' ' HIS . . . -107.26 35.49 3.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -1.148 . . . . 0.0 109.668 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.8 35.99 84.78 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' A' ' 14' ' ' LEU . 1.9 mtp -95.69 67.28 2.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.084 -1.245 . . . . 0.0 109.091 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.49 HG22 ' HB2' ' A' ' 88' ' ' TYR . 59.7 t -140.32 107.95 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 109.96 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.561 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -106.64 154.94 16.67 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.489 ' HG2' HG23 ' A' ' 86' ' ' THR . 46.3 mtmt -130.74 135.53 47.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.071 -1.253 . . . . 0.0 110.08 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.944 HD11 ' CG2' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -101.74 123.5 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.189 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.489 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 1.0 OUTLIER -98.91 108.47 21.16 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.103 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.506 HG22 ' CD1' ' A' ' 23' ' ' ILE . 20.7 t -99.15 94.51 3.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.35 -0.844 . . . . 0.0 109.491 -178.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -175.8 -157.19 0.05 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.368 -0.833 . . . . 0.0 109.345 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 CA-C-O 117.989 -1.451 . . . . 0.0 109.596 179.857 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.273 0.559 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.8 m -137.12 149.4 47.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 0.0 109.568 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.76 ' CB ' HD21 ' A' ' 21' ' ' LEU . 16.8 m-85 -133.95 148.48 51.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.21 -0.931 . . . . 0.0 109.291 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 4' ' ' THR . 1.7 t -137.92 103.67 5.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 109.801 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.706 HG12 ' HD2' ' A' ' 18' ' ' PRO . 21.8 m -87.37 67.26 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.239 -0.913 . . . . 0.0 109.292 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.59 ' HB3' HD21 ' A' ' 32' ' ' LEU . 1.3 ptmm? -51.35 108.97 0.29 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.89 . . . . 0.0 109.725 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.678 HD13 ' ND1' ' A' ' 39' ' ' HIS . 0.2 OUTLIER -68.02 175.69 3.01 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.233 -0.917 . . . . 0.0 109.322 179.688 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 14' ' ' LEU . . . 67.21 110.45 0.02 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.2 p -68.14 -104.0 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.262 -1.14 . . . . 0.0 109.178 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -171.77 26.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.885 -1.135 . . . . 0.0 109.848 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -132.22 -9.44 3.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.098 -1.001 . . . . 0.0 110.283 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 129.19 3.53 5.25 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.121 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 mt -111.43 142.0 44.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.067 -1.255 . . . . 0.0 109.565 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.636 HD11 ' CG1' ' A' ' 36' ' ' VAL . 65.7 mt -103.19 102.43 12.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.305 -0.872 . . . . 0.0 109.705 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.8 m -142.94 138.41 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 109.249 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.461 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 10.9 m-85 -56.46 148.9 18.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.156 -0.965 . . . . 0.0 109.538 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 16' ' ' PHE . 3.9 mm-40 -143.18 108.52 5.33 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.352 -0.842 . . . . 0.0 109.304 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.706 ' HD2' HG12 ' A' ' 5' ' ' VAL . 35.9 Cg_endo -78.17 174.53 51.35 Favored 'Cis proline' 0 C--N 1.312 -1.377 0 C-N-CA 123.779 -1.342 . . . . 0.0 110.638 0.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.59 -54.9 7.85 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.184 -0.948 . . . . 0.0 109.17 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -100.58 138.34 37.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -0.878 . . . . 0.0 109.073 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.76 HD21 ' CB ' ' A' ' 3' ' ' TYR . 15.8 tp -126.14 113.18 16.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.165 -0.959 . . . . 0.0 110.26 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.7 m -82.42 94.93 7.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.208 -0.933 . . . . 0.0 108.526 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.793 ' CD1' HD13 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -99.14 172.42 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.241 -0.912 . . . . 0.0 110.276 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.554 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 2.8 mmtt -91.99 168.71 12.43 Favored Pre-proline 0 C--N 1.303 -1.428 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.951 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 33.7 Cg_endo -77.18 81.86 2.51 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.052 1.834 . . . . 0.0 110.576 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 129.47 -1.67 6.07 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -74.41 177.91 5.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.113 -1.228 . . . . 0.0 109.574 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.459 HG22 ' N ' ' A' ' 29' ' ' VAL . 36.9 m -111.63 157.16 20.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.299 -0.876 . . . . 0.0 109.419 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.091 HG21 HD11 ' A' ' 101' ' ' ILE . 4.6 t -130.52 150.67 34.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.281 -0.887 . . . . 0.0 109.014 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -126.91 104.67 8.15 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.08 -1.012 . . . . 0.0 110.254 -179.467 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.553 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -107.9 91.45 3.65 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.24 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.713 HD12 ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -95.87 161.9 13.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.288 -0.882 . . . . 0.0 110.728 -178.176 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.561 ' HA ' HD11 ' A' ' 7' ' ' LEU . 2.0 p-10 -80.36 160.29 25.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.626 -0.671 . . . . 0.0 109.404 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 7' ' ' LEU . 59.5 t30 -103.41 -76.21 0.59 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.949 -1.094 . . . . 0.0 109.211 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.443 ' C ' HG23 ' A' ' 36' ' ' VAL . 1.5 pttt -157.61 34.33 0.27 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.907 . . . . 0.0 108.897 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.636 ' CG1' HD11 ' A' ' 14' ' ' LEU . 14.9 t -154.17 65.05 4.91 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.582 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 35.3 Cg_endo -78.57 176.04 10.35 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 123.091 2.527 . . . . 0.0 110.934 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.582 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 39.2 Cg_endo -87.62 157.65 45.61 Favored 'Cis proline' 0 C--N 1.311 -1.428 0 O-C-N 123.818 1.43 . . . . 0.0 110.868 -1.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.713 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 73.7 m-70 -118.41 118.72 32.52 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.578 -0.701 . . . . 0.0 109.783 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.481 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 17.7 t-20 -100.32 126.0 46.61 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.884 . . . . 0.0 108.762 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.504 ' HB ' ' NE2' ' A' ' 61' ' ' HIS . 71.0 t -104.92 131.15 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.083 -1.011 . . . . 0.0 109.992 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.653 HG12 ' HB3' ' A' ' 60' ' ' SER . 0.0 OUTLIER -152.62 172.86 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.716 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.79 ' CD2' HD23 ' A' ' 59' ' ' LEU . 3.6 m-85 -124.53 109.77 13.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.017 -1.052 . . . . 0.0 109.903 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.504 ' HB3' HD12 ' A' ' 47' ' ' LEU . 37.0 t0 -47.11 131.01 12.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.42 -0.8 . . . . 0.0 109.404 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.4 18.23 5.44 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.269 -0.894 . . . . 0.0 109.967 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -120.86 9.56 10.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.026 -1.046 . . . . 0.0 109.652 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.504 HD12 ' HB3' ' A' ' 44' ' ' ASP . 3.2 mt -131.06 60.38 1.66 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.176 -0.953 . . . . 0.0 109.464 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.519 ' ND2' ' HA ' ' A' ' 51' ' ' LYS . 0.7 OUTLIER -121.58 163.66 29.37 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.932 . . . . 0.0 109.514 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 35.1 Cg_endo -77.51 -46.21 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.627 2.218 . . . . 0.0 110.821 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.469 ' C ' ' HG2' ' A' ' 51' ' ' LYS . . . -115.76 37.34 3.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -0.981 . . . . 0.0 109.995 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.519 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.9 OUTLIER 36.21 47.22 0.45 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.664 -0.647 . . . . 0.0 110.545 179.545 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.571 ' O ' HD23 ' A' ' 55' ' ' LEU . 26.8 m -99.79 89.84 4.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.138 -0.976 . . . . 0.0 109.373 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.76 -19.61 58.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.486 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.08 -25.54 45.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.483 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 52' ' ' SER . 1.8 pp -75.88 -25.35 56.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.692 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 58' ' ' SER . . . -74.1 -53.99 8.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.896 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 56' ' ' ALA . 1.4 mmtt -43.57 -26.2 0.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 109.735 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 56' ' ' ALA . 2.8 m -110.97 22.18 15.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.103 -0.998 . . . . 0.0 109.859 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.79 HD23 ' CD2' ' A' ' 43' ' ' PHE . 8.2 tp -128.24 -36.91 1.89 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.074 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.653 ' HB3' HG12 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -77.55 141.91 39.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.396 -0.815 . . . . 0.0 109.601 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.558 ' CE1' ' O ' ' A' ' 63' ' ' GLN . 21.1 p80 -99.91 -23.02 15.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.444 -0.785 . . . . 0.0 109.862 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 70.62 -65.67 0.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.144 -0.973 . . . . 0.0 109.236 -179.714 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.558 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 0.8 OUTLIER -45.42 127.2 7.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.453 179.732 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.469 ' H ' HD12 ' A' ' 64' ' ' LEU . 5.0 mp -68.01 170.45 8.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.222 -0.924 . . . . 0.0 109.727 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.766 HD22 ' HA ' ' A' ' 71' ' ' SER . 6.2 mt -115.74 100.55 8.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.363 -0.836 . . . . 0.0 109.032 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 62.5 mtt -96.99 2.82 51.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.277 -0.889 . . . . 0.0 109.828 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 t -79.88 139.74 53.95 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.112 -0.992 . . . . 0.0 109.24 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.63 88.78 1.41 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.613 2.209 . . . . 0.0 110.918 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.713 ' HA2' HD12 ' A' ' 32' ' ' LEU . . . 88.25 49.01 3.86 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -172.74 92.36 0.11 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.333 -1.098 . . . . 0.0 109.108 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.766 ' HA ' HD22 ' A' ' 65' ' ' LEU . 80.0 p -99.07 -140.37 0.32 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 72' ' ' THR . 10.2 t -123.21 127.69 48.98 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.979 -1.076 . . . . 0.0 108.337 178.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.439 ' O ' ' OG ' ' A' ' 73' ' ' SER . 17.9 p -79.18 96.88 6.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.137 -0.977 . . . . 0.0 109.639 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.618 HG21 ' O ' ' A' ' 59' ' ' LEU . 1.2 m -70.3 113.63 7.64 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.402 -0.811 . . . . 0.0 109.259 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 76' ' ' PHE . 54.5 m -79.25 88.71 4.91 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.361 -0.837 . . . . 0.0 109.113 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 1.116 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 10.4 m-85 -43.13 160.43 0.21 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.376 -0.828 . . . . 0.0 108.903 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.501 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 32.6 Cg_endo -76.22 150.7 33.39 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.443 2.095 . . . . 0.0 111.483 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.463 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . . . -69.47 -11.28 60.7 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.457 ' O ' ' C ' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -100.65 15.9 26.63 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.332 -0.855 . . . . 0.0 109.141 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.951 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -39.65 109.86 0.59 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.605 -0.684 . . . . 0.0 109.313 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.448 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 33.7 Cg_endo -75.02 121.35 6.52 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.354 2.036 . . . . 0.0 110.514 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -43.64 136.93 3.17 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.479 -0.763 . . . . 0.0 109.382 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 164.64 -167.38 38.42 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -120.68 115.62 23.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.407 -1.055 . . . . 0.0 109.484 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.448 ' OH ' ' HD2' ' A' ' 81' ' ' PRO . 23.2 m-85 -93.88 165.27 12.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.369 -0.832 . . . . 0.0 109.07 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.776 HG22 ' CG2' ' A' ' 98' ' ' VAL . 0.2 OUTLIER -144.46 97.81 3.1 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.057 -1.027 . . . . 0.0 110.205 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.571 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.5 OUTLIER -101.96 157.77 16.62 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.356 -0.84 . . . . 0.0 108.842 178.988 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.531 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 4.5 p90 -160.24 -148.4 0.17 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.157 -0.964 . . . . 0.0 109.653 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.485 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 74.7 m -132.96 161.29 34.69 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.159 -0.963 . . . . 0.0 109.641 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.588 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 19.5 tt0 -77.71 -47.25 2.37 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.298 -0.876 . . . . 0.0 109.23 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.5 Cg_endo -79.23 -66.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.106 0 C-N-CA 122.206 1.938 . . . . 0.0 110.478 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.713 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 14.4 m80 -55.03 87.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.063 -1.023 . . . . 0.0 109.149 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 91' ' ' PRO . 3.7 mtm180 -131.05 32.73 4.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.162 -0.961 . . . . 0.0 109.592 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -149.99 16.78 1.05 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -138.69 37.32 2.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.279 -1.13 . . . . 0.0 109.479 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.71 53.65 28.41 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.573 ' HE1' ' HB2' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -102.04 56.86 0.81 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.21 -1.171 . . . . 0.0 109.423 179.807 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.776 ' CG2' HG22 ' A' ' 86' ' ' THR . 2.5 p -135.6 94.72 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.244 -0.91 . . . . 0.0 109.383 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.571 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -70.99 179.24 31.89 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.585 ' HG2' HG23 ' A' ' 86' ' ' THR . 23.0 mtmm -154.81 131.18 10.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -1.133 . . . . 0.0 109.707 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 1.116 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -96.99 136.68 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.166 -0.959 . . . . 0.0 108.594 179.207 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.4 100.59 7.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.147 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.554 HG22 ' CD1' ' A' ' 23' ' ' ILE . 1.6 t -99.94 125.55 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.889 . . . . 0.0 109.562 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -105.49 -74.96 0.64 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.23 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 CA-C-O 117.938 -1.479 . . . . 0.0 109.437 179.84 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.275 0.56 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.65 139.91 42.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.282 -0.886 . . . . 0.0 109.458 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.457 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 15.8 m-85 -117.08 174.45 6.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 109.468 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.9 m -156.35 116.41 3.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.909 . . . . 0.0 109.466 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.744 HG12 ' H ' ' A' ' 17' ' ' GLU . 1.4 t -104.17 82.58 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.91 . . . . 0.0 109.449 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.979 ' HG2' HD11 ' A' ' 32' ' ' LEU . 6.7 mttp -69.8 85.97 0.49 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.284 -0.885 . . . . 0.0 109.383 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.67 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -62.54 -172.58 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.239 -0.913 . . . . 0.0 109.599 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.481 ' CA ' HD23 ' A' ' 14' ' ' LEU . . . 54.92 87.4 0.02 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.8 p -60.55 -90.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -1.153 . . . . 0.0 109.422 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -175.57 29.55 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.243 -0.911 . . . . 0.0 109.718 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -123.05 -19.28 6.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.188 -0.945 . . . . 0.0 109.523 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.03 -13.83 5.74 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 mt -96.23 147.65 23.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -1.116 . . . . 0.0 109.141 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.538 ' CD1' ' CD2' ' A' ' 92' ' ' HIS . 16.0 mt -109.8 112.18 24.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 109.553 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.56 HG12 ' HA3' ' A' ' 96' ' ' GLY . 6.0 m -138.56 136.0 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 109.468 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.634 ' HD2' HG11 ' A' ' 5' ' ' VAL . 28.4 m-85 -54.57 143.4 24.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.212 -0.93 . . . . 0.0 109.363 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.744 ' H ' HG12 ' A' ' 5' ' ' VAL . 27.3 mt-10 -143.0 108.76 5.42 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.26 -0.9 . . . . 0.0 108.995 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.4 Cg_endo -76.59 164.68 86.99 Favored 'Cis proline' 0 C--N 1.311 -1.408 0 C-N-CA 123.811 -1.329 . . . . 0.0 110.894 0.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.51 -60.25 2.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.435 -0.791 . . . . 0.0 109.914 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.474 ' O ' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -78.78 136.59 37.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 109.553 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.481 HD13 ' HA ' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -127.04 109.55 12.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.232 -0.918 . . . . 0.0 109.777 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.4 m -88.71 94.98 10.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.215 -0.928 . . . . 0.0 108.835 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.655 HD12 ' O ' ' A' ' 24' ' ' LYS . 1.1 pp -106.72 165.41 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.32 -0.862 . . . . 0.0 110.197 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.655 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -88.68 -178.76 1.1 Allowed Pre-proline 0 C--N 1.302 -1.485 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.815 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.601 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 36.3 Cg_endo -80.2 86.3 1.68 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.123 1.882 . . . . 0.0 110.694 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.498 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 123.74 2.07 8.83 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.479 ' OD2' ' HG3' ' A' ' 24' ' ' LYS . 4.0 m-20 -66.22 -179.17 0.73 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.221 -1.164 . . . . 0.0 109.21 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 57.2 m -121.97 120.46 34.48 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.293 -0.88 . . . . 0.0 109.362 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.026 ' CG2' HD11 ' A' ' 101' ' ' ILE . 21.8 t -99.15 123.75 52.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.345 -0.847 . . . . 0.0 108.994 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.61 123.03 43.49 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.242 -0.911 . . . . 0.0 109.9 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.603 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -122.64 142.85 50.21 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.124 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.979 HD11 ' HG2' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -142.43 179.2 7.09 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.977 -1.077 . . . . 0.0 110.222 -179.584 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.577 ' ND2' ' O ' ' A' ' 67' ' ' SER . 0.4 OUTLIER -105.88 130.64 53.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.641 -0.662 . . . . 0.0 109.716 179.072 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 45.6 t30 -72.16 -59.57 2.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.068 -1.02 . . . . 0.0 109.205 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.72 36.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.311 -0.868 . . . . 0.0 109.42 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.614 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 32.1 t -148.65 55.79 2.25 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.303 -0.873 . . . . 0.0 109.729 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.614 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 37.0 Cg_endo -78.8 174.62 11.99 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.461 2.107 . . . . 0.0 110.443 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 37.8 Cg_endo -84.89 169.92 48.65 Favored 'Cis proline' 0 C--N 1.31 -1.477 0 C-N-CA 123.463 -1.474 . . . . 0.0 110.145 -1.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.689 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 71.9 m-70 -123.03 152.89 40.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.279 -0.888 . . . . 0.0 110.543 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.428 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 0.1 OUTLIER -124.23 103.11 8.05 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.7 t -98.92 109.35 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.71 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.794 HG13 ' HB3' ' A' ' 60' ' ' SER . 3.1 t -134.26 162.32 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.44 -0.788 . . . . 0.0 109.591 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.588 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 6.0 m-85 -110.13 96.76 6.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.397 -0.814 . . . . 0.0 109.666 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 43' ' ' PHE . 9.0 t70 -43.34 167.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.506 -0.746 . . . . 0.0 109.86 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -115.91 15.2 16.28 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.397 -0.815 . . . . 0.0 109.437 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -120.24 -3.71 10.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.614 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.0 mp -114.2 40.21 2.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.159 -0.963 . . . . 0.0 109.497 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.49 ' OD1' ' HA ' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -109.6 165.93 11.74 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 0.0 109.442 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.649 ' CG ' ' HB1' ' A' ' 82' ' ' ALA . 34.9 Cg_endo -77.11 -53.39 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.631 2.221 . . . . 0.0 110.493 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -100.61 30.37 3.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.363 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.49 ' HA ' ' OD1' ' A' ' 48' ' ' ASN . 0.3 OUTLIER 39.82 54.35 2.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.703 -0.623 . . . . 0.0 109.76 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.43 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 1.5 m -99.98 152.59 20.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 109.494 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.85 47.84 1.53 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 109.515 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 54' ' ' ASP . 4.6 m-20 -115.09 -71.78 0.73 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.235 -0.916 . . . . 0.0 109.57 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.473 ' HG ' ' N ' ' A' ' 56' ' ' ALA . 1.1 pp -53.92 -27.67 32.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 109.46 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.473 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -66.15 -38.58 88.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 109.325 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -36.33 75.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.247 -0.908 . . . . 0.0 109.39 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.7 t -101.77 30.47 4.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 0.0 109.499 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.76 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 10.2 tp -120.26 -33.49 3.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.243 -0.911 . . . . 0.0 109.293 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.794 ' HB3' HG13 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -78.88 152.69 31.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.353 -0.842 . . . . 0.0 110.603 -178.972 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.656 ' CD2' HG21 ' A' ' 72' ' ' THR . 10.3 p80 -98.07 168.55 10.2 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.66 -33.02 4.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.047 -1.033 . . . . 0.0 109.784 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -73.81 108.31 6.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 109.553 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.437 ' HA ' HD22 ' A' ' 64' ' ' LEU . 1.5 mm? -44.47 157.9 0.06 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.15 -0.969 . . . . 0.0 109.566 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.954 HD13 ' HB2' ' A' ' 71' ' ' SER . 0.8 OUTLIER -104.82 91.56 3.88 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.479 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -89.18 -15.46 33.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.208 -0.932 . . . . 0.0 110.869 -178.703 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.577 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 22.9 t -78.75 113.06 31.81 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.857 -1.152 . . . . 0.0 108.52 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 66' ' ' MET . 32.1 Cg_endo -73.44 120.21 6.38 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.301 2.0 . . . . 0.0 111.007 -178.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.55 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 110.74 -15.4 29.09 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.56 ' N ' ' OD1' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -149.45 113.39 5.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.349 -1.089 . . . . 0.0 109.097 179.795 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.954 ' HB2' HD13 ' A' ' 65' ' ' LEU . 4.2 p -103.31 -135.91 0.33 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.123 -0.985 . . . . 0.0 108.931 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.672 ' N ' HD22 ' A' ' 65' ' ' LEU . 6.9 t -114.94 157.08 23.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.746 -1.221 . . . . 0.0 109.296 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.93 -173.41 2.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.15 -0.969 . . . . 0.0 109.414 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.58 HG21 ' HG ' ' A' ' 59' ' ' LEU . 29.8 m -162.78 108.2 1.16 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.728 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.96 88.99 7.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.415 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 1.033 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 8.9 m-85 -45.34 163.63 0.2 Allowed Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.324 -0.86 . . . . 0.0 109.286 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.498 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.6 Cg_endo -76.91 161.1 33.43 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.602 2.202 . . . . 0.0 111.159 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.45 -3.2 13.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.498 -0.751 . . . . 0.0 110.035 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.528 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -99.37 -76.16 0.55 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.09 -1.006 . . . . 0.0 109.2 179.826 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.56 ' HB1' HG21 ' A' ' 103' ' ' VAL . . . 37.7 57.52 4.45 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.553 -0.717 . . . . 0.0 110.399 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.648 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 36.1 Cg_endo -77.93 -160.37 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.373 2.049 . . . . 0.0 110.282 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.649 ' HB1' ' CG ' ' A' ' 49' ' ' PRO . . . 72.7 -73.83 0.09 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.888 . . . . 0.0 109.896 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.427 ' HA2' ' N ' ' A' ' 103' ' ' VAL . . . 108.12 25.43 5.86 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -151.37 111.56 4.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.316 -1.108 . . . . 0.0 109.895 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 100' ' ' LYS . 52.5 m-85 -138.54 83.85 1.99 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.447 ' OG1' ' CD ' ' A' ' 100' ' ' LYS . 18.4 m -78.29 121.29 24.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.874 . . . . 0.0 110.596 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CE1' ' C ' ' A' ' 99' ' ' GLY . 2.0 p90 -117.07 173.1 6.85 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.476 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 2.9 p90 -158.78 -157.4 0.61 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.836 -1.165 . . . . 0.0 110.228 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 0.1 OUTLIER -131.83 151.99 51.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.4 -0.813 . . . . 0.0 109.725 -179.305 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.612 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 1.8 tm-20 -82.77 -45.61 0.9 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.0 109.932 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.7 Cg_endo -80.53 -51.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.125 1.883 . . . . 0.0 110.592 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.689 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 12.9 m80 -86.01 40.61 0.87 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 109.71 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.443 ' HG2' ' N ' ' A' ' 94' ' ' GLY . 16.5 ttt180 -76.49 141.09 41.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.198 -0.939 . . . . 0.0 109.358 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.443 ' N ' ' HG2' ' A' ' 93' ' ' ARG . . . 72.63 17.66 78.16 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.88 37.68 4.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.157 -1.202 . . . . 0.0 109.513 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.56 ' HA3' HG12 ' A' ' 15' ' ' VAL . . . 72.65 12.09 77.65 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.535 ' CE ' ' HB2' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -95.66 64.66 2.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -1.19 . . . . 0.0 109.497 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 28.3 t -140.24 73.84 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 109.661 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.492 ' C ' ' CE1' ' A' ' 87' ' ' PHE . . . -89.05 167.73 34.78 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 14.3 mttp -144.23 138.08 27.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.152 -1.205 . . . . 0.0 109.758 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 1.033 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -89.14 126.31 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 108.876 179.683 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 99.6 m -101.91 99.6 9.81 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.56 HG21 ' HB1' ' A' ' 80' ' ' ALA . 2.5 t -98.9 73.45 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.222 -0.924 . . . . 0.0 109.672 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 103' ' ' VAL . . . -42.98 95.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.369 -0.832 . . . . 0.0 109.414 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 103' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.304 0 CA-C-O 117.98 -1.455 . . . . 0.0 109.469 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.19 167.57 10.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.219 -0.926 . . . . 0.0 109.482 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -131.07 93.08 3.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 109.322 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.734 HG23 ' HB3' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -92.7 103.41 15.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.922 . . . . 0.0 109.597 -179.841 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.449 HG11 HD13 ' A' ' 21' ' ' LEU . 8.2 m -96.05 110.86 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.212 -0.93 . . . . 0.0 109.281 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.447 ' C ' HD13 ' A' ' 7' ' ' LEU . 11.1 mttt -79.82 133.55 36.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.238 -0.914 . . . . 0.0 109.454 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.982 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -110.03 73.46 0.84 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.736 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.452 ' HA2' HD23 ' A' ' 14' ' ' LEU . . . 165.52 77.85 0.03 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.478 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 2.0 p -47.84 -31.13 4.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -1.139 . . . . 0.0 109.186 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 9' ' ' SER . 6.4 t0 75.78 19.1 2.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.339 -0.851 . . . . 0.0 109.562 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -135.46 7.42 3.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.93 . . . . 0.0 109.722 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -173.49 -79.63 0.05 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.17 -171.48 2.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -1.155 . . . . 0.0 109.743 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.596 ' HB3' ' HE1' ' A' ' 97' ' ' MET . 8.6 mt -106.12 126.81 52.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.386 -0.821 . . . . 0.0 108.956 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -157.18 136.5 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.089 -1.007 . . . . 0.0 109.769 -179.658 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -53.22 157.89 1.76 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.124 -0.985 . . . . 0.0 108.901 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 2.2 mt-10 -150.96 108.44 3.04 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 109.518 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 35.2 Cg_endo -78.95 166.62 78.82 Favored 'Cis proline' 0 C--N 1.313 -1.291 0 C-N-CA 123.898 -1.292 . . . . 0.0 110.534 -0.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.9 -54.21 14.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.094 -1.004 . . . . 0.0 108.978 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -86.06 159.42 19.57 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.361 -0.837 . . . . 0.0 108.893 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.449 HD13 HG11 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -157.99 129.01 6.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.012 -1.055 . . . . 0.0 109.944 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.0 m -100.0 90.14 4.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.378 -0.826 . . . . 0.0 109.213 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.79 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -99.56 166.1 2.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.206 -0.934 . . . . 0.0 109.995 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.476 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -89.28 173.0 6.48 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.348 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.688 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 34.7 Cg_endo -76.64 83.3 2.1 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.178 1.919 . . . . 0.0 110.497 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 137.56 -26.73 2.89 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.476 ' OD2' ' HB2' ' A' ' 24' ' ' LYS . 3.1 m-20 -43.8 165.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -1.156 . . . . 0.0 109.414 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 86.7 m -111.05 118.34 35.78 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.205 -0.934 . . . . 0.0 109.678 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.898 HG21 HD11 ' A' ' 101' ' ' ILE . 2.7 t -99.21 123.85 52.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.199 -0.938 . . . . 0.0 109.17 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.734 ' HB3' HG23 ' A' ' 4' ' ' THR . 0.0 OUTLIER -100.23 128.61 46.27 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.245 -0.909 . . . . 0.0 109.975 -179.532 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.581 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -129.23 146.1 51.21 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.982 ' O ' HD21 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -140.63 -167.74 2.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.966 -1.084 . . . . 0.0 110.353 -179.609 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 67' ' ' SER . 2.1 p-10 -114.83 160.22 19.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.263 -0.898 . . . . 0.0 109.57 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.413 ' CG ' ' HA3' ' A' ' 8' ' ' GLY . 12.9 t30 -104.47 -154.28 0.5 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.249 -0.907 . . . . 0.0 109.417 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -92.89 28.31 2.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.13 -0.981 . . . . 0.0 109.254 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.592 ' HB ' HD11 ' A' ' 14' ' ' LEU . 3.0 t -141.84 61.89 13.6 Favored Pre-proline 0 C--N 1.299 -1.611 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.585 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.4 Cg_endo -77.93 177.32 8.94 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 123.05 2.5 . . . . 0.0 110.804 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.585 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 39.6 Cg_endo -87.91 158.91 44.84 Favored 'Cis proline' 0 C--N 1.313 -1.315 0 O-C-N 123.723 1.381 . . . . 0.0 110.908 -1.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.707 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 72.5 m-70 -118.65 156.73 28.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.493 -0.754 . . . . 0.0 109.501 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.442 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 18.9 t30 -140.08 114.33 9.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.293 -0.879 . . . . 0.0 109.019 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.558 ' O ' HG13 ' A' ' 42' ' ' VAL . 3.8 t -99.72 122.75 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.889 . . . . 0.0 109.125 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.636 ' HA ' ' CB ' ' A' ' 60' ' ' SER . 0.2 OUTLIER -157.96 141.36 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.106 -0.996 . . . . 0.0 110.231 179.746 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.628 ' CE2' ' CG ' ' A' ' 59' ' ' LEU . 4.4 m-85 -85.98 121.5 28.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.737 -0.602 . . . . 0.0 109.793 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 43' ' ' PHE . 24.9 t70 -45.74 169.0 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.413 -0.804 . . . . 0.0 109.419 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.86 -16.06 14.24 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.219 -0.926 . . . . 0.0 109.943 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.69 -14.01 11.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.138 -0.977 . . . . 0.0 109.682 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 2.8 mm? -94.1 48.83 1.27 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.182 -0.949 . . . . 0.0 109.433 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.526 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 3.5 p30 -129.48 163.83 43.82 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.254 -0.904 . . . . 0.0 109.496 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.526 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 34.0 Cg_endo -76.3 -11.57 19.15 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.486 2.124 . . . . 0.0 109.95 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 52' ' ' SER . . . -139.4 77.33 1.61 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -40.4 93.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.973 -179.417 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 50' ' ' ALA . 2.0 m -140.35 154.23 46.68 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.321 -0.862 . . . . 0.0 109.389 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.01 72.03 0.87 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.269 -0.894 . . . . 0.0 109.254 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -167.73 -38.4 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.156 -0.965 . . . . 0.0 109.699 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.856 ' O ' HD12 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -78.13 -8.14 57.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.112 -0.992 . . . . 0.0 109.517 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 57' ' ' LYS . . . -112.47 -43.83 3.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.901 . . . . 0.0 109.632 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 56' ' ' ALA . 47.7 tttp -43.52 -48.63 7.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.894 . . . . 0.0 109.575 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -98.15 25.55 6.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.893 . . . . 0.0 109.682 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.768 ' HG ' HG21 ' A' ' 74' ' ' THR . 17.1 tp -104.1 -62.53 1.3 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.147 -0.971 . . . . 0.0 109.625 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.636 ' CB ' ' HA ' ' A' ' 42' ' ' VAL . 0.3 OUTLIER -85.8 -167.61 1.92 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.222 -0.924 . . . . 0.0 110.637 -178.778 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.663 ' HB3' HG21 ' A' ' 72' ' ' THR . 25.3 p80 -120.68 142.0 49.88 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.29 -42.33 13.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 0.0 109.59 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.467 ' NE2' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -46.65 163.76 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.898 . . . . 0.0 109.496 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.741 ' H ' HD12 ' A' ' 64' ' ' LEU . 2.3 mp -97.37 -179.01 4.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.938 . . . . 0.0 109.411 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.701 HD12 ' O ' ' A' ' 64' ' ' LEU . 7.1 mp -118.96 81.98 1.79 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -0.951 . . . . 0.0 109.407 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.13 -34.7 29.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 109.524 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.52 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 46.0 t -80.58 146.83 61.83 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.922 . . . . 0.0 109.531 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.464 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 35.5 Cg_endo -77.84 102.55 1.6 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.641 2.228 . . . . 0.0 110.594 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.493 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 109.24 -26.67 14.37 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.512 ' CB ' ' HB3' ' A' ' 67' ' ' SER . 6.8 tt0 -62.22 105.63 0.63 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.132 -1.217 . . . . 0.0 108.464 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.576 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . 21.5 p -137.86 -161.48 1.18 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.165 -0.959 . . . . 0.0 110.695 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.663 HG21 ' HB3' ' A' ' 61' ' ' HIS . 1.8 t -153.82 124.16 7.02 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.3 p -79.27 135.93 36.9 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.141 -0.974 . . . . 0.0 109.517 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.768 HG21 ' HG ' ' A' ' 59' ' ' LEU . 86.3 m -98.54 114.33 26.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.377 -0.827 . . . . 0.0 109.711 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.456 HG22 ' H ' ' A' ' 75' ' ' THR . 1.2 t -83.83 82.97 8.1 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -0.89 . . . . 0.0 109.452 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 1.017 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 14.6 m-85 -43.34 149.1 0.59 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.094 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.486 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.6 Cg_endo -75.99 168.89 23.24 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.592 2.194 . . . . 0.0 110.842 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.34 6.59 6.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.424 -0.797 . . . . 0.0 109.783 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' A' ' 80' ' ' ALA . 30.9 t70 -99.12 -77.6 0.51 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.103 -0.998 . . . . 0.0 109.242 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.688 ' HB3' ' HB3' ' A' ' 25' ' ' PRO . . . 56.66 109.31 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.35 -0.843 . . . . 0.0 108.856 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.437 ' HG2' ' HG2' ' A' ' 49' ' ' PRO . 33.3 Cg_endo -74.31 113.55 3.82 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.328 2.018 . . . . 0.0 110.688 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -46.41 109.3 0.18 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.365 -0.834 . . . . 0.0 109.459 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.446 ' HA3' ' HB3' ' A' ' 49' ' ' PRO . . . 179.13 -119.28 0.64 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -160.44 106.23 1.5 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.2 -1.176 . . . . 0.0 109.784 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.607 ' CD2' ' CG2' ' A' ' 101' ' ' ILE . 0.7 OUTLIER -82.35 131.58 35.22 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.244 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 92.4 m -111.92 117.25 32.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.052 -1.03 . . . . 0.0 110.669 -179.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.591 ' O ' HG13 ' A' ' 98' ' ' VAL . 0.3 OUTLIER -111.51 169.91 8.48 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.658 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.467 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 7.1 p90 -159.12 -154.11 0.4 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.856 -1.152 . . . . 0.0 110.089 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 0.5 OUTLIER -128.78 141.78 51.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.398 -0.814 . . . . 0.0 109.795 -179.205 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.619 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 7.4 tp10 -72.08 -47.02 11.33 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.201 -0.937 . . . . 0.0 109.57 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.9 Cg_endo -79.73 -68.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.157 0 C-N-CA 122.271 1.981 . . . . 0.0 110.333 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.707 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 9.9 m80 -69.98 64.44 0.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.135 -0.978 . . . . 0.0 109.048 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 91' ' ' PRO . 4.2 mtm180 -84.58 -10.2 57.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.678 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -122.78 54.32 0.71 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.587 ' HB3' ' HG3' ' A' ' 97' ' ' MET . . . -151.39 39.3 0.65 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -1.13 . . . . 0.0 109.549 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 48.24 22.05 2.16 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.596 ' HE1' ' HB3' ' A' ' 14' ' ' LEU . 2.5 mtp -80.5 55.71 2.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.981 -1.306 . . . . 0.0 109.116 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 87' ' ' PHE . 39.4 t -130.63 113.57 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.635 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.55 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -96.55 -173.1 35.12 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 14.9 mttt -160.53 122.34 3.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -1.182 . . . . 0.0 109.66 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 1.017 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 0.7 OUTLIER -91.06 119.03 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.149 -0.97 . . . . 0.0 109.344 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.0 m -105.17 94.98 5.53 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.608 HG23 ' CG2' ' A' ' 101' ' ' ILE . 91.3 t -99.28 129.18 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.218 -0.926 . . . . 0.0 109.825 -179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -90.41 177.2 6.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.406 -0.809 . . . . 0.0 109.481 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 CA-C-O 117.957 -1.468 . . . . 0.0 109.545 179.888 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.27 0.557 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.461 HG23 ' HB ' ' A' ' 28' ' ' THR . 0.3 OUTLIER -127.47 111.52 13.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.263 -0.898 . . . . 0.0 109.434 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -90.23 154.27 19.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.437 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.98 107.91 13.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.718 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.496 ' CG1' ' HB3' ' A' ' 16' ' ' PHE . 1.3 t -105.93 123.28 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.887 . . . . 0.0 109.324 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.413 ' HG2' HD12 ' A' ' 32' ' ' LEU . 13.8 mttm -117.75 90.3 3.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 109.41 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.49 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -50.55 164.38 0.13 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.166 -0.959 . . . . 0.0 109.528 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.18 76.36 0.91 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 3.2 p -48.02 -60.44 2.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -1.164 . . . . 0.0 109.306 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 9' ' ' SER . 1.1 t70 174.46 -62.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.403 -0.81 . . . . 0.0 109.288 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.85 18.95 6.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.313 -0.867 . . . . 0.0 109.283 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.435 ' O ' ' HG ' ' A' ' 13' ' ' LEU . . . -105.84 -92.5 2.27 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 13' ' ' LEU . 1.1 mp -143.86 -165.37 2.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.262 -1.14 . . . . 0.0 109.668 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.736 HD13 ' HE1' ' A' ' 39' ' ' HIS . 10.8 mt -100.64 52.37 0.87 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.41 -0.806 . . . . 0.0 109.359 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.438 HG12 ' O ' ' A' ' 96' ' ' GLY . 4.0 m -94.84 149.91 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 109.514 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.496 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 51.8 m-85 -65.16 177.35 1.06 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -0.923 . . . . 0.0 109.309 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 16' ' ' PHE . 4.7 mt-10 -160.16 108.01 1.4 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.907 . . . . 0.0 109.367 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 33.0 Cg_endo -75.13 170.14 72.64 Favored 'Cis proline' 0 C--N 1.311 -1.408 0 C-N-CA 123.602 -1.416 . . . . 0.0 110.678 0.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.66 -63.27 1.11 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.246 -0.909 . . . . 0.0 109.421 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.43 ' C ' HD12 ' A' ' 21' ' ' LEU . 1.9 ptpt -80.02 158.1 26.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.176 -0.952 . . . . 0.0 109.309 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.43 HD12 ' C ' ' A' ' 20' ' ' LYS . 1.0 OUTLIER -150.47 118.79 6.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.416 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 102' ' ' THR . 24.2 m -89.51 92.1 8.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.235 -0.916 . . . . 0.0 109.611 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.683 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -99.62 175.8 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.291 -0.881 . . . . 0.0 109.569 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.638 ' C ' HG13 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -88.69 179.2 1.71 Allowed Pre-proline 0 C--N 1.302 -1.464 0 O-C-N 121.355 -0.841 . . . . 0.0 108.818 179.613 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.675 ' HA ' HG11 ' A' ' 103' ' ' VAL . 35.1 Cg_endo -78.58 77.23 4.11 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.371 2.047 . . . . 0.0 110.889 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 116.4 27.4 2.87 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.465 ' CG ' ' HB2' ' A' ' 24' ' ' LYS . 6.0 m-20 -84.1 -176.68 6.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.154 -1.203 . . . . 0.0 109.097 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.461 ' HB ' HG23 ' A' ' 2' ' ' THR . 90.2 m -112.98 129.02 56.64 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.251 -0.906 . . . . 0.0 109.583 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.037 HG21 HD11 ' A' ' 101' ' ' ILE . 4.2 t -115.59 124.35 71.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.309 -0.87 . . . . 0.0 108.77 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -99.15 125.47 44.72 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.27 -0.894 . . . . 0.0 109.649 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.891 ' O ' HD23 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -116.3 153.78 31.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.38 -0.825 . . . . 0.0 108.941 -179.868 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.891 HD23 ' O ' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -141.36 -171.62 3.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.981 -1.075 . . . . 0.0 109.95 -179.603 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.68 ' HB3' HD23 ' A' ' 65' ' ' LEU . 3.2 p-10 -123.14 167.45 13.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.382 -0.823 . . . . 0.0 109.093 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -157.31 -58.16 0.08 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.906 -1.121 . . . . 0.0 110.111 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.56 ' HB3' ' CD2' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -71.51 -150.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 0.0 110.161 -179.356 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.2 t -69.37 115.27 30.76 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.594 -0.691 . . . . 0.0 110.352 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.571 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.4 Cg_endo -79.62 178.53 7.23 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 122.915 2.41 . . . . 0.0 109.997 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.571 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 41.5 Cg_endo -88.48 163.61 41.92 Favored 'Cis proline' 0 C--N 1.313 -1.331 0 O-C-N 123.339 1.179 . . . . 0.0 110.707 -1.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.736 ' HE1' HD13 ' A' ' 14' ' ' LEU . 97.3 m-70 -126.01 122.59 36.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.175 -0.953 . . . . 0.0 110.018 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.456 ' OD1' ' HA ' ' A' ' 64' ' ' LEU . 2.0 t30 -99.45 142.55 30.79 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.425 -0.797 . . . . 0.0 109.163 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.494 HG12 ' OG ' ' A' ' 60' ' ' SER . 7.1 t -110.51 118.13 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.937 . . . . 0.0 109.422 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.625 ' HA ' ' CB ' ' A' ' 60' ' ' SER . 1.6 t -153.84 138.69 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.164 -0.96 . . . . 0.0 110.099 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.751 ' CE2' HD23 ' A' ' 59' ' ' LEU . 2.8 m-85 -87.33 126.22 34.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.658 -0.651 . . . . 0.0 109.643 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.469 ' OD2' ' HB3' ' A' ' 46' ' ' ALA . 38.8 t70 -51.67 137.54 24.94 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.236 -0.915 . . . . 0.0 108.924 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.93 14.92 3.66 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.186 -0.946 . . . . 0.0 109.815 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.469 ' HB3' ' OD2' ' A' ' 44' ' ' ASP . . . -129.07 11.87 6.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.156 -0.965 . . . . 0.0 109.62 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.423 HD12 ' HB3' ' A' ' 44' ' ' ASP . 76.1 mt -126.66 50.4 1.94 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.93 . . . . 0.0 109.635 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 51' ' ' LYS . 5.2 p30 -119.67 159.39 46.47 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 0.0 109.122 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 36.2 Cg_endo -77.85 -2.23 12.37 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.566 2.177 . . . . 0.0 110.664 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.519 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -123.17 28.74 7.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.204 -0.935 . . . . 0.0 109.655 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.519 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER 28.49 40.88 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.108 0.48 . . . . 0.0 110.728 179.819 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 50' ' ' ALA . 72.9 m -135.91 -171.52 2.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.123 -0.986 . . . . 0.0 109.816 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.34 19.58 1.37 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.305 -0.872 . . . . 0.0 109.598 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -68.96 -31.31 70.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 109.499 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.708 ' O ' HD12 ' A' ' 55' ' ' LEU . 0.6 OUTLIER -102.0 22.77 12.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.546 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -117.36 -54.99 2.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -0.881 . . . . 0.0 109.351 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -56.97 -28.58 62.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.372 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.4 p -108.99 30.22 6.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.283 -0.886 . . . . 0.0 109.625 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.783 ' O ' HG23 ' A' ' 74' ' ' THR . 26.7 tp -115.87 -62.15 1.63 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.205 -0.934 . . . . 0.0 109.444 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.625 ' CB ' ' HA ' ' A' ' 42' ' ' VAL . 0.6 OUTLIER -80.15 -171.46 2.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.264 -0.898 . . . . 0.0 110.627 -178.703 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -115.11 157.36 23.68 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.627 -0.671 . . . . 0.0 109.295 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.58 -14.44 16.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 109.682 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -76.93 130.36 37.43 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.172 -0.955 . . . . 0.0 109.488 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.497 HD12 ' N ' ' A' ' 64' ' ' LEU . 8.6 mp -60.86 179.98 0.15 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.267 -0.895 . . . . 0.0 109.375 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.997 HD21 ' CB ' ' A' ' 71' ' ' SER . 2.5 mp -98.57 135.22 40.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.232 -0.918 . . . . 0.0 109.349 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 3.1 mmt -127.11 1.56 6.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.187 -0.946 . . . . 0.0 109.413 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.3 t -111.45 129.41 24.12 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.908 . . . . 0.0 109.229 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.518 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.2 Cg_endo -78.47 87.0 1.58 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.338 2.026 . . . . 0.0 110.514 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.551 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 114.87 35.01 1.42 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.56 ' N ' ' HB3' ' A' ' 32' ' ' LEU . 1.0 OUTLIER 178.55 112.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -1.133 . . . . 0.0 109.366 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.997 ' CB ' HD21 ' A' ' 65' ' ' LEU . 21.5 p -104.85 -82.19 0.52 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.108 -0.995 . . . . 0.0 109.429 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.589 ' N ' ' OG ' ' A' ' 71' ' ' SER . 85.2 m -160.83 156.28 24.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.007 -1.058 . . . . 0.0 109.346 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 75' ' ' THR . 0.8 OUTLIER -102.68 67.31 0.98 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.158 -0.964 . . . . 0.0 109.309 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.783 HG23 ' O ' ' A' ' 59' ' ' LEU . 97.8 m -46.26 99.28 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.364 -0.835 . . . . 0.0 109.642 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.416 ' N ' ' O ' ' A' ' 73' ' ' SER . 19.0 m -78.89 95.87 5.54 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.654 ' CE2' HD21 ' A' ' 59' ' ' LEU . 8.0 m-85 -47.85 162.45 0.32 Allowed Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.526 -0.734 . . . . 0.0 109.34 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.563 ' HD3' ' CD1' ' A' ' 59' ' ' LEU . 35.0 Cg_endo -76.61 173.37 14.59 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.695 2.263 . . . . 0.0 111.12 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.75 8.51 7.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.295 -0.878 . . . . 0.0 109.629 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -99.32 -71.01 0.71 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.217 -0.927 . . . . 0.0 109.147 179.781 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 79' ' ' ASP . . . 42.76 88.26 0.1 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.336 -0.852 . . . . 0.0 109.374 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.435 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 33.4 Cg_endo -75.61 127.79 10.53 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.616 2.21 . . . . 0.0 110.654 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.433 ' HB1' ' HA2' ' A' ' 105' ' ' GLY . . . -43.06 136.92 2.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.439 -0.788 . . . . 0.0 109.553 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.482 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . 152.65 172.92 21.57 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -96.88 126.34 41.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -1.144 . . . . 0.0 109.519 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.493 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 12.6 m-85 -97.6 -173.7 2.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 108.853 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 99.4 m -164.83 103.58 0.79 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.922 -1.111 . . . . 0.0 110.443 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.578 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.5 OUTLIER -101.24 166.07 10.96 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.563 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 97' ' ' MET . 4.9 p90 -159.96 -153.38 0.34 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.724 -1.235 . . . . 0.0 110.547 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 97' ' ' MET . 0.5 OUTLIER -129.1 148.03 51.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.543 -0.723 . . . . 0.0 109.49 -179.406 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 0.4 OUTLIER -84.0 -43.58 0.77 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.943 . . . . 0.0 110.511 179.621 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.2 Cg_endo -78.68 -67.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.065 0 C-N-CA 122.109 1.873 . . . . 0.0 110.872 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.675 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 69.5 m80 -65.93 75.36 0.08 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.99 -1.069 . . . . 0.0 109.551 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 91' ' ' PRO . 45.5 mtm180 -91.84 110.94 22.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.126 -0.984 . . . . 0.0 109.139 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.7 1.71 30.63 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.03 33.59 2.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -1.16 . . . . 0.0 109.475 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.438 ' O ' HG12 ' A' ' 15' ' ' VAL . . . 64.27 13.14 53.22 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.638 ' HE2' ' O ' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -74.13 63.1 0.95 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.824 -1.398 . . . . 0.0 109.201 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.1 t -140.72 107.99 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.891 . . . . 0.0 109.61 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.578 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -112.21 179.45 19.48 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.457 ' HG3' ' C ' ' A' ' 99' ' ' GLY . 2.7 mtmp? -152.46 134.24 14.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.115 -1.227 . . . . 0.0 109.784 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 1.037 HD11 HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -95.82 132.73 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.88 . . . . 0.0 108.831 179.568 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -107.02 97.8 7.53 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.137 -0.977 . . . . 0.0 108.829 179.252 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.675 HG11 ' HA ' ' A' ' 25' ' ' PRO . 3.8 t -99.3 73.86 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.028 -1.045 . . . . 0.0 109.463 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 54.15 33.4 17.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.395 -0.816 . . . . 0.0 109.538 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.482 ' HA2' ' N ' ' A' ' 83' ' ' GLY . . . . . . . . 0 N--CA 1.492 2.403 0 CA-C-O 118.097 -1.391 . . . . 0.0 109.756 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.59 108.86 11.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.586 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.799 ' CD2' HD21 ' A' ' 21' ' ' LEU . 23.1 m-85 -86.1 163.39 17.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.319 -0.863 . . . . 0.0 109.302 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.802 HG23 ' HB3' ' A' ' 30' ' ' GLU . 0.9 OUTLIER -151.93 111.96 4.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.044 -1.035 . . . . 0.0 109.957 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.473 ' CG1' HD12 ' A' ' 21' ' ' LEU . 6.5 m -104.98 79.97 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.275 -0.89 . . . . 0.0 109.255 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -58.2 148.32 27.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.314 -0.866 . . . . 0.0 109.714 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.732 HD11 ' HA ' ' A' ' 33' ' ' ASN . 0.4 OUTLIER -118.05 -173.79 2.52 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.236 -0.915 . . . . 0.0 109.485 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.6 ' HA2' HD23 ' A' ' 14' ' ' LEU . . . 65.28 88.57 0.05 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.559 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -66.55 -22.84 66.16 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.31 -1.112 . . . . 0.0 109.384 179.699 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.559 ' CB ' ' O ' ' A' ' 9' ' ' SER . 8.4 t70 83.36 20.05 0.2 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.467 ' HB2' HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -115.63 9.74 15.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 109.361 179.774 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.56 5.16 45.78 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.513 ' N ' HD23 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -134.95 154.4 51.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -1.161 . . . . 0.0 109.825 -179.792 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.618 ' CD1' ' CD2' ' A' ' 92' ' ' HIS . 95.1 mt -113.91 121.4 43.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.353 -0.842 . . . . 0.0 109.172 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 m -149.07 153.6 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.111 -0.993 . . . . 0.0 109.863 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.477 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 12.0 m-85 -76.57 156.21 32.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.172 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 16' ' ' PHE . 4.1 mt-10 -141.98 109.77 5.99 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.128 -0.983 . . . . 0.0 109.393 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.5 Cg_endo -77.51 -177.7 21.92 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 123.767 -1.347 . . . . 0.0 110.698 0.469 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.21 -58.36 3.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 109.333 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.07 168.74 9.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.915 . . . . 0.0 109.16 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.799 HD21 ' CD2' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -160.1 146.06 15.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.082 -1.011 . . . . 0.0 109.927 -179.812 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 102' ' ' THR . 90.5 m -114.31 112.88 23.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.843 . . . . 0.0 109.011 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.737 ' CD1' HD13 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -117.59 164.05 14.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.265 -0.897 . . . . 0.0 110.073 -179.682 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.571 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 17.0 mmmt -82.16 165.48 42.66 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.615 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 32.7 Cg_endo -74.81 86.26 1.41 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 121.945 1.763 . . . . 0.0 110.306 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 126.26 4.43 6.45 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.494 ' OD2' ' CG ' ' A' ' 24' ' ' LYS . 59.0 m-20 -71.07 -176.73 1.47 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -1.158 . . . . 0.0 109.58 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.745 HG23 ' HA ' ' A' ' 75' ' ' THR . 0.2 OUTLIER -120.04 122.93 42.21 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.284 -0.885 . . . . 0.0 109.636 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.86 HG21 HD11 ' A' ' 101' ' ' ILE . 1.4 t -111.17 147.32 15.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.224 -0.923 . . . . 0.0 109.334 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.802 ' HB3' HG23 ' A' ' 4' ' ' THR . 5.3 tp10 -117.56 141.34 48.47 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.176 -0.953 . . . . 0.0 110.111 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.567 ' CE2' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -145.33 89.73 1.96 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.716 ' O ' HD11 ' A' ' 7' ' ' LEU . 0.5 OUTLIER -97.84 179.88 4.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.44 -0.787 . . . . 0.0 111.257 -178.028 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.732 ' HA ' HD11 ' A' ' 7' ' ' LEU . 3.8 p-10 -93.21 165.42 12.82 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.533 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . 13.3 t-20 -115.7 -84.0 0.62 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.073 -1.017 . . . . 0.0 109.477 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.516 ' O ' HG22 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -145.95 35.15 1.01 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.087 -1.008 . . . . 0.0 109.643 179.892 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.55 ' O ' ' NE2' ' A' ' 92' ' ' HIS . 2.0 t -156.87 60.36 2.13 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.86 . . . . 0.0 109.305 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 35.8 Cg_endo -78.26 174.08 12.94 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.661 2.24 . . . . 0.0 110.631 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.533 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.9 Cg_endo -86.38 162.18 54.53 Favored 'Cis proline' 0 C--N 1.311 -1.445 0 O-C-N 123.798 1.42 . . . . 0.0 110.297 -1.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.711 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 65.2 m-70 -118.59 146.73 44.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.187 -0.946 . . . . 0.0 110.17 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -120.04 114.47 22.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 109.237 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.497 HG21 ' HB2' ' A' ' 31' ' ' PHE . 24.7 t -99.92 114.06 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.508 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.679 HG13 ' CB ' ' A' ' 60' ' ' SER . 1.6 t -150.59 157.4 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.928 . . . . 0.0 109.874 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.573 ' CE2' HD23 ' A' ' 59' ' ' LEU . 3.8 m-85 -109.14 110.99 22.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.422 -0.799 . . . . 0.0 109.41 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -47.16 158.35 0.15 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.0 109.519 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.73 31.2 5.64 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.292 -0.88 . . . . 0.0 109.532 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.99 -31.71 4.99 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.182 -0.949 . . . . 0.0 109.644 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 mp -101.43 64.5 1.01 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.94 . . . . 0.0 109.656 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.443 ' CG ' ' HA ' ' A' ' 51' ' ' LYS . 0.7 OUTLIER -111.79 158.72 35.83 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.309 -0.869 . . . . 0.0 109.394 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -80.01 -33.7 1.07 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.78 2.32 . . . . 0.0 110.564 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.507 ' O ' ' HG3' ' A' ' 51' ' ' LYS . . . -122.6 35.7 4.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.15 -0.969 . . . . 0.0 109.845 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.507 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 0.3 OUTLIER 34.28 49.75 0.34 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.869 -0.519 . . . . 0.0 110.529 179.634 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 m -127.44 141.21 51.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.12 -0.987 . . . . 0.0 109.675 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -121.04 10.43 10.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 109.401 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -62.31 -39.65 93.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.392 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.528 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 1.7 pp -80.93 -32.27 34.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.362 -0.836 . . . . 0.0 109.57 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.506 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -69.01 -43.74 74.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.081 -1.012 . . . . 0.0 109.571 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.12 -30.91 12.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.313 -0.867 . . . . 0.0 109.748 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 59' ' ' LEU . 0.1 OUTLIER -105.74 -40.42 5.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.163 -0.961 . . . . 0.0 110.009 -179.623 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.978 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 13.2 tp -43.01 -56.56 3.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.217 -0.927 . . . . 0.0 109.917 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.679 ' CB ' HG13 ' A' ' 42' ' ' VAL . 64.3 p -78.83 153.05 30.95 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.487 -0.758 . . . . 0.0 110.619 -177.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.498 ' CE1' ' O ' ' A' ' 63' ' ' GLN . 12.8 p80 -93.69 176.67 6.27 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.87 -57.61 2.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.726 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.498 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 21.8 pt20 -44.09 145.48 0.75 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 109.552 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 mp -78.29 167.98 20.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 109.505 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.477 ' CD1' ' CE1' ' A' ' 61' ' ' HIS . 7.7 mp -95.32 108.96 21.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 0.0 109.38 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 4.2 ttp -117.81 -0.4 11.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 0.0 109.673 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.522 ' OG ' ' CB ' ' A' ' 70' ' ' GLN . 3.2 t -91.23 147.28 35.21 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.147 -0.971 . . . . 0.0 109.557 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.23 87.96 1.48 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.712 2.275 . . . . 0.0 110.823 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.536 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 89.22 35.37 8.12 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.522 ' CB ' ' OG ' ' A' ' 67' ' ' SER . 1.6 tt0 -147.25 94.0 2.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.128 -1.219 . . . . 0.0 109.205 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.562 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . 4.4 p -99.88 -105.89 0.22 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.33 -0.856 . . . . 0.0 109.676 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.548 HG23 ' O ' ' A' ' 72' ' ' THR . 9.9 t -160.56 123.74 3.4 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.7 m -79.26 82.31 5.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.046 -1.034 . . . . 0.0 109.341 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.521 HG21 ' HG ' ' A' ' 59' ' ' LEU . 99.6 m -59.67 101.51 0.11 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.399 -0.813 . . . . 0.0 109.504 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.745 ' HA ' HG23 ' A' ' 28' ' ' THR . 3.1 t -78.95 86.18 4.85 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.978 ' CZ ' HD21 ' A' ' 59' ' ' LEU . 3.2 m-85 -36.22 147.97 0.18 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.887 -0.508 . . . . 0.0 110.125 -178.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.442 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.7 Cg_endo -78.28 175.74 10.75 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.793 2.329 . . . . 0.0 111.52 -178.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.76 9.78 13.15 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.493 ' O ' ' C ' ' A' ' 80' ' ' ALA . 2.2 t70 -99.15 -12.99 19.97 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.411 -0.806 . . . . 0.0 108.886 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.615 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -34.6 104.54 0.25 Allowed Pre-proline 0 N--CA 1.497 1.919 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.445 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 33.9 Cg_endo -75.57 152.65 38.4 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.531 2.154 . . . . 0.0 110.899 -179.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -71.67 131.6 43.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.437 -0.79 . . . . 0.0 109.413 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 155.34 -149.61 20.83 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.454 ' CD ' HG23 ' A' ' 102' ' ' THR . 0.0 OUTLIER -126.48 137.83 53.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.214 -1.168 . . . . 0.0 109.664 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.549 ' CD1' HG22 ' A' ' 101' ' ' ILE . 6.4 m-85 -101.51 -170.95 1.9 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.347 -0.846 . . . . 0.0 108.723 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 85' ' ' TYR . 92.6 m -166.79 98.4 0.55 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.859 -1.151 . . . . 0.0 110.463 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.524 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.6 OUTLIER -101.95 162.27 13.04 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.243 -0.911 . . . . 0.0 108.677 178.622 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -154.31 -162.0 1.33 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.927 -1.108 . . . . 0.0 110.112 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.63 141.45 48.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.492 -0.755 . . . . 0.0 109.391 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 19.2 tt0 -77.95 -44.71 2.34 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.213 -0.929 . . . . 0.0 110.181 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.0 Cg_endo -78.68 -64.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 122.0 1.8 . . . . 0.0 110.439 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.711 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 9.2 m80 -73.86 57.14 0.59 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.22 -0.925 . . . . 0.0 109.315 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 16.8 ttt85 -102.91 -8.6 20.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.564 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -88.66 22.9 18.76 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.92 -129.62 0.14 Allowed 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.313 -1.11 . . . . 0.0 108.692 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -127.74 36.95 2.42 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.535 ' CE ' ' HB3' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -80.61 70.29 7.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.121 -1.223 . . . . 0.0 109.602 179.784 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 53.0 t -140.97 113.24 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.212 -0.93 . . . . 0.0 109.626 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.524 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -114.77 172.12 14.07 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.446 ' HB3' ' O ' ' A' ' 85' ' ' TYR . 6.7 mttm -148.88 128.54 13.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -1.151 . . . . 0.0 109.648 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.86 HD11 HG21 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -80.27 154.96 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.885 . . . . 0.0 108.971 179.676 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.616 ' O ' HG23 ' A' ' 22' ' ' THR . 0.7 OUTLIER -129.26 90.17 2.97 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.259 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.65 HG23 ' CG2' ' A' ' 101' ' ' ILE . 28.0 t -99.89 121.81 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.259 -0.9 . . . . 0.0 109.835 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -105.7 -152.31 0.47 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.398 -0.814 . . . . 0.0 109.392 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 CA-C-O 117.984 -1.453 . . . . 0.0 109.511 179.952 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.49 128.46 49.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.884 . . . . 0.0 109.344 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.466 ' O ' ' N ' ' A' ' 30' ' ' GLU . 43.1 m-85 -89.37 116.7 27.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -0.917 . . . . 0.0 109.615 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.6 m -118.42 120.57 37.96 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.319 -0.863 . . . . 0.0 109.3 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.539 HG12 ' C ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -107.93 102.66 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 109.387 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 7' ' ' LEU . 2.4 ttmt -80.68 83.89 6.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.325 -0.859 . . . . 0.0 109.464 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.679 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -47.42 173.23 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.356 -0.84 . . . . 0.0 109.677 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.533 ' HA3' ' CB ' ' A' ' 34' ' ' ASN . . . 83.34 94.4 0.61 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.472 ' OG ' ' N ' ' A' ' 10' ' ' ASP . 95.0 p -49.92 -75.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.289 -1.124 . . . . 0.0 109.536 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.472 ' N ' ' OG ' ' A' ' 9' ' ' SER . 20.9 t0 -173.16 -71.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.567 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.17 55.51 1.85 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.277 -0.889 . . . . 0.0 109.385 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.77 -95.23 0.1 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.458 ' HA ' HD22 ' A' ' 13' ' ' LEU . 0.8 OUTLIER -113.42 166.24 11.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.297 -1.12 . . . . 0.0 109.46 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.719 ' HB3' ' HE1' ' A' ' 97' ' ' MET . 17.2 mt -101.69 123.65 46.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.213 -0.929 . . . . 0.0 109.392 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.2 m -143.98 159.08 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.615 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.41 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 3.2 m-85 -71.92 164.32 26.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 109.376 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.539 ' C ' HG12 ' A' ' 5' ' ' VAL . 14.6 mt-10 -154.24 104.59 2.41 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 109.419 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 33.5 Cg_endo -77.09 169.22 74.89 Favored 'Cis proline' 0 C--N 1.311 -1.441 0 C-N-CA 123.693 -1.378 . . . . 0.0 110.448 0.328 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.79 -25.41 62.0 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.232 -0.918 . . . . 0.0 109.738 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.445 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 10.6 mmtm -112.62 160.4 17.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.113 -0.992 . . . . 0.0 109.832 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 20' ' ' LYS . 7.0 mt -143.72 108.75 4.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -0.866 . . . . 0.0 109.291 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.517 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 5.3 m -89.05 90.32 8.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.277 -0.889 . . . . 0.0 109.752 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.741 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.2 pt -101.35 171.67 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.24 -0.912 . . . . 0.0 109.685 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.646 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 7.8 mttt -86.83 -164.23 0.06 OUTLIER Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.646 ' HD2' ' CB ' ' A' ' 24' ' ' LYS . 30.8 Cg_endo -74.95 62.35 5.8 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 N-CA-C 109.314 -1.072 . . . . 0.0 109.314 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.568 ' O ' ' HB2' ' A' ' 76' ' ' PHE . . . 142.52 -92.19 0.17 Allowed Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.423 ' CG ' ' HG3' ' A' ' 24' ' ' LYS . 1.3 m-20 49.61 -176.2 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.119 -1.224 . . . . 0.0 109.55 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.513 ' CG2' ' OG ' ' A' ' 73' ' ' SER . 64.0 m -122.68 142.49 50.62 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.309 -0.869 . . . . 0.0 109.523 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.758 HG21 HD11 ' A' ' 101' ' ' ILE . 2.4 t -125.13 148.79 29.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.289 -0.882 . . . . 0.0 109.307 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 3' ' ' TYR . 1.9 mt-10 -127.27 132.61 50.3 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.197 -0.939 . . . . 0.0 109.746 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.578 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -138.1 105.01 5.38 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.77 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.751 HD23 ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -100.33 -171.47 2.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.066 -1.021 . . . . 0.0 111.026 -178.654 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.52 ' HA ' HD11 ' A' ' 7' ' ' LEU . 3.2 p-10 -105.55 168.33 9.16 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.706 -0.621 . . . . 0.0 109.725 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.533 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . 30.2 t30 -114.64 -142.05 0.38 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.295 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.405 ' C ' ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -99.36 36.11 1.81 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.997 -1.064 . . . . 0.0 109.241 179.76 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.595 HG21 HD21 ' A' ' 14' ' ' LEU . 2.1 t -151.46 61.95 4.64 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.579 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.2 Cg_endo -77.42 175.63 11.06 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.694 2.263 . . . . 0.0 110.955 -178.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.579 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 40.5 Cg_endo -87.87 158.51 44.81 Favored 'Cis proline' 0 C--N 1.313 -1.338 0 C-N-CA 123.573 -1.428 . . . . 0.0 110.74 -1.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.713 ' C ' HD12 ' A' ' 65' ' ' LEU . 80.6 m-70 -121.99 160.88 23.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.382 -0.824 . . . . 0.0 109.858 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -139.74 165.8 26.31 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.4 -0.813 . . . . 0.0 108.847 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.564 ' HB ' ' CD2' ' A' ' 61' ' ' HIS . 43.3 t -137.45 114.65 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.113 -0.992 . . . . 0.0 109.144 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.54 HG13 ' HB2' ' A' ' 60' ' ' SER . 0.0 OUTLIER -144.37 174.74 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.244 -0.91 . . . . 0.0 109.518 -179.443 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.669 ' CD2' HD23 ' A' ' 59' ' ' LEU . 4.2 m-85 -131.33 112.24 12.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 0.0 109.392 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.623 ' CG ' HD12 ' A' ' 47' ' ' LEU . 8.0 t70 -54.0 136.49 41.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 109.633 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.87 -2.67 58.71 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.261 -0.9 . . . . 0.0 109.648 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.443 ' O ' ' HG ' ' A' ' 47' ' ' LEU . . . -107.75 13.82 26.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.181 -0.949 . . . . 0.0 109.645 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.623 HD12 ' CG ' ' A' ' 44' ' ' ASP . 1.5 mt -140.32 46.66 1.81 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 0.0 109.424 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.502 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 1.2 p30 -123.86 165.75 22.18 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.321 -0.862 . . . . 0.0 109.287 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.502 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 33.5 Cg_endo -76.02 -23.71 11.93 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.437 2.092 . . . . 0.0 109.689 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 52' ' ' SER . . . -140.17 83.9 1.94 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -40.06 95.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.462 -0.774 . . . . 0.0 109.986 -179.369 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 50' ' ' ALA . 4.5 m -138.31 107.26 5.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.391 -0.818 . . . . 0.0 109.159 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.89 -0.85 17.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 109.719 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -75.79 -53.69 8.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.906 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.483 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 2.1 pp -63.28 -29.84 71.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.158 -0.964 . . . . 0.0 109.591 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.462 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -73.45 -37.97 65.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 0.0 109.631 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.1 mttp -52.4 -30.35 28.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -0.947 . . . . 0.0 109.714 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.3 p -115.6 38.36 3.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -0.908 . . . . 0.0 109.507 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.743 ' HG ' HG21 ' A' ' 74' ' ' THR . 7.3 tp -135.64 -48.64 0.7 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -0.881 . . . . 0.0 109.29 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.54 ' HB2' HG13 ' A' ' 42' ' ' VAL . 1.2 p -78.88 122.16 25.75 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.478 -0.764 . . . . 0.0 110.289 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.564 ' CD2' ' HB ' ' A' ' 41' ' ' VAL . 4.4 p80 -90.71 159.32 16.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.367 -0.833 . . . . 0.0 108.974 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.48 -161.66 0.76 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.133 -0.979 . . . . 0.0 109.654 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 66.9 106.92 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.412 -0.805 . . . . 0.0 109.609 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.449 HD23 ' HB2' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -54.31 143.33 23.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 109.609 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.713 HD12 ' C ' ' A' ' 39' ' ' HIS . 1.1 mt -89.01 87.24 7.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.361 -0.837 . . . . 0.0 109.151 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' MET . . . . . 0.52 ' HG3' ' N ' ' A' ' 67' ' ' SER . 0.0 OUTLIER -85.4 -24.61 27.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.108 -0.995 . . . . 0.0 109.954 -179.636 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.52 ' N ' ' HG3' ' A' ' 66' ' ' MET . 1.9 t -79.98 147.66 66.35 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.288 -0.883 . . . . 0.0 109.425 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.458 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 35.0 Cg_endo -77.86 100.37 1.37 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.572 2.181 . . . . 0.0 110.156 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.71 -25.84 17.9 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.448 ' HB2' ' OG ' ' A' ' 67' ' ' SER . 50.9 tt0 -62.52 110.79 1.8 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.14 -1.212 . . . . 0.0 108.532 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.553 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . 12.0 p -132.8 -155.03 0.65 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.138 -0.976 . . . . 0.0 110.934 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.7 m -152.05 116.66 5.08 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.513 ' OG ' ' CG2' ' A' ' 28' ' ' THR . 13.7 t -79.05 104.26 9.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -0.961 . . . . 0.0 108.966 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.743 HG21 ' HG ' ' A' ' 59' ' ' LEU . 91.6 m -73.27 109.07 6.52 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.408 -0.808 . . . . 0.0 109.956 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 75' ' ' THR . 3.3 t -79.39 80.42 5.76 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.7 ' CE2' HD21 ' A' ' 59' ' ' LEU . 10.3 m-85 -36.24 151.97 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.819 -0.551 . . . . 0.0 110.162 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.402 ' HD3' HD13 ' A' ' 59' ' ' LEU . 36.2 Cg_endo -78.38 171.01 17.59 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.799 2.332 . . . . 0.0 111.016 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -86.37 9.44 17.99 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 80' ' ' ALA . 1.0 OUTLIER -101.51 -8.73 21.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.455 -0.778 . . . . 0.0 109.477 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.492 ' HB1' HG21 ' A' ' 103' ' ' VAL . . . -38.2 105.28 0.32 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.559 -0.713 . . . . 0.0 109.66 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.421 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 35.3 Cg_endo -77.34 146.51 24.92 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.501 2.134 . . . . 0.0 110.747 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.502 ' HB2' ' OXT' ' A' ' 105' ' ' GLY . . . -56.59 132.1 50.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.297 -0.877 . . . . 0.0 109.513 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 145.9 161.9 9.43 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 3.8 mt-10 -85.24 131.91 34.35 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.214 -1.168 . . . . 0.0 109.562 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.736 ' CD1' HG22 ' A' ' 101' ' ' ILE . 29.0 m-85 -84.44 -156.12 0.22 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -163.88 87.04 0.5 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.685 -1.26 . . . . 0.0 110.551 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.787 ' O ' HG23 ' A' ' 98' ' ' VAL . 1.1 p90 -99.92 160.97 13.9 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.519 ' CB ' ' HB ' ' A' ' 98' ' ' VAL . 9.5 p90 -159.22 -163.11 1.15 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.919 -1.113 . . . . 0.0 110.396 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.489 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 0.1 OUTLIER -123.49 133.64 54.0 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.513 -0.742 . . . . 0.0 109.775 -179.615 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.631 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.7 tm-20 -74.16 -43.01 5.87 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.336 -0.853 . . . . 0.0 110.669 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.1 Cg_endo -77.63 -54.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.902 1.735 . . . . 0.0 110.833 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.712 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 42.6 m80 -85.38 60.44 6.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.052 -1.03 . . . . 0.0 109.535 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.45 -4.26 53.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.909 . . . . 0.0 109.427 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.71 14.62 17.3 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 96' ' ' GLY . . . -120.37 33.13 5.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -1.136 . . . . 0.0 109.376 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 95' ' ' ALA . . . 41.72 60.73 2.42 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.719 ' HE1' ' HB3' ' A' ' 14' ' ' LEU . 5.4 mtp -107.37 53.82 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.174 -1.192 . . . . 0.0 109.417 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 87' ' ' PHE . 1.4 p -139.44 143.82 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 109.694 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -151.04 176.09 29.71 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.444 ' HB3' ' O ' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -127.29 141.89 51.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.178 -1.19 . . . . 0.0 109.716 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.758 HD11 HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -85.6 155.59 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.889 . . . . 0.0 109.014 179.749 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.517 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -115.46 98.35 6.68 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.157 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.662 HG22 ' CD1' ' A' ' 23' ' ' ILE . 53.7 t -99.24 78.71 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.258 -0.901 . . . . 0.0 109.572 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.19 136.53 57.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.342 -0.849 . . . . 0.0 109.399 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.502 ' OXT' ' HB2' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.271 0 CA-C-O 118.012 -1.438 . . . . 0.0 109.555 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.427 HG23 ' HB ' ' A' ' 28' ' ' THR . 0.2 OUTLIER -127.13 131.67 50.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 109.501 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.622 ' CG ' HD21 ' A' ' 21' ' ' LEU . 6.6 m-85 -103.29 174.14 6.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.12 -0.987 . . . . 0.0 109.285 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.409 HG22 HD21 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -143.73 105.04 4.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.089 -1.007 . . . . 0.0 110.062 -179.607 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 5' ' ' VAL . 20.5 m -93.71 65.84 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.218 -0.926 . . . . 0.0 109.131 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.418 ' HG3' HD11 ' A' ' 32' ' ' LEU . 1.5 ttmt -49.48 98.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 110.026 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -65.49 157.96 28.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.119 -0.988 . . . . 0.0 108.983 179.466 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 14' ' ' LEU . . . 72.18 137.07 0.22 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.459 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 1.5 p -100.72 -68.99 0.79 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.149 -1.206 . . . . 0.0 109.686 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 1.6 p30 167.24 -49.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 109.856 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.444 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -127.27 24.75 6.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 109.69 -179.768 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.811 ' C ' HD22 ' A' ' 13' ' ' LEU . . . -126.49 -116.5 2.06 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.825 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.6 mm? -121.98 -169.1 1.82 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.309 -1.113 . . . . 0.0 109.254 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.954 HD21 ' HB3' ' A' ' 35' ' ' LYS . 47.5 mt -98.84 102.54 14.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.263 -0.898 . . . . 0.0 108.671 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.1 m -137.69 164.05 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 0.0 109.724 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -80.07 137.25 36.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.372 -0.83 . . . . 0.0 109.205 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 34.5 mm-40 -126.13 105.64 25.28 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.202 -0.936 . . . . 0.0 109.551 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.8 Cg_endo -78.25 169.51 72.79 Favored 'Cis proline' 0 C--N 1.312 -1.381 0 C-N-CA 123.817 -1.326 . . . . 0.0 110.557 0.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.42 -64.79 0.81 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.147 -0.971 . . . . 0.0 108.879 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.4 pttm -84.76 160.03 20.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.37 -0.832 . . . . 0.0 109.029 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.836 HD23 HG23 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -152.12 149.13 28.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.081 -1.012 . . . . 0.0 110.078 -179.809 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.8 m -111.79 119.44 38.62 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.836 HG23 HD23 ' A' ' 21' ' ' LEU . 0.9 OUTLIER -132.43 175.74 10.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.143 -0.973 . . . . 0.0 110.029 -179.437 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.571 ' C ' HG13 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -91.69 175.99 3.07 Favored Pre-proline 0 C--N 1.303 -1.421 0 O-C-N 121.394 -0.816 . . . . 0.0 109.049 179.578 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.674 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 35.4 Cg_endo -77.26 92.17 1.14 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.331 2.021 . . . . 0.0 110.646 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 111.06 5.8 26.6 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.455 ' OD2' ' HB2' ' A' ' 24' ' ' LYS . 11.5 m-20 -66.4 -178.84 0.72 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.122 -1.222 . . . . 0.0 109.293 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.427 ' HB ' HG23 ' A' ' 2' ' ' THR . 3.6 m -115.38 129.28 56.54 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.349 -0.845 . . . . 0.0 109.549 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.032 HG21 HD11 ' A' ' 101' ' ' ILE . 5.2 t -115.62 135.05 56.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.189 -0.944 . . . . 0.0 109.539 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -103.43 129.42 50.54 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.172 -0.955 . . . . 0.0 109.662 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.582 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -127.17 83.56 2.18 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.599 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.4 OUTLIER -96.11 157.56 15.84 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.757 0.789 . . . . 0.0 110.726 -178.198 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.546 ' C ' ' OD1' ' A' ' 33' ' ' ASN . 4.5 p30 -77.47 171.42 14.92 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.703 0.763 . . . . 0.0 110.895 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' A' ' 7' ' ' LEU . 3.6 t30 -150.04 -37.46 0.15 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.954 ' HB3' HD21 ' A' ' 14' ' ' LEU . 1.9 tttt -99.4 -144.32 0.33 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.444 -0.785 . . . . 0.0 109.461 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -68.74 113.14 13.99 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.527 -0.733 . . . . 0.0 110.781 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.541 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 37.8 Cg_endo -84.13 178.41 5.29 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.999 2.466 . . . . 0.0 109.776 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 39.7 Cg_endo -88.5 168.19 37.51 Favored 'Cis proline' 0 C--N 1.314 -1.276 0 O-C-N 123.391 1.206 . . . . 0.0 109.849 -2.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.66 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 81.6 m-70 -122.89 143.47 49.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.066 -1.022 . . . . 0.0 109.999 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -103.84 144.08 31.98 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.359 -0.838 . . . . 0.0 108.983 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.459 ' HB ' ' NE2' ' A' ' 61' ' ' HIS . 54.5 t -119.17 124.48 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -0.969 . . . . 0.0 109.927 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.487 HG13 ' CB ' ' A' ' 60' ' ' SER . 1.4 t -150.24 167.31 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.389 -0.82 . . . . 0.0 108.987 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.603 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 7.0 m-85 -118.5 119.69 35.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.138 -0.976 . . . . 0.0 109.809 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.457 ' HB3' ' HB2' ' A' ' 47' ' ' LEU . 17.8 t0 -41.98 148.17 0.19 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.442 -0.786 . . . . 0.0 110.028 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.16 -14.46 17.73 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.359 -0.838 . . . . 0.0 109.234 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.466 ' O ' HD22 ' A' ' 47' ' ' LEU . . . -99.91 0.32 41.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.37 -0.831 . . . . 0.0 109.544 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.466 HD22 ' O ' ' A' ' 46' ' ' ALA . 1.6 mm? -117.81 46.65 1.71 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.173 -0.954 . . . . 0.0 109.215 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.47 ' OD1' ' HA ' ' A' ' 51' ' ' LYS . 1.2 p30 -105.42 162.38 19.89 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.343 -0.848 . . . . 0.0 109.488 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 36.3 Cg_endo -77.88 -31.62 3.04 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.765 2.31 . . . . 0.0 110.907 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.496 ' O ' ' HG3' ' A' ' 51' ' ' LYS . . . -122.5 31.26 6.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.102 -0.999 . . . . 0.0 110.047 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 0.1 OUTLIER 35.32 36.79 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.88 -0.512 . . . . 0.0 110.479 179.492 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 50' ' ' ALA . 2.4 m -101.12 143.1 31.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.083 -1.011 . . . . 0.0 109.926 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -92.5 54.78 2.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.898 . . . . 0.0 109.523 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -140.63 23.22 2.3 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.2 -0.937 . . . . 0.0 109.563 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.408 ' HA ' HD13 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -118.44 9.59 12.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.246 -0.909 . . . . 0.0 109.531 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.504 ' HB2' ' HB2' ' A' ' 43' ' ' PHE . . . -142.9 -47.12 0.31 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.405 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -48.07 -25.22 1.34 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 0.0 109.344 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.8 t -118.4 -20.19 8.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.22 -0.925 . . . . 0.0 109.36 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.965 HD21 ' CE2' ' A' ' 76' ' ' PHE . 9.9 tp -79.29 -37.93 36.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 0.0 109.226 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.487 ' CB ' HG13 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -78.9 132.14 36.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.282 -0.886 . . . . 0.0 109.633 -179.735 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.459 ' NE2' ' HB ' ' A' ' 41' ' ' VAL . 12.5 p80 -83.84 -9.55 58.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.455 -0.778 . . . . 0.0 109.605 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 0.1 OUTLIER 54.65 -170.78 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 109.709 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.487 ' CB ' ' O ' ' A' ' 62' ' ' LYS . 4.0 tt0 75.45 -179.75 0.17 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.336 -0.852 . . . . 0.0 109.687 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.703 HD12 ' N ' ' A' ' 64' ' ' LEU . 4.4 mp -118.52 155.75 30.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.299 -0.875 . . . . 0.0 109.473 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 39' ' ' HIS . 4.6 mp -84.09 -175.32 5.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.911 . . . . 0.0 109.482 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -160.74 -37.35 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.15 -0.969 . . . . 0.0 109.904 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.534 ' HB3' ' CB ' ' A' ' 70' ' ' GLN . 5.5 t -83.71 147.11 51.23 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.149 -0.97 . . . . 0.0 109.901 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.458 ' HD2' ' OG ' ' A' ' 67' ' ' SER . 36.0 Cg_endo -79.08 92.18 1.16 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.817 2.345 . . . . 0.0 110.398 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.488 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 103.71 6.04 44.14 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.534 ' CB ' ' HB3' ' A' ' 67' ' ' SER . 1.2 tt0 -124.91 102.78 7.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -1.154 . . . . 0.0 109.093 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.599 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . 11.5 p -104.77 -104.27 0.31 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.339 -0.851 . . . . 0.0 110.132 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.9 m -159.97 149.58 18.03 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.9 p -97.34 103.76 15.72 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.037 -1.04 . . . . 0.0 109.424 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.482 ' HG1' ' HE1' ' A' ' 31' ' ' PHE . 94.1 m -76.8 103.27 6.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -0.889 . . . . 0.0 109.54 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 76' ' ' PHE . 23.2 m -79.06 92.58 5.01 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.965 ' CE2' HD21 ' A' ' 59' ' ' LEU . 5.4 m-85 -43.01 165.13 0.11 Allowed Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.47 -0.769 . . . . 0.0 109.537 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.517 ' HD3' HD13 ' A' ' 59' ' ' LEU . 32.3 Cg_endo -73.84 174.03 13.0 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.466 2.111 . . . . 0.0 111.282 -178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.59 8.19 8.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.545 -0.722 . . . . 0.0 109.515 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.484 ' O ' ' C ' ' A' ' 80' ' ' ALA . 10.5 m-20 -99.43 -74.61 0.59 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.25 -0.907 . . . . 0.0 109.156 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.674 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . 34.84 69.7 1.02 Allowed Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.723 -0.61 . . . . 0.0 110.074 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.44 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 34.2 Cg_endo -75.91 158.29 38.68 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.533 2.156 . . . . 0.0 110.819 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -49.07 98.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.352 -0.842 . . . . 0.0 109.609 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.569 ' O ' ' CE1' ' A' ' 85' ' ' TYR . . . -166.92 149.92 16.16 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -81.72 140.11 34.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.214 -1.168 . . . . 0.0 109.54 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.569 ' CE1' ' O ' ' A' ' 83' ' ' GLY . 66.5 m-85 -118.71 147.74 43.52 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.465 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 95.2 m -134.14 118.43 17.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.987 -1.07 . . . . 0.0 110.718 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.582 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -110.44 171.35 7.51 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.403 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' A' ' 97' ' ' MET . 14.1 p90 -158.94 -163.84 1.31 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.77 -1.206 . . . . 0.0 110.476 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.447 ' SG ' ' HD2' ' A' ' 91' ' ' PRO . 0.5 OUTLIER -126.25 145.29 50.46 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.578 -0.701 . . . . 0.0 109.408 -179.623 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.627 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 24.2 tp10 -82.97 -42.81 0.87 Allowed Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 121.254 -0.904 . . . . 0.0 110.599 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.3 Cg_endo -78.1 -75.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 121.946 1.764 . . . . 0.0 110.82 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.66 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 13.4 m80 -65.5 69.18 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.056 -1.028 . . . . 0.0 109.531 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 91' ' ' PRO . 10.8 tpt180 -90.72 -14.94 31.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.138 -0.976 . . . . 0.0 109.179 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.57 1.64 87.22 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.449 ' CB ' ' HB2' ' A' ' 14' ' ' LEU . . . -114.14 33.42 5.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -1.163 . . . . 0.0 109.487 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.494 ' O ' ' N ' ' A' ' 98' ' ' VAL . . . 40.16 36.6 0.92 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.513 ' SD ' ' HB3' ' A' ' 14' ' ' LEU . 4.0 mtp -65.35 72.85 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.036 -1.273 . . . . 0.0 109.177 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 96' ' ' GLY . 98.5 t -132.7 112.23 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 109.732 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.581 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -100.31 -174.92 30.08 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.519 ' N ' ' CZ ' ' A' ' 87' ' ' PHE . 22.4 mtpt -158.12 144.92 17.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.052 -1.263 . . . . 0.0 109.977 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 1.032 HD11 HG21 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -110.73 135.88 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 108.677 179.446 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 21' ' ' LEU . 3.1 m -114.11 95.29 5.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.271 -0.893 . . . . 0.0 109.1 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.64 HG22 ' CD1' ' A' ' 23' ' ' ILE . 2.3 t -99.87 124.71 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.277 -0.89 . . . . 0.0 109.805 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.25 -147.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 109.252 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.406 ' OXT' ' HG3' ' A' ' 25' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.295 0 CA-C-O 117.995 -1.447 . . . . 0.0 109.538 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.47 127.3 48.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.501 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.698 ' HB3' HD21 ' A' ' 21' ' ' LEU . 25.8 m-85 -84.45 169.05 14.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 0.0 109.154 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 30' ' ' GLU . 31.6 m -160.18 122.2 3.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.108 -0.995 . . . . 0.0 109.776 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.907 HG12 ' H ' ' A' ' 17' ' ' GLU . 0.6 OUTLIER -106.13 -155.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 109.001 179.446 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.472 ' H ' HG12 ' A' ' 5' ' ' VAL . 10.5 tttt -175.22 127.93 0.27 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.33 -0.856 . . . . 0.0 109.507 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.787 HD12 ' CG ' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -100.56 93.89 5.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 0.0 109.156 179.775 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.746 ' HA2' HD23 ' A' ' 14' ' ' LEU . . . 152.07 70.14 0.01 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 8' ' ' GLY . 1.4 p -46.56 150.39 0.68 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.192 -1.181 . . . . 0.0 109.021 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -88.28 36.9 0.79 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.228 -0.92 . . . . 0.0 109.625 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.5 mtmm -122.37 -29.24 4.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 109.406 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.418 ' O ' ' HG ' ' A' ' 13' ' ' LEU . . . 137.91 46.02 0.08 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 12' ' ' GLY . 1.9 mt -164.3 172.68 13.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.224 -1.162 . . . . 0.0 109.626 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.746 HD23 ' HA2' ' A' ' 8' ' ' GLY . 88.1 mt -118.8 97.09 5.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 109.841 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.2 m -140.95 154.68 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.294 -0.878 . . . . 0.0 109.398 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -62.93 160.47 14.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.124 -0.985 . . . . 0.0 109.113 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.907 ' H ' HG12 ' A' ' 5' ' ' VAL . 0.6 OUTLIER -134.15 103.55 11.65 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.933 . . . . 0.0 109.651 -179.915 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.3 Cg_endo -77.53 -163.59 3.44 Favored 'Cis proline' 0 C--N 1.311 -1.397 0 C-N-CA 123.633 -1.403 . . . . 0.0 110.499 0.122 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.85 -36.12 70.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.267 -0.896 . . . . 0.0 109.593 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -116.14 168.84 9.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 0.0 109.399 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.698 HD21 ' HB3' ' A' ' 3' ' ' TYR . 2.7 tp -149.75 147.75 28.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.219 -0.926 . . . . 0.0 109.527 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.484 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 30.7 m -115.22 100.35 8.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 109.464 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.872 ' CD1' HD13 ' A' ' 101' ' ' ILE . 2.3 pt -100.45 178.53 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.255 -0.903 . . . . 0.0 109.739 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.699 ' O ' HG13 ' A' ' 103' ' ' VAL . 0.2 OUTLIER -95.57 -174.4 0.39 Allowed Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.536 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.613 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 35.7 Cg_endo -80.21 70.42 7.53 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.934 1.756 . . . . 0.0 110.694 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.543 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 111.08 48.31 0.72 Allowed Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.194 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.507 ' OD2' ' HG3' ' A' ' 24' ' ' LYS . 0.9 OUTLIER -108.16 -164.98 1.0 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.398 -1.06 . . . . 0.0 108.759 178.846 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 95.8 m -115.71 145.69 42.53 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.034 -1.041 . . . . 0.0 110.333 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.663 HG21 HD11 ' A' ' 101' ' ' ILE . 1.9 t -127.28 121.88 58.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.528 ' O ' HG23 ' A' ' 4' ' ' THR . 25.6 mt-10 -99.53 103.3 15.03 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.085 -1.01 . . . . 0.0 110.836 -178.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.708 ' C ' HD23 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -93.49 152.13 19.27 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.546 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.878 HD21 ' O ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -141.61 169.15 18.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.689 -1.257 . . . . 0.0 110.808 -179.37 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.53 ' OD1' ' HA ' ' A' ' 68' ' ' PRO . 6.7 p-10 -97.51 160.23 14.45 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.628 -0.67 . . . . 0.0 109.202 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.542 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . 51.9 t30 -110.07 -78.87 0.59 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.907 -1.121 . . . . 0.0 109.748 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.513 ' O ' HG22 ' A' ' 36' ' ' VAL . 5.7 tptt -151.25 34.71 0.58 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.026 -1.046 . . . . 0.0 109.886 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.603 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 0.9 OUTLIER -156.39 56.34 1.22 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.28 -0.887 . . . . 0.0 109.65 179.298 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.603 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 36.3 Cg_endo -78.59 176.37 9.96 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.697 2.265 . . . . 0.0 110.669 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.2 Cg_endo -86.13 162.23 56.26 Favored 'Cis proline' 0 C--N 1.312 -1.392 0 O-C-N 123.753 1.396 . . . . 0.0 110.416 -1.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.787 ' CG ' HD12 ' A' ' 7' ' ' LEU . 73.3 m-70 -122.28 140.73 52.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 110.215 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.505 ' HB2' ' HD3' ' A' ' 91' ' ' PRO . 1.2 m120 -115.15 134.76 54.87 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.55 ' HB ' ' CD2' ' A' ' 61' ' ' HIS . 35.5 t -100.82 135.07 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.105 -0.997 . . . . 0.0 110.03 -179.179 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.532 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 2.5 t -149.22 171.1 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.376 -0.828 . . . . 0.0 109.477 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.694 ' CZ ' HD12 ' A' ' 59' ' ' LEU . 1.6 m-85 -139.21 115.33 10.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.144 -0.973 . . . . 0.0 109.668 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -47.59 142.8 4.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.179 -0.951 . . . . 0.0 109.132 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.22 19.98 16.6 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.187 -0.945 . . . . 0.0 109.819 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -108.35 -40.17 5.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.207 -0.933 . . . . 0.0 109.561 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.612 ' N ' HD12 ' A' ' 47' ' ' LEU . 10.2 mp -87.17 55.9 3.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.922 . . . . 0.0 109.611 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.493 ' OD1' ' HA ' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -102.53 165.76 13.2 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.331 -0.856 . . . . 0.0 109.47 179.71 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.516 ' HG2' ' HG2' ' A' ' 81' ' ' PRO . 34.9 Cg_endo -77.78 -33.07 2.4 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.638 2.225 . . . . 0.0 110.807 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -124.06 30.72 6.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.037 -1.039 . . . . 0.0 109.719 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.493 ' HA ' ' OD1' ' A' ' 48' ' ' ASN . 12.5 mmtm 39.45 31.46 0.07 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.71 -0.619 . . . . 0.0 109.841 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 50' ' ' ALA . 28.8 m -101.62 125.01 48.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.68 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -100.35 97.53 8.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.353 -0.842 . . . . 0.0 109.368 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -163.49 -46.01 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.274 -0.891 . . . . 0.0 109.529 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 0.9 OUTLIER -68.4 -15.88 63.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.898 . . . . 0.0 109.381 -179.902 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.94 -50.5 8.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.252 -0.905 . . . . 0.0 109.637 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.29 -23.66 0.6 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.719 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.2 t -106.86 -3.52 20.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.062 -1.024 . . . . 0.0 109.902 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.015 HD21 ' CD2' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -95.12 -37.12 11.22 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.09 -1.006 . . . . 0.0 108.554 179.935 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.498 ' CB ' ' HA ' ' A' ' 42' ' ' VAL . 1.4 m -78.91 132.73 36.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.191 -0.943 . . . . 0.0 110.383 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.683 ' CE1' HD21 ' A' ' 65' ' ' LEU . 18.9 p80 -109.61 138.49 45.89 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.46 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -127.74 119.42 25.74 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.009 -1.057 . . . . 0.0 110.114 -179.785 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.606 ' O ' ' O ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER 167.53 29.44 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.558 -0.714 . . . . 0.0 110.303 179.248 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.606 ' O ' ' O ' ' A' ' 63' ' ' GLN . 4.1 mt 47.66 123.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.734 0.778 . . . . 0.0 111.319 178.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.683 HD21 ' CE1' ' A' ' 61' ' ' HIS . 6.3 mt -78.49 155.32 29.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.246 -1.534 . . . . 0.0 108.77 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 41.1 mtm -137.28 9.64 2.97 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -0.904 . . . . 0.0 109.595 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 70' ' ' GLN . 1.9 t -110.28 129.55 23.82 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 109.375 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.53 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.2 Cg_endo -79.18 93.31 1.1 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.362 2.041 . . . . 0.0 110.453 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 114.39 0.83 23.49 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.436 ' HG2' ' C ' ' A' ' 69' ' ' GLY . 32.5 mm-40 -144.43 112.94 6.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -1.112 . . . . 0.0 108.777 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.55 ' OG ' ' N ' ' A' ' 72' ' ' THR . 51.9 p -99.95 -80.28 0.48 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.001 -1.062 . . . . 0.0 109.671 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.598 ' HB ' ' CD2' ' A' ' 61' ' ' HIS . 4.3 m -160.33 107.8 1.61 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.077 -1.015 . . . . 0.0 109.474 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 29' ' ' VAL . 3.9 m -80.08 76.35 6.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -0.932 . . . . 0.0 109.154 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.651 HG21 HD13 ' A' ' 59' ' ' LEU . 1.0 OUTLIER -60.68 124.15 19.56 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.417 -0.802 . . . . 0.0 110.06 -179.61 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 75' ' ' THR . 3.8 t -82.87 90.08 6.91 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.392 -0.818 . . . . 0.0 108.986 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 1.015 ' CD2' HD21 ' A' ' 59' ' ' LEU . 22.7 m-85 -41.41 157.11 0.2 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.464 -0.773 . . . . 0.0 109.693 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.543 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.6 Cg_endo -78.1 161.14 29.67 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.814 2.343 . . . . 0.0 111.031 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.09 5.4 8.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.22 -0.925 . . . . 0.0 110.023 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.469 ' OD1' ' HB2' ' A' ' 77' ' ' PRO . 2.0 p-10 -100.09 -11.04 20.85 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.001 -1.062 . . . . 0.0 109.616 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 79' ' ' ASP . . . -40.4 100.6 0.22 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.497 -0.752 . . . . 0.0 109.832 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.516 ' HG2' ' HG2' ' A' ' 49' ' ' PRO . 36.3 Cg_endo -78.54 -176.11 3.09 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.497 2.131 . . . . 0.0 110.442 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.72 123.33 27.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.355 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 169.1 148.28 5.74 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.437 ' O ' ' CG ' ' A' ' 84' ' ' GLU . 10.8 pt-20 -80.37 111.68 17.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.309 -1.112 . . . . 0.0 109.752 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.544 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 5.6 m-30 -86.5 98.04 10.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.934 . . . . 0.0 108.867 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 17.3 m -77.45 105.76 8.79 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.226 -0.921 . . . . 0.0 110.191 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.487 ' HB3' ' CD2' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -104.16 176.93 4.99 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.283 -0.886 . . . . 0.0 108.796 179.103 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.477 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 5.7 p90 -160.7 -147.7 0.15 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.014 -1.054 . . . . 0.0 109.722 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 93' ' ' ARG . 0.5 OUTLIER -130.93 159.02 38.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 109.746 -179.466 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.602 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.3 tt0 -91.79 -44.21 0.36 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.362 -0.836 . . . . 0.0 111.161 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.8 Cg_endo -80.58 -56.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.09 0 C-N-CA 122.117 1.878 . . . . 0.0 110.674 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.726 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 19.9 m80 -77.78 5.02 10.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.62 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 89' ' ' CYS . 20.0 ttt-85 -43.26 120.0 1.74 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.17 -0.956 . . . . 0.0 109.37 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.73 11.07 33.72 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.7 39.26 3.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -1.163 . . . . 0.0 109.328 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.74 -0.16 66.44 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.626 ' HE3' ' HB2' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -71.39 66.9 0.48 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.164 -1.198 . . . . 0.0 109.664 -179.865 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.0 t -135.25 120.0 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.189 -0.944 . . . . 0.0 109.444 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 86' ' ' THR . . . -133.77 -178.52 15.65 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 10.0 mttt -148.78 140.77 23.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -1.187 . . . . 0.0 109.669 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.872 HD13 ' CD1' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -96.88 133.73 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 109.111 179.718 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.484 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 0.5 OUTLIER -101.28 104.13 15.15 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.691 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.834 HG22 ' CD1' ' A' ' 23' ' ' ILE . 59.4 t -98.9 114.18 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.295 -0.878 . . . . 0.0 109.601 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 105' ' ' GLY . . . -88.04 120.72 29.67 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.347 -0.846 . . . . 0.0 109.31 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 104' ' ' ALA . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.26 0.552 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 49.2 m -133.7 127.16 32.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.304 -0.873 . . . . 0.0 109.559 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.44 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 16.1 m-85 -90.69 137.61 32.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.281 -0.887 . . . . 0.0 109.361 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.962 HG23 ' HB3' ' A' ' 30' ' ' GLU . 2.0 m -139.19 110.62 7.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.646 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 5' ' ' VAL . 26.8 m -96.49 109.14 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.244 -0.91 . . . . 0.0 109.466 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -86.75 137.9 32.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -0.949 . . . . 0.0 109.43 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.734 ' HB2' ' HE3' ' A' ' 97' ' ' MET . 0.1 OUTLIER -98.47 80.27 2.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.0 109.1 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.468 ' O ' ' ND2' ' A' ' 34' ' ' ASN . . . 134.48 79.94 0.13 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 p -52.58 -88.59 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.251 -1.147 . . . . 0.0 109.563 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -172.38 37.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.555 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.21 20.37 6.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 109.435 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.432 ' HA2' ' CE ' ' A' ' 35' ' ' LYS . . . 73.02 37.41 56.3 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.455 ' O ' ' HA2' ' A' ' 8' ' ' GLY . 74.7 mt -139.89 139.38 36.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -1.121 . . . . 0.0 109.442 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.793 HD22 ' CE1' ' A' ' 39' ' ' HIS . 17.0 mt -101.25 114.31 28.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.204 -0.935 . . . . 0.0 109.561 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 14' ' ' LEU . 15.0 m -157.59 157.65 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 0.0 109.378 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -81.82 147.09 29.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 109.614 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 14.2 mm-40 -139.61 107.01 7.06 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.251 -0.905 . . . . 0.0 109.424 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.7 Cg_endo -78.1 176.19 44.15 Favored 'Cis proline' 0 C--N 1.312 -1.374 0 C-N-CA 123.761 -1.349 . . . . 0.0 110.675 0.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.07 -61.05 1.95 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.335 -0.853 . . . . 0.0 109.298 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.5 tttp -82.03 174.72 10.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.912 . . . . 0.0 109.198 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.519 ' CD2' HG13 ' A' ' 29' ' ' VAL . 5.2 tp -158.95 104.73 1.74 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.12 -0.988 . . . . 0.0 110.083 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . 0.475 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 32.1 m -87.01 90.09 8.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.188 -0.945 . . . . 0.0 108.477 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.688 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -99.7 163.43 2.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.316 -0.865 . . . . 0.0 110.348 -178.999 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.607 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 14.1 mmtt -88.03 166.74 22.6 Favored Pre-proline 0 C--N 1.301 -1.526 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PRO . . . . . 0.873 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 31.4 Cg_endo -73.09 88.86 0.92 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.693 1.596 . . . . 0.0 110.017 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 125.59 -3.13 8.15 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.485 ' OD2' ' CG ' ' A' ' 24' ' ' LYS . 62.6 m-20 -62.47 -168.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -1.145 . . . . 0.0 109.566 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.2 m -129.33 130.63 46.35 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.278 -0.889 . . . . 0.0 109.369 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.091 HG21 HD11 ' A' ' 101' ' ' ILE . 3.3 t -121.42 115.91 48.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.251 -0.905 . . . . 0.0 109.346 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.962 ' HB3' HG23 ' A' ' 4' ' ' THR . 2.0 mm-40 -99.58 132.92 44.6 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.27 -0.893 . . . . 0.0 109.635 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.6 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -131.7 94.41 3.51 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . 0.582 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.4 OUTLIER -96.58 179.68 4.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.343 -0.848 . . . . 0.0 110.663 -178.35 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASN . . . . . 0.575 ' ND2' ' HB3' ' A' ' 37' ' ' PRO . 1.7 p-10 -107.87 155.05 20.7 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.47 -0.768 . . . . 0.0 109.469 -178.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.468 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 53.2 t30 -151.19 -58.52 0.16 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.985 -1.072 . . . . 0.0 110.009 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.691 ' HB3' HD21 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -60.72 -147.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.27 -0.894 . . . . 0.0 109.124 -179.345 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.431 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 65.4 t -68.05 112.35 10.46 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.371 -0.831 . . . . 0.0 109.382 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.575 ' HB3' ' ND2' ' A' ' 33' ' ' ASN . 37.5 Cg_endo -82.01 175.33 9.32 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.807 2.338 . . . . 0.0 110.636 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.552 ' O ' ' CG ' ' A' ' 39' ' ' HIS . 37.8 Cg_endo -84.57 -156.09 1.13 Allowed 'Cis proline' 0 C--N 1.311 -1.404 0 C-N-CA 123.631 -1.404 . . . . 0.0 109.86 -1.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.793 ' CE1' HD22 ' A' ' 14' ' ' LEU . 86.0 m-70 -160.44 143.27 13.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.961 -1.087 . . . . 0.0 109.708 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.485 ' OD1' ' N ' ' A' ' 41' ' ' VAL . 63.7 t-20 -113.58 147.42 38.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.278 -0.889 . . . . 0.0 109.201 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.485 ' N ' ' OD1' ' A' ' 40' ' ' ASN . 18.8 t -128.6 118.58 47.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.277 -0.889 . . . . 0.0 109.182 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.894 HG12 ' CB ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -153.04 175.59 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.294 -0.879 . . . . 0.0 109.379 -179.804 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.65 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -130.03 135.0 47.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.941 . . . . 0.0 109.538 -179.471 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -59.6 130.49 47.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 109.353 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.87 1.99 32.44 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.245 -0.909 . . . . 0.0 109.904 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.45 ' C ' HD12 ' A' ' 47' ' ' LEU . . . -103.64 5.73 36.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.611 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.45 HD12 ' C ' ' A' ' 46' ' ' ALA . 3.6 mp -131.21 57.1 1.77 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.137 -0.977 . . . . 0.0 109.672 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -114.44 156.18 44.87 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.274 179.744 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.464 ' HG2' ' HG2' ' A' ' 81' ' ' PRO . 36.2 Cg_endo -79.38 -40.36 0.26 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.67 2.247 . . . . 0.0 110.907 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ALA . . . . . 0.501 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -106.5 28.9 7.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.07 -1.019 . . . . 0.0 109.788 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.501 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER 32.5 45.88 0.06 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.186 0.517 . . . . 0.0 110.316 179.652 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.2 m -100.56 111.93 24.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.17 -0.957 . . . . 0.0 109.783 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.76 -28.3 64.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.94 . . . . 0.0 108.982 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . 0.478 ' HA ' ' HB2' ' A' ' 57' ' ' LYS . 2.1 t0 -68.17 -23.85 64.9 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.375 -0.828 . . . . 0.0 109.435 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 17.8 tp -56.11 -61.09 2.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 109.532 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.747 ' HB1' ' OG ' ' A' ' 60' ' ' SER . . . -66.61 -23.98 66.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.649 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.478 ' HB2' ' HA ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -45.65 -64.58 0.7 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 109.52 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.98 -23.07 36.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.0 109.538 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.686 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 4.7 tp -72.65 -58.07 3.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 109.498 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . 0.894 ' CB ' HG12 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -79.67 133.52 36.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.306 -0.871 . . . . 0.0 110.021 -179.153 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.428 ' ND1' ' C ' ' A' ' 61' ' ' HIS . 16.2 p80 -107.34 149.98 27.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.384 -0.822 . . . . 0.0 108.941 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.428 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -99.59 174.5 6.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.096 -1.003 . . . . 0.0 109.461 -179.785 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.428 ' CB ' ' O ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER 70.27 126.73 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.315 -0.866 . . . . 0.0 109.42 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.0 mp -70.67 163.97 25.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 109.528 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.9 mt -83.25 160.71 21.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 109.126 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -132.26 9.29 4.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.116 -0.99 . . . . 0.0 109.81 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.503 ' HB3' ' HB2' ' A' ' 70' ' ' GLN . 9.0 t -124.66 138.31 30.99 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.18 -0.95 . . . . 0.0 109.143 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.522 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.7 Cg_endo -79.3 105.72 1.93 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.538 2.159 . . . . 0.0 110.967 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 92.75 39.09 5.34 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLN . . . . . 0.503 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 9.3 mt-30 -153.11 82.04 1.2 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.232 -1.158 . . . . 0.0 109.177 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.6 ' CB ' ' O ' ' A' ' 31' ' ' PHE . 3.2 p -99.08 -169.21 1.73 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.164 -0.96 . . . . 0.0 109.457 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 72' ' ' THR . 4.1 t -102.75 125.16 49.39 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.0 p -78.98 93.84 5.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.072 -1.018 . . . . 0.0 109.443 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' THR . . . . . 0.533 ' HG1' ' HE1' ' A' ' 31' ' ' PHE . 4.6 m -72.36 97.96 2.13 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.367 -0.833 . . . . 0.0 109.409 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.451 ' O ' ' C ' ' A' ' 76' ' ' PHE . 11.2 m -78.56 89.07 4.49 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 1.03 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 9.9 m-85 -40.46 150.26 0.28 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.744 -0.598 . . . . 0.0 109.459 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 76' ' ' PHE . 34.8 Cg_endo -77.53 168.27 22.95 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.846 2.364 . . . . 0.0 111.434 -179.049 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' A' ' 25' ' ' PRO . . . -83.46 5.45 23.75 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 81' ' ' PRO . 1.8 m-20 -99.19 -7.21 26.87 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.179 -0.951 . . . . 0.0 109.113 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.873 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -38.59 99.11 0.18 Allowed Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.593 -0.692 . . . . 0.0 109.462 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.464 ' HG2' ' HG2' ' A' ' 49' ' ' PRO . 34.8 Cg_endo -77.25 141.47 20.55 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.425 2.083 . . . . 0.0 110.629 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . 0.828 ' HB2' ' O ' ' A' ' 104' ' ' ALA . . . -43.5 132.01 4.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.409 -0.807 . . . . 0.0 109.358 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . 0.401 ' HA3' ' HB3' ' A' ' 49' ' ' PRO . . . 158.29 148.78 5.27 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -89.46 117.7 28.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.154 -1.204 . . . . 0.0 109.893 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' TYR . . . . . 0.462 ' O ' ' HB3' ' A' ' 100' ' ' LYS . 60.9 m-85 -84.02 -166.69 1.49 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.244 -0.91 . . . . 0.0 108.934 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' THR . . . . . 0.46 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 39.2 m -166.59 105.72 0.62 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.897 -1.127 . . . . 0.0 110.836 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.561 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.4 OUTLIER -104.75 165.67 10.91 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.26 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' TYR . . . . . 0.426 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 29.7 p90 -157.22 -166.62 2.1 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.786 -1.197 . . . . 0.0 110.561 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' CYS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 97' ' ' MET . 0.5 OUTLIER -130.28 126.85 38.28 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.811 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.625 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 6.0 tp10 -67.94 -43.25 36.46 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.89 . . . . 0.0 111.514 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 34.4 Cg_endo -76.59 -53.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.968 1.779 . . . . 0.0 111.205 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.592 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 34.8 m80 -89.78 30.34 1.06 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.016 -1.052 . . . . 0.0 109.614 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.6 ttt-85 -60.26 91.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.283 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 137.74 -15.82 3.56 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 14' ' ' LEU . . . -91.32 37.19 0.94 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.353 -1.086 . . . . 0.0 109.493 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.08 23.02 72.84 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' MET . . . . . 0.734 ' HE3' ' HB2' ' A' ' 7' ' ' LEU . 0.8 OUTLIER -91.26 53.57 2.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.063 -1.257 . . . . 0.0 109.299 179.791 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.3 t -137.26 118.43 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 109.445 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.561 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -127.32 172.47 18.69 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 85' ' ' TYR . 35.7 mttt -145.84 135.86 23.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -1.141 . . . . 0.0 109.649 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 1.091 HD11 HG21 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -87.36 140.69 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.957 . . . . 0.0 108.878 179.661 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.475 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 0.3 OUTLIER -115.77 95.55 5.18 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.331 -0.856 . . . . 0.0 108.883 179.305 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' VAL . . . . . 0.643 HG22 ' CD1' ' A' ' 23' ' ' ILE . 12.5 t -99.77 150.42 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.146 -0.971 . . . . 0.0 109.597 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.828 ' O ' ' HB2' ' A' ' 82' ' ' ALA . . . -89.67 -34.27 16.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.492 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 CA-C-O 117.983 -1.454 . . . . 0.0 109.49 179.973 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 28' ' ' THR . 11.9 t . . . . . 0 N--CA 1.49 1.559 0 CA-C-O 121.265 0.555 . . . . 0.0 109.585 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.477 ' CD1' HG22 ' A' ' 23' ' ' ILE . 53.1 m-85 -93.88 153.75 18.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 0.0 109.28 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.508 HG23 ' O ' ' A' ' 30' ' ' GLU . 9.5 m -142.85 135.92 28.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 109.736 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.862 HG13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -117.39 100.33 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.239 -0.913 . . . . 0.0 109.338 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.563 ' HG2' HD11 ' A' ' 32' ' ' LEU . 8.6 tttt -69.46 79.21 0.4 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.257 -0.902 . . . . 0.0 109.497 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.774 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -52.33 136.55 30.81 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.193 -0.942 . . . . 0.0 109.243 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.419 ' HA2' HD23 ' A' ' 14' ' ' LEU . . . 101.54 115.56 3.95 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.51 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 97.4 p -69.86 -82.45 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -1.129 . . . . 0.0 109.608 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 11' ' ' LYS . 2.8 p30 163.45 -50.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.885 . . . . 0.0 109.049 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.515 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 4.0 mttt -120.59 -5.72 9.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.349 -0.845 . . . . 0.0 109.252 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -100.38 -103.78 2.59 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.65 -156.51 0.69 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -1.152 . . . . 0.0 109.562 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.637 ' CD1' ' CD2' ' A' ' 92' ' ' HIS . 30.9 mt -99.86 120.57 39.98 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.18 -0.95 . . . . 0.0 109.873 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 14' ' ' LEU . 16.1 m -160.53 126.68 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.921 . . . . 0.0 109.621 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.428 ' O ' ' O ' ' A' ' 15' ' ' VAL . 6.0 m-85 -44.47 165.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.055 -1.028 . . . . 0.0 109.301 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 22.9 mt-10 -148.16 104.62 3.58 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.195 -0.94 . . . . 0.0 109.405 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.2 Cg_endo -77.59 -176.03 17.92 Favored 'Cis proline' 0 C--N 1.311 -1.426 0 C-N-CA 123.736 -1.36 . . . . 0.0 110.563 0.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.12 -47.56 50.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.622 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.81 178.04 5.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 109.331 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.862 HD11 HG13 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -153.04 141.73 20.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.967 . . . . 0.0 109.87 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.2 m -120.21 115.3 23.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.336 -0.852 . . . . 0.0 109.213 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.663 HD12 ' O ' ' A' ' 24' ' ' LYS . 1.0 OUTLIER -132.36 -176.75 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.209 -0.932 . . . . 0.0 109.738 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.663 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -104.63 177.39 1.41 Allowed Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.188 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.562 ' HD2' ' CG ' ' A' ' 24' ' ' LYS . 34.3 Cg_endo -77.18 76.69 4.09 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.213 1.942 . . . . 0.0 110.349 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 132.6 -11.78 5.19 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 26' ' ' GLY . 9.2 m-20 -53.3 -176.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.165 -1.197 . . . . 0.0 109.407 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.533 HG23 ' HA ' ' A' ' 75' ' ' THR . 26.8 m -123.39 146.62 47.83 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.163 -0.96 . . . . 0.0 109.461 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.951 HG21 HD11 ' A' ' 101' ' ' ILE . 3.4 t -137.5 124.23 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.202 -0.937 . . . . 0.0 109.24 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.533 ' OE1' ' CA ' ' A' ' 73' ' ' SER . 21.8 tp10 -100.99 130.85 47.05 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.25 -0.906 . . . . 0.0 110.109 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.484 ' O ' ' OG ' ' A' ' 71' ' ' SER . 0.4 OUTLIER -113.59 151.27 31.89 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.032 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.774 ' O ' HD21 ' A' ' 7' ' ' LEU . 2.4 pp -142.09 -177.6 5.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.816 -1.178 . . . . 0.0 110.635 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.547 ' OD1' ' HA ' ' A' ' 68' ' ' PRO . 2.5 p-10 -116.55 152.96 33.05 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -101.5 -109.01 0.23 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.815 -1.178 . . . . 0.0 109.601 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.435 ' C ' ' CG2' ' A' ' 36' ' ' VAL . 0.9 OUTLIER -128.98 36.58 4.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.805 -1.185 . . . . 0.0 109.412 -179.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.555 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 2.5 t -153.02 61.98 4.0 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.502 -0.749 . . . . 0.0 109.141 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.564 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.9 Cg_endo -80.24 175.9 9.82 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.811 2.341 . . . . 0.0 110.55 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.658 ' CG ' HD13 ' A' ' 64' ' ' LEU . 38.3 Cg_endo -85.78 159.46 59.65 Favored 'Cis proline' 0 C--N 1.31 -1.449 0 C-N-CA 123.525 -1.448 . . . . 0.0 110.483 -1.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.715 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 74.6 m-70 -116.46 141.64 47.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.472 -0.767 . . . . 0.0 109.435 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.51 126.71 53.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 109.45 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.4 ' HB ' ' NE2' ' A' ' 61' ' ' HIS . 19.8 t -116.37 126.27 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -0.936 . . . . 0.0 109.445 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.797 HG12 ' CB ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -160.12 166.39 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.38 -0.825 . . . . 0.0 109.322 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.593 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -116.74 109.65 17.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 109.382 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -53.06 144.43 15.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.874 . . . . 0.0 109.682 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.57 19.21 3.47 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.183 -0.948 . . . . 0.0 109.479 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -121.31 -30.31 4.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.083 -1.011 . . . . 0.0 109.724 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.621 HD22 HG21 ' A' ' 86' ' ' THR . 6.2 mp -96.33 61.16 2.0 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.037 -1.039 . . . . 0.0 109.518 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.503 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 10.2 p30 -141.6 162.51 46.45 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.286 -0.884 . . . . 0.0 109.49 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 33.5 Cg_endo -75.6 -16.54 18.86 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.446 2.098 . . . . 0.0 109.904 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 52' ' ' SER . . . -133.54 68.55 1.49 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -40.37 92.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.607 -0.683 . . . . 0.0 109.987 -179.519 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 50' ' ' ALA . 19.5 m -140.71 -159.21 0.93 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.341 -0.849 . . . . 0.0 109.191 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -155.81 56.95 0.61 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.245 -0.909 . . . . 0.0 109.535 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -138.78 -60.99 0.58 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.219 -0.925 . . . . 0.0 109.378 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.467 ' HG ' ' N ' ' A' ' 56' ' ' ALA . 1.6 pp -54.28 -28.16 40.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.93 . . . . 0.0 109.044 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.467 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -72.41 -39.3 68.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.324 -0.86 . . . . 0.0 109.243 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 56' ' ' ALA . 65.9 tttt -44.3 -45.8 8.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.316 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -98.01 25.45 6.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.292 -0.88 . . . . 0.0 109.421 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.716 HD21 ' CE2' ' A' ' 76' ' ' PHE . 8.2 tp -127.0 -54.88 1.38 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.869 . . . . 0.0 109.267 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.797 ' CB ' HG12 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -78.49 147.24 33.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.307 -0.871 . . . . 0.0 110.082 -178.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.4 ' NE2' ' HB ' ' A' ' 41' ' ' VAL . 30.5 p80 -122.18 174.81 6.73 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -125.06 -160.2 0.94 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.196 -0.94 . . . . 0.0 109.226 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 65.87 135.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.202 -0.936 . . . . 0.0 109.802 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.658 HD13 ' CG ' ' A' ' 38' ' ' PRO . 6.6 mt -64.76 158.63 24.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.392 -0.818 . . . . 0.0 109.576 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.697 HD22 ' HB2' ' A' ' 39' ' ' HIS . 3.5 mp -79.31 87.26 5.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.079 -1.013 . . . . 0.0 109.155 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -83.32 4.59 26.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 109.759 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.473 ' OG ' ' HG2' ' A' ' 70' ' ' GLN . 12.0 t -102.81 115.79 63.65 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.144 -0.973 . . . . 0.0 109.009 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.547 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.4 Cg_endo -78.51 95.23 1.07 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.4 2.067 . . . . 0.0 111.004 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.504 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 127.45 -17.12 6.2 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.595 -1.288 . . . . 0.0 110.125 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.502 ' HA ' ' HB3' ' A' ' 32' ' ' LEU . 8.0 pt20 -149.99 149.69 30.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.111 -1.229 . . . . 0.0 109.602 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.597 ' HG ' ' H ' ' A' ' 72' ' ' THR . 81.1 p -120.01 -78.46 0.59 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.122 -0.986 . . . . 0.0 109.5 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.597 ' H ' ' HG ' ' A' ' 71' ' ' SER . 22.8 m -160.14 119.0 2.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.327 -0.858 . . . . 0.0 109.424 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.533 ' CA ' ' OE1' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -79.53 99.75 7.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.0 109.228 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.641 HG21 ' HG ' ' A' ' 59' ' ' LEU . 26.3 m -82.54 108.4 15.91 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.337 -0.852 . . . . 0.0 109.665 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.533 ' HA ' HG23 ' A' ' 28' ' ' THR . 0.0 OUTLIER -79.36 85.77 5.15 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.476 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.931 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 23.7 m-85 -40.45 137.02 1.37 Allowed Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.5 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 35.3 Cg_endo -77.74 174.49 12.52 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.605 2.203 . . . . 0.0 111.719 -178.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.29 4.03 11.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.583 -0.698 . . . . 0.0 109.211 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.466 ' O ' ' C ' ' A' ' 80' ' ' ALA . 0.5 OUTLIER -98.13 -10.77 23.66 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.24 -0.912 . . . . 0.0 108.591 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.502 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -39.95 110.88 0.68 Allowed Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -75.19 130.97 13.57 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.263 1.975 . . . . 0.0 110.68 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -56.42 162.03 2.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.463 -0.773 . . . . 0.0 109.374 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 125.92 -117.78 2.97 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -160.51 122.5 3.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -1.152 . . . . 0.0 109.718 -179.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.632 ' CD2' ' CG2' ' A' ' 101' ' ' ILE . 4.1 m-30 -85.88 -165.43 1.24 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.14 -0.975 . . . . 0.0 108.726 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.621 HG21 HD22 ' A' ' 47' ' ' LEU . 20.7 m -165.18 101.23 0.74 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.839 -1.163 . . . . 0.0 110.678 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.504 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -107.18 165.9 11.03 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.517 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 3.9 p90 -157.07 -171.41 3.63 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.823 -1.173 . . . . 0.0 110.442 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.58 143.76 47.46 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.56 -0.713 . . . . 0.0 109.332 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.617 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 31.5 tt0 -77.6 -45.14 2.54 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.323 -0.861 . . . . 0.0 109.846 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.3 Cg_endo -79.53 -65.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 122.008 1.805 . . . . 0.0 110.197 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.715 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 3.3 m80 -73.39 63.25 0.76 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 109.375 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.1 tpp85 -90.42 -26.91 19.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.332 -0.855 . . . . 0.0 109.174 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -95.33 35.53 4.24 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 14' ' ' LEU . . . -135.73 34.42 2.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -1.145 . . . . 0.0 109.573 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 48.45 25.44 4.45 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.575 ' HE3' ' HB3' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -78.53 54.42 1.46 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.066 -1.255 . . . . 0.0 109.354 179.742 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.1 t -125.74 104.24 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.442 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.93 174.76 22.69 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.434 ' HG2' ' HA ' ' A' ' 86' ' ' THR . 11.2 mttm -150.56 131.41 14.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -1.144 . . . . 0.0 109.788 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.951 HD11 HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -83.29 126.58 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 21' ' ' LEU . 3.5 m -104.25 102.26 11.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.183 -0.948 . . . . 0.0 109.443 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.651 HG13 ' C ' ' A' ' 24' ' ' LYS . 2.4 t -99.76 92.95 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.185 -0.947 . . . . 0.0 109.466 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.923 . . . . 0.0 109.561 -179.977 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 19.0 m-85 -112.3 150.51 30.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.237 -0.914 . . . . 0.0 109.536 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.595 HG23 ' HB3' ' A' ' 30' ' ' GLU . 45.3 m -145.58 114.06 6.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.894 . . . . 0.0 109.413 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.449 ' O ' HD23 ' A' ' 7' ' ' LEU . 4.4 m -91.77 80.99 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.187 -0.946 . . . . 0.0 109.58 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 5' ' ' VAL . 9.3 mtmt -44.26 110.51 0.22 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.157 -0.964 . . . . 0.0 109.393 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.539 ' HB2' ' CE ' ' A' ' 97' ' ' MET . 0.1 OUTLIER -91.14 83.94 5.62 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.224 -0.923 . . . . 0.0 109.362 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 14' ' ' LEU . . . 144.3 102.6 0.39 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.51 ' OG ' ' N ' ' A' ' 10' ' ' ASP . 89.8 p -50.47 -82.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -1.13 . . . . 0.0 109.492 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.51 ' N ' ' OG ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -176.88 -93.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.227 -0.921 . . . . 0.0 109.508 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -100.06 54.28 0.91 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.14 -0.975 . . . . 0.0 109.625 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.59 -82.38 0.04 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.464 HD12 ' HA ' ' A' ' 13' ' ' LEU . 5.6 tp -144.89 -159.32 0.98 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.395 -1.062 . . . . 0.0 109.134 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.748 HD11 ' HB ' ' A' ' 36' ' ' VAL . 49.8 mt -119.58 124.16 45.68 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.164 -0.96 . . . . 0.0 109.425 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.451 HG13 ' O ' ' A' ' 14' ' ' LEU . 25.6 m -156.63 155.44 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.869 . . . . 0.0 109.338 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 7' ' ' LEU . 6.2 m-85 -68.45 156.57 37.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.224 -0.922 . . . . 0.0 109.674 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 16.1 mt-10 -157.39 101.07 1.88 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.462 -0.774 . . . . 0.0 109.243 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 35.3 Cg_endo -77.9 179.8 29.71 Favored 'Cis proline' 0 C--N 1.311 -1.42 0 C-N-CA 123.67 -1.388 . . . . 0.0 110.584 0.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.17 -54.69 3.61 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.267 -0.896 . . . . 0.0 109.413 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.08 153.77 24.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -0.877 . . . . 0.0 109.495 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 1.009 HD23 HG23 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -158.48 108.12 2.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.091 -1.006 . . . . 0.0 110.046 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.9 m -91.14 102.82 15.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 108.836 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 1.009 HG23 HD23 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -103.24 -179.72 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.256 -0.903 . . . . 0.0 110.49 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.734 ' O ' HG13 ' A' ' 103' ' ' VAL . 5.3 mttm -94.5 -175.81 0.51 Allowed Pre-proline 0 N--CA 1.488 1.443 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.721 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 33.6 Cg_endo -78.48 76.52 4.41 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.002 1.801 . . . . 0.0 110.607 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 121.23 43.99 0.41 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.497 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 5.0 m-20 -94.11 -178.06 4.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.253 -1.145 . . . . 0.0 108.876 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.9 m -117.7 126.1 51.87 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.203 -0.936 . . . . 0.0 109.534 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.987 HG21 HD11 ' A' ' 101' ' ' ILE . 0.7 OUTLIER -119.44 134.14 63.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.284 -0.885 . . . . 0.0 109.398 -179.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.595 ' HB3' HG23 ' A' ' 4' ' ' THR . 4.6 tt0 -105.69 141.24 37.48 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.231 -0.918 . . . . 0.0 109.813 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.564 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -134.19 96.57 3.65 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.647 ' HA ' ' HB3' ' A' ' 71' ' ' SER . 0.5 OUTLIER -98.59 168.81 9.94 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.283 -0.886 . . . . 0.0 110.491 -178.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.548 ' HB2' ' CD2' ' A' ' 39' ' ' HIS . 3.5 p-10 -94.66 153.72 17.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.547 -0.721 . . . . 0.0 109.572 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.469 ' HB2' ' HA3' ' A' ' 8' ' ' GLY . 38.5 t30 -97.1 -129.63 0.17 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.027 -1.045 . . . . 0.0 108.915 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.438 ' C ' ' CG2' ' A' ' 36' ' ' VAL . 0.5 OUTLIER -108.86 36.55 2.83 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.757 -1.214 . . . . 0.0 109.364 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.748 ' HB ' HD11 ' A' ' 14' ' ' LEU . 4.3 t -154.96 67.89 5.35 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 109.421 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.536 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.5 Cg_endo -80.41 173.95 11.82 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.6 2.2 . . . . 0.0 110.788 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 39.1 Cg_endo -85.83 165.06 54.78 Favored 'Cis proline' 0 C--N 1.312 -1.378 0 C-N-CA 123.494 -1.461 . . . . 0.0 110.305 -1.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.709 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 57.4 m-70 -119.58 140.24 50.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.934 . . . . 0.0 109.762 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 1.3 t-20 -121.92 125.96 47.55 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.356 -0.84 . . . . 0.0 109.544 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.458 ' O ' HG22 ' A' ' 42' ' ' VAL . 24.8 t -114.13 134.22 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.92 . . . . 0.0 109.17 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.775 HG13 ' HB2' ' A' ' 60' ' ' SER . 0.2 OUTLIER -156.84 166.82 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.071 -1.018 . . . . 0.0 109.855 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.517 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 4.5 m-85 -119.39 112.04 18.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.836 . . . . 0.0 109.183 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' A' ' 47' ' ' LEU . 7.5 t70 -43.74 143.21 1.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.305 -0.872 . . . . 0.0 109.733 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.876 ' HB1' ' HB2' ' A' ' 53' ' ' ALA . . . -90.54 -3.43 57.6 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.39 -0.819 . . . . 0.0 109.737 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.36 9.56 21.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.621 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.512 HD22 ' HB ' ' A' ' 86' ' ' THR . 0.5 OUTLIER -122.29 39.35 3.92 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.135 -0.978 . . . . 0.0 109.735 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.523 ' OD1' ' CA ' ' A' ' 51' ' ' LYS . 0.6 OUTLIER -112.31 165.3 13.28 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 109.419 179.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.494 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 35.0 Cg_endo -76.59 -10.06 18.63 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.606 2.204 . . . . 0.0 110.826 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -125.0 26.18 7.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.11 -0.994 . . . . 0.0 109.493 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.523 ' CA ' ' OD1' ' A' ' 48' ' ' ASN . 0.6 OUTLIER 34.28 35.58 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.134 0.492 . . . . 0.0 110.325 179.66 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 50' ' ' ALA . 19.1 m -110.85 164.03 13.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.151 -0.968 . . . . 0.0 109.74 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.876 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . . . -132.51 45.8 2.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.305 -0.872 . . . . 0.0 109.295 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.41 ' C ' ' OD1' ' A' ' 54' ' ' ASP . 7.5 t0 -111.94 -56.4 2.39 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.311 -0.868 . . . . 0.0 109.58 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.679 ' C ' HD12 ' A' ' 55' ' ' LEU . 3.3 pp -55.34 -29.87 59.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.917 . . . . 0.0 109.556 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.44 ' N ' HD12 ' A' ' 55' ' ' LEU . . . -68.11 -43.5 78.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.62 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -57.7 -39.82 78.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.367 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.4 m -87.84 16.36 5.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.227 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.858 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 9.7 tp -122.93 -45.25 2.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.346 -0.846 . . . . 0.0 109.375 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.775 ' HB2' HG13 ' A' ' 42' ' ' VAL . 37.0 p -82.16 159.35 23.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.491 -0.756 . . . . 0.0 110.247 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.55 ' HB3' HG21 ' A' ' 72' ' ' THR . 20.7 p80 -110.38 174.53 5.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.563 -0.711 . . . . 0.0 109.496 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -121.25 -163.07 1.01 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.367 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 59.19 -165.82 0.18 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.916 . . . . 0.0 109.386 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.584 ' C ' HD12 ' A' ' 65' ' ' LEU . 4.5 mp -128.55 165.08 21.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 109.327 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.584 HD12 ' C ' ' A' ' 64' ' ' LEU . 7.4 mp -103.05 107.35 18.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.179 -0.95 . . . . 0.0 109.48 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -98.19 -18.83 18.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 0.0 109.443 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.523 ' CB ' ' HB2' ' A' ' 70' ' ' GLN . 46.0 t -85.67 142.91 37.53 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.915 . . . . 0.0 109.24 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.472 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.6 Cg_endo -79.14 107.06 2.15 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.81 2.34 . . . . 0.0 111.3 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.497 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 93.61 -18.35 56.65 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.523 ' HB2' ' CB ' ' A' ' 67' ' ' SER . 0.0 OUTLIER -80.2 103.15 9.88 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.063 -1.257 . . . . 0.0 109.266 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.647 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -124.62 -168.87 1.88 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.378 -0.826 . . . . 0.0 110.22 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.682 HG23 ' O ' ' A' ' 72' ' ' THR . 9.0 t -122.01 110.33 15.69 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.7 p -78.44 111.22 14.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 108.932 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.74 HG21 ' O ' ' A' ' 59' ' ' LEU . 1.7 m -88.03 108.96 19.48 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.475 -0.766 . . . . 0.0 109.846 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.791 HG23 ' O ' ' A' ' 75' ' ' THR . 10.2 t -78.86 94.73 5.24 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.858 ' CZ ' HD21 ' A' ' 59' ' ' LEU . 4.5 m-30 -39.79 160.03 0.11 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.698 -0.626 . . . . 0.0 109.693 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.534 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 33.8 Cg_endo -75.51 163.83 33.5 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.749 2.299 . . . . 0.0 111.417 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.31 1.65 7.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.379 -0.825 . . . . 0.0 110.294 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.495 ' O ' ' O ' ' A' ' 80' ' ' ALA . 0.7 OUTLIER -98.85 -61.41 1.37 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.005 -1.059 . . . . 0.0 109.065 179.766 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.721 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . 42.88 94.7 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.447 -0.783 . . . . 0.0 109.679 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.49 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 34.3 Cg_endo -75.7 121.64 6.43 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.312 2.008 . . . . 0.0 110.155 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -42.58 133.49 3.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.47 -0.769 . . . . 0.0 109.612 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 85' ' ' TYR . . . 160.57 158.29 9.18 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.38 125.45 29.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.196 -1.179 . . . . 0.0 109.747 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.571 ' O ' ' CD2' ' A' ' 87' ' ' PHE . 9.6 m-85 -100.71 70.76 1.44 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.512 ' HB ' HD22 ' A' ' 47' ' ' LEU . 57.0 m -62.83 97.53 0.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.42 -0.8 . . . . 0.0 110.464 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.571 ' CD2' ' O ' ' A' ' 85' ' ' TYR . 1.5 p90 -99.91 162.97 12.66 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.154 -0.966 . . . . 0.0 108.635 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 97' ' ' MET . 28.9 p90 -149.99 -173.97 4.58 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.98 -1.075 . . . . 0.0 109.954 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 0.1 OUTLIER -116.34 132.27 56.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.503 -0.748 . . . . 0.0 109.562 -179.651 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.612 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 25.8 tt0 -65.92 -45.0 63.97 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.207 -0.933 . . . . 0.0 109.975 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.5 Cg_endo -79.23 -45.37 0.11 Allowed 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 121.93 1.753 . . . . 0.0 110.18 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.709 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 4.7 m80 -106.84 67.25 0.7 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 109.316 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.74 133.99 37.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 109.521 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 82.27 -4.99 74.48 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 14' ' ' LEU . . . -93.43 39.08 1.05 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.213 -1.169 . . . . 0.0 109.503 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.422 ' HA3' HG12 ' A' ' 15' ' ' VAL . . . 79.84 -3.88 67.99 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.539 ' CE ' ' HB2' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -86.59 47.17 1.44 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.178 -1.189 . . . . 0.0 109.34 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.5 t -124.23 76.15 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 0.0 109.498 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.542 ' C ' ' CE1' ' A' ' 87' ' ' PHE . . . -96.92 162.94 22.17 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.466 ' HD2' ' OG1' ' A' ' 86' ' ' THR . 15.0 mtmt -139.38 135.15 33.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -1.138 . . . . 0.0 109.199 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.987 HD11 HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -84.01 139.08 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.169 -0.957 . . . . 0.0 109.462 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.58 99.43 7.95 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.734 HG13 ' O ' ' A' ' 24' ' ' LYS . 21.8 t -99.01 95.46 4.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.196 -0.94 . . . . 0.0 110.014 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.488 0 O-C-N 121.52 -0.737 . . . . 0.0 109.329 179.854 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 CA-C-O 121.378 0.609 . . . . 0.0 109.832 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.528 ' CE1' HG22 ' A' ' 23' ' ' ILE . 10.6 m-85 -126.13 170.9 11.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.329 -0.857 . . . . 0.0 108.871 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 30' ' ' GLU . 87.1 m -157.46 116.94 3.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.07 -1.018 . . . . 0.0 110.167 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.643 HG12 ' CD1' ' A' ' 21' ' ' LEU . 10.4 m -98.57 170.78 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 121.345 -0.847 . . . . 0.0 109.032 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -143.56 87.2 1.92 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.06 -1.025 . . . . 0.0 109.874 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.633 ' HB2' ' HE1' ' A' ' 97' ' ' MET . 0.0 OUTLIER -50.86 100.12 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.183 -0.948 . . . . 0.0 109.254 179.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 14' ' ' LEU . . . 129.1 98.87 0.9 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 2.3 p -48.0 -95.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -1.161 . . . . 0.0 109.371 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 9' ' ' SER . 48.5 t0 176.86 33.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.946 . . . . 0.0 109.508 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.08 -43.05 0.64 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.159 -0.963 . . . . 0.0 109.603 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.13 44.29 0.02 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 13' ' ' LEU . 13.6 mt -151.32 160.94 43.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -1.141 . . . . 0.0 109.458 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.877 HD21 ' HB ' ' A' ' 36' ' ' VAL . 12.9 mt -120.48 103.21 8.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.308 -0.87 . . . . 0.0 109.501 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.412 HG12 ' HA3' ' A' ' 96' ' ' GLY . 26.7 m -149.8 138.6 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.718 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -56.49 153.73 9.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.15 -0.969 . . . . 0.0 108.85 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 4.6 mm-40 -143.51 103.61 5.02 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 120.995 -1.066 . . . . 0.0 109.81 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 35.6 Cg_endo -79.29 178.54 33.46 Favored 'Cis proline' 0 C--N 1.314 -1.286 0 C-N-CA 123.796 -1.335 . . . . 0.0 110.452 -0.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.03 -51.42 18.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.223 -0.923 . . . . 0.0 109.255 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? -99.15 146.45 26.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 0.0 109.237 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.643 ' CD1' HG12 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -140.46 142.36 35.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.113 -0.992 . . . . 0.0 109.826 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.452 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 32.1 m -106.52 126.22 51.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.344 -0.847 . . . . 0.0 109.096 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.846 ' CD1' HG22 ' A' ' 103' ' ' VAL . 1.0 OUTLIER -136.76 174.94 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.138 -0.976 . . . . 0.0 109.969 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.57 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -96.6 173.15 4.37 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.622 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 35.2 Cg_endo -77.58 91.66 1.17 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.346 2.03 . . . . 0.0 110.39 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 123.27 -11.35 8.6 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.501 ' OD1' ' CB ' ' A' ' 24' ' ' LYS . 5.8 m-20 -55.81 -178.69 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.287 -1.125 . . . . 0.0 109.096 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 97.3 m -124.09 140.99 52.44 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.205 -0.934 . . . . 0.0 109.43 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.977 HG21 HD11 ' A' ' 101' ' ' ILE . 1.3 t -130.93 119.28 44.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.278 -0.889 . . . . 0.0 109.364 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 4' ' ' THR . 30.9 tt0 -99.51 135.88 40.26 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.263 -0.898 . . . . 0.0 109.514 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.475 ' CD1' ' O ' ' A' ' 72' ' ' THR . 0.1 OUTLIER -127.28 152.0 48.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.126 -0.984 . . . . 0.0 108.856 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.551 ' HB3' ' N ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -140.49 -170.07 2.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.018 -1.052 . . . . 0.0 109.772 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.513 ' OD1' ' HA ' ' A' ' 68' ' ' PRO . 8.6 p-10 -114.05 169.81 8.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.429 -0.795 . . . . 0.0 109.002 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -110.02 -95.49 0.41 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.078 -1.014 . . . . 0.0 109.517 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.05 33.14 1.36 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.009 -1.057 . . . . 0.0 109.376 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.877 ' HB ' HD21 ' A' ' 14' ' ' LEU . 37.6 t -151.49 59.58 3.32 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.519 -0.738 . . . . 0.0 109.063 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 36.4 Cg_endo -77.66 173.43 14.16 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.744 2.296 . . . . 0.0 110.943 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.58 ' O ' ' CG ' ' A' ' 39' ' ' HIS . 37.5 Cg_endo -82.42 -158.57 1.69 Allowed 'Cis proline' 0 C--N 1.31 -1.467 0 C-N-CA 123.292 -1.545 . . . . 0.0 110.175 -0.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.58 ' CG ' ' O ' ' A' ' 38' ' ' PRO . 86.9 m-70 -160.85 129.52 4.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.238 -0.914 . . . . 0.0 109.431 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.07 106.04 17.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.208 -0.933 . . . . 0.0 109.379 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.648 ' O ' HG13 ' A' ' 42' ' ' VAL . 41.2 t -99.7 120.64 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.098 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.951 HG12 ' HB2' ' A' ' 60' ' ' SER . 0.8 OUTLIER -159.5 158.01 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.146 -0.972 . . . . 0.0 109.899 -179.521 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.857 ' CE2' HD23 ' A' ' 59' ' ' LEU . 3.4 m-85 -94.9 116.35 28.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.396 -0.815 . . . . 0.0 109.498 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.703 ' OD2' HD12 ' A' ' 47' ' ' LEU . 38.3 t0 -52.9 130.09 32.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.357 -0.839 . . . . 0.0 109.709 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.97 -1.9 53.7 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.214 -0.929 . . . . 0.0 109.605 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.68 12.99 34.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.156 -0.965 . . . . 0.0 109.609 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.703 HD12 ' OD2' ' A' ' 44' ' ' ASP . 5.1 mt -139.84 52.81 1.69 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.178 -0.951 . . . . 0.0 109.45 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.509 ' OD1' ' HA ' ' A' ' 51' ' ' LYS . 0.7 OUTLIER -105.07 164.36 15.29 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.935 . . . . 0.0 109.504 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 35.1 Cg_endo -78.12 -20.63 11.28 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.675 2.25 . . . . 0.0 110.956 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.486 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -126.32 26.32 6.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.041 -1.037 . . . . 0.0 109.919 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.509 ' HA ' ' OD1' ' A' ' 48' ' ' ASN . 15.6 mmtt 34.53 36.79 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.16 0.505 . . . . 0.0 110.284 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 50' ' ' ALA . 41.0 m -99.75 -162.32 0.94 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.206 -0.934 . . . . 0.0 109.584 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -166.12 80.31 0.27 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.346 -0.846 . . . . 0.0 109.268 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -155.92 -48.96 0.08 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.252 -0.905 . . . . 0.0 109.469 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.516 ' O ' HD12 ' A' ' 55' ' ' LEU . 1.5 pp -62.23 -17.14 57.49 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.163 -0.961 . . . . 0.0 109.222 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.411 ' O ' ' C ' ' A' ' 57' ' ' LYS . . . -90.33 -30.43 17.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.332 -0.855 . . . . 0.0 109.539 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -43.86 -62.73 1.02 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.913 . . . . 0.0 109.503 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.9 m -94.39 49.57 1.3 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 0.0 109.417 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.857 HD23 ' CE2' ' A' ' 43' ' ' PHE . 7.3 tp -136.27 -60.89 0.71 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.347 -0.846 . . . . 0.0 109.34 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.951 ' HB2' HG12 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -77.48 152.17 34.31 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.462 -0.774 . . . . 0.0 110.159 -178.432 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.422 ' NE2' ' N ' ' A' ' 41' ' ' VAL . 27.4 p80 -97.17 -168.59 1.72 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.547 -0.721 . . . . 0.0 109.327 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.11 -46.17 0.34 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.178 -0.951 . . . . 0.0 109.391 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -65.72 132.82 49.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.2 -0.938 . . . . 0.0 109.402 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.626 ' H ' HD12 ' A' ' 64' ' ' LEU . 5.7 mp -58.86 169.76 0.95 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.18 -0.95 . . . . 0.0 109.356 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.679 HD13 ' HB2' ' A' ' 71' ' ' SER . 0.0 OUTLIER -115.6 127.04 54.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.19 -0.944 . . . . 0.0 109.262 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.9 mtt -120.29 9.78 11.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.266 -0.896 . . . . 0.0 109.599 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.44 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 32.3 t -94.07 138.44 22.62 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 109.322 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.513 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.5 Cg_endo -79.92 95.65 1.03 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.579 2.186 . . . . 0.0 110.62 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.463 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 99.76 48.63 1.61 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.551 ' N ' ' HB3' ' A' ' 32' ' ' LEU . 6.4 tt0 -179.22 100.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.14 -1.212 . . . . 0.0 109.334 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.679 ' HB2' HD13 ' A' ' 65' ' ' LEU . 24.1 p -103.8 -79.63 0.54 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.145 -0.972 . . . . 0.0 109.723 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.572 ' N ' ' OG ' ' A' ' 71' ' ' SER . 0.4 OUTLIER -160.72 107.95 1.53 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.925 -1.109 . . . . 0.0 109.751 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.22 99.38 7.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.047 -1.033 . . . . 0.0 108.818 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.42 HG21 ' HA ' ' A' ' 59' ' ' LEU . 6.9 m -102.97 124.99 49.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.343 -0.848 . . . . 0.0 110.047 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.462 ' O ' ' C ' ' A' ' 76' ' ' PHE . 0.8 OUTLIER -89.9 93.69 9.52 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.168 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.931 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 32.5 m-85 -39.95 157.15 0.15 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.475 -0.766 . . . . 0.0 109.64 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.506 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.1 Cg_endo -75.5 161.58 37.09 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.703 2.269 . . . . 0.0 111.238 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 25' ' ' PRO . . . -74.54 5.11 5.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.557 -0.715 . . . . 0.0 109.964 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.474 ' O ' ' C ' ' A' ' 80' ' ' ALA . 0.4 OUTLIER -98.6 -67.22 0.86 Allowed 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.015 -1.053 . . . . 0.0 109.202 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.976 ' CB ' HG11 ' A' ' 103' ' ' VAL . . . 40.65 76.49 0.5 Allowed Pre-proline 0 N--CA 1.493 1.687 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 82' ' ' ALA . 35.3 Cg_endo -76.73 119.91 5.33 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.866 2.378 . . . . 0.0 111.697 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 81' ' ' PRO . . . 50.89 106.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.597 -0.689 . . . . 0.0 110.482 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.533 ' CA ' ' H ' ' A' ' 103' ' ' VAL . . . -49.0 103.71 0.08 OUTLIER Glycine 0 N--CA 1.48 1.626 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 49' ' ' PRO . 1.1 tp10 -160.32 53.33 0.32 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.273 -1.134 . . . . 0.0 109.744 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.562 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 1.1 m-85 -111.45 128.45 56.0 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.495 HG23 ' HG2' ' A' ' 100' ' ' LYS . 59.3 m -124.72 114.85 19.85 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.143 -0.973 . . . . 0.0 110.09 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.54 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.6 OUTLIER -99.98 164.45 11.99 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 89' ' ' CYS . 55.2 p90 -155.36 -162.37 1.33 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.013 -1.054 . . . . 0.0 109.662 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.436 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 0.1 OUTLIER -133.27 124.38 27.23 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.568 -0.707 . . . . 0.0 109.52 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.616 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 6.3 tt0 -61.47 -43.85 90.37 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.313 -0.867 . . . . 0.0 110.739 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.2 Cg_endo -79.42 -66.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 122.09 1.86 . . . . 0.0 110.729 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.683 ' CD2' HD13 ' A' ' 14' ' ' LEU . 10.1 m80 -75.68 55.61 0.86 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.159 -0.963 . . . . 0.0 109.256 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -82.19 109.86 16.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.34 -0.85 . . . . 0.0 109.631 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.7 -1.19 28.99 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.473 ' O ' ' O ' ' A' ' 14' ' ' LEU . . . -101.1 35.12 2.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.176 -1.191 . . . . 0.0 109.467 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.412 ' HA3' HG12 ' A' ' 15' ' ' VAL . . . 70.12 19.69 75.84 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.633 ' HE1' ' HB2' ' A' ' 7' ' ' LEU . 1.0 OUTLIER -92.04 37.25 0.98 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.082 -1.246 . . . . 0.0 109.329 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 89.4 t -125.59 110.27 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.187 -0.946 . . . . 0.0 109.686 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.54 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -118.34 173.27 14.79 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.495 ' HG2' HG23 ' A' ' 86' ' ' THR . 7.6 mtmm -148.15 129.8 15.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.099 -1.236 . . . . 0.0 109.823 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.977 HD11 HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -83.49 129.02 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.286 -0.884 . . . . 0.0 108.669 179.409 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.452 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 2.8 m -99.66 95.1 6.73 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.173 -0.954 . . . . 0.0 108.988 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.976 HG11 ' CB ' ' A' ' 80' ' ' ALA . 60.1 t -98.5 99.4 8.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.464 -0.773 . . . . 0.0 109.664 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.56 0 O-C-N 121.375 -0.828 . . . . 0.0 109.587 -179.944 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 55.6 m . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.279 0.561 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -92.7 150.21 20.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 109.39 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 30' ' ' GLU . 1.4 t -157.22 135.39 11.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.215 -0.928 . . . . 0.0 109.591 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.505 ' CG1' HD12 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -109.12 102.36 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.295 -0.878 . . . . 0.0 109.37 179.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -68.43 127.66 33.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.407 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.595 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -97.79 177.26 5.52 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.118 -0.989 . . . . 0.0 109.09 179.53 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.483 ' CA ' HD23 ' A' ' 14' ' ' LEU . . . 59.03 86.72 0.03 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.473 ' OG ' ' N ' ' A' ' 10' ' ' ASP . 93.6 p -45.27 -88.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.301 -1.117 . . . . 0.0 109.587 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.473 ' N ' ' OG ' ' A' ' 9' ' ' SER . 6.8 t70 179.6 -47.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 109.157 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.58 30.71 5.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.332 -0.855 . . . . 0.0 109.146 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.417 ' C ' ' HG ' ' A' ' 13' ' ' LEU . . . -138.96 -108.78 0.82 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.417 ' HG ' ' C ' ' A' ' 12' ' ' GLY . 0.5 OUTLIER -130.87 -155.24 0.68 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.24 -1.153 . . . . 0.0 109.61 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.579 HD22 ' CE1' ' A' ' 39' ' ' HIS . 5.3 mt -107.7 118.12 35.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.298 -0.876 . . . . 0.0 109.38 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.4 m -146.07 159.25 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.528 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -82.05 138.26 34.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.319 -0.863 . . . . 0.0 109.248 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 83.3 mt-10 -126.17 111.86 23.96 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 109.368 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.474 ' HG2' ' HG ' ' A' ' 21' ' ' LEU . 35.2 Cg_endo -78.88 -178.2 23.17 Favored 'Cis proline' 0 C--N 1.311 -1.429 0 C-N-CA 123.841 -1.316 . . . . 0.0 110.517 -0.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.61 -59.27 2.93 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.315 -0.865 . . . . 0.0 109.086 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.28 160.71 14.08 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.355 -0.84 . . . . 0.0 108.861 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.505 HD12 ' CG1' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -155.24 121.02 5.07 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.961 -1.087 . . . . 0.0 110.314 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.489 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 34.0 m -92.81 107.64 19.38 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.828 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -105.74 171.44 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.19 -0.944 . . . . 0.0 110.42 -178.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.494 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -89.58 171.34 8.94 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.017 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.644 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 34.7 Cg_endo -76.6 79.39 3.04 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.219 1.946 . . . . 0.0 110.728 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.498 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 136.91 -22.6 3.27 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.394 -1.384 . . . . 0.0 110.424 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 26' ' ' GLY . 16.4 m-20 -46.66 172.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.031 -1.276 . . . . 0.0 109.533 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.738 HG23 ' HA ' ' A' ' 75' ' ' THR . 1.3 m -115.96 119.6 36.44 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.337 -0.852 . . . . 0.0 109.406 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.051 HG21 HD11 ' A' ' 101' ' ' ILE . 2.5 t -99.48 132.31 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 121.222 -0.924 . . . . 0.0 109.518 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.477 ' HB3' ' HB ' ' A' ' 4' ' ' THR . 10.6 tt0 -113.47 142.68 45.63 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.197 -0.939 . . . . 0.0 109.53 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.589 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -138.55 95.02 2.91 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.81 HD12 ' O ' ' A' ' 33' ' ' ASN . 1.1 pp -98.77 160.4 14.3 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.228 -0.92 . . . . 0.0 110.456 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.81 ' O ' HD12 ' A' ' 32' ' ' LEU . 2.3 p-10 -79.0 -173.82 3.75 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.629 -0.67 . . . . 0.0 109.271 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.465 ' ND2' ' HG2' ' A' ' 35' ' ' LYS . 25.3 t30 -134.73 -93.27 0.3 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.138 -0.976 . . . . 0.0 109.291 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.465 ' HG2' ' ND2' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -138.45 36.17 2.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.1 -1.0 . . . . 0.0 109.412 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.557 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -157.11 61.11 2.29 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.44 -0.788 . . . . 0.0 109.011 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.557 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 36.0 Cg_endo -79.42 173.39 13.23 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.632 2.221 . . . . 0.0 111.007 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.581 ' O ' ' CD2' ' A' ' 39' ' ' HIS . 37.9 Cg_endo -84.47 -157.1 1.26 Allowed 'Cis proline' 0 C--N 1.31 -1.482 0 C-N-CA 123.298 -1.543 . . . . 0.0 110.163 -1.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.581 ' CD2' ' O ' ' A' ' 38' ' ' PRO . 81.6 m-70 -161.46 142.46 11.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.46 -0.775 . . . . 0.0 109.754 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -116.63 123.47 47.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 109.31 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.428 ' C ' ' CG2' ' A' ' 42' ' ' VAL . 70.4 t -110.17 128.55 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.326 -0.859 . . . . 0.0 109.425 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.507 ' HA ' ' HB3' ' A' ' 60' ' ' SER . 1.2 t -151.64 178.1 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.931 . . . . 0.0 109.489 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.586 ' HB2' ' HB1' ' A' ' 56' ' ' ALA . 12.1 m-85 -130.14 121.47 26.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.235 -0.915 . . . . 0.0 109.533 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.455 ' O ' ' O ' ' A' ' 43' ' ' PHE . 8.5 t0 -50.77 -177.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.355 -0.84 . . . . 0.0 109.455 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.84 14.3 2.9 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.247 -0.908 . . . . 0.0 109.501 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.71 15.37 2.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.899 . . . . 0.0 109.607 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 mp -117.29 35.72 4.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.101 -1.0 . . . . 0.0 109.601 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.531 ' OD1' ' CA ' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -130.13 156.39 79.33 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.319 -0.863 . . . . 0.0 109.071 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.761 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 35.5 Cg_endo -77.93 2.67 7.69 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.611 2.207 . . . . 0.0 111.145 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.505 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -140.2 29.64 2.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.88 -1.138 . . . . 0.0 110.103 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.531 ' CA ' ' OD1' ' A' ' 48' ' ' ASN . 0.3 OUTLIER 30.54 96.35 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 121.234 0.54 . . . . 0.0 110.577 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.579 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 1.7 m -99.23 -177.68 3.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.008 -1.057 . . . . 0.0 109.904 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.579 ' HB2' ' O ' ' A' ' 52' ' ' SER . . . 170.59 -33.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.434 -0.791 . . . . 0.0 109.21 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -89.15 -17.63 28.8 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.332 -0.855 . . . . 0.0 109.51 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 0.7 OUTLIER -106.26 -28.17 10.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.121 -0.987 . . . . 0.0 109.508 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.586 ' HB1' ' HB2' ' A' ' 43' ' ' PHE . . . -87.45 -7.07 58.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.339 -0.851 . . . . 0.0 109.85 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -79.72 -49.77 11.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.155 -0.966 . . . . 0.0 109.347 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 t -82.53 -22.06 35.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 109.559 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.922 ' HG ' HG21 ' A' ' 74' ' ' THR . 9.1 tp -53.0 -32.25 45.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.937 . . . . 0.0 108.83 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.507 ' HB3' ' HA ' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -78.8 127.92 32.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.336 -0.852 . . . . 0.0 109.74 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.891 ' HB3' HG21 ' A' ' 72' ' ' THR . 9.7 p80 -73.38 -28.58 62.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.149 -0.969 . . . . 0.0 109.048 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 1.3 mtpt 56.65 118.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.497 -0.752 . . . . 0.0 110.011 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.52 ' CB ' ' O ' ' A' ' 62' ' ' LYS . 0.5 OUTLIER 160.46 169.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.466 -0.771 . . . . 0.0 109.438 179.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 mp -102.68 123.56 46.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.172 -0.955 . . . . 0.0 109.218 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 70' ' ' GLN . 9.1 mp -84.47 81.9 8.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.581 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 30.9 mtp -93.98 2.69 56.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.164 -0.96 . . . . 0.0 109.822 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.505 ' OG ' ' HD2' ' A' ' 68' ' ' PRO . 1.0 OUTLIER -115.81 152.42 47.41 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.121 -0.987 . . . . 0.0 109.089 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.505 ' HD2' ' OG ' ' A' ' 67' ' ' SER . 33.8 Cg_endo -76.13 102.18 1.58 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.407 2.071 . . . . 0.0 110.151 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.98 -26.31 14.28 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.492 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.5 108.73 0.19 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.277 -1.131 . . . . 0.0 108.991 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.559 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . 5.2 p -140.42 -159.57 0.97 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.097 -1.002 . . . . 0.0 110.083 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.891 HG21 ' HB3' ' A' ' 61' ' ' HIS . 4.2 m -157.06 112.39 2.84 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.5 p -79.41 76.2 5.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.121 -0.987 . . . . 0.0 109.293 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.922 HG21 ' HG ' ' A' ' 59' ' ' LEU . 60.9 m -51.1 111.0 0.49 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.538 -0.726 . . . . 0.0 109.939 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.738 ' HA ' HG23 ' A' ' 28' ' ' THR . 96.0 m -80.39 92.25 5.8 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.339 -0.85 . . . . 0.0 109.047 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.941 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 11.6 m-85 -44.74 165.11 0.16 Allowed Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.374 -0.829 . . . . 0.0 109.399 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.498 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 32.6 Cg_endo -75.64 155.38 40.01 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.552 2.168 . . . . 0.0 111.362 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.26 -6.5 24.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.61 -0.681 . . . . 0.0 109.801 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -99.96 -66.31 0.91 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.2 -0.937 . . . . 0.0 109.2 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.695 ' HB3' HG11 ' A' ' 103' ' ' VAL . . . 42.59 65.75 4.88 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.407 -0.808 . . . . 0.0 109.59 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.622 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 33.5 Cg_endo -76.27 -159.81 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.374 2.049 . . . . 0.0 109.907 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.761 ' HB1' ' HD2' ' A' ' 49' ' ' PRO . . . 69.62 -84.84 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.076 -1.015 . . . . 0.0 109.189 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.441 ' HA2' ' C ' ' A' ' 103' ' ' VAL . . . 116.22 19.64 5.43 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -160.02 96.67 1.23 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.153 -1.204 . . . . 0.0 110.243 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.526 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 5.5 m-85 -111.85 125.46 54.04 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.3 m -112.69 118.3 34.64 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.0 -1.063 . . . . 0.0 110.946 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.54 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.7 OUTLIER -103.77 175.17 5.57 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.272 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -160.53 -177.61 6.32 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.662 -1.273 . . . . 0.0 110.427 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.0 137.08 54.82 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -77.24 -46.98 2.65 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.888 . . . . 0.0 110.905 -179.49 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 33.3 Cg_endo -77.49 -47.83 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.331 2.02 . . . . 0.0 112.145 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.608 ' CE1' ' HG2' ' A' ' 91' ' ' PRO . 3.3 m80 -101.32 65.42 1.06 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.736 -1.227 . . . . 0.0 110.142 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -90.12 4.83 49.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 109.163 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.31 -14.73 23.38 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.509 ' HB1' ' O ' ' A' ' 14' ' ' LEU . . . -95.91 35.01 1.45 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -1.162 . . . . 0.0 109.181 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 98' ' ' VAL . . . 48.93 27.29 6.45 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.473 ' SD ' ' HB2' ' A' ' 92' ' ' HIS . 4.1 mtp -68.39 60.73 0.09 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.976 -1.308 . . . . 0.0 109.138 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' A' ' 96' ' ' GLY . 96.7 t -139.14 110.18 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.88 . . . . 0.0 109.761 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.54 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -103.69 -171.55 25.59 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 18.2 mttt -155.1 123.63 6.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.162 -1.199 . . . . 0.0 109.758 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 1.051 HD11 HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -90.97 124.43 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.233 -0.917 . . . . 0.0 108.795 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.489 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 18.2 m -105.26 97.65 7.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.252 -0.905 . . . . 0.0 108.856 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.695 HG11 ' HB3' ' A' ' 80' ' ' ALA . 4.0 t -99.8 73.37 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.013 -1.055 . . . . 0.0 109.512 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.893 . . . . 0.0 109.526 179.967 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.4 m . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.694 ' HD2' HG22 ' A' ' 23' ' ' ILE . 58.8 m-85 -105.77 130.82 53.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -0.893 . . . . 0.0 109.328 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.659 HG23 ' O ' ' A' ' 4' ' ' THR . 10.1 t -127.61 108.76 11.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.714 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.491 HG21 ' CE1' ' A' ' 16' ' ' PHE . 19.5 m -92.83 159.5 2.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.23 -0.919 . . . . 0.0 109.537 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.403 ' O ' ' N ' ' A' ' 8' ' ' GLY . 25.4 mttt -128.26 84.26 2.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.426 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.572 ' HB2' ' CE ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -45.15 100.7 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.25 -0.906 . . . . 0.0 109.536 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 14' ' ' LEU . . . 104.46 114.22 3.93 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 1.8 p -76.21 -81.3 0.08 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -1.121 . . . . 0.0 109.254 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 9' ' ' SER . 7.5 t70 167.83 -30.19 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.335 -0.853 . . . . 0.0 109.483 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.422 ' HB2' ' HE2' ' A' ' 11' ' ' LYS . 3.3 ttmm -114.85 -14.9 11.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 109.588 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.68 -85.92 1.77 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -164.34 -148.73 0.12 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -1.135 . . . . 0.0 109.296 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.669 HD11 ' HB ' ' A' ' 36' ' ' VAL . 83.9 mt -106.11 94.92 5.43 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.257 -0.902 . . . . 0.0 109.432 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.5 m -144.57 155.41 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.199 -0.938 . . . . 0.0 109.591 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.491 ' CE1' HG21 ' A' ' 5' ' ' VAL . 10.0 m-85 -70.06 142.99 52.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 109.764 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 2.8 mt-10 -134.44 105.18 11.03 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.235 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 33.9 Cg_endo -76.34 -175.71 17.06 Favored 'Cis proline' 0 C--N 1.311 -1.403 0 C-N-CA 123.664 -1.39 . . . . 0.0 110.639 0.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.29 -9.61 54.52 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.242 -0.911 . . . . 0.0 109.89 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.852 ' C ' HD22 ' A' ' 21' ' ' LEU . 30.2 mtmt -139.02 137.34 36.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.095 -1.003 . . . . 0.0 109.492 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.852 HD22 ' C ' ' A' ' 20' ' ' LYS . 4.6 mm? -123.54 127.77 48.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.33 -0.856 . . . . 0.0 109.887 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.4 m -99.67 97.98 8.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 108.705 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.818 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.1 pt -104.16 -175.87 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.227 -0.92 . . . . 0.0 110.4 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.625 ' C ' HG13 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -113.85 179.72 0.74 Allowed Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.075 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.567 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 34.1 Cg_endo -76.93 76.47 4.12 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.009 1.806 . . . . 0.0 110.571 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 134.31 -2.02 4.18 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.5 -1.334 . . . . 0.0 110.101 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.91 -170.86 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.092 -1.24 . . . . 0.0 109.249 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.403 HG23 ' HA ' ' A' ' 75' ' ' THR . 52.2 m -137.85 112.93 9.16 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.135 -0.978 . . . . 0.0 109.675 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.993 HG21 HD11 ' A' ' 101' ' ' ILE . 0.8 OUTLIER -99.89 128.43 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.214 -0.929 . . . . 0.0 109.422 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 3' ' ' TYR . 46.3 mt-10 -99.48 163.49 12.49 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.232 -0.917 . . . . 0.0 109.205 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.519 ' CZ ' ' O ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -149.44 152.87 36.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.209 -0.932 . . . . 0.0 109.391 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.566 ' N ' HD12 ' A' ' 32' ' ' LEU . 2.3 mp -141.73 -162.59 1.42 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.146 -0.971 . . . . 0.0 109.953 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 3.3 p-10 -123.97 172.99 8.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.446 -0.784 . . . . 0.0 109.011 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 26.0 t-20 -111.64 -96.36 0.43 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.939 -1.1 . . . . 0.0 109.193 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.486 ' HE2' HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -147.13 30.91 0.93 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.18 -0.95 . . . . 0.0 108.862 179.523 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.669 ' HB ' HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -151.1 59.42 3.34 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.579 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 36.6 Cg_endo -78.49 174.86 11.75 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.761 2.307 . . . . 0.0 110.617 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.556 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 37.9 Cg_endo -84.15 172.62 44.03 Favored 'Cis proline' 0 C--N 1.31 -1.461 0 C-N-CA 123.518 -1.451 . . . . 0.0 110.37 -1.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.902 ' HB2' HD22 ' A' ' 65' ' ' LEU . 91.9 m-70 -132.04 142.01 49.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.141 -0.974 . . . . 0.0 109.729 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.519 ' ND2' ' HB3' ' A' ' 63' ' ' GLN . 4.9 t-20 -112.47 119.29 37.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.335 -0.853 . . . . 0.0 109.604 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.9 t -108.03 112.94 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.657 HG13 ' CB ' ' A' ' 60' ' ' SER . 2.4 t -139.19 170.8 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.979 -1.075 . . . . 0.0 110.566 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.53 ' H ' HG12 ' A' ' 42' ' ' VAL . 4.4 m-85 -118.45 110.58 17.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.491 -0.756 . . . . 0.0 109.345 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.517 ' HB3' ' CD2' ' A' ' 47' ' ' LEU . 6.1 t0 -48.83 139.3 10.1 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.192 -0.942 . . . . 0.0 109.278 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.29 12.84 6.0 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.251 -0.906 . . . . 0.0 109.888 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -119.8 23.99 10.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.069 -1.019 . . . . 0.0 109.668 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.517 ' CD2' ' HB3' ' A' ' 44' ' ' ASP . 0.7 OUTLIER -131.03 46.33 2.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.226 -0.921 . . . . 0.0 109.474 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 48' ' ' ASN . 0.5 OUTLIER -119.47 156.38 53.31 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.214 -0.929 . . . . 0.0 109.603 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.36 -21.56 11.65 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.676 2.251 . . . . 0.0 110.305 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.451 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -123.89 28.06 7.0 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.264 -0.898 . . . . 0.0 109.424 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.474 ' HA ' ' OD1' ' A' ' 48' ' ' ASN . 0.1 OUTLIER 38.55 48.17 1.22 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.295 0.569 . . . . 0.0 110.025 179.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.435 ' N ' ' ND2' ' A' ' 48' ' ' ASN . 22.3 m -112.02 139.22 47.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.165 -0.959 . . . . 0.0 109.434 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.464 ' O ' ' HD2' ' A' ' 57' ' ' LYS . . . -121.54 21.82 10.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.802 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.86 -32.85 34.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.203 -0.936 . . . . 0.0 109.568 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.512 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 0.5 OUTLIER -97.39 21.42 10.14 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.215 -0.928 . . . . 0.0 109.415 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -113.35 -33.88 5.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.328 -0.858 . . . . 0.0 109.294 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.464 ' HD2' ' O ' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -71.34 -48.66 48.93 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.275 -0.891 . . . . 0.0 109.028 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.1 t -77.83 -2.12 34.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 0.0 109.44 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.885 HD21 ' CE2' ' A' ' 76' ' ' PHE . 9.7 tp -89.05 -48.41 7.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.109 -0.994 . . . . 0.0 109.097 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.657 ' CB ' HG13 ' A' ' 42' ' ' VAL . 10.1 p -79.78 164.65 23.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.527 -0.733 . . . . 0.0 110.507 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.535 ' CD2' HG21 ' A' ' 72' ' ' THR . 3.5 p80 -125.0 -164.74 1.31 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.526 -0.734 . . . . 0.0 109.217 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.466 ' N ' ' CG ' ' A' ' 61' ' ' HIS . 2.2 mttp -65.43 -162.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.119 -0.988 . . . . 0.0 109.353 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.519 ' HB3' ' ND2' ' A' ' 40' ' ' ASN . 5.4 pt20 -137.07 42.44 2.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.102 -0.999 . . . . 0.0 109.876 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.61 76.53 1.64 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.182 -0.948 . . . . 0.0 109.938 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.902 HD22 ' HB2' ' A' ' 39' ' ' HIS . 4.9 mp -85.58 105.0 15.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.131 -0.981 . . . . 0.0 109.21 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.1 ttt -109.04 3.82 22.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 0.0 109.578 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.428 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 2.6 t -98.28 133.63 22.74 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 109.123 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 67' ' ' SER . 36.0 Cg_endo -78.86 78.92 3.53 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.413 2.076 . . . . 0.0 110.512 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.533 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 112.63 50.36 0.56 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.531 ' N ' ' HB3' ' A' ' 32' ' ' LEU . 0.0 OUTLIER 172.3 111.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -1.103 . . . . 0.0 109.385 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' A' ' 72' ' ' THR . 77.8 p -111.14 -78.89 0.58 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.209 -0.932 . . . . 0.0 109.199 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.535 HG21 ' CD2' ' A' ' 61' ' ' HIS . 14.7 t -160.4 164.28 32.47 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.387 -0.821 . . . . 0.0 108.945 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.2 t -115.44 126.47 54.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.156 -0.965 . . . . 0.0 109.226 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.755 HG21 ' HG ' ' A' ' 59' ' ' LEU . 56.0 m -108.3 101.74 10.91 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.303 -0.873 . . . . 0.0 109.716 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.478 ' O ' HG22 ' A' ' 75' ' ' THR . 25.1 m -79.14 80.13 5.51 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.925 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 9.1 m-85 -36.83 146.54 0.23 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.964 -0.46 . . . . 0.0 109.886 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.459 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.0 Cg_endo -75.63 168.81 23.61 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.625 2.217 . . . . 0.0 110.895 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.75 11.82 8.4 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.493 -0.754 . . . . 0.0 109.424 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 81' ' ' PRO . 0.9 OUTLIER -99.55 -24.36 14.78 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.285 -0.885 . . . . 0.0 109.329 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.567 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -37.04 96.58 0.11 Allowed Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.815 -0.553 . . . . 0.0 109.769 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.488 ' N ' ' O ' ' A' ' 79' ' ' ASP . 35.9 Cg_endo -78.62 -177.0 3.57 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.643 2.229 . . . . 0.0 110.732 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -70.39 127.32 32.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.301 -0.874 . . . . 0.0 109.266 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 167.11 145.75 4.61 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -85.07 117.02 23.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -1.137 . . . . 0.0 109.808 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.489 ' CD1' HG22 ' A' ' 101' ' ' ILE . 26.5 m-85 -92.51 153.4 19.1 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.499 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 29.6 m -138.81 114.33 9.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.837 -1.164 . . . . 0.0 110.762 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.592 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.4 OUTLIER -108.33 154.75 21.38 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.282 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.524 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 5.0 p90 -143.49 -156.77 0.72 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.052 -1.03 . . . . 0.0 110.11 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.456 ' SG ' ' HD2' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -133.41 139.19 46.62 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.323 -0.861 . . . . 0.0 109.491 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.629 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 63.1 tt0 -79.45 -42.64 1.6 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.349 -0.844 . . . . 0.0 111.035 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 34.2 Cg_endo -76.93 -46.04 0.16 Allowed 'Trans proline' 0 C--N 1.316 -1.148 0 C-N-CA 121.931 1.754 . . . . 0.0 111.068 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.687 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 15.2 m80 -102.3 33.32 3.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.0 -1.062 . . . . 0.0 109.6 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.9 ttt-85 -50.65 -36.9 37.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.129 -0.982 . . . . 0.0 109.718 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -96.27 40.26 2.64 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 92' ' ' HIS . . . -133.68 33.38 3.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.231 -1.158 . . . . 0.0 109.541 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.11 24.12 54.01 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.231 -1.147 . . . . 0.0 110.231 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.572 ' CE ' ' HB2' ' A' ' 7' ' ' LEU . 2.7 mtp -87.54 71.59 9.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.039 -1.271 . . . . 0.0 109.217 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 88.6 t -137.62 127.94 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.541 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.592 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -123.66 -174.78 14.27 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.527 ' CG ' ' O ' ' A' ' 99' ' ' GLY . 22.2 mttt -162.33 122.27 2.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.175 -1.191 . . . . 0.0 110.169 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.993 HD11 HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -88.16 121.25 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.107 -0.995 . . . . 0.0 108.406 178.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.6 101.41 12.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.021 -1.05 . . . . 0.0 109.329 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.705 HG22 ' CD1' ' A' ' 23' ' ' ILE . 2.4 t -99.77 116.47 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 109.367 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 109.385 -179.917 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.27 0.557 . . . . 0.0 109.749 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.707 ' CD2' HG22 ' A' ' 23' ' ' ILE . 23.2 m-85 -80.17 173.87 12.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.281 -0.887 . . . . 0.0 109.373 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.501 HG23 ' CB ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -156.08 113.57 3.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.149 -0.97 . . . . 0.0 109.814 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.768 ' CG1' HD13 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -101.41 114.3 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.908 . . . . 0.0 109.129 179.514 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -82.03 107.53 14.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.244 -0.91 . . . . 0.0 109.475 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.567 HD22 ' CE1' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -88.94 -169.1 2.4 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.16 -0.963 . . . . 0.0 109.108 179.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.675 ' HA2' HD23 ' A' ' 14' ' ' LEU . . . 65.05 74.51 0.48 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 p -58.44 151.57 19.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -1.177 . . . . 0.0 109.531 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -89.52 -0.72 57.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.758 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.53 -0.41 8.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.1 -1.0 . . . . 0.0 109.769 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -131.78 -105.95 1.03 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.431 ' O ' HD23 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -148.2 -91.3 0.08 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.336 -1.097 . . . . 0.0 109.462 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.675 HD23 ' HA2' ' A' ' 8' ' ' GLY . 74.0 mt -133.76 108.05 8.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.224 -0.923 . . . . 0.0 109.714 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.48 116.68 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.33 -0.856 . . . . 0.0 109.284 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.567 ' CE1' HD22 ' A' ' 7' ' ' LEU . 37.6 m-85 -45.39 151.09 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.165 -0.959 . . . . 0.0 109.27 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 7.5 mt-10 -144.69 112.91 5.0 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.159 -0.963 . . . . 0.0 109.296 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.9 Cg_endo -76.7 177.62 38.81 Favored 'Cis proline' 0 C--N 1.312 -1.387 0 C-N-CA 123.678 -1.384 . . . . 0.0 110.609 0.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.38 -1.95 35.89 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.283 -0.886 . . . . 0.0 109.675 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -134.19 161.49 34.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 109.281 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.768 HD13 ' CG1' ' A' ' 5' ' ' VAL . 0.5 OUTLIER -156.5 118.07 3.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.001 -1.062 . . . . 0.0 110.032 -179.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.516 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 92.6 m -90.5 101.4 14.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.849 . . . . 0.0 108.876 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.806 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -102.14 -172.75 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.317 -0.864 . . . . 0.0 110.317 -179.135 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.556 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -111.94 172.53 3.47 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.159 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.57 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 34.3 Cg_endo -77.41 79.83 3.07 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.364 2.043 . . . . 0.0 110.725 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 130.12 -24.56 4.48 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.577 -1.297 . . . . 0.0 109.898 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 26' ' ' GLY . 0.7 OUTLIER -51.43 -176.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.123 -1.222 . . . . 0.0 109.623 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.2 m -122.6 146.17 47.69 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.318 -0.864 . . . . 0.0 109.441 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.951 HG21 HD11 ' A' ' 101' ' ' ILE . 2.4 t -127.17 140.36 49.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.23 -0.919 . . . . 0.0 109.451 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.501 ' CB ' HG23 ' A' ' 4' ' ' THR . 1.8 mt-10 -106.85 155.85 19.3 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.165 -0.959 . . . . 0.0 109.814 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.529 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -153.52 84.63 1.18 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.598 ' H ' HD23 ' A' ' 32' ' ' LEU . 1.7 pt? -96.55 165.3 12.23 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.98 0.895 . . . . 0.0 111.941 -177.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.615 ' HB2' ' CD2' ' A' ' 39' ' ' HIS . 3.9 p30 -87.45 154.85 20.32 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.97 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 48.4 t30 -92.98 -62.78 1.31 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.057 -1.027 . . . . 0.0 109.36 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.472 ' C ' HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -158.19 35.53 0.24 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.243 -0.91 . . . . 0.0 109.291 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.593 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 26.7 t -154.73 57.42 1.71 Allowed Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.411 -0.806 . . . . 0.0 109.794 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.593 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 37.0 Cg_endo -79.97 174.54 11.44 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.579 2.186 . . . . 0.0 110.515 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.525 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.1 Cg_endo -84.34 175.57 34.37 Favored 'Cis proline' 0 C--N 1.31 -1.462 0 C-N-CA 123.549 -1.438 . . . . 0.0 110.137 -1.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.689 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 51.0 m-70 -127.09 146.56 50.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.335 -0.853 . . . . 0.0 110.116 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -113.11 110.04 19.8 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.423 HG21 ' HB2' ' A' ' 31' ' ' PHE . 42.7 t -99.28 117.82 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.143 -0.973 . . . . 0.0 109.681 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.003 HG12 ' HB2' ' A' ' 60' ' ' SER . 0.8 OUTLIER -147.81 171.49 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.445 -0.785 . . . . 0.0 109.407 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.643 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.9 OUTLIER -124.66 109.59 13.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.331 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -46.96 136.46 8.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -0.884 . . . . 0.0 109.584 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.53 45.99 1.19 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.254 -0.904 . . . . 0.0 109.538 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.68 -30.52 0.82 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 110.186 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.9 mt -103.12 77.36 1.54 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.038 -1.039 . . . . 0.0 110.013 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.469 ' OD1' ' HA ' ' A' ' 51' ' ' LYS . 1.9 p30 -126.19 153.74 74.36 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.284 -0.885 . . . . 0.0 109.159 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.06 -14.31 13.58 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.562 2.175 . . . . 0.0 111.076 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -135.9 24.46 3.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.929 -1.107 . . . . 0.0 109.999 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.469 ' HA ' ' OD1' ' A' ' 48' ' ' ASN . 1.0 OUTLIER 35.75 87.39 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.115 0.483 . . . . 0.0 110.111 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.5 m -136.99 159.57 41.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.107 -0.996 . . . . 0.0 109.763 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.81 43.87 3.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 109.271 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -143.97 -41.05 0.28 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.347 -0.845 . . . . 0.0 109.648 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.567 ' O ' HD12 ' A' ' 55' ' ' LEU . 1.3 pp -58.9 -18.11 30.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.044 -1.035 . . . . 0.0 109.135 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 57' ' ' LYS . . . -89.56 -38.74 13.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.342 -0.849 . . . . 0.0 109.314 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -44.15 -45.03 8.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 109.249 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.28 32.32 2.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -0.863 . . . . 0.0 109.16 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.795 HD21 ' CE2' ' A' ' 76' ' ' PHE . 7.1 tp -133.1 -51.37 0.89 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 0.0 109.648 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 1.003 ' HB2' HG12 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -78.74 121.18 24.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 109.766 -179.16 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.502 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 18.0 p80 -99.76 125.38 45.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.299 -0.876 . . . . 0.0 109.541 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 63' ' ' GLN . 2.2 mtpp -78.31 -37.22 45.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.186 -0.946 . . . . 0.0 109.591 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.436 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 2.4 tt0 -45.56 123.56 4.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.165 -0.959 . . . . 0.0 109.446 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.8 mp -75.97 170.66 15.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.478 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.734 HD21 ' CB ' ' A' ' 71' ' ' SER . 3.5 mp -93.1 -179.72 5.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -0.955 . . . . 0.0 109.429 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.447 ' HG3' ' C ' ' A' ' 65' ' ' LEU . 3.9 mtt -145.45 -48.52 0.23 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.065 -1.022 . . . . 0.0 110.151 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.503 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 47.2 t -80.58 144.96 57.69 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.058 -1.026 . . . . 0.0 110.224 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.475 ' HA ' HD21 ' A' ' 33' ' ' ASN . 36.5 Cg_endo -80.16 95.02 1.0 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 123.024 2.482 . . . . 0.0 110.454 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 33' ' ' ASN . . . 116.96 49.79 0.41 Allowed Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.228 -1.463 . . . . 0.0 109.83 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.537 ' N ' ' HB2' ' A' ' 32' ' ' LEU . 1.7 pt20 167.7 108.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -1.129 . . . . 0.0 109.457 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.734 ' CB ' HD21 ' A' ' 65' ' ' LEU . 95.6 p -100.1 -100.24 0.24 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.228 -0.92 . . . . 0.0 109.445 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.532 ' N ' ' OG ' ' A' ' 71' ' ' SER . 36.9 p -146.32 -157.85 0.84 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 p -143.05 93.68 2.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.06 -1.025 . . . . 0.0 109.389 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.712 HG21 ' HG ' ' A' ' 59' ' ' LEU . 42.6 m -67.44 103.24 1.26 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.377 -0.827 . . . . 0.0 109.428 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 76' ' ' PHE . 1.9 m -78.65 78.73 5.09 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.223 -0.923 . . . . 0.0 108.859 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.898 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 14.5 m-85 -40.79 144.02 0.65 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.651 -0.656 . . . . 0.0 109.306 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.475 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.9 Cg_endo -77.5 168.65 22.39 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.702 2.268 . . . . 0.0 111.149 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.45 9.78 8.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.429 -0.795 . . . . 0.0 109.447 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.469 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 28.0 t70 -99.15 -19.78 16.99 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.171 -0.956 . . . . 0.0 108.865 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.57 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -40.08 99.97 0.21 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.683 -0.635 . . . . 0.0 109.573 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.48 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 34.8 Cg_endo -76.29 133.99 15.26 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.312 2.008 . . . . 0.0 110.357 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -46.1 136.05 7.1 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.26 -0.9 . . . . 0.0 109.354 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 167.47 -139.37 5.68 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -135.67 120.1 18.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.29 -1.123 . . . . 0.0 109.733 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.585 ' CD1' HG22 ' A' ' 101' ' ' ILE . 4.0 m-85 -102.02 -179.41 3.99 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.4 m -163.63 115.41 1.42 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.9 -1.125 . . . . 0.0 110.38 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.551 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.5 OUTLIER -110.83 162.62 14.62 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -149.87 -162.01 1.46 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.989 -1.069 . . . . 0.0 109.954 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.12 126.28 28.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.348 -0.845 . . . . 0.0 109.838 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -59.33 -46.3 99.06 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 109.961 179.467 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.2 Cg_endo -78.85 -69.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.152 0 C-N-CA 122.182 1.921 . . . . 0.0 110.725 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.689 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 9.5 m80 -66.96 63.98 0.05 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.036 -1.04 . . . . 0.0 109.423 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 91' ' ' PRO . 5.8 ttp180 -92.62 -9.08 42.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 0.0 109.599 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.68 39.84 2.76 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.47 36.4 0.98 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.099 -1.236 . . . . 0.0 109.573 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' A' ' 98' ' ' VAL . . . 50.48 21.96 4.99 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.537 ' CE ' ' HB3' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -66.85 67.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.094 -1.239 . . . . 0.0 109.432 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' A' ' 96' ' ' GLY . 97.2 t -138.34 92.54 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.104 -0.997 . . . . 0.0 109.546 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.551 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -88.44 -173.31 47.14 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.501 ' CG ' ' O ' ' A' ' 99' ' ' GLY . 12.6 mttp -157.96 122.79 4.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -1.178 . . . . 0.0 109.541 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.951 HD11 HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -85.15 135.26 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 109.091 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.516 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 75.7 m -115.72 112.17 21.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.962 . . . . 0.0 108.635 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.787 HG22 ' CD1' ' A' ' 23' ' ' ILE . 8.6 t -99.37 131.64 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.941 . . . . 0.0 109.64 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 0.0 109.587 -179.92 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.487 HG22 ' HB ' ' A' ' 28' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.408 ' O ' ' N ' ' A' ' 30' ' ' GLU . 26.3 m-85 -118.47 125.42 49.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.256 -0.903 . . . . 0.0 109.499 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 30' ' ' GLU . 1.7 t -115.49 136.02 53.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 109.504 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.659 ' O ' HD23 ' A' ' 7' ' ' LEU . 0.9 OUTLIER -111.09 85.71 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.578 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -56.18 128.29 34.86 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.178 -0.951 . . . . 0.0 109.328 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.745 HD23 ' N ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -104.48 179.5 4.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.243 -0.911 . . . . 0.0 109.504 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.844 ' HA2' HD23 ' A' ' 14' ' ' LEU . . . 68.36 75.63 0.49 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.466 ' O ' ' OD2' ' A' ' 10' ' ' ASP . 1.4 p -44.84 -30.28 0.95 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -1.186 . . . . 0.0 109.501 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.469 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER 77.07 -3.06 2.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.472 -0.768 . . . . 0.0 109.652 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.33 13.67 8.26 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.132 -0.98 . . . . 0.0 109.641 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.07 -82.1 0.05 OUTLIER Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.7 tp -140.38 -151.42 0.36 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.231 -1.159 . . . . 0.0 109.685 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.844 HD23 ' HA2' ' A' ' 8' ' ' GLY . 87.5 mt -112.17 118.38 35.18 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.357 -0.84 . . . . 0.0 109.354 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 96' ' ' GLY . 6.1 m -152.03 156.91 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.179 -0.95 . . . . 0.0 109.381 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -71.41 156.37 39.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.211 -0.931 . . . . 0.0 109.454 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 47.6 mt-10 -143.88 112.86 5.35 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.416 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.1 Cg_endo -77.63 -178.6 24.53 Favored 'Cis proline' 0 C--N 1.312 -1.346 0 C-N-CA 123.739 -1.359 . . . . 0.0 110.462 0.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.14 -34.5 61.65 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.266 -0.896 . . . . 0.0 109.741 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.73 158.04 19.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 0.0 109.265 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.9 tp -151.83 107.45 3.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.102 -0.999 . . . . 0.0 109.891 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.405 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 41.0 m -81.43 95.23 7.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.152 -0.968 . . . . 0.0 109.058 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.787 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -99.7 168.62 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.397 -0.814 . . . . 0.0 110.163 -179.3 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.572 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 37.0 mttt -88.28 168.21 17.08 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.727 ' HA ' HG11 ' A' ' 103' ' ' VAL . 32.5 Cg_endo -75.54 82.77 2.03 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 121.872 1.714 . . . . 0.0 110.559 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 132.05 -13.52 5.23 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.434 ' OD2' ' HG3' ' A' ' 24' ' ' LYS . 6.8 m-20 -54.8 -176.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.16 -1.2 . . . . 0.0 109.699 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.828 HG23 ' HA ' ' A' ' 75' ' ' THR . 0.2 OUTLIER -122.1 138.77 54.33 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.365 -0.834 . . . . 0.0 109.495 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.955 HG21 HD11 ' A' ' 101' ' ' ILE . 2.0 t -118.09 137.2 52.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.172 -0.955 . . . . 0.0 109.598 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -115.18 125.6 53.6 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.246 -0.909 . . . . 0.0 109.861 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.597 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -124.69 101.48 7.13 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.598 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 1.5 mp -97.08 178.15 5.36 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.294 -0.879 . . . . 0.0 110.926 -178.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 2.8 p-10 -97.37 164.13 12.59 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.753 -0.592 . . . . 0.0 109.741 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 7' ' ' LEU . 23.7 t30 -109.35 -85.18 0.54 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.137 -0.977 . . . . 0.0 108.962 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HG2' ' ND2' ' A' ' 34' ' ' ASN . 10.5 ptmt -150.91 29.75 0.66 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.386 -0.821 . . . . 0.0 108.911 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.575 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 3.0 t -148.68 58.5 3.65 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.575 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 35.7 Cg_endo -77.65 175.06 11.7 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.564 2.176 . . . . 0.0 110.781 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.566 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.9 Cg_endo -85.45 161.96 61.32 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 123.537 -1.443 . . . . 0.0 110.614 -1.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.718 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 65.5 m-70 -120.21 142.25 49.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.357 -0.839 . . . . 0.0 109.845 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 6.6 m120 -130.83 126.4 36.18 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.545 ' HB ' ' NE2' ' A' ' 61' ' ' HIS . 1.2 t -99.57 135.7 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.209 -0.932 . . . . 0.0 109.108 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.622 HG12 ' H ' ' A' ' 43' ' ' PHE . 2.2 t -140.07 178.04 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.332 -0.855 . . . . 0.0 109.24 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.622 ' H ' HG12 ' A' ' 42' ' ' VAL . 17.6 m-85 -137.56 120.85 16.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.189 -0.945 . . . . 0.0 109.479 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 43' ' ' PHE . 5.9 t0 -54.28 -166.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.423 -0.798 . . . . 0.0 109.785 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -147.69 25.8 1.05 Allowed 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.239 -0.913 . . . . 0.0 109.614 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -119.42 -10.13 9.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.407 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.597 HD13 ' OG1' ' A' ' 86' ' ' THR . 4.7 mt -110.82 55.68 0.65 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.281 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' A' ' 48' ' ' ASN . 0.9 OUTLIER -120.01 152.96 54.91 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.258 -0.901 . . . . 0.0 109.476 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.92 -19.86 12.12 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.669 2.246 . . . . 0.0 110.644 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.47 ' O ' ' HG3' ' A' ' 51' ' ' LYS . . . -126.57 29.89 5.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.065 -1.022 . . . . 0.0 109.71 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER 34.46 59.21 0.65 Allowed 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.153 0.501 . . . . 0.0 110.33 179.665 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.8 m -132.49 171.72 13.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.15 -0.969 . . . . 0.0 109.543 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.82 16.8 0.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 109.758 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 54' ' ' ASP . 2.0 p-10 -71.11 -23.13 62.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.16 -0.963 . . . . 0.0 109.444 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.525 ' HG ' ' N ' ' A' ' 56' ' ' ALA . 1.1 pp -87.63 -27.7 22.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.242 -0.911 . . . . 0.0 109.501 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.525 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -79.73 -31.33 41.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 0.0 109.959 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -58.08 -31.54 67.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.166 -0.959 . . . . 0.0 109.745 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.5 p -105.29 -8.3 18.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.95 . . . . 0.0 110.071 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.884 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 9.3 tp -80.73 -33.02 35.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.053 -1.029 . . . . 0.0 109.297 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.479 ' HB3' ' HA ' ' A' ' 42' ' ' VAL . 0.8 OUTLIER -78.62 136.08 37.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.332 -0.855 . . . . 0.0 110.163 -179.009 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.545 ' NE2' ' HB ' ' A' ' 41' ' ' VAL . 0.4 OUTLIER -117.12 94.48 4.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.42 -0.8 . . . . 0.0 109.016 179.615 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.515 ' O ' HD13 ' A' ' 64' ' ' LEU . 0.9 OUTLIER -61.32 -12.28 13.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.307 -0.871 . . . . 0.0 110.016 -179.529 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.468 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 20.8 tt0 -43.43 122.14 2.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.142 -0.974 . . . . 0.0 109.718 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.814 ' H ' HD22 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -64.53 121.85 15.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.844 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.568 HD12 ' N ' ' A' ' 65' ' ' LEU . 8.1 mp -84.2 93.71 8.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.252 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.0 tpt -97.02 -6.56 35.07 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.268 -0.895 . . . . 0.0 109.472 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.493 ' CB ' ' HB3' ' A' ' 70' ' ' GLN . 35.1 t -84.29 138.57 39.09 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.174 -0.954 . . . . 0.0 109.325 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 67' ' ' SER . 36.3 Cg_endo -79.29 92.35 1.14 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.558 2.172 . . . . 0.0 110.86 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 91.86 24.93 24.01 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.493 ' HB3' ' CB ' ' A' ' 67' ' ' SER . 0.6 OUTLIER -137.84 89.68 2.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.242 -1.152 . . . . 0.0 109.278 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.598 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . 6.4 p -105.66 -167.92 1.38 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.154 -0.966 . . . . 0.0 109.88 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.1 t -105.6 123.08 47.33 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 73' ' ' SER . 1.7 p -78.7 109.29 12.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.985 -1.072 . . . . 0.0 109.507 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.605 HG21 ' HG ' ' A' ' 59' ' ' LEU . 24.7 m -78.44 107.3 10.98 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.422 -0.799 . . . . 0.0 109.555 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.828 ' HA ' HG23 ' A' ' 28' ' ' THR . 18.7 m -79.55 93.57 5.47 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.248 -0.907 . . . . 0.0 109.034 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.884 ' CZ ' HD21 ' A' ' 59' ' ' LEU . 3.3 m-85 -44.08 156.74 0.31 Allowed Pre-proline 0 N--CA 1.487 1.407 0 O-C-N 121.401 -0.812 . . . . 0.0 109.268 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.442 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.0 Cg_endo -76.86 168.21 23.91 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.818 2.345 . . . . 0.0 111.788 -179.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.66 8.18 15.19 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 80' ' ' ALA . 2.8 m-20 -98.87 -8.05 26.32 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.329 -0.857 . . . . 0.0 108.957 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.689 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -36.61 98.13 0.15 Allowed Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.809 -0.557 . . . . 0.0 109.702 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.455 ' N ' ' O ' ' A' ' 79' ' ' ASP . 35.3 Cg_endo -76.68 155.42 35.31 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.536 2.157 . . . . 0.0 110.628 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.54 108.34 1.64 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 109.636 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -175.44 -177.17 44.3 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 pm0 -107.69 143.79 35.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.22 -1.165 . . . . 0.0 109.661 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.555 ' CD1' HG22 ' A' ' 101' ' ' ILE . 17.9 m-85 -118.85 165.45 14.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.306 -0.872 . . . . 0.0 109.066 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.597 ' OG1' HD13 ' A' ' 47' ' ' LEU . 44.7 m -146.06 109.26 4.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.139 -0.976 . . . . 0.0 110.045 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.564 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.8 OUTLIER -106.27 160.11 15.6 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.338 -0.851 . . . . 0.0 109.16 179.435 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 88' ' ' TYR . 16.0 p90 -146.17 -168.04 2.89 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.192 -0.942 . . . . 0.0 109.59 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 0.1 OUTLIER -120.51 140.89 50.8 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.339 -0.85 . . . . 0.0 109.707 -179.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.601 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.6 tt0 -75.64 -45.73 4.2 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.291 -0.881 . . . . 0.0 109.892 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.2 Cg_endo -78.34 -51.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.14 0 C-N-CA 121.898 1.732 . . . . 0.0 110.562 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.718 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 19.8 m80 -90.25 43.58 1.15 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.137 -0.977 . . . . 0.0 109.316 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.484 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -59.38 -57.73 11.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -0.88 . . . . 0.0 109.521 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -81.23 49.82 4.07 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -138.63 38.19 2.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -1.151 . . . . 0.0 109.431 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.482 ' O ' HG12 ' A' ' 15' ' ' VAL . . . 47.58 30.47 6.39 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.521 ' HE2' ' C ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -92.32 68.56 5.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.221 -1.164 . . . . 0.0 109.203 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.2 t -136.12 112.06 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.912 . . . . 0.0 109.579 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.564 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -108.96 -171.54 20.94 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.489 ' HG2' ' HA ' ' A' ' 86' ' ' THR . 14.5 mttp -159.12 119.62 3.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -1.157 . . . . 0.0 109.855 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.955 HD11 HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -82.96 143.34 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.089 -1.007 . . . . 0.0 108.47 179.19 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.405 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -119.54 95.93 4.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.149 -0.969 . . . . 0.0 109.041 179.648 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.731 HG22 ' CD1' ' A' ' 23' ' ' ILE . 2.1 t -99.86 131.81 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.272 -0.893 . . . . 0.0 109.655 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.621 0 O-C-N 121.292 -0.88 . . . . 0.0 109.305 179.929 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.27 0.557 . . . . 0.0 109.5 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -94.06 136.95 33.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.242 -0.911 . . . . 0.0 109.529 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.87 102.84 7.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.885 . . . . 0.0 109.557 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.899 HG22 ' O ' ' A' ' 30' ' ' GLU . 2.8 m -91.79 48.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.231 -0.918 . . . . 0.0 109.614 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -47.54 92.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 109.43 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -53.97 170.54 0.12 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.228 -0.92 . . . . 0.0 109.665 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.496 ' HA3' ' HB2' ' A' ' 34' ' ' ASN . . . 74.35 122.29 0.1 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.1 p -68.55 -70.12 0.29 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.218 -1.166 . . . . 0.0 109.545 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 179.79 -59.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 109.358 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -140.06 41.25 1.96 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.284 -0.885 . . . . 0.0 109.517 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.95 -97.17 0.34 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 mt -116.7 170.51 8.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.262 -1.14 . . . . 0.0 109.691 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.779 HD11 ' HB ' ' A' ' 36' ' ' VAL . 46.0 mt -100.08 120.07 39.27 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.374 -0.829 . . . . 0.0 108.987 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 14' ' ' LEU . 1.4 m -159.95 145.97 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.076 -1.015 . . . . 0.0 109.716 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.497 ' HA ' ' HA ' ' A' ' 7' ' ' LEU . 7.2 m-85 -56.68 154.53 8.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 109.046 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 42.5 mt-10 -145.29 109.65 4.59 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.124 -0.985 . . . . 0.0 109.448 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 35.7 Cg_endo -78.8 174.8 49.34 Favored 'Cis proline' 0 C--N 1.312 -1.354 0 C-N-CA 123.904 -1.29 . . . . 0.0 110.491 0.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.75 -62.37 1.41 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.14 -0.975 . . . . 0.0 109.053 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -89.5 154.04 20.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.35 -0.844 . . . . 0.0 108.787 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.843 ' CD1' HG12 ' A' ' 5' ' ' VAL . 1.2 mt -147.12 135.88 22.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.951 -1.093 . . . . 0.0 110.216 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 102' ' ' THR . 28.6 m -109.03 98.12 7.64 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.755 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -102.35 177.69 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.396 -0.815 . . . . 0.0 110.156 -179.277 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.55 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -101.2 174.73 2.73 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.552 ' HA ' ' CB ' ' A' ' 80' ' ' ALA . 34.9 Cg_endo -77.15 79.19 3.21 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.262 1.975 . . . . 0.0 110.505 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 134.96 -12.49 4.46 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.445 ' OD2' ' HB2' ' A' ' 24' ' ' LYS . 64.1 m-20 -55.09 -179.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.151 -1.206 . . . . 0.0 109.294 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 90.5 m -126.64 113.64 16.99 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.149 -0.97 . . . . 0.0 109.658 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.815 HG21 HD11 ' A' ' 101' ' ' ILE . 2.0 t -104.74 131.0 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.149 -0.969 . . . . 0.0 109.53 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.899 ' O ' HG22 ' A' ' 5' ' ' VAL . 1.7 mp0 -101.84 155.54 18.07 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.249 -0.907 . . . . 0.0 109.696 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -148.35 85.25 1.51 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.572 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.5 OUTLIER -97.55 179.51 4.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.362 -0.836 . . . . 0.0 110.942 -178.491 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 2.1 p-10 -90.09 157.01 17.98 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.591 -0.693 . . . . 0.0 109.263 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.496 ' HB2' ' HA3' ' A' ' 8' ' ' GLY . 3.8 t30 -97.59 -73.65 0.6 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.982 -1.074 . . . . 0.0 109.338 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.494 ' C ' HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -163.5 31.91 0.09 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 108.923 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.779 ' HB ' HD11 ' A' ' 14' ' ' LEU . 27.8 t -157.47 63.95 3.03 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.603 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 33.6 Cg_endo -77.32 177.33 8.98 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 123.097 2.531 . . . . 0.0 111.026 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.603 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 39.7 Cg_endo -87.28 158.81 48.42 Favored 'Cis proline' 0 C--N 1.313 -1.316 0 O-C-N 123.698 1.367 . . . . 0.0 111.328 -1.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.703 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 65.3 m-70 -119.55 141.52 49.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.707 -0.62 . . . . 0.0 109.388 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -117.99 119.36 34.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.872 . . . . 0.0 108.94 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.574 ' HB ' ' NE2' ' A' ' 61' ' ' HIS . 2.0 t -100.42 128.48 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.131 -0.98 . . . . 0.0 109.8 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.916 HG12 ' CB ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -157.3 165.5 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.546 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.64 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.4 OUTLIER -124.03 134.61 53.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.099 -1.001 . . . . 0.0 109.284 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -66.97 133.35 49.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.348 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.542 ' HB1' ' CB ' ' A' ' 53' ' ' ALA . . . -82.37 10.63 6.7 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.27 -0.894 . . . . 0.0 109.918 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.8 19.65 13.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.129 -0.982 . . . . 0.0 109.437 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.26 49.88 2.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -0.934 . . . . 0.0 109.687 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.521 ' OD1' ' CA ' ' A' ' 51' ' ' LYS . 1.5 p30 -118.26 160.47 39.32 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.347 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.482 ' HG2' ' HB2' ' A' ' 81' ' ' PRO . 36.3 Cg_endo -77.82 -5.31 15.24 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.512 2.142 . . . . 0.0 110.662 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -125.46 27.36 6.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.115 -0.991 . . . . 0.0 109.62 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.521 ' CA ' ' OD1' ' A' ' 48' ' ' ASN . 3.6 ptmt 34.0 38.55 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.134 0.493 . . . . 0.0 110.39 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.51 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 1.8 m -115.47 170.19 8.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.083 -1.011 . . . . 0.0 109.676 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.542 ' CB ' ' HB1' ' A' ' 45' ' ' ALA . . . -139.68 51.9 1.73 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.958 . . . . 0.0 109.57 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -115.38 -42.07 3.2 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.311 -0.868 . . . . 0.0 109.493 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.94 HD22 ' HG3' ' A' ' 81' ' ' PRO . 1.8 pp -56.71 -28.18 60.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.892 . . . . 0.0 109.498 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.477 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -79.93 -35.06 38.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.929 . . . . 0.0 109.538 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -51.1 -22.92 2.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.177 -0.952 . . . . 0.0 109.373 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.1 m -123.18 18.42 9.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.626 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.878 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 12.3 tp -119.69 -41.97 2.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.11 -0.994 . . . . 0.0 109.635 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.916 ' CB ' HG12 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -78.04 127.44 32.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.384 -179.445 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.746 ' CG ' HG21 ' A' ' 72' ' ' THR . 0.5 OUTLIER -108.63 137.14 47.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.374 -0.829 . . . . 0.0 109.486 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -85.83 -159.74 0.48 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.227 -0.921 . . . . 0.0 109.51 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.518 ' CB ' ' O ' ' A' ' 62' ' ' LYS . 1.6 tt0 77.33 136.4 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.408 -0.807 . . . . 0.0 109.533 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.461 ' HB2' ' CE ' ' A' ' 66' ' ' MET . 5.2 mp -85.91 133.5 33.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.451 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.755 HD22 ' HA ' ' A' ' 71' ' ' SER . 9.9 mt -80.12 124.21 28.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 0.0 109.48 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.461 ' CE ' ' HB2' ' A' ' 64' ' ' LEU . 6.7 mtt -124.99 4.58 7.98 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.25 -0.906 . . . . 0.0 109.601 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.464 ' OG ' ' HB3' ' A' ' 70' ' ' GLN . 47.4 t -91.89 142.33 26.39 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.188 -0.945 . . . . 0.0 109.332 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.6 86.3 1.7 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.62 2.213 . . . . 0.0 110.892 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.528 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 95.23 44.41 3.27 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.487 ' HA ' HD23 ' A' ' 32' ' ' LEU . 3.6 tp60 -162.32 101.45 1.08 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.243 -1.151 . . . . 0.0 109.244 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.755 ' HA ' HD22 ' A' ' 65' ' ' LEU . 3.2 p -112.11 -103.77 0.4 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.405 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.746 HG21 ' CG ' ' A' ' 61' ' ' HIS . 9.0 t -161.02 117.94 2.3 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.0 t -78.54 116.58 19.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.957 -1.089 . . . . 0.0 109.895 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.436 ' HG1' ' HE1' ' A' ' 31' ' ' PHE . 0.6 OUTLIER -95.52 105.05 16.98 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 76' ' ' PHE . 41.4 m -78.91 92.27 4.89 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.248 -0.907 . . . . 0.0 108.905 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.878 ' CZ ' HD21 ' A' ' 59' ' ' LEU . 7.0 m-85 -42.8 161.34 0.19 Allowed Pre-proline 0 N--CA 1.488 1.442 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.477 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 33.1 Cg_endo -75.45 159.04 40.11 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.346 2.031 . . . . 0.0 111.185 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.54 -5.64 20.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.551 -0.718 . . . . 0.0 109.644 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 80' ' ' ALA . 0.9 OUTLIER -99.41 -65.6 0.95 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.187 -0.946 . . . . 0.0 109.284 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.552 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . . . 61.26 133.09 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.337 -0.852 . . . . 0.0 109.407 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.94 ' HG3' HD22 ' A' ' 55' ' ' LEU . 36.1 Cg_endo -78.42 99.75 1.3 Allowed 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.345 2.03 . . . . 0.0 110.284 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.448 ' C ' ' O ' ' A' ' 81' ' ' PRO . . . -41.42 117.82 0.96 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.378 -0.826 . . . . 0.0 109.683 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.454 ' HA3' ' HG3' ' A' ' 49' ' ' PRO . . . 156.13 -156.31 26.98 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.599 ' HG3' HG23 ' A' ' 102' ' ' THR . 0.4 OUTLIER -122.0 126.1 47.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -1.167 . . . . 0.0 109.508 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.627 ' CD2' ' CG2' ' A' ' 101' ' ' ILE . 1.5 m-30 -92.89 -164.7 1.21 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.889 . . . . 0.0 108.941 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.491 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 65.4 m -167.19 111.68 0.72 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.868 -1.145 . . . . 0.0 110.505 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 0.7 OUTLIER -112.05 157.4 20.8 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.378 -0.826 . . . . 0.0 108.774 178.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.783 ' CB ' HG22 ' A' ' 98' ' ' VAL . 24.2 p90 -145.47 -162.93 1.61 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.013 -1.055 . . . . 0.0 109.916 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.502 ' O ' ' HB3' ' A' ' 93' ' ' ARG . 0.1 OUTLIER -126.94 129.14 47.57 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.373 -0.83 . . . . 0.0 109.829 -179.265 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.613 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.3 tt0 -65.77 -43.77 60.99 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.264 -0.898 . . . . 0.0 110.264 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.4 Cg_endo -78.35 -52.64 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 121.889 1.726 . . . . 0.0 110.446 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.703 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 9.2 m80 -90.21 34.23 0.87 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.172 -0.955 . . . . 0.0 109.24 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.502 ' HB3' ' O ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -64.52 126.53 28.13 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.237 -0.914 . . . . 0.0 109.532 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 92.31 2.33 68.35 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.538 ' HB3' ' HE3' ' A' ' 97' ' ' MET . . . -98.23 32.97 2.29 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.117 -1.225 . . . . 0.0 109.414 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.39 7.09 37.58 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.538 ' HE3' ' HB3' ' A' ' 95' ' ' ALA . 16.7 mtm -90.75 63.28 5.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.976 -1.308 . . . . 0.0 109.598 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.783 HG22 ' CB ' ' A' ' 88' ' ' TYR . 84.2 t -140.52 76.24 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.387 -0.82 . . . . 0.0 109.41 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.489 ' O ' ' CG ' ' A' ' 100' ' ' LYS . . . -72.27 -167.72 10.22 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.491 ' HG2' ' HA ' ' A' ' 86' ' ' THR . 5.7 mtmt -159.25 131.37 6.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.355 -1.085 . . . . 0.0 109.484 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.865 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 0.4 OUTLIER -82.59 133.37 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.12 -0.987 . . . . 0.0 108.925 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.599 HG23 ' HG3' ' A' ' 84' ' ' GLU . 7.6 m -116.31 91.75 3.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.257 -0.902 . . . . 0.0 109.038 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.521 HG22 HG13 ' A' ' 23' ' ' ILE . 2.1 t -99.42 135.92 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.205 -0.935 . . . . 0.0 109.6 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.576 0 O-C-N 121.259 -0.901 . . . . 0.0 109.472 -179.975 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.64 ' CD2' HG22 ' A' ' 23' ' ' ILE . 83.4 m-85 -96.93 168.78 10.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.935 . . . . 0.0 109.301 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.6 m -156.99 144.17 18.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 109.761 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.689 HG12 ' H ' ' A' ' 17' ' ' GLU . 2.5 t -128.96 69.57 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.392 -0.817 . . . . 0.0 109.0 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -51.07 106.74 0.14 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.389 -0.819 . . . . 0.0 110.017 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.624 HD11 ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -90.86 150.91 21.36 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.292 -0.88 . . . . 0.0 109.054 179.399 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.452 ' HA3' ' CB ' ' A' ' 34' ' ' ASN . . . 117.6 66.88 0.35 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.511 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -51.22 -23.32 3.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.162 -1.199 . . . . 0.0 109.262 179.646 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.511 ' CB ' ' O ' ' A' ' 9' ' ' SER . 10.5 t0 80.4 29.54 0.23 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.609 -0.682 . . . . 0.0 109.45 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.78 19.12 10.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -0.9 . . . . 0.0 109.209 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.18 11.11 53.47 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.802 ' C ' HD23 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -156.88 143.87 18.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.328 -1.101 . . . . 0.0 109.419 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 1.003 HD12 ' CE1' ' A' ' 39' ' ' HIS . 1.1 mt -101.93 143.44 31.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.181 -0.949 . . . . 0.0 109.315 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 14' ' ' LEU . 1.8 m -154.57 128.78 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.92 . . . . 0.0 109.601 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.639 ' HD2' HG11 ' A' ' 5' ' ' VAL . 38.2 m-85 -48.83 142.01 6.84 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.188 -0.945 . . . . 0.0 109.106 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.689 ' H ' HG12 ' A' ' 5' ' ' VAL . 19.4 mt-10 -136.56 109.71 9.49 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.273 -0.892 . . . . 0.0 109.254 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.474 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 34.9 Cg_endo -77.29 -178.03 22.92 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 123.73 -1.362 . . . . 0.0 110.64 0.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.19 4.29 20.73 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.244 -0.91 . . . . 0.0 109.763 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 5.2 pttt -146.06 160.72 41.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.149 -0.969 . . . . 0.0 109.488 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.678 HD12 HG22 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -157.73 136.62 11.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.187 -0.946 . . . . 0.0 109.48 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.0 m -104.93 99.16 8.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.296 -0.878 . . . . 0.0 109.286 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.792 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -99.48 173.47 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.234 -0.916 . . . . 0.0 109.523 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.582 ' CG ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -95.33 177.54 1.76 Allowed Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.044 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.684 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 34.7 Cg_endo -76.41 72.72 5.39 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.088 1.859 . . . . 0.0 110.342 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 126.18 28.6 1.0 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.18 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.517 ' OD1' ' CB ' ' A' ' 24' ' ' LYS . 4.5 m-20 -88.13 -165.84 1.43 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.205 -1.173 . . . . 0.0 108.852 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.731 HG23 ' HA ' ' A' ' 75' ' ' THR . 21.4 m -136.56 110.56 8.26 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.956 -1.09 . . . . 0.0 109.695 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.993 HG21 HD11 ' A' ' 101' ' ' ILE . 1.7 t -99.36 136.13 31.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.321 -0.862 . . . . 0.0 109.102 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -104.76 142.54 34.52 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.104 -0.997 . . . . 0.0 110.198 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.592 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -139.7 142.63 36.87 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.375 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.732 HD23 ' N ' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -140.94 -169.95 2.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.894 -1.129 . . . . 0.0 110.523 -179.383 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.514 ' OD1' ' HA ' ' A' ' 68' ' ' PRO . 6.4 p-10 -114.9 154.28 28.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.467 -0.771 . . . . 0.0 109.352 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 7' ' ' LEU . 35.3 t30 -100.38 -88.09 0.36 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.024 -1.047 . . . . 0.0 109.637 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.403 ' C ' HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -144.14 33.72 1.22 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.073 -1.017 . . . . 0.0 109.197 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.877 ' HB ' HD11 ' A' ' 14' ' ' LEU . 92.3 t -153.77 64.53 4.88 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.478 -0.763 . . . . 0.0 109.135 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.564 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.5 Cg_endo -79.79 175.85 10.09 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.775 2.317 . . . . 0.0 110.455 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.564 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.8 Cg_endo -86.24 -172.93 8.84 Favored 'Cis proline' 0 C--N 1.31 -1.46 0 C-N-CA 123.655 -1.394 . . . . 0.0 110.65 -1.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 1.003 ' CE1' HD12 ' A' ' 14' ' ' LEU . 63.2 m-70 -137.91 159.23 42.55 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.38 -0.825 . . . . 0.0 109.583 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -138.71 118.33 13.04 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.5 t -99.58 111.45 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.668 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.492 ' HA ' ' CB ' ' A' ' 60' ' ' SER . 13.8 t -135.91 162.64 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.338 -0.851 . . . . 0.0 109.311 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.915 ' CE2' HD23 ' A' ' 59' ' ' LEU . 20.1 m-85 -115.88 120.75 40.23 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.262 -0.899 . . . . 0.0 109.62 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.633 ' OD2' HD23 ' A' ' 47' ' ' LEU . 39.8 t0 -44.08 140.54 2.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.415 -0.803 . . . . 0.0 109.768 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.7 1.06 55.49 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.339 -0.851 . . . . 0.0 109.646 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.58 -26.19 13.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.551 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.633 HD23 ' OD2' ' A' ' 44' ' ' ASP . 4.0 mm? -95.49 61.73 2.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 109.265 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 52' ' ' SER . 2.3 p30 -107.59 150.06 39.67 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.324 -0.86 . . . . 0.0 109.487 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.491 ' HB3' ' HA3' ' A' ' 83' ' ' GLY . 35.8 Cg_endo -77.96 -9.78 16.76 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.616 2.211 . . . . 0.0 110.331 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.452 ' C ' ' HG2' ' A' ' 51' ' ' LYS . . . -134.55 31.59 3.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.27 -0.894 . . . . 0.0 109.452 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.462 ' HA ' ' OD1' ' A' ' 48' ' ' ASN . 27.3 pttt 36.47 39.08 0.09 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.814 -0.554 . . . . 0.0 110.166 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.522 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 6.0 m -108.76 -157.63 0.62 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.568 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -169.07 33.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -0.859 . . . . 0.0 109.508 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.19 -42.26 3.76 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.215 -0.928 . . . . 0.0 109.826 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.672 ' C ' HD12 ' A' ' 55' ' ' LEU . 2.0 pp -47.35 -33.32 5.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 109.449 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.84 -37.41 24.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 109.483 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.77 -31.26 2.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 0.0 109.388 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.4 p -115.02 31.67 6.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.245 -0.909 . . . . 0.0 109.39 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.919 HD21 ' CE2' ' A' ' 76' ' ' PHE . 8.3 tp -131.37 -52.71 1.02 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.926 . . . . 0.0 109.613 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.51 ' OG ' ' CD2' ' A' ' 43' ' ' PHE . 10.2 m -77.37 160.37 28.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 110.29 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.546 ' CE1' ' O ' ' A' ' 63' ' ' GLN . 18.9 p80 -119.99 147.29 44.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.531 -0.731 . . . . 0.0 109.336 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.52 -55.86 3.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -0.945 . . . . 0.0 109.529 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.546 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -46.74 120.84 3.18 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.347 -0.846 . . . . 0.0 109.665 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.659 ' H ' HD12 ' A' ' 64' ' ' LEU . 6.3 mp -66.48 162.06 21.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.091 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.848 HD13 ' HA ' ' A' ' 71' ' ' SER . 0.5 OUTLIER -109.06 152.07 25.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.051 -1.031 . . . . 0.0 109.692 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 3.4 mtp -136.6 7.45 3.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.314 -0.866 . . . . 0.0 109.548 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.52 ' HB3' ' CG ' ' A' ' 70' ' ' GLN . 8.4 t -79.27 134.53 58.84 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.235 -0.916 . . . . 0.0 109.347 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.514 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 35.9 Cg_endo -78.44 90.1 1.29 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.721 2.28 . . . . 0.0 111.612 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.514 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 113.17 34.76 1.74 Allowed Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.63 -1.272 . . . . 0.0 110.678 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.534 ' N ' ' HB2' ' A' ' 32' ' ' LEU . 0.7 OUTLIER 177.01 119.93 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.01 -1.288 . . . . 0.0 109.669 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.848 ' HA ' HD13 ' A' ' 65' ' ' LEU . 60.2 p -109.97 -75.14 0.63 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.284 -0.885 . . . . 0.0 109.325 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.539 ' N ' ' OG ' ' A' ' 71' ' ' SER . 1.6 t -160.75 107.84 1.52 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.186 -0.946 . . . . 0.0 109.633 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.3 t -78.78 85.01 4.81 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.026 -1.046 . . . . 0.0 108.298 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.786 HG21 ' HG ' ' A' ' 59' ' ' LEU . 22.6 m -75.63 108.37 8.42 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.523 -0.736 . . . . 0.0 110.378 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.731 ' HA ' HG23 ' A' ' 28' ' ' THR . 3.2 t -79.13 87.99 4.86 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 1.004 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 30.1 m-85 -36.69 150.75 0.12 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.782 -0.574 . . . . 0.0 110.314 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.508 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 35.2 Cg_endo -76.74 161.36 33.7 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.995 2.463 . . . . 0.0 111.501 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.49 6.57 10.01 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.5 ' O ' ' C ' ' A' ' 80' ' ' ALA . 3.1 p30 -98.87 -4.84 32.11 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.286 -0.884 . . . . 0.0 109.096 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.684 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -33.82 105.27 0.25 Allowed Pre-proline 0 N--CA 1.498 1.961 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 82' ' ' ALA . 35.9 Cg_endo -77.84 41.44 1.0 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.522 2.148 . . . . 0.0 111.407 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.519 ' HA ' ' HB ' ' A' ' 103' ' ' VAL . . . 46.87 -178.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -0.866 . . . . 0.0 110.006 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.491 ' HA3' ' HB3' ' A' ' 49' ' ' PRO . . . 94.21 -168.14 28.22 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -111.92 153.83 26.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.522 -0.987 . . . . 0.0 109.635 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.448 ' O ' ' HB ' ' A' ' 86' ' ' THR . 19.8 m-30 -113.63 -39.32 4.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.392 -0.817 . . . . 0.0 108.92 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.448 ' HB ' ' O ' ' A' ' 85' ' ' TYR . 92.4 m 61.79 100.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.313 -0.867 . . . . 0.0 110.333 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -105.05 173.17 6.42 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.203 -0.936 . . . . 0.0 108.905 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 97' ' ' MET . 16.7 p90 -155.39 -164.07 1.68 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.893 -1.13 . . . . 0.0 110.046 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.516 ' HB2' ' HB3' ' A' ' 97' ' ' MET . 0.6 OUTLIER -136.75 144.75 43.96 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.424 -0.798 . . . . 0.0 109.447 -179.692 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.604 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 40.6 tt0 -83.12 -45.07 0.86 Allowed Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.264 -0.898 . . . . 0.0 110.433 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.0 Cg_endo -78.31 -46.93 0.11 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.048 1.832 . . . . 0.0 110.902 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.74 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 68.7 m80 -87.79 18.07 4.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.014 -1.054 . . . . 0.0 109.643 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -53.25 135.94 37.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.127 -0.983 . . . . 0.0 109.421 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.05 -8.25 80.29 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.12 38.66 1.37 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.16 -1.2 . . . . 0.0 109.603 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.98 12.5 29.78 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.516 ' HB3' ' HB2' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -81.92 56.8 3.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.179 -1.189 . . . . 0.0 109.699 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 88' ' ' TYR . 21.6 t -139.6 72.15 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.104 -0.998 . . . . 0.0 109.947 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.438 ' C ' ' CG ' ' A' ' 100' ' ' LYS . . . -80.95 -173.23 47.18 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.438 ' CG ' ' C ' ' A' ' 99' ' ' GLY . 0.1 OUTLIER -152.15 136.23 16.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.933 -1.334 . . . . 0.0 110.148 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 1.004 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -86.58 119.54 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.172 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.74 103.42 15.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.217 -0.927 . . . . 0.0 109.099 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.724 HG22 ' CD1' ' A' ' 23' ' ' ILE . 17.3 t -99.19 68.45 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.487 -0.758 . . . . 0.0 109.444 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.468 0 O-C-N 121.316 -0.865 . . . . 0.0 109.275 -179.996 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.6 m . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 121.285 0.564 . . . . 0.0 109.51 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.518 ' CD2' HG22 ' A' ' 23' ' ' ILE . 23.5 m-85 -84.35 108.88 17.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.731 ' CG2' HD21 ' A' ' 32' ' ' LEU . 52.9 m -109.58 150.06 28.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.564 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.722 HG12 ' H ' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -113.43 160.84 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -0.924 . . . . 0.0 109.227 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -125.75 101.1 6.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.929 . . . . 0.0 109.505 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.611 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -89.19 170.98 10.14 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.168 -0.958 . . . . 0.0 109.252 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.85 ' CA ' HD23 ' A' ' 14' ' ' LEU . . . 86.52 77.39 1.23 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 13' ' ' LEU . 99.7 p -44.29 -65.65 0.49 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -1.151 . . . . 0.0 109.218 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 9' ' ' SER . 0.4 OUTLIER 168.47 -25.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.07 179.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -113.77 49.54 0.98 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.059 -1.025 . . . . 0.0 110.078 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.22 -37.85 3.24 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' A' ' 9' ' ' SER . 2.9 mp -69.61 118.85 13.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.124 -1.221 . . . . 0.0 109.578 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.85 HD23 ' CA ' ' A' ' 8' ' ' GLY . 0.5 OUTLIER -116.19 110.81 19.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.349 -0.844 . . . . 0.0 109.488 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.68 133.34 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.345 -0.847 . . . . 0.0 109.516 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -49.31 153.73 0.98 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.045 -1.034 . . . . 0.0 109.097 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.722 ' H ' HG12 ' A' ' 5' ' ' VAL . 5.7 mt-10 -143.0 109.06 5.44 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.156 -0.965 . . . . 0.0 109.445 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 35.0 Cg_endo -77.21 179.56 30.84 Favored 'Cis proline' 0 C--N 1.312 -1.368 0 C-N-CA 123.82 -1.325 . . . . 0.0 110.491 0.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.68 -44.08 71.18 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.214 -0.929 . . . . 0.0 108.877 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.29 139.6 40.54 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.613 ' CD1' HG22 ' A' ' 5' ' ' VAL . 1.7 mt -126.79 126.66 43.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 110.088 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 102' ' ' THR . 18.8 m -89.26 97.83 11.42 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.86 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -99.3 172.49 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.149 -0.969 . . . . 0.0 109.865 -179.387 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.503 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 0.3 OUTLIER -86.31 175.55 4.34 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.419 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.612 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 35.8 Cg_endo -78.0 72.84 5.99 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.377 2.052 . . . . 0.0 110.962 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 129.08 -9.75 6.28 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.22 -1.467 . . . . 0.0 110.603 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.487 ' OD1' ' HB2' ' A' ' 24' ' ' LYS . 1.2 m-20 -50.54 -178.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.093 -1.239 . . . . 0.0 109.085 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.579 HG23 ' HA ' ' A' ' 75' ' ' THR . 23.8 m -117.4 118.37 32.03 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.036 -1.04 . . . . 0.0 109.676 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.955 HG21 HD11 ' A' ' 101' ' ' ILE . 1.7 t -99.81 111.53 29.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.371 -0.83 . . . . 0.0 109.475 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.645 ' O ' HG23 ' A' ' 4' ' ' THR . 5.1 mt-10 -99.43 123.17 43.47 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.254 -0.904 . . . . 0.0 109.112 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -106.29 153.19 22.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.348 -0.845 . . . . 0.0 109.109 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.731 HD21 ' CG2' ' A' ' 4' ' ' THR . 0.0 OUTLIER -140.54 177.81 7.75 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.09 -1.007 . . . . 0.0 110.033 -179.494 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.645 ' HB3' HD23 ' A' ' 65' ' ' LEU . 3.2 p-10 -109.45 169.64 8.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.355 -0.841 . . . . 0.0 109.268 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.539 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . 28.3 t30 -112.88 -73.68 0.66 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.01 -1.056 . . . . 0.0 109.378 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.8 ttpt -162.91 28.39 0.1 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.064 -1.023 . . . . 0.0 109.266 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.59 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 11.1 t -148.05 58.61 3.96 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.59 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 36.2 Cg_endo -77.94 174.78 12.02 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.69 2.26 . . . . 0.0 110.664 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.557 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.6 Cg_endo -86.95 158.44 50.15 Favored 'Cis proline' 0 C--N 1.309 -1.547 0 C-N-CA 123.402 -1.499 . . . . 0.0 110.713 -1.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.881 ' HB2' HD22 ' A' ' 65' ' ' LEU . 70.4 m-70 -113.77 125.41 54.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.483 -0.761 . . . . 0.0 108.961 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.453 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 1.8 m120 -99.85 123.96 44.65 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.292 -0.88 . . . . 0.0 109.294 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.6 t -107.8 109.49 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.243 -0.91 . . . . 0.0 109.911 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.617 HG13 ' CB ' ' A' ' 60' ' ' SER . 1.4 t -134.74 167.11 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.383 -0.823 . . . . 0.0 108.852 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.718 ' CZ ' HD12 ' A' ' 59' ' ' LEU . 7.8 m-85 -118.9 106.52 12.57 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.136 -0.977 . . . . 0.0 109.831 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -49.91 118.66 3.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.443 -0.786 . . . . 0.0 109.861 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.41 2.14 29.9 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.433 -0.792 . . . . 0.0 109.638 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -102.09 -15.03 16.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.139 -0.976 . . . . 0.0 109.753 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.0 mt -113.88 61.08 0.66 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.142 -0.974 . . . . 0.0 109.523 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.496 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 5.7 p30 -134.1 163.14 53.29 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.255 -0.903 . . . . 0.0 109.449 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.574 ' HG3' ' CA ' ' A' ' 83' ' ' GLY . 33.7 Cg_endo -77.31 -16.81 15.19 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.596 2.197 . . . . 0.0 109.423 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 52' ' ' SER . . . -135.0 77.08 1.66 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.47 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -35.88 95.43 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.351 0.596 . . . . 0.0 110.413 -179.459 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 50' ' ' ALA . 10.4 m -140.42 -174.49 3.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.423 -0.798 . . . . 0.0 109.271 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -159.86 23.94 0.18 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.934 . . . . 0.0 109.413 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -89.08 -66.03 0.96 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.279 -0.888 . . . . 0.0 109.794 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.517 ' HG ' ' N ' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -64.89 -25.31 67.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -0.929 . . . . 0.0 109.636 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.517 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -65.02 -58.18 6.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.115 -0.991 . . . . 0.0 109.343 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.45 -31.59 1.79 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.268 -0.895 . . . . 0.0 109.521 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.61 13.03 36.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.926 . . . . 0.0 109.973 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.836 ' HA ' HG21 ' A' ' 74' ' ' THR . 0.0 OUTLIER -108.0 -42.45 4.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.997 -1.064 . . . . 0.0 108.47 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.617 ' CB ' HG13 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -78.11 174.57 11.01 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.457 -0.777 . . . . 0.0 110.347 -179.418 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.795 ' HB3' HG21 ' A' ' 72' ' ' THR . 26.4 p80 -125.19 174.2 8.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.64 -0.662 . . . . 0.0 109.338 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -125.19 -12.91 6.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.156 -0.965 . . . . 0.0 109.71 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -92.59 105.66 17.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.965 . . . . 0.0 109.653 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.614 ' H ' HD12 ' A' ' 64' ' ' LEU . 4.4 mp -49.26 165.01 0.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -0.896 . . . . 0.0 109.291 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.897 HD21 ' HB2' ' A' ' 71' ' ' SER . 5.9 mp -81.49 137.4 35.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.124 -0.985 . . . . 0.0 109.546 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.93 -2.56 5.22 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.368 -0.832 . . . . 0.0 109.538 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.3 t -116.0 144.93 33.74 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.141 -0.975 . . . . 0.0 109.247 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.58 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.6 Cg_endo -80.91 83.46 2.21 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.645 2.23 . . . . 0.0 111.608 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.542 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 124.94 45.41 0.26 Allowed Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.121 -1.514 . . . . 0.0 111.437 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.484 ' HB3' ' O ' ' A' ' 69' ' ' GLY . 4.1 pt20 170.15 117.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.014 -1.286 . . . . 0.0 109.974 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.897 ' HB2' HD21 ' A' ' 65' ' ' LEU . 2.8 p -115.51 -146.82 0.41 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.226 -0.922 . . . . 0.0 109.09 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.795 HG21 ' HB3' ' A' ' 61' ' ' HIS . 96.4 m -95.15 100.67 12.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.098 -1.001 . . . . 0.0 109.951 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' A' ' 30' ' ' GLU . 42.4 p -79.99 111.71 16.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.229 -0.919 . . . . 0.0 108.884 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.836 HG21 ' HA ' ' A' ' 59' ' ' LEU . 1.9 m -98.63 129.09 45.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 109.86 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.579 ' HA ' HG23 ' A' ' 28' ' ' THR . 0.1 OUTLIER -82.65 96.81 8.24 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.139 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.727 ' CD2' HD21 ' A' ' 59' ' ' LEU . 26.1 m-85 -45.58 153.12 0.62 Allowed Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 121.066 -1.021 . . . . 0.0 108.862 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.509 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.3 Cg_endo -77.11 165.38 28.17 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.5 2.133 . . . . 0.0 111.421 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.93 8.0 6.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.46 -0.775 . . . . 0.0 109.535 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 81' ' ' PRO . 2.4 m-20 -99.08 -12.5 20.47 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.045 -1.034 . . . . 0.0 109.006 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.612 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -32.85 93.58 0.06 OUTLIER Pre-proline 0 N--CA 1.5 2.041 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.534 ' N ' ' O ' ' A' ' 79' ' ' ASP . 36.3 Cg_endo -78.73 163.83 26.1 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.586 2.191 . . . . 0.0 110.786 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -64.77 113.19 3.62 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.406 -0.809 . . . . 0.0 109.302 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.574 ' CA ' ' HG3' ' A' ' 49' ' ' PRO . . . -174.54 155.83 21.89 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 84' ' ' GLU . 0.7 OUTLIER -90.47 104.69 17.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -1.098 . . . . 0.0 109.706 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.461 ' CD2' HG22 ' A' ' 101' ' ' ILE . 7.7 m-30 -81.08 167.25 19.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.204 -0.935 . . . . 0.0 108.863 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.506 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 95.4 m -151.81 115.52 4.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.935 -1.103 . . . . 0.0 110.573 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.627 ' O ' HG23 ' A' ' 98' ' ' VAL . 2.0 p90 -117.4 168.63 10.18 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 98' ' ' VAL . 30.4 p90 -160.47 -162.41 0.96 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.79 -1.194 . . . . 0.0 110.645 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 1.3 m -119.07 136.41 54.16 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.69 -0.631 . . . . 0.0 109.723 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.629 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -73.17 -45.09 8.08 Favored Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.287 -0.883 . . . . 0.0 109.762 178.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.4 Cg_endo -78.35 -60.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.063 0 C-N-CA 121.983 1.789 . . . . 0.0 110.524 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.639 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 10.8 m80 -72.48 57.23 0.39 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.017 -1.052 . . . . 0.0 109.179 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.54 18.59 9.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.368 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.85 -34.0 2.7 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 96' ' ' GLY . . . -91.81 34.35 1.0 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.143 -1.21 . . . . 0.0 109.642 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 95' ' ' ALA . . . 41.61 61.72 2.11 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.564 ' CE ' ' HB3' ' A' ' 92' ' ' HIS . 9.3 mtt -91.64 63.97 4.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.163 -1.198 . . . . 0.0 109.35 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 87' ' ' PHE . 4.9 p -127.63 96.48 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.2 -0.937 . . . . 0.0 109.775 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.495 ' O ' ' HG3' ' A' ' 100' ' ' LYS . . . -76.47 -164.42 18.51 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.506 ' HG2' ' HA ' ' A' ' 86' ' ' THR . 26.5 mtmt -163.44 120.53 1.82 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -1.149 . . . . 0.0 109.649 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.955 HD11 HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -82.58 138.88 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.154 -0.966 . . . . 0.0 108.898 179.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 22' ' ' THR . 8.3 m -118.04 93.93 4.32 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.613 HG22 HG13 ' A' ' 23' ' ' ILE . 1.8 t -99.2 118.6 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.23 -0.918 . . . . 0.0 109.596 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 109.634 -179.82 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.8 m . . . . . 0 N--CA 1.489 1.488 0 N-CA-C 109.427 -0.583 . . . . 0.0 109.427 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.593 ' HB2' HG13 ' A' ' 29' ' ' VAL . 40.0 m-85 -123.52 98.46 5.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.174 -0.954 . . . . 0.0 109.349 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.727 HG23 HD11 ' A' ' 32' ' ' LEU . 18.8 m -87.54 83.87 7.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.749 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 5' ' ' VAL . 24.7 m -82.55 107.15 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.152 -0.967 . . . . 0.0 109.454 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.495 ' HE3' ' HA2' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -92.25 100.86 13.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 109.333 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.535 ' CD2' ' O ' ' A' ' 32' ' ' LEU . 0.9 OUTLIER -59.68 172.48 0.7 Allowed 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.148 -0.97 . . . . 0.0 109.295 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.484 ' HA3' ' HB3' ' A' ' 34' ' ' ASN . . . 69.35 70.36 1.18 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.467 ' OG ' ' N ' ' A' ' 10' ' ' ASP . 86.4 p -47.67 -91.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.316 -1.108 . . . . 0.0 109.531 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.467 ' N ' ' OG ' ' A' ' 9' ' ' SER . 2.2 t0 177.36 -34.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.427 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.61 38.73 3.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.0 109.38 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.407 ' O ' HD22 ' A' ' 13' ' ' LEU . . . -154.07 -106.35 0.28 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.476 HD22 ' HA ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -149.6 -148.3 0.26 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -1.115 . . . . 0.0 109.359 -179.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.689 HD13 ' HE1' ' A' ' 39' ' ' HIS . 20.8 mt -98.75 109.0 21.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.945 -1.097 . . . . 0.0 109.366 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 7' ' ' LEU . 21.4 m -148.51 165.73 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.906 . . . . 0.0 109.487 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -85.79 135.18 33.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 109.407 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -125.64 108.34 26.04 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.188 -0.945 . . . . 0.0 109.542 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -78.44 175.81 45.4 Favored 'Cis proline' 0 C--N 1.312 -1.358 0 C-N-CA 123.793 -1.336 . . . . 0.0 110.465 0.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.64 -39.53 31.28 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.225 -0.922 . . . . 0.0 109.474 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.78 138.15 45.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.309 -0.87 . . . . 0.0 109.294 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.465 HD11 HG11 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -135.51 110.34 8.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 109.588 -179.872 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.489 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 97.5 m -84.14 99.23 10.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.167 -0.958 . . . . 0.0 109.291 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.862 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.5 pt -99.64 -178.37 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.288 -0.882 . . . . 0.0 109.698 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.586 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -94.91 -179.16 0.9 Allowed Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.448 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.824 ' C ' ' HB3' ' A' ' 80' ' ' ALA . 34.5 Cg_endo -77.88 66.69 8.15 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.093 1.862 . . . . 0.0 110.386 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.709 ' N ' ' HB3' ' A' ' 80' ' ' ALA . . . 121.08 73.96 0.35 Allowed Glycine 0 N--CA 1.487 2.08 0 C-N-CA 119.52 -1.324 . . . . 0.0 109.922 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.48 ' OD2' ' HG2' ' A' ' 24' ' ' LYS . 7.7 m-20 -125.77 -142.66 0.29 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.32 -1.106 . . . . 0.0 108.581 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.588 HG23 ' HA ' ' A' ' 75' ' ' THR . 44.3 m -148.04 99.49 3.07 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.944 -1.098 . . . . 0.0 109.563 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.944 ' CG2' HD11 ' A' ' 101' ' ' ILE . 2.9 t -99.87 119.45 47.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.466 -0.771 . . . . 0.0 109.044 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.482 ' C ' ' CD1' ' A' ' 31' ' ' PHE . 56.1 tt0 -99.61 156.33 17.12 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.171 -0.956 . . . . 0.0 109.81 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.483 ' CD2' ' O ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -148.34 149.13 31.26 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.727 HD11 HG23 ' A' ' 4' ' ' THR . 3.1 mp -141.97 -170.98 3.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.127 -0.983 . . . . 0.0 109.807 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.915 ' HB3' HD23 ' A' ' 65' ' ' LEU . 8.0 p-10 -113.66 159.92 19.15 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.315 -0.865 . . . . 0.0 109.441 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.495 ' HB2' ' O ' ' A' ' 7' ' ' LEU . 17.5 t30 -94.97 -94.49 0.18 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.015 -1.053 . . . . 0.0 109.301 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.54 37.29 1.34 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.173 -0.954 . . . . 0.0 109.304 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.683 ' HB ' HD21 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -150.81 62.8 5.44 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.446 -0.784 . . . . 0.0 109.004 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.539 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 35.0 Cg_endo -77.54 174.68 12.29 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.693 2.262 . . . . 0.0 110.26 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.602 ' O ' ' CG ' ' A' ' 39' ' ' HIS . 37.9 Cg_endo -83.83 -163.12 2.98 Favored 'Cis proline' 0 C--N 1.308 -1.566 0 C-N-CA 123.558 -1.434 . . . . 0.0 110.571 -0.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.689 ' HE1' HD13 ' A' ' 14' ' ' LEU . 89.4 m-70 -161.77 124.59 3.03 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.413 -0.804 . . . . 0.0 109.758 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -100.97 111.93 24.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.211 -0.931 . . . . 0.0 109.213 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 52.4 t -102.06 128.4 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 0.0 109.719 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.768 HG12 ' CB ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -159.85 167.12 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.29 -0.882 . . . . 0.0 109.496 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.508 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 3.2 m-85 -109.41 133.6 52.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.261 -0.899 . . . . 0.0 109.294 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -57.26 136.05 56.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.073 -1.017 . . . . 0.0 108.952 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.33 21.77 1.66 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.233 -0.917 . . . . 0.0 110.102 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.31 5.93 2.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.983 -1.073 . . . . 0.0 109.635 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.8 mp -113.49 41.44 2.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 0.0 109.556 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.476 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -114.03 165.34 13.83 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.346 -0.846 . . . . 0.0 109.232 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 35.5 Cg_endo -77.75 -32.08 2.9 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.615 2.21 . . . . 0.0 111.442 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -125.79 24.79 7.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.876 -1.14 . . . . 0.0 110.268 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.469 ' HA ' ' CG ' ' A' ' 48' ' ' ASN . 9.9 mtmm 36.48 91.13 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.865 -0.522 . . . . 0.0 110.182 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.463 ' HB3' ' OD1' ' A' ' 54' ' ' ASP . 73.7 m -139.92 136.49 33.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.071 -1.018 . . . . 0.0 109.681 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.24 -47.92 32.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.46 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 55' ' ' LEU . 6.8 p30 -46.45 -31.84 2.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.699 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 39.1 tp -87.68 55.2 3.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 109.36 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 55' ' ' LEU . . . 163.88 -50.27 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.347 -0.845 . . . . 0.0 109.235 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -54.91 -37.95 66.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 109.437 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.6 t -104.38 -20.07 13.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.897 . . . . 0.0 109.526 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.912 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 16.1 tp -65.04 -49.4 70.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 109.469 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.768 ' CB ' HG12 ' A' ' 42' ' ' VAL . 55.4 p -82.76 178.38 8.21 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.749 0.785 . . . . 0.0 110.936 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.461 ' CE1' ' O ' ' A' ' 63' ' ' GLN . 19.1 p80 -108.99 -154.23 0.53 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.446 ' N ' ' ND1' ' A' ' 61' ' ' HIS . 19.3 mmtt -148.05 -62.14 0.26 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.291 -0.881 . . . . 0.0 109.439 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.461 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 3.4 pm0 -46.1 148.18 0.91 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.647 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 mp -73.97 165.57 24.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 109.498 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.915 HD23 ' HB3' ' A' ' 33' ' ' ASN . 2.1 mp -82.47 126.17 31.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.368 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.01 -23.81 4.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.196 -0.94 . . . . 0.0 109.79 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.3 t -90.85 142.1 27.32 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.148 -0.97 . . . . 0.0 109.426 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.445 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 35.4 Cg_endo -78.18 101.63 1.49 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.477 2.118 . . . . 0.0 110.423 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.723 ' O ' HD23 ' A' ' 32' ' ' LEU . . . 98.93 47.41 1.91 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.411 ' N ' ' HB3' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -170.83 94.01 0.19 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.428 -1.042 . . . . 0.0 109.232 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.858 ' CB ' HD21 ' A' ' 65' ' ' LEU . 10.6 p -103.2 -79.91 0.53 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.016 -1.053 . . . . 0.0 109.336 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.591 ' H ' ' HG ' ' A' ' 71' ' ' SER . 13.5 m -160.95 110.11 1.64 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.106 -0.996 . . . . 0.0 108.761 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.4 t -79.24 78.74 5.71 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.158 -0.964 . . . . 0.0 108.757 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.806 HG21 ' HG ' ' A' ' 59' ' ' LEU . 84.9 m -62.4 96.77 0.08 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.45 -0.781 . . . . 0.0 109.847 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.588 ' HA ' HG23 ' A' ' 28' ' ' THR . 1.7 t -79.23 74.3 5.82 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.912 ' CZ ' HD21 ' A' ' 59' ' ' LEU . 28.4 m-85 -33.88 146.05 0.14 Allowed Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.537 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 34.5 Cg_endo -76.22 -179.63 5.44 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.841 2.361 . . . . 0.0 111.482 -178.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.05 11.6 9.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.456 -0.777 . . . . 0.0 109.062 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' A' ' 80' ' ' ALA . 18.8 m-20 -98.88 -71.21 0.7 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.824 ' HB3' ' C ' ' A' ' 25' ' ' PRO . . . 31.51 98.05 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 122.023 -0.423 . . . . 0.0 111.06 178.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.34 157.57 37.11 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.424 2.083 . . . . 0.0 110.708 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.32 139.87 52.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 0.0 109.482 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 157.55 171.87 24.06 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -88.73 129.95 35.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.344 -1.092 . . . . 0.0 109.661 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.464 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 9.3 m-85 -110.95 137.69 48.27 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.489 HG23 ' HG2' ' A' ' 100' ' ' LYS . 81.1 m -137.07 116.7 12.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.978 -1.076 . . . . 0.0 110.619 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.567 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -111.13 164.43 12.86 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.791 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.49 ' HB2' HG22 ' A' ' 98' ' ' VAL . 6.6 p90 -157.1 -156.42 0.6 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.777 -1.202 . . . . 0.0 110.565 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 93' ' ' ARG . 0.5 OUTLIER -132.43 155.88 47.7 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.639 -0.663 . . . . 0.0 109.281 -179.539 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.597 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 12.3 tp10 -88.67 -44.6 0.45 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.088 -1.008 . . . . 0.0 110.715 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.8 Cg_endo -80.27 -55.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 122.157 1.905 . . . . 0.0 111.041 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.573 ' CD2' HD13 ' A' ' 14' ' ' LEU . 5.2 m80 -88.34 32.97 0.75 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.104 -0.998 . . . . 0.0 109.518 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.478 ' HB3' ' O ' ' A' ' 89' ' ' CYS . 12.8 ptt180 -63.09 -23.22 67.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.139 -0.976 . . . . 0.0 109.611 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.15 7.85 62.54 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 92' ' ' HIS . . . -107.26 35.49 3.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -1.148 . . . . 0.0 109.668 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.8 35.99 84.78 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' A' ' 14' ' ' LEU . 1.9 mtp -95.69 67.28 2.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.084 -1.245 . . . . 0.0 109.091 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.49 HG22 ' HB2' ' A' ' 88' ' ' TYR . 59.7 t -140.32 107.95 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 109.96 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.561 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -106.64 154.94 16.67 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.489 ' HG2' HG23 ' A' ' 86' ' ' THR . 46.3 mtmt -130.74 135.53 47.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.071 -1.253 . . . . 0.0 110.08 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.944 HD11 ' CG2' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -101.74 123.5 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.189 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.489 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 1.0 OUTLIER -98.91 108.47 21.16 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.103 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.506 HG22 ' CD1' ' A' ' 23' ' ' ILE . 20.7 t -99.15 94.51 3.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.35 -0.844 . . . . 0.0 109.491 -178.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.531 0 O-C-N 121.368 -0.833 . . . . 0.0 109.345 -179.939 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.49 1.57 0 CA-C-O 121.33 0.586 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.76 ' CB ' HD21 ' A' ' 21' ' ' LEU . 16.8 m-85 -133.95 148.48 51.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.21 -0.931 . . . . 0.0 109.291 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 4' ' ' THR . 1.7 t -137.92 103.67 5.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 109.801 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.706 HG12 ' HD2' ' A' ' 18' ' ' PRO . 21.8 m -87.37 67.26 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.239 -0.913 . . . . 0.0 109.292 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.59 ' HB3' HD21 ' A' ' 32' ' ' LEU . 1.3 ptmm? -51.35 108.97 0.29 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.89 . . . . 0.0 109.725 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.678 HD13 ' ND1' ' A' ' 39' ' ' HIS . 0.2 OUTLIER -68.02 175.69 3.01 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.233 -0.917 . . . . 0.0 109.322 179.688 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 14' ' ' LEU . . . 67.21 110.45 0.02 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.2 p -68.14 -104.0 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.262 -1.14 . . . . 0.0 109.178 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -171.77 26.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.885 -1.135 . . . . 0.0 109.848 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -132.22 -9.44 3.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.098 -1.001 . . . . 0.0 110.283 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 129.19 3.53 5.25 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.121 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 mt -111.43 142.0 44.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.067 -1.255 . . . . 0.0 109.565 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.636 HD11 ' CG1' ' A' ' 36' ' ' VAL . 65.7 mt -103.19 102.43 12.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.305 -0.872 . . . . 0.0 109.705 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.8 m -142.94 138.41 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 109.249 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.461 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 10.9 m-85 -56.46 148.9 18.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.156 -0.965 . . . . 0.0 109.538 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 16' ' ' PHE . 3.9 mm-40 -143.18 108.52 5.33 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.352 -0.842 . . . . 0.0 109.304 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.706 ' HD2' HG12 ' A' ' 5' ' ' VAL . 35.9 Cg_endo -78.17 174.53 51.35 Favored 'Cis proline' 0 C--N 1.312 -1.377 0 C-N-CA 123.779 -1.342 . . . . 0.0 110.638 0.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.59 -54.9 7.85 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.184 -0.948 . . . . 0.0 109.17 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -100.58 138.34 37.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -0.878 . . . . 0.0 109.073 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.76 HD21 ' CB ' ' A' ' 3' ' ' TYR . 15.8 tp -126.14 113.18 16.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.165 -0.959 . . . . 0.0 110.26 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.7 m -82.42 94.93 7.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.208 -0.933 . . . . 0.0 108.526 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.793 ' CD1' HD13 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -99.14 172.42 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.241 -0.912 . . . . 0.0 110.276 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.554 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 2.8 mmtt -91.99 168.71 12.43 Favored Pre-proline 0 C--N 1.303 -1.428 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.951 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 33.7 Cg_endo -77.18 81.86 2.51 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.052 1.834 . . . . 0.0 110.576 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 129.47 -1.67 6.07 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -74.41 177.91 5.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.113 -1.228 . . . . 0.0 109.574 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.459 HG22 ' N ' ' A' ' 29' ' ' VAL . 36.9 m -111.63 157.16 20.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.299 -0.876 . . . . 0.0 109.419 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.091 HG21 HD11 ' A' ' 101' ' ' ILE . 4.6 t -130.52 150.67 34.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.281 -0.887 . . . . 0.0 109.014 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -126.91 104.67 8.15 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.08 -1.012 . . . . 0.0 110.254 -179.467 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.553 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -107.9 91.45 3.65 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.24 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.713 HD12 ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -95.87 161.9 13.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.288 -0.882 . . . . 0.0 110.728 -178.176 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.561 ' HA ' HD11 ' A' ' 7' ' ' LEU . 2.0 p-10 -80.36 160.29 25.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.626 -0.671 . . . . 0.0 109.404 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 7' ' ' LEU . 59.5 t30 -103.41 -76.21 0.59 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.949 -1.094 . . . . 0.0 109.211 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.443 ' C ' HG23 ' A' ' 36' ' ' VAL . 1.5 pttt -157.61 34.33 0.27 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.907 . . . . 0.0 108.897 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.636 ' CG1' HD11 ' A' ' 14' ' ' LEU . 14.9 t -154.17 65.05 4.91 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.582 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 35.3 Cg_endo -78.57 176.04 10.35 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 123.091 2.527 . . . . 0.0 110.934 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.582 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 39.2 Cg_endo -87.62 157.65 45.61 Favored 'Cis proline' 0 C--N 1.311 -1.428 0 O-C-N 123.818 1.43 . . . . 0.0 110.868 -1.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.713 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 73.7 m-70 -118.41 118.72 32.52 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.578 -0.701 . . . . 0.0 109.783 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.481 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 17.7 t-20 -100.32 126.0 46.61 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.884 . . . . 0.0 108.762 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.504 ' HB ' ' NE2' ' A' ' 61' ' ' HIS . 71.0 t -104.92 131.15 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.083 -1.011 . . . . 0.0 109.992 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.653 HG12 ' HB3' ' A' ' 60' ' ' SER . 0.0 OUTLIER -152.62 172.86 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.716 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.79 ' CD2' HD23 ' A' ' 59' ' ' LEU . 3.6 m-85 -124.53 109.77 13.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.017 -1.052 . . . . 0.0 109.903 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.504 ' HB3' HD12 ' A' ' 47' ' ' LEU . 37.0 t0 -47.11 131.01 12.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.42 -0.8 . . . . 0.0 109.404 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.4 18.23 5.44 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.269 -0.894 . . . . 0.0 109.967 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -120.86 9.56 10.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.026 -1.046 . . . . 0.0 109.652 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.504 HD12 ' HB3' ' A' ' 44' ' ' ASP . 3.2 mt -131.06 60.38 1.66 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.176 -0.953 . . . . 0.0 109.464 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.519 ' ND2' ' HA ' ' A' ' 51' ' ' LYS . 0.7 OUTLIER -121.58 163.66 29.37 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.932 . . . . 0.0 109.514 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 35.1 Cg_endo -77.51 -46.21 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.627 2.218 . . . . 0.0 110.821 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.469 ' C ' ' HG2' ' A' ' 51' ' ' LYS . . . -115.76 37.34 3.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -0.981 . . . . 0.0 109.995 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.519 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.9 OUTLIER 36.21 47.22 0.45 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.664 -0.647 . . . . 0.0 110.545 179.545 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.571 ' O ' HD23 ' A' ' 55' ' ' LEU . 26.8 m -99.79 89.84 4.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.138 -0.976 . . . . 0.0 109.373 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.76 -19.61 58.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.486 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.08 -25.54 45.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.483 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 52' ' ' SER . 1.8 pp -75.88 -25.35 56.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.692 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 58' ' ' SER . . . -74.1 -53.99 8.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.896 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 56' ' ' ALA . 1.4 mmtt -43.57 -26.2 0.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 109.735 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 56' ' ' ALA . 2.8 m -110.97 22.18 15.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.103 -0.998 . . . . 0.0 109.859 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.79 HD23 ' CD2' ' A' ' 43' ' ' PHE . 8.2 tp -128.24 -36.91 1.89 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.074 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.653 ' HB3' HG12 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -77.55 141.91 39.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.396 -0.815 . . . . 0.0 109.601 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.558 ' CE1' ' O ' ' A' ' 63' ' ' GLN . 21.1 p80 -99.91 -23.02 15.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.444 -0.785 . . . . 0.0 109.862 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 70.62 -65.67 0.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.144 -0.973 . . . . 0.0 109.236 -179.714 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.558 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 0.8 OUTLIER -45.42 127.2 7.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.453 179.732 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.469 ' H ' HD12 ' A' ' 64' ' ' LEU . 5.0 mp -68.01 170.45 8.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.222 -0.924 . . . . 0.0 109.727 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.766 HD22 ' HA ' ' A' ' 71' ' ' SER . 6.2 mt -115.74 100.55 8.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.363 -0.836 . . . . 0.0 109.032 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 62.5 mtt -96.99 2.82 51.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.277 -0.889 . . . . 0.0 109.828 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 t -79.88 139.74 53.95 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.112 -0.992 . . . . 0.0 109.24 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.63 88.78 1.41 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.613 2.209 . . . . 0.0 110.918 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.713 ' HA2' HD12 ' A' ' 32' ' ' LEU . . . 88.25 49.01 3.86 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -172.74 92.36 0.11 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.333 -1.098 . . . . 0.0 109.108 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.766 ' HA ' HD22 ' A' ' 65' ' ' LEU . 80.0 p -99.07 -140.37 0.32 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 72' ' ' THR . 10.2 t -123.21 127.69 48.98 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.979 -1.076 . . . . 0.0 108.337 178.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.439 ' O ' ' OG ' ' A' ' 73' ' ' SER . 17.9 p -79.18 96.88 6.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.137 -0.977 . . . . 0.0 109.639 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.618 HG21 ' O ' ' A' ' 59' ' ' LEU . 1.2 m -70.3 113.63 7.64 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.402 -0.811 . . . . 0.0 109.259 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 76' ' ' PHE . 54.5 m -79.25 88.71 4.91 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.361 -0.837 . . . . 0.0 109.113 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 1.116 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 10.4 m-85 -43.13 160.43 0.21 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.376 -0.828 . . . . 0.0 108.903 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.501 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 32.6 Cg_endo -76.22 150.7 33.39 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.443 2.095 . . . . 0.0 111.483 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.463 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . . . -69.47 -11.28 60.7 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.457 ' O ' ' C ' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -100.65 15.9 26.63 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.332 -0.855 . . . . 0.0 109.141 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.951 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -39.65 109.86 0.59 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.605 -0.684 . . . . 0.0 109.313 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.448 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 33.7 Cg_endo -75.02 121.35 6.52 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.354 2.036 . . . . 0.0 110.514 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -43.64 136.93 3.17 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.479 -0.763 . . . . 0.0 109.382 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 164.64 -167.38 38.42 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -120.68 115.62 23.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.407 -1.055 . . . . 0.0 109.484 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.448 ' OH ' ' HD2' ' A' ' 81' ' ' PRO . 23.2 m-85 -93.88 165.27 12.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.369 -0.832 . . . . 0.0 109.07 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.776 HG22 ' CG2' ' A' ' 98' ' ' VAL . 0.2 OUTLIER -144.46 97.81 3.1 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.057 -1.027 . . . . 0.0 110.205 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.571 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.5 OUTLIER -101.96 157.77 16.62 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.356 -0.84 . . . . 0.0 108.842 178.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.531 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 4.5 p90 -160.24 -148.4 0.17 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.157 -0.964 . . . . 0.0 109.653 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.485 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 74.7 m -132.96 161.29 34.69 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.159 -0.963 . . . . 0.0 109.641 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.588 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 19.5 tt0 -77.71 -47.25 2.37 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.298 -0.876 . . . . 0.0 109.23 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.5 Cg_endo -79.23 -66.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.106 0 C-N-CA 122.206 1.938 . . . . 0.0 110.478 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.713 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 14.4 m80 -55.03 87.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.063 -1.023 . . . . 0.0 109.149 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 91' ' ' PRO . 3.7 mtm180 -131.05 32.73 4.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.162 -0.961 . . . . 0.0 109.592 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -149.99 16.78 1.05 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -138.69 37.32 2.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.279 -1.13 . . . . 0.0 109.479 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.71 53.65 28.41 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.573 ' HE1' ' HB2' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -102.04 56.86 0.81 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.21 -1.171 . . . . 0.0 109.423 179.807 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.776 ' CG2' HG22 ' A' ' 86' ' ' THR . 2.5 p -135.6 94.72 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.244 -0.91 . . . . 0.0 109.383 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.571 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -70.99 179.24 31.89 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.585 ' HG2' HG23 ' A' ' 86' ' ' THR . 23.0 mtmm -154.81 131.18 10.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -1.133 . . . . 0.0 109.707 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 1.116 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -96.99 136.68 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.166 -0.959 . . . . 0.0 108.594 179.207 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.4 100.59 7.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.147 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.554 HG22 ' CD1' ' A' ' 23' ' ' ILE . 1.6 t -99.94 125.55 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.889 . . . . 0.0 109.562 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.23 179.764 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.457 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 15.8 m-85 -117.08 174.45 6.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 109.468 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.9 m -156.35 116.41 3.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.909 . . . . 0.0 109.466 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.744 HG12 ' H ' ' A' ' 17' ' ' GLU . 1.4 t -104.17 82.58 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.91 . . . . 0.0 109.449 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.979 ' HG2' HD11 ' A' ' 32' ' ' LEU . 6.7 mttp -69.8 85.97 0.49 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.284 -0.885 . . . . 0.0 109.383 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.67 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -62.54 -172.58 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.239 -0.913 . . . . 0.0 109.599 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.481 ' CA ' HD23 ' A' ' 14' ' ' LEU . . . 54.92 87.4 0.02 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.8 p -60.55 -90.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -1.153 . . . . 0.0 109.422 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -175.57 29.55 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.243 -0.911 . . . . 0.0 109.718 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -123.05 -19.28 6.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.188 -0.945 . . . . 0.0 109.523 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.03 -13.83 5.74 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 mt -96.23 147.65 23.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -1.116 . . . . 0.0 109.141 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.538 ' CD1' ' CD2' ' A' ' 92' ' ' HIS . 16.0 mt -109.8 112.18 24.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 109.553 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.56 HG12 ' HA3' ' A' ' 96' ' ' GLY . 6.0 m -138.56 136.0 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 109.468 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.634 ' HD2' HG11 ' A' ' 5' ' ' VAL . 28.4 m-85 -54.57 143.4 24.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.212 -0.93 . . . . 0.0 109.363 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.744 ' H ' HG12 ' A' ' 5' ' ' VAL . 27.3 mt-10 -143.0 108.76 5.42 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.26 -0.9 . . . . 0.0 108.995 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.4 Cg_endo -76.59 164.68 86.99 Favored 'Cis proline' 0 C--N 1.311 -1.408 0 C-N-CA 123.811 -1.329 . . . . 0.0 110.894 0.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.51 -60.25 2.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.435 -0.791 . . . . 0.0 109.914 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.474 ' O ' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -78.78 136.59 37.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 109.553 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.481 HD13 ' HA ' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -127.04 109.55 12.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.232 -0.918 . . . . 0.0 109.777 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.4 m -88.71 94.98 10.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.215 -0.928 . . . . 0.0 108.835 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.655 HD12 ' O ' ' A' ' 24' ' ' LYS . 1.1 pp -106.72 165.41 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.32 -0.862 . . . . 0.0 110.197 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.655 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -88.68 -178.76 1.1 Allowed Pre-proline 0 C--N 1.302 -1.485 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.815 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.601 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 36.3 Cg_endo -80.2 86.3 1.68 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.123 1.882 . . . . 0.0 110.694 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.498 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 123.74 2.07 8.83 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.479 ' OD2' ' HG3' ' A' ' 24' ' ' LYS . 4.0 m-20 -66.22 -179.17 0.73 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.221 -1.164 . . . . 0.0 109.21 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 57.2 m -121.97 120.46 34.48 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.293 -0.88 . . . . 0.0 109.362 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.026 ' CG2' HD11 ' A' ' 101' ' ' ILE . 21.8 t -99.15 123.75 52.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.345 -0.847 . . . . 0.0 108.994 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.61 123.03 43.49 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.242 -0.911 . . . . 0.0 109.9 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.603 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -122.64 142.85 50.21 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.124 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.979 HD11 ' HG2' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -142.43 179.2 7.09 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.977 -1.077 . . . . 0.0 110.222 -179.584 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.577 ' ND2' ' O ' ' A' ' 67' ' ' SER . 0.4 OUTLIER -105.88 130.64 53.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.641 -0.662 . . . . 0.0 109.716 179.072 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 45.6 t30 -72.16 -59.57 2.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.068 -1.02 . . . . 0.0 109.205 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.72 36.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.311 -0.868 . . . . 0.0 109.42 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.614 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 32.1 t -148.65 55.79 2.25 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.303 -0.873 . . . . 0.0 109.729 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.614 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 37.0 Cg_endo -78.8 174.62 11.99 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.461 2.107 . . . . 0.0 110.443 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 37.8 Cg_endo -84.89 169.92 48.65 Favored 'Cis proline' 0 C--N 1.31 -1.477 0 C-N-CA 123.463 -1.474 . . . . 0.0 110.145 -1.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.689 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 71.9 m-70 -123.03 152.89 40.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.279 -0.888 . . . . 0.0 110.543 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.428 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 0.1 OUTLIER -124.23 103.11 8.05 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.7 t -98.92 109.35 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.71 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.794 HG13 ' HB3' ' A' ' 60' ' ' SER . 3.1 t -134.26 162.32 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.44 -0.788 . . . . 0.0 109.591 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.588 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 6.0 m-85 -110.13 96.76 6.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.397 -0.814 . . . . 0.0 109.666 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 43' ' ' PHE . 9.0 t70 -43.34 167.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.506 -0.746 . . . . 0.0 109.86 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -115.91 15.2 16.28 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.397 -0.815 . . . . 0.0 109.437 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -120.24 -3.71 10.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.614 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.0 mp -114.2 40.21 2.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.159 -0.963 . . . . 0.0 109.497 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.49 ' OD1' ' HA ' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -109.6 165.93 11.74 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 0.0 109.442 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.649 ' CG ' ' HB1' ' A' ' 82' ' ' ALA . 34.9 Cg_endo -77.11 -53.39 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.631 2.221 . . . . 0.0 110.493 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -100.61 30.37 3.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.363 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.49 ' HA ' ' OD1' ' A' ' 48' ' ' ASN . 0.3 OUTLIER 39.82 54.35 2.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.703 -0.623 . . . . 0.0 109.76 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.43 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 1.5 m -99.98 152.59 20.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 109.494 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.85 47.84 1.53 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 109.515 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 54' ' ' ASP . 4.6 m-20 -115.09 -71.78 0.73 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.235 -0.916 . . . . 0.0 109.57 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.473 ' HG ' ' N ' ' A' ' 56' ' ' ALA . 1.1 pp -53.92 -27.67 32.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 109.46 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.473 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -66.15 -38.58 88.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 109.325 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -36.33 75.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.247 -0.908 . . . . 0.0 109.39 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.7 t -101.77 30.47 4.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 0.0 109.499 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.76 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 10.2 tp -120.26 -33.49 3.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.243 -0.911 . . . . 0.0 109.293 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.794 ' HB3' HG13 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -78.88 152.69 31.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.353 -0.842 . . . . 0.0 110.603 -178.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.656 ' CD2' HG21 ' A' ' 72' ' ' THR . 10.3 p80 -98.07 168.55 10.2 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.66 -33.02 4.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.047 -1.033 . . . . 0.0 109.784 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -73.81 108.31 6.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 109.553 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.437 ' HA ' HD22 ' A' ' 64' ' ' LEU . 1.5 mm? -44.47 157.9 0.06 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.15 -0.969 . . . . 0.0 109.566 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.954 HD13 ' HB2' ' A' ' 71' ' ' SER . 0.8 OUTLIER -104.82 91.56 3.88 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.479 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -89.18 -15.46 33.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.208 -0.932 . . . . 0.0 110.869 -178.703 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.577 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 22.9 t -78.75 113.06 31.81 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.857 -1.152 . . . . 0.0 108.52 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 66' ' ' MET . 32.1 Cg_endo -73.44 120.21 6.38 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.301 2.0 . . . . 0.0 111.007 -178.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.55 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 110.74 -15.4 29.09 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.56 ' N ' ' OD1' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -149.45 113.39 5.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.349 -1.089 . . . . 0.0 109.097 179.795 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.954 ' HB2' HD13 ' A' ' 65' ' ' LEU . 4.2 p -103.31 -135.91 0.33 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.123 -0.985 . . . . 0.0 108.931 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.672 ' N ' HD22 ' A' ' 65' ' ' LEU . 6.9 t -114.94 157.08 23.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.746 -1.221 . . . . 0.0 109.296 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.93 -173.41 2.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.15 -0.969 . . . . 0.0 109.414 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.58 HG21 ' HG ' ' A' ' 59' ' ' LEU . 29.8 m -162.78 108.2 1.16 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.728 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.96 88.99 7.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.415 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 1.033 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 8.9 m-85 -45.34 163.63 0.2 Allowed Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.324 -0.86 . . . . 0.0 109.286 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.498 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.6 Cg_endo -76.91 161.1 33.43 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.602 2.202 . . . . 0.0 111.159 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.45 -3.2 13.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.498 -0.751 . . . . 0.0 110.035 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.528 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -99.37 -76.16 0.55 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.09 -1.006 . . . . 0.0 109.2 179.826 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.56 ' HB1' HG21 ' A' ' 103' ' ' VAL . . . 37.7 57.52 4.45 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.553 -0.717 . . . . 0.0 110.399 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.648 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 36.1 Cg_endo -77.93 -160.37 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.373 2.049 . . . . 0.0 110.282 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.649 ' HB1' ' CG ' ' A' ' 49' ' ' PRO . . . 72.7 -73.83 0.09 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.888 . . . . 0.0 109.896 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.427 ' HA2' ' N ' ' A' ' 103' ' ' VAL . . . 108.12 25.43 5.86 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -151.37 111.56 4.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.316 -1.108 . . . . 0.0 109.895 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 100' ' ' LYS . 52.5 m-85 -138.54 83.85 1.99 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.447 ' OG1' ' CD ' ' A' ' 100' ' ' LYS . 18.4 m -78.29 121.29 24.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.874 . . . . 0.0 110.596 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CE1' ' C ' ' A' ' 99' ' ' GLY . 2.0 p90 -117.07 173.1 6.85 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.476 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 2.9 p90 -158.78 -157.4 0.61 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.836 -1.165 . . . . 0.0 110.228 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 0.1 OUTLIER -131.83 151.99 51.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.4 -0.813 . . . . 0.0 109.725 -179.305 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.612 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 1.8 tm-20 -82.77 -45.61 0.9 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.0 109.932 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.7 Cg_endo -80.53 -51.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.125 1.883 . . . . 0.0 110.592 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.689 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 12.9 m80 -86.01 40.61 0.87 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 109.71 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.443 ' HG2' ' N ' ' A' ' 94' ' ' GLY . 16.5 ttt180 -76.49 141.09 41.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.198 -0.939 . . . . 0.0 109.358 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.443 ' N ' ' HG2' ' A' ' 93' ' ' ARG . . . 72.63 17.66 78.16 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.88 37.68 4.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.157 -1.202 . . . . 0.0 109.513 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.56 ' HA3' HG12 ' A' ' 15' ' ' VAL . . . 72.65 12.09 77.65 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.535 ' CE ' ' HB2' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -95.66 64.66 2.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -1.19 . . . . 0.0 109.497 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 28.3 t -140.24 73.84 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 109.661 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.492 ' C ' ' CE1' ' A' ' 87' ' ' PHE . . . -89.05 167.73 34.78 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 14.3 mttp -144.23 138.08 27.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.152 -1.205 . . . . 0.0 109.758 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 1.033 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -89.14 126.31 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 108.876 179.683 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 99.6 m -101.91 99.6 9.81 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.56 HG21 ' HB1' ' A' ' 80' ' ' ALA . 2.5 t -98.9 73.45 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.222 -0.924 . . . . 0.0 109.672 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 103' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.369 -0.832 . . . . 0.0 109.414 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -131.07 93.08 3.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 109.322 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.734 HG23 ' HB3' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -92.7 103.41 15.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.922 . . . . 0.0 109.597 -179.841 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.449 HG11 HD13 ' A' ' 21' ' ' LEU . 8.2 m -96.05 110.86 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.212 -0.93 . . . . 0.0 109.281 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.447 ' C ' HD13 ' A' ' 7' ' ' LEU . 11.1 mttt -79.82 133.55 36.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.238 -0.914 . . . . 0.0 109.454 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.982 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -110.03 73.46 0.84 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.736 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.452 ' HA2' HD23 ' A' ' 14' ' ' LEU . . . 165.52 77.85 0.03 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.478 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 2.0 p -47.84 -31.13 4.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -1.139 . . . . 0.0 109.186 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 9' ' ' SER . 6.4 t0 75.78 19.1 2.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.339 -0.851 . . . . 0.0 109.562 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -135.46 7.42 3.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.93 . . . . 0.0 109.722 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -173.49 -79.63 0.05 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.17 -171.48 2.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -1.155 . . . . 0.0 109.743 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.596 ' HB3' ' HE1' ' A' ' 97' ' ' MET . 8.6 mt -106.12 126.81 52.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.386 -0.821 . . . . 0.0 108.956 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -157.18 136.5 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.089 -1.007 . . . . 0.0 109.769 -179.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -53.22 157.89 1.76 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.124 -0.985 . . . . 0.0 108.901 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 2.2 mt-10 -150.96 108.44 3.04 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 109.518 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 35.2 Cg_endo -78.95 166.62 78.82 Favored 'Cis proline' 0 C--N 1.313 -1.291 0 C-N-CA 123.898 -1.292 . . . . 0.0 110.534 -0.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.9 -54.21 14.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.094 -1.004 . . . . 0.0 108.978 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -86.06 159.42 19.57 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.361 -0.837 . . . . 0.0 108.893 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.449 HD13 HG11 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -157.99 129.01 6.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.012 -1.055 . . . . 0.0 109.944 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.0 m -100.0 90.14 4.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.378 -0.826 . . . . 0.0 109.213 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.79 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -99.56 166.1 2.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.206 -0.934 . . . . 0.0 109.995 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.476 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -89.28 173.0 6.48 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.348 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.688 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 34.7 Cg_endo -76.64 83.3 2.1 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.178 1.919 . . . . 0.0 110.497 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 137.56 -26.73 2.89 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.476 ' OD2' ' HB2' ' A' ' 24' ' ' LYS . 3.1 m-20 -43.8 165.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -1.156 . . . . 0.0 109.414 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 86.7 m -111.05 118.34 35.78 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.205 -0.934 . . . . 0.0 109.678 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.898 HG21 HD11 ' A' ' 101' ' ' ILE . 2.7 t -99.21 123.85 52.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.199 -0.938 . . . . 0.0 109.17 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.734 ' HB3' HG23 ' A' ' 4' ' ' THR . 0.0 OUTLIER -100.23 128.61 46.27 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.245 -0.909 . . . . 0.0 109.975 -179.532 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.581 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -129.23 146.1 51.21 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.982 ' O ' HD21 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -140.63 -167.74 2.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.966 -1.084 . . . . 0.0 110.353 -179.609 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 67' ' ' SER . 2.1 p-10 -114.83 160.22 19.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.263 -0.898 . . . . 0.0 109.57 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.413 ' CG ' ' HA3' ' A' ' 8' ' ' GLY . 12.9 t30 -104.47 -154.28 0.5 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.249 -0.907 . . . . 0.0 109.417 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -92.89 28.31 2.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.13 -0.981 . . . . 0.0 109.254 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.592 ' HB ' HD11 ' A' ' 14' ' ' LEU . 3.0 t -141.84 61.89 13.6 Favored Pre-proline 0 C--N 1.299 -1.611 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.585 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.4 Cg_endo -77.93 177.32 8.94 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 123.05 2.5 . . . . 0.0 110.804 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.585 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 39.6 Cg_endo -87.91 158.91 44.84 Favored 'Cis proline' 0 C--N 1.313 -1.315 0 O-C-N 123.723 1.381 . . . . 0.0 110.908 -1.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.716 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 72.5 m-70 -118.65 156.73 28.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.493 -0.754 . . . . 0.0 109.501 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.442 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 18.9 t30 -140.08 114.33 9.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.293 -0.879 . . . . 0.0 109.019 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.558 ' O ' HG13 ' A' ' 42' ' ' VAL . 3.8 t -99.72 122.75 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.889 . . . . 0.0 109.125 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.636 ' HA ' ' CB ' ' A' ' 60' ' ' SER . 0.2 OUTLIER -157.96 141.36 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.106 -0.996 . . . . 0.0 110.231 179.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.628 ' CE2' ' CG ' ' A' ' 59' ' ' LEU . 4.4 m-85 -85.98 121.5 28.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.737 -0.602 . . . . 0.0 109.793 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 43' ' ' PHE . 24.9 t70 -45.74 169.0 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.413 -0.804 . . . . 0.0 109.419 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.86 -16.06 14.24 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.219 -0.926 . . . . 0.0 109.943 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.69 -14.01 11.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.138 -0.977 . . . . 0.0 109.682 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 2.8 mm? -94.1 48.83 1.27 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.182 -0.949 . . . . 0.0 109.433 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.526 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 3.5 p30 -129.48 163.83 43.82 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.254 -0.904 . . . . 0.0 109.496 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.526 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 34.0 Cg_endo -76.3 -11.57 19.15 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.486 2.124 . . . . 0.0 109.95 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 52' ' ' SER . . . -139.4 77.33 1.61 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -40.4 93.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.973 -179.417 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 50' ' ' ALA . 2.0 m -140.35 154.23 46.68 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.321 -0.862 . . . . 0.0 109.389 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.01 72.03 0.87 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.269 -0.894 . . . . 0.0 109.254 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -167.73 -38.4 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.156 -0.965 . . . . 0.0 109.699 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.856 ' O ' HD12 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -78.13 -8.14 57.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.112 -0.992 . . . . 0.0 109.517 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 57' ' ' LYS . . . -112.47 -43.83 3.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.901 . . . . 0.0 109.632 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 56' ' ' ALA . 47.7 tttp -43.52 -48.63 7.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.894 . . . . 0.0 109.575 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -98.15 25.55 6.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.893 . . . . 0.0 109.682 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.768 ' HG ' HG21 ' A' ' 74' ' ' THR . 17.1 tp -104.1 -62.53 1.3 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.147 -0.971 . . . . 0.0 109.625 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.636 ' CB ' ' HA ' ' A' ' 42' ' ' VAL . 0.3 OUTLIER -85.8 -167.61 1.92 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.222 -0.924 . . . . 0.0 110.637 -178.778 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.663 ' HB3' HG21 ' A' ' 72' ' ' THR . 25.3 p80 -120.68 142.0 49.88 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.29 -42.33 13.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 0.0 109.59 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.467 ' NE2' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -46.65 163.76 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.898 . . . . 0.0 109.496 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.741 ' H ' HD12 ' A' ' 64' ' ' LEU . 2.3 mp -97.37 -179.01 4.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.938 . . . . 0.0 109.411 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.701 HD12 ' O ' ' A' ' 64' ' ' LEU . 7.1 mp -118.96 81.98 1.79 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -0.951 . . . . 0.0 109.407 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.13 -34.7 29.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 109.524 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.52 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 46.0 t -80.58 146.83 61.83 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.922 . . . . 0.0 109.531 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.464 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 35.5 Cg_endo -77.84 102.55 1.6 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.641 2.228 . . . . 0.0 110.594 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.493 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 109.24 -26.67 14.37 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.512 ' CB ' ' HB3' ' A' ' 67' ' ' SER . 6.8 tt0 -62.22 105.63 0.63 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.132 -1.217 . . . . 0.0 108.464 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.576 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . 21.5 p -137.86 -161.48 1.18 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.165 -0.959 . . . . 0.0 110.695 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.663 HG21 ' HB3' ' A' ' 61' ' ' HIS . 1.8 t -153.82 124.16 7.02 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.3 p -79.27 135.93 36.9 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.141 -0.974 . . . . 0.0 109.517 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.768 HG21 ' HG ' ' A' ' 59' ' ' LEU . 86.3 m -98.54 114.33 26.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.377 -0.827 . . . . 0.0 109.711 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.456 HG22 ' H ' ' A' ' 75' ' ' THR . 1.2 t -83.83 82.97 8.1 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -0.89 . . . . 0.0 109.452 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 1.017 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 14.6 m-85 -43.34 149.1 0.59 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.094 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.486 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.6 Cg_endo -75.99 168.89 23.24 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.592 2.194 . . . . 0.0 110.842 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.34 6.59 6.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.424 -0.797 . . . . 0.0 109.783 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' A' ' 80' ' ' ALA . 30.9 t70 -99.12 -77.6 0.51 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.103 -0.998 . . . . 0.0 109.242 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.688 ' HB3' ' HB3' ' A' ' 25' ' ' PRO . . . 56.66 109.31 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.35 -0.843 . . . . 0.0 108.856 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.437 ' HG2' ' HG2' ' A' ' 49' ' ' PRO . 33.3 Cg_endo -74.31 113.55 3.82 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.328 2.018 . . . . 0.0 110.688 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -46.41 109.3 0.18 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.365 -0.834 . . . . 0.0 109.459 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.446 ' HA3' ' HB3' ' A' ' 49' ' ' PRO . . . 179.13 -119.28 0.64 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -160.44 106.23 1.5 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.2 -1.176 . . . . 0.0 109.784 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.607 ' CD2' ' CG2' ' A' ' 101' ' ' ILE . 0.7 OUTLIER -82.35 131.58 35.22 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.244 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 92.4 m -111.92 117.25 32.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.052 -1.03 . . . . 0.0 110.669 -179.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.591 ' O ' HG13 ' A' ' 98' ' ' VAL . 0.3 OUTLIER -111.51 169.91 8.48 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.467 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 7.1 p90 -159.12 -154.11 0.4 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.856 -1.152 . . . . 0.0 110.089 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 0.5 OUTLIER -128.78 141.78 51.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.398 -0.814 . . . . 0.0 109.795 -179.205 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.619 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 7.4 tp10 -72.08 -47.02 11.33 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.201 -0.937 . . . . 0.0 109.57 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.9 Cg_endo -79.73 -68.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.157 0 C-N-CA 122.271 1.981 . . . . 0.0 110.333 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.716 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 9.9 m80 -69.98 64.44 0.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.135 -0.978 . . . . 0.0 109.048 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 91' ' ' PRO . 4.2 mtm180 -84.58 -10.2 57.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.678 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -122.78 54.32 0.71 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.587 ' HB3' ' HG3' ' A' ' 97' ' ' MET . . . -151.39 39.3 0.65 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -1.13 . . . . 0.0 109.549 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 48.24 22.05 2.16 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.596 ' HE1' ' HB3' ' A' ' 14' ' ' LEU . 2.5 mtp -80.5 55.71 2.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.981 -1.306 . . . . 0.0 109.116 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 87' ' ' PHE . 39.4 t -130.63 113.57 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.635 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.55 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -96.55 -173.1 35.12 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 14.9 mttt -160.53 122.34 3.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -1.182 . . . . 0.0 109.66 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 1.017 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 0.7 OUTLIER -91.06 119.03 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.149 -0.97 . . . . 0.0 109.344 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.0 m -105.17 94.98 5.53 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.608 HG23 ' CG2' ' A' ' 101' ' ' ILE . 91.3 t -99.28 129.18 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.218 -0.926 . . . . 0.0 109.825 -179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.406 -0.809 . . . . 0.0 109.481 179.956 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.461 HG23 ' HB ' ' A' ' 28' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -90.23 154.27 19.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.437 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.98 107.91 13.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.718 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.496 ' CG1' ' HB3' ' A' ' 16' ' ' PHE . 1.3 t -105.93 123.28 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.887 . . . . 0.0 109.324 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.413 ' HG2' HD12 ' A' ' 32' ' ' LEU . 13.8 mttm -117.75 90.3 3.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 109.41 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.49 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -50.55 164.38 0.13 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.166 -0.959 . . . . 0.0 109.528 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.18 76.36 0.91 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 3.2 p -48.02 -60.44 2.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -1.164 . . . . 0.0 109.306 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 9' ' ' SER . 1.1 t70 174.46 -62.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.403 -0.81 . . . . 0.0 109.288 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.85 18.95 6.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.313 -0.867 . . . . 0.0 109.283 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.435 ' O ' ' HG ' ' A' ' 13' ' ' LEU . . . -105.84 -92.5 2.27 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 13' ' ' LEU . 1.1 mp -143.86 -165.37 2.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.262 -1.14 . . . . 0.0 109.668 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.736 HD13 ' HE1' ' A' ' 39' ' ' HIS . 10.8 mt -100.64 52.37 0.87 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.41 -0.806 . . . . 0.0 109.359 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.438 HG12 ' O ' ' A' ' 96' ' ' GLY . 4.0 m -94.84 149.91 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 109.514 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.496 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 51.8 m-85 -65.16 177.35 1.06 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -0.923 . . . . 0.0 109.309 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 16' ' ' PHE . 4.7 mt-10 -160.16 108.01 1.4 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.907 . . . . 0.0 109.367 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 33.0 Cg_endo -75.13 170.14 72.64 Favored 'Cis proline' 0 C--N 1.311 -1.408 0 C-N-CA 123.602 -1.416 . . . . 0.0 110.678 0.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.66 -63.27 1.11 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.246 -0.909 . . . . 0.0 109.421 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.43 ' C ' HD12 ' A' ' 21' ' ' LEU . 1.9 ptpt -80.02 158.1 26.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.176 -0.952 . . . . 0.0 109.309 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.43 HD12 ' C ' ' A' ' 20' ' ' LYS . 1.0 OUTLIER -150.47 118.79 6.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.416 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 102' ' ' THR . 24.2 m -89.51 92.1 8.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.235 -0.916 . . . . 0.0 109.611 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.683 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -99.62 175.8 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.291 -0.881 . . . . 0.0 109.569 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.638 ' C ' HG13 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -88.69 179.2 1.71 Allowed Pre-proline 0 C--N 1.302 -1.464 0 O-C-N 121.355 -0.841 . . . . 0.0 108.818 179.613 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.675 ' HA ' HG11 ' A' ' 103' ' ' VAL . 35.1 Cg_endo -78.58 77.23 4.11 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.371 2.047 . . . . 0.0 110.889 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 116.4 27.4 2.87 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.465 ' CG ' ' HB2' ' A' ' 24' ' ' LYS . 6.0 m-20 -84.1 -176.68 6.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.154 -1.203 . . . . 0.0 109.097 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.461 ' HB ' HG23 ' A' ' 2' ' ' THR . 90.2 m -112.98 129.02 56.64 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.251 -0.906 . . . . 0.0 109.583 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.037 HG21 HD11 ' A' ' 101' ' ' ILE . 4.2 t -115.59 124.35 71.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.309 -0.87 . . . . 0.0 108.77 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -99.15 125.47 44.72 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.27 -0.894 . . . . 0.0 109.649 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.891 ' O ' HD23 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -116.3 153.78 31.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.38 -0.825 . . . . 0.0 108.941 -179.868 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.891 HD23 ' O ' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -141.36 -171.62 3.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.981 -1.075 . . . . 0.0 109.95 -179.603 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.68 ' HB3' HD23 ' A' ' 65' ' ' LEU . 3.2 p-10 -123.14 167.45 13.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.382 -0.823 . . . . 0.0 109.093 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -157.31 -58.16 0.08 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.906 -1.121 . . . . 0.0 110.111 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.56 ' HB3' ' CD2' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -71.51 -150.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 0.0 110.161 -179.356 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.2 t -69.37 115.27 30.76 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.594 -0.691 . . . . 0.0 110.352 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.571 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.4 Cg_endo -79.62 178.53 7.23 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 122.915 2.41 . . . . 0.0 109.997 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.571 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 41.5 Cg_endo -88.48 163.61 41.92 Favored 'Cis proline' 0 C--N 1.313 -1.331 0 O-C-N 123.339 1.179 . . . . 0.0 110.707 -1.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.736 ' HE1' HD13 ' A' ' 14' ' ' LEU . 97.3 m-70 -126.01 122.59 36.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.175 -0.953 . . . . 0.0 110.018 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.456 ' OD1' ' HA ' ' A' ' 64' ' ' LEU . 2.0 t30 -99.45 142.55 30.79 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.425 -0.797 . . . . 0.0 109.163 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.494 HG12 ' OG ' ' A' ' 60' ' ' SER . 7.1 t -110.51 118.13 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.937 . . . . 0.0 109.422 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.625 ' HA ' ' CB ' ' A' ' 60' ' ' SER . 1.6 t -153.84 138.69 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.164 -0.96 . . . . 0.0 110.099 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.751 ' CE2' HD23 ' A' ' 59' ' ' LEU . 2.8 m-85 -87.33 126.22 34.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.658 -0.651 . . . . 0.0 109.643 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.469 ' OD2' ' HB3' ' A' ' 46' ' ' ALA . 38.8 t70 -51.67 137.54 24.94 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.236 -0.915 . . . . 0.0 108.924 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.93 14.92 3.66 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.186 -0.946 . . . . 0.0 109.815 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.469 ' HB3' ' OD2' ' A' ' 44' ' ' ASP . . . -129.07 11.87 6.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.156 -0.965 . . . . 0.0 109.62 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.423 HD12 ' HB3' ' A' ' 44' ' ' ASP . 76.1 mt -126.66 50.4 1.94 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.93 . . . . 0.0 109.635 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 51' ' ' LYS . 5.2 p30 -119.67 159.39 46.47 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 0.0 109.122 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 36.2 Cg_endo -77.85 -2.23 12.37 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.566 2.177 . . . . 0.0 110.664 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.519 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -123.17 28.74 7.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.204 -0.935 . . . . 0.0 109.655 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.519 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER 28.49 40.88 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.108 0.48 . . . . 0.0 110.728 179.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 50' ' ' ALA . 72.9 m -135.91 -171.52 2.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.123 -0.986 . . . . 0.0 109.816 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.34 19.58 1.37 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.305 -0.872 . . . . 0.0 109.598 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -68.96 -31.31 70.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 109.499 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.708 ' O ' HD12 ' A' ' 55' ' ' LEU . 0.6 OUTLIER -102.0 22.77 12.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.546 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -117.36 -54.99 2.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -0.881 . . . . 0.0 109.351 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -56.97 -28.58 62.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.372 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.4 p -108.99 30.22 6.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.283 -0.886 . . . . 0.0 109.625 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.783 ' O ' HG23 ' A' ' 74' ' ' THR . 26.7 tp -115.87 -62.15 1.63 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.205 -0.934 . . . . 0.0 109.444 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.625 ' CB ' ' HA ' ' A' ' 42' ' ' VAL . 0.6 OUTLIER -80.15 -171.46 2.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.264 -0.898 . . . . 0.0 110.627 -178.703 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -115.11 157.36 23.68 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.627 -0.671 . . . . 0.0 109.295 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.58 -14.44 16.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 109.682 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -76.93 130.36 37.43 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.172 -0.955 . . . . 0.0 109.488 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.497 HD12 ' N ' ' A' ' 64' ' ' LEU . 8.6 mp -60.86 179.98 0.15 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.267 -0.895 . . . . 0.0 109.375 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.997 HD21 ' CB ' ' A' ' 71' ' ' SER . 2.5 mp -98.57 135.22 40.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.232 -0.918 . . . . 0.0 109.349 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 3.1 mmt -127.11 1.56 6.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.187 -0.946 . . . . 0.0 109.413 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.3 t -111.45 129.41 24.12 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.908 . . . . 0.0 109.229 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.518 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.2 Cg_endo -78.47 87.0 1.58 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.338 2.026 . . . . 0.0 110.514 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.551 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 114.87 35.01 1.42 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.56 ' N ' ' HB3' ' A' ' 32' ' ' LEU . 1.0 OUTLIER 178.55 112.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -1.133 . . . . 0.0 109.366 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.997 ' CB ' HD21 ' A' ' 65' ' ' LEU . 21.5 p -104.85 -82.19 0.52 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.108 -0.995 . . . . 0.0 109.429 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.589 ' N ' ' OG ' ' A' ' 71' ' ' SER . 85.2 m -160.83 156.28 24.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.007 -1.058 . . . . 0.0 109.346 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 75' ' ' THR . 0.8 OUTLIER -102.68 67.31 0.98 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.158 -0.964 . . . . 0.0 109.309 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.783 HG23 ' O ' ' A' ' 59' ' ' LEU . 97.8 m -46.26 99.28 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.364 -0.835 . . . . 0.0 109.642 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.416 ' N ' ' O ' ' A' ' 73' ' ' SER . 19.0 m -78.89 95.87 5.54 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.654 ' CE2' HD21 ' A' ' 59' ' ' LEU . 8.0 m-85 -47.85 162.45 0.32 Allowed Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.526 -0.734 . . . . 0.0 109.34 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.563 ' HD3' ' CD1' ' A' ' 59' ' ' LEU . 35.0 Cg_endo -76.61 173.37 14.59 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.695 2.263 . . . . 0.0 111.12 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.75 8.51 7.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.295 -0.878 . . . . 0.0 109.629 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -99.32 -71.01 0.71 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.217 -0.927 . . . . 0.0 109.147 179.781 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 79' ' ' ASP . . . 42.76 88.26 0.1 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.336 -0.852 . . . . 0.0 109.374 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.435 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 33.4 Cg_endo -75.61 127.79 10.53 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.616 2.21 . . . . 0.0 110.654 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -43.06 136.92 2.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.439 -0.788 . . . . 0.0 109.553 -179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 152.65 172.92 21.57 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -96.88 126.34 41.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -1.144 . . . . 0.0 109.519 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.493 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 12.6 m-85 -97.6 -173.7 2.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 108.853 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 99.4 m -164.83 103.58 0.79 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.922 -1.111 . . . . 0.0 110.443 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.578 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.5 OUTLIER -101.24 166.07 10.96 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.563 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 97' ' ' MET . 4.9 p90 -159.96 -153.38 0.34 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.724 -1.235 . . . . 0.0 110.547 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 97' ' ' MET . 0.5 OUTLIER -129.1 148.03 51.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.543 -0.723 . . . . 0.0 109.49 -179.406 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 0.4 OUTLIER -84.0 -43.58 0.77 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.943 . . . . 0.0 110.511 179.621 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.2 Cg_endo -78.68 -67.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.065 0 C-N-CA 122.109 1.873 . . . . 0.0 110.872 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.675 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 69.5 m80 -65.93 75.36 0.08 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.99 -1.069 . . . . 0.0 109.551 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 91' ' ' PRO . 45.5 mtm180 -91.84 110.94 22.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.126 -0.984 . . . . 0.0 109.139 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.7 1.71 30.63 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.03 33.59 2.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -1.16 . . . . 0.0 109.475 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.438 ' O ' HG12 ' A' ' 15' ' ' VAL . . . 64.27 13.14 53.22 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.638 ' HE2' ' O ' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -74.13 63.1 0.95 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.824 -1.398 . . . . 0.0 109.201 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.1 t -140.72 107.99 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.891 . . . . 0.0 109.61 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.578 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -112.21 179.45 19.48 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.457 ' HG3' ' C ' ' A' ' 99' ' ' GLY . 2.7 mtmp? -152.46 134.24 14.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.115 -1.227 . . . . 0.0 109.784 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 1.037 HD11 HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -95.82 132.73 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.88 . . . . 0.0 108.831 179.568 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -107.02 97.8 7.53 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.137 -0.977 . . . . 0.0 108.829 179.252 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.675 HG11 ' HA ' ' A' ' 25' ' ' PRO . 3.8 t -99.3 73.86 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.028 -1.045 . . . . 0.0 109.463 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.499 0 O-C-N 121.395 -0.816 . . . . 0.0 109.538 179.942 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.24 0.543 . . . . 0.0 109.586 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.799 ' CD2' HD21 ' A' ' 21' ' ' LEU . 23.1 m-85 -86.1 163.39 17.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.319 -0.863 . . . . 0.0 109.302 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.802 HG23 ' HB3' ' A' ' 30' ' ' GLU . 0.9 OUTLIER -151.93 111.96 4.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.044 -1.035 . . . . 0.0 109.957 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.473 ' CG1' HD12 ' A' ' 21' ' ' LEU . 6.5 m -104.98 79.97 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.275 -0.89 . . . . 0.0 109.255 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -58.2 148.32 27.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.314 -0.866 . . . . 0.0 109.714 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.732 HD11 ' HA ' ' A' ' 33' ' ' ASN . 0.4 OUTLIER -118.05 -173.79 2.52 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.236 -0.915 . . . . 0.0 109.485 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.6 ' HA2' HD23 ' A' ' 14' ' ' LEU . . . 65.28 88.57 0.05 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.559 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -66.55 -22.84 66.16 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.31 -1.112 . . . . 0.0 109.384 179.699 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.559 ' CB ' ' O ' ' A' ' 9' ' ' SER . 8.4 t70 83.36 20.05 0.2 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.467 ' HB2' HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -115.63 9.74 15.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 109.361 179.774 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.56 5.16 45.78 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.513 ' N ' HD23 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -134.95 154.4 51.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -1.161 . . . . 0.0 109.825 -179.792 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.618 ' CD1' ' CD2' ' A' ' 92' ' ' HIS . 95.1 mt -113.91 121.4 43.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.353 -0.842 . . . . 0.0 109.172 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 m -149.07 153.6 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.111 -0.993 . . . . 0.0 109.863 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.477 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 12.0 m-85 -76.57 156.21 32.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.172 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 16' ' ' PHE . 4.1 mt-10 -141.98 109.77 5.99 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.128 -0.983 . . . . 0.0 109.393 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.5 Cg_endo -77.51 -177.7 21.92 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 123.767 -1.347 . . . . 0.0 110.698 0.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.21 -58.36 3.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 109.333 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.07 168.74 9.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.915 . . . . 0.0 109.16 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.799 HD21 ' CD2' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -160.1 146.06 15.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.082 -1.011 . . . . 0.0 109.927 -179.812 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 102' ' ' THR . 90.5 m -114.31 112.88 23.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.843 . . . . 0.0 109.011 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.737 ' CD1' HD13 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -117.59 164.05 14.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.265 -0.897 . . . . 0.0 110.073 -179.682 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.571 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 17.0 mmmt -82.16 165.48 42.66 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.615 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 32.7 Cg_endo -74.81 86.26 1.41 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 121.945 1.763 . . . . 0.0 110.306 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 126.26 4.43 6.45 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.494 ' OD2' ' CG ' ' A' ' 24' ' ' LYS . 59.0 m-20 -71.07 -176.73 1.47 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -1.158 . . . . 0.0 109.58 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.745 HG23 ' HA ' ' A' ' 75' ' ' THR . 0.2 OUTLIER -120.04 122.93 42.21 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.284 -0.885 . . . . 0.0 109.636 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.86 HG21 HD11 ' A' ' 101' ' ' ILE . 1.4 t -111.17 147.32 15.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.224 -0.923 . . . . 0.0 109.334 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.802 ' HB3' HG23 ' A' ' 4' ' ' THR . 5.3 tp10 -117.56 141.34 48.47 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.176 -0.953 . . . . 0.0 110.111 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.567 ' CE2' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -145.33 89.73 1.96 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.716 ' O ' HD11 ' A' ' 7' ' ' LEU . 0.5 OUTLIER -97.84 179.88 4.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.44 -0.787 . . . . 0.0 111.257 -178.028 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.732 ' HA ' HD11 ' A' ' 7' ' ' LEU . 3.8 p-10 -93.21 165.42 12.82 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.533 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . 42.0 t30 -115.7 -84.0 0.62 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.073 -1.017 . . . . 0.0 109.477 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.516 ' O ' HG22 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -145.95 35.15 1.01 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.087 -1.008 . . . . 0.0 109.643 179.892 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.55 ' O ' ' NE2' ' A' ' 92' ' ' HIS . 2.0 t -156.87 60.36 2.13 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.86 . . . . 0.0 109.305 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 35.8 Cg_endo -78.26 174.08 12.94 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.661 2.24 . . . . 0.0 110.631 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.533 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.9 Cg_endo -86.38 162.18 54.53 Favored 'Cis proline' 0 C--N 1.311 -1.445 0 O-C-N 123.798 1.42 . . . . 0.0 110.297 -1.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.711 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 65.2 m-70 -118.59 146.73 44.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.187 -0.946 . . . . 0.0 110.17 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -120.04 114.47 22.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 109.237 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.497 HG21 ' HB2' ' A' ' 31' ' ' PHE . 24.7 t -99.92 114.06 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.508 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.679 HG13 ' CB ' ' A' ' 60' ' ' SER . 1.6 t -150.59 157.4 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.928 . . . . 0.0 109.874 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.573 ' CE2' HD23 ' A' ' 59' ' ' LEU . 3.8 m-85 -109.14 110.99 22.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.422 -0.799 . . . . 0.0 109.41 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -47.16 158.35 0.15 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.0 109.519 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.73 31.2 5.64 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.292 -0.88 . . . . 0.0 109.532 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.99 -31.71 4.99 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.182 -0.949 . . . . 0.0 109.644 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 mp -101.43 64.5 1.01 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.94 . . . . 0.0 109.656 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.443 ' CG ' ' HA ' ' A' ' 51' ' ' LYS . 0.7 OUTLIER -111.79 158.72 35.83 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.309 -0.869 . . . . 0.0 109.394 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -80.01 -33.7 1.07 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.78 2.32 . . . . 0.0 110.564 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.507 ' O ' ' HG3' ' A' ' 51' ' ' LYS . . . -122.6 35.7 4.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.15 -0.969 . . . . 0.0 109.845 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.507 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 0.3 OUTLIER 34.28 49.75 0.34 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.869 -0.519 . . . . 0.0 110.529 179.634 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 m -127.44 141.21 51.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.12 -0.987 . . . . 0.0 109.675 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -121.04 10.43 10.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 109.401 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -62.31 -39.65 93.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.392 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.528 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 1.7 pp -80.93 -32.27 34.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.362 -0.836 . . . . 0.0 109.57 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.506 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -69.01 -43.74 74.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.081 -1.012 . . . . 0.0 109.571 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.12 -30.91 12.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.313 -0.867 . . . . 0.0 109.748 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 59' ' ' LEU . 0.1 OUTLIER -105.74 -40.42 5.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.163 -0.961 . . . . 0.0 110.009 -179.623 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.978 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 13.2 tp -43.01 -56.56 3.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.217 -0.927 . . . . 0.0 109.917 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.679 ' CB ' HG13 ' A' ' 42' ' ' VAL . 64.3 p -78.83 153.05 30.95 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.487 -0.758 . . . . 0.0 110.619 -177.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.498 ' CE1' ' O ' ' A' ' 63' ' ' GLN . 12.8 p80 -93.69 176.67 6.27 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.87 -57.61 2.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.726 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.498 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 3.3 pt20 -44.09 145.48 0.75 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 109.552 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 mp -78.29 167.98 20.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 109.505 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.477 ' CD1' ' CE1' ' A' ' 61' ' ' HIS . 7.7 mp -95.32 108.96 21.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 0.0 109.38 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 4.2 ttp -117.81 -0.4 11.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 0.0 109.673 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.522 ' OG ' ' CB ' ' A' ' 70' ' ' GLN . 3.2 t -91.23 147.28 35.21 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.147 -0.971 . . . . 0.0 109.557 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.23 87.96 1.48 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.712 2.275 . . . . 0.0 110.823 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.536 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 89.22 35.37 8.12 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.522 ' CB ' ' OG ' ' A' ' 67' ' ' SER . 1.6 tt0 -147.25 94.0 2.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.128 -1.219 . . . . 0.0 109.205 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.562 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . 4.4 p -99.88 -105.89 0.22 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.33 -0.856 . . . . 0.0 109.676 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.548 HG23 ' O ' ' A' ' 72' ' ' THR . 9.9 t -160.56 123.74 3.4 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.7 m -79.26 82.31 5.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.046 -1.034 . . . . 0.0 109.341 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.521 HG21 ' HG ' ' A' ' 59' ' ' LEU . 99.6 m -59.67 101.51 0.11 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.399 -0.813 . . . . 0.0 109.504 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.745 ' HA ' HG23 ' A' ' 28' ' ' THR . 3.1 t -78.95 86.18 4.85 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.978 ' CZ ' HD21 ' A' ' 59' ' ' LEU . 3.2 m-85 -36.22 147.97 0.18 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.887 -0.508 . . . . 0.0 110.125 -178.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.442 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.7 Cg_endo -78.28 175.74 10.75 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.793 2.329 . . . . 0.0 111.52 -178.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.76 9.78 13.15 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.493 ' O ' ' C ' ' A' ' 80' ' ' ALA . 2.2 t70 -99.15 -12.99 19.97 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.411 -0.806 . . . . 0.0 108.886 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.615 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -34.6 104.54 0.25 Allowed Pre-proline 0 N--CA 1.497 1.919 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.445 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 33.9 Cg_endo -75.57 152.65 38.4 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.531 2.154 . . . . 0.0 110.899 -179.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -71.67 131.6 43.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.437 -0.79 . . . . 0.0 109.413 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 155.34 -149.61 20.83 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.454 ' CD ' HG23 ' A' ' 102' ' ' THR . 0.0 OUTLIER -126.48 137.83 53.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.214 -1.168 . . . . 0.0 109.664 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.549 ' CD1' HG22 ' A' ' 101' ' ' ILE . 6.4 m-85 -101.51 -170.95 1.9 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.347 -0.846 . . . . 0.0 108.723 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 85' ' ' TYR . 92.6 m -166.79 98.4 0.55 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.859 -1.151 . . . . 0.0 110.463 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.524 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.6 OUTLIER -101.95 162.27 13.04 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.243 -0.911 . . . . 0.0 108.677 178.622 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -154.31 -162.0 1.33 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.927 -1.108 . . . . 0.0 110.112 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.63 141.45 48.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.492 -0.755 . . . . 0.0 109.391 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 19.2 tt0 -77.95 -44.71 2.34 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.213 -0.929 . . . . 0.0 110.181 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.0 Cg_endo -78.68 -64.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 122.0 1.8 . . . . 0.0 110.439 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.711 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 9.2 m80 -73.86 57.14 0.59 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.22 -0.925 . . . . 0.0 109.315 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 16.8 ttt85 -102.91 -8.6 20.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.564 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -88.66 22.9 18.76 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.92 -129.62 0.14 Allowed 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.313 -1.11 . . . . 0.0 108.692 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -127.74 36.95 2.42 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.535 ' CE ' ' HB3' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -80.61 70.29 7.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.121 -1.223 . . . . 0.0 109.602 179.784 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 53.0 t -140.97 113.24 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.212 -0.93 . . . . 0.0 109.626 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.524 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -114.77 172.12 14.07 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.446 ' HB3' ' O ' ' A' ' 85' ' ' TYR . 6.7 mttm -148.88 128.54 13.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -1.151 . . . . 0.0 109.648 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.86 HD11 HG21 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -80.27 154.96 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.885 . . . . 0.0 108.971 179.676 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.616 ' O ' HG23 ' A' ' 22' ' ' THR . 0.7 OUTLIER -129.26 90.17 2.97 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.259 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.65 HG23 ' CG2' ' A' ' 101' ' ' ILE . 28.0 t -99.89 121.81 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.259 -0.9 . . . . 0.0 109.835 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.492 0 O-C-N 121.398 -0.814 . . . . 0.0 109.392 -179.966 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.466 ' O ' ' N ' ' A' ' 30' ' ' GLU . 43.1 m-85 -89.37 116.7 27.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -0.917 . . . . 0.0 109.615 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.6 m -118.42 120.57 37.96 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.319 -0.863 . . . . 0.0 109.3 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.539 HG12 ' C ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -107.93 102.66 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 109.387 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 7' ' ' LEU . 2.4 ttmt -80.68 83.89 6.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.325 -0.859 . . . . 0.0 109.464 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.679 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -47.42 173.23 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.356 -0.84 . . . . 0.0 109.677 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.533 ' HA3' ' CB ' ' A' ' 34' ' ' ASN . . . 83.34 94.4 0.61 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.472 ' OG ' ' N ' ' A' ' 10' ' ' ASP . 95.0 p -49.92 -75.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.289 -1.124 . . . . 0.0 109.536 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.472 ' N ' ' OG ' ' A' ' 9' ' ' SER . 20.9 t0 -173.16 -71.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.567 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.17 55.51 1.85 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.277 -0.889 . . . . 0.0 109.385 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.77 -95.23 0.1 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.458 ' HA ' HD22 ' A' ' 13' ' ' LEU . 0.8 OUTLIER -113.42 166.24 11.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.297 -1.12 . . . . 0.0 109.46 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.719 ' HB3' ' HE1' ' A' ' 97' ' ' MET . 17.2 mt -101.69 123.65 46.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.213 -0.929 . . . . 0.0 109.392 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.2 m -143.98 159.08 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.615 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.41 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 3.2 m-85 -71.92 164.32 26.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 109.376 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.539 ' C ' HG12 ' A' ' 5' ' ' VAL . 14.6 mt-10 -154.24 104.59 2.41 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 109.419 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 33.5 Cg_endo -77.09 169.22 74.89 Favored 'Cis proline' 0 C--N 1.311 -1.441 0 C-N-CA 123.693 -1.378 . . . . 0.0 110.448 0.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.79 -25.41 62.0 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.232 -0.918 . . . . 0.0 109.738 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.445 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 10.6 mmtm -112.62 160.4 17.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.113 -0.992 . . . . 0.0 109.832 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 20' ' ' LYS . 7.0 mt -143.72 108.75 4.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -0.866 . . . . 0.0 109.291 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.517 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 5.3 m -89.05 90.32 8.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.277 -0.889 . . . . 0.0 109.752 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.741 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.2 pt -101.35 171.67 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.24 -0.912 . . . . 0.0 109.685 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.646 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 7.8 mttt -86.83 -164.23 0.06 OUTLIER Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.646 ' HD2' ' CB ' ' A' ' 24' ' ' LYS . 30.8 Cg_endo -74.95 62.35 5.8 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 N-CA-C 109.314 -1.072 . . . . 0.0 109.314 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.568 ' O ' ' HB2' ' A' ' 76' ' ' PHE . . . 142.52 -92.19 0.17 Allowed Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.423 ' CG ' ' HG3' ' A' ' 24' ' ' LYS . 1.3 m-20 49.61 -176.2 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.119 -1.224 . . . . 0.0 109.55 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.513 ' CG2' ' OG ' ' A' ' 73' ' ' SER . 64.0 m -122.68 142.49 50.62 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.309 -0.869 . . . . 0.0 109.523 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.758 HG21 HD11 ' A' ' 101' ' ' ILE . 2.4 t -125.13 148.79 29.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.289 -0.882 . . . . 0.0 109.307 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 3' ' ' TYR . 1.9 mt-10 -127.27 132.61 50.3 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.197 -0.939 . . . . 0.0 109.746 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.578 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -138.1 105.01 5.38 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.77 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.751 HD23 ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -100.33 -171.47 2.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.066 -1.021 . . . . 0.0 111.026 -178.654 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.52 ' HA ' HD11 ' A' ' 7' ' ' LEU . 3.2 p-10 -105.55 168.33 9.16 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.706 -0.621 . . . . 0.0 109.725 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.533 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . 30.2 t30 -114.64 -142.05 0.38 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.295 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.405 ' C ' ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -99.36 36.11 1.81 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.997 -1.064 . . . . 0.0 109.241 179.76 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.595 HG21 HD21 ' A' ' 14' ' ' LEU . 2.1 t -151.46 61.95 4.64 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.579 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.2 Cg_endo -77.42 175.63 11.06 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.694 2.263 . . . . 0.0 110.955 -178.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.579 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 40.5 Cg_endo -87.87 158.51 44.81 Favored 'Cis proline' 0 C--N 1.313 -1.338 0 C-N-CA 123.573 -1.428 . . . . 0.0 110.74 -1.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.713 ' C ' HD12 ' A' ' 65' ' ' LEU . 80.6 m-70 -121.99 160.88 23.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.382 -0.824 . . . . 0.0 109.858 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.74 165.8 26.31 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.4 -0.813 . . . . 0.0 108.847 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.564 ' HB ' ' CD2' ' A' ' 61' ' ' HIS . 43.3 t -137.45 114.65 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.113 -0.992 . . . . 0.0 109.144 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.54 HG13 ' HB2' ' A' ' 60' ' ' SER . 0.0 OUTLIER -144.37 174.74 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.244 -0.91 . . . . 0.0 109.518 -179.443 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.669 ' CD2' HD23 ' A' ' 59' ' ' LEU . 4.2 m-85 -131.33 112.24 12.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 0.0 109.392 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.623 ' CG ' HD12 ' A' ' 47' ' ' LEU . 8.0 t70 -54.0 136.49 41.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 109.633 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.87 -2.67 58.71 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.261 -0.9 . . . . 0.0 109.648 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.443 ' O ' ' HG ' ' A' ' 47' ' ' LEU . . . -107.75 13.82 26.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.181 -0.949 . . . . 0.0 109.645 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.623 HD12 ' CG ' ' A' ' 44' ' ' ASP . 1.5 mt -140.32 46.66 1.81 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 0.0 109.424 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.502 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 1.2 p30 -123.86 165.75 22.18 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.321 -0.862 . . . . 0.0 109.287 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.502 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 33.5 Cg_endo -76.02 -23.71 11.93 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.437 2.092 . . . . 0.0 109.689 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 52' ' ' SER . . . -140.17 83.9 1.94 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -40.06 95.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.462 -0.774 . . . . 0.0 109.986 -179.369 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 50' ' ' ALA . 4.5 m -138.31 107.26 5.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.391 -0.818 . . . . 0.0 109.159 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.89 -0.85 17.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 109.719 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -75.79 -53.69 8.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.906 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.483 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 2.1 pp -63.28 -29.84 71.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.158 -0.964 . . . . 0.0 109.591 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.462 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -73.45 -37.97 65.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 0.0 109.631 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.1 mttp -52.4 -30.35 28.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -0.947 . . . . 0.0 109.714 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.3 p -115.6 38.36 3.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -0.908 . . . . 0.0 109.507 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.743 ' HG ' HG21 ' A' ' 74' ' ' THR . 7.3 tp -135.64 -48.64 0.7 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -0.881 . . . . 0.0 109.29 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.54 ' HB2' HG13 ' A' ' 42' ' ' VAL . 1.2 p -78.88 122.16 25.75 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.478 -0.764 . . . . 0.0 110.289 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.564 ' CD2' ' HB ' ' A' ' 41' ' ' VAL . 4.4 p80 -90.71 159.32 16.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.367 -0.833 . . . . 0.0 108.974 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.48 -161.66 0.76 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.133 -0.979 . . . . 0.0 109.654 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 66.9 106.92 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.412 -0.805 . . . . 0.0 109.609 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.449 HD23 ' HB2' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -54.31 143.33 23.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 109.609 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.713 HD12 ' C ' ' A' ' 39' ' ' HIS . 1.1 mt -89.01 87.24 7.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.361 -0.837 . . . . 0.0 109.151 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . 0.52 ' HG3' ' N ' ' A' ' 67' ' ' SER . 0.0 OUTLIER -85.4 -24.61 27.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.108 -0.995 . . . . 0.0 109.954 -179.636 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.52 ' N ' ' HG3' ' A' ' 66' ' ' MET . 1.9 t -79.98 147.66 66.35 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.288 -0.883 . . . . 0.0 109.425 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.458 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 35.0 Cg_endo -77.86 100.37 1.37 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.572 2.181 . . . . 0.0 110.156 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.71 -25.84 17.9 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.448 ' HB2' ' OG ' ' A' ' 67' ' ' SER . 50.9 tt0 -62.52 110.79 1.8 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.14 -1.212 . . . . 0.0 108.532 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.553 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . 12.0 p -132.8 -155.03 0.65 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.138 -0.976 . . . . 0.0 110.934 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.7 m -152.05 116.66 5.08 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.513 ' OG ' ' CG2' ' A' ' 28' ' ' THR . 13.7 t -79.05 104.26 9.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -0.961 . . . . 0.0 108.966 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.743 HG21 ' HG ' ' A' ' 59' ' ' LEU . 91.6 m -73.27 109.07 6.52 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.408 -0.808 . . . . 0.0 109.956 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 75' ' ' THR . 3.3 t -79.39 80.42 5.76 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.7 ' CE2' HD21 ' A' ' 59' ' ' LEU . 10.3 m-85 -36.24 151.97 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.819 -0.551 . . . . 0.0 110.162 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.402 ' HD3' HD13 ' A' ' 59' ' ' LEU . 36.2 Cg_endo -78.38 171.01 17.59 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.799 2.332 . . . . 0.0 111.016 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -86.37 9.44 17.99 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 80' ' ' ALA . 1.0 OUTLIER -101.51 -8.73 21.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.455 -0.778 . . . . 0.0 109.477 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.492 ' HB1' HG21 ' A' ' 103' ' ' VAL . . . -38.2 105.28 0.32 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.559 -0.713 . . . . 0.0 109.66 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.421 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 35.3 Cg_endo -77.34 146.51 24.92 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.501 2.134 . . . . 0.0 110.747 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -56.59 132.1 50.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.297 -0.877 . . . . 0.0 109.513 -179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 145.9 161.9 9.43 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 3.8 mt-10 -85.24 131.91 34.35 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.214 -1.168 . . . . 0.0 109.562 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.736 ' CD1' HG22 ' A' ' 101' ' ' ILE . 29.0 m-85 -84.44 -156.12 0.22 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -163.88 87.04 0.5 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.685 -1.26 . . . . 0.0 110.551 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.787 ' O ' HG23 ' A' ' 98' ' ' VAL . 1.1 p90 -99.92 160.97 13.9 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.519 ' CB ' ' HB ' ' A' ' 98' ' ' VAL . 9.5 p90 -159.22 -163.11 1.15 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.919 -1.113 . . . . 0.0 110.396 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.489 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 0.1 OUTLIER -123.49 133.64 54.0 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.513 -0.742 . . . . 0.0 109.775 -179.615 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.631 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.7 tm-20 -74.16 -43.01 5.87 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.336 -0.853 . . . . 0.0 110.669 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.1 Cg_endo -77.63 -54.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.902 1.735 . . . . 0.0 110.833 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.712 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 42.6 m80 -85.38 60.44 6.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.052 -1.03 . . . . 0.0 109.535 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.45 -4.26 53.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.909 . . . . 0.0 109.427 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.71 14.62 17.3 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 96' ' ' GLY . . . -120.37 33.13 5.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -1.136 . . . . 0.0 109.376 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 95' ' ' ALA . . . 41.72 60.73 2.42 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.719 ' HE1' ' HB3' ' A' ' 14' ' ' LEU . 5.4 mtp -107.37 53.82 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.174 -1.192 . . . . 0.0 109.417 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 87' ' ' PHE . 1.4 p -139.44 143.82 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 109.694 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -151.04 176.09 29.71 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.444 ' HB3' ' O ' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -127.29 141.89 51.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.178 -1.19 . . . . 0.0 109.716 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.758 HD11 HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -85.6 155.59 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.889 . . . . 0.0 109.014 179.749 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.517 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -115.46 98.35 6.68 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.157 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.662 HG22 ' CD1' ' A' ' 23' ' ' ILE . 53.7 t -99.24 78.71 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.258 -0.901 . . . . 0.0 109.572 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.527 0 O-C-N 121.342 -0.849 . . . . 0.0 109.399 179.911 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.427 HG23 ' HB ' ' A' ' 28' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.345 0.593 . . . . 0.0 109.501 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.622 ' CG ' HD21 ' A' ' 21' ' ' LEU . 6.6 m-85 -103.29 174.14 6.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.12 -0.987 . . . . 0.0 109.285 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.409 HG22 HD21 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -143.73 105.04 4.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.089 -1.007 . . . . 0.0 110.062 -179.607 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 5' ' ' VAL . 20.5 m -93.71 65.84 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.218 -0.926 . . . . 0.0 109.131 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.418 ' HG3' HD11 ' A' ' 32' ' ' LEU . 1.5 ttmt -49.48 98.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 110.026 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -65.49 157.96 28.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.119 -0.988 . . . . 0.0 108.983 179.466 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 14' ' ' LEU . . . 72.18 137.07 0.22 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.459 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 1.5 p -100.72 -68.99 0.79 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.149 -1.206 . . . . 0.0 109.686 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 1.6 p30 167.24 -49.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 109.856 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . 0.444 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -127.27 24.75 6.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 109.69 -179.768 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.811 ' C ' HD22 ' A' ' 13' ' ' LEU . . . -126.49 -116.5 2.06 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.825 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.6 mm? -121.98 -169.1 1.82 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.309 -1.113 . . . . 0.0 109.254 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.954 HD21 ' HB3' ' A' ' 35' ' ' LYS . 47.5 mt -98.84 102.54 14.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.263 -0.898 . . . . 0.0 108.671 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.1 m -137.69 164.05 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 0.0 109.724 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -80.07 137.25 36.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.372 -0.83 . . . . 0.0 109.205 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 34.5 mm-40 -126.13 105.64 25.28 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.202 -0.936 . . . . 0.0 109.551 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.8 Cg_endo -78.25 169.51 72.79 Favored 'Cis proline' 0 C--N 1.312 -1.381 0 C-N-CA 123.817 -1.326 . . . . 0.0 110.557 0.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.42 -64.79 0.81 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.147 -0.971 . . . . 0.0 108.879 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.4 pttm -84.76 160.03 20.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.37 -0.832 . . . . 0.0 109.029 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.836 HD23 HG23 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -152.12 149.13 28.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.081 -1.012 . . . . 0.0 110.078 -179.809 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.8 m -111.79 119.44 38.62 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.836 HG23 HD23 ' A' ' 21' ' ' LEU . 0.9 OUTLIER -132.43 175.74 10.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.143 -0.973 . . . . 0.0 110.029 -179.437 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.571 ' C ' HG13 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -91.69 175.99 3.07 Favored Pre-proline 0 C--N 1.303 -1.421 0 O-C-N 121.394 -0.816 . . . . 0.0 109.049 179.578 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.674 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 35.4 Cg_endo -77.26 92.17 1.14 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.331 2.021 . . . . 0.0 110.646 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 111.06 5.8 26.6 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.455 ' OD2' ' HB2' ' A' ' 24' ' ' LYS . 11.5 m-20 -66.4 -178.84 0.72 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.122 -1.222 . . . . 0.0 109.293 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.427 ' HB ' HG23 ' A' ' 2' ' ' THR . 3.6 m -115.38 129.28 56.54 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.349 -0.845 . . . . 0.0 109.549 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.032 HG21 HD11 ' A' ' 101' ' ' ILE . 5.2 t -115.62 135.05 56.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.189 -0.944 . . . . 0.0 109.539 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -103.43 129.42 50.54 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.172 -0.955 . . . . 0.0 109.662 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.582 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -127.17 83.56 2.18 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.599 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.4 OUTLIER -96.11 157.56 15.84 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.757 0.789 . . . . 0.0 110.726 -178.198 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.546 ' C ' ' OD1' ' A' ' 33' ' ' ASN . 4.5 p30 -77.47 171.42 14.92 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.703 0.763 . . . . 0.0 110.895 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' A' ' 7' ' ' LEU . 3.6 t30 -150.04 -37.46 0.15 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.954 ' HB3' HD21 ' A' ' 14' ' ' LEU . 1.9 tttt -99.4 -144.32 0.33 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.444 -0.785 . . . . 0.0 109.461 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -68.74 113.14 13.99 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.527 -0.733 . . . . 0.0 110.781 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.541 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 37.8 Cg_endo -84.13 178.41 5.29 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.999 2.466 . . . . 0.0 109.776 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 39.7 Cg_endo -88.5 168.19 37.51 Favored 'Cis proline' 0 C--N 1.314 -1.276 0 O-C-N 123.391 1.206 . . . . 0.0 109.849 -2.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.66 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 81.6 m-70 -122.89 143.47 49.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.066 -1.022 . . . . 0.0 109.999 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -103.84 144.08 31.98 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.359 -0.838 . . . . 0.0 108.983 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.459 ' HB ' ' NE2' ' A' ' 61' ' ' HIS . 54.5 t -119.17 124.48 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -0.969 . . . . 0.0 109.927 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.487 HG13 ' CB ' ' A' ' 60' ' ' SER . 1.4 t -150.24 167.31 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.389 -0.82 . . . . 0.0 108.987 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.603 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 7.0 m-85 -118.5 119.69 35.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.138 -0.976 . . . . 0.0 109.809 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.457 ' HB3' ' HB2' ' A' ' 47' ' ' LEU . 17.8 t0 -41.98 148.17 0.19 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.442 -0.786 . . . . 0.0 110.028 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.16 -14.46 17.73 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.359 -0.838 . . . . 0.0 109.234 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.466 ' O ' HD22 ' A' ' 47' ' ' LEU . . . -99.91 0.32 41.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.37 -0.831 . . . . 0.0 109.544 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.466 HD22 ' O ' ' A' ' 46' ' ' ALA . 1.6 mm? -117.81 46.65 1.71 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.173 -0.954 . . . . 0.0 109.215 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.47 ' OD1' ' HA ' ' A' ' 51' ' ' LYS . 1.2 p30 -105.42 162.38 19.89 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.343 -0.848 . . . . 0.0 109.488 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 36.3 Cg_endo -77.88 -31.62 3.04 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.765 2.31 . . . . 0.0 110.907 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.496 ' O ' ' HG3' ' A' ' 51' ' ' LYS . . . -122.5 31.26 6.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.102 -0.999 . . . . 0.0 110.047 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 0.1 OUTLIER 35.32 36.79 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.88 -0.512 . . . . 0.0 110.479 179.492 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 50' ' ' ALA . 2.4 m -101.12 143.1 31.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.083 -1.011 . . . . 0.0 109.926 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -92.5 54.78 2.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.898 . . . . 0.0 109.523 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -140.63 23.22 2.3 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.2 -0.937 . . . . 0.0 109.563 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.408 ' HA ' HD13 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -118.44 9.59 12.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.246 -0.909 . . . . 0.0 109.531 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.504 ' HB2' ' HB2' ' A' ' 43' ' ' PHE . . . -142.9 -47.12 0.31 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.405 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -48.07 -25.22 1.34 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 0.0 109.344 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.8 t -118.4 -20.19 8.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.22 -0.925 . . . . 0.0 109.36 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.965 HD21 ' CE2' ' A' ' 76' ' ' PHE . 9.9 tp -79.29 -37.93 36.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 0.0 109.226 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.487 ' CB ' HG13 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -78.9 132.14 36.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.282 -0.886 . . . . 0.0 109.633 -179.735 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.459 ' NE2' ' HB ' ' A' ' 41' ' ' VAL . 12.5 p80 -83.84 -9.55 58.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.455 -0.778 . . . . 0.0 109.605 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 0.1 OUTLIER 54.65 -170.78 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 109.709 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.487 ' CB ' ' O ' ' A' ' 62' ' ' LYS . 4.0 tt0 75.45 -179.75 0.17 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.336 -0.852 . . . . 0.0 109.687 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.703 HD12 ' N ' ' A' ' 64' ' ' LEU . 4.4 mp -118.52 155.75 30.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.299 -0.875 . . . . 0.0 109.473 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 39' ' ' HIS . 4.6 mp -84.09 -175.32 5.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.911 . . . . 0.0 109.482 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -160.74 -37.35 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.15 -0.969 . . . . 0.0 109.904 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.534 ' HB3' ' CB ' ' A' ' 70' ' ' GLN . 5.5 t -83.71 147.11 51.23 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.149 -0.97 . . . . 0.0 109.901 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.458 ' HD2' ' OG ' ' A' ' 67' ' ' SER . 36.0 Cg_endo -79.08 92.18 1.16 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.817 2.345 . . . . 0.0 110.398 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.488 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 103.71 6.04 44.14 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.534 ' CB ' ' HB3' ' A' ' 67' ' ' SER . 1.2 tt0 -124.91 102.78 7.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -1.154 . . . . 0.0 109.093 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.599 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . 11.5 p -104.77 -104.27 0.31 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.339 -0.851 . . . . 0.0 110.132 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.9 m -159.97 149.58 18.03 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.9 p -97.34 103.76 15.72 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.037 -1.04 . . . . 0.0 109.424 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.482 ' HG1' ' HE1' ' A' ' 31' ' ' PHE . 94.1 m -76.8 103.27 6.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -0.889 . . . . 0.0 109.54 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 76' ' ' PHE . 23.2 m -79.06 92.58 5.01 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.965 ' CE2' HD21 ' A' ' 59' ' ' LEU . 5.4 m-85 -43.01 165.13 0.11 Allowed Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.47 -0.769 . . . . 0.0 109.537 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.517 ' HD3' HD13 ' A' ' 59' ' ' LEU . 32.3 Cg_endo -73.84 174.03 13.0 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.466 2.111 . . . . 0.0 111.282 -178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.59 8.19 8.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.545 -0.722 . . . . 0.0 109.515 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.484 ' O ' ' C ' ' A' ' 80' ' ' ALA . 10.5 m-20 -99.43 -74.61 0.59 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.25 -0.907 . . . . 0.0 109.156 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.674 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . 34.84 69.7 1.02 Allowed Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.723 -0.61 . . . . 0.0 110.074 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.44 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 34.2 Cg_endo -75.91 158.29 38.68 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.533 2.156 . . . . 0.0 110.819 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -49.07 98.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.352 -0.842 . . . . 0.0 109.609 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.569 ' O ' ' CE1' ' A' ' 85' ' ' TYR . . . -166.92 149.92 16.16 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -81.72 140.11 34.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.214 -1.168 . . . . 0.0 109.54 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.569 ' CE1' ' O ' ' A' ' 83' ' ' GLY . 66.5 m-85 -118.71 147.74 43.52 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.465 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 95.2 m -134.14 118.43 17.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.987 -1.07 . . . . 0.0 110.718 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.582 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -110.44 171.35 7.51 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.403 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' A' ' 97' ' ' MET . 14.1 p90 -158.94 -163.84 1.31 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.77 -1.206 . . . . 0.0 110.476 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.447 ' SG ' ' HD2' ' A' ' 91' ' ' PRO . 0.5 OUTLIER -126.25 145.29 50.46 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.578 -0.701 . . . . 0.0 109.408 -179.623 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.627 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 24.2 tp10 -82.97 -42.81 0.87 Allowed Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 121.254 -0.904 . . . . 0.0 110.599 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.3 Cg_endo -78.1 -75.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 121.946 1.764 . . . . 0.0 110.82 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.66 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 13.4 m80 -65.5 69.18 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.056 -1.028 . . . . 0.0 109.531 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 91' ' ' PRO . 10.8 tpt180 -90.72 -14.94 31.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.138 -0.976 . . . . 0.0 109.179 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.57 1.64 87.22 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.449 ' CB ' ' HB2' ' A' ' 14' ' ' LEU . . . -114.14 33.42 5.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -1.163 . . . . 0.0 109.487 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.494 ' O ' ' N ' ' A' ' 98' ' ' VAL . . . 40.16 36.6 0.92 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.513 ' SD ' ' HB3' ' A' ' 14' ' ' LEU . 4.0 mtp -65.35 72.85 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.036 -1.273 . . . . 0.0 109.177 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 96' ' ' GLY . 98.5 t -132.7 112.23 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 109.732 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.581 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -100.31 -174.92 30.08 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.519 ' N ' ' CZ ' ' A' ' 87' ' ' PHE . 22.4 mtpt -158.12 144.92 17.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.052 -1.263 . . . . 0.0 109.977 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 1.032 HD11 HG21 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -110.73 135.88 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 108.677 179.446 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 21' ' ' LEU . 3.1 m -114.11 95.29 5.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.271 -0.893 . . . . 0.0 109.1 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.64 HG22 ' CD1' ' A' ' 23' ' ' ILE . 2.3 t -99.87 124.71 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.277 -0.89 . . . . 0.0 109.805 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 109.252 179.757 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.698 ' HB3' HD21 ' A' ' 21' ' ' LEU . 25.8 m-85 -84.45 169.05 14.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 0.0 109.154 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 30' ' ' GLU . 31.6 m -160.18 122.2 3.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.108 -0.995 . . . . 0.0 109.776 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.907 HG12 ' H ' ' A' ' 17' ' ' GLU . 0.6 OUTLIER -106.13 -155.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 109.001 179.446 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.472 ' H ' HG12 ' A' ' 5' ' ' VAL . 10.5 tttt -175.22 127.93 0.27 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.33 -0.856 . . . . 0.0 109.507 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.787 HD12 ' CG ' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -100.56 93.89 5.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 0.0 109.156 179.775 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.746 ' HA2' HD23 ' A' ' 14' ' ' LEU . . . 152.07 70.14 0.01 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 8' ' ' GLY . 1.4 p -46.56 150.39 0.68 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.192 -1.181 . . . . 0.0 109.021 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -88.28 36.9 0.79 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.228 -0.92 . . . . 0.0 109.625 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.5 mtmm -122.37 -29.24 4.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 109.406 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.418 ' O ' ' HG ' ' A' ' 13' ' ' LEU . . . 137.91 46.02 0.08 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 12' ' ' GLY . 1.9 mt -164.3 172.68 13.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.224 -1.162 . . . . 0.0 109.626 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.746 HD23 ' HA2' ' A' ' 8' ' ' GLY . 88.1 mt -118.8 97.09 5.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 109.841 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.2 m -140.95 154.68 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.294 -0.878 . . . . 0.0 109.398 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -62.93 160.47 14.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.124 -0.985 . . . . 0.0 109.113 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.907 ' H ' HG12 ' A' ' 5' ' ' VAL . 0.6 OUTLIER -134.15 103.55 11.65 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.933 . . . . 0.0 109.651 -179.915 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.3 Cg_endo -77.53 -163.59 3.44 Favored 'Cis proline' 0 C--N 1.311 -1.397 0 C-N-CA 123.633 -1.403 . . . . 0.0 110.499 0.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.85 -36.12 70.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.267 -0.896 . . . . 0.0 109.593 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -116.14 168.84 9.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 0.0 109.399 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.698 HD21 ' HB3' ' A' ' 3' ' ' TYR . 2.7 tp -149.75 147.75 28.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.219 -0.926 . . . . 0.0 109.527 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.484 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 30.7 m -115.22 100.35 8.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 109.464 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.872 ' CD1' HD13 ' A' ' 101' ' ' ILE . 2.3 pt -100.45 178.53 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.255 -0.903 . . . . 0.0 109.739 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.699 ' O ' HG13 ' A' ' 103' ' ' VAL . 0.2 OUTLIER -95.57 -174.4 0.39 Allowed Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.536 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.613 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 35.7 Cg_endo -80.21 70.42 7.53 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.934 1.756 . . . . 0.0 110.694 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.543 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 111.08 48.31 0.72 Allowed Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.194 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.507 ' OD2' ' HG3' ' A' ' 24' ' ' LYS . 0.9 OUTLIER -108.16 -164.98 1.0 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.398 -1.06 . . . . 0.0 108.759 178.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 95.8 m -115.71 145.69 42.53 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.034 -1.041 . . . . 0.0 110.333 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.663 HG21 HD11 ' A' ' 101' ' ' ILE . 1.9 t -127.28 121.88 58.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.528 ' O ' HG23 ' A' ' 4' ' ' THR . 25.6 mt-10 -99.53 103.3 15.03 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.085 -1.01 . . . . 0.0 110.836 -178.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.708 ' C ' HD23 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -93.49 152.13 19.27 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.546 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.878 HD21 ' O ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -141.61 169.15 18.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.689 -1.257 . . . . 0.0 110.808 -179.37 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.53 ' OD1' ' HA ' ' A' ' 68' ' ' PRO . 6.7 p-10 -97.51 160.23 14.45 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.628 -0.67 . . . . 0.0 109.202 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.542 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . 51.9 t30 -110.07 -78.87 0.59 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.907 -1.121 . . . . 0.0 109.748 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.513 ' O ' HG22 ' A' ' 36' ' ' VAL . 5.7 tptt -151.25 34.71 0.58 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.026 -1.046 . . . . 0.0 109.886 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.603 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 0.9 OUTLIER -156.39 56.34 1.22 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.28 -0.887 . . . . 0.0 109.65 179.298 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.603 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 36.3 Cg_endo -78.59 176.37 9.96 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.697 2.265 . . . . 0.0 110.669 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.2 Cg_endo -86.13 162.23 56.26 Favored 'Cis proline' 0 C--N 1.312 -1.392 0 O-C-N 123.753 1.396 . . . . 0.0 110.416 -1.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.787 ' CG ' HD12 ' A' ' 7' ' ' LEU . 73.3 m-70 -122.28 140.73 52.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 110.215 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.505 ' HB2' ' HD3' ' A' ' 91' ' ' PRO . 1.2 m120 -115.15 134.76 54.87 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.55 ' HB ' ' CD2' ' A' ' 61' ' ' HIS . 35.5 t -100.82 135.07 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.105 -0.997 . . . . 0.0 110.03 -179.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.532 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 2.5 t -149.22 171.1 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.376 -0.828 . . . . 0.0 109.477 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.694 ' CZ ' HD12 ' A' ' 59' ' ' LEU . 1.6 m-85 -139.21 115.33 10.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.144 -0.973 . . . . 0.0 109.668 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -47.59 142.8 4.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.179 -0.951 . . . . 0.0 109.132 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.22 19.98 16.6 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.187 -0.945 . . . . 0.0 109.819 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -108.35 -40.17 5.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.207 -0.933 . . . . 0.0 109.561 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.612 ' N ' HD12 ' A' ' 47' ' ' LEU . 10.2 mp -87.17 55.9 3.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.922 . . . . 0.0 109.611 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.493 ' OD1' ' HA ' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -102.53 165.76 13.2 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.331 -0.856 . . . . 0.0 109.47 179.71 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.516 ' HG2' ' HG2' ' A' ' 81' ' ' PRO . 34.9 Cg_endo -77.78 -33.07 2.4 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.638 2.225 . . . . 0.0 110.807 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -124.06 30.72 6.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.037 -1.039 . . . . 0.0 109.719 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.493 ' HA ' ' OD1' ' A' ' 48' ' ' ASN . 12.5 mmtm 39.45 31.46 0.07 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.71 -0.619 . . . . 0.0 109.841 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 50' ' ' ALA . 28.8 m -101.62 125.01 48.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.68 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -100.35 97.53 8.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.353 -0.842 . . . . 0.0 109.368 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -163.49 -46.01 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.274 -0.891 . . . . 0.0 109.529 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 0.9 OUTLIER -68.4 -15.88 63.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.898 . . . . 0.0 109.381 -179.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.94 -50.5 8.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.252 -0.905 . . . . 0.0 109.637 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.29 -23.66 0.6 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.719 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.2 t -106.86 -3.52 20.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.062 -1.024 . . . . 0.0 109.902 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.015 HD21 ' CD2' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -95.12 -37.12 11.22 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.09 -1.006 . . . . 0.0 108.554 179.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.498 ' CB ' ' HA ' ' A' ' 42' ' ' VAL . 1.4 m -78.91 132.73 36.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.191 -0.943 . . . . 0.0 110.383 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.683 ' CE1' HD21 ' A' ' 65' ' ' LEU . 18.9 p80 -109.61 138.49 45.89 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.46 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -127.74 119.42 25.74 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.009 -1.057 . . . . 0.0 110.114 -179.785 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.606 ' O ' ' O ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER 167.53 29.44 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.558 -0.714 . . . . 0.0 110.303 179.248 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.606 ' O ' ' O ' ' A' ' 63' ' ' GLN . 4.1 mt 47.66 123.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.734 0.778 . . . . 0.0 111.319 178.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.683 HD21 ' CE1' ' A' ' 61' ' ' HIS . 6.3 mt -78.49 155.32 29.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.246 -1.534 . . . . 0.0 108.77 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 41.1 mtm -137.28 9.64 2.97 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -0.904 . . . . 0.0 109.595 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 70' ' ' GLN . 1.9 t -110.28 129.55 23.82 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 109.375 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.53 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.2 Cg_endo -79.18 93.31 1.1 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.362 2.041 . . . . 0.0 110.453 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 114.39 0.83 23.49 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.436 ' HG2' ' C ' ' A' ' 69' ' ' GLY . 32.5 mm-40 -144.43 112.94 6.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -1.112 . . . . 0.0 108.777 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.55 ' OG ' ' N ' ' A' ' 72' ' ' THR . 51.9 p -99.95 -80.28 0.48 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.001 -1.062 . . . . 0.0 109.671 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.598 ' HB ' ' CD2' ' A' ' 61' ' ' HIS . 4.3 m -160.33 107.8 1.61 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.077 -1.015 . . . . 0.0 109.474 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 29' ' ' VAL . 3.9 m -80.08 76.35 6.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -0.932 . . . . 0.0 109.154 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.651 HG21 HD13 ' A' ' 59' ' ' LEU . 1.0 OUTLIER -60.68 124.15 19.56 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.417 -0.802 . . . . 0.0 110.06 -179.61 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 75' ' ' THR . 3.8 t -82.87 90.08 6.91 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.392 -0.818 . . . . 0.0 108.986 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 1.015 ' CD2' HD21 ' A' ' 59' ' ' LEU . 22.7 m-85 -41.41 157.11 0.2 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.464 -0.773 . . . . 0.0 109.693 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.543 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.6 Cg_endo -78.1 161.14 29.67 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.814 2.343 . . . . 0.0 111.031 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.09 5.4 8.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.22 -0.925 . . . . 0.0 110.023 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.469 ' OD1' ' HB2' ' A' ' 77' ' ' PRO . 2.0 p-10 -100.09 -11.04 20.85 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.001 -1.062 . . . . 0.0 109.616 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 79' ' ' ASP . . . -40.4 100.6 0.22 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.497 -0.752 . . . . 0.0 109.832 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.516 ' HG2' ' HG2' ' A' ' 49' ' ' PRO . 36.3 Cg_endo -78.54 -176.11 3.09 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.497 2.131 . . . . 0.0 110.442 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.72 123.33 27.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.355 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 169.1 148.28 5.74 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.437 ' O ' ' CG ' ' A' ' 84' ' ' GLU . 10.8 pt-20 -80.37 111.68 17.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.309 -1.112 . . . . 0.0 109.752 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.544 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 5.6 m-30 -86.5 98.04 10.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.934 . . . . 0.0 108.867 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 17.3 m -77.45 105.76 8.79 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.226 -0.921 . . . . 0.0 110.191 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.487 ' HB3' ' CD2' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -104.16 176.93 4.99 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.283 -0.886 . . . . 0.0 108.796 179.103 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.477 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 5.7 p90 -160.7 -147.7 0.15 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.014 -1.054 . . . . 0.0 109.722 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 93' ' ' ARG . 0.5 OUTLIER -130.93 159.02 38.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 109.746 -179.466 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.602 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.3 tt0 -91.79 -44.21 0.36 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.362 -0.836 . . . . 0.0 111.161 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.8 Cg_endo -80.58 -56.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.09 0 C-N-CA 122.117 1.878 . . . . 0.0 110.674 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.726 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 19.9 m80 -77.78 5.02 10.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.62 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 89' ' ' CYS . 20.0 ttt-85 -43.26 120.0 1.74 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.17 -0.956 . . . . 0.0 109.37 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.73 11.07 33.72 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.7 39.26 3.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -1.163 . . . . 0.0 109.328 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.74 -0.16 66.44 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.626 ' HE3' ' HB2' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -71.39 66.9 0.48 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.164 -1.198 . . . . 0.0 109.664 -179.865 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.0 t -135.25 120.0 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.189 -0.944 . . . . 0.0 109.444 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 86' ' ' THR . . . -133.77 -178.52 15.65 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 10.0 mttt -148.78 140.77 23.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -1.187 . . . . 0.0 109.669 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.872 HD13 ' CD1' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -96.88 133.73 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 109.111 179.718 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.484 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 0.5 OUTLIER -101.28 104.13 15.15 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.834 HG22 ' CD1' ' A' ' 23' ' ' ILE . 59.4 t -98.9 114.18 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.295 -0.878 . . . . 0.0 109.601 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.427 0 O-C-N 121.347 -0.846 . . . . 0.0 109.31 179.98 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 49.2 m . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.44 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 16.1 m-85 -90.69 137.61 32.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.281 -0.887 . . . . 0.0 109.361 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.962 HG23 ' HB3' ' A' ' 30' ' ' GLU . 2.0 m -139.19 110.62 7.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.646 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 5' ' ' VAL . 26.8 m -96.49 109.14 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.244 -0.91 . . . . 0.0 109.466 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -86.75 137.9 32.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -0.949 . . . . 0.0 109.43 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.734 ' HB2' ' HE3' ' A' ' 97' ' ' MET . 0.1 OUTLIER -98.47 80.27 2.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.0 109.1 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.468 ' O ' ' ND2' ' A' ' 34' ' ' ASN . . . 134.48 79.94 0.13 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 p -52.58 -88.59 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.251 -1.147 . . . . 0.0 109.563 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -172.38 37.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.555 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.21 20.37 6.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 109.435 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.432 ' HA2' ' CE ' ' A' ' 35' ' ' LYS . . . 73.02 37.41 56.3 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.455 ' O ' ' HA2' ' A' ' 8' ' ' GLY . 74.7 mt -139.89 139.38 36.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -1.121 . . . . 0.0 109.442 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.793 HD22 ' CE1' ' A' ' 39' ' ' HIS . 17.0 mt -101.25 114.31 28.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.204 -0.935 . . . . 0.0 109.561 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 14' ' ' LEU . 15.0 m -157.59 157.65 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 0.0 109.378 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -81.82 147.09 29.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 109.614 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 14.2 mm-40 -139.61 107.01 7.06 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.251 -0.905 . . . . 0.0 109.424 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.7 Cg_endo -78.1 176.19 44.15 Favored 'Cis proline' 0 C--N 1.312 -1.374 0 C-N-CA 123.761 -1.349 . . . . 0.0 110.675 0.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.07 -61.05 1.95 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.335 -0.853 . . . . 0.0 109.298 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.5 tttp -82.03 174.72 10.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.912 . . . . 0.0 109.198 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.519 ' CD2' HG13 ' A' ' 29' ' ' VAL . 5.2 tp -158.95 104.73 1.74 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.12 -0.988 . . . . 0.0 110.083 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . 0.475 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 32.1 m -87.01 90.09 8.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.188 -0.945 . . . . 0.0 108.477 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.688 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -99.7 163.43 2.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.316 -0.865 . . . . 0.0 110.348 -178.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.607 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 14.1 mmtt -88.03 166.74 22.6 Favored Pre-proline 0 C--N 1.301 -1.526 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PRO . . . . . 0.873 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 31.4 Cg_endo -73.09 88.86 0.92 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.693 1.596 . . . . 0.0 110.017 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 125.59 -3.13 8.15 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.485 ' OD2' ' CG ' ' A' ' 24' ' ' LYS . 62.6 m-20 -62.47 -168.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -1.145 . . . . 0.0 109.566 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.2 m -129.33 130.63 46.35 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.278 -0.889 . . . . 0.0 109.369 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.091 HG21 HD11 ' A' ' 101' ' ' ILE . 3.3 t -121.42 115.91 48.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.251 -0.905 . . . . 0.0 109.346 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . 0.962 ' HB3' HG23 ' A' ' 4' ' ' THR . 2.0 mm-40 -99.58 132.92 44.6 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.27 -0.893 . . . . 0.0 109.635 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.6 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -131.7 94.41 3.51 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . 0.582 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.4 OUTLIER -96.58 179.68 4.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.343 -0.848 . . . . 0.0 110.663 -178.35 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASN . . . . . 0.575 ' ND2' ' HB3' ' A' ' 37' ' ' PRO . 1.7 p-10 -107.87 155.05 20.7 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.47 -0.768 . . . . 0.0 109.469 -178.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.468 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 53.2 t30 -151.19 -58.52 0.16 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.985 -1.072 . . . . 0.0 110.009 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.691 ' HB3' HD21 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -60.72 -147.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.27 -0.894 . . . . 0.0 109.124 -179.345 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.431 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 65.4 t -68.05 112.35 10.46 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.371 -0.831 . . . . 0.0 109.382 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.575 ' HB3' ' ND2' ' A' ' 33' ' ' ASN . 37.5 Cg_endo -82.01 175.33 9.32 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.807 2.338 . . . . 0.0 110.636 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.552 ' O ' ' CG ' ' A' ' 39' ' ' HIS . 37.8 Cg_endo -84.57 -156.09 1.13 Allowed 'Cis proline' 0 C--N 1.311 -1.404 0 C-N-CA 123.631 -1.404 . . . . 0.0 109.86 -1.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.793 ' CE1' HD22 ' A' ' 14' ' ' LEU . 86.0 m-70 -160.44 143.27 13.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.961 -1.087 . . . . 0.0 109.708 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.485 ' OD1' ' N ' ' A' ' 41' ' ' VAL . 63.7 t-20 -113.58 147.42 38.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.278 -0.889 . . . . 0.0 109.201 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.485 ' N ' ' OD1' ' A' ' 40' ' ' ASN . 18.8 t -128.6 118.58 47.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.277 -0.889 . . . . 0.0 109.182 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.894 HG12 ' CB ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -153.04 175.59 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.294 -0.879 . . . . 0.0 109.379 -179.804 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.65 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -130.03 135.0 47.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.941 . . . . 0.0 109.538 -179.471 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -59.6 130.49 47.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 109.353 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.87 1.99 32.44 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.245 -0.909 . . . . 0.0 109.904 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.45 ' C ' HD12 ' A' ' 47' ' ' LEU . . . -103.64 5.73 36.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.611 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.45 HD12 ' C ' ' A' ' 46' ' ' ALA . 3.6 mp -131.21 57.1 1.77 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.137 -0.977 . . . . 0.0 109.672 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -114.44 156.18 44.87 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.274 179.744 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.464 ' HG2' ' HG2' ' A' ' 81' ' ' PRO . 36.2 Cg_endo -79.38 -40.36 0.26 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.67 2.247 . . . . 0.0 110.907 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ALA . . . . . 0.501 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -106.5 28.9 7.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.07 -1.019 . . . . 0.0 109.788 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.501 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER 32.5 45.88 0.06 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.186 0.517 . . . . 0.0 110.316 179.652 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.2 m -100.56 111.93 24.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.17 -0.957 . . . . 0.0 109.783 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.76 -28.3 64.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.94 . . . . 0.0 108.982 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . 0.478 ' HA ' ' HB2' ' A' ' 57' ' ' LYS . 2.1 t0 -68.17 -23.85 64.9 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.375 -0.828 . . . . 0.0 109.435 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 17.8 tp -56.11 -61.09 2.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 109.532 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.747 ' HB1' ' OG ' ' A' ' 60' ' ' SER . . . -66.61 -23.98 66.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.649 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.478 ' HB2' ' HA ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -45.65 -64.58 0.7 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 109.52 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.98 -23.07 36.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.0 109.538 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.686 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 4.7 tp -72.65 -58.07 3.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 109.498 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . 0.894 ' CB ' HG12 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -79.67 133.52 36.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.306 -0.871 . . . . 0.0 110.021 -179.153 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.428 ' ND1' ' C ' ' A' ' 61' ' ' HIS . 16.2 p80 -107.34 149.98 27.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.384 -0.822 . . . . 0.0 108.941 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.428 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -99.59 174.5 6.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.096 -1.003 . . . . 0.0 109.461 -179.785 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . 0.428 ' CB ' ' O ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER 70.27 126.73 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.315 -0.866 . . . . 0.0 109.42 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.0 mp -70.67 163.97 25.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 109.528 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.9 mt -83.25 160.71 21.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 109.126 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -132.26 9.29 4.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.116 -0.99 . . . . 0.0 109.81 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.503 ' HB3' ' HB2' ' A' ' 70' ' ' GLN . 9.0 t -124.66 138.31 30.99 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.18 -0.95 . . . . 0.0 109.143 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.522 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.7 Cg_endo -79.3 105.72 1.93 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.538 2.159 . . . . 0.0 110.967 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 92.75 39.09 5.34 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLN . . . . . 0.503 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 9.3 mt-30 -153.11 82.04 1.2 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.232 -1.158 . . . . 0.0 109.177 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.6 ' CB ' ' O ' ' A' ' 31' ' ' PHE . 3.2 p -99.08 -169.21 1.73 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.164 -0.96 . . . . 0.0 109.457 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 72' ' ' THR . 4.1 t -102.75 125.16 49.39 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.0 p -78.98 93.84 5.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.072 -1.018 . . . . 0.0 109.443 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' THR . . . . . 0.533 ' HG1' ' HE1' ' A' ' 31' ' ' PHE . 4.6 m -72.36 97.96 2.13 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.367 -0.833 . . . . 0.0 109.409 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.451 ' O ' ' C ' ' A' ' 76' ' ' PHE . 11.2 m -78.56 89.07 4.49 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 1.03 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 9.9 m-85 -40.46 150.26 0.28 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.744 -0.598 . . . . 0.0 109.459 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 76' ' ' PHE . 34.8 Cg_endo -77.53 168.27 22.95 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.846 2.364 . . . . 0.0 111.434 -179.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' A' ' 25' ' ' PRO . . . -83.46 5.45 23.75 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 81' ' ' PRO . 1.8 m-20 -99.19 -7.21 26.87 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.179 -0.951 . . . . 0.0 109.113 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.873 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -38.59 99.11 0.18 Allowed Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.593 -0.692 . . . . 0.0 109.462 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.464 ' HG2' ' HG2' ' A' ' 49' ' ' PRO . 34.8 Cg_endo -77.25 141.47 20.55 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.425 2.083 . . . . 0.0 110.629 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . 0.828 ' HB2' ' O ' ' A' ' 104' ' ' ALA . . . -43.5 132.01 4.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.409 -0.807 . . . . 0.0 109.358 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . 0.401 ' HA3' ' HB3' ' A' ' 49' ' ' PRO . . . 158.29 148.78 5.27 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -89.46 117.7 28.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.154 -1.204 . . . . 0.0 109.893 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' TYR . . . . . 0.462 ' O ' ' HB3' ' A' ' 100' ' ' LYS . 60.9 m-85 -84.02 -166.69 1.49 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.244 -0.91 . . . . 0.0 108.934 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' THR . . . . . 0.46 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 39.2 m -166.59 105.72 0.62 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.897 -1.127 . . . . 0.0 110.836 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.561 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.4 OUTLIER -104.75 165.67 10.91 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.26 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' TYR . . . . . 0.426 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 29.7 p90 -157.22 -166.62 2.1 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.786 -1.197 . . . . 0.0 110.561 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' CYS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 97' ' ' MET . 0.5 OUTLIER -130.28 126.85 38.28 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.811 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.625 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 6.0 tp10 -67.94 -43.25 36.46 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.89 . . . . 0.0 111.514 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 34.4 Cg_endo -76.59 -53.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.968 1.779 . . . . 0.0 111.205 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' HIS . . . . . 0.592 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 34.8 m80 -89.78 30.34 1.06 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.016 -1.052 . . . . 0.0 109.614 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.6 ttt-85 -60.26 91.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.283 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 137.74 -15.82 3.56 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 14' ' ' LEU . . . -91.32 37.19 0.94 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.353 -1.086 . . . . 0.0 109.493 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.08 23.02 72.84 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' MET . . . . . 0.734 ' HE3' ' HB2' ' A' ' 7' ' ' LEU . 0.8 OUTLIER -91.26 53.57 2.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.063 -1.257 . . . . 0.0 109.299 179.791 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.3 t -137.26 118.43 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 109.445 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.561 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -127.32 172.47 18.69 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 85' ' ' TYR . 35.7 mttt -145.84 135.86 23.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -1.141 . . . . 0.0 109.649 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 1.091 HD11 HG21 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -87.36 140.69 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.957 . . . . 0.0 108.878 179.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.475 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 0.3 OUTLIER -115.77 95.55 5.18 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.331 -0.856 . . . . 0.0 108.883 179.305 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' VAL . . . . . 0.643 HG22 ' CD1' ' A' ' 23' ' ' ILE . 12.5 t -99.77 150.42 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.146 -0.971 . . . . 0.0 109.597 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.828 ' O ' ' HB2' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.492 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 . . . . . 0 N--CA 1.49 1.553 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.412 ' OG1' ' O ' ' A' ' 28' ' ' THR . 11.9 t -112.07 157.69 20.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.255 -0.903 . . . . 0.0 109.585 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.477 ' CD1' HG22 ' A' ' 23' ' ' ILE . 53.1 m-85 -93.88 153.75 18.08 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.907 . . . . 0.0 109.28 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.508 HG23 ' O ' ' A' ' 30' ' ' GLU . 9.5 m -142.85 135.92 28.21 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 109.736 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.862 HG13 HD11 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -117.39 100.33 10.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.239 -0.913 . . . . 0.0 109.338 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.563 ' HG2' HD11 ' A' ' 32' ' ' LEU . 8.6 tttt -69.46 79.21 0.4 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.257 -0.902 . . . . 0.0 109.497 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.774 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -52.33 136.55 30.81 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.193 -0.942 . . . . 0.0 109.243 179.875 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.419 ' HA2' HD23 ' A' ' 14' ' ' LEU . . . 101.54 115.56 3.95 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.285 -1.526 . . . . 0.0 109.285 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.51 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 97.4 p -69.86 -82.45 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.281 -1.129 . . . . 0.0 109.608 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 11' ' ' LYS . 2.8 p30 163.45 -50.17 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.885 . . . . 0.0 109.049 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.515 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 4.0 mttt -120.59 -5.72 9.75 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.349 -0.845 . . . . 0.0 109.252 179.647 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -100.38 -103.78 2.59 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -138.65 -156.51 0.69 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.242 -1.152 . . . . 0.0 109.562 -179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.637 ' CD1' ' CD2' ' A' ' 92' ' ' HIS . 30.9 mt -99.86 120.57 39.98 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.18 -0.95 . . . . 0.0 109.873 -179.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 14' ' ' LEU . 16.1 m -160.53 126.68 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.227 -0.921 . . . . 0.0 109.621 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.428 ' O ' ' O ' ' A' ' 15' ' ' VAL . 6.0 m-85 -44.47 165.83 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.055 -1.028 . . . . 0.0 109.301 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.463 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 22.9 mt-10 -148.16 104.62 3.58 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.195 -0.94 . . . . 0.0 109.405 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.463 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.2 Cg_endo -77.59 -176.03 17.92 Favored 'Cis proline' 0 C--N 1.311 -1.426 0 C-N-CA 123.736 -1.36 . . . . 0.0 110.563 0.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.12 -47.56 50.29 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.265 -0.897 . . . . 0.0 109.622 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.81 178.04 5.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.24 -0.912 . . . . 0.0 109.331 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.862 HD11 HG13 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -153.04 141.73 20.97 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.967 . . . . 0.0 109.87 -179.968 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.2 m -120.21 115.3 23.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.336 -0.852 . . . . 0.0 109.213 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.663 HD12 ' O ' ' A' ' 24' ' ' LYS . 1.0 OUTLIER -132.36 -176.75 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.209 -0.932 . . . . 0.0 109.738 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.663 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -104.63 177.39 1.41 Allowed Pre-proline 0 C--N 1.303 -1.45 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.188 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.562 ' HD2' ' CG ' ' A' ' 24' ' ' LYS . 34.3 Cg_endo -77.18 76.69 4.09 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.213 1.942 . . . . 0.0 110.349 -179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.5 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 132.6 -11.78 5.19 Favored Glycine 0 N--CA 1.492 2.368 0 N-CA-C 109.94 -1.264 . . . . 0.0 109.94 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.423 ' O ' ' O ' ' A' ' 26' ' ' GLY . 9.2 m-20 -53.3 -176.14 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.165 -1.197 . . . . 0.0 109.407 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.533 HG23 ' HA ' ' A' ' 75' ' ' THR . 26.8 m -123.39 146.62 47.83 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.163 -0.96 . . . . 0.0 109.461 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.951 HG21 HD11 ' A' ' 101' ' ' ILE . 3.4 t -137.5 124.23 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 121.202 -0.937 . . . . 0.0 109.24 179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.533 ' OE1' ' CA ' ' A' ' 73' ' ' SER . 21.8 tp10 -100.99 130.85 47.05 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.25 -0.906 . . . . 0.0 110.109 -179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.484 ' O ' ' OG ' ' A' ' 71' ' ' SER . 0.4 OUTLIER -113.59 151.27 31.89 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 108.216 -1.031 . . . . 0.0 108.216 179.032 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.774 ' O ' HD21 ' A' ' 7' ' ' LEU . 2.4 pp -142.09 -177.6 5.3 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.816 -1.178 . . . . 0.0 110.635 -179.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.547 ' OD1' ' HA ' ' A' ' 68' ' ' PRO . 2.5 p-10 -116.55 152.96 33.05 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 179.244 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -101.5 -109.01 0.23 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.815 -1.178 . . . . 0.0 109.601 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.435 ' C ' ' CG2' ' A' ' 36' ' ' VAL . 0.9 OUTLIER -128.98 36.58 4.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.805 -1.185 . . . . 0.0 109.412 -179.824 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.555 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 2.5 t -153.02 61.98 4.0 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.502 -0.749 . . . . 0.0 109.141 179.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.564 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.9 Cg_endo -80.24 175.9 9.82 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.811 2.341 . . . . 0.0 110.55 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.658 ' CG ' HD13 ' A' ' 64' ' ' LEU . 38.3 Cg_endo -85.78 159.46 59.65 Favored 'Cis proline' 0 C--N 1.31 -1.449 0 C-N-CA 123.525 -1.448 . . . . 0.0 110.483 -1.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.715 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 74.6 m-70 -116.46 141.64 47.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.472 -0.767 . . . . 0.0 109.435 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.51 126.71 53.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.286 -0.884 . . . . 0.0 109.45 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.4 ' HB ' ' NE2' ' A' ' 61' ' ' HIS . 19.8 t -116.37 126.27 73.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.202 -0.936 . . . . 0.0 109.445 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.797 HG12 ' CB ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -160.12 166.39 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.38 -0.825 . . . . 0.0 109.322 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.593 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.7 OUTLIER -116.74 109.65 17.41 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.15 -0.969 . . . . 0.0 109.382 179.756 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -53.06 144.43 15.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.874 . . . . 0.0 109.682 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -87.57 19.21 3.47 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.183 -0.948 . . . . 0.0 109.479 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -121.31 -30.31 4.31 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.083 -1.011 . . . . 0.0 109.724 -179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.621 HD22 HG21 ' A' ' 86' ' ' THR . 6.2 mp -96.33 61.16 2.0 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.037 -1.039 . . . . 0.0 109.518 -179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.503 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 10.2 p30 -141.6 162.51 46.45 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.286 -0.884 . . . . 0.0 109.49 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.503 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 33.5 Cg_endo -75.6 -16.54 18.86 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.446 2.098 . . . . 0.0 109.904 179.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.531 ' O ' ' N ' ' A' ' 52' ' ' SER . . . -133.54 68.55 1.49 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -40.37 92.94 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.607 -0.683 . . . . 0.0 109.987 -179.519 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 50' ' ' ALA . 19.5 m -140.71 -159.21 0.93 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.341 -0.849 . . . . 0.0 109.191 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -155.81 56.95 0.61 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.245 -0.909 . . . . 0.0 109.535 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 20.9 t0 -138.78 -60.99 0.58 Allowed 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.219 -0.925 . . . . 0.0 109.378 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.467 ' HG ' ' N ' ' A' ' 56' ' ' ALA . 1.6 pp -54.28 -28.16 40.05 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.211 -0.93 . . . . 0.0 109.044 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.467 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -72.41 -39.3 68.01 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.324 -0.86 . . . . 0.0 109.243 179.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.421 ' C ' ' O ' ' A' ' 56' ' ' ALA . 65.9 tttt -44.3 -45.8 8.88 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -0.914 . . . . 0.0 109.316 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.2 m -98.01 25.45 6.04 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.292 -0.88 . . . . 0.0 109.421 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.716 HD21 ' CE2' ' A' ' 76' ' ' PHE . 8.2 tp -127.0 -54.88 1.38 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.309 -0.869 . . . . 0.0 109.267 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.797 ' CB ' HG12 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -78.49 147.24 33.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.307 -0.871 . . . . 0.0 110.082 -178.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.4 ' NE2' ' HB ' ' A' ' 41' ' ' VAL . 30.5 p80 -122.18 174.81 6.73 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 1.9 mttp -125.06 -160.2 0.94 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.196 -0.94 . . . . 0.0 109.226 179.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER 65.87 135.51 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.202 -0.936 . . . . 0.0 109.802 179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.658 HD13 ' CG ' ' A' ' 38' ' ' PRO . 6.6 mt -64.76 158.63 24.3 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.392 -0.818 . . . . 0.0 109.576 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.697 HD22 ' HB2' ' A' ' 39' ' ' HIS . 3.5 mp -79.31 87.26 5.0 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.079 -1.013 . . . . 0.0 109.155 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -83.32 4.59 26.58 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.231 -0.918 . . . . 0.0 109.759 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.473 ' OG ' ' HG2' ' A' ' 70' ' ' GLN . 12.0 t -102.81 115.79 63.65 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.144 -0.973 . . . . 0.0 109.009 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.547 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.4 Cg_endo -78.51 95.23 1.07 Allowed 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 122.4 2.067 . . . . 0.0 111.004 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.504 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 127.45 -17.12 6.2 Favored Glycine 0 N--CA 1.491 2.353 0 C-N-CA 119.595 -1.288 . . . . 0.0 110.125 179.317 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.502 ' HA ' ' HB3' ' A' ' 32' ' ' LEU . 8.0 pt20 -149.99 149.69 30.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.111 -1.229 . . . . 0.0 109.602 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.597 ' HG ' ' H ' ' A' ' 72' ' ' THR . 81.1 p -120.01 -78.46 0.59 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.122 -0.986 . . . . 0.0 109.5 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.597 ' H ' ' HG ' ' A' ' 71' ' ' SER . 22.8 m -160.14 119.0 2.71 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.327 -0.858 . . . . 0.0 109.424 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.533 ' CA ' ' OE1' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -79.53 99.75 7.43 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.213 -0.929 . . . . 0.0 109.228 179.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.641 HG21 ' HG ' ' A' ' 59' ' ' LEU . 26.3 m -82.54 108.4 15.91 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.337 -0.852 . . . . 0.0 109.665 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.533 ' HA ' HG23 ' A' ' 28' ' ' THR . 0.0 OUTLIER -79.36 85.77 5.15 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 179.476 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.931 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 23.7 m-85 -40.45 137.02 1.37 Allowed Pre-proline 0 N--CA 1.489 1.5 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.5 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 35.3 Cg_endo -77.74 174.49 12.52 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.605 2.203 . . . . 0.0 111.719 -178.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.29 4.03 11.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.583 -0.698 . . . . 0.0 109.211 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.466 ' O ' ' C ' ' A' ' 80' ' ' ALA . 0.5 OUTLIER -98.13 -10.77 23.66 Favored 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.24 -0.912 . . . . 0.0 108.591 179.472 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.502 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -39.95 110.88 0.68 Allowed Pre-proline 0 N--CA 1.492 1.633 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 179.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -75.19 130.97 13.57 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 C-N-CA 122.263 1.975 . . . . 0.0 110.68 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.477 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -56.42 162.03 2.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.463 -0.773 . . . . 0.0 109.374 -179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 125.92 -117.78 2.97 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -160.51 122.5 3.17 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -1.152 . . . . 0.0 109.718 -179.792 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.632 ' CD2' ' CG2' ' A' ' 101' ' ' ILE . 4.1 m-30 -85.88 -165.43 1.24 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.14 -0.975 . . . . 0.0 108.726 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.621 HG21 HD22 ' A' ' 47' ' ' LEU . 20.7 m -165.18 101.23 0.74 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.839 -1.163 . . . . 0.0 110.678 -179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.504 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 0.5 OUTLIER -107.18 165.9 11.03 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.623 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.517 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 3.9 p90 -157.07 -171.41 3.63 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.823 -1.173 . . . . 0.0 110.442 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.58 143.76 47.46 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.56 -0.713 . . . . 0.0 109.332 -179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.617 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 31.5 tt0 -77.6 -45.14 2.54 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.323 -0.861 . . . . 0.0 109.846 179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.3 Cg_endo -79.53 -65.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.123 0 C-N-CA 122.008 1.805 . . . . 0.0 110.197 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.715 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 3.3 m80 -73.39 63.25 0.76 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.249 -0.907 . . . . 0.0 109.375 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 2.1 tpp85 -90.42 -26.91 19.62 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.332 -0.855 . . . . 0.0 109.174 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -95.33 35.53 4.24 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.411 ' O ' ' O ' ' A' ' 14' ' ' LEU . . . -135.73 34.42 2.92 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.253 -1.145 . . . . 0.0 109.573 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 48.45 25.44 4.45 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.927 -1.269 . . . . 0.0 109.927 179.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.575 ' HE3' ' HB3' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -78.53 54.42 1.46 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.066 -1.255 . . . . 0.0 109.354 179.742 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.1 t -125.74 104.24 12.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.241 -0.912 . . . . 0.0 109.442 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -103.93 174.76 22.69 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.434 ' HG2' ' HA ' ' A' ' 86' ' ' THR . 11.2 mttm -150.56 131.41 14.16 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.256 -1.144 . . . . 0.0 109.788 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.951 HD11 HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -83.29 126.58 40.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 179.358 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 21' ' ' LEU . 3.5 m -104.25 102.26 11.96 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.183 -0.948 . . . . 0.0 109.443 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.651 HG13 ' C ' ' A' ' 24' ' ' LYS . 2.4 t -99.76 92.95 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.185 -0.947 . . . . 0.0 109.466 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -46.03 161.64 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.224 -0.923 . . . . 0.0 109.561 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.259 0 CA-C-O 117.96 -1.467 . . . . 0.0 109.474 179.85 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -129.39 138.74 51.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.235 -0.915 . . . . 0.0 109.434 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.416 ' CD1' ' N ' ' A' ' 3' ' ' TYR . 19.0 m-85 -112.3 150.51 30.88 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.237 -0.914 . . . . 0.0 109.536 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.595 HG23 ' HB3' ' A' ' 30' ' ' GLU . 45.3 m -145.58 114.06 6.72 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.27 -0.894 . . . . 0.0 109.413 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.449 ' O ' HD23 ' A' ' 7' ' ' LEU . 4.4 m -91.77 80.99 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.187 -0.946 . . . . 0.0 109.58 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.403 ' C ' ' O ' ' A' ' 5' ' ' VAL . 9.3 mtmt -44.26 110.51 0.22 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.157 -0.964 . . . . 0.0 109.393 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.539 ' HB2' ' CE ' ' A' ' 97' ' ' MET . 0.1 OUTLIER -91.14 83.94 5.62 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.224 -0.923 . . . . 0.0 109.362 179.813 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.487 ' HA2' ' HA ' ' A' ' 14' ' ' LEU . . . 144.3 102.6 0.39 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.51 ' OG ' ' N ' ' A' ' 10' ' ' ASP . 89.8 p -50.47 -82.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.279 -1.13 . . . . 0.0 109.492 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.51 ' N ' ' OG ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -176.88 -93.67 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.227 -0.921 . . . . 0.0 109.508 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.6 tttt -100.06 54.28 0.91 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.14 -0.975 . . . . 0.0 109.625 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -147.59 -82.38 0.04 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.464 HD12 ' HA ' ' A' ' 13' ' ' LEU . 5.6 tp -144.89 -159.32 0.98 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.395 -1.062 . . . . 0.0 109.134 179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.748 HD11 ' HB ' ' A' ' 36' ' ' VAL . 49.8 mt -119.58 124.16 45.68 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.164 -0.96 . . . . 0.0 109.425 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.451 HG13 ' O ' ' A' ' 14' ' ' LEU . 25.6 m -156.63 155.44 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.309 -0.869 . . . . 0.0 109.338 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.482 ' HA ' ' HA ' ' A' ' 7' ' ' LEU . 6.2 m-85 -68.45 156.57 37.65 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.224 -0.922 . . . . 0.0 109.674 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.459 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 16.1 mt-10 -157.39 101.07 1.88 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.462 -0.774 . . . . 0.0 109.243 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 35.3 Cg_endo -77.9 179.8 29.71 Favored 'Cis proline' 0 C--N 1.311 -1.42 0 C-N-CA 123.67 -1.388 . . . . 0.0 110.584 0.183 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.17 -54.69 3.61 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.267 -0.896 . . . . 0.0 109.413 179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.08 153.77 24.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -0.877 . . . . 0.0 109.495 179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 1.009 HD23 HG23 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -158.48 108.12 2.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.091 -1.006 . . . . 0.0 110.046 -179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 54.9 m -91.14 102.82 15.56 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -0.912 . . . . 0.0 108.836 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 1.009 HG23 HD23 ' A' ' 21' ' ' LEU . 1.0 OUTLIER -103.24 -179.72 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.256 -0.903 . . . . 0.0 110.49 -179.222 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.734 ' O ' HG13 ' A' ' 103' ' ' VAL . 5.3 mttm -94.5 -175.81 0.51 Allowed Pre-proline 0 N--CA 1.488 1.443 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.721 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 33.6 Cg_endo -78.48 76.52 4.41 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.002 1.801 . . . . 0.0 110.607 -179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.534 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 121.23 43.99 0.41 Allowed Glycine 0 N--CA 1.489 2.187 0 N-CA-C 110.148 -1.181 . . . . 0.0 110.148 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.497 ' HB2' ' HB ' ' A' ' 23' ' ' ILE . 5.0 m-20 -94.11 -178.06 4.5 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.253 -1.145 . . . . 0.0 108.876 179.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 56.9 m -117.7 126.1 51.87 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.203 -0.936 . . . . 0.0 109.534 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.987 HG21 HD11 ' A' ' 101' ' ' ILE . 0.7 OUTLIER -119.44 134.14 63.99 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.383 0 O-C-N 121.284 -0.885 . . . . 0.0 109.398 -179.832 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.595 ' HB3' HG23 ' A' ' 4' ' ' THR . 4.6 tt0 -105.69 141.24 37.48 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.231 -0.918 . . . . 0.0 109.813 -179.754 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.564 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -134.19 96.57 3.65 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.905 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.647 ' HA ' ' HB3' ' A' ' 71' ' ' SER . 0.5 OUTLIER -98.59 168.81 9.94 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.283 -0.886 . . . . 0.0 110.491 -178.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.548 ' HB2' ' CD2' ' A' ' 39' ' ' HIS . 3.5 p-10 -94.66 153.72 17.68 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.547 -0.721 . . . . 0.0 109.572 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.469 ' HB2' ' HA3' ' A' ' 8' ' ' GLY . 38.5 t30 -97.1 -129.63 0.17 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.027 -1.045 . . . . 0.0 108.915 179.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.438 ' C ' ' CG2' ' A' ' 36' ' ' VAL . 0.5 OUTLIER -108.86 36.55 2.83 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.757 -1.214 . . . . 0.0 109.364 179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.748 ' HB ' HD11 ' A' ' 14' ' ' LEU . 4.3 t -154.96 67.89 5.35 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 109.421 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.536 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.5 Cg_endo -80.41 173.95 11.82 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.6 2.2 . . . . 0.0 110.788 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 39.1 Cg_endo -85.83 165.06 54.78 Favored 'Cis proline' 0 C--N 1.312 -1.378 0 C-N-CA 123.494 -1.461 . . . . 0.0 110.305 -1.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.709 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 57.4 m-70 -119.58 140.24 50.87 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.205 -0.934 . . . . 0.0 109.762 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.482 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 1.3 t-20 -121.92 125.96 47.55 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.356 -0.84 . . . . 0.0 109.544 -179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.458 ' O ' HG22 ' A' ' 42' ' ' VAL . 24.8 t -114.13 134.22 57.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.227 -0.92 . . . . 0.0 109.17 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.775 HG13 ' HB2' ' A' ' 60' ' ' SER . 0.2 OUTLIER -156.84 166.82 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.071 -1.018 . . . . 0.0 109.855 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.517 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 4.5 m-85 -119.39 112.04 18.92 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.363 -0.836 . . . . 0.0 109.183 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.502 ' HB3' ' HB2' ' A' ' 47' ' ' LEU . 7.5 t70 -43.74 143.21 1.07 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.305 -0.872 . . . . 0.0 109.733 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.876 ' HB1' ' HB2' ' A' ' 53' ' ' ALA . . . -90.54 -3.43 57.6 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.39 -0.819 . . . . 0.0 109.737 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -111.36 9.56 21.54 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.189 -0.944 . . . . 0.0 109.621 -179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.512 HD22 ' HB ' ' A' ' 86' ' ' THR . 0.5 OUTLIER -122.29 39.35 3.92 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.135 -0.978 . . . . 0.0 109.735 -179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.523 ' OD1' ' CA ' ' A' ' 51' ' ' LYS . 0.6 OUTLIER -112.31 165.3 13.28 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.205 -0.934 . . . . 0.0 109.419 179.756 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.494 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 35.0 Cg_endo -76.59 -10.06 18.63 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.606 2.204 . . . . 0.0 110.826 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.477 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -125.0 26.18 7.08 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.11 -0.994 . . . . 0.0 109.493 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.523 ' CA ' ' OD1' ' A' ' 48' ' ' ASN . 0.6 OUTLIER 34.28 35.58 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.134 0.492 . . . . 0.0 110.325 179.66 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.472 ' N ' ' O ' ' A' ' 50' ' ' ALA . 19.1 m -110.85 164.03 13.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.151 -0.968 . . . . 0.0 109.74 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.876 ' HB2' ' HB1' ' A' ' 45' ' ' ALA . . . -132.51 45.8 2.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.305 -0.872 . . . . 0.0 109.295 179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.41 ' C ' ' OD1' ' A' ' 54' ' ' ASP . 7.5 t0 -111.94 -56.4 2.39 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.311 -0.868 . . . . 0.0 109.58 -179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.679 ' C ' HD12 ' A' ' 55' ' ' LEU . 3.3 pp -55.34 -29.87 59.18 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.232 -0.917 . . . . 0.0 109.556 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.44 ' N ' HD12 ' A' ' 55' ' ' LEU . . . -68.11 -43.5 78.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.235 -0.916 . . . . 0.0 109.62 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.0 mptt -57.7 -39.82 78.08 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.219 -0.926 . . . . 0.0 109.367 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 13.4 m -87.84 16.36 5.95 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.267 -0.896 . . . . 0.0 109.227 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.858 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 9.7 tp -122.93 -45.25 2.15 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.346 -0.846 . . . . 0.0 109.375 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.775 ' HB2' HG13 ' A' ' 42' ' ' VAL . 37.0 p -82.16 159.35 23.34 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.491 -0.756 . . . . 0.0 110.247 -178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.55 ' HB3' HG21 ' A' ' 72' ' ' THR . 20.7 p80 -110.38 174.53 5.82 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.563 -0.711 . . . . 0.0 109.496 -179.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -121.25 -163.07 1.01 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.26 -0.9 . . . . 0.0 109.367 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER 59.19 -165.82 0.18 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.234 -0.916 . . . . 0.0 109.386 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.584 ' C ' HD12 ' A' ' 65' ' ' LEU . 4.5 mp -128.55 165.08 21.44 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.218 -0.926 . . . . 0.0 109.327 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.584 HD12 ' C ' ' A' ' 64' ' ' LEU . 7.4 mp -103.05 107.35 18.11 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.179 -0.95 . . . . 0.0 109.48 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -98.19 -18.83 18.23 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.277 -0.889 . . . . 0.0 109.443 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.523 ' CB ' ' HB2' ' A' ' 70' ' ' GLN . 46.0 t -85.67 142.91 37.53 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.237 -0.915 . . . . 0.0 109.24 179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.472 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.6 Cg_endo -79.14 107.06 2.15 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.81 2.34 . . . . 0.0 111.3 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.497 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 93.61 -18.35 56.65 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.119 -1.192 . . . . 0.0 110.119 179.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.523 ' HB2' ' CB ' ' A' ' 67' ' ' SER . 0.0 OUTLIER -80.2 103.15 9.88 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.063 -1.257 . . . . 0.0 109.266 179.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.647 ' HB3' ' HA ' ' A' ' 32' ' ' LEU . 0.3 OUTLIER -124.62 -168.87 1.88 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 121.378 -0.826 . . . . 0.0 110.22 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.682 HG23 ' O ' ' A' ' 72' ' ' THR . 9.0 t -122.01 110.33 15.69 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.7 p -78.44 111.22 14.24 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.239 -0.913 . . . . 0.0 108.932 -179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.74 HG21 ' O ' ' A' ' 59' ' ' LEU . 1.7 m -88.03 108.96 19.48 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.475 -0.766 . . . . 0.0 109.846 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.791 HG23 ' O ' ' A' ' 75' ' ' THR . 10.2 t -78.86 94.73 5.24 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 179.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.858 ' CZ ' HD21 ' A' ' 59' ' ' LEU . 4.5 m-30 -39.79 160.03 0.11 Allowed Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.698 -0.626 . . . . 0.0 109.693 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.534 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 33.8 Cg_endo -75.51 163.83 33.5 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.749 2.299 . . . . 0.0 111.417 -178.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.31 1.65 7.41 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.379 -0.825 . . . . 0.0 110.294 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.495 ' O ' ' O ' ' A' ' 80' ' ' ALA . 0.7 OUTLIER -98.85 -61.41 1.37 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.005 -1.059 . . . . 0.0 109.065 179.766 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.721 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . 42.88 94.7 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.447 -0.783 . . . . 0.0 109.679 179.547 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.49 ' HB2' ' HG2' ' A' ' 49' ' ' PRO . 34.3 Cg_endo -75.7 121.64 6.43 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 122.312 2.008 . . . . 0.0 110.155 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.446 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -42.58 133.49 3.38 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.47 -0.769 . . . . 0.0 109.612 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.442 ' O ' ' CE1' ' A' ' 85' ' ' TYR . . . 160.57 158.29 9.18 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -79.38 125.45 29.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.196 -1.179 . . . . 0.0 109.747 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.571 ' O ' ' CD2' ' A' ' 87' ' ' PHE . 9.6 m-85 -100.71 70.76 1.44 Allowed 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.512 ' HB ' HD22 ' A' ' 47' ' ' LEU . 57.0 m -62.83 97.53 0.11 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.42 -0.8 . . . . 0.0 110.464 -179.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.571 ' CD2' ' O ' ' A' ' 85' ' ' TYR . 1.5 p90 -99.91 162.97 12.66 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.154 -0.966 . . . . 0.0 108.635 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.404 ' HA ' ' O ' ' A' ' 97' ' ' MET . 28.9 p90 -149.99 -173.97 4.58 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.98 -1.075 . . . . 0.0 109.954 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.482 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 0.1 OUTLIER -116.34 132.27 56.72 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.503 -0.748 . . . . 0.0 109.562 -179.651 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.612 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 25.8 tt0 -65.92 -45.0 63.97 Favored Pre-proline 0 N--CA 1.488 1.431 0 O-C-N 121.207 -0.933 . . . . 0.0 109.975 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.5 Cg_endo -79.23 -45.37 0.11 Allowed 'Trans proline' 0 C--N 1.316 -1.174 0 C-N-CA 121.93 1.753 . . . . 0.0 110.18 179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.709 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 4.7 m80 -106.84 67.25 0.7 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -0.887 . . . . 0.0 109.316 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.74 133.99 37.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.164 -0.96 . . . . 0.0 109.521 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 82.27 -4.99 74.48 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.481 ' O ' ' O ' ' A' ' 14' ' ' LEU . . . -93.43 39.08 1.05 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.213 -1.169 . . . . 0.0 109.503 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.422 ' HA3' HG12 ' A' ' 15' ' ' VAL . . . 79.84 -3.88 67.99 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.539 ' CE ' ' HB2' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -86.59 47.17 1.44 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.178 -1.189 . . . . 0.0 109.34 179.93 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 60.5 t -124.23 76.15 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.294 -0.879 . . . . 0.0 109.498 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.542 ' C ' ' CE1' ' A' ' 87' ' ' PHE . . . -96.92 162.94 22.17 Favored Glycine 0 N--CA 1.487 2.053 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.466 ' HD2' ' OG1' ' A' ' 86' ' ' THR . 15.0 mtmt -139.38 135.15 33.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.266 -1.138 . . . . 0.0 109.199 179.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.987 HD11 HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -84.01 139.08 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.169 -0.957 . . . . 0.0 109.462 -179.876 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -112.58 99.43 7.95 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 178.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.734 HG13 ' O ' ' A' ' 24' ' ' LYS . 21.8 t -99.01 95.46 4.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.196 -0.94 . . . . 0.0 110.014 -178.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -119.39 -151.49 0.48 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.52 -0.737 . . . . 0.0 109.329 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.906 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . 0.425 ' HG2' ' OD1' ' A' ' 27' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -139.8 123.34 17.23 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.198 -0.938 . . . . 0.0 109.832 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.528 ' CE1' HG22 ' A' ' 23' ' ' ILE . 10.6 m-85 -126.13 170.9 11.33 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.329 -0.857 . . . . 0.0 108.871 179.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.477 ' HA ' ' O ' ' A' ' 30' ' ' GLU . 87.1 m -157.46 116.94 3.34 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.07 -1.018 . . . . 0.0 110.167 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.643 HG12 ' CD1' ' A' ' 21' ' ' LEU . 10.4 m -98.57 170.78 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 O-C-N 121.345 -0.847 . . . . 0.0 109.032 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -143.56 87.2 1.92 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.06 -1.025 . . . . 0.0 109.874 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.633 ' HB2' ' HE1' ' A' ' 97' ' ' MET . 0.0 OUTLIER -50.86 100.12 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.183 -0.948 . . . . 0.0 109.254 179.63 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 14' ' ' LEU . . . 129.1 98.87 0.9 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.455 -1.458 . . . . 0.0 109.455 -179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 2.3 p -48.0 -95.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.226 -1.161 . . . . 0.0 109.371 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 9' ' ' SER . 48.5 t0 176.86 33.27 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.187 -0.946 . . . . 0.0 109.508 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.08 -43.05 0.64 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.159 -0.963 . . . . 0.0 109.603 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.13 44.29 0.02 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.466 HD23 ' HA ' ' A' ' 13' ' ' LEU . 13.6 mt -151.32 160.94 43.52 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.261 -1.141 . . . . 0.0 109.458 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.877 HD21 ' HB ' ' A' ' 36' ' ' VAL . 12.9 mt -120.48 103.21 8.99 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.308 -0.87 . . . . 0.0 109.501 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.412 HG12 ' HA3' ' A' ' 96' ' ' GLY . 26.7 m -149.8 138.6 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.223 -0.923 . . . . 0.0 109.718 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -56.49 153.73 9.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.15 -0.969 . . . . 0.0 108.85 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 4.6 mm-40 -143.51 103.61 5.02 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 120.995 -1.066 . . . . 0.0 109.81 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.505 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 35.6 Cg_endo -79.29 178.54 33.46 Favored 'Cis proline' 0 C--N 1.314 -1.286 0 C-N-CA 123.796 -1.335 . . . . 0.0 110.452 -0.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -73.03 -51.42 18.26 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.223 -0.923 . . . . 0.0 109.255 179.654 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 3.2 ptpp? -99.15 146.45 26.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.922 . . . . 0.0 109.237 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.643 ' CD1' HG12 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -140.46 142.36 35.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.113 -0.992 . . . . 0.0 109.826 -179.655 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.452 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 32.1 m -106.52 126.22 51.99 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.344 -0.847 . . . . 0.0 109.096 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.846 ' CD1' HG22 ' A' ' 103' ' ' VAL . 1.0 OUTLIER -136.76 174.94 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 O-C-N 121.138 -0.976 . . . . 0.0 109.969 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.57 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.1 OUTLIER -96.6 173.15 4.37 Favored Pre-proline 0 C--N 1.303 -1.425 0 N-CA-C 108.737 -0.838 . . . . 0.0 108.737 179.36 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.622 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 35.2 Cg_endo -77.58 91.66 1.17 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 C-N-CA 122.346 2.03 . . . . 0.0 110.39 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 123.27 -11.35 8.6 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.501 ' OD1' ' CB ' ' A' ' 24' ' ' LYS . 5.8 m-20 -55.81 -178.69 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.287 -1.125 . . . . 0.0 109.096 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 97.3 m -124.09 140.99 52.44 Favored 'General case' 0 C--N 1.303 -1.43 0 O-C-N 121.205 -0.934 . . . . 0.0 109.43 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.977 HG21 HD11 ' A' ' 101' ' ' ILE . 1.3 t -130.93 119.28 44.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 O-C-N 121.278 -0.889 . . . . 0.0 109.364 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 4' ' ' THR . 30.9 tt0 -99.51 135.88 40.26 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.263 -0.898 . . . . 0.0 109.514 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.475 ' CD1' ' O ' ' A' ' 72' ' ' THR . 0.1 OUTLIER -127.28 152.0 48.0 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.126 -0.984 . . . . 0.0 108.856 179.897 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.551 ' HB3' ' N ' ' A' ' 70' ' ' GLN . 0.0 OUTLIER -140.49 -170.07 2.92 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.018 -1.052 . . . . 0.0 109.772 -179.616 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.513 ' OD1' ' HA ' ' A' ' 68' ' ' PRO . 8.6 p-10 -114.05 169.81 8.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.429 -0.795 . . . . 0.0 109.002 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.2 t-20 -110.02 -95.49 0.41 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.078 -1.014 . . . . 0.0 109.517 179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.05 33.14 1.36 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.009 -1.057 . . . . 0.0 109.376 179.84 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.877 ' HB ' HD21 ' A' ' 14' ' ' LEU . 37.6 t -151.49 59.58 3.32 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.519 -0.738 . . . . 0.0 109.063 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 36.4 Cg_endo -77.66 173.43 14.16 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.744 2.296 . . . . 0.0 110.943 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.58 ' O ' ' CG ' ' A' ' 39' ' ' HIS . 37.5 Cg_endo -82.42 -158.57 1.69 Allowed 'Cis proline' 0 C--N 1.31 -1.467 0 C-N-CA 123.292 -1.545 . . . . 0.0 110.175 -0.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.58 ' CG ' ' O ' ' A' ' 38' ' ' PRO . 86.9 m-70 -160.85 129.52 4.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.238 -0.914 . . . . 0.0 109.431 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -101.07 106.04 17.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.208 -0.933 . . . . 0.0 109.379 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.648 ' O ' HG13 ' A' ' 42' ' ' VAL . 41.2 t -99.7 120.64 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 109.098 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.951 HG12 ' HB2' ' A' ' 60' ' ' SER . 0.8 OUTLIER -159.5 158.01 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.379 0 O-C-N 121.146 -0.972 . . . . 0.0 109.899 -179.521 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.857 ' CE2' HD23 ' A' ' 59' ' ' LEU . 3.4 m-85 -94.9 116.35 28.61 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.396 -0.815 . . . . 0.0 109.498 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.703 ' OD2' HD12 ' A' ' 47' ' ' LEU . 38.3 t0 -52.9 130.09 32.26 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.357 -0.839 . . . . 0.0 109.709 -179.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -82.97 -1.9 53.7 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.214 -0.929 . . . . 0.0 109.605 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -103.68 12.99 34.08 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.156 -0.965 . . . . 0.0 109.609 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.703 HD12 ' OD2' ' A' ' 44' ' ' ASP . 5.1 mt -139.84 52.81 1.69 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.178 -0.951 . . . . 0.0 109.45 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.509 ' OD1' ' HA ' ' A' ' 51' ' ' LYS . 0.7 OUTLIER -105.07 164.36 15.29 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.205 -0.935 . . . . 0.0 109.504 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 35.1 Cg_endo -78.12 -20.63 11.28 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 C-N-CA 122.675 2.25 . . . . 0.0 110.956 -179.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.486 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -126.32 26.32 6.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.041 -1.037 . . . . 0.0 109.919 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.509 ' HA ' ' OD1' ' A' ' 48' ' ' ASN . 15.6 mmtt 34.53 36.79 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.83 0 CA-C-O 121.16 0.505 . . . . 0.0 110.284 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 50' ' ' ALA . 41.0 m -99.75 -162.32 0.94 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.206 -0.934 . . . . 0.0 109.584 -179.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -166.12 80.31 0.27 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.346 -0.846 . . . . 0.0 109.268 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -155.92 -48.96 0.08 Allowed 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.252 -0.905 . . . . 0.0 109.469 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.516 ' O ' HD12 ' A' ' 55' ' ' LEU . 1.5 pp -62.23 -17.14 57.49 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.163 -0.961 . . . . 0.0 109.222 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.411 ' O ' ' C ' ' A' ' 57' ' ' LYS . . . -90.33 -30.43 17.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.332 -0.855 . . . . 0.0 109.539 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 56' ' ' ALA . 0.1 OUTLIER -43.86 -62.73 1.02 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.24 -0.913 . . . . 0.0 109.503 -179.921 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 2.9 m -94.39 49.57 1.3 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 0.0 109.417 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.857 HD23 ' CE2' ' A' ' 43' ' ' PHE . 7.3 tp -136.27 -60.89 0.71 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.347 -0.846 . . . . 0.0 109.34 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.951 ' HB2' HG12 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -77.48 152.17 34.31 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.462 -0.774 . . . . 0.0 110.159 -178.432 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.422 ' NE2' ' N ' ' A' ' 41' ' ' VAL . 27.4 p80 -97.17 -168.59 1.72 Allowed 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.547 -0.721 . . . . 0.0 109.327 -179.739 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.11 -46.17 0.34 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.178 -0.951 . . . . 0.0 109.391 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -65.72 132.82 49.7 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.2 -0.938 . . . . 0.0 109.402 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.626 ' H ' HD12 ' A' ' 64' ' ' LEU . 5.7 mp -58.86 169.76 0.95 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.18 -0.95 . . . . 0.0 109.356 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.679 HD13 ' HB2' ' A' ' 71' ' ' SER . 0.0 OUTLIER -115.6 127.04 54.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.19 -0.944 . . . . 0.0 109.262 179.944 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.9 mtt -120.29 9.78 11.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.266 -0.896 . . . . 0.0 109.599 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.44 ' HA ' ' HD3' ' A' ' 68' ' ' PRO . 32.3 t -94.07 138.44 22.62 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.209 -0.932 . . . . 0.0 109.322 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.513 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.5 Cg_endo -79.92 95.65 1.03 Allowed 'Trans proline' 0 C--N 1.311 -1.416 0 C-N-CA 122.579 2.186 . . . . 0.0 110.62 -179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.463 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 99.76 48.63 1.61 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.551 ' N ' ' HB3' ' A' ' 32' ' ' LEU . 6.4 tt0 -179.22 100.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.14 -1.212 . . . . 0.0 109.334 179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.679 ' HB2' HD13 ' A' ' 65' ' ' LEU . 24.1 p -103.8 -79.63 0.54 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.145 -0.972 . . . . 0.0 109.723 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.572 ' N ' ' OG ' ' A' ' 71' ' ' SER . 0.4 OUTLIER -160.72 107.95 1.53 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.925 -1.109 . . . . 0.0 109.751 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -79.22 99.38 7.01 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.047 -1.033 . . . . 0.0 108.818 179.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.42 HG21 ' HA ' ' A' ' 59' ' ' LEU . 6.9 m -102.97 124.99 49.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.343 -0.848 . . . . 0.0 110.047 -179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.462 ' O ' ' C ' ' A' ' 76' ' ' PHE . 0.8 OUTLIER -89.9 93.69 9.52 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.168 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.931 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 32.5 m-85 -39.95 157.15 0.15 Allowed Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.475 -0.766 . . . . 0.0 109.64 -179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.506 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.1 Cg_endo -75.5 161.58 37.09 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.703 2.269 . . . . 0.0 111.238 -178.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 25' ' ' PRO . . . -74.54 5.11 5.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.557 -0.715 . . . . 0.0 109.964 179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.474 ' O ' ' C ' ' A' ' 80' ' ' ALA . 0.4 OUTLIER -98.6 -67.22 0.86 Allowed 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.015 -1.053 . . . . 0.0 109.202 179.923 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.976 ' CB ' HG11 ' A' ' 103' ' ' VAL . . . 40.65 76.49 0.5 Allowed Pre-proline 0 N--CA 1.493 1.687 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 82' ' ' ALA . 35.3 Cg_endo -76.73 119.91 5.33 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 C-N-CA 122.866 2.378 . . . . 0.0 111.697 -178.288 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 81' ' ' PRO . . . 50.89 106.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.597 -0.689 . . . . 0.0 110.482 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.533 ' CA ' ' H ' ' A' ' 103' ' ' VAL . . . -49.0 103.71 0.08 OUTLIER Glycine 0 N--CA 1.48 1.626 0 N-CA-C 110.095 -1.202 . . . . 0.0 110.095 179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 49' ' ' PRO . 1.1 tp10 -160.32 53.33 0.32 Allowed 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.273 -1.134 . . . . 0.0 109.744 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.562 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 1.1 m-85 -111.45 128.45 56.0 Favored 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.495 HG23 ' HG2' ' A' ' 100' ' ' LYS . 59.3 m -124.72 114.85 19.85 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.143 -0.973 . . . . 0.0 110.09 -179.354 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.54 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.6 OUTLIER -99.98 164.45 11.99 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 178.898 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.436 ' CD1' ' N ' ' A' ' 89' ' ' CYS . 55.2 p90 -155.36 -162.37 1.33 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.013 -1.054 . . . . 0.0 109.662 -179.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.436 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 0.1 OUTLIER -133.27 124.38 27.23 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.568 -0.707 . . . . 0.0 109.52 179.996 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.616 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 6.3 tt0 -61.47 -43.85 90.37 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.313 -0.867 . . . . 0.0 110.739 -179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.2 Cg_endo -79.42 -66.78 0.02 OUTLIER 'Trans proline' 0 C--N 1.315 -1.196 0 C-N-CA 122.09 1.86 . . . . 0.0 110.729 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.683 ' CD2' HD13 ' A' ' 14' ' ' LEU . 10.1 m80 -75.68 55.61 0.86 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.159 -0.963 . . . . 0.0 109.256 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -82.19 109.86 16.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.34 -0.85 . . . . 0.0 109.631 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 110.7 -1.19 28.99 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.473 ' O ' ' O ' ' A' ' 14' ' ' LEU . . . -101.1 35.12 2.31 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.176 -1.191 . . . . 0.0 109.467 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.412 ' HA3' HG12 ' A' ' 15' ' ' VAL . . . 70.12 19.69 75.84 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.633 ' HE1' ' HB2' ' A' ' 7' ' ' LEU . 1.0 OUTLIER -92.04 37.25 0.98 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.082 -1.246 . . . . 0.0 109.329 179.799 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 89.4 t -125.59 110.27 23.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.187 -0.946 . . . . 0.0 109.686 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.54 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -118.34 173.27 14.79 Favored Glycine 0 N--CA 1.486 2.015 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.495 ' HG2' HG23 ' A' ' 86' ' ' THR . 7.6 mtmm -148.15 129.8 15.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.099 -1.236 . . . . 0.0 109.823 -179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.977 HD11 HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -83.49 129.02 38.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.286 -0.884 . . . . 0.0 108.669 179.409 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.452 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 2.8 m -99.66 95.1 6.73 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.173 -0.954 . . . . 0.0 108.988 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.976 HG11 ' CB ' ' A' ' 80' ' ' ALA . 60.1 t -98.5 99.4 8.59 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 O-C-N 121.464 -0.773 . . . . 0.0 109.664 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -57.19 127.65 33.01 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.375 -0.828 . . . . 0.0 109.587 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.264 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.886 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 55.6 m -135.79 130.79 34.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.301 -0.874 . . . . 0.0 109.593 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 57.9 m-85 -92.7 150.21 20.82 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.262 -0.899 . . . . 0.0 109.39 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.477 ' HB ' ' HB3' ' A' ' 30' ' ' GLU . 1.4 t -157.22 135.39 11.11 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.215 -0.928 . . . . 0.0 109.591 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.505 ' CG1' HD12 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -109.12 102.36 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.295 -0.878 . . . . 0.0 109.37 179.823 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -68.43 127.66 33.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.22 -0.925 . . . . 0.0 109.407 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.595 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -97.79 177.26 5.52 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.118 -0.989 . . . . 0.0 109.09 179.53 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.483 ' CA ' HD23 ' A' ' 14' ' ' LEU . . . 59.03 86.72 0.03 OUTLIER Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.157 -1.577 . . . . 0.0 109.157 -179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.473 ' OG ' ' N ' ' A' ' 10' ' ' ASP . 93.6 p -45.27 -88.44 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.301 -1.117 . . . . 0.0 109.587 -179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.473 ' N ' ' OG ' ' A' ' 9' ' ' SER . 6.8 t70 179.6 -47.39 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.261 -0.899 . . . . 0.0 109.157 -179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.58 30.71 5.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.332 -0.855 . . . . 0.0 109.146 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.417 ' C ' ' HG ' ' A' ' 13' ' ' LEU . . . -138.96 -108.78 0.82 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 -179.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.417 ' HG ' ' C ' ' A' ' 12' ' ' GLY . 0.5 OUTLIER -130.87 -155.24 0.68 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.24 -1.153 . . . . 0.0 109.61 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.579 HD22 ' CE1' ' A' ' 39' ' ' HIS . 5.3 mt -107.7 118.12 35.91 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.298 -0.876 . . . . 0.0 109.38 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 2.4 m -146.07 159.25 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 109.528 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 17.6 m-85 -82.05 138.26 34.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.319 -0.863 . . . . 0.0 109.248 179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 83.3 mt-10 -126.17 111.86 23.96 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.22 -0.925 . . . . 0.0 109.368 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.474 ' HG2' ' HG ' ' A' ' 21' ' ' LEU . 35.2 Cg_endo -78.88 -178.2 23.17 Favored 'Cis proline' 0 C--N 1.311 -1.429 0 C-N-CA 123.841 -1.316 . . . . 0.0 110.517 -0.052 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.61 -59.27 2.93 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.315 -0.865 . . . . 0.0 109.086 179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -99.28 160.71 14.08 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.355 -0.84 . . . . 0.0 108.861 179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.505 HD12 ' CG1' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -155.24 121.02 5.07 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.961 -1.087 . . . . 0.0 110.314 -179.697 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.489 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 34.0 m -92.81 107.64 19.38 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.828 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -105.74 171.44 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.421 0 O-C-N 121.19 -0.944 . . . . 0.0 110.42 -178.882 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.494 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -89.58 171.34 8.94 Favored Pre-proline 0 C--N 1.301 -1.524 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.017 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.644 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 34.7 Cg_endo -76.6 79.39 3.04 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 C-N-CA 122.219 1.946 . . . . 0.0 110.728 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.498 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 136.91 -22.6 3.27 Favored Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.394 -1.384 . . . . 0.0 110.424 179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.467 ' O ' ' O ' ' A' ' 26' ' ' GLY . 16.4 m-20 -46.66 172.52 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.031 -1.276 . . . . 0.0 109.533 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.738 HG23 ' HA ' ' A' ' 75' ' ' THR . 1.3 m -115.96 119.6 36.44 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.337 -0.852 . . . . 0.0 109.406 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.051 HG21 HD11 ' A' ' 101' ' ' ILE . 2.5 t -99.48 132.31 45.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 O-C-N 121.222 -0.924 . . . . 0.0 109.518 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.477 ' HB3' ' HB ' ' A' ' 4' ' ' THR . 10.6 tt0 -113.47 142.68 45.63 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.197 -0.939 . . . . 0.0 109.53 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.589 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -138.55 95.02 2.91 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.956 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.81 HD12 ' O ' ' A' ' 33' ' ' ASN . 1.1 pp -98.77 160.4 14.3 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.228 -0.92 . . . . 0.0 110.456 -178.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.81 ' O ' HD12 ' A' ' 32' ' ' LEU . 2.3 p-10 -79.0 -173.82 3.75 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.629 -0.67 . . . . 0.0 109.271 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.465 ' ND2' ' HG2' ' A' ' 35' ' ' LYS . 25.3 t30 -134.73 -93.27 0.3 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.138 -0.976 . . . . 0.0 109.291 179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.465 ' HG2' ' ND2' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -138.45 36.17 2.26 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.1 -1.0 . . . . 0.0 109.412 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.557 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 0.1 OUTLIER -157.11 61.11 2.29 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.44 -0.788 . . . . 0.0 109.011 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.557 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 36.0 Cg_endo -79.42 173.39 13.23 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.632 2.221 . . . . 0.0 111.007 -179.577 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.581 ' O ' ' CD2' ' A' ' 39' ' ' HIS . 37.9 Cg_endo -84.47 -157.1 1.26 Allowed 'Cis proline' 0 C--N 1.31 -1.482 0 C-N-CA 123.298 -1.543 . . . . 0.0 110.163 -1.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.581 ' CD2' ' O ' ' A' ' 38' ' ' PRO . 81.6 m-70 -161.46 142.46 11.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.46 -0.775 . . . . 0.0 109.754 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -116.63 123.47 47.39 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.319 -0.863 . . . . 0.0 109.31 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.428 ' C ' ' CG2' ' A' ' 42' ' ' VAL . 70.4 t -110.17 128.55 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.326 -0.859 . . . . 0.0 109.425 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.507 ' HA ' ' HB3' ' A' ' 60' ' ' SER . 1.2 t -151.64 178.1 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.211 -0.931 . . . . 0.0 109.489 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.586 ' HB2' ' HB1' ' A' ' 56' ' ' ALA . 12.1 m-85 -130.14 121.47 26.36 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.235 -0.915 . . . . 0.0 109.533 -179.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.455 ' O ' ' O ' ' A' ' 43' ' ' PHE . 8.5 t0 -50.77 -177.35 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.355 -0.84 . . . . 0.0 109.455 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -137.84 14.3 2.9 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.247 -0.908 . . . . 0.0 109.501 -179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.71 15.37 2.33 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.899 . . . . 0.0 109.607 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 mp -117.29 35.72 4.54 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.101 -1.0 . . . . 0.0 109.601 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.531 ' OD1' ' CA ' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -130.13 156.39 79.33 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.319 -0.863 . . . . 0.0 109.071 179.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.761 ' HD2' ' HB1' ' A' ' 82' ' ' ALA . 35.5 Cg_endo -77.93 2.67 7.69 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.611 2.207 . . . . 0.0 111.145 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.505 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -140.2 29.64 2.01 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.88 -1.138 . . . . 0.0 110.103 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.531 ' CA ' ' OD1' ' A' ' 48' ' ' ASN . 0.3 OUTLIER 30.54 96.35 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.122 0 CA-C-O 121.234 0.54 . . . . 0.0 110.577 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.579 ' O ' ' HB2' ' A' ' 53' ' ' ALA . 1.7 m -99.23 -177.68 3.68 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.008 -1.057 . . . . 0.0 109.904 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.579 ' HB2' ' O ' ' A' ' 52' ' ' SER . . . 170.59 -33.33 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.434 -0.791 . . . . 0.0 109.21 -179.736 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -89.15 -17.63 28.8 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.332 -0.855 . . . . 0.0 109.51 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 0.7 OUTLIER -106.26 -28.17 10.58 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.121 -0.987 . . . . 0.0 109.508 179.925 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.586 ' HB1' ' HB2' ' A' ' 43' ' ' PHE . . . -87.45 -7.07 58.08 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.339 -0.851 . . . . 0.0 109.85 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.1 tttp -79.72 -49.77 11.58 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.155 -0.966 . . . . 0.0 109.347 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.9 t -82.53 -22.06 35.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.305 -0.872 . . . . 0.0 109.559 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.922 ' HG ' HG21 ' A' ' 74' ' ' THR . 9.1 tp -53.0 -32.25 45.47 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.202 -0.937 . . . . 0.0 108.83 -179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.507 ' HB3' ' HA ' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -78.8 127.92 32.7 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.336 -0.852 . . . . 0.0 109.74 -179.817 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.891 ' HB3' HG21 ' A' ' 72' ' ' THR . 9.7 p80 -73.38 -28.58 62.1 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.149 -0.969 . . . . 0.0 109.048 179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.52 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 1.3 mtpt 56.65 118.94 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.497 -0.752 . . . . 0.0 110.011 179.659 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.52 ' CB ' ' O ' ' A' ' 62' ' ' LYS . 0.5 OUTLIER 160.46 169.83 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.466 -0.771 . . . . 0.0 109.438 179.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.7 mp -102.68 123.56 46.6 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.172 -0.955 . . . . 0.0 109.218 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 70' ' ' GLN . 9.1 mp -84.47 81.9 8.64 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.581 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 30.9 mtp -93.98 2.69 56.04 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.164 -0.96 . . . . 0.0 109.822 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.505 ' OG ' ' HD2' ' A' ' 68' ' ' PRO . 1.0 OUTLIER -115.81 152.42 47.41 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.121 -0.987 . . . . 0.0 109.089 -179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.505 ' HD2' ' OG ' ' A' ' 67' ' ' SER . 33.8 Cg_endo -76.13 102.18 1.58 Allowed 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.407 2.071 . . . . 0.0 110.151 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 109.98 -26.31 14.28 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.492 ' O ' ' HG ' ' A' ' 65' ' ' LEU . 0.0 OUTLIER -48.5 108.73 0.19 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.277 -1.131 . . . . 0.0 108.991 179.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.559 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . 5.2 p -140.42 -159.57 0.97 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.097 -1.002 . . . . 0.0 110.083 -179.589 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.891 HG21 ' HB3' ' A' ' 61' ' ' HIS . 4.2 m -157.06 112.39 2.84 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.5 p -79.41 76.2 5.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.121 -0.987 . . . . 0.0 109.293 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.922 HG21 ' HG ' ' A' ' 59' ' ' LEU . 60.9 m -51.1 111.0 0.49 Allowed 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.538 -0.726 . . . . 0.0 109.939 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.738 ' HA ' HG23 ' A' ' 28' ' ' THR . 96.0 m -80.39 92.25 5.8 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.339 -0.85 . . . . 0.0 109.047 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.941 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 11.6 m-85 -44.74 165.11 0.16 Allowed Pre-proline 0 C--N 1.302 -1.468 0 O-C-N 121.374 -0.829 . . . . 0.0 109.399 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.498 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 32.6 Cg_endo -75.64 155.38 40.01 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.552 2.168 . . . . 0.0 111.362 -179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.26 -6.5 24.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.61 -0.681 . . . . 0.0 109.801 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.431 ' O ' ' C ' ' A' ' 80' ' ' ALA . 0.2 OUTLIER -99.96 -66.31 0.91 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.2 -0.937 . . . . 0.0 109.2 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.695 ' HB3' HG11 ' A' ' 103' ' ' VAL . . . 42.59 65.75 4.88 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.407 -0.808 . . . . 0.0 109.59 179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.622 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 33.5 Cg_endo -76.27 -159.81 0.1 Allowed 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.374 2.049 . . . . 0.0 109.907 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.761 ' HB1' ' HD2' ' A' ' 49' ' ' PRO . . . 69.62 -84.84 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.076 -1.015 . . . . 0.0 109.189 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.441 ' HA2' ' C ' ' A' ' 103' ' ' VAL . . . 116.22 19.64 5.43 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -160.02 96.67 1.23 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.153 -1.204 . . . . 0.0 110.243 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.526 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 5.5 m-85 -111.85 125.46 54.04 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 24.3 m -112.69 118.3 34.64 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.0 -1.063 . . . . 0.0 110.946 -178.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.54 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.7 OUTLIER -103.77 175.17 5.57 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.272 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 40.7 p90 -160.53 -177.61 6.32 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.662 -1.273 . . . . 0.0 110.427 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -121.0 137.08 54.82 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -77.24 -46.98 2.65 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.28 -0.888 . . . . 0.0 110.905 -179.49 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 33.3 Cg_endo -77.49 -47.83 0.12 Allowed 'Trans proline' 0 C--N 1.312 -1.393 0 C-N-CA 122.331 2.02 . . . . 0.0 112.145 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.608 ' CE1' ' HG2' ' A' ' 91' ' ' PRO . 3.3 m80 -101.32 65.42 1.06 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 120.736 -1.227 . . . . 0.0 110.142 -179.125 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 4.6 ttp180 -90.12 4.83 49.22 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.223 -0.923 . . . . 0.0 109.163 179.288 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -104.31 -14.73 23.38 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.509 ' HB1' ' O ' ' A' ' 14' ' ' LEU . . . -95.91 35.01 1.45 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.225 -1.162 . . . . 0.0 109.181 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.505 ' O ' ' N ' ' A' ' 98' ' ' VAL . . . 48.93 27.29 6.45 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.473 ' SD ' ' HB2' ' A' ' 92' ' ' HIS . 4.1 mtp -68.39 60.73 0.09 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.976 -1.308 . . . . 0.0 109.138 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.505 ' N ' ' O ' ' A' ' 96' ' ' GLY . 96.7 t -139.14 110.18 4.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.293 -0.88 . . . . 0.0 109.761 -179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.54 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -103.69 -171.55 25.59 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.491 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 18.2 mttt -155.1 123.63 6.02 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.162 -1.199 . . . . 0.0 109.758 179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 1.051 HD11 HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -90.97 124.43 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.233 -0.917 . . . . 0.0 108.795 179.517 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.489 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 18.2 m -105.26 97.65 7.46 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.252 -0.905 . . . . 0.0 108.856 179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.695 HG11 ' HB3' ' A' ' 80' ' ' ALA . 4.0 t -99.8 73.37 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.013 -1.055 . . . . 0.0 109.512 -179.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -45.02 109.04 0.14 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.272 -0.893 . . . . 0.0 109.526 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.45 ' OXT' ' HA ' ' A' ' 81' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.309 0 CA-C-O 118.005 -1.441 . . . . 0.0 109.551 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 4.2 mp0 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.356 -0.609 . . . . 0.0 109.356 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.4 m -123.1 128.8 50.61 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.285 -0.884 . . . . 0.0 109.553 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.694 ' HD2' HG22 ' A' ' 23' ' ' ILE . 58.8 m-85 -105.77 130.82 53.69 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.271 -0.893 . . . . 0.0 109.328 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.659 HG23 ' O ' ' A' ' 4' ' ' THR . 10.1 t -127.61 108.76 11.05 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.267 -0.896 . . . . 0.0 109.714 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.491 HG21 ' CE1' ' A' ' 16' ' ' PHE . 19.5 m -92.83 159.5 2.78 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.23 -0.919 . . . . 0.0 109.537 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.403 ' O ' ' N ' ' A' ' 8' ' ' GLY . 25.4 mttt -128.26 84.26 2.23 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.247 -0.908 . . . . 0.0 109.426 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.572 ' HB2' ' CE ' ' A' ' 97' ' ' MET . 0.0 OUTLIER -45.15 100.7 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.25 -0.906 . . . . 0.0 109.536 179.944 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.513 ' HA2' ' HA ' ' A' ' 14' ' ' LEU . . . 104.46 114.22 3.93 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 1.8 p -76.21 -81.3 0.08 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.294 -1.121 . . . . 0.0 109.254 179.659 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 9' ' ' SER . 7.5 t70 167.83 -30.19 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.335 -0.853 . . . . 0.0 109.483 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.422 ' HB2' ' HE2' ' A' ' 11' ' ' LYS . 3.3 ttmm -114.85 -14.9 11.9 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.124 -0.985 . . . . 0.0 109.588 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -96.68 -85.92 1.77 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -164.34 -148.73 0.12 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.27 -1.135 . . . . 0.0 109.296 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.669 HD11 ' HB ' ' A' ' 36' ' ' VAL . 83.9 mt -106.11 94.92 5.43 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.257 -0.902 . . . . 0.0 109.432 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 3.5 m -144.57 155.41 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.199 -0.938 . . . . 0.0 109.591 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.491 ' CE1' HG21 ' A' ' 5' ' ' VAL . 10.0 m-85 -70.06 142.99 52.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 109.764 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.478 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 2.8 mt-10 -134.44 105.18 11.03 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.329 -0.857 . . . . 0.0 109.235 179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.478 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 33.9 Cg_endo -76.34 -175.71 17.06 Favored 'Cis proline' 0 C--N 1.311 -1.403 0 C-N-CA 123.664 -1.39 . . . . 0.0 110.639 0.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -87.29 -9.61 54.52 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.242 -0.911 . . . . 0.0 109.89 -179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.852 ' C ' HD22 ' A' ' 21' ' ' LEU . 30.2 mtmt -139.02 137.34 36.21 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.095 -1.003 . . . . 0.0 109.492 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.852 HD22 ' C ' ' A' ' 20' ' ' LYS . 4.6 mm? -123.54 127.77 48.8 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.33 -0.856 . . . . 0.0 109.887 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 69.4 m -99.67 97.98 8.87 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.327 -0.858 . . . . 0.0 108.705 179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.818 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.1 pt -104.16 -175.87 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 O-C-N 121.227 -0.92 . . . . 0.0 110.4 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.625 ' C ' HG13 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -113.85 179.72 0.74 Allowed Pre-proline 0 C--N 1.303 -1.447 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 179.075 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.567 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 34.1 Cg_endo -76.93 76.47 4.12 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.009 1.806 . . . . 0.0 110.571 -179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.459 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 134.31 -2.02 4.18 Favored Glycine 0 N--CA 1.491 2.311 0 C-N-CA 119.5 -1.334 . . . . 0.0 110.101 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -62.91 -170.86 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.092 -1.24 . . . . 0.0 109.249 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.403 HG23 ' HA ' ' A' ' 75' ' ' THR . 52.2 m -137.85 112.93 9.16 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.135 -0.978 . . . . 0.0 109.675 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.993 HG21 HD11 ' A' ' 101' ' ' ILE . 0.8 OUTLIER -99.89 128.43 51.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 O-C-N 121.214 -0.929 . . . . 0.0 109.422 -179.971 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.461 ' N ' ' O ' ' A' ' 3' ' ' TYR . 46.3 mt-10 -99.48 163.49 12.49 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.232 -0.917 . . . . 0.0 109.205 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.519 ' CZ ' ' O ' ' A' ' 29' ' ' VAL . 0.2 OUTLIER -149.44 152.87 36.42 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.209 -0.932 . . . . 0.0 109.391 -179.605 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.566 ' N ' HD12 ' A' ' 32' ' ' LEU . 2.3 mp -141.73 -162.59 1.42 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.146 -0.971 . . . . 0.0 109.953 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.533 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 3.3 p-10 -123.97 172.99 8.52 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.446 -0.784 . . . . 0.0 109.011 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.453 ' HB2' ' O ' ' A' ' 8' ' ' GLY . 26.0 t-20 -111.64 -96.36 0.43 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.939 -1.1 . . . . 0.0 109.193 179.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.486 ' HE2' HG22 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -147.13 30.91 0.93 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.18 -0.95 . . . . 0.0 108.862 179.523 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.669 ' HB ' HD11 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -151.1 59.42 3.34 Favored Pre-proline 0 N--CA 1.49 1.557 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 179.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.579 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 36.6 Cg_endo -78.49 174.86 11.75 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 C-N-CA 122.761 2.307 . . . . 0.0 110.617 -179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.556 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 37.9 Cg_endo -84.15 172.62 44.03 Favored 'Cis proline' 0 C--N 1.31 -1.461 0 C-N-CA 123.518 -1.451 . . . . 0.0 110.37 -1.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.902 ' HB2' HD22 ' A' ' 65' ' ' LEU . 91.9 m-70 -132.04 142.01 49.42 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.141 -0.974 . . . . 0.0 109.729 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.519 ' ND2' ' HB3' ' A' ' 63' ' ' GLN . 4.9 t-20 -112.47 119.29 37.69 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.335 -0.853 . . . . 0.0 109.604 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.9 t -108.03 112.94 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.657 HG13 ' CB ' ' A' ' 60' ' ' SER . 2.4 t -139.19 170.8 15.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.979 -1.075 . . . . 0.0 110.566 -179.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.53 ' H ' HG12 ' A' ' 42' ' ' VAL . 4.4 m-85 -118.45 110.58 17.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.491 -0.756 . . . . 0.0 109.345 179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.517 ' HB3' ' CD2' ' A' ' 47' ' ' LEU . 6.1 t0 -48.83 139.3 10.1 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.192 -0.942 . . . . 0.0 109.278 179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.29 12.84 6.0 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.251 -0.906 . . . . 0.0 109.888 -179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -119.8 23.99 10.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.069 -1.019 . . . . 0.0 109.668 -179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.517 ' CD2' ' HB3' ' A' ' 44' ' ' ASP . 0.7 OUTLIER -131.03 46.33 2.69 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.226 -0.921 . . . . 0.0 109.474 -179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 48' ' ' ASN . 0.5 OUTLIER -119.47 156.38 53.31 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.214 -0.929 . . . . 0.0 109.603 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.36 -21.56 11.65 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.676 2.251 . . . . 0.0 110.305 179.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.451 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -123.89 28.06 7.0 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.264 -0.898 . . . . 0.0 109.424 179.919 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.474 ' HA ' ' OD1' ' A' ' 48' ' ' ASN . 0.1 OUTLIER 38.55 48.17 1.22 Allowed 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.295 0.569 . . . . 0.0 110.025 179.711 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.435 ' N ' ' ND2' ' A' ' 48' ' ' ASN . 22.3 m -112.02 139.22 47.71 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.165 -0.959 . . . . 0.0 109.434 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.464 ' O ' ' HD2' ' A' ' 57' ' ' LYS . . . -121.54 21.82 10.81 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.186 -0.946 . . . . 0.0 109.802 -179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -80.86 -32.85 34.82 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.203 -0.936 . . . . 0.0 109.568 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.512 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 0.5 OUTLIER -97.39 21.42 10.14 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.215 -0.928 . . . . 0.0 109.415 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -113.35 -33.88 5.8 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.328 -0.858 . . . . 0.0 109.294 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.464 ' HD2' ' O ' ' A' ' 53' ' ' ALA . 0.0 OUTLIER -71.34 -48.66 48.93 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.275 -0.891 . . . . 0.0 109.028 179.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 6.1 t -77.83 -2.12 34.95 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.314 -0.866 . . . . 0.0 109.44 179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.885 HD21 ' CE2' ' A' ' 76' ' ' PHE . 9.7 tp -89.05 -48.41 7.44 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.109 -0.994 . . . . 0.0 109.097 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.657 ' CB ' HG13 ' A' ' 42' ' ' VAL . 10.1 p -79.78 164.65 23.49 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.527 -0.733 . . . . 0.0 110.507 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.535 ' CD2' HG21 ' A' ' 72' ' ' THR . 3.5 p80 -125.0 -164.74 1.31 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.526 -0.734 . . . . 0.0 109.217 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.466 ' N ' ' CG ' ' A' ' 61' ' ' HIS . 2.2 mttp -65.43 -162.98 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.119 -0.988 . . . . 0.0 109.353 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.519 ' HB3' ' ND2' ' A' ' 40' ' ' ASN . 5.4 pt20 -137.07 42.44 2.42 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.102 -0.999 . . . . 0.0 109.876 -179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -126.61 76.53 1.64 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.182 -0.948 . . . . 0.0 109.938 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.902 HD22 ' HB2' ' A' ' 39' ' ' HIS . 4.9 mp -85.58 105.0 15.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.131 -0.981 . . . . 0.0 109.21 179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.1 ttt -109.04 3.82 22.49 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 0.0 109.578 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.428 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 2.6 t -98.28 133.63 22.74 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.213 -0.929 . . . . 0.0 109.123 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 67' ' ' SER . 36.0 Cg_endo -78.86 78.92 3.53 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 C-N-CA 122.413 2.076 . . . . 0.0 110.512 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.533 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 112.63 50.36 0.56 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.909 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.531 ' N ' ' HB3' ' A' ' 32' ' ' LEU . 0.0 OUTLIER 172.3 111.68 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.324 -1.103 . . . . 0.0 109.385 179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' A' ' 72' ' ' THR . 77.8 p -111.14 -78.89 0.58 Allowed 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.209 -0.932 . . . . 0.0 109.199 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.535 HG21 ' CD2' ' A' ' 61' ' ' HIS . 14.7 t -160.4 164.28 32.47 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.387 -0.821 . . . . 0.0 108.945 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.2 t -115.44 126.47 54.39 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.156 -0.965 . . . . 0.0 109.226 179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.755 HG21 ' HG ' ' A' ' 59' ' ' LEU . 56.0 m -108.3 101.74 10.91 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.303 -0.873 . . . . 0.0 109.716 -179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.478 ' O ' HG22 ' A' ' 75' ' ' THR . 25.1 m -79.14 80.13 5.51 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 179.156 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.925 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 9.1 m-85 -36.83 146.54 0.23 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.964 -0.46 . . . . 0.0 109.886 -179.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.459 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.0 Cg_endo -75.63 168.81 23.61 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 C-N-CA 122.625 2.217 . . . . 0.0 110.895 -179.034 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.75 11.82 8.4 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.493 -0.754 . . . . 0.0 109.424 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 81' ' ' PRO . 0.9 OUTLIER -99.55 -24.36 14.78 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.285 -0.885 . . . . 0.0 109.329 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.567 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -37.04 96.58 0.11 Allowed Pre-proline 0 N--CA 1.495 1.823 0 O-C-N 121.815 -0.553 . . . . 0.0 109.769 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.488 ' N ' ' O ' ' A' ' 79' ' ' ASP . 35.9 Cg_endo -78.62 -177.0 3.57 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.643 2.229 . . . . 0.0 110.732 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.563 ' HB2' ' HA3' ' A' ' 105' ' ' GLY . . . -70.39 127.32 32.35 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.301 -0.874 . . . . 0.0 109.266 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 167.11 145.75 4.61 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 7.3 mt-10 -85.07 117.02 23.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.266 -1.137 . . . . 0.0 109.808 -179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.489 ' CD1' HG22 ' A' ' 101' ' ' ILE . 26.5 m-85 -92.51 153.4 19.1 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.499 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 29.6 m -138.81 114.33 9.75 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.837 -1.164 . . . . 0.0 110.762 -179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.592 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.4 OUTLIER -108.33 154.75 21.38 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.282 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.524 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 5.0 p90 -143.49 -156.77 0.72 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.052 -1.03 . . . . 0.0 110.11 -179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.456 ' SG ' ' HD2' ' A' ' 91' ' ' PRO . 0.6 OUTLIER -133.41 139.19 46.62 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.323 -0.861 . . . . 0.0 109.491 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.629 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 63.1 tt0 -79.45 -42.64 1.6 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.349 -0.844 . . . . 0.0 111.035 -179.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 34.2 Cg_endo -76.93 -46.04 0.16 Allowed 'Trans proline' 0 C--N 1.316 -1.148 0 C-N-CA 121.931 1.754 . . . . 0.0 111.068 -179.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.687 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 15.2 m80 -102.3 33.32 3.16 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.0 -1.062 . . . . 0.0 109.6 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 12.9 ttt-85 -50.65 -36.9 37.84 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.129 -0.982 . . . . 0.0 109.718 -179.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -96.27 40.26 2.64 Favored Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 92' ' ' HIS . . . -133.68 33.38 3.5 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.231 -1.158 . . . . 0.0 109.541 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.11 24.12 54.01 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 110.231 -1.147 . . . . 0.0 110.231 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.572 ' CE ' ' HB2' ' A' ' 7' ' ' LEU . 2.7 mtp -87.54 71.59 9.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.039 -1.271 . . . . 0.0 109.217 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 88.6 t -137.62 127.94 37.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.246 -0.909 . . . . 0.0 109.541 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.592 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -123.66 -174.78 14.27 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.527 ' CG ' ' O ' ' A' ' 99' ' ' GLY . 22.2 mttt -162.33 122.27 2.41 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.175 -1.191 . . . . 0.0 110.169 -179.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.993 HD11 HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -88.16 121.25 38.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.107 -0.995 . . . . 0.0 108.406 178.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.6 101.41 12.31 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.021 -1.05 . . . . 0.0 109.329 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.705 HG22 ' CD1' ' A' ' 23' ' ' ILE . 2.4 t -99.77 116.47 43.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.282 -0.886 . . . . 0.0 109.367 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -64.43 -172.8 0.08 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.218 -0.926 . . . . 0.0 109.385 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.563 ' HA3' ' HB2' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.291 0 CA-C-O 118.024 -1.431 . . . . 0.0 109.528 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.574 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.31 142.93 50.99 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.749 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.707 ' CD2' HG22 ' A' ' 23' ' ' ILE . 23.2 m-85 -80.17 173.87 12.16 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.281 -0.887 . . . . 0.0 109.373 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.501 HG23 ' CB ' ' A' ' 30' ' ' GLU . 0.2 OUTLIER -156.08 113.57 3.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.149 -0.97 . . . . 0.0 109.814 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.768 ' CG1' HD13 ' A' ' 21' ' ' LEU . 0.3 OUTLIER -101.41 114.3 40.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.246 -0.908 . . . . 0.0 109.129 179.514 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -82.03 107.53 14.81 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.244 -0.91 . . . . 0.0 109.475 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.567 HD22 ' CE1' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -88.94 -169.1 2.4 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.16 -0.963 . . . . 0.0 109.108 179.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.675 ' HA2' HD23 ' A' ' 14' ' ' LEU . . . 65.05 74.51 0.48 Allowed Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.6 p -58.44 151.57 19.78 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.199 -1.177 . . . . 0.0 109.531 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -89.52 -0.72 57.7 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.212 -0.93 . . . . 0.0 109.758 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -124.53 -0.41 8.13 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.1 -1.0 . . . . 0.0 109.769 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -131.78 -105.95 1.03 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.431 ' O ' HD23 ' A' ' 14' ' ' LEU . 0.4 OUTLIER -148.2 -91.3 0.08 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.336 -1.097 . . . . 0.0 109.462 -179.926 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.675 HD23 ' HA2' ' A' ' 8' ' ' GLY . 74.0 mt -133.76 108.05 8.27 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.224 -0.923 . . . . 0.0 109.714 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -148.48 116.68 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.33 -0.856 . . . . 0.0 109.284 179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.567 ' CE1' HD22 ' A' ' 7' ' ' LEU . 37.6 m-85 -45.39 151.09 0.4 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.165 -0.959 . . . . 0.0 109.27 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 7.5 mt-10 -144.69 112.91 5.0 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.159 -0.963 . . . . 0.0 109.296 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.481 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.9 Cg_endo -76.7 177.62 38.81 Favored 'Cis proline' 0 C--N 1.312 -1.387 0 C-N-CA 123.678 -1.384 . . . . 0.0 110.609 0.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -78.38 -1.95 35.89 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.283 -0.886 . . . . 0.0 109.675 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.424 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -134.19 161.49 34.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.202 -0.936 . . . . 0.0 109.281 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.768 HD13 ' CG1' ' A' ' 5' ' ' VAL . 0.5 OUTLIER -156.5 118.07 3.86 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.001 -1.062 . . . . 0.0 110.032 -179.85 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.516 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 92.6 m -90.5 101.4 14.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.341 -0.849 . . . . 0.0 108.876 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.806 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -102.14 -172.75 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 O-C-N 121.317 -0.864 . . . . 0.0 110.317 -179.135 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.556 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -111.94 172.53 3.47 Favored Pre-proline 0 C--N 1.303 -1.433 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 179.159 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.57 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 34.3 Cg_endo -77.41 79.83 3.07 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.364 2.043 . . . . 0.0 110.725 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.475 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 130.12 -24.56 4.48 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.577 -1.297 . . . . 0.0 109.898 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 26' ' ' GLY . 0.7 OUTLIER -51.43 -176.93 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.123 -1.222 . . . . 0.0 109.623 -179.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 88.2 m -122.6 146.17 47.69 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.318 -0.864 . . . . 0.0 109.441 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.951 HG21 HD11 ' A' ' 101' ' ' ILE . 2.4 t -127.17 140.36 49.31 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.356 0 O-C-N 121.23 -0.919 . . . . 0.0 109.451 179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.501 ' CB ' HG23 ' A' ' 4' ' ' THR . 1.8 mt-10 -106.85 155.85 19.3 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.165 -0.959 . . . . 0.0 109.814 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.529 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -153.52 84.63 1.18 Allowed 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 -179.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.598 ' H ' HD23 ' A' ' 32' ' ' LEU . 1.7 pt? -96.55 165.3 12.23 Favored 'General case' 0 N--CA 1.492 1.633 0 CA-C-O 121.98 0.895 . . . . 0.0 111.941 -177.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.615 ' HB2' ' CD2' ' A' ' 39' ' ' HIS . 3.9 p30 -87.45 154.85 20.32 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.97 -179.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 48.4 t30 -92.98 -62.78 1.31 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.057 -1.027 . . . . 0.0 109.36 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.472 ' C ' HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -158.19 35.53 0.24 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.243 -0.91 . . . . 0.0 109.291 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.593 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 26.7 t -154.73 57.42 1.71 Allowed Pre-proline 0 N--CA 1.489 1.499 0 O-C-N 121.411 -0.806 . . . . 0.0 109.794 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.593 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 37.0 Cg_endo -79.97 174.54 11.44 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 122.579 2.186 . . . . 0.0 110.515 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.525 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.1 Cg_endo -84.34 175.57 34.37 Favored 'Cis proline' 0 C--N 1.31 -1.462 0 C-N-CA 123.549 -1.438 . . . . 0.0 110.137 -1.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.689 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 51.0 m-70 -127.09 146.56 50.33 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.335 -0.853 . . . . 0.0 110.116 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 45.9 t-20 -113.11 110.04 19.8 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.598 -0.889 . . . . 0.0 108.598 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.423 HG21 ' HB2' ' A' ' 31' ' ' PHE . 42.7 t -99.28 117.82 44.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.143 -0.973 . . . . 0.0 109.681 -179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.003 HG12 ' HB2' ' A' ' 60' ' ' SER . 0.8 OUTLIER -147.81 171.49 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.445 -0.785 . . . . 0.0 109.407 -179.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.643 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.9 OUTLIER -124.66 109.59 13.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.22 -0.925 . . . . 0.0 109.331 -179.895 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -46.96 136.46 8.35 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.286 -0.884 . . . . 0.0 109.584 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -84.53 45.99 1.19 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.254 -0.904 . . . . 0.0 109.538 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.68 -30.52 0.82 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.251 -0.906 . . . . 0.0 110.186 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.9 mt -103.12 77.36 1.54 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.038 -1.039 . . . . 0.0 110.013 -179.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.469 ' OD1' ' HA ' ' A' ' 51' ' ' LYS . 1.9 p30 -126.19 153.74 74.36 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.284 -0.885 . . . . 0.0 109.159 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.06 -14.31 13.58 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.562 2.175 . . . . 0.0 111.076 -179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.448 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -135.9 24.46 3.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.929 -1.107 . . . . 0.0 109.999 -179.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.469 ' HA ' ' OD1' ' A' ' 48' ' ' ASN . 1.0 OUTLIER 35.75 87.39 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 121.115 0.483 . . . . 0.0 110.111 179.496 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 21.5 m -136.99 159.57 41.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.107 -0.996 . . . . 0.0 109.763 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -130.81 43.87 3.04 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.346 -0.846 . . . . 0.0 109.271 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 p30 -143.97 -41.05 0.28 Allowed 'General case' 0 N--CA 1.486 1.359 0 O-C-N 121.347 -0.845 . . . . 0.0 109.648 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.567 ' O ' HD12 ' A' ' 55' ' ' LEU . 1.3 pp -58.9 -18.11 30.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.044 -1.035 . . . . 0.0 109.135 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.415 ' O ' ' C ' ' A' ' 57' ' ' LYS . . . -89.56 -38.74 13.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.342 -0.849 . . . . 0.0 109.314 179.809 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.415 ' C ' ' O ' ' A' ' 56' ' ' ALA . 0.0 OUTLIER -44.15 -45.03 8.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.24 -0.912 . . . . 0.0 109.249 179.867 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.28 32.32 2.51 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.32 -0.863 . . . . 0.0 109.16 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.795 HD21 ' CE2' ' A' ' 76' ' ' PHE . 7.1 tp -133.1 -51.37 0.89 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.341 -0.849 . . . . 0.0 109.648 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 1.003 ' HB2' HG12 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -78.74 121.18 24.43 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.282 -0.886 . . . . 0.0 109.766 -179.16 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.502 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 18.0 p80 -99.76 125.38 45.66 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.299 -0.876 . . . . 0.0 109.541 -179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.403 ' O ' ' C ' ' A' ' 63' ' ' GLN . 2.2 mtpp -78.31 -37.22 45.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.186 -0.946 . . . . 0.0 109.591 -179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.436 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 2.4 tt0 -45.56 123.56 4.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.165 -0.959 . . . . 0.0 109.446 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.8 mp -75.97 170.66 15.83 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.237 -0.914 . . . . 0.0 109.478 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.734 HD21 ' CB ' ' A' ' 71' ' ' SER . 3.5 mp -93.1 -179.72 5.18 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.171 -0.955 . . . . 0.0 109.429 -179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.447 ' HG3' ' C ' ' A' ' 65' ' ' LEU . 3.9 mtt -145.45 -48.52 0.23 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.065 -1.022 . . . . 0.0 110.151 -179.644 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.503 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 47.2 t -80.58 144.96 57.69 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.058 -1.026 . . . . 0.0 110.224 -179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.475 ' HA ' HD21 ' A' ' 33' ' ' ASN . 36.5 Cg_endo -80.16 95.02 1.0 Allowed 'Trans proline' 0 C--N 1.313 -1.297 0 C-N-CA 123.024 2.482 . . . . 0.0 110.454 179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 33' ' ' ASN . . . 116.96 49.79 0.41 Allowed Glycine 0 N--CA 1.492 2.403 0 C-N-CA 119.228 -1.463 . . . . 0.0 109.83 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.537 ' N ' ' HB2' ' A' ' 32' ' ' LEU . 1.7 pt20 167.7 108.22 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -1.129 . . . . 0.0 109.457 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.734 ' CB ' HD21 ' A' ' 65' ' ' LEU . 95.6 p -100.1 -100.24 0.24 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.228 -0.92 . . . . 0.0 109.445 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.532 ' N ' ' OG ' ' A' ' 71' ' ' SER . 36.9 p -146.32 -157.85 0.84 Allowed 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.5 p -143.05 93.68 2.53 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.06 -1.025 . . . . 0.0 109.389 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.712 HG21 ' HG ' ' A' ' 59' ' ' LEU . 42.6 m -67.44 103.24 1.26 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.377 -0.827 . . . . 0.0 109.428 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.444 ' O ' ' C ' ' A' ' 76' ' ' PHE . 1.9 m -78.65 78.73 5.09 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.223 -0.923 . . . . 0.0 108.859 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.898 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 14.5 m-85 -40.79 144.02 0.65 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.651 -0.656 . . . . 0.0 109.306 -179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.475 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.9 Cg_endo -77.5 168.65 22.39 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.702 2.268 . . . . 0.0 111.149 -179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.45 9.78 8.48 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.429 -0.795 . . . . 0.0 109.447 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.469 ' O ' ' HD3' ' A' ' 81' ' ' PRO . 28.0 t70 -99.15 -19.78 16.99 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.171 -0.956 . . . . 0.0 108.865 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.57 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -40.08 99.97 0.21 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.683 -0.635 . . . . 0.0 109.573 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.48 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 34.8 Cg_endo -76.29 133.99 15.26 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.312 2.008 . . . . 0.0 110.357 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.483 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -46.1 136.05 7.1 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.26 -0.9 . . . . 0.0 109.354 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 167.47 -139.37 5.68 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -135.67 120.1 18.03 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.29 -1.123 . . . . 0.0 109.733 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.585 ' CD1' HG22 ' A' ' 101' ' ' ILE . 4.0 m-85 -102.02 -179.41 3.99 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 52.4 m -163.63 115.41 1.42 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.9 -1.125 . . . . 0.0 110.38 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.551 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.5 OUTLIER -110.83 162.62 14.62 Favored 'General case' 0 C--N 1.304 -1.391 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 178.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 46.1 p90 -149.87 -162.01 1.46 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.989 -1.069 . . . . 0.0 109.954 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -135.12 126.28 28.01 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.348 -0.845 . . . . 0.0 109.838 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 1.0 OUTLIER -59.33 -46.3 99.06 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.2 -0.937 . . . . 0.0 109.961 179.467 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.2 Cg_endo -78.85 -69.3 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.152 0 C-N-CA 122.182 1.921 . . . . 0.0 110.725 -179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.689 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 9.5 m80 -66.96 63.98 0.05 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.036 -1.04 . . . . 0.0 109.423 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.522 ' N ' ' O ' ' A' ' 91' ' ' PRO . 5.8 ttp180 -92.62 -9.08 42.32 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.226 -0.921 . . . . 0.0 109.599 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.68 39.84 2.76 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -146.47 36.4 0.98 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.099 -1.236 . . . . 0.0 109.573 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.474 ' O ' ' N ' ' A' ' 98' ' ' VAL . . . 50.48 21.96 4.99 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.89 -1.284 . . . . 0.0 109.89 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.537 ' CE ' ' HB3' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -66.85 67.77 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.094 -1.239 . . . . 0.0 109.432 179.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.474 ' N ' ' O ' ' A' ' 96' ' ' GLY . 97.2 t -138.34 92.54 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.104 -0.997 . . . . 0.0 109.546 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.551 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -88.44 -173.31 47.14 Favored Glycine 0 N--CA 1.486 1.986 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.501 ' CG ' ' O ' ' A' ' 99' ' ' GLY . 12.6 mttp -157.96 122.79 4.33 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.198 -1.178 . . . . 0.0 109.541 -179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.951 HD11 HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -85.15 135.26 25.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.273 -0.892 . . . . 0.0 109.091 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.516 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 75.7 m -115.72 112.17 21.65 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.16 -0.962 . . . . 0.0 108.635 178.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.787 HG22 ' CD1' ' A' ' 23' ' ' ILE . 8.6 t -99.37 131.64 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.195 -0.941 . . . . 0.0 109.64 -179.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -179.79 -74.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.311 -0.868 . . . . 0.0 109.587 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.278 0 CA-C-O 117.977 -1.457 . . . . 0.0 109.617 -179.897 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 . . . . . 0 N--CA 1.491 1.588 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.487 HG22 ' HB ' ' A' ' 28' ' ' THR . 0.0 OUTLIER -102.57 147.71 26.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.169 -0.957 . . . . 0.0 109.454 179.983 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.408 ' O ' ' N ' ' A' ' 30' ' ' GLU . 26.3 m-85 -118.47 125.42 49.89 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.256 -0.903 . . . . 0.0 109.499 -179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.498 ' HA ' ' O ' ' A' ' 30' ' ' GLU . 1.7 t -115.49 136.02 53.51 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.289 -0.882 . . . . 0.0 109.504 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.659 ' O ' HD23 ' A' ' 7' ' ' LEU . 0.9 OUTLIER -111.09 85.71 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.218 -0.926 . . . . 0.0 109.578 -179.915 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -56.18 128.29 34.86 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.178 -0.951 . . . . 0.0 109.328 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.745 HD23 ' N ' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -104.48 179.5 4.25 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.243 -0.911 . . . . 0.0 109.504 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.844 ' HA2' HD23 ' A' ' 14' ' ' LEU . . . 68.36 75.63 0.49 Allowed Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.466 ' O ' ' OD2' ' A' ' 10' ' ' ASP . 1.4 p -44.84 -30.28 0.95 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.183 -1.186 . . . . 0.0 109.501 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.469 ' O ' ' OD1' ' A' ' 10' ' ' ASP . 0.0 OUTLIER 77.07 -3.06 2.56 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.472 -0.768 . . . . 0.0 109.652 -179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -125.33 13.67 8.26 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.132 -0.98 . . . . 0.0 109.641 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.07 -82.1 0.05 OUTLIER Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.702 -1.359 . . . . 0.0 109.702 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.7 tp -140.38 -151.42 0.36 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.231 -1.159 . . . . 0.0 109.685 -179.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.844 HD23 ' HA2' ' A' ' 8' ' ' GLY . 87.5 mt -112.17 118.38 35.18 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.357 -0.84 . . . . 0.0 109.354 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.482 HG12 ' O ' ' A' ' 96' ' ' GLY . 6.1 m -152.03 156.91 5.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.179 -0.95 . . . . 0.0 109.381 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -71.41 156.37 39.55 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.211 -0.931 . . . . 0.0 109.454 179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 47.6 mt-10 -143.88 112.86 5.35 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.416 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.466 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.1 Cg_endo -77.63 -178.6 24.53 Favored 'Cis proline' 0 C--N 1.312 -1.346 0 C-N-CA 123.739 -1.359 . . . . 0.0 110.462 0.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -75.14 -34.5 61.65 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.266 -0.896 . . . . 0.0 109.741 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -111.73 158.04 19.79 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.166 -0.959 . . . . 0.0 109.265 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 6.9 tp -151.83 107.45 3.34 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.102 -0.999 . . . . 0.0 109.891 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.405 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 41.0 m -81.43 95.23 7.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.152 -0.968 . . . . 0.0 109.058 179.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.787 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -99.7 168.62 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 O-C-N 121.397 -0.814 . . . . 0.0 110.163 -179.3 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.572 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 37.0 mttt -88.28 168.21 17.08 Favored Pre-proline 0 C--N 1.302 -1.469 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.727 ' HA ' HG11 ' A' ' 103' ' ' VAL . 32.5 Cg_endo -75.54 82.77 2.03 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 121.872 1.714 . . . . 0.0 110.559 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 132.05 -13.52 5.23 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 109.928 -1.269 . . . . 0.0 109.928 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.434 ' OD2' ' HG3' ' A' ' 24' ' ' LYS . 6.8 m-20 -54.8 -176.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.16 -1.2 . . . . 0.0 109.699 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.828 HG23 ' HA ' ' A' ' 75' ' ' THR . 0.2 OUTLIER -122.1 138.77 54.33 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.365 -0.834 . . . . 0.0 109.495 -179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.955 HG21 HD11 ' A' ' 101' ' ' ILE . 2.0 t -118.09 137.2 52.8 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 O-C-N 121.172 -0.955 . . . . 0.0 109.598 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.498 ' O ' ' HA ' ' A' ' 4' ' ' THR . 0.2 OUTLIER -115.18 125.6 53.6 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.246 -0.909 . . . . 0.0 109.861 -179.794 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.597 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -124.69 101.48 7.13 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 179.792 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.598 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 1.5 mp -97.08 178.15 5.36 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.294 -0.879 . . . . 0.0 110.926 -178.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.521 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 2.8 p-10 -97.37 164.13 12.59 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.753 -0.592 . . . . 0.0 109.741 -179.097 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 7' ' ' LEU . 23.7 t30 -109.35 -85.18 0.54 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.137 -0.977 . . . . 0.0 108.962 179.585 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HG2' ' ND2' ' A' ' 34' ' ' ASN . 10.5 ptmt -150.91 29.75 0.66 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.386 -0.821 . . . . 0.0 108.911 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.575 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 3.0 t -148.68 58.5 3.65 Favored Pre-proline 0 N--CA 1.489 1.513 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.575 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 35.7 Cg_endo -77.65 175.06 11.7 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.564 2.176 . . . . 0.0 110.781 -179.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.566 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.9 Cg_endo -85.45 161.96 61.32 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 123.537 -1.443 . . . . 0.0 110.614 -1.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.718 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 65.5 m-70 -120.21 142.25 49.17 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.357 -0.839 . . . . 0.0 109.845 179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 6.6 m120 -130.83 126.4 36.18 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.421 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.545 ' HB ' ' NE2' ' A' ' 61' ' ' HIS . 1.2 t -99.57 135.7 33.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.209 -0.932 . . . . 0.0 109.108 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.622 HG12 ' H ' ' A' ' 43' ' ' PHE . 2.2 t -140.07 178.04 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.332 -0.855 . . . . 0.0 109.24 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.622 ' H ' HG12 ' A' ' 42' ' ' VAL . 17.6 m-85 -137.56 120.85 16.92 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.189 -0.945 . . . . 0.0 109.479 -179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 43' ' ' PHE . 5.9 t0 -54.28 -166.8 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.423 -0.798 . . . . 0.0 109.785 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -147.69 25.8 1.05 Allowed 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.239 -0.913 . . . . 0.0 109.614 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -119.42 -10.13 9.74 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.407 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.597 HD13 ' OG1' ' A' ' 86' ' ' THR . 4.7 mt -110.82 55.68 0.65 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.29 -0.881 . . . . 0.0 109.281 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' A' ' 48' ' ' ASN . 0.9 OUTLIER -120.01 152.96 54.91 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.258 -0.901 . . . . 0.0 109.476 -179.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.92 -19.86 12.12 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.669 2.246 . . . . 0.0 110.644 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.47 ' O ' ' HG3' ' A' ' 51' ' ' LYS . . . -126.57 29.89 5.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.065 -1.022 . . . . 0.0 109.71 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER 34.46 59.21 0.65 Allowed 'General case' 0 N--CA 1.498 1.94 0 CA-C-O 121.153 0.501 . . . . 0.0 110.33 179.665 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 14.8 m -132.49 171.72 13.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.15 -0.969 . . . . 0.0 109.543 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -152.82 16.8 0.58 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.279 -0.888 . . . . 0.0 109.758 -179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.487 ' OD1' ' N ' ' A' ' 54' ' ' ASP . 2.0 p-10 -71.11 -23.13 62.04 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.16 -0.963 . . . . 0.0 109.444 -179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.525 ' HG ' ' N ' ' A' ' 56' ' ' ALA . 1.1 pp -87.63 -27.7 22.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.242 -0.911 . . . . 0.0 109.501 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.525 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -79.73 -31.33 41.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 0.0 109.959 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 2.0 ptpt -58.08 -31.54 67.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.166 -0.959 . . . . 0.0 109.745 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 60.5 p -105.29 -8.3 18.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -0.95 . . . . 0.0 110.071 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.884 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 9.3 tp -80.73 -33.02 35.52 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.053 -1.029 . . . . 0.0 109.297 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.479 ' HB3' ' HA ' ' A' ' 42' ' ' VAL . 0.8 OUTLIER -78.62 136.08 37.4 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.332 -0.855 . . . . 0.0 110.163 -179.009 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.545 ' NE2' ' HB ' ' A' ' 41' ' ' VAL . 0.4 OUTLIER -117.12 94.48 4.59 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.42 -0.8 . . . . 0.0 109.016 179.615 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.515 ' O ' HD13 ' A' ' 64' ' ' LEU . 0.9 OUTLIER -61.32 -12.28 13.18 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.307 -0.871 . . . . 0.0 110.016 -179.529 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.468 ' O ' ' CD1' ' A' ' 65' ' ' LEU . 20.8 tt0 -43.43 122.14 2.51 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.142 -0.974 . . . . 0.0 109.718 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.814 ' H ' HD22 ' A' ' 64' ' ' LEU . 0.3 OUTLIER -64.53 121.85 15.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 109.844 -179.917 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.568 HD12 ' N ' ' A' ' 65' ' ' LEU . 8.1 mp -84.2 93.71 8.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.262 -0.899 . . . . 0.0 109.252 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 2.0 tpt -97.02 -6.56 35.07 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.268 -0.895 . . . . 0.0 109.472 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.493 ' CB ' ' HB3' ' A' ' 70' ' ' GLN . 35.1 t -84.29 138.57 39.09 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.174 -0.954 . . . . 0.0 109.325 179.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 67' ' ' SER . 36.3 Cg_endo -79.29 92.35 1.14 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.558 2.172 . . . . 0.0 110.86 -179.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 91.86 24.93 24.01 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 179.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.493 ' HB3' ' CB ' ' A' ' 67' ' ' SER . 0.6 OUTLIER -137.84 89.68 2.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.242 -1.152 . . . . 0.0 109.278 179.992 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.598 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . 6.4 p -105.66 -167.92 1.38 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.154 -0.966 . . . . 0.0 109.88 -179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.1 t -105.6 123.08 47.33 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.448 ' O ' ' OG ' ' A' ' 73' ' ' SER . 1.7 p -78.7 109.29 12.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.985 -1.072 . . . . 0.0 109.507 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.605 HG21 ' HG ' ' A' ' 59' ' ' LEU . 24.7 m -78.44 107.3 10.98 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.422 -0.799 . . . . 0.0 109.555 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.828 ' HA ' HG23 ' A' ' 28' ' ' THR . 18.7 m -79.55 93.57 5.47 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.248 -0.907 . . . . 0.0 109.034 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.884 ' CZ ' HD21 ' A' ' 59' ' ' LEU . 3.3 m-85 -44.08 156.74 0.31 Allowed Pre-proline 0 N--CA 1.487 1.407 0 O-C-N 121.401 -0.812 . . . . 0.0 109.268 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.442 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.0 Cg_endo -76.86 168.21 23.91 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.818 2.345 . . . . 0.0 111.788 -179.061 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.66 8.18 15.19 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.475 ' O ' ' C ' ' A' ' 80' ' ' ALA . 2.8 m-20 -98.87 -8.05 26.32 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.329 -0.857 . . . . 0.0 108.957 179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.689 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -36.61 98.13 0.15 Allowed Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.809 -0.557 . . . . 0.0 109.702 179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.455 ' N ' ' O ' ' A' ' 79' ' ' ASP . 35.3 Cg_endo -76.68 155.42 35.31 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 122.536 2.157 . . . . 0.0 110.628 -179.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.54 108.34 1.64 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.303 -0.873 . . . . 0.0 109.636 -179.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -175.44 -177.17 44.3 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.5 pm0 -107.69 143.79 35.7 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.22 -1.165 . . . . 0.0 109.661 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.555 ' CD1' HG22 ' A' ' 101' ' ' ILE . 17.9 m-85 -118.85 165.45 14.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.306 -0.872 . . . . 0.0 109.066 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.597 ' OG1' HD13 ' A' ' 47' ' ' LEU . 44.7 m -146.06 109.26 4.66 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.139 -0.976 . . . . 0.0 110.045 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.564 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.8 OUTLIER -106.27 160.11 15.6 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.338 -0.851 . . . . 0.0 109.16 179.435 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.444 ' CD1' ' N ' ' A' ' 88' ' ' TYR . 16.0 p90 -146.17 -168.04 2.89 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.192 -0.942 . . . . 0.0 109.59 179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.427 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 0.1 OUTLIER -120.51 140.89 50.8 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.339 -0.85 . . . . 0.0 109.707 -179.597 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.601 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.6 tt0 -75.64 -45.73 4.2 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.291 -0.881 . . . . 0.0 109.892 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.601 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.2 Cg_endo -78.34 -51.09 0.07 OUTLIER 'Trans proline' 0 C--N 1.316 -1.14 0 C-N-CA 121.898 1.732 . . . . 0.0 110.562 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.718 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 19.8 m80 -90.25 43.58 1.15 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.137 -0.977 . . . . 0.0 109.316 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.484 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -59.38 -57.73 11.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -0.88 . . . . 0.0 109.521 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -81.23 49.82 4.07 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -138.63 38.19 2.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.243 -1.151 . . . . 0.0 109.431 179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.482 ' O ' HG12 ' A' ' 15' ' ' VAL . . . 47.58 30.47 6.39 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.521 ' HE2' ' C ' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -92.32 68.56 5.02 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.221 -1.164 . . . . 0.0 109.203 179.752 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 58.2 t -136.12 112.06 12.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.24 -0.912 . . . . 0.0 109.579 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.564 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -108.96 -171.54 20.94 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.874 -1.29 . . . . 0.0 109.874 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.489 ' HG2' ' HA ' ' A' ' 86' ' ' THR . 14.5 mttp -159.12 119.62 3.18 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.233 -1.157 . . . . 0.0 109.855 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.955 HD11 HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -82.96 143.34 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.089 -1.007 . . . . 0.0 108.47 179.19 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.405 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -119.54 95.93 4.99 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.149 -0.969 . . . . 0.0 109.041 179.648 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.731 HG22 ' CD1' ' A' ' 23' ' ' ILE . 2.1 t -99.86 131.81 46.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.272 -0.893 . . . . 0.0 109.655 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -90.14 -174.68 4.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.292 -0.88 . . . . 0.0 109.305 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.351 0 CA-C-O 118.001 -1.444 . . . . 0.0 109.619 179.951 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.4 pt-20 . . . . . 0 N--CA 1.49 1.554 0 CA-C-O 121.286 0.565 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -118.86 134.23 55.3 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.269 -0.894 . . . . 0.0 109.5 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -94.06 136.95 33.81 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.242 -0.911 . . . . 0.0 109.529 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.87 102.84 7.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.885 . . . . 0.0 109.557 -179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.899 HG22 ' O ' ' A' ' 30' ' ' GLU . 2.8 m -91.79 48.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.231 -0.918 . . . . 0.0 109.614 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -47.54 92.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 109.43 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -53.97 170.54 0.12 Allowed 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.228 -0.92 . . . . 0.0 109.665 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.496 ' HA3' ' HB2' ' A' ' 34' ' ' ASN . . . 74.35 122.29 0.1 OUTLIER Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.1 p -68.55 -70.12 0.29 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.218 -1.166 . . . . 0.0 109.545 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 179.79 -59.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.332 -0.855 . . . . 0.0 109.358 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.2 ttpm? -140.06 41.25 1.96 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.284 -0.885 . . . . 0.0 109.517 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -139.95 -97.17 0.34 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.4 mt -116.7 170.51 8.54 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.262 -1.14 . . . . 0.0 109.691 -179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.779 HD11 ' HB ' ' A' ' 36' ' ' VAL . 46.0 mt -100.08 120.07 39.27 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.374 -0.829 . . . . 0.0 108.987 179.543 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.629 HG13 ' O ' ' A' ' 14' ' ' LEU . 1.4 m -159.95 145.97 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.076 -1.015 . . . . 0.0 109.716 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.497 ' HA ' ' HA ' ' A' ' 7' ' ' LEU . 7.2 m-85 -56.68 154.53 8.81 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.229 -0.919 . . . . 0.0 109.046 179.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 42.5 mt-10 -145.29 109.65 4.59 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.124 -0.985 . . . . 0.0 109.448 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 35.7 Cg_endo -78.8 174.8 49.34 Favored 'Cis proline' 0 C--N 1.312 -1.354 0 C-N-CA 123.904 -1.29 . . . . 0.0 110.491 0.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.75 -62.37 1.41 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.14 -0.975 . . . . 0.0 109.053 179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 10.0 mttp -89.5 154.04 20.33 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.35 -0.844 . . . . 0.0 108.787 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.843 ' CD1' HG12 ' A' ' 5' ' ' VAL . 1.2 mt -147.12 135.88 22.11 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 120.951 -1.093 . . . . 0.0 110.216 -179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.524 HG23 ' O ' ' A' ' 102' ' ' THR . 28.6 m -109.03 98.12 7.64 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.119 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.755 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -102.35 177.69 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.4 0 O-C-N 121.396 -0.815 . . . . 0.0 110.156 -179.277 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.55 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -101.2 174.73 2.73 Favored Pre-proline 0 C--N 1.301 -1.501 0 N-CA-C 108.739 -0.838 . . . . 0.0 108.739 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.552 ' HA ' ' CB ' ' A' ' 80' ' ' ALA . 34.9 Cg_endo -77.15 79.19 3.21 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 C-N-CA 122.262 1.975 . . . . 0.0 110.505 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 134.96 -12.49 4.46 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.445 ' OD2' ' HB2' ' A' ' 24' ' ' LYS . 64.1 m-20 -55.09 -179.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.151 -1.206 . . . . 0.0 109.294 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 90.5 m -126.64 113.64 16.99 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.149 -0.97 . . . . 0.0 109.658 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.815 HG21 HD11 ' A' ' 101' ' ' ILE . 2.0 t -104.74 131.0 54.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.149 -0.969 . . . . 0.0 109.53 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.899 ' O ' HG22 ' A' ' 5' ' ' VAL . 1.7 mp0 -101.84 155.54 18.07 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 121.249 -0.907 . . . . 0.0 109.696 -179.827 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.588 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -148.35 85.25 1.51 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.572 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.5 OUTLIER -97.55 179.51 4.82 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.362 -0.836 . . . . 0.0 110.942 -178.491 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.528 ' OD1' ' N ' ' A' ' 69' ' ' GLY . 2.1 p-10 -90.09 157.01 17.98 Favored 'General case' 0 N--CA 1.487 1.375 0 O-C-N 121.591 -0.693 . . . . 0.0 109.263 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.496 ' HB2' ' HA3' ' A' ' 8' ' ' GLY . 3.8 t30 -97.59 -73.65 0.6 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.982 -1.074 . . . . 0.0 109.338 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.494 ' C ' HG23 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -163.5 31.91 0.09 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 108.923 179.461 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.779 ' HB ' HD11 ' A' ' 14' ' ' LEU . 27.8 t -157.47 63.95 3.03 Favored Pre-proline 0 N--CA 1.49 1.528 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.603 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 33.6 Cg_endo -77.32 177.33 8.98 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 123.097 2.531 . . . . 0.0 111.026 -179.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.603 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 39.7 Cg_endo -87.28 158.81 48.42 Favored 'Cis proline' 0 C--N 1.313 -1.316 0 O-C-N 123.698 1.367 . . . . 0.0 111.328 -1.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.703 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 65.3 m-70 -119.55 141.52 49.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.707 -0.62 . . . . 0.0 109.388 179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -117.99 119.36 34.55 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.304 -0.872 . . . . 0.0 108.94 179.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.574 ' HB ' ' NE2' ' A' ' 61' ' ' HIS . 2.0 t -100.42 128.48 52.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.131 -0.98 . . . . 0.0 109.8 -179.348 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.916 HG12 ' CB ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -157.3 165.5 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.546 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.64 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.4 OUTLIER -124.03 134.61 53.39 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.099 -1.001 . . . . 0.0 109.284 179.86 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -66.97 133.35 49.79 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.227 -0.921 . . . . 0.0 109.348 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.542 ' HB1' ' CB ' ' A' ' 53' ' ' ALA . . . -82.37 10.63 6.7 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.27 -0.894 . . . . 0.0 109.918 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.8 19.65 13.69 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.129 -0.982 . . . . 0.0 109.437 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -133.26 49.88 2.27 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.205 -0.934 . . . . 0.0 109.687 -179.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.521 ' OD1' ' CA ' ' A' ' 51' ' ' LYS . 1.5 p30 -118.26 160.47 39.32 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.22 -0.925 . . . . 0.0 109.347 179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.482 ' HG2' ' HB2' ' A' ' 81' ' ' PRO . 36.3 Cg_endo -77.82 -5.31 15.24 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.512 2.142 . . . . 0.0 110.662 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.474 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -125.46 27.36 6.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.115 -0.991 . . . . 0.0 109.62 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.521 ' CA ' ' OD1' ' A' ' 48' ' ' ASN . 3.6 ptmt 34.0 38.55 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.134 0.493 . . . . 0.0 110.39 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.51 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 1.8 m -115.47 170.19 8.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.083 -1.011 . . . . 0.0 109.676 -179.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.542 ' CB ' ' HB1' ' A' ' 45' ' ' ALA . . . -139.68 51.9 1.73 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.168 -0.958 . . . . 0.0 109.57 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -115.38 -42.07 3.2 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.311 -0.868 . . . . 0.0 109.493 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.94 HD22 ' HG3' ' A' ' 81' ' ' PRO . 1.8 pp -56.71 -28.18 60.44 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.272 -0.892 . . . . 0.0 109.498 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.477 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -79.93 -35.06 38.34 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.213 -0.929 . . . . 0.0 109.538 -179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 8.4 tmtt? -51.1 -22.92 2.74 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.177 -0.952 . . . . 0.0 109.373 179.978 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 35.1 m -123.18 18.42 9.93 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.239 -0.913 . . . . 0.0 109.626 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.878 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 12.3 tp -119.69 -41.97 2.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.11 -0.994 . . . . 0.0 109.635 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.916 ' CB ' HG12 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -78.04 127.44 32.33 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.199 -0.938 . . . . 0.0 109.384 -179.445 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.746 ' CG ' HG21 ' A' ' 72' ' ' THR . 0.5 OUTLIER -108.63 137.14 47.05 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.374 -0.829 . . . . 0.0 109.486 -179.74 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.518 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 0.2 OUTLIER -85.83 -159.74 0.48 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.227 -0.921 . . . . 0.0 109.51 -179.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.518 ' CB ' ' O ' ' A' ' 62' ' ' LYS . 1.6 tt0 77.33 136.4 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.408 -0.807 . . . . 0.0 109.533 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.461 ' HB2' ' CE ' ' A' ' 66' ' ' MET . 5.2 mp -85.91 133.5 33.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.251 -0.906 . . . . 0.0 109.451 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.755 HD22 ' HA ' ' A' ' 71' ' ' SER . 9.9 mt -80.12 124.21 28.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.288 -0.882 . . . . 0.0 109.48 -179.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.461 ' CE ' ' HB2' ' A' ' 64' ' ' LEU . 6.7 mtt -124.99 4.58 7.98 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.25 -0.906 . . . . 0.0 109.601 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.464 ' OG ' ' HB3' ' A' ' 70' ' ' GLN . 47.4 t -91.89 142.33 26.39 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.188 -0.945 . . . . 0.0 109.332 179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.6 86.3 1.7 Allowed 'Trans proline' 0 C--N 1.311 -1.435 0 C-N-CA 122.62 2.213 . . . . 0.0 110.892 -179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.528 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 95.23 44.41 3.27 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.487 ' HA ' HD23 ' A' ' 32' ' ' LEU . 3.6 tp60 -162.32 101.45 1.08 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.243 -1.151 . . . . 0.0 109.244 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.755 ' HA ' HD22 ' A' ' 65' ' ' LEU . 3.2 p -112.11 -103.77 0.4 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.244 -0.91 . . . . 0.0 109.405 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.746 HG21 ' CG ' ' A' ' 61' ' ' HIS . 9.0 t -161.02 117.94 2.3 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.0 t -78.54 116.58 19.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.957 -1.089 . . . . 0.0 109.895 -178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.436 ' HG1' ' HE1' ' A' ' 31' ' ' PHE . 0.6 OUTLIER -95.52 105.05 16.98 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 179.81 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.427 ' O ' ' O ' ' A' ' 76' ' ' PHE . 41.4 m -78.91 92.27 4.89 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.248 -0.907 . . . . 0.0 108.905 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.878 ' CZ ' HD21 ' A' ' 59' ' ' LEU . 7.0 m-85 -42.8 161.34 0.19 Allowed Pre-proline 0 N--CA 1.488 1.442 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.477 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 33.1 Cg_endo -75.45 159.04 40.11 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 122.346 2.031 . . . . 0.0 111.185 -179.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.54 -5.64 20.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.551 -0.718 . . . . 0.0 109.644 -179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 80' ' ' ALA . 0.9 OUTLIER -99.41 -65.6 0.95 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.187 -0.946 . . . . 0.0 109.284 179.984 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.552 ' CB ' ' HA ' ' A' ' 25' ' ' PRO . . . 61.26 133.09 0.03 OUTLIER Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.337 -0.852 . . . . 0.0 109.407 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.94 ' HG3' HD22 ' A' ' 55' ' ' LEU . 36.1 Cg_endo -78.42 99.75 1.3 Allowed 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.345 2.03 . . . . 0.0 110.284 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.46 ' HB2' ' HA3' ' A' ' 105' ' ' GLY . . . -41.42 117.82 0.96 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.378 -0.826 . . . . 0.0 109.683 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.454 ' HA3' ' HG3' ' A' ' 49' ' ' PRO . . . 156.13 -156.31 26.98 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.599 ' HG3' HG23 ' A' ' 102' ' ' THR . 0.4 OUTLIER -122.0 126.1 47.78 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.217 -1.167 . . . . 0.0 109.508 179.962 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.627 ' CD2' ' CG2' ' A' ' 101' ' ' ILE . 1.5 m-30 -92.89 -164.7 1.21 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.277 -0.889 . . . . 0.0 108.941 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.491 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 65.4 m -167.19 111.68 0.72 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.868 -1.145 . . . . 0.0 110.505 -179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.471 ' HA ' ' O ' ' A' ' 42' ' ' VAL . 0.7 OUTLIER -112.05 157.4 20.8 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.378 -0.826 . . . . 0.0 108.774 178.729 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.783 ' CB ' HG22 ' A' ' 98' ' ' VAL . 24.2 p90 -145.47 -162.93 1.61 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.013 -1.055 . . . . 0.0 109.916 -179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.502 ' O ' ' HB3' ' A' ' 93' ' ' ARG . 0.1 OUTLIER -126.94 129.14 47.57 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.373 -0.83 . . . . 0.0 109.829 -179.265 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.613 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.3 tt0 -65.77 -43.77 60.99 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.264 -0.898 . . . . 0.0 110.264 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.4 Cg_endo -78.35 -52.64 0.06 OUTLIER 'Trans proline' 0 C--N 1.318 -1.029 0 C-N-CA 121.889 1.726 . . . . 0.0 110.446 -179.848 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.703 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 9.2 m80 -90.21 34.23 0.87 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.172 -0.955 . . . . 0.0 109.24 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.502 ' HB3' ' O ' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -64.52 126.53 28.13 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.237 -0.914 . . . . 0.0 109.532 179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 92.31 2.33 68.35 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.538 ' HB3' ' HE3' ' A' ' 97' ' ' MET . . . -98.23 32.97 2.29 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.117 -1.225 . . . . 0.0 109.414 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 66.39 7.09 37.58 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 110.037 -1.225 . . . . 0.0 110.037 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.538 ' HE3' ' HB3' ' A' ' 95' ' ' ALA . 16.7 mtm -90.75 63.28 5.3 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.976 -1.308 . . . . 0.0 109.598 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.783 HG22 ' CB ' ' A' ' 88' ' ' TYR . 84.2 t -140.52 76.24 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.387 -0.82 . . . . 0.0 109.41 179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.489 ' O ' ' CG ' ' A' ' 100' ' ' LYS . . . -72.27 -167.72 10.22 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.491 ' HG2' ' HA ' ' A' ' 86' ' ' THR . 5.7 mtmt -159.25 131.37 6.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.355 -1.085 . . . . 0.0 109.484 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.865 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 0.4 OUTLIER -82.59 133.37 29.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.12 -0.987 . . . . 0.0 108.925 179.552 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.599 HG23 ' HG3' ' A' ' 84' ' ' GLU . 7.6 m -116.31 91.75 3.68 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.257 -0.902 . . . . 0.0 109.038 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.521 HG22 HG13 ' A' ' 23' ' ' ILE . 2.1 t -99.42 135.92 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.205 -0.935 . . . . 0.0 109.6 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -82.97 -173.96 5.0 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.259 -0.901 . . . . 0.0 109.472 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.46 ' HA3' ' HB2' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.491 2.322 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.4 m -121.66 131.97 54.39 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.2 -0.937 . . . . 0.0 109.494 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.64 ' CD2' HG22 ' A' ' 23' ' ' ILE . 83.4 m-85 -96.93 168.78 10.27 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.205 -0.935 . . . . 0.0 109.301 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.6 m -156.99 144.17 18.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.266 -0.896 . . . . 0.0 109.761 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.689 HG12 ' H ' ' A' ' 17' ' ' GLU . 2.5 t -128.96 69.57 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.392 -0.817 . . . . 0.0 109.0 179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 1.1 ttmm -51.07 106.74 0.14 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.389 -0.819 . . . . 0.0 110.017 -179.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.624 HD11 ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -90.86 150.91 21.36 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.292 -0.88 . . . . 0.0 109.054 179.399 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.452 ' HA3' ' CB ' ' A' ' 34' ' ' ASN . . . 117.6 66.88 0.35 Allowed Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.511 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -51.22 -23.32 3.31 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.162 -1.199 . . . . 0.0 109.262 179.646 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.511 ' CB ' ' O ' ' A' ' 9' ' ' SER . 10.5 t0 80.4 29.54 0.23 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.609 -0.682 . . . . 0.0 109.45 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -122.78 19.12 10.24 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.26 -0.9 . . . . 0.0 109.209 179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 97.18 11.11 53.47 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.802 ' C ' HD23 ' A' ' 14' ' ' LEU . 0.2 OUTLIER -156.88 143.87 18.64 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.328 -1.101 . . . . 0.0 109.419 -179.95 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 1.003 HD12 ' CE1' ' A' ' 39' ' ' HIS . 1.1 mt -101.93 143.44 31.79 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.181 -0.949 . . . . 0.0 109.315 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.449 HG13 ' O ' ' A' ' 14' ' ' LEU . 1.8 m -154.57 128.78 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.229 -0.92 . . . . 0.0 109.601 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.639 ' HD2' HG11 ' A' ' 5' ' ' VAL . 38.2 m-85 -48.83 142.01 6.84 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.188 -0.945 . . . . 0.0 109.106 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.689 ' H ' HG12 ' A' ' 5' ' ' VAL . 19.4 mt-10 -136.56 109.71 9.49 Favored Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.273 -0.892 . . . . 0.0 109.254 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.474 ' HG2' ' O ' ' A' ' 20' ' ' LYS . 34.9 Cg_endo -77.29 -178.03 22.92 Favored 'Cis proline' 0 C--N 1.311 -1.398 0 C-N-CA 123.73 -1.362 . . . . 0.0 110.64 0.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -81.19 4.29 20.73 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.244 -0.91 . . . . 0.0 109.763 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 5.2 pttt -146.06 160.72 41.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.149 -0.969 . . . . 0.0 109.488 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.678 HD12 HG22 ' A' ' 5' ' ' VAL . 0.7 OUTLIER -157.73 136.62 11.51 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.187 -0.946 . . . . 0.0 109.48 -179.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.0 m -104.93 99.16 8.79 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.296 -0.878 . . . . 0.0 109.286 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.792 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -99.48 173.47 1.05 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 O-C-N 121.234 -0.916 . . . . 0.0 109.523 -179.848 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.582 ' CG ' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -95.33 177.54 1.76 Allowed Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.044 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.684 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 34.7 Cg_endo -76.41 72.72 5.39 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 C-N-CA 122.088 1.859 . . . . 0.0 110.342 -179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 126.18 28.6 1.0 Allowed Glycine 0 N--CA 1.492 2.393 0 C-N-CA 119.711 -1.233 . . . . 0.0 110.18 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.517 ' OD1' ' CB ' ' A' ' 24' ' ' LYS . 4.5 m-20 -88.13 -165.84 1.43 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.205 -1.173 . . . . 0.0 108.852 179.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.731 HG23 ' HA ' ' A' ' 75' ' ' THR . 21.4 m -136.56 110.56 8.26 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 120.956 -1.09 . . . . 0.0 109.695 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.993 HG21 HD11 ' A' ' 101' ' ' ILE . 1.7 t -99.36 136.13 31.76 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 O-C-N 121.321 -0.862 . . . . 0.0 109.102 179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -104.76 142.54 34.52 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.104 -0.997 . . . . 0.0 110.198 -179.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.592 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.1 OUTLIER -139.7 142.63 36.87 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.375 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.732 HD23 ' N ' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -140.94 -169.95 2.93 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 120.894 -1.129 . . . . 0.0 110.523 -179.383 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.514 ' OD1' ' HA ' ' A' ' 68' ' ' PRO . 6.4 p-10 -114.9 154.28 28.98 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.467 -0.771 . . . . 0.0 109.352 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.491 ' HB2' ' O ' ' A' ' 7' ' ' LEU . 35.3 t30 -100.38 -88.09 0.36 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.024 -1.047 . . . . 0.0 109.637 -179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.403 ' C ' HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -144.14 33.72 1.22 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.073 -1.017 . . . . 0.0 109.197 -179.97 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.877 ' HB ' HD11 ' A' ' 14' ' ' LEU . 92.3 t -153.77 64.53 4.88 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.478 -0.763 . . . . 0.0 109.135 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.564 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.5 Cg_endo -79.79 175.85 10.09 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 C-N-CA 122.775 2.317 . . . . 0.0 110.455 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.564 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.8 Cg_endo -86.24 -172.93 8.84 Favored 'Cis proline' 0 C--N 1.31 -1.46 0 C-N-CA 123.655 -1.394 . . . . 0.0 110.65 -1.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 1.003 ' CE1' HD12 ' A' ' 14' ' ' LEU . 63.2 m-70 -137.91 159.23 42.55 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.38 -0.825 . . . . 0.0 109.583 179.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -138.71 118.33 13.04 Favored 'General case' 0 C--N 1.303 -1.442 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 179.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 20.5 t -99.58 111.45 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.247 -0.908 . . . . 0.0 109.668 -179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.492 ' HA ' ' CB ' ' A' ' 60' ' ' SER . 13.8 t -135.91 162.64 36.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.338 -0.851 . . . . 0.0 109.311 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.915 ' CE2' HD23 ' A' ' 59' ' ' LEU . 20.1 m-85 -115.88 120.75 40.23 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.262 -0.899 . . . . 0.0 109.62 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.633 ' OD2' HD23 ' A' ' 47' ' ' LEU . 39.8 t0 -44.08 140.54 2.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.415 -0.803 . . . . 0.0 109.768 -179.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -94.7 1.06 55.49 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.339 -0.851 . . . . 0.0 109.646 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -101.58 -26.19 13.62 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.219 -0.926 . . . . 0.0 109.551 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.633 HD23 ' OD2' ' A' ' 44' ' ' ASP . 4.0 mm? -95.49 61.73 2.34 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.271 -0.893 . . . . 0.0 109.265 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 52' ' ' SER . 2.3 p30 -107.59 150.06 39.67 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.324 -0.86 . . . . 0.0 109.487 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.491 ' HB3' ' HA3' ' A' ' 83' ' ' GLY . 35.8 Cg_endo -77.96 -9.78 16.76 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.616 2.211 . . . . 0.0 110.331 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.452 ' C ' ' HG2' ' A' ' 51' ' ' LYS . . . -134.55 31.59 3.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.27 -0.894 . . . . 0.0 109.452 179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.462 ' HA ' ' OD1' ' A' ' 48' ' ' ASN . 27.3 pttt 36.47 39.08 0.09 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.814 -0.554 . . . . 0.0 110.166 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.522 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 6.0 m -108.76 -157.63 0.62 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.568 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -169.07 33.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.325 -0.859 . . . . 0.0 109.508 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -112.19 -42.26 3.76 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.215 -0.928 . . . . 0.0 109.826 -179.803 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.672 ' C ' HD12 ' A' ' 55' ' ' LEU . 2.0 pp -47.35 -33.32 5.67 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.196 -0.94 . . . . 0.0 109.449 -179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.84 -37.41 24.43 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 109.483 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -46.77 -31.26 2.87 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.277 -0.889 . . . . 0.0 109.388 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 18.4 p -115.02 31.67 6.54 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.245 -0.909 . . . . 0.0 109.39 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.919 HD21 ' CE2' ' A' ' 76' ' ' PHE . 8.3 tp -131.37 -52.71 1.02 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.219 -0.926 . . . . 0.0 109.613 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.51 ' OG ' ' CD2' ' A' ' 43' ' ' PHE . 10.2 m -77.37 160.37 28.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.194 -0.941 . . . . 0.0 110.29 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.546 ' CE1' ' O ' ' A' ' 63' ' ' GLN . 18.9 p80 -119.99 147.29 44.96 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.531 -0.731 . . . . 0.0 109.336 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.52 -55.86 3.42 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -0.945 . . . . 0.0 109.529 -179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.546 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -46.74 120.84 3.18 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.347 -0.846 . . . . 0.0 109.665 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.659 ' H ' HD12 ' A' ' 64' ' ' LEU . 6.3 mp -66.48 162.06 21.46 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.255 -0.903 . . . . 0.0 109.091 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.848 HD13 ' HA ' ' A' ' 71' ' ' SER . 0.5 OUTLIER -109.06 152.07 25.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.051 -1.031 . . . . 0.0 109.692 -179.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 3.4 mtp -136.6 7.45 3.03 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.314 -0.866 . . . . 0.0 109.548 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.52 ' HB3' ' CG ' ' A' ' 70' ' ' GLN . 8.4 t -79.27 134.53 58.84 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.235 -0.916 . . . . 0.0 109.347 -179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.514 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 35.9 Cg_endo -78.44 90.1 1.29 Allowed 'Trans proline' 0 C--N 1.311 -1.399 0 C-N-CA 122.721 2.28 . . . . 0.0 111.612 -179.347 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.514 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 113.17 34.76 1.74 Allowed Glycine 0 N--CA 1.493 2.482 0 C-N-CA 119.63 -1.272 . . . . 0.0 110.678 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.534 ' N ' ' HB2' ' A' ' 32' ' ' LEU . 0.7 OUTLIER 177.01 119.93 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.01 -1.288 . . . . 0.0 109.669 179.577 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.848 ' HA ' HD13 ' A' ' 65' ' ' LEU . 60.2 p -109.97 -75.14 0.63 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.284 -0.885 . . . . 0.0 109.325 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.539 ' N ' ' OG ' ' A' ' 71' ' ' SER . 1.6 t -160.75 107.84 1.52 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.186 -0.946 . . . . 0.0 109.633 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 26.3 t -78.78 85.01 4.81 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.026 -1.046 . . . . 0.0 108.298 179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.786 HG21 ' HG ' ' A' ' 59' ' ' LEU . 22.6 m -75.63 108.37 8.42 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.523 -0.736 . . . . 0.0 110.378 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.731 ' HA ' HG23 ' A' ' 28' ' ' THR . 3.2 t -79.13 87.99 4.86 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 1.004 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 30.1 m-85 -36.69 150.75 0.12 Allowed Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.782 -0.574 . . . . 0.0 110.314 -178.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.508 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 35.2 Cg_endo -76.74 161.36 33.7 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 C-N-CA 122.995 2.463 . . . . 0.0 111.501 -178.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.49 6.57 10.01 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 109.04 -0.726 . . . . 0.0 109.04 178.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.5 ' O ' ' C ' ' A' ' 80' ' ' ALA . 3.1 p30 -98.87 -4.84 32.11 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.286 -0.884 . . . . 0.0 109.096 179.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.684 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -33.82 105.27 0.25 Allowed Pre-proline 0 N--CA 1.498 1.961 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.487 ' O ' ' O ' ' A' ' 82' ' ' ALA . 35.9 Cg_endo -77.84 41.44 1.0 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 C-N-CA 122.522 2.148 . . . . 0.0 111.407 -179.19 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.519 ' HA ' ' HB ' ' A' ' 103' ' ' VAL . . . 46.87 -178.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.315 -0.866 . . . . 0.0 110.006 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.491 ' HA3' ' HB3' ' A' ' 49' ' ' PRO . . . 94.21 -168.14 28.22 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 110.002 -1.239 . . . . 0.0 110.002 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -111.92 153.83 26.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.522 -0.987 . . . . 0.0 109.635 -179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.448 ' O ' ' HB ' ' A' ' 86' ' ' THR . 19.8 m-30 -113.63 -39.32 4.07 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.392 -0.817 . . . . 0.0 108.92 179.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.448 ' HB ' ' O ' ' A' ' 85' ' ' TYR . 92.4 m 61.79 100.49 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.313 -0.867 . . . . 0.0 110.333 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -105.05 173.17 6.42 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.203 -0.936 . . . . 0.0 108.905 178.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 97' ' ' MET . 16.7 p90 -155.39 -164.07 1.68 Allowed 'General case' 0 C--N 1.304 -1.394 0 O-C-N 120.893 -1.13 . . . . 0.0 110.046 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.516 ' HB2' ' HB3' ' A' ' 97' ' ' MET . 0.6 OUTLIER -136.75 144.75 43.96 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.424 -0.798 . . . . 0.0 109.447 -179.692 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.604 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 40.6 tt0 -83.12 -45.07 0.86 Allowed Pre-proline 0 N--CA 1.488 1.47 0 O-C-N 121.264 -0.898 . . . . 0.0 110.433 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.604 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.0 Cg_endo -78.31 -46.93 0.11 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 C-N-CA 122.048 1.832 . . . . 0.0 110.902 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.74 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 68.7 m80 -87.79 18.07 4.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.014 -1.054 . . . . 0.0 109.643 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 1.5 ttp180 -53.25 135.94 37.5 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.127 -0.983 . . . . 0.0 109.421 179.868 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 89.05 -8.25 80.29 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.77 -1.332 . . . . 0.0 109.77 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -99.12 38.66 1.37 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.16 -1.2 . . . . 0.0 109.603 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 60.98 12.5 29.78 Favored Glycine 0 N--CA 1.492 2.408 0 N-CA-C 109.955 -1.258 . . . . 0.0 109.955 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.516 ' HB3' ' HB2' ' A' ' 89' ' ' CYS . 0.0 OUTLIER -81.92 56.8 3.22 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.179 -1.189 . . . . 0.0 109.699 179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 88' ' ' TYR . 21.6 t -139.6 72.15 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.104 -0.998 . . . . 0.0 109.947 -179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.438 ' C ' ' CG ' ' A' ' 100' ' ' LYS . . . -80.95 -173.23 47.18 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.438 ' CG ' ' C ' ' A' ' 99' ' ' GLY . 0.1 OUTLIER -152.15 136.23 16.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.933 -1.334 . . . . 0.0 110.148 -179.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 1.004 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -86.58 119.54 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.172 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -99.74 103.42 15.08 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.217 -0.927 . . . . 0.0 109.099 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.724 HG22 ' CD1' ' A' ' 23' ' ' ILE . 17.3 t -99.19 68.45 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 121.487 -0.758 . . . . 0.0 109.444 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.406 ' O ' ' O ' ' A' ' 105' ' ' GLY . . . 53.09 -171.44 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.316 -0.865 . . . . 0.0 109.275 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.406 ' O ' ' O ' ' A' ' 104' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.6 m -117.66 103.88 10.47 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.298 -0.876 . . . . 0.0 109.51 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.518 ' CD2' HG22 ' A' ' 23' ' ' ILE . 23.5 m-85 -84.35 108.88 17.43 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.731 ' CG2' HD21 ' A' ' 32' ' ' LEU . 52.9 m -109.58 150.06 28.74 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.271 -0.893 . . . . 0.0 109.564 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.722 HG12 ' H ' ' A' ' 17' ' ' GLU . 0.3 OUTLIER -113.43 160.84 12.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.221 -0.924 . . . . 0.0 109.227 179.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.2 mtpm? -125.75 101.1 6.71 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.929 . . . . 0.0 109.505 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.611 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -89.19 170.98 10.14 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.168 -0.958 . . . . 0.0 109.252 179.789 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.85 ' CA ' HD23 ' A' ' 14' ' ' LEU . . . 86.52 77.39 1.23 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.477 ' N ' ' O ' ' A' ' 13' ' ' LEU . 99.7 p -44.29 -65.65 0.49 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.243 -1.151 . . . . 0.0 109.218 179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.465 ' CB ' ' O ' ' A' ' 9' ' ' SER . 0.4 OUTLIER 168.47 -25.65 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.25 -0.906 . . . . 0.0 110.07 179.631 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 30.2 tttt -113.77 49.54 0.98 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.059 -1.025 . . . . 0.0 110.078 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 88.22 -37.85 3.24 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.013 -1.235 . . . . 0.0 110.013 179.417 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.477 ' O ' ' N ' ' A' ' 9' ' ' SER . 2.9 mp -69.61 118.85 13.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.124 -1.221 . . . . 0.0 109.578 -179.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.85 HD23 ' CA ' ' A' ' 8' ' ' GLY . 0.5 OUTLIER -116.19 110.81 19.31 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.349 -0.844 . . . . 0.0 109.488 -179.88 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -129.68 133.34 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.345 -0.847 . . . . 0.0 109.516 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -49.31 153.73 0.98 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.045 -1.034 . . . . 0.0 109.097 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.722 ' H ' HG12 ' A' ' 5' ' ' VAL . 5.7 mt-10 -143.0 109.06 5.44 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.156 -0.965 . . . . 0.0 109.445 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.47 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 35.0 Cg_endo -77.21 179.56 30.84 Favored 'Cis proline' 0 C--N 1.312 -1.368 0 C-N-CA 123.82 -1.325 . . . . 0.0 110.491 0.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.68 -44.08 71.18 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.214 -0.929 . . . . 0.0 108.877 179.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.29 139.6 40.54 Favored 'General case' 0 N--CA 1.489 1.5 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.264 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.613 ' CD1' HG22 ' A' ' 5' ' ' VAL . 1.7 mt -126.79 126.66 43.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.07 -1.019 . . . . 0.0 110.088 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 102' ' ' THR . 18.8 m -89.26 97.83 11.42 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.86 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -99.3 172.49 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.149 -0.969 . . . . 0.0 109.865 -179.387 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.503 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 0.3 OUTLIER -86.31 175.55 4.34 Favored Pre-proline 0 C--N 1.302 -1.484 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.419 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.612 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 35.8 Cg_endo -78.0 72.84 5.99 Favored 'Trans proline' 0 C--N 1.305 -1.714 0 C-N-CA 122.377 2.052 . . . . 0.0 110.962 -179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.509 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 129.08 -9.75 6.28 Favored Glycine 0 N--CA 1.492 2.368 0 C-N-CA 119.22 -1.467 . . . . 0.0 110.603 179.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.487 ' OD1' ' HB2' ' A' ' 24' ' ' LYS . 1.2 m-20 -50.54 -178.21 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.093 -1.239 . . . . 0.0 109.085 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.579 HG23 ' HA ' ' A' ' 75' ' ' THR . 23.8 m -117.4 118.37 32.03 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.036 -1.04 . . . . 0.0 109.676 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.955 HG21 HD11 ' A' ' 101' ' ' ILE . 1.7 t -99.81 111.53 29.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.371 -0.83 . . . . 0.0 109.475 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.645 ' O ' HG23 ' A' ' 4' ' ' THR . 5.1 mt-10 -99.43 123.17 43.47 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.254 -0.904 . . . . 0.0 109.112 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.496 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.3 OUTLIER -106.29 153.19 22.53 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.348 -0.845 . . . . 0.0 109.109 -179.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.731 HD21 ' CG2' ' A' ' 4' ' ' THR . 0.0 OUTLIER -140.54 177.81 7.75 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.09 -1.007 . . . . 0.0 110.033 -179.494 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.645 ' HB3' HD23 ' A' ' 65' ' ' LEU . 3.2 p-10 -109.45 169.64 8.57 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.355 -0.841 . . . . 0.0 109.268 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.539 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . 28.3 t30 -112.88 -73.68 0.66 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.01 -1.056 . . . . 0.0 109.378 179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 5.8 ttpt -162.91 28.39 0.1 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.064 -1.023 . . . . 0.0 109.266 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.59 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 11.1 t -148.05 58.61 3.96 Favored Pre-proline 0 C--N 1.3 -1.561 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.59 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 36.2 Cg_endo -77.94 174.78 12.02 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.69 2.26 . . . . 0.0 110.664 -179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.557 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.6 Cg_endo -86.95 158.44 50.15 Favored 'Cis proline' 0 C--N 1.309 -1.547 0 C-N-CA 123.402 -1.499 . . . . 0.0 110.713 -1.825 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.881 ' HB2' HD22 ' A' ' 65' ' ' LEU . 70.4 m-70 -113.77 125.41 54.07 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.483 -0.761 . . . . 0.0 108.961 179.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.453 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 1.8 m120 -99.85 123.96 44.65 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.292 -0.88 . . . . 0.0 109.294 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 42.6 t -107.8 109.49 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.243 -0.91 . . . . 0.0 109.911 -179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.617 HG13 ' CB ' ' A' ' 60' ' ' SER . 1.4 t -134.74 167.11 26.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.383 -0.823 . . . . 0.0 108.852 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.718 ' CZ ' HD12 ' A' ' 59' ' ' LEU . 7.8 m-85 -118.9 106.52 12.57 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.136 -0.977 . . . . 0.0 109.831 -179.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -49.91 118.66 3.01 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.443 -0.786 . . . . 0.0 109.861 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.41 2.14 29.9 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.433 -0.792 . . . . 0.0 109.638 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -102.09 -15.03 16.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.139 -0.976 . . . . 0.0 109.753 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 8.0 mt -113.88 61.08 0.66 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.142 -0.974 . . . . 0.0 109.523 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.496 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 5.7 p30 -134.1 163.14 53.29 Favored Pre-proline 0 N--CA 1.488 1.434 0 O-C-N 121.255 -0.903 . . . . 0.0 109.449 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.574 ' HG3' ' CA ' ' A' ' 83' ' ' GLY . 33.7 Cg_endo -77.31 -16.81 15.19 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 122.596 2.197 . . . . 0.0 109.423 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.48 ' O ' ' N ' ' A' ' 52' ' ' SER . . . -135.0 77.08 1.66 Allowed 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.47 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -35.88 95.43 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 CA-C-O 121.351 0.596 . . . . 0.0 110.413 -179.459 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.48 ' N ' ' O ' ' A' ' 50' ' ' ALA . 10.4 m -140.42 -174.49 3.97 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.423 -0.798 . . . . 0.0 109.271 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -159.86 23.94 0.18 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.206 -0.934 . . . . 0.0 109.413 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 6.8 t0 -89.08 -66.03 0.96 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 121.279 -0.888 . . . . 0.0 109.794 -179.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.517 ' HG ' ' N ' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -64.89 -25.31 67.83 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.214 -0.929 . . . . 0.0 109.636 -179.751 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.517 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -65.02 -58.18 6.74 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.115 -0.991 . . . . 0.0 109.343 179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -45.45 -31.59 1.79 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.268 -0.895 . . . . 0.0 109.521 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.61 13.03 36.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.926 . . . . 0.0 109.973 -179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.836 ' HA ' HG21 ' A' ' 74' ' ' THR . 0.0 OUTLIER -108.0 -42.45 4.67 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.997 -1.064 . . . . 0.0 108.47 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.617 ' CB ' HG13 ' A' ' 42' ' ' VAL . 0.7 OUTLIER -78.11 174.57 11.01 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.457 -0.777 . . . . 0.0 110.347 -179.418 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.795 ' HB3' HG21 ' A' ' 72' ' ' THR . 26.4 p80 -125.19 174.2 8.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.64 -0.662 . . . . 0.0 109.338 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.1 mttm -125.19 -12.91 6.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.156 -0.965 . . . . 0.0 109.71 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 10.6 tt0 -92.59 105.66 17.78 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.155 -0.965 . . . . 0.0 109.653 -179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.614 ' H ' HD12 ' A' ' 64' ' ' LEU . 4.4 mp -49.26 165.01 0.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.267 -0.896 . . . . 0.0 109.291 179.849 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.897 HD21 ' HB2' ' A' ' 71' ' ' SER . 5.9 mp -81.49 137.4 35.61 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.124 -0.985 . . . . 0.0 109.546 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -128.93 -2.56 5.22 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.368 -0.832 . . . . 0.0 109.538 179.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.3 t -116.0 144.93 33.74 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.141 -0.975 . . . . 0.0 109.247 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.58 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.6 Cg_endo -80.91 83.46 2.21 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.645 2.23 . . . . 0.0 111.608 -179.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.542 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 124.94 45.41 0.26 Allowed Glycine 0 N--CA 1.492 2.431 0 C-N-CA 119.121 -1.514 . . . . 0.0 111.437 178.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.484 ' HB3' ' O ' ' A' ' 69' ' ' GLY . 4.1 pt20 170.15 117.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.014 -1.286 . . . . 0.0 109.974 178.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.897 ' HB2' HD21 ' A' ' 65' ' ' LEU . 2.8 p -115.51 -146.82 0.41 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.226 -0.922 . . . . 0.0 109.09 179.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.795 HG21 ' HB3' ' A' ' 61' ' ' HIS . 96.4 m -95.15 100.67 12.44 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.098 -1.001 . . . . 0.0 109.951 -179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.446 ' HB3' ' HB3' ' A' ' 30' ' ' GLU . 42.4 p -79.99 111.71 16.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.229 -0.919 . . . . 0.0 108.884 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.836 HG21 ' HA ' ' A' ' 59' ' ' LEU . 1.9 m -98.63 129.09 45.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.199 -0.938 . . . . 0.0 109.86 -179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.579 ' HA ' HG23 ' A' ' 28' ' ' THR . 0.1 OUTLIER -82.65 96.81 8.24 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 179.139 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.727 ' CD2' HD21 ' A' ' 59' ' ' LEU . 26.1 m-85 -45.58 153.12 0.62 Allowed Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 121.066 -1.021 . . . . 0.0 108.862 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.509 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.3 Cg_endo -77.11 165.38 28.17 Favored 'Trans proline' 0 C--N 1.306 -1.702 0 C-N-CA 122.5 2.133 . . . . 0.0 111.421 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -78.93 8.0 6.28 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.46 -0.775 . . . . 0.0 109.535 179.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.534 ' O ' ' N ' ' A' ' 81' ' ' PRO . 2.4 m-20 -99.08 -12.5 20.47 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.045 -1.034 . . . . 0.0 109.006 179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.612 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -32.85 93.58 0.06 OUTLIER Pre-proline 0 N--CA 1.5 2.041 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.534 ' N ' ' O ' ' A' ' 79' ' ' ASP . 36.3 Cg_endo -78.73 163.83 26.1 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.586 2.191 . . . . 0.0 110.786 -179.237 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -64.77 113.19 3.62 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.406 -0.809 . . . . 0.0 109.302 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.574 ' CA ' ' HG3' ' A' ' 49' ' ' PRO . . . -174.54 155.83 21.89 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.434 ' O ' ' CG ' ' A' ' 84' ' ' GLU . 0.7 OUTLIER -90.47 104.69 17.24 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.334 -1.098 . . . . 0.0 109.706 -179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.461 ' CD2' HG22 ' A' ' 101' ' ' ILE . 7.7 m-30 -81.08 167.25 19.94 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.204 -0.935 . . . . 0.0 108.863 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.506 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 95.4 m -151.81 115.52 4.87 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.935 -1.103 . . . . 0.0 110.573 -179.667 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.627 ' O ' HG23 ' A' ' 98' ' ' VAL . 2.0 p90 -117.4 168.63 10.18 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.515 ' HA ' ' HA ' ' A' ' 98' ' ' VAL . 30.4 p90 -160.47 -162.41 0.96 Allowed 'General case' 0 C--N 1.304 -1.384 0 O-C-N 120.79 -1.194 . . . . 0.0 110.645 -179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.453 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 1.3 m -119.07 136.41 54.16 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.69 -0.631 . . . . 0.0 109.723 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.629 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -73.17 -45.09 8.08 Favored Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.287 -0.883 . . . . 0.0 109.762 178.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.629 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.4 Cg_endo -78.35 -60.42 0.03 OUTLIER 'Trans proline' 0 C--N 1.318 -1.063 0 C-N-CA 121.983 1.789 . . . . 0.0 110.524 -179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.639 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 10.8 m80 -72.48 57.23 0.39 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.017 -1.052 . . . . 0.0 109.179 179.637 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.54 18.59 9.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.14 -0.975 . . . . 0.0 109.368 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -108.85 -34.0 2.7 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.41 ' O ' ' C ' ' A' ' 96' ' ' GLY . . . -91.81 34.35 1.0 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.143 -1.21 . . . . 0.0 109.642 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.41 ' C ' ' O ' ' A' ' 95' ' ' ALA . . . 41.61 61.72 2.11 Favored Glycine 0 N--CA 1.493 2.435 0 N-CA-C 110.048 -1.221 . . . . 0.0 110.048 179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.564 ' CE ' ' HB3' ' A' ' 92' ' ' HIS . 9.3 mtt -91.64 63.97 4.81 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.163 -1.198 . . . . 0.0 109.35 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.627 HG23 ' O ' ' A' ' 87' ' ' PHE . 4.9 p -127.63 96.48 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.2 -0.937 . . . . 0.0 109.775 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.495 ' O ' ' HG3' ' A' ' 100' ' ' LYS . . . -76.47 -164.42 18.51 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.506 ' HG2' ' HA ' ' A' ' 86' ' ' THR . 26.5 mtmt -163.44 120.53 1.82 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.246 -1.149 . . . . 0.0 109.649 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.955 HD11 HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -82.58 138.88 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.154 -0.966 . . . . 0.0 108.898 179.654 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.422 ' O ' ' HA ' ' A' ' 22' ' ' THR . 8.3 m -118.04 93.93 4.32 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.613 HG22 HG13 ' A' ' 23' ' ' ILE . 1.8 t -99.2 118.6 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.23 -0.918 . . . . 0.0 109.596 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -93.2 146.38 23.73 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.313 -0.867 . . . . 0.0 109.634 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.327 0 CA-C-O 118.032 -1.427 . . . . 0.0 109.653 179.89 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 38.8 m -119.88 134.14 55.34 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.25 -0.907 . . . . 0.0 109.427 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.593 ' HB2' HG13 ' A' ' 29' ' ' VAL . 40.0 m-85 -123.52 98.46 5.85 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.174 -0.954 . . . . 0.0 109.349 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.727 HG23 HD11 ' A' ' 32' ' ' LEU . 18.8 m -87.54 83.87 7.2 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.217 -0.927 . . . . 0.0 109.749 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 5' ' ' VAL . 24.7 m -82.55 107.15 14.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.322 0 O-C-N 121.152 -0.967 . . . . 0.0 109.454 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.495 ' HE3' ' HA2' ' A' ' 69' ' ' GLY . 0.2 OUTLIER -92.25 100.86 13.38 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.291 -0.881 . . . . 0.0 109.333 179.97 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.535 ' CD2' ' O ' ' A' ' 32' ' ' LEU . 0.9 OUTLIER -59.68 172.48 0.7 Allowed 'General case' 0 C--N 1.306 -1.3 0 O-C-N 121.148 -0.97 . . . . 0.0 109.295 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.484 ' HA3' ' HB3' ' A' ' 34' ' ' ASN . . . 69.35 70.36 1.18 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.467 ' OG ' ' N ' ' A' ' 10' ' ' ASP . 86.4 p -47.67 -91.31 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.316 -1.108 . . . . 0.0 109.531 -179.868 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.467 ' N ' ' OG ' ' A' ' 9' ' ' SER . 2.2 t0 177.36 -34.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.427 -179.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -116.61 38.73 3.36 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.883 . . . . 0.0 109.38 -179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.407 ' O ' HD22 ' A' ' 13' ' ' LEU . . . -154.07 -106.35 0.28 Allowed Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.476 HD22 ' HA ' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -149.6 -148.3 0.26 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.304 -1.115 . . . . 0.0 109.359 -179.685 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.689 HD13 ' HE1' ' A' ' 39' ' ' HIS . 20.8 mt -98.75 109.0 21.83 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.945 -1.097 . . . . 0.0 109.366 -179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.444 ' O ' ' HA ' ' A' ' 7' ' ' LEU . 21.4 m -148.51 165.73 4.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.251 -0.906 . . . . 0.0 109.487 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 28.4 m-85 -85.79 135.18 33.83 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 109.407 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -125.64 108.34 26.04 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.188 -0.945 . . . . 0.0 109.542 -179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -78.44 175.81 45.4 Favored 'Cis proline' 0 C--N 1.312 -1.358 0 C-N-CA 123.793 -1.336 . . . . 0.0 110.465 0.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -79.64 -39.53 31.28 Favored 'General case' 0 N--CA 1.487 1.395 0 O-C-N 121.225 -0.922 . . . . 0.0 109.474 179.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.78 138.15 45.56 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.309 -0.87 . . . . 0.0 109.294 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.465 HD11 HG11 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -135.51 110.34 8.73 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 109.588 -179.872 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.489 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 97.5 m -84.14 99.23 10.37 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.167 -0.958 . . . . 0.0 109.291 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.862 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.5 pt -99.64 -178.37 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.288 -0.882 . . . . 0.0 109.698 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.586 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 0.0 OUTLIER -94.91 -179.16 0.9 Allowed Pre-proline 0 C--N 1.301 -1.52 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.448 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.824 ' C ' ' HB3' ' A' ' 80' ' ' ALA . 34.5 Cg_endo -77.88 66.69 8.15 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.093 1.862 . . . . 0.0 110.386 -179.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.709 ' N ' ' HB3' ' A' ' 80' ' ' ALA . . . 121.08 73.96 0.35 Allowed Glycine 0 N--CA 1.487 2.08 0 C-N-CA 119.52 -1.324 . . . . 0.0 109.922 179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.48 ' OD2' ' HG2' ' A' ' 24' ' ' LYS . 7.7 m-20 -125.77 -142.66 0.29 Allowed 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.32 -1.106 . . . . 0.0 108.581 179.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.588 HG23 ' HA ' ' A' ' 75' ' ' THR . 44.3 m -148.04 99.49 3.07 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 120.944 -1.098 . . . . 0.0 109.563 179.49 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.944 ' CG2' HD11 ' A' ' 101' ' ' ILE . 2.9 t -99.87 119.45 47.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.466 -0.771 . . . . 0.0 109.044 179.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.482 ' C ' ' CD1' ' A' ' 31' ' ' PHE . 56.1 tt0 -99.61 156.33 17.12 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.171 -0.956 . . . . 0.0 109.81 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.483 ' CD2' ' O ' ' A' ' 72' ' ' THR . 0.0 OUTLIER -148.34 149.13 31.26 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.727 HD11 HG23 ' A' ' 4' ' ' THR . 3.1 mp -141.97 -170.98 3.26 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.127 -0.983 . . . . 0.0 109.807 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.915 ' HB3' HD23 ' A' ' 65' ' ' LEU . 8.0 p-10 -113.66 159.92 19.15 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.315 -0.865 . . . . 0.0 109.441 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.495 ' HB2' ' O ' ' A' ' 7' ' ' LEU . 17.5 t30 -94.97 -94.49 0.18 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.015 -1.053 . . . . 0.0 109.301 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.54 37.29 1.34 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.173 -0.954 . . . . 0.0 109.304 179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.683 ' HB ' HD21 ' A' ' 14' ' ' LEU . 0.5 OUTLIER -150.81 62.8 5.44 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.446 -0.784 . . . . 0.0 109.004 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.539 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 35.0 Cg_endo -77.54 174.68 12.29 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.693 2.262 . . . . 0.0 110.26 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.602 ' O ' ' CG ' ' A' ' 39' ' ' HIS . 37.9 Cg_endo -83.83 -163.12 2.98 Favored 'Cis proline' 0 C--N 1.308 -1.566 0 C-N-CA 123.558 -1.434 . . . . 0.0 110.571 -0.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.689 ' HE1' HD13 ' A' ' 14' ' ' LEU . 89.4 m-70 -161.77 124.59 3.03 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.413 -0.804 . . . . 0.0 109.758 179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -100.97 111.93 24.26 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.211 -0.931 . . . . 0.0 109.213 179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 52.4 t -102.06 128.4 54.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 0.0 109.719 -179.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.768 HG12 ' CB ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -159.85 167.12 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.29 -0.882 . . . . 0.0 109.496 179.958 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.508 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 3.2 m-85 -109.41 133.6 52.87 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.261 -0.899 . . . . 0.0 109.294 179.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 14.0 t0 -57.26 136.05 56.49 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.073 -1.017 . . . . 0.0 108.952 179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -85.33 21.77 1.66 Allowed 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.233 -0.917 . . . . 0.0 110.102 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -137.31 5.93 2.77 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.983 -1.073 . . . . 0.0 109.635 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.8 mp -113.49 41.44 2.16 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.145 -0.972 . . . . 0.0 109.556 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.476 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 0.6 OUTLIER -114.03 165.34 13.83 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.346 -0.846 . . . . 0.0 109.232 179.897 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 35.5 Cg_endo -77.75 -32.08 2.9 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.615 2.21 . . . . 0.0 111.442 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.45 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -125.79 24.79 7.02 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 120.876 -1.14 . . . . 0.0 110.268 -179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.469 ' HA ' ' CG ' ' A' ' 48' ' ' ASN . 9.9 mtmm 36.48 91.13 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.865 -0.522 . . . . 0.0 110.182 179.445 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.463 ' HB3' ' OD1' ' A' ' 54' ' ' ASP . 73.7 m -139.92 136.49 33.93 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.071 -1.018 . . . . 0.0 109.681 -179.83 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -74.24 -47.92 32.11 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.305 -0.872 . . . . 0.0 109.46 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 55' ' ' LEU . 6.8 p30 -46.45 -31.84 2.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.246 -0.909 . . . . 0.0 109.396 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.699 ' O ' ' HB2' ' A' ' 56' ' ' ALA . 39.1 tp -87.68 55.2 3.39 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.354 -0.841 . . . . 0.0 109.36 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 55' ' ' LEU . . . 163.88 -50.27 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.347 -0.845 . . . . 0.0 109.235 -179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 4.4 ttmt -54.91 -37.95 66.99 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.31 -0.869 . . . . 0.0 109.437 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 4.6 t -104.38 -20.07 13.86 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.264 -0.897 . . . . 0.0 109.526 179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.912 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 16.1 tp -65.04 -49.4 70.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.271 -0.893 . . . . 0.0 109.469 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.768 ' CB ' HG12 ' A' ' 42' ' ' VAL . 55.4 p -82.76 178.38 8.21 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.749 0.785 . . . . 0.0 110.936 -178.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.461 ' CE1' ' O ' ' A' ' 63' ' ' GLN . 19.1 p80 -108.99 -154.23 0.53 Allowed 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.881 -0.785 . . . . 0.0 108.881 179.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.446 ' N ' ' ND1' ' A' ' 61' ' ' HIS . 19.3 mmtt -148.05 -62.14 0.26 Allowed 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.291 -0.881 . . . . 0.0 109.439 179.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.461 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 3.4 pm0 -46.1 148.18 0.91 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.272 -0.893 . . . . 0.0 109.647 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 2.2 mp -73.97 165.57 24.9 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.219 -0.926 . . . . 0.0 109.498 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.915 HD23 ' HB3' ' A' ' 33' ' ' ASN . 2.1 mp -82.47 126.17 31.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.27 -0.894 . . . . 0.0 109.368 179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -124.01 -23.81 4.53 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.196 -0.94 . . . . 0.0 109.79 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.3 t -90.85 142.1 27.32 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.148 -0.97 . . . . 0.0 109.426 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.445 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 35.4 Cg_endo -78.18 101.63 1.49 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.477 2.118 . . . . 0.0 110.423 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.723 ' O ' HD23 ' A' ' 32' ' ' LEU . . . 98.93 47.41 1.91 Allowed Glycine 0 N--CA 1.489 2.194 0 N-CA-C 109.175 -1.57 . . . . 0.0 109.175 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.411 ' N ' ' HB3' ' A' ' 32' ' ' LEU . 0.5 OUTLIER -170.83 94.01 0.19 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.428 -1.042 . . . . 0.0 109.232 -179.697 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.858 ' CB ' HD21 ' A' ' 65' ' ' LEU . 10.6 p -103.2 -79.91 0.53 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.016 -1.053 . . . . 0.0 109.336 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.591 ' H ' ' HG ' ' A' ' 71' ' ' SER . 13.5 m -160.95 110.11 1.64 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.106 -0.996 . . . . 0.0 108.761 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.4 t -79.24 78.74 5.71 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.158 -0.964 . . . . 0.0 108.757 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.806 HG21 ' HG ' ' A' ' 59' ' ' LEU . 84.9 m -62.4 96.77 0.08 Allowed 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.45 -0.781 . . . . 0.0 109.847 -179.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.588 ' HA ' HG23 ' A' ' 28' ' ' THR . 1.7 t -79.23 74.3 5.82 Favored 'General case' 0 C--N 1.302 -1.481 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.912 ' CZ ' HD21 ' A' ' 59' ' ' LEU . 28.4 m-85 -33.88 146.05 0.14 Allowed Pre-proline 0 N--CA 1.493 1.724 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.537 ' O ' ' CA ' ' A' ' 26' ' ' GLY . 34.5 Cg_endo -76.22 -179.63 5.44 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.841 2.361 . . . . 0.0 111.482 -178.438 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.05 11.6 9.31 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.456 -0.777 . . . . 0.0 109.062 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.497 ' O ' ' O ' ' A' ' 80' ' ' ALA . 18.8 m-20 -98.88 -71.21 0.7 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.824 ' HB3' ' C ' ' A' ' 25' ' ' PRO . . . 31.51 98.05 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.061 0 O-C-N 122.023 -0.423 . . . . 0.0 111.06 178.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -76.34 157.57 37.11 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.424 2.083 . . . . 0.0 110.708 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.32 139.87 52.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.239 -0.913 . . . . 0.0 109.482 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 157.55 171.87 24.06 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -88.73 129.95 35.44 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.344 -1.092 . . . . 0.0 109.661 -179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.464 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 9.3 m-85 -110.95 137.69 48.27 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.489 HG23 ' HG2' ' A' ' 100' ' ' LYS . 81.1 m -137.07 116.7 12.94 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.978 -1.076 . . . . 0.0 110.619 -179.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.567 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 0.3 OUTLIER -111.13 164.43 12.86 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 178.791 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.49 ' HB2' HG22 ' A' ' 98' ' ' VAL . 6.6 p90 -157.1 -156.42 0.6 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.777 -1.202 . . . . 0.0 110.565 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.478 ' O ' ' HB3' ' A' ' 93' ' ' ARG . 0.5 OUTLIER -132.43 155.88 47.7 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.639 -0.663 . . . . 0.0 109.281 -179.539 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.597 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 12.3 tp10 -88.67 -44.6 0.45 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.088 -1.008 . . . . 0.0 110.715 -179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.597 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.8 Cg_endo -80.27 -55.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.316 -1.132 0 C-N-CA 122.157 1.905 . . . . 0.0 111.041 -179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.573 ' CD2' HD13 ' A' ' 14' ' ' LEU . 5.2 m80 -88.34 32.97 0.75 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.104 -0.998 . . . . 0.0 109.518 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.478 ' HB3' ' O ' ' A' ' 89' ' ' CYS . 12.8 ptt180 -63.09 -23.22 67.34 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.139 -0.976 . . . . 0.0 109.611 -179.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -98.15 7.85 62.54 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.405 ' HB3' ' HB3' ' A' ' 92' ' ' HIS . . . -107.26 35.49 3.03 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.249 -1.148 . . . . 0.0 109.668 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 58.8 35.99 84.78 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.498 ' HG2' ' O ' ' A' ' 14' ' ' LEU . 1.9 mtp -95.69 67.28 2.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.084 -1.245 . . . . 0.0 109.091 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.49 HG22 ' HB2' ' A' ' 88' ' ' TYR . 59.7 t -140.32 107.95 2.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.277 -0.889 . . . . 0.0 109.96 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.561 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -106.64 154.94 16.67 Favored Glycine 0 N--CA 1.487 2.079 0 N-CA-C 109.096 -1.602 . . . . 0.0 109.096 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.489 ' HG2' HG23 ' A' ' 86' ' ' THR . 46.3 mtmt -130.74 135.53 47.88 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.071 -1.253 . . . . 0.0 110.08 -179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.944 HD11 ' CG2' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -101.74 123.5 54.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 N-CA-C 108.534 -0.913 . . . . 0.0 108.534 179.189 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.489 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 1.0 OUTLIER -98.91 108.47 21.16 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 179.103 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.506 HG22 ' CD1' ' A' ' 23' ' ' ILE . 20.7 t -99.15 94.51 3.67 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.35 -0.844 . . . . 0.0 109.491 -178.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -175.8 -157.19 0.05 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.368 -0.833 . . . . 0.0 109.345 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 CA-C-O 117.989 -1.451 . . . . 0.0 109.596 179.857 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.273 0.559 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.8 m -137.12 149.4 47.29 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.235 -0.916 . . . . 0.0 109.568 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.76 ' CB ' HD21 ' A' ' 21' ' ' LEU . 16.8 m-85 -133.95 148.48 51.17 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.21 -0.931 . . . . 0.0 109.291 179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 4' ' ' THR . 1.7 t -137.92 103.67 5.05 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.18 -0.95 . . . . 0.0 109.801 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.706 HG12 ' HD2' ' A' ' 18' ' ' PRO . 21.8 m -87.37 67.26 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.387 0 O-C-N 121.239 -0.913 . . . . 0.0 109.292 179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.59 ' HB3' HD21 ' A' ' 32' ' ' LEU . 1.3 ptmm? -51.35 108.97 0.29 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.275 -0.89 . . . . 0.0 109.725 -179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.678 HD13 ' ND1' ' A' ' 39' ' ' HIS . 0.2 OUTLIER -68.02 175.69 3.01 Favored 'General case' 0 C--N 1.306 -1.297 0 O-C-N 121.233 -0.917 . . . . 0.0 109.322 179.688 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 14' ' ' LEU . . . 67.21 110.45 0.02 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 55.2 p -68.14 -104.0 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.262 -1.14 . . . . 0.0 109.178 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -171.77 26.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 120.885 -1.135 . . . . 0.0 109.848 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -132.22 -9.44 3.36 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.098 -1.001 . . . . 0.0 110.283 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 129.19 3.53 5.25 Favored Glycine 0 N--CA 1.492 2.39 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.121 179.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 6.0 mt -111.43 142.0 44.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.067 -1.255 . . . . 0.0 109.565 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.636 HD11 ' CG1' ' A' ' 36' ' ' VAL . 65.7 mt -103.19 102.43 12.41 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.305 -0.872 . . . . 0.0 109.705 -179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 27.8 m -142.94 138.41 27.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 109.249 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.461 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 10.9 m-85 -56.46 148.9 18.13 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.156 -0.965 . . . . 0.0 109.538 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 16' ' ' PHE . 3.9 mm-40 -143.18 108.52 5.33 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.352 -0.842 . . . . 0.0 109.304 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.706 ' HD2' HG12 ' A' ' 5' ' ' VAL . 35.9 Cg_endo -78.17 174.53 51.35 Favored 'Cis proline' 0 C--N 1.312 -1.377 0 C-N-CA 123.779 -1.342 . . . . 0.0 110.638 0.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -72.59 -54.9 7.85 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.184 -0.948 . . . . 0.0 109.17 179.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -100.58 138.34 37.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.294 -0.878 . . . . 0.0 109.073 179.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.76 HD21 ' CB ' ' A' ' 3' ' ' TYR . 15.8 tp -126.14 113.18 16.69 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.165 -0.959 . . . . 0.0 110.26 -179.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 47.7 m -82.42 94.93 7.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.208 -0.933 . . . . 0.0 108.526 178.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.793 ' CD1' HD13 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -99.14 172.42 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.241 -0.912 . . . . 0.0 110.276 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.554 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 2.8 mmtt -91.99 168.71 12.43 Favored Pre-proline 0 C--N 1.303 -1.428 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 179.118 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.951 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 33.7 Cg_endo -77.18 81.86 2.51 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.052 1.834 . . . . 0.0 110.576 -179.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.501 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 129.47 -1.67 6.07 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.812 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -74.41 177.91 5.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.113 -1.228 . . . . 0.0 109.574 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.459 HG22 ' N ' ' A' ' 29' ' ' VAL . 36.9 m -111.63 157.16 20.75 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.299 -0.876 . . . . 0.0 109.419 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.091 HG21 HD11 ' A' ' 101' ' ' ILE . 4.6 t -130.52 150.67 34.86 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.376 0 O-C-N 121.281 -0.887 . . . . 0.0 109.014 179.74 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -126.91 104.67 8.15 Favored 'General case' 0 N--CA 1.485 1.313 0 O-C-N 121.08 -1.012 . . . . 0.0 110.254 -179.467 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.553 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -107.9 91.45 3.65 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.24 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.713 HD12 ' HA2' ' A' ' 69' ' ' GLY . 0.5 OUTLIER -95.87 161.9 13.81 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.288 -0.882 . . . . 0.0 110.728 -178.176 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.561 ' HA ' HD11 ' A' ' 7' ' ' LEU . 2.0 p-10 -80.36 160.29 25.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.626 -0.671 . . . . 0.0 109.404 -179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.435 ' HB2' ' O ' ' A' ' 7' ' ' LEU . 59.5 t30 -103.41 -76.21 0.59 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.949 -1.094 . . . . 0.0 109.211 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.443 ' C ' HG23 ' A' ' 36' ' ' VAL . 1.5 pttt -157.61 34.33 0.27 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.248 -0.907 . . . . 0.0 108.897 179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.636 ' CG1' HD11 ' A' ' 14' ' ' LEU . 14.9 t -154.17 65.05 4.91 Favored Pre-proline 0 N--CA 1.489 1.482 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.582 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 35.3 Cg_endo -78.57 176.04 10.35 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 123.091 2.527 . . . . 0.0 110.934 -179.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.582 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 39.2 Cg_endo -87.62 157.65 45.61 Favored 'Cis proline' 0 C--N 1.311 -1.428 0 O-C-N 123.818 1.43 . . . . 0.0 110.868 -1.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.713 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 73.7 m-70 -118.41 118.72 32.52 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.578 -0.701 . . . . 0.0 109.783 179.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.481 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 17.7 t-20 -100.32 126.0 46.61 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.285 -0.884 . . . . 0.0 108.762 179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.504 ' HB ' ' NE2' ' A' ' 61' ' ' HIS . 71.0 t -104.92 131.15 54.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.083 -1.011 . . . . 0.0 109.992 -179.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.653 HG12 ' HB3' ' A' ' 60' ' ' SER . 0.0 OUTLIER -152.62 172.86 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 179.716 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.79 ' CD2' HD23 ' A' ' 59' ' ' LEU . 3.6 m-85 -124.53 109.77 13.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.017 -1.052 . . . . 0.0 109.903 -179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.504 ' HB3' HD12 ' A' ' 47' ' ' LEU . 37.0 t0 -47.11 131.01 12.77 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.42 -0.8 . . . . 0.0 109.404 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -89.4 18.23 5.44 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.269 -0.894 . . . . 0.0 109.967 -179.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -120.86 9.56 10.69 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.026 -1.046 . . . . 0.0 109.652 179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.504 HD12 ' HB3' ' A' ' 44' ' ' ASP . 3.2 mt -131.06 60.38 1.66 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.176 -0.953 . . . . 0.0 109.464 -179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.519 ' ND2' ' HA ' ' A' ' 51' ' ' LYS . 0.7 OUTLIER -121.58 163.66 29.37 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.208 -0.932 . . . . 0.0 109.514 -179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.462 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 35.1 Cg_endo -77.51 -46.21 0.14 Allowed 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.627 2.218 . . . . 0.0 110.821 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.469 ' C ' ' HG2' ' A' ' 51' ' ' LYS . . . -115.76 37.34 3.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.131 -0.981 . . . . 0.0 109.995 -179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.519 ' HA ' ' ND2' ' A' ' 48' ' ' ASN . 0.9 OUTLIER 36.21 47.22 0.45 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.664 -0.647 . . . . 0.0 110.545 179.545 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.571 ' O ' HD23 ' A' ' 55' ' ' LEU . 26.8 m -99.79 89.84 4.24 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.138 -0.976 . . . . 0.0 109.373 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -75.76 -19.61 58.9 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.263 -0.898 . . . . 0.0 109.486 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.08 -25.54 45.76 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.246 -0.909 . . . . 0.0 109.483 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.571 HD23 ' O ' ' A' ' 52' ' ' SER . 1.8 pp -75.88 -25.35 56.06 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.239 -0.913 . . . . 0.0 109.692 -179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.417 ' O ' ' N ' ' A' ' 58' ' ' SER . . . -74.1 -53.99 8.75 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.226 -0.921 . . . . 0.0 109.896 -179.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 56' ' ' ALA . 1.4 mmtt -43.57 -26.2 0.21 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.194 -0.941 . . . . 0.0 109.735 -179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.417 ' N ' ' O ' ' A' ' 56' ' ' ALA . 2.8 m -110.97 22.18 15.6 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.103 -0.998 . . . . 0.0 109.859 -179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.79 HD23 ' CD2' ' A' ' 43' ' ' PHE . 8.2 tp -128.24 -36.91 1.89 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.154 -0.966 . . . . 0.0 109.074 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.653 ' HB3' HG12 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -77.55 141.91 39.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.396 -0.815 . . . . 0.0 109.601 -179.783 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.558 ' CE1' ' O ' ' A' ' 63' ' ' GLN . 21.1 p80 -99.91 -23.02 15.06 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.444 -0.785 . . . . 0.0 109.862 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 61' ' ' HIS . 0.0 OUTLIER 70.62 -65.67 0.32 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.144 -0.973 . . . . 0.0 109.236 -179.714 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.558 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 0.8 OUTLIER -45.42 127.2 7.15 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.259 -0.901 . . . . 0.0 109.453 179.732 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.469 ' H ' HD12 ' A' ' 64' ' ' LEU . 5.0 mp -68.01 170.45 8.31 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.222 -0.924 . . . . 0.0 109.727 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.766 HD22 ' HA ' ' A' ' 71' ' ' SER . 6.2 mt -115.74 100.55 8.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.363 -0.836 . . . . 0.0 109.032 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 62.5 mtt -96.99 2.82 51.99 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.277 -0.889 . . . . 0.0 109.828 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 13.1 t -79.88 139.74 53.95 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.112 -0.992 . . . . 0.0 109.24 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -78.63 88.78 1.41 Allowed 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.613 2.209 . . . . 0.0 110.918 -179.634 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.713 ' HA2' HD12 ' A' ' 32' ' ' LEU . . . 88.25 49.01 3.86 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -172.74 92.36 0.11 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.333 -1.098 . . . . 0.0 109.108 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.766 ' HA ' HD22 ' A' ' 65' ' ' LEU . 80.0 p -99.07 -140.37 0.32 Allowed 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.55 -0.908 . . . . 0.0 108.55 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.473 HG23 ' O ' ' A' ' 72' ' ' THR . 10.2 t -123.21 127.69 48.98 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.979 -1.076 . . . . 0.0 108.337 178.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.439 ' O ' ' OG ' ' A' ' 73' ' ' SER . 17.9 p -79.18 96.88 6.0 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.137 -0.977 . . . . 0.0 109.639 -179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.618 HG21 ' O ' ' A' ' 59' ' ' LEU . 1.2 m -70.3 113.63 7.64 Favored 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.402 -0.811 . . . . 0.0 109.259 179.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.44 ' O ' ' C ' ' A' ' 76' ' ' PHE . 54.5 m -79.25 88.71 4.91 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.361 -0.837 . . . . 0.0 109.113 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 1.116 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 10.4 m-85 -43.13 160.43 0.21 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.376 -0.828 . . . . 0.0 108.903 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.501 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 32.6 Cg_endo -76.22 150.7 33.39 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.443 2.095 . . . . 0.0 111.483 -179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.463 ' HA ' ' HA3' ' A' ' 26' ' ' GLY . . . -69.47 -11.28 60.7 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 109.125 -0.694 . . . . 0.0 109.125 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.457 ' O ' ' C ' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -100.65 15.9 26.63 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 121.332 -0.855 . . . . 0.0 109.141 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.951 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -39.65 109.86 0.59 Allowed Pre-proline 0 N--CA 1.493 1.678 0 O-C-N 121.605 -0.684 . . . . 0.0 109.313 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.448 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 33.7 Cg_endo -75.02 121.35 6.52 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.354 2.036 . . . . 0.0 110.514 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.492 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -43.64 136.93 3.17 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.479 -0.763 . . . . 0.0 109.382 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 164.64 -167.38 38.42 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -120.68 115.62 23.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.407 -1.055 . . . . 0.0 109.484 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.448 ' OH ' ' HD2' ' A' ' 81' ' ' PRO . 23.2 m-85 -93.88 165.27 12.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.369 -0.832 . . . . 0.0 109.07 179.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.776 HG22 ' CG2' ' A' ' 98' ' ' VAL . 0.2 OUTLIER -144.46 97.81 3.1 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.057 -1.027 . . . . 0.0 110.205 -179.809 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.571 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.5 OUTLIER -101.96 157.77 16.62 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.356 -0.84 . . . . 0.0 108.842 178.988 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.531 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 4.5 p90 -160.24 -148.4 0.17 Allowed 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.157 -0.964 . . . . 0.0 109.653 -179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.485 ' HB3' ' HD2' ' A' ' 91' ' ' PRO . 74.7 m -132.96 161.29 34.69 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.159 -0.963 . . . . 0.0 109.641 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.588 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 19.5 tt0 -77.71 -47.25 2.37 Favored Pre-proline 0 C--N 1.304 -1.399 0 O-C-N 121.298 -0.876 . . . . 0.0 109.23 178.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.588 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.5 Cg_endo -79.23 -66.55 0.02 OUTLIER 'Trans proline' 0 C--N 1.317 -1.106 0 C-N-CA 122.206 1.938 . . . . 0.0 110.478 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.713 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 14.4 m80 -55.03 87.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.063 -1.023 . . . . 0.0 109.149 179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 91' ' ' PRO . 3.7 mtm180 -131.05 32.73 4.26 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.162 -0.961 . . . . 0.0 109.592 -179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -149.99 16.78 1.05 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.499 -1.44 . . . . 0.0 109.499 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -138.69 37.32 2.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.279 -1.13 . . . . 0.0 109.479 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 51.71 53.65 28.41 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.573 ' HE1' ' HB2' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -102.04 56.86 0.81 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.21 -1.171 . . . . 0.0 109.423 179.807 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.776 ' CG2' HG22 ' A' ' 86' ' ' THR . 2.5 p -135.6 94.72 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.244 -0.91 . . . . 0.0 109.383 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.571 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -70.99 179.24 31.89 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 110.007 -1.237 . . . . 0.0 110.007 -179.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.585 ' HG2' HG23 ' A' ' 86' ' ' THR . 23.0 mtmm -154.81 131.18 10.44 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.274 -1.133 . . . . 0.0 109.707 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 1.116 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 0.1 OUTLIER -96.99 136.68 26.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.166 -0.959 . . . . 0.0 108.594 179.207 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -122.4 100.59 7.02 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.246 -0.909 . . . . 0.0 109.147 179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.554 HG22 ' CD1' ' A' ' 23' ' ' ILE . 1.6 t -99.94 125.55 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.889 . . . . 0.0 109.562 -179.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -105.49 -74.96 0.64 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.193 -0.942 . . . . 0.0 109.23 179.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.248 0 CA-C-O 117.938 -1.479 . . . . 0.0 109.437 179.84 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.275 0.56 . . . . 0.0 109.571 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -136.65 139.91 42.37 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.282 -0.886 . . . . 0.0 109.458 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.457 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 15.8 m-85 -117.08 174.45 6.1 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.258 -0.901 . . . . 0.0 109.468 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 23.9 m -156.35 116.41 3.61 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.246 -0.909 . . . . 0.0 109.466 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.744 HG12 ' H ' ' A' ' 17' ' ' GLU . 1.4 t -104.17 82.58 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.91 . . . . 0.0 109.449 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.979 ' HG2' HD11 ' A' ' 32' ' ' LEU . 6.7 mttp -69.8 85.97 0.49 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.284 -0.885 . . . . 0.0 109.383 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.67 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.2 OUTLIER -62.54 -172.58 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.281 0 O-C-N 121.239 -0.913 . . . . 0.0 109.599 -179.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.481 ' CA ' HD23 ' A' ' 14' ' ' LEU . . . 54.92 87.4 0.02 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.8 p -60.55 -90.43 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.24 -1.153 . . . . 0.0 109.422 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -175.57 29.55 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.243 -0.911 . . . . 0.0 109.718 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -123.05 -19.28 6.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.188 -0.945 . . . . 0.0 109.523 179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.03 -13.83 5.74 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.323 -1.511 . . . . 0.0 109.323 -179.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.1 mt -96.23 147.65 23.54 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.303 -1.116 . . . . 0.0 109.141 179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.538 ' CD1' ' CD2' ' A' ' 92' ' ' HIS . 16.0 mt -109.8 112.18 24.07 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.179 -0.951 . . . . 0.0 109.553 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.56 HG12 ' HA3' ' A' ' 96' ' ' GLY . 6.0 m -138.56 136.0 43.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.258 -0.901 . . . . 0.0 109.468 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.634 ' HD2' HG11 ' A' ' 5' ' ' VAL . 28.4 m-85 -54.57 143.4 24.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.212 -0.93 . . . . 0.0 109.363 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.744 ' H ' HG12 ' A' ' 5' ' ' VAL . 27.3 mt-10 -143.0 108.76 5.42 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.26 -0.9 . . . . 0.0 108.995 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.464 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.4 Cg_endo -76.59 164.68 86.99 Favored 'Cis proline' 0 C--N 1.311 -1.408 0 C-N-CA 123.811 -1.329 . . . . 0.0 110.894 0.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.51 -60.25 2.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.435 -0.791 . . . . 0.0 109.914 -179.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.474 ' O ' HD22 ' A' ' 21' ' ' LEU . 0.0 OUTLIER -78.78 136.59 37.41 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.223 -0.923 . . . . 0.0 109.553 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.481 HD13 ' HA ' ' A' ' 21' ' ' LEU . 0.8 OUTLIER -127.04 109.55 12.01 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.232 -0.918 . . . . 0.0 109.777 -179.764 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 6.4 m -88.71 94.98 10.09 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.215 -0.928 . . . . 0.0 108.835 179.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.655 HD12 ' O ' ' A' ' 24' ' ' LYS . 1.1 pp -106.72 165.41 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 O-C-N 121.32 -0.862 . . . . 0.0 110.197 -179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.655 ' O ' HD12 ' A' ' 23' ' ' ILE . 0.0 OUTLIER -88.68 -178.76 1.1 Allowed Pre-proline 0 C--N 1.302 -1.485 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 178.815 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.601 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 36.3 Cg_endo -80.2 86.3 1.68 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.123 1.882 . . . . 0.0 110.694 -179.143 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.498 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 123.74 2.07 8.83 Favored Glycine 0 N--CA 1.492 2.4 0 N-CA-C 109.84 -1.304 . . . . 0.0 109.84 179.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.479 ' OD2' ' HG3' ' A' ' 24' ' ' LYS . 4.0 m-20 -66.22 -179.17 0.73 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.221 -1.164 . . . . 0.0 109.21 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 57.2 m -121.97 120.46 34.48 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.293 -0.88 . . . . 0.0 109.362 179.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.026 ' CG2' HD11 ' A' ' 101' ' ' ILE . 21.8 t -99.15 123.75 52.0 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.345 -0.847 . . . . 0.0 108.994 179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -99.61 123.03 43.49 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.242 -0.911 . . . . 0.0 109.9 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.603 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -122.64 142.85 50.21 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 179.124 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.979 HD11 ' HG2' ' A' ' 6' ' ' LYS . 0.0 OUTLIER -142.43 179.2 7.09 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.977 -1.077 . . . . 0.0 110.222 -179.584 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.577 ' ND2' ' O ' ' A' ' 67' ' ' SER . 0.4 OUTLIER -105.88 130.64 53.8 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.641 -0.662 . . . . 0.0 109.716 179.072 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.461 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 45.6 t30 -72.16 -59.57 2.67 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.068 -1.02 . . . . 0.0 109.205 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -172.72 36.02 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.311 -0.868 . . . . 0.0 109.42 179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.614 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 32.1 t -148.65 55.79 2.25 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.303 -0.873 . . . . 0.0 109.729 179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.614 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 37.0 Cg_endo -78.8 174.62 11.99 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.461 2.107 . . . . 0.0 110.443 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 37.8 Cg_endo -84.89 169.92 48.65 Favored 'Cis proline' 0 C--N 1.31 -1.477 0 C-N-CA 123.463 -1.474 . . . . 0.0 110.145 -1.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.689 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 71.9 m-70 -123.03 152.89 40.52 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.279 -0.888 . . . . 0.0 110.543 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.428 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 0.1 OUTLIER -124.23 103.11 8.05 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 178.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 33.7 t -98.92 109.35 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.71 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.794 HG13 ' HB3' ' A' ' 60' ' ' SER . 3.1 t -134.26 162.32 39.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.44 -0.788 . . . . 0.0 109.591 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.588 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 6.0 m-85 -110.13 96.76 6.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.397 -0.814 . . . . 0.0 109.666 -179.437 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 43' ' ' PHE . 9.0 t70 -43.34 167.64 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.506 -0.746 . . . . 0.0 109.86 -179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -115.91 15.2 16.28 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.397 -0.815 . . . . 0.0 109.437 179.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -120.24 -3.71 10.01 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.271 -0.893 . . . . 0.0 109.614 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.0 mp -114.2 40.21 2.56 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.159 -0.963 . . . . 0.0 109.497 -179.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.49 ' OD1' ' HA ' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -109.6 165.93 11.74 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.268 -0.895 . . . . 0.0 109.442 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.649 ' CG ' ' HB1' ' A' ' 82' ' ' ALA . 34.9 Cg_endo -77.11 -53.39 0.07 OUTLIER 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 122.631 2.221 . . . . 0.0 110.493 -179.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.454 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -100.61 30.37 3.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.18 -0.95 . . . . 0.0 109.363 179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.49 ' HA ' ' OD1' ' A' ' 48' ' ' ASN . 0.3 OUTLIER 39.82 54.35 2.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.703 -0.623 . . . . 0.0 109.76 179.888 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.43 ' O ' ' ND2' ' A' ' 48' ' ' ASN . 1.5 m -99.98 152.59 20.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.919 . . . . 0.0 109.494 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.85 47.84 1.53 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.242 -0.911 . . . . 0.0 109.515 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.401 ' N ' ' OD1' ' A' ' 54' ' ' ASP . 4.6 m-20 -115.09 -71.78 0.73 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.235 -0.916 . . . . 0.0 109.57 -179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.473 ' HG ' ' N ' ' A' ' 56' ' ' ALA . 1.1 pp -53.92 -27.67 32.08 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.205 -0.934 . . . . 0.0 109.46 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.473 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -66.15 -38.58 88.47 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.204 -0.935 . . . . 0.0 109.325 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.29 -36.33 75.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.247 -0.908 . . . . 0.0 109.39 -179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 20.7 t -101.77 30.47 4.35 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.249 -0.907 . . . . 0.0 109.499 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.76 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 10.2 tp -120.26 -33.49 3.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.243 -0.911 . . . . 0.0 109.293 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.794 ' HB3' HG13 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -78.88 152.69 31.06 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.353 -0.842 . . . . 0.0 110.603 -178.972 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.656 ' CD2' HG21 ' A' ' 72' ' ' THR . 10.3 p80 -98.07 168.55 10.2 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.66 -33.02 4.39 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.047 -1.033 . . . . 0.0 109.784 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 54.6 tt0 -73.81 108.31 6.57 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.113 -0.992 . . . . 0.0 109.553 -179.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.437 ' HA ' HD22 ' A' ' 64' ' ' LEU . 1.5 mm? -44.47 157.9 0.06 Allowed 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.15 -0.969 . . . . 0.0 109.566 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.954 HD13 ' HB2' ' A' ' 71' ' ' SER . 0.8 OUTLIER -104.82 91.56 3.88 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.479 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 0.0 OUTLIER -89.18 -15.46 33.7 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.208 -0.932 . . . . 0.0 110.869 -178.703 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.577 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 22.9 t -78.75 113.06 31.81 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 120.857 -1.152 . . . . 0.0 108.52 179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 66' ' ' MET . 32.1 Cg_endo -73.44 120.21 6.38 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 C-N-CA 122.301 2.0 . . . . 0.0 111.007 -178.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.55 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 110.74 -15.4 29.09 Favored Glycine 0 N--CA 1.494 2.512 0 N-CA-C 109.633 -1.387 . . . . 0.0 109.633 -179.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.56 ' N ' ' OD1' ' A' ' 33' ' ' ASN . 0.0 OUTLIER -149.45 113.39 5.13 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.349 -1.089 . . . . 0.0 109.097 179.795 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.954 ' HB2' HD13 ' A' ' 65' ' ' LEU . 4.2 p -103.31 -135.91 0.33 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.123 -0.985 . . . . 0.0 108.931 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.672 ' N ' HD22 ' A' ' 65' ' ' LEU . 6.9 t -114.94 157.08 23.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.746 -1.221 . . . . 0.0 109.296 179.666 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.93 -173.41 2.44 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.15 -0.969 . . . . 0.0 109.414 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.58 HG21 ' HG ' ' A' ' 59' ' ' LEU . 29.8 m -162.78 108.2 1.16 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.234 -0.916 . . . . 0.0 109.728 -179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -84.96 88.99 7.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.249 -0.907 . . . . 0.0 109.415 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 1.033 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 8.9 m-85 -45.34 163.63 0.2 Allowed Pre-proline 0 N--CA 1.488 1.445 0 O-C-N 121.324 -0.86 . . . . 0.0 109.286 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.498 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.6 Cg_endo -76.91 161.1 33.43 Favored 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.602 2.202 . . . . 0.0 111.159 -179.211 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.45 -3.2 13.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.498 -0.751 . . . . 0.0 110.035 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.528 ' O ' ' HB3' ' A' ' 25' ' ' PRO . 0.8 OUTLIER -99.37 -76.16 0.55 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.09 -1.006 . . . . 0.0 109.2 179.826 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.56 ' HB1' HG21 ' A' ' 103' ' ' VAL . . . 37.7 57.52 4.45 Favored Pre-proline 0 N--CA 1.494 1.761 0 O-C-N 121.553 -0.717 . . . . 0.0 110.399 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.648 ' O ' ' HB3' ' A' ' 82' ' ' ALA . 36.1 Cg_endo -77.93 -160.37 0.12 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.373 2.049 . . . . 0.0 110.282 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.649 ' HB1' ' CG ' ' A' ' 49' ' ' PRO . . . 72.7 -73.83 0.09 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.28 -0.888 . . . . 0.0 109.896 179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.427 ' HA2' ' N ' ' A' ' 103' ' ' VAL . . . 108.12 25.43 5.86 Favored Glycine 0 N--CA 1.487 2.056 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.543 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -151.37 111.56 4.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.316 -1.108 . . . . 0.0 109.895 -179.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.479 ' O ' ' HA ' ' A' ' 100' ' ' LYS . 52.5 m-85 -138.54 83.85 1.99 Allowed 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.447 ' OG1' ' CD ' ' A' ' 100' ' ' LYS . 18.4 m -78.29 121.29 24.23 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.301 -0.874 . . . . 0.0 110.596 -178.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.492 ' CE1' ' C ' ' A' ' 99' ' ' GLY . 2.0 p90 -117.07 173.1 6.85 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.476 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 2.9 p90 -158.78 -157.4 0.61 Allowed 'General case' 0 C--N 1.303 -1.455 0 O-C-N 120.836 -1.165 . . . . 0.0 110.228 -179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 0.1 OUTLIER -131.83 151.99 51.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.4 -0.813 . . . . 0.0 109.725 -179.305 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.612 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 1.8 tm-20 -82.77 -45.61 0.9 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.262 -0.899 . . . . 0.0 109.932 179.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.7 Cg_endo -80.53 -51.12 0.05 OUTLIER 'Trans proline' 0 C--N 1.316 -1.184 0 C-N-CA 122.125 1.883 . . . . 0.0 110.592 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.689 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 12.9 m80 -86.01 40.61 0.87 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.276 -0.89 . . . . 0.0 109.71 -179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.443 ' HG2' ' N ' ' A' ' 94' ' ' GLY . 16.5 ttt180 -76.49 141.09 41.41 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.198 -0.939 . . . . 0.0 109.358 179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.443 ' N ' ' HG2' ' A' ' 93' ' ' ARG . . . 72.63 17.66 78.16 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.663 -1.375 . . . . 0.0 109.663 179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.88 37.68 4.25 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.157 -1.202 . . . . 0.0 109.513 179.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.56 ' HA3' HG12 ' A' ' 15' ' ' VAL . . . 72.65 12.09 77.65 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 -179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.535 ' CE ' ' HB2' ' A' ' 7' ' ' LEU . 0.2 OUTLIER -95.66 64.66 2.56 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.176 -1.19 . . . . 0.0 109.497 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 28.3 t -140.24 73.84 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.224 -0.923 . . . . 0.0 109.661 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.492 ' C ' ' CE1' ' A' ' 87' ' ' PHE . . . -89.05 167.73 34.78 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.479 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 14.3 mttp -144.23 138.08 27.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.152 -1.205 . . . . 0.0 109.758 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 1.033 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -89.14 126.31 42.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.263 -0.898 . . . . 0.0 108.876 179.683 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 99.6 m -101.91 99.6 9.81 Favored 'General case' 0 C--N 1.302 -1.486 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 179.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.56 HG21 ' HB1' ' A' ' 80' ' ' ALA . 2.5 t -98.9 73.45 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.222 -0.924 . . . . 0.0 109.672 -179.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.432 ' C ' ' O ' ' A' ' 103' ' ' VAL . . . -42.98 95.54 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.369 -0.832 . . . . 0.0 109.414 179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 103' ' ' VAL . . . . . . . . 0 N--CA 1.491 2.304 0 CA-C-O 117.98 -1.455 . . . . 0.0 109.469 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 . . . . . 0 N--CA 1.491 1.59 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.19 167.57 10.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.219 -0.926 . . . . 0.0 109.482 -179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -131.07 93.08 3.32 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.228 -0.92 . . . . 0.0 109.322 179.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.734 HG23 ' HB3' ' A' ' 30' ' ' GLU . 0.1 OUTLIER -92.7 103.41 15.79 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.224 -0.922 . . . . 0.0 109.597 -179.841 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.449 HG11 HD13 ' A' ' 21' ' ' LEU . 8.2 m -96.05 110.86 25.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.212 -0.93 . . . . 0.0 109.281 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.447 ' C ' HD13 ' A' ' 7' ' ' LEU . 11.1 mttt -79.82 133.55 36.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.238 -0.914 . . . . 0.0 109.454 -179.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.982 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -110.03 73.46 0.84 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.219 -0.926 . . . . 0.0 109.736 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.452 ' HA2' HD23 ' A' ' 14' ' ' LEU . . . 165.52 77.85 0.03 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.831 -1.307 . . . . 0.0 109.831 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.478 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 2.0 p -47.84 -31.13 4.65 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.265 -1.139 . . . . 0.0 109.186 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.478 ' CB ' ' O ' ' A' ' 9' ' ' SER . 6.4 t0 75.78 19.1 2.03 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.339 -0.851 . . . . 0.0 109.562 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 11.0 mttp -135.46 7.42 3.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.211 -0.93 . . . . 0.0 109.722 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -173.49 -79.63 0.05 OUTLIER Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.826 -1.31 . . . . 0.0 109.826 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -132.17 -171.48 2.65 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -1.155 . . . . 0.0 109.743 -179.617 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.596 ' HB3' ' HE1' ' A' ' 97' ' ' MET . 8.6 mt -106.12 126.81 52.67 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.386 -0.821 . . . . 0.0 108.956 179.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.515 HG13 ' O ' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -157.18 136.5 3.6 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.089 -1.007 . . . . 0.0 109.769 -179.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -53.22 157.89 1.76 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.124 -0.985 . . . . 0.0 108.901 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 2.2 mt-10 -150.96 108.44 3.04 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.183 -0.948 . . . . 0.0 109.518 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.499 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 35.2 Cg_endo -78.95 166.62 78.82 Favored 'Cis proline' 0 C--N 1.313 -1.291 0 C-N-CA 123.898 -1.292 . . . . 0.0 110.534 -0.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.9 -54.21 14.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.094 -1.004 . . . . 0.0 108.978 179.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 18.7 mtmm -86.06 159.42 19.57 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.361 -0.837 . . . . 0.0 108.893 179.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.449 HD13 HG11 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -157.99 129.01 6.49 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.012 -1.055 . . . . 0.0 109.944 -179.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 86.0 m -100.0 90.14 4.29 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.378 -0.826 . . . . 0.0 109.213 179.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.79 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -99.56 166.1 2.21 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 O-C-N 121.206 -0.934 . . . . 0.0 109.995 -179.661 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.476 ' HB2' ' OD2' ' A' ' 27' ' ' ASP . 0.1 OUTLIER -89.28 173.0 6.48 Favored Pre-proline 0 C--N 1.301 -1.518 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 179.348 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.688 ' HB3' ' HB3' ' A' ' 80' ' ' ALA . 34.7 Cg_endo -76.64 83.3 2.1 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 C-N-CA 122.178 1.919 . . . . 0.0 110.497 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.486 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 137.56 -26.73 2.89 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 109.771 -1.332 . . . . 0.0 109.771 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.476 ' OD2' ' HB2' ' A' ' 24' ' ' LYS . 3.1 m-20 -43.8 165.35 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.234 -1.156 . . . . 0.0 109.414 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 86.7 m -111.05 118.34 35.78 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.205 -0.934 . . . . 0.0 109.678 -179.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.898 HG21 HD11 ' A' ' 101' ' ' ILE . 2.7 t -99.21 123.85 52.14 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.346 0 O-C-N 121.199 -0.938 . . . . 0.0 109.17 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.734 ' HB3' HG23 ' A' ' 4' ' ' THR . 0.0 OUTLIER -100.23 128.61 46.27 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.245 -0.909 . . . . 0.0 109.975 -179.532 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.581 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -129.23 146.1 51.21 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.479 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.982 ' O ' HD21 ' A' ' 7' ' ' LEU . 0.0 OUTLIER -140.63 -167.74 2.41 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.966 -1.084 . . . . 0.0 110.353 -179.609 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.52 ' ND2' ' O ' ' A' ' 67' ' ' SER . 2.1 p-10 -114.83 160.22 19.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.263 -0.898 . . . . 0.0 109.57 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.413 ' CG ' ' HA3' ' A' ' 8' ' ' GLY . 12.9 t30 -104.47 -154.28 0.5 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.249 -0.907 . . . . 0.0 109.417 179.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 11.2 ptmt -92.89 28.31 2.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.13 -0.981 . . . . 0.0 109.254 179.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.592 ' HB ' HD11 ' A' ' 14' ' ' LEU . 3.0 t -141.84 61.89 13.6 Favored Pre-proline 0 C--N 1.299 -1.611 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.351 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.585 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.4 Cg_endo -77.93 177.32 8.94 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 123.05 2.5 . . . . 0.0 110.804 -179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.585 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 39.6 Cg_endo -87.91 158.91 44.84 Favored 'Cis proline' 0 C--N 1.313 -1.315 0 O-C-N 123.723 1.381 . . . . 0.0 110.908 -1.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.707 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 72.5 m-70 -118.65 156.73 28.73 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.493 -0.754 . . . . 0.0 109.501 179.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.442 ' O ' ' HA ' ' A' ' 89' ' ' CYS . 18.9 t30 -140.08 114.33 9.12 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.293 -0.879 . . . . 0.0 109.019 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.558 ' O ' HG13 ' A' ' 42' ' ' VAL . 3.8 t -99.72 122.75 51.93 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.277 -0.889 . . . . 0.0 109.125 -179.728 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.636 ' HA ' ' CB ' ' A' ' 60' ' ' SER . 0.2 OUTLIER -157.96 141.36 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.106 -0.996 . . . . 0.0 110.231 179.746 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.628 ' CE2' ' CG ' ' A' ' 59' ' ' LEU . 4.4 m-85 -85.98 121.5 28.69 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.737 -0.602 . . . . 0.0 109.793 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 43' ' ' PHE . 24.9 t70 -45.74 169.0 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.413 -0.804 . . . . 0.0 109.419 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -108.86 -16.06 14.24 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.219 -0.926 . . . . 0.0 109.943 -179.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -115.69 -14.01 11.44 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.138 -0.977 . . . . 0.0 109.682 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.428 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 2.8 mm? -94.1 48.83 1.27 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.182 -0.949 . . . . 0.0 109.433 -179.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.526 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 3.5 p30 -129.48 163.83 43.82 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.254 -0.904 . . . . 0.0 109.496 -179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.526 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 34.0 Cg_endo -76.3 -11.57 19.15 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.486 2.124 . . . . 0.0 109.95 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.529 ' O ' ' N ' ' A' ' 52' ' ' SER . . . -139.4 77.33 1.61 Allowed 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.433 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.4 OUTLIER -40.4 93.7 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.588 -0.695 . . . . 0.0 109.973 -179.417 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.529 ' N ' ' O ' ' A' ' 50' ' ' ALA . 2.0 m -140.35 154.23 46.68 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.321 -0.862 . . . . 0.0 109.389 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -119.01 72.03 0.87 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.269 -0.894 . . . . 0.0 109.254 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -167.73 -38.4 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.156 -0.965 . . . . 0.0 109.699 -179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.856 ' O ' HD12 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -78.13 -8.14 57.89 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.112 -0.992 . . . . 0.0 109.517 -179.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.425 ' O ' ' C ' ' A' ' 57' ' ' LYS . . . -112.47 -43.83 3.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.259 -0.901 . . . . 0.0 109.632 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 56' ' ' ALA . 47.7 tttp -43.52 -48.63 7.44 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.269 -0.894 . . . . 0.0 109.575 -179.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 1.1 m -98.15 25.55 6.05 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.893 . . . . 0.0 109.682 -179.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.768 ' HG ' HG21 ' A' ' 74' ' ' THR . 17.1 tp -104.1 -62.53 1.3 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.147 -0.971 . . . . 0.0 109.625 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.636 ' CB ' ' HA ' ' A' ' 42' ' ' VAL . 0.3 OUTLIER -85.8 -167.61 1.92 Allowed 'General case' 0 N--CA 1.486 1.335 0 O-C-N 121.222 -0.924 . . . . 0.0 110.637 -178.778 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.663 ' HB3' HG21 ' A' ' 72' ' ' THR . 25.3 p80 -120.68 142.0 49.88 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 109.16 -0.682 . . . . 0.0 109.16 -179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.29 -42.33 13.83 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 0.0 109.59 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.467 ' NE2' ' O ' ' A' ' 64' ' ' LEU . 0.0 OUTLIER -46.65 163.76 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.898 . . . . 0.0 109.496 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.741 ' H ' HD12 ' A' ' 64' ' ' LEU . 2.3 mp -97.37 -179.01 4.35 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.2 -0.938 . . . . 0.0 109.411 179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.701 HD12 ' O ' ' A' ' 64' ' ' LEU . 7.1 mp -118.96 81.98 1.79 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -0.951 . . . . 0.0 109.407 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -82.13 -34.7 29.1 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.236 -0.915 . . . . 0.0 109.524 -179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.52 ' O ' ' ND2' ' A' ' 33' ' ' ASN . 46.0 t -80.58 146.83 61.83 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.224 -0.922 . . . . 0.0 109.531 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.464 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 35.5 Cg_endo -77.84 102.55 1.6 Allowed 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.641 2.228 . . . . 0.0 110.594 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.493 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 109.24 -26.67 14.37 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.512 ' CB ' ' HB3' ' A' ' 67' ' ' SER . 6.8 tt0 -62.22 105.63 0.63 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.132 -1.217 . . . . 0.0 108.464 179.596 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.576 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . 21.5 p -137.86 -161.48 1.18 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.165 -0.959 . . . . 0.0 110.695 -178.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.663 HG21 ' HB3' ' A' ' 61' ' ' HIS . 1.8 t -153.82 124.16 7.02 Favored 'General case' 0 N--CA 1.488 1.472 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 4.3 p -79.27 135.93 36.9 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.141 -0.974 . . . . 0.0 109.517 -179.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.768 HG21 ' HG ' ' A' ' 59' ' ' LEU . 86.3 m -98.54 114.33 26.71 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.377 -0.827 . . . . 0.0 109.711 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.456 HG22 ' H ' ' A' ' 75' ' ' THR . 1.2 t -83.83 82.97 8.1 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.277 -0.89 . . . . 0.0 109.452 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 1.017 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 14.6 m-85 -43.34 149.1 0.59 Allowed Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 109.094 179.766 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.486 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.6 Cg_endo -75.99 168.89 23.24 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.592 2.194 . . . . 0.0 110.842 -179.168 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.34 6.59 6.56 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.424 -0.797 . . . . 0.0 109.783 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.489 ' O ' ' O ' ' A' ' 80' ' ' ALA . 30.9 t70 -99.12 -77.6 0.51 Allowed 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.103 -0.998 . . . . 0.0 109.242 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.688 ' HB3' ' HB3' ' A' ' 25' ' ' PRO . . . 56.66 109.31 0.02 OUTLIER Pre-proline 0 N--CA 1.489 1.516 0 O-C-N 121.35 -0.843 . . . . 0.0 108.856 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.437 ' HG2' ' HG2' ' A' ' 49' ' ' PRO . 33.3 Cg_endo -74.31 113.55 3.82 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.328 2.018 . . . . 0.0 110.688 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.438 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -46.41 109.3 0.18 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.365 -0.834 . . . . 0.0 109.459 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.446 ' HA3' ' HB3' ' A' ' 49' ' ' PRO . . . 179.13 -119.28 0.64 Allowed Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -160.44 106.23 1.5 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.2 -1.176 . . . . 0.0 109.784 -179.975 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.607 ' CD2' ' CG2' ' A' ' 101' ' ' ILE . 0.7 OUTLIER -82.35 131.58 35.22 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 179.244 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . . . . . . . . . 92.4 m -111.92 117.25 32.22 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.052 -1.03 . . . . 0.0 110.669 -179.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.591 ' O ' HG13 ' A' ' 98' ' ' VAL . 0.3 OUTLIER -111.51 169.91 8.48 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.658 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.467 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 7.1 p90 -159.12 -154.11 0.4 Allowed 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.856 -1.152 . . . . 0.0 110.089 -179.582 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.442 ' HA ' ' O ' ' A' ' 40' ' ' ASN . 0.5 OUTLIER -128.78 141.78 51.2 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.398 -0.814 . . . . 0.0 109.795 -179.205 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.619 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 7.4 tp10 -72.08 -47.02 11.33 Favored Pre-proline 0 N--CA 1.488 1.454 0 O-C-N 121.201 -0.937 . . . . 0.0 109.57 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.619 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.9 Cg_endo -79.73 -68.25 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.157 0 C-N-CA 122.271 1.981 . . . . 0.0 110.333 179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.707 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 9.9 m80 -69.98 64.44 0.23 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.135 -0.978 . . . . 0.0 109.048 179.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.426 ' N ' ' O ' ' A' ' 91' ' ' PRO . 4.2 mtm180 -84.58 -10.2 57.61 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.248 -0.908 . . . . 0.0 109.678 -179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -122.78 54.32 0.71 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.587 ' HB3' ' HG3' ' A' ' 97' ' ' MET . . . -151.39 39.3 0.65 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.279 -1.13 . . . . 0.0 109.549 179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 48.24 22.05 2.16 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.173 -1.171 . . . . 0.0 110.173 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.596 ' HE1' ' HB3' ' A' ' 14' ' ' LEU . 2.5 mtp -80.5 55.71 2.37 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.981 -1.306 . . . . 0.0 109.116 179.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.591 HG13 ' O ' ' A' ' 87' ' ' PHE . 39.4 t -130.63 113.57 25.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.249 -0.907 . . . . 0.0 109.635 -179.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.55 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -96.55 -173.1 35.12 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.492 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 14.9 mttt -160.53 122.34 3.13 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -1.182 . . . . 0.0 109.66 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 1.017 HD12 ' CZ ' ' A' ' 76' ' ' PHE . 0.7 OUTLIER -91.06 119.03 37.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.149 -0.97 . . . . 0.0 109.344 179.861 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 2.0 m -105.17 94.98 5.53 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 178.831 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.608 HG23 ' CG2' ' A' ' 101' ' ' ILE . 91.3 t -99.28 129.18 50.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.218 -0.926 . . . . 0.0 109.825 -179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -90.41 177.2 6.45 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.406 -0.809 . . . . 0.0 109.481 179.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.312 0 CA-C-O 117.957 -1.468 . . . . 0.0 109.545 179.888 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 8.4 mt-10 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.27 0.557 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.461 HG23 ' HB ' ' A' ' 28' ' ' THR . 0.3 OUTLIER -127.47 111.52 13.91 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.263 -0.898 . . . . 0.0 109.434 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -90.23 154.27 19.86 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 109.437 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.98 107.91 13.67 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.21 -0.931 . . . . 0.0 109.718 -179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.496 ' CG1' ' HB3' ' A' ' 16' ' ' PHE . 1.3 t -105.93 123.28 60.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.28 -0.887 . . . . 0.0 109.324 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.413 ' HG2' HD12 ' A' ' 32' ' ' LEU . 13.8 mttm -117.75 90.3 3.3 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 109.41 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.49 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -50.55 164.38 0.13 Allowed 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.166 -0.959 . . . . 0.0 109.528 179.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 78.18 76.36 0.91 Allowed Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.434 ' O ' ' HB2' ' A' ' 10' ' ' ASP . 3.2 p -48.02 -60.44 2.61 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.221 -1.164 . . . . 0.0 109.306 179.811 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.434 ' HB2' ' O ' ' A' ' 9' ' ' SER . 1.1 t70 174.46 -62.58 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.403 -0.81 . . . . 0.0 109.288 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.85 18.95 6.66 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.313 -0.867 . . . . 0.0 109.283 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.435 ' O ' ' HG ' ' A' ' 13' ' ' LEU . . . -105.84 -92.5 2.27 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 -179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 13' ' ' LEU . 1.1 mp -143.86 -165.37 2.09 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.262 -1.14 . . . . 0.0 109.668 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.736 HD13 ' HE1' ' A' ' 39' ' ' HIS . 10.8 mt -100.64 52.37 0.87 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.41 -0.806 . . . . 0.0 109.359 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.438 HG12 ' O ' ' A' ' 96' ' ' GLY . 4.0 m -94.84 149.91 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.226 -0.921 . . . . 0.0 109.514 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.496 ' HB3' ' CG1' ' A' ' 5' ' ' VAL . 51.8 m-85 -65.16 177.35 1.06 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.223 -0.923 . . . . 0.0 109.309 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 16' ' ' PHE . 4.7 mt-10 -160.16 108.01 1.4 Allowed Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.248 -0.907 . . . . 0.0 109.367 179.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 33.0 Cg_endo -75.13 170.14 72.64 Favored 'Cis proline' 0 C--N 1.311 -1.408 0 C-N-CA 123.602 -1.416 . . . . 0.0 110.678 0.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.66 -63.27 1.11 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.246 -0.909 . . . . 0.0 109.421 -179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.43 ' C ' HD12 ' A' ' 21' ' ' LEU . 1.9 ptpt -80.02 158.1 26.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.176 -0.952 . . . . 0.0 109.309 179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.43 HD12 ' C ' ' A' ' 20' ' ' LYS . 1.0 OUTLIER -150.47 118.79 6.39 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.257 -0.902 . . . . 0.0 109.416 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.488 ' HA ' ' O ' ' A' ' 102' ' ' THR . 24.2 m -89.51 92.1 8.97 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.235 -0.916 . . . . 0.0 109.611 -179.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.683 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -99.62 175.8 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 O-C-N 121.291 -0.881 . . . . 0.0 109.569 179.987 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.638 ' C ' HG13 ' A' ' 103' ' ' VAL . 0.0 OUTLIER -88.69 179.2 1.71 Allowed Pre-proline 0 C--N 1.302 -1.464 0 O-C-N 121.355 -0.841 . . . . 0.0 108.818 179.613 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.675 ' HA ' HG11 ' A' ' 103' ' ' VAL . 35.1 Cg_endo -78.58 77.23 4.11 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.371 2.047 . . . . 0.0 110.889 -179.493 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.525 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 116.4 27.4 2.87 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.028 -1.229 . . . . 0.0 110.028 179.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.465 ' CG ' ' HB2' ' A' ' 24' ' ' LYS . 6.0 m-20 -84.1 -176.68 6.38 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.154 -1.203 . . . . 0.0 109.097 179.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.461 ' HB ' HG23 ' A' ' 2' ' ' THR . 90.2 m -112.98 129.02 56.64 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.251 -0.906 . . . . 0.0 109.583 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.037 HG21 HD11 ' A' ' 101' ' ' ILE . 4.2 t -115.59 124.35 71.96 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 121.309 -0.87 . . . . 0.0 108.77 179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -99.15 125.47 44.72 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.27 -0.894 . . . . 0.0 109.649 -179.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.891 ' O ' HD23 ' A' ' 32' ' ' LEU . 0.3 OUTLIER -116.3 153.78 31.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.38 -0.825 . . . . 0.0 108.941 -179.868 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.891 HD23 ' O ' ' A' ' 31' ' ' PHE . 0.1 OUTLIER -141.36 -171.62 3.34 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.981 -1.075 . . . . 0.0 109.95 -179.603 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.68 ' HB3' HD23 ' A' ' 65' ' ' LEU . 3.2 p-10 -123.14 167.45 13.67 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.382 -0.823 . . . . 0.0 109.093 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 33.3 t30 -157.31 -58.16 0.08 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.906 -1.121 . . . . 0.0 110.111 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.56 ' HB3' ' CD2' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -71.51 -150.8 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.185 -0.947 . . . . 0.0 110.161 -179.356 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 84.2 t -69.37 115.27 30.76 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.594 -0.691 . . . . 0.0 110.352 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.571 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.4 Cg_endo -79.62 178.53 7.23 Favored 'Trans proline' 0 C--N 1.315 -1.236 0 C-N-CA 122.915 2.41 . . . . 0.0 109.997 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.571 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 41.5 Cg_endo -88.48 163.61 41.92 Favored 'Cis proline' 0 C--N 1.313 -1.331 0 O-C-N 123.339 1.179 . . . . 0.0 110.707 -1.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.736 ' HE1' HD13 ' A' ' 14' ' ' LEU . 97.3 m-70 -126.01 122.59 36.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.175 -0.953 . . . . 0.0 110.018 179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.456 ' OD1' ' HA ' ' A' ' 64' ' ' LEU . 2.0 t30 -99.45 142.55 30.79 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.425 -0.797 . . . . 0.0 109.163 179.852 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.494 HG12 ' OG ' ' A' ' 60' ' ' SER . 7.1 t -110.51 118.13 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.2 -0.937 . . . . 0.0 109.422 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.625 ' HA ' ' CB ' ' A' ' 60' ' ' SER . 1.6 t -153.84 138.69 10.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.164 -0.96 . . . . 0.0 110.099 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.751 ' CE2' HD23 ' A' ' 59' ' ' LEU . 2.8 m-85 -87.33 126.22 34.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.658 -0.651 . . . . 0.0 109.643 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.469 ' OD2' ' HB3' ' A' ' 46' ' ' ALA . 38.8 t70 -51.67 137.54 24.94 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.236 -0.915 . . . . 0.0 108.924 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -83.93 14.92 3.66 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.186 -0.946 . . . . 0.0 109.815 -179.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.469 ' HB3' ' OD2' ' A' ' 44' ' ' ASP . . . -129.07 11.87 6.06 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.156 -0.965 . . . . 0.0 109.62 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.423 HD12 ' HB3' ' A' ' 44' ' ' ASP . 76.1 mt -126.66 50.4 1.94 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.211 -0.93 . . . . 0.0 109.635 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 51' ' ' LYS . 5.2 p30 -119.67 159.39 46.47 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.322 -0.861 . . . . 0.0 109.122 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 36.2 Cg_endo -77.85 -2.23 12.37 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.566 2.177 . . . . 0.0 110.664 -179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.519 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -123.17 28.74 7.0 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.204 -0.935 . . . . 0.0 109.655 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.519 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER 28.49 40.88 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.983 0 CA-C-O 121.108 0.48 . . . . 0.0 110.728 179.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.512 ' N ' ' O ' ' A' ' 50' ' ' ALA . 72.9 m -135.91 -171.52 2.88 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.123 -0.986 . . . . 0.0 109.816 -179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -146.34 19.58 1.37 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.305 -0.872 . . . . 0.0 109.598 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -68.96 -31.31 70.09 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.24 -0.913 . . . . 0.0 109.499 -179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.708 ' O ' HD12 ' A' ' 55' ' ' LEU . 0.6 OUTLIER -102.0 22.77 12.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.22 -0.925 . . . . 0.0 109.546 -179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -117.36 -54.99 2.35 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.29 -0.881 . . . . 0.0 109.351 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 3.6 mmpt? -56.97 -28.58 62.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.263 -0.898 . . . . 0.0 109.372 179.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.4 p -108.99 30.22 6.76 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.283 -0.886 . . . . 0.0 109.625 -179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.783 ' O ' HG23 ' A' ' 74' ' ' THR . 26.7 tp -115.87 -62.15 1.63 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.205 -0.934 . . . . 0.0 109.444 179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.625 ' CB ' ' HA ' ' A' ' 42' ' ' VAL . 0.6 OUTLIER -80.15 -171.46 2.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.264 -0.898 . . . . 0.0 110.627 -178.703 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . . . . . . . . . 32.3 p80 -115.11 157.36 23.68 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.627 -0.671 . . . . 0.0 109.295 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.58 -14.44 16.17 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.285 -0.884 . . . . 0.0 109.682 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 8.3 mm-40 -76.93 130.36 37.43 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.172 -0.955 . . . . 0.0 109.488 -179.647 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.497 HD12 ' N ' ' A' ' 64' ' ' LEU . 8.6 mp -60.86 179.98 0.15 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.267 -0.895 . . . . 0.0 109.375 179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.997 HD21 ' CB ' ' A' ' 71' ' ' SER . 2.5 mp -98.57 135.22 40.41 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.232 -0.918 . . . . 0.0 109.349 179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 3.1 mmt -127.11 1.56 6.49 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.187 -0.946 . . . . 0.0 109.413 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.3 t -111.45 129.41 24.12 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 121.248 -0.908 . . . . 0.0 109.229 179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.518 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.2 Cg_endo -78.47 87.0 1.58 Allowed 'Trans proline' 0 C--N 1.31 -1.451 0 C-N-CA 122.338 2.026 . . . . 0.0 110.514 179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.551 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 114.87 35.01 1.42 Allowed Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.657 -1.377 . . . . 0.0 109.657 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.56 ' N ' ' HB3' ' A' ' 32' ' ' LEU . 1.0 OUTLIER 178.55 112.36 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.275 -1.133 . . . . 0.0 109.366 179.8 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.997 ' CB ' HD21 ' A' ' 65' ' ' LEU . 21.5 p -104.85 -82.19 0.52 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.108 -0.995 . . . . 0.0 109.429 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.589 ' N ' ' OG ' ' A' ' 71' ' ' SER . 85.2 m -160.83 156.28 24.89 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.007 -1.058 . . . . 0.0 109.346 179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.416 ' O ' ' N ' ' A' ' 75' ' ' THR . 0.8 OUTLIER -102.68 67.31 0.98 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.158 -0.964 . . . . 0.0 109.309 179.889 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.783 HG23 ' O ' ' A' ' 59' ' ' LEU . 97.8 m -46.26 99.28 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.364 -0.835 . . . . 0.0 109.642 -179.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.416 ' N ' ' O ' ' A' ' 73' ' ' SER . 19.0 m -78.89 95.87 5.54 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.654 ' CE2' HD21 ' A' ' 59' ' ' LEU . 8.0 m-85 -47.85 162.45 0.32 Allowed Pre-proline 0 C--N 1.302 -1.473 0 O-C-N 121.526 -0.734 . . . . 0.0 109.34 -179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.563 ' HD3' ' CD1' ' A' ' 59' ' ' LEU . 35.0 Cg_endo -76.61 173.37 14.59 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.695 2.263 . . . . 0.0 111.12 -178.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.75 8.51 7.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.295 -0.878 . . . . 0.0 109.629 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -99.32 -71.01 0.71 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.217 -0.927 . . . . 0.0 109.147 179.781 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.438 ' C ' ' O ' ' A' ' 79' ' ' ASP . . . 42.76 88.26 0.1 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.336 -0.852 . . . . 0.0 109.374 179.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.435 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 33.4 Cg_endo -75.61 127.79 10.53 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.616 2.21 . . . . 0.0 110.654 -179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.433 ' HB1' ' HA2' ' A' ' 105' ' ' GLY . . . -43.06 136.92 2.64 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.439 -0.788 . . . . 0.0 109.553 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.482 ' N ' ' HA2' ' A' ' 105' ' ' GLY . . . 152.65 172.92 21.57 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 8.8 mt-10 -96.88 126.34 41.96 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -1.144 . . . . 0.0 109.519 -179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.493 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 12.6 m-85 -97.6 -173.7 2.71 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.211 -0.931 . . . . 0.0 108.853 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 99.4 m -164.83 103.58 0.79 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 120.922 -1.111 . . . . 0.0 110.443 -179.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.578 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.5 OUTLIER -101.24 166.07 10.96 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 178.563 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.46 ' HA ' ' O ' ' A' ' 97' ' ' MET . 4.9 p90 -159.96 -153.38 0.34 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.724 -1.235 . . . . 0.0 110.547 -179.411 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.511 ' HB2' ' HB3' ' A' ' 97' ' ' MET . 0.5 OUTLIER -129.1 148.03 51.01 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.543 -0.723 . . . . 0.0 109.49 -179.406 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 0.4 OUTLIER -84.0 -43.58 0.77 Allowed Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.192 -0.943 . . . . 0.0 110.511 179.621 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.2 Cg_endo -78.68 -67.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.318 -1.065 0 C-N-CA 122.109 1.873 . . . . 0.0 110.872 -179.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.675 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 69.5 m80 -65.93 75.36 0.08 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.99 -1.069 . . . . 0.0 109.551 -179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.451 ' N ' ' O ' ' A' ' 91' ' ' PRO . 45.5 mtm180 -91.84 110.94 22.29 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.126 -0.984 . . . . 0.0 109.139 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 109.7 1.71 30.63 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.449 -1.46 . . . . 0.0 109.449 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -98.03 33.59 2.11 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.227 -1.16 . . . . 0.0 109.475 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.438 ' O ' HG12 ' A' ' 15' ' ' VAL . . . 64.27 13.14 53.22 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 110.191 -1.164 . . . . 0.0 110.191 179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.638 ' HE2' ' O ' ' A' ' 14' ' ' LEU . 0.3 OUTLIER -74.13 63.1 0.95 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.824 -1.398 . . . . 0.0 109.201 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 17.1 t -140.72 107.99 2.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.275 -0.891 . . . . 0.0 109.61 -179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.578 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -112.21 179.45 19.48 Favored Glycine 0 N--CA 1.486 2.02 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.457 ' HG3' ' C ' ' A' ' 99' ' ' GLY . 2.7 mtmp? -152.46 134.24 14.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.115 -1.227 . . . . 0.0 109.784 -179.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 1.037 HD11 HG21 ' A' ' 29' ' ' VAL . 0.1 OUTLIER -95.82 132.73 39.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.293 -0.88 . . . . 0.0 108.831 179.568 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -107.02 97.8 7.53 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.137 -0.977 . . . . 0.0 108.829 179.252 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.675 HG11 ' HA ' ' A' ' 25' ' ' PRO . 3.8 t -99.3 73.86 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.028 -1.045 . . . . 0.0 109.463 -179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . 54.15 33.4 17.85 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.395 -0.816 . . . . 0.0 109.538 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.482 ' HA2' ' N ' ' A' ' 83' ' ' GLY . . . . . . . . 0 N--CA 1.492 2.403 0 CA-C-O 118.097 -1.391 . . . . 0.0 109.756 -179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.59 108.86 11.51 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.201 -0.937 . . . . 0.0 109.586 -179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.799 ' CD2' HD21 ' A' ' 21' ' ' LEU . 23.1 m-85 -86.1 163.39 17.91 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.319 -0.863 . . . . 0.0 109.302 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.802 HG23 ' HB3' ' A' ' 30' ' ' GLU . 0.9 OUTLIER -151.93 111.96 4.06 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.044 -1.035 . . . . 0.0 109.957 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.473 ' CG1' HD12 ' A' ' 21' ' ' LEU . 6.5 m -104.98 79.97 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.411 0 O-C-N 121.275 -0.89 . . . . 0.0 109.255 179.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.1 mtmt -58.2 148.32 27.42 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.314 -0.866 . . . . 0.0 109.714 -179.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.732 HD11 ' HA ' ' A' ' 33' ' ' ASN . 0.4 OUTLIER -118.05 -173.79 2.52 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.236 -0.915 . . . . 0.0 109.485 179.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.6 ' HA2' HD23 ' A' ' 14' ' ' LEU . . . 65.28 88.57 0.05 OUTLIER Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.859 -1.296 . . . . 0.0 109.859 179.635 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.559 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 0.5 OUTLIER -66.55 -22.84 66.16 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.31 -1.112 . . . . 0.0 109.384 179.699 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.559 ' CB ' ' O ' ' A' ' 9' ' ' SER . 8.4 t70 83.36 20.05 0.2 Allowed 'General case' 0 N--CA 1.494 1.735 0 N-CA-C 109.322 -0.621 . . . . 0.0 109.322 -179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.467 ' HB2' HD21 ' A' ' 13' ' ' LEU . 0.0 OUTLIER -115.63 9.74 15.37 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.255 -0.903 . . . . 0.0 109.361 179.774 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 103.56 5.16 45.78 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.513 ' N ' HD23 ' A' ' 13' ' ' LEU . 0.4 OUTLIER -134.95 154.4 51.72 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.227 -1.161 . . . . 0.0 109.825 -179.792 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.618 ' CD1' ' CD2' ' A' ' 92' ' ' HIS . 95.1 mt -113.91 121.4 43.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.353 -0.842 . . . . 0.0 109.172 179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 15.6 m -149.07 153.6 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.111 -0.993 . . . . 0.0 109.863 -179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.477 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 12.0 m-85 -76.57 156.21 32.99 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.256 -0.903 . . . . 0.0 109.172 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.477 ' HG2' ' O ' ' A' ' 16' ' ' PHE . 4.1 mt-10 -141.98 109.77 5.99 Favored Pre-proline 0 N--CA 1.489 1.491 0 O-C-N 121.128 -0.983 . . . . 0.0 109.393 -179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.448 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.5 Cg_endo -77.51 -177.7 21.92 Favored 'Cis proline' 0 C--N 1.312 -1.38 0 C-N-CA 123.767 -1.347 . . . . 0.0 110.698 0.469 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -70.21 -58.36 3.87 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.281 -0.887 . . . . 0.0 109.333 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -99.07 168.74 9.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.237 -0.915 . . . . 0.0 109.16 179.771 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.799 HD21 ' CD2' ' A' ' 3' ' ' TYR . 0.4 OUTLIER -160.1 146.06 15.53 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.082 -1.011 . . . . 0.0 109.927 -179.812 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.616 HG23 ' O ' ' A' ' 102' ' ' THR . 90.5 m -114.31 112.88 23.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.352 -0.843 . . . . 0.0 109.011 179.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.737 ' CD1' HD13 ' A' ' 101' ' ' ILE . 0.9 OUTLIER -117.59 164.05 14.21 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.265 -0.897 . . . . 0.0 110.073 -179.682 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.571 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 17.0 mmmt -82.16 165.48 42.66 Favored Pre-proline 0 C--N 1.3 -1.571 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 178.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.615 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 32.7 Cg_endo -74.81 86.26 1.41 Allowed 'Trans proline' 0 C--N 1.306 -1.679 0 C-N-CA 121.945 1.763 . . . . 0.0 110.306 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.442 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 126.26 4.43 6.45 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.494 ' OD2' ' CG ' ' A' ' 24' ' ' LYS . 59.0 m-20 -71.07 -176.73 1.47 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.232 -1.158 . . . . 0.0 109.58 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.745 HG23 ' HA ' ' A' ' 75' ' ' THR . 0.2 OUTLIER -120.04 122.93 42.21 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.284 -0.885 . . . . 0.0 109.636 -179.995 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.86 HG21 HD11 ' A' ' 101' ' ' ILE . 1.4 t -111.17 147.32 15.25 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 O-C-N 121.224 -0.923 . . . . 0.0 109.334 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.802 ' HB3' HG23 ' A' ' 4' ' ' THR . 5.3 tp10 -117.56 141.34 48.47 Favored 'General case' 0 C--N 1.305 -1.348 0 O-C-N 121.176 -0.953 . . . . 0.0 110.111 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.567 ' CE2' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -145.33 89.73 1.96 Allowed 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 108.056 -1.091 . . . . 0.0 108.056 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.716 ' O ' HD11 ' A' ' 7' ' ' LEU . 0.5 OUTLIER -97.84 179.88 4.66 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.44 -0.787 . . . . 0.0 111.257 -178.028 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.732 ' HA ' HD11 ' A' ' 7' ' ' LEU . 3.8 p-10 -93.21 165.42 12.82 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 109.576 -0.528 . . . . 0.0 109.576 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.533 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . 42.0 t30 -115.7 -84.0 0.62 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.073 -1.017 . . . . 0.0 109.477 179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.516 ' O ' HG22 ' A' ' 36' ' ' VAL . 0.5 OUTLIER -145.95 35.15 1.01 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.087 -1.008 . . . . 0.0 109.643 179.892 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.55 ' O ' ' NE2' ' A' ' 92' ' ' HIS . 2.0 t -156.87 60.36 2.13 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.325 -0.86 . . . . 0.0 109.305 179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 35.8 Cg_endo -78.26 174.08 12.94 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.661 2.24 . . . . 0.0 110.631 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.533 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.9 Cg_endo -86.38 162.18 54.53 Favored 'Cis proline' 0 C--N 1.311 -1.445 0 O-C-N 123.798 1.42 . . . . 0.0 110.297 -1.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.711 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 65.2 m-70 -118.59 146.73 44.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.187 -0.946 . . . . 0.0 110.17 179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -120.04 114.47 22.05 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.292 -0.88 . . . . 0.0 109.237 179.648 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.497 HG21 ' HB2' ' A' ' 31' ' ' PHE . 24.7 t -99.92 114.06 37.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.898 . . . . 0.0 109.508 -179.762 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.679 HG13 ' CB ' ' A' ' 60' ' ' SER . 1.6 t -150.59 157.4 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.216 -0.928 . . . . 0.0 109.874 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.573 ' CE2' HD23 ' A' ' 59' ' ' LEU . 3.8 m-85 -109.14 110.99 22.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.422 -0.799 . . . . 0.0 109.41 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 6.1 t0 -47.16 158.35 0.15 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.211 -0.931 . . . . 0.0 109.519 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -107.73 31.2 5.64 Favored 'General case' 0 N--CA 1.486 1.326 0 O-C-N 121.292 -0.88 . . . . 0.0 109.532 179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -117.99 -31.71 4.99 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.182 -0.949 . . . . 0.0 109.644 -179.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 2.7 mp -101.43 64.5 1.01 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.195 -0.94 . . . . 0.0 109.656 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.443 ' CG ' ' HA ' ' A' ' 51' ' ' LYS . 0.7 OUTLIER -111.79 158.72 35.83 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.309 -0.869 . . . . 0.0 109.394 179.841 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -80.01 -33.7 1.07 Allowed 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 122.78 2.32 . . . . 0.0 110.564 -179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.507 ' O ' ' HG3' ' A' ' 51' ' ' LYS . . . -122.6 35.7 4.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.15 -0.969 . . . . 0.0 109.845 -179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.507 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 0.3 OUTLIER 34.28 49.75 0.34 Allowed 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.869 -0.519 . . . . 0.0 110.529 179.634 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.9 m -127.44 141.21 51.73 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.12 -0.987 . . . . 0.0 109.675 179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -121.04 10.43 10.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.276 -0.89 . . . . 0.0 109.401 179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 34.9 t0 -62.31 -39.65 93.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.244 -0.91 . . . . 0.0 109.392 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.528 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 1.7 pp -80.93 -32.27 34.71 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.362 -0.836 . . . . 0.0 109.57 179.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.506 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -69.01 -43.74 74.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.081 -1.012 . . . . 0.0 109.571 179.84 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.12 -30.91 12.1 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.313 -0.867 . . . . 0.0 109.748 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . 0.423 ' O ' ' C ' ' A' ' 59' ' ' LEU . 0.1 OUTLIER -105.74 -40.42 5.74 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.163 -0.961 . . . . 0.0 110.009 -179.623 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.978 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 13.2 tp -43.01 -56.56 3.27 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.217 -0.927 . . . . 0.0 109.917 -179.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.679 ' CB ' HG13 ' A' ' 42' ' ' VAL . 64.3 p -78.83 153.05 30.95 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.487 -0.758 . . . . 0.0 110.619 -177.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.498 ' CE1' ' O ' ' A' ' 63' ' ' GLN . 12.8 p80 -93.69 176.67 6.27 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.87 -57.61 2.26 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 0.0 109.726 -179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.498 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 3.3 pt20 -44.09 145.48 0.75 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.202 -0.936 . . . . 0.0 109.552 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.4 mp -78.29 167.98 20.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 109.505 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.477 ' CD1' ' CE1' ' A' ' 61' ' ' HIS . 7.7 mp -95.32 108.96 21.16 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.231 -0.918 . . . . 0.0 109.38 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 4.2 ttp -117.81 -0.4 11.76 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.193 -0.942 . . . . 0.0 109.673 -179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.522 ' OG ' ' CB ' ' A' ' 70' ' ' GLN . 3.2 t -91.23 147.28 35.21 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.147 -0.971 . . . . 0.0 109.557 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.23 87.96 1.48 Allowed 'Trans proline' 0 C--N 1.31 -1.495 0 C-N-CA 122.712 2.275 . . . . 0.0 110.823 -179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.536 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 89.22 35.37 8.12 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.941 -1.264 . . . . 0.0 109.941 179.419 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.522 ' CB ' ' OG ' ' A' ' 67' ' ' SER . 1.6 tt0 -147.25 94.0 2.33 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.128 -1.219 . . . . 0.0 109.205 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.562 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . 4.4 p -99.88 -105.89 0.22 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.33 -0.856 . . . . 0.0 109.676 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.548 HG23 ' O ' ' A' ' 72' ' ' THR . 9.9 t -160.56 123.74 3.4 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.7 m -79.26 82.31 5.42 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.046 -1.034 . . . . 0.0 109.341 -179.569 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.521 HG21 ' HG ' ' A' ' 59' ' ' LEU . 99.6 m -59.67 101.51 0.11 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.399 -0.813 . . . . 0.0 109.504 -179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.745 ' HA ' HG23 ' A' ' 28' ' ' THR . 3.1 t -78.95 86.18 4.85 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.978 ' CZ ' HD21 ' A' ' 59' ' ' LEU . 3.2 m-85 -36.22 147.97 0.18 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.887 -0.508 . . . . 0.0 110.125 -178.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.442 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.7 Cg_endo -78.28 175.74 10.75 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 C-N-CA 122.793 2.329 . . . . 0.0 111.52 -178.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -84.76 9.78 13.15 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 178.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.493 ' O ' ' C ' ' A' ' 80' ' ' ALA . 2.2 t70 -99.15 -12.99 19.97 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.411 -0.806 . . . . 0.0 108.886 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.615 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -34.6 104.54 0.25 Allowed Pre-proline 0 N--CA 1.497 1.919 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.445 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 33.9 Cg_endo -75.57 152.65 38.4 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.531 2.154 . . . . 0.0 110.899 -179.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -71.67 131.6 43.39 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.437 -0.79 . . . . 0.0 109.413 179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 155.34 -149.61 20.83 Favored Glycine 0 N--CA 1.49 2.233 0 N-CA-C 109.447 -1.461 . . . . 0.0 109.447 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.454 ' CD ' HG23 ' A' ' 102' ' ' THR . 0.0 OUTLIER -126.48 137.83 53.43 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.214 -1.168 . . . . 0.0 109.664 -179.882 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.549 ' CD1' HG22 ' A' ' 101' ' ' ILE . 6.4 m-85 -101.51 -170.95 1.9 Allowed 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.347 -0.846 . . . . 0.0 108.723 179.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.448 ' OG1' ' O ' ' A' ' 85' ' ' TYR . 92.6 m -166.79 98.4 0.55 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.859 -1.151 . . . . 0.0 110.463 -179.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.524 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.6 OUTLIER -101.95 162.27 13.04 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.243 -0.911 . . . . 0.0 108.677 178.622 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . . . . . . . . . 49.4 p90 -154.31 -162.0 1.33 Allowed 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.927 -1.108 . . . . 0.0 110.112 -179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.63 141.45 48.66 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.492 -0.755 . . . . 0.0 109.391 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.615 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 19.2 tt0 -77.95 -44.71 2.34 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.213 -0.929 . . . . 0.0 110.181 179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.615 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.0 Cg_endo -78.68 -64.11 0.02 OUTLIER 'Trans proline' 0 C--N 1.316 -1.136 0 C-N-CA 122.0 1.8 . . . . 0.0 110.439 -179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.711 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 9.2 m80 -73.86 57.14 0.59 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.22 -0.925 . . . . 0.0 109.315 179.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 16.8 ttt85 -102.91 -8.6 20.57 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.303 -0.873 . . . . 0.0 109.564 -179.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -88.66 22.9 18.76 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.479 -1.448 . . . . 0.0 109.479 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -136.92 -129.62 0.14 Allowed 'General case' 0 C--N 1.306 -1.316 0 O-C-N 121.313 -1.11 . . . . 0.0 108.692 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -127.74 36.95 2.42 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.826 -1.309 . . . . 0.0 109.826 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.535 ' CE ' ' HB3' ' A' ' 14' ' ' LEU . 0.0 OUTLIER -80.61 70.29 7.3 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.121 -1.223 . . . . 0.0 109.602 179.784 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 53.0 t -140.97 113.24 4.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.212 -0.93 . . . . 0.0 109.626 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.524 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -114.77 172.12 14.07 Favored Glycine 0 N--CA 1.485 1.935 0 N-CA-C 109.499 -1.441 . . . . 0.0 109.499 179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.446 ' HB3' ' O ' ' A' ' 85' ' ' TYR . 6.7 mttm -148.88 128.54 13.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -1.151 . . . . 0.0 109.648 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.86 HD11 HG21 ' A' ' 29' ' ' VAL . 0.8 OUTLIER -80.27 154.96 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.283 -0.885 . . . . 0.0 108.971 179.676 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.616 ' O ' HG23 ' A' ' 22' ' ' THR . 0.7 OUTLIER -129.26 90.17 2.97 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 179.259 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.65 HG23 ' CG2' ' A' ' 101' ' ' ILE . 28.0 t -99.89 121.81 51.02 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.259 -0.9 . . . . 0.0 109.835 -179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -105.7 -152.31 0.47 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.398 -0.814 . . . . 0.0 109.392 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.272 0 CA-C-O 117.984 -1.453 . . . . 0.0 109.511 179.952 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.49 128.46 49.11 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.285 -0.884 . . . . 0.0 109.344 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.466 ' O ' ' N ' ' A' ' 30' ' ' GLU . 43.1 m-85 -89.37 116.7 27.77 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.232 -0.917 . . . . 0.0 109.615 -179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 9.6 m -118.42 120.57 37.96 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.319 -0.863 . . . . 0.0 109.3 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.539 HG12 ' C ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -107.93 102.66 14.3 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.229 -0.919 . . . . 0.0 109.387 179.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 7' ' ' LEU . 2.4 ttmt -80.68 83.89 6.35 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.325 -0.859 . . . . 0.0 109.464 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.679 HD21 ' O ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -47.42 173.23 0.01 OUTLIER 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.356 -0.84 . . . . 0.0 109.677 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.533 ' HA3' ' CB ' ' A' ' 34' ' ' ASN . . . 83.34 94.4 0.61 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.472 ' OG ' ' N ' ' A' ' 10' ' ' ASP . 95.0 p -49.92 -75.98 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.289 -1.124 . . . . 0.0 109.536 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.472 ' N ' ' OG ' ' A' ' 9' ' ' SER . 20.9 t0 -173.16 -71.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.265 -0.897 . . . . 0.0 109.567 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.17 55.51 1.85 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.277 -0.889 . . . . 0.0 109.385 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -161.77 -95.23 0.1 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.458 ' HA ' HD22 ' A' ' 13' ' ' LEU . 0.8 OUTLIER -113.42 166.24 11.68 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.297 -1.12 . . . . 0.0 109.46 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.719 ' HB3' ' HE1' ' A' ' 97' ' ' MET . 17.2 mt -101.69 123.65 46.02 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.213 -0.929 . . . . 0.0 109.392 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 22.2 m -143.98 159.08 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.239 -0.913 . . . . 0.0 109.615 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.41 ' O ' ' HG2' ' A' ' 17' ' ' GLU . 3.2 m-85 -71.92 164.32 26.27 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.308 -0.87 . . . . 0.0 109.376 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.539 ' C ' HG12 ' A' ' 5' ' ' VAL . 14.6 mt-10 -154.24 104.59 2.41 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.236 -0.915 . . . . 0.0 109.419 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 33.5 Cg_endo -77.09 169.22 74.89 Favored 'Cis proline' 0 C--N 1.311 -1.441 0 C-N-CA 123.693 -1.378 . . . . 0.0 110.448 0.328 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.79 -25.41 62.0 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.232 -0.918 . . . . 0.0 109.738 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.445 ' O ' ' HG ' ' A' ' 21' ' ' LEU . 10.6 mmtm -112.62 160.4 17.9 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.113 -0.992 . . . . 0.0 109.832 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.445 ' HG ' ' O ' ' A' ' 20' ' ' LYS . 7.0 mt -143.72 108.75 4.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -0.866 . . . . 0.0 109.291 179.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.517 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 5.3 m -89.05 90.32 8.35 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.277 -0.889 . . . . 0.0 109.752 -179.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.741 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.2 pt -101.35 171.67 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.347 0 O-C-N 121.24 -0.912 . . . . 0.0 109.685 179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.646 ' CB ' ' HD2' ' A' ' 25' ' ' PRO . 7.8 mttt -86.83 -164.23 0.06 OUTLIER Pre-proline 0 C--N 1.3 -1.554 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 178.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.646 ' HD2' ' CB ' ' A' ' 24' ' ' LYS . 30.8 Cg_endo -74.95 62.35 5.8 Favored 'Trans proline' 0 C--N 1.316 -1.174 0 N-CA-C 109.314 -1.072 . . . . 0.0 109.314 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.568 ' O ' ' HB2' ' A' ' 76' ' ' PHE . . . 142.52 -92.19 0.17 Allowed Glycine 0 N--CA 1.486 2.006 0 N-CA-C 109.016 -1.634 . . . . 0.0 109.016 -179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.423 ' CG ' ' HG3' ' A' ' 24' ' ' LYS . 1.3 m-20 49.61 -176.2 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.119 -1.224 . . . . 0.0 109.55 179.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.513 ' CG2' ' OG ' ' A' ' 73' ' ' SER . 64.0 m -122.68 142.49 50.62 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.309 -0.869 . . . . 0.0 109.523 -179.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.758 HG21 HD11 ' A' ' 101' ' ' ILE . 2.4 t -125.13 148.79 29.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.34 0 O-C-N 121.289 -0.882 . . . . 0.0 109.307 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.466 ' N ' ' O ' ' A' ' 3' ' ' TYR . 1.9 mt-10 -127.27 132.61 50.3 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.197 -0.939 . . . . 0.0 109.746 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.578 ' CD1' ' N ' ' A' ' 31' ' ' PHE . 0.0 OUTLIER -138.1 105.01 5.38 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 179.77 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.751 HD23 ' N ' ' A' ' 32' ' ' LEU . 0.0 OUTLIER -100.33 -171.47 2.03 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.066 -1.021 . . . . 0.0 111.026 -178.654 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.52 ' HA ' HD11 ' A' ' 7' ' ' LEU . 3.2 p-10 -105.55 168.33 9.16 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.706 -0.621 . . . . 0.0 109.725 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.533 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . 30.2 t30 -114.64 -142.05 0.38 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.236 -0.915 . . . . 0.0 109.295 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.405 ' C ' ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -99.36 36.11 1.81 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.997 -1.064 . . . . 0.0 109.241 179.76 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.595 HG21 HD21 ' A' ' 14' ' ' LEU . 2.1 t -151.46 61.95 4.64 Favored Pre-proline 0 N--CA 1.491 1.611 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.579 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 36.2 Cg_endo -77.42 175.63 11.06 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 C-N-CA 122.694 2.263 . . . . 0.0 110.955 -178.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.579 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 40.5 Cg_endo -87.87 158.51 44.81 Favored 'Cis proline' 0 C--N 1.313 -1.338 0 C-N-CA 123.573 -1.428 . . . . 0.0 110.74 -1.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.713 ' C ' HD12 ' A' ' 65' ' ' LEU . 80.6 m-70 -121.99 160.88 23.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.382 -0.824 . . . . 0.0 109.858 179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -139.74 165.8 26.31 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.4 -0.813 . . . . 0.0 108.847 179.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.564 ' HB ' ' CD2' ' A' ' 61' ' ' HIS . 43.3 t -137.45 114.65 12.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.113 -0.992 . . . . 0.0 109.144 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.54 HG13 ' HB2' ' A' ' 60' ' ' SER . 0.0 OUTLIER -144.37 174.74 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.244 -0.91 . . . . 0.0 109.518 -179.443 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.669 ' CD2' HD23 ' A' ' 59' ' ' LEU . 4.2 m-85 -131.33 112.24 12.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.327 -0.858 . . . . 0.0 109.392 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.623 ' CG ' HD12 ' A' ' 47' ' ' LEU . 8.0 t70 -54.0 136.49 41.31 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.263 -0.898 . . . . 0.0 109.633 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -88.87 -2.67 58.71 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.261 -0.9 . . . . 0.0 109.648 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.443 ' O ' ' HG ' ' A' ' 47' ' ' LEU . . . -107.75 13.82 26.12 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.181 -0.949 . . . . 0.0 109.645 -179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.623 HD12 ' CG ' ' A' ' 44' ' ' ASP . 1.5 mt -140.32 46.66 1.81 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.218 -0.926 . . . . 0.0 109.424 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.502 ' HB2' ' HD2' ' A' ' 49' ' ' PRO . 1.2 p30 -123.86 165.75 22.18 Favored Pre-proline 0 N--CA 1.489 1.519 0 O-C-N 121.321 -0.862 . . . . 0.0 109.287 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.502 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 33.5 Cg_endo -76.02 -23.71 11.93 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.437 2.092 . . . . 0.0 109.689 179.514 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.51 ' O ' ' N ' ' A' ' 52' ' ' SER . . . -140.17 83.9 1.94 Allowed 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 179.289 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.441 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER -40.06 95.27 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.462 -0.774 . . . . 0.0 109.986 -179.369 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.51 ' N ' ' O ' ' A' ' 50' ' ' ALA . 4.5 m -138.31 107.26 5.99 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.391 -0.818 . . . . 0.0 109.159 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.89 -0.85 17.31 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.25 -0.906 . . . . 0.0 109.719 -179.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -75.79 -53.69 8.1 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.174 -0.954 . . . . 0.0 109.906 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.483 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 2.1 pp -63.28 -29.84 71.09 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.158 -0.964 . . . . 0.0 109.591 -179.676 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.462 ' N ' ' HG ' ' A' ' 55' ' ' LEU . . . -73.45 -37.97 65.64 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.182 -0.949 . . . . 0.0 109.631 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 11.1 mttp -52.4 -30.35 28.75 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.185 -0.947 . . . . 0.0 109.714 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 3.3 p -115.6 38.36 3.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.248 -0.908 . . . . 0.0 109.507 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.743 ' HG ' HG21 ' A' ' 74' ' ' THR . 7.3 tp -135.64 -48.64 0.7 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.29 -0.881 . . . . 0.0 109.29 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.54 ' HB2' HG13 ' A' ' 42' ' ' VAL . 1.2 p -78.88 122.16 25.75 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.478 -0.764 . . . . 0.0 110.289 -179.279 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.564 ' CD2' ' HB ' ' A' ' 41' ' ' VAL . 4.4 p80 -90.71 159.32 16.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.367 -0.833 . . . . 0.0 108.974 179.258 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -110.48 -161.66 0.76 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.133 -0.979 . . . . 0.0 109.654 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 66.9 106.92 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.412 -0.805 . . . . 0.0 109.609 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.449 HD23 ' HB2' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -54.31 143.33 23.62 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.278 -0.889 . . . . 0.0 109.609 -179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.713 HD12 ' C ' ' A' ' 39' ' ' HIS . 1.1 mt -89.01 87.24 7.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.361 -0.837 . . . . 0.0 109.151 179.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . 0.52 ' HG3' ' N ' ' A' ' 67' ' ' SER . 0.0 OUTLIER -85.4 -24.61 27.44 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.108 -0.995 . . . . 0.0 109.954 -179.636 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.52 ' N ' ' HG3' ' A' ' 66' ' ' MET . 1.9 t -79.98 147.66 66.35 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.288 -0.883 . . . . 0.0 109.425 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.458 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 35.0 Cg_endo -77.86 100.37 1.37 Allowed 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 122.572 2.181 . . . . 0.0 110.156 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 108.71 -25.84 17.9 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.448 ' HB2' ' OG ' ' A' ' 67' ' ' SER . 50.9 tt0 -62.52 110.79 1.8 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.14 -1.212 . . . . 0.0 108.532 179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.553 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . 12.0 p -132.8 -155.03 0.65 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.138 -0.976 . . . . 0.0 110.934 -178.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 4.7 m -152.05 116.66 5.08 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.513 ' OG ' ' CG2' ' A' ' 28' ' ' THR . 13.7 t -79.05 104.26 9.56 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -0.961 . . . . 0.0 108.966 -179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.743 HG21 ' HG ' ' A' ' 59' ' ' LEU . 91.6 m -73.27 109.07 6.52 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.408 -0.808 . . . . 0.0 109.956 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 75' ' ' THR . 3.3 t -79.39 80.42 5.76 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.531 -0.915 . . . . 0.0 108.531 179.064 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.7 ' CE2' HD21 ' A' ' 59' ' ' LEU . 10.3 m-85 -36.24 151.97 0.1 OUTLIER Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.819 -0.551 . . . . 0.0 110.162 -179.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.402 ' HD3' HD13 ' A' ' 59' ' ' LEU . 36.2 Cg_endo -78.38 171.01 17.59 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.799 2.332 . . . . 0.0 111.016 -179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -86.37 9.44 17.99 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.461 ' O ' ' C ' ' A' ' 80' ' ' ALA . 1.0 OUTLIER -101.51 -8.73 21.66 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.455 -0.778 . . . . 0.0 109.477 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.492 ' HB1' HG21 ' A' ' 103' ' ' VAL . . . -38.2 105.28 0.32 Allowed Pre-proline 0 N--CA 1.496 1.833 0 O-C-N 121.559 -0.713 . . . . 0.0 109.66 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.421 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 35.3 Cg_endo -77.34 146.51 24.92 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 C-N-CA 122.501 2.134 . . . . 0.0 110.747 -179.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.502 ' HB2' ' OXT' ' A' ' 105' ' ' GLY . . . -56.59 132.1 50.71 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.297 -0.877 . . . . 0.0 109.513 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 145.9 161.9 9.43 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 101' ' ' ILE . 3.8 mt-10 -85.24 131.91 34.35 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.214 -1.168 . . . . 0.0 109.562 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.736 ' CD1' HG22 ' A' ' 101' ' ' ILE . 29.0 m-85 -84.44 -156.12 0.22 Allowed 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 179.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.447 ' OG1' ' O ' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -163.88 87.04 0.5 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 120.685 -1.26 . . . . 0.0 110.551 -179.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.787 ' O ' HG23 ' A' ' 98' ' ' VAL . 1.1 p90 -99.92 160.97 13.9 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 108.177 -1.046 . . . . 0.0 108.177 178.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.519 ' CB ' ' HB ' ' A' ' 98' ' ' VAL . 9.5 p90 -159.22 -163.11 1.15 Allowed 'General case' 0 C--N 1.301 -1.503 0 O-C-N 120.919 -1.113 . . . . 0.0 110.396 -179.404 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.489 ' HB2' ' HB2' ' A' ' 97' ' ' MET . 0.1 OUTLIER -123.49 133.64 54.0 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.513 -0.742 . . . . 0.0 109.775 -179.615 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.631 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.7 tm-20 -74.16 -43.01 5.87 Favored Pre-proline 0 C--N 1.302 -1.478 0 O-C-N 121.336 -0.853 . . . . 0.0 110.669 179.687 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.631 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.1 Cg_endo -77.63 -54.81 0.05 OUTLIER 'Trans proline' 0 C--N 1.317 -1.087 0 C-N-CA 121.902 1.735 . . . . 0.0 110.833 -179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.712 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 42.6 m80 -85.38 60.44 6.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.052 -1.03 . . . . 0.0 109.535 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -80.45 -4.26 53.07 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.246 -0.909 . . . . 0.0 109.427 179.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -115.71 14.62 17.3 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.428 ' O ' ' C ' ' A' ' 96' ' ' GLY . . . -120.37 33.13 5.71 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.269 -1.136 . . . . 0.0 109.376 179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.428 ' C ' ' O ' ' A' ' 95' ' ' ALA . . . 41.72 60.73 2.42 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.943 -1.263 . . . . 0.0 109.943 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.719 ' HE1' ' HB3' ' A' ' 14' ' ' LEU . 5.4 mtp -107.37 53.82 0.68 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.174 -1.192 . . . . 0.0 109.417 179.85 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 87' ' ' PHE . 1.4 p -139.44 143.82 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.177 -0.952 . . . . 0.0 109.694 -179.951 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -151.04 176.09 29.71 Favored Glycine 0 N--CA 1.486 2.032 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.444 ' HB3' ' O ' ' A' ' 85' ' ' TYR . 0.2 OUTLIER -127.29 141.89 51.6 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.178 -1.19 . . . . 0.0 109.716 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.758 HD11 HG21 ' A' ' 29' ' ' VAL . 0.0 OUTLIER -85.6 155.59 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.889 . . . . 0.0 109.014 179.749 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.517 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 0.2 OUTLIER -115.46 98.35 6.68 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 179.157 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.662 HG22 ' CD1' ' A' ' 23' ' ' ILE . 53.7 t -99.24 78.71 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.463 0 O-C-N 121.258 -0.901 . . . . 0.0 109.572 -179.432 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.19 136.53 57.8 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.342 -0.849 . . . . 0.0 109.399 179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.502 ' OXT' ' HB2' ' A' ' 82' ' ' ALA . . . . . . . . 0 N--CA 1.49 2.271 0 CA-C-O 118.012 -1.438 . . . . 0.0 109.555 -179.93 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.454 -0.572 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.427 HG23 ' HB ' ' A' ' 28' ' ' THR . 0.2 OUTLIER -127.13 131.67 50.73 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.0 109.501 -179.882 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.622 ' CG ' HD21 ' A' ' 21' ' ' LEU . 6.6 m-85 -103.29 174.14 6.0 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.12 -0.987 . . . . 0.0 109.285 179.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.409 HG22 HD21 ' A' ' 32' ' ' LEU . 0.2 OUTLIER -143.73 105.04 4.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.089 -1.007 . . . . 0.0 110.062 -179.607 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 5' ' ' VAL . 20.5 m -93.71 65.84 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.353 0 O-C-N 121.218 -0.926 . . . . 0.0 109.131 179.535 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.418 ' HG3' HD11 ' A' ' 32' ' ' LEU . 1.5 ttmt -49.48 98.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.253 -0.904 . . . . 0.0 110.026 -179.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 32' ' ' LEU . 0.1 OUTLIER -65.49 157.96 28.18 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.119 -0.988 . . . . 0.0 108.983 179.466 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.411 ' HA2' ' HA ' ' A' ' 14' ' ' LEU . . . 72.18 137.07 0.22 Allowed Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.459 ' O ' ' CB ' ' A' ' 10' ' ' ASP . 1.5 p -100.72 -68.99 0.79 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.149 -1.206 . . . . 0.0 109.686 -179.799 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . 0.492 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 1.6 p30 167.24 -49.35 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.191 -0.943 . . . . 0.0 109.856 -179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.444 ' N ' ' OD1' ' A' ' 10' ' ' ASP . 0.1 OUTLIER -127.27 24.75 6.26 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.202 -0.936 . . . . 0.0 109.69 -179.768 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.811 ' C ' HD22 ' A' ' 13' ' ' LEU . . . -126.49 -116.5 2.06 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.259 -1.536 . . . . 0.0 109.259 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.825 HD22 ' N ' ' A' ' 13' ' ' LEU . 2.6 mm? -121.98 -169.1 1.82 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.309 -1.113 . . . . 0.0 109.254 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.954 HD21 ' HB3' ' A' ' 35' ' ' LYS . 47.5 mt -98.84 102.54 14.3 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.263 -0.898 . . . . 0.0 108.671 179.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 9.1 m -137.69 164.05 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.209 -0.932 . . . . 0.0 109.724 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -80.07 137.25 36.74 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.372 -0.83 . . . . 0.0 109.205 179.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 34.5 mm-40 -126.13 105.64 25.28 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.202 -0.936 . . . . 0.0 109.551 -179.801 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.8 Cg_endo -78.25 169.51 72.79 Favored 'Cis proline' 0 C--N 1.312 -1.381 0 C-N-CA 123.817 -1.326 . . . . 0.0 110.557 0.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.42 -64.79 0.81 Allowed 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.147 -0.971 . . . . 0.0 108.879 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 4.4 pttm -84.76 160.03 20.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.37 -0.832 . . . . 0.0 109.029 179.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.836 HD23 HG23 ' A' ' 23' ' ' ILE . 0.3 OUTLIER -152.12 149.13 28.46 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.081 -1.012 . . . . 0.0 110.078 -179.809 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.8 m -111.79 119.44 38.62 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.836 HG23 HD23 ' A' ' 21' ' ' LEU . 0.9 OUTLIER -132.43 175.74 10.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.373 0 O-C-N 121.143 -0.973 . . . . 0.0 110.029 -179.437 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.571 ' C ' HG13 ' A' ' 103' ' ' VAL . 0.1 OUTLIER -91.69 175.99 3.07 Favored Pre-proline 0 C--N 1.303 -1.421 0 O-C-N 121.394 -0.816 . . . . 0.0 109.049 179.578 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.674 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 35.4 Cg_endo -77.26 92.17 1.14 Allowed 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.331 2.021 . . . . 0.0 110.646 -179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 111.06 5.8 26.6 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.715 -1.354 . . . . 0.0 109.715 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.455 ' OD2' ' HB2' ' A' ' 24' ' ' LYS . 11.5 m-20 -66.4 -178.84 0.72 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.122 -1.222 . . . . 0.0 109.293 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.427 ' HB ' HG23 ' A' ' 2' ' ' THR . 3.6 m -115.38 129.28 56.54 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.349 -0.845 . . . . 0.0 109.549 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.032 HG21 HD11 ' A' ' 101' ' ' ILE . 5.2 t -115.62 135.05 56.94 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 O-C-N 121.189 -0.944 . . . . 0.0 109.539 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -103.43 129.42 50.54 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.172 -0.955 . . . . 0.0 109.662 -179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.582 ' CZ ' ' HB ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -127.17 83.56 2.18 Favored 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.777 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.599 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.4 OUTLIER -96.11 157.56 15.84 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-O 121.757 0.789 . . . . 0.0 110.726 -178.198 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.546 ' C ' ' OD1' ' A' ' 33' ' ' ASN . 4.5 p30 -77.47 171.42 14.92 Favored 'General case' 0 C--N 1.305 -1.367 0 CA-C-O 121.703 0.763 . . . . 0.0 110.895 -178.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.405 ' HB3' ' O ' ' A' ' 7' ' ' LEU . 3.6 t30 -150.04 -37.46 0.15 Allowed 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.954 ' HB3' HD21 ' A' ' 14' ' ' LEU . 1.9 tttt -99.4 -144.32 0.33 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.444 -0.785 . . . . 0.0 109.461 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 46.8 t -68.74 113.14 13.99 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.527 -0.733 . . . . 0.0 110.781 -179.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.541 ' CB ' ' HA ' ' A' ' 38' ' ' PRO . 37.8 Cg_endo -84.13 178.41 5.29 Favored 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 122.999 2.466 . . . . 0.0 109.776 179.079 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 39.7 Cg_endo -88.5 168.19 37.51 Favored 'Cis proline' 0 C--N 1.314 -1.276 0 O-C-N 123.391 1.206 . . . . 0.0 109.849 -2.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.66 ' CE1' ' CE1' ' A' ' 92' ' ' HIS . 81.6 m-70 -122.89 143.47 49.86 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.066 -1.022 . . . . 0.0 109.999 179.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -103.84 144.08 31.98 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.359 -0.838 . . . . 0.0 108.983 179.544 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.459 ' HB ' ' NE2' ' A' ' 61' ' ' HIS . 54.5 t -119.17 124.48 73.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.15 -0.969 . . . . 0.0 109.927 -179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.487 HG13 ' CB ' ' A' ' 60' ' ' SER . 1.4 t -150.24 167.31 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.389 -0.82 . . . . 0.0 108.987 179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.603 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 7.0 m-85 -118.5 119.69 35.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.138 -0.976 . . . . 0.0 109.809 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.457 ' HB3' ' HB2' ' A' ' 47' ' ' LEU . 17.8 t0 -41.98 148.17 0.19 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.442 -0.786 . . . . 0.0 110.028 -179.573 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.16 -14.46 17.73 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.359 -0.838 . . . . 0.0 109.234 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.466 ' O ' HD22 ' A' ' 47' ' ' LEU . . . -99.91 0.32 41.04 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.37 -0.831 . . . . 0.0 109.544 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.466 HD22 ' O ' ' A' ' 46' ' ' ALA . 1.6 mm? -117.81 46.65 1.71 Allowed 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.173 -0.954 . . . . 0.0 109.215 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.47 ' OD1' ' HA ' ' A' ' 51' ' ' LYS . 1.2 p30 -105.42 162.38 19.89 Favored Pre-proline 0 N--CA 1.49 1.53 0 O-C-N 121.343 -0.848 . . . . 0.0 109.488 -179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.453 ' HD2' ' HB2' ' A' ' 48' ' ' ASN . 36.3 Cg_endo -77.88 -31.62 3.04 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 122.765 2.31 . . . . 0.0 110.907 -179.51 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.496 ' O ' ' HG3' ' A' ' 51' ' ' LYS . . . -122.5 31.26 6.18 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.102 -0.999 . . . . 0.0 110.047 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 50' ' ' ALA . 0.1 OUTLIER 35.32 36.79 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.88 -0.512 . . . . 0.0 110.479 179.492 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.416 ' N ' ' O ' ' A' ' 50' ' ' ALA . 2.4 m -101.12 143.1 31.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.083 -1.011 . . . . 0.0 109.926 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -92.5 54.78 2.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.264 -0.898 . . . . 0.0 109.523 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -140.63 23.22 2.3 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.2 -0.937 . . . . 0.0 109.563 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.408 ' HA ' HD13 ' A' ' 55' ' ' LEU . 0.3 OUTLIER -118.44 9.59 12.42 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.246 -0.909 . . . . 0.0 109.531 -179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.504 ' HB2' ' HB2' ' A' ' 43' ' ' PHE . . . -142.9 -47.12 0.31 Allowed 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.263 -0.898 . . . . 0.0 109.405 179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -48.07 -25.22 1.34 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.215 -0.928 . . . . 0.0 109.344 -179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 9.8 t -118.4 -20.19 8.58 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.22 -0.925 . . . . 0.0 109.36 179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.965 HD21 ' CE2' ' A' ' 76' ' ' PHE . 9.9 tp -79.29 -37.93 36.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.216 -0.928 . . . . 0.0 109.226 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.487 ' CB ' HG13 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -78.9 132.14 36.65 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.282 -0.886 . . . . 0.0 109.633 -179.735 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.459 ' NE2' ' HB ' ' A' ' 41' ' ' VAL . 12.5 p80 -83.84 -9.55 58.68 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.455 -0.778 . . . . 0.0 109.605 -179.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.487 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 0.1 OUTLIER 54.65 -170.78 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.223 -0.923 . . . . 0.0 109.709 179.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.487 ' CB ' ' O ' ' A' ' 62' ' ' LYS . 4.0 tt0 75.45 -179.75 0.17 Allowed 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.336 -0.852 . . . . 0.0 109.687 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.703 HD12 ' N ' ' A' ' 64' ' ' LEU . 4.4 mp -118.52 155.75 30.32 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.299 -0.875 . . . . 0.0 109.473 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 39' ' ' HIS . 4.6 mp -84.09 -175.32 5.75 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.243 -0.911 . . . . 0.0 109.482 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -160.74 -37.35 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.15 -0.969 . . . . 0.0 109.904 -179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.534 ' HB3' ' CB ' ' A' ' 70' ' ' GLN . 5.5 t -83.71 147.11 51.23 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.149 -0.97 . . . . 0.0 109.901 -179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.458 ' HD2' ' OG ' ' A' ' 67' ' ' SER . 36.0 Cg_endo -79.08 92.18 1.16 Allowed 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.817 2.345 . . . . 0.0 110.398 179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.488 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 103.71 6.04 44.14 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.534 ' CB ' ' HB3' ' A' ' 67' ' ' SER . 1.2 tt0 -124.91 102.78 7.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.238 -1.154 . . . . 0.0 109.093 179.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.599 ' CB ' ' HA ' ' A' ' 32' ' ' LEU . 11.5 p -104.77 -104.27 0.31 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.339 -0.851 . . . . 0.0 110.132 -179.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 15.9 m -159.97 149.58 18.03 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 2.9 p -97.34 103.76 15.72 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.037 -1.04 . . . . 0.0 109.424 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.482 ' HG1' ' HE1' ' A' ' 31' ' ' PHE . 94.1 m -76.8 103.27 6.67 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.277 -0.889 . . . . 0.0 109.54 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.461 ' O ' ' O ' ' A' ' 76' ' ' PHE . 23.2 m -79.06 92.58 5.01 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 179.278 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.965 ' CE2' HD21 ' A' ' 59' ' ' LEU . 5.4 m-85 -43.01 165.13 0.11 Allowed Pre-proline 0 C--N 1.302 -1.471 0 O-C-N 121.47 -0.769 . . . . 0.0 109.537 -179.228 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.517 ' HD3' HD13 ' A' ' 59' ' ' LEU . 32.3 Cg_endo -73.84 174.03 13.0 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 122.466 2.111 . . . . 0.0 111.282 -178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.59 8.19 8.41 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.545 -0.722 . . . . 0.0 109.515 -179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.484 ' O ' ' C ' ' A' ' 80' ' ' ALA . 10.5 m-20 -99.43 -74.61 0.59 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.25 -0.907 . . . . 0.0 109.156 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.674 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . 34.84 69.7 1.02 Allowed Pre-proline 0 N--CA 1.496 1.865 0 O-C-N 121.723 -0.61 . . . . 0.0 110.074 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.44 ' HD2' ' OH ' ' A' ' 85' ' ' TYR . 34.2 Cg_endo -75.91 158.29 38.68 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.533 2.156 . . . . 0.0 110.819 -179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 103' ' ' VAL . . . -49.07 98.61 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.352 -0.842 . . . . 0.0 109.609 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.569 ' O ' ' CE1' ' A' ' 85' ' ' TYR . . . -166.92 149.92 16.16 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -81.72 140.11 34.49 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.214 -1.168 . . . . 0.0 109.54 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.569 ' CE1' ' O ' ' A' ' 83' ' ' GLY . 66.5 m-85 -118.71 147.74 43.52 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.539 -0.911 . . . . 0.0 108.539 179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.465 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 95.2 m -134.14 118.43 17.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.987 -1.07 . . . . 0.0 110.718 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.582 ' N ' ' CD1' ' A' ' 87' ' ' PHE . 0.2 OUTLIER -110.44 171.35 7.51 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.403 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.469 ' HA ' ' O ' ' A' ' 97' ' ' MET . 14.1 p90 -158.94 -163.84 1.31 Allowed 'General case' 0 C--N 1.303 -1.454 0 O-C-N 120.77 -1.206 . . . . 0.0 110.476 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.447 ' SG ' ' HD2' ' A' ' 91' ' ' PRO . 0.5 OUTLIER -126.25 145.29 50.46 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.578 -0.701 . . . . 0.0 109.408 -179.623 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.627 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 24.2 tp10 -82.97 -42.81 0.87 Allowed Pre-proline 0 C--N 1.302 -1.47 0 O-C-N 121.254 -0.904 . . . . 0.0 110.599 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.627 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 35.3 Cg_endo -78.1 -75.61 0.01 OUTLIER 'Trans proline' 0 C--N 1.319 -1.024 0 C-N-CA 121.946 1.764 . . . . 0.0 110.82 -179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.66 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 13.4 m80 -65.5 69.18 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.056 -1.028 . . . . 0.0 109.531 -179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 91' ' ' PRO . 10.8 tpt180 -90.72 -14.94 31.16 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.138 -0.976 . . . . 0.0 109.179 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -86.57 1.64 87.22 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.449 ' CB ' ' HB2' ' A' ' 14' ' ' LEU . . . -114.14 33.42 5.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.223 -1.163 . . . . 0.0 109.487 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.494 ' O ' ' N ' ' A' ' 98' ' ' VAL . . . 40.16 36.6 0.92 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.513 ' SD ' ' HB3' ' A' ' 14' ' ' LEU . 4.0 mtp -65.35 72.85 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.036 -1.273 . . . . 0.0 109.177 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.494 ' N ' ' O ' ' A' ' 96' ' ' GLY . 98.5 t -132.7 112.23 18.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 109.732 -179.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.581 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -100.31 -174.92 30.08 Favored Glycine 0 N--CA 1.486 1.989 0 N-CA-C 109.341 -1.504 . . . . 0.0 109.341 179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.519 ' N ' ' CZ ' ' A' ' 87' ' ' PHE . 22.4 mtpt -158.12 144.92 17.74 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.052 -1.263 . . . . 0.0 109.977 -179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 1.032 HD11 HG21 ' A' ' 29' ' ' VAL . 0.4 OUTLIER -110.73 135.88 48.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.314 -0.866 . . . . 0.0 108.677 179.446 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 21' ' ' LEU . 3.1 m -114.11 95.29 5.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.271 -0.893 . . . . 0.0 109.1 179.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.64 HG22 ' CD1' ' A' ' 23' ' ' ILE . 2.3 t -99.87 124.71 53.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.277 -0.89 . . . . 0.0 109.805 -179.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.25 -147.9 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.296 -0.878 . . . . 0.0 109.252 179.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.406 ' OXT' ' HG3' ' A' ' 25' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.295 0 CA-C-O 117.995 -1.447 . . . . 0.0 109.538 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.47 127.3 48.2 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.252 -0.905 . . . . 0.0 109.501 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.698 ' HB3' HD21 ' A' ' 21' ' ' LEU . 25.8 m-85 -84.45 169.05 14.93 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.21 -0.931 . . . . 0.0 109.154 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.528 HG23 ' O ' ' A' ' 30' ' ' GLU . 31.6 m -160.18 122.2 3.25 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.108 -0.995 . . . . 0.0 109.776 -179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.907 HG12 ' H ' ' A' ' 17' ' ' GLU . 0.6 OUTLIER -106.13 -155.22 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 109.001 179.446 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.472 ' H ' HG12 ' A' ' 5' ' ' VAL . 10.5 tttt -175.22 127.93 0.27 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.33 -0.856 . . . . 0.0 109.507 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.787 HD12 ' CG ' ' A' ' 39' ' ' HIS . 0.1 OUTLIER -100.56 93.89 5.84 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.267 -0.896 . . . . 0.0 109.156 179.775 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.746 ' HA2' HD23 ' A' ' 14' ' ' LEU . . . 152.07 70.14 0.01 OUTLIER Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.434 -1.467 . . . . 0.0 109.434 -179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.409 ' C ' ' O ' ' A' ' 8' ' ' GLY . 1.4 p -46.56 150.39 0.68 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.192 -1.181 . . . . 0.0 109.021 179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -88.28 36.9 0.79 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.228 -0.92 . . . . 0.0 109.625 -179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 1.5 mtmm -122.37 -29.24 4.16 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.243 -0.911 . . . . 0.0 109.406 179.875 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.418 ' O ' ' HG ' ' A' ' 13' ' ' LEU . . . 137.91 46.02 0.08 OUTLIER Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 12' ' ' GLY . 1.9 mt -164.3 172.68 13.21 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.224 -1.162 . . . . 0.0 109.626 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.746 HD23 ' HA2' ' A' ' 8' ' ' GLY . 88.1 mt -118.8 97.09 5.54 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.255 -0.903 . . . . 0.0 109.841 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 33.2 m -140.95 154.68 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 121.294 -0.878 . . . . 0.0 109.398 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -62.93 160.47 14.74 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.124 -0.985 . . . . 0.0 109.113 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.907 ' H ' HG12 ' A' ' 5' ' ' VAL . 0.6 OUTLIER -134.15 103.55 11.65 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.933 . . . . 0.0 109.651 -179.915 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.3 Cg_endo -77.53 -163.59 3.44 Favored 'Cis proline' 0 C--N 1.311 -1.397 0 C-N-CA 123.633 -1.403 . . . . 0.0 110.499 0.122 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -71.85 -36.12 70.06 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.267 -0.896 . . . . 0.0 109.593 -179.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.437 ' O ' ' HG2' ' A' ' 18' ' ' PRO . 0.0 OUTLIER -116.14 168.84 9.75 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 0.0 109.399 -179.95 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.698 HD21 ' HB3' ' A' ' 3' ' ' TYR . 2.7 tp -149.75 147.75 28.4 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.219 -0.926 . . . . 0.0 109.527 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.484 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 30.7 m -115.22 100.35 8.08 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.241 -0.912 . . . . 0.0 109.464 179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.872 ' CD1' HD13 ' A' ' 101' ' ' ILE . 2.3 pt -100.45 178.53 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.255 -0.903 . . . . 0.0 109.739 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.699 ' O ' HG13 ' A' ' 103' ' ' VAL . 0.2 OUTLIER -95.57 -174.4 0.39 Allowed Pre-proline 0 C--N 1.304 -1.393 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 179.536 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.613 ' HD2' ' HB3' ' A' ' 24' ' ' LYS . 35.7 Cg_endo -80.21 70.42 7.53 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 C-N-CA 121.934 1.756 . . . . 0.0 110.694 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.543 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 111.08 48.31 0.72 Allowed Glycine 0 N--CA 1.489 2.201 0 C-N-CA 119.581 -1.295 . . . . 0.0 110.194 179.482 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.507 ' OD2' ' HG3' ' A' ' 24' ' ' LYS . 0.9 OUTLIER -108.16 -164.98 1.0 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.398 -1.06 . . . . 0.0 108.759 178.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 95.8 m -115.71 145.69 42.53 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.034 -1.041 . . . . 0.0 110.333 -179.426 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.663 HG21 HD11 ' A' ' 101' ' ' ILE . 1.9 t -127.28 121.88 58.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 179.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.528 ' O ' HG23 ' A' ' 4' ' ' THR . 25.6 mt-10 -99.53 103.3 15.03 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.085 -1.01 . . . . 0.0 110.836 -178.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.708 ' C ' HD23 ' A' ' 32' ' ' LEU . 0.4 OUTLIER -93.49 152.13 19.27 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 178.546 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.878 HD21 ' O ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -141.61 169.15 18.15 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.689 -1.257 . . . . 0.0 110.808 -179.37 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.53 ' OD1' ' HA ' ' A' ' 68' ' ' PRO . 6.7 p-10 -97.51 160.23 14.45 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.628 -0.67 . . . . 0.0 109.202 179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.542 ' CB ' ' HA3' ' A' ' 8' ' ' GLY . 51.9 t30 -110.07 -78.87 0.59 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 120.907 -1.121 . . . . 0.0 109.748 179.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.513 ' O ' HG22 ' A' ' 36' ' ' VAL . 5.7 tptt -151.25 34.71 0.58 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.026 -1.046 . . . . 0.0 109.886 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.603 ' N ' ' HD3' ' A' ' 37' ' ' PRO . 0.9 OUTLIER -156.39 56.34 1.22 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.28 -0.887 . . . . 0.0 109.65 179.298 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.603 ' HD3' ' N ' ' A' ' 36' ' ' VAL . 36.3 Cg_endo -78.59 176.37 9.96 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.697 2.265 . . . . 0.0 110.669 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.57 ' HA ' ' CB ' ' A' ' 37' ' ' PRO . 38.2 Cg_endo -86.13 162.23 56.26 Favored 'Cis proline' 0 C--N 1.312 -1.392 0 O-C-N 123.753 1.396 . . . . 0.0 110.416 -1.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.787 ' CG ' HD12 ' A' ' 7' ' ' LEU . 73.3 m-70 -122.28 140.73 52.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.256 -0.903 . . . . 0.0 110.215 179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.505 ' HB2' ' HD3' ' A' ' 91' ' ' PRO . 1.2 m120 -115.15 134.76 54.87 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 108.512 -0.922 . . . . 0.0 108.512 178.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.55 ' HB ' ' CD2' ' A' ' 61' ' ' HIS . 35.5 t -100.82 135.07 38.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.105 -0.997 . . . . 0.0 110.03 -179.179 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.532 ' C ' ' CD1' ' A' ' 43' ' ' PHE . 2.5 t -149.22 171.1 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.376 -0.828 . . . . 0.0 109.477 179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.694 ' CZ ' HD12 ' A' ' 59' ' ' LEU . 1.6 m-85 -139.21 115.33 10.3 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.144 -0.973 . . . . 0.0 109.668 -179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 18.2 t0 -47.59 142.8 4.17 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.179 -0.951 . . . . 0.0 109.132 179.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -101.22 19.98 16.6 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.187 -0.945 . . . . 0.0 109.819 -179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -108.35 -40.17 5.23 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.207 -0.933 . . . . 0.0 109.561 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.612 ' N ' HD12 ' A' ' 47' ' ' LEU . 10.2 mp -87.17 55.9 3.76 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.226 -0.922 . . . . 0.0 109.611 -179.798 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.493 ' OD1' ' HA ' ' A' ' 51' ' ' LYS . 0.4 OUTLIER -102.53 165.76 13.2 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.331 -0.856 . . . . 0.0 109.47 179.71 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.516 ' HG2' ' HG2' ' A' ' 81' ' ' PRO . 34.9 Cg_endo -77.78 -33.07 2.4 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.638 2.225 . . . . 0.0 110.807 -179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.46 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -124.06 30.72 6.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.037 -1.039 . . . . 0.0 109.719 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.493 ' HA ' ' OD1' ' A' ' 48' ' ' ASN . 12.5 mmtm 39.45 31.46 0.07 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.71 -0.619 . . . . 0.0 109.841 179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . 0.423 ' N ' ' O ' ' A' ' 50' ' ' ALA . 28.8 m -101.62 125.01 48.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.274 -0.891 . . . . 0.0 109.68 -179.749 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -100.35 97.53 8.28 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.353 -0.842 . . . . 0.0 109.368 179.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -163.49 -46.01 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.274 -0.891 . . . . 0.0 109.529 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.486 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 0.9 OUTLIER -68.4 -15.88 63.72 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.264 -0.898 . . . . 0.0 109.381 -179.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -82.94 -50.5 8.51 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.252 -0.905 . . . . 0.0 109.637 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.29 -23.66 0.6 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.217 -0.927 . . . . 0.0 109.719 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 23.2 t -106.86 -3.52 20.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.062 -1.024 . . . . 0.0 109.902 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.015 HD21 ' CD2' ' A' ' 76' ' ' PHE . 0.0 OUTLIER -95.12 -37.12 11.22 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.09 -1.006 . . . . 0.0 108.554 179.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.498 ' CB ' ' HA ' ' A' ' 42' ' ' VAL . 1.4 m -78.91 132.73 36.86 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.191 -0.943 . . . . 0.0 110.383 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.683 ' CE1' HD21 ' A' ' 65' ' ' LEU . 18.9 p80 -109.61 138.49 45.89 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.481 -0.933 . . . . 0.0 108.481 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.46 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 0.1 OUTLIER -127.74 119.42 25.74 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.009 -1.057 . . . . 0.0 110.114 -179.785 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.606 ' O ' ' O ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER 167.53 29.44 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.558 -0.714 . . . . 0.0 110.303 179.248 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.606 ' O ' ' O ' ' A' ' 63' ' ' GLN . 4.1 mt 47.66 123.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.734 0.778 . . . . 0.0 111.319 178.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.683 HD21 ' CE1' ' A' ' 61' ' ' HIS . 6.3 mt -78.49 155.32 29.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.246 -1.534 . . . . 0.0 108.77 179.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 41.1 mtm -137.28 9.64 2.97 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.254 -0.904 . . . . 0.0 109.595 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.431 ' HB3' ' O ' ' A' ' 70' ' ' GLN . 1.9 t -110.28 129.55 23.82 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.3 -0.875 . . . . 0.0 109.375 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.53 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.2 Cg_endo -79.18 93.31 1.1 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 C-N-CA 122.362 2.041 . . . . 0.0 110.453 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.521 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 114.39 0.83 23.49 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.709 -1.356 . . . . 0.0 109.709 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.436 ' HG2' ' C ' ' A' ' 69' ' ' GLY . 32.5 mm-40 -144.43 112.94 6.58 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.31 -1.112 . . . . 0.0 108.777 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.55 ' OG ' ' N ' ' A' ' 72' ' ' THR . 51.9 p -99.95 -80.28 0.48 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.001 -1.062 . . . . 0.0 109.671 -179.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.598 ' HB ' ' CD2' ' A' ' 61' ' ' HIS . 4.3 m -160.33 107.8 1.61 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.077 -1.015 . . . . 0.0 109.474 -179.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 29' ' ' VAL . 3.9 m -80.08 76.35 6.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.209 -0.932 . . . . 0.0 109.154 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.651 HG21 HD13 ' A' ' 59' ' ' LEU . 1.0 OUTLIER -60.68 124.15 19.56 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.417 -0.802 . . . . 0.0 110.06 -179.61 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.634 HG23 ' O ' ' A' ' 75' ' ' THR . 3.8 t -82.87 90.08 6.91 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.392 -0.818 . . . . 0.0 108.986 179.431 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 1.015 ' CD2' HD21 ' A' ' 59' ' ' LEU . 22.7 m-85 -41.41 157.11 0.2 Allowed Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.464 -0.773 . . . . 0.0 109.693 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.543 ' O ' ' HA2' ' A' ' 26' ' ' GLY . 34.6 Cg_endo -78.1 161.14 29.67 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 C-N-CA 122.814 2.343 . . . . 0.0 111.031 -179.66 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -77.09 5.4 8.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.22 -0.925 . . . . 0.0 110.023 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.469 ' OD1' ' HB2' ' A' ' 77' ' ' PRO . 2.0 p-10 -100.09 -11.04 20.85 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.001 -1.062 . . . . 0.0 109.616 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.439 ' C ' ' O ' ' A' ' 79' ' ' ASP . . . -40.4 100.6 0.22 Allowed Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.497 -0.752 . . . . 0.0 109.832 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.516 ' HG2' ' HG2' ' A' ' 49' ' ' PRO . 36.3 Cg_endo -78.54 -176.11 3.09 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 C-N-CA 122.497 2.131 . . . . 0.0 110.442 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.72 123.33 27.58 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.355 179.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 169.1 148.28 5.74 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.61 -1.396 . . . . 0.0 109.61 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.437 ' O ' ' CG ' ' A' ' 84' ' ' GLU . 10.8 pt-20 -80.37 111.68 17.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.309 -1.112 . . . . 0.0 109.752 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.544 ' N ' ' CD1' ' A' ' 85' ' ' TYR . 5.6 m-30 -86.5 98.04 10.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.934 . . . . 0.0 108.867 179.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.483 ' HA ' ' O ' ' A' ' 99' ' ' GLY . 17.3 m -77.45 105.76 8.79 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.226 -0.921 . . . . 0.0 110.191 -179.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.487 ' HB3' ' CD2' ' A' ' 43' ' ' PHE . 0.6 OUTLIER -104.16 176.93 4.99 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.283 -0.886 . . . . 0.0 108.796 179.103 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.477 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 5.7 p90 -160.7 -147.7 0.15 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.014 -1.054 . . . . 0.0 109.722 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.488 ' O ' ' HB2' ' A' ' 93' ' ' ARG . 0.5 OUTLIER -130.93 159.02 38.66 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.268 -0.895 . . . . 0.0 109.746 -179.466 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.602 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 2.3 tt0 -91.79 -44.21 0.36 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.362 -0.836 . . . . 0.0 111.161 -179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.602 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 36.8 Cg_endo -80.58 -56.82 0.04 OUTLIER 'Trans proline' 0 C--N 1.317 -1.09 0 C-N-CA 122.117 1.878 . . . . 0.0 110.674 -179.228 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.726 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 19.9 m80 -77.78 5.02 10.28 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.289 -0.882 . . . . 0.0 109.62 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . 0.488 ' HB2' ' O ' ' A' ' 89' ' ' CYS . 20.0 ttt-85 -43.26 120.0 1.74 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.17 -0.956 . . . . 0.0 109.37 179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 103.73 11.07 33.72 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -120.7 39.26 3.81 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.223 -1.163 . . . . 0.0 109.328 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.74 -0.16 66.44 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.81 -1.316 . . . . 0.0 109.81 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.626 ' HE3' ' HB2' ' A' ' 7' ' ' LEU . 0.1 OUTLIER -71.39 66.9 0.48 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.164 -1.198 . . . . 0.0 109.664 -179.865 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 41.0 t -135.25 120.0 27.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.189 -0.944 . . . . 0.0 109.444 179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.483 ' O ' ' HA ' ' A' ' 86' ' ' THR . . . -133.77 -178.52 15.65 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 85' ' ' TYR . 10.0 mttt -148.78 140.77 23.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.183 -1.187 . . . . 0.0 109.669 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.872 HD13 ' CD1' ' A' ' 23' ' ' ILE . 0.1 OUTLIER -96.88 133.73 37.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.251 -0.906 . . . . 0.0 109.111 179.718 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.484 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 0.5 OUTLIER -101.28 104.13 15.15 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 178.691 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.834 HG22 ' CD1' ' A' ' 23' ' ' ILE . 59.4 t -98.9 114.18 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.295 -0.878 . . . . 0.0 109.601 -179.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.418 ' O ' ' C ' ' A' ' 105' ' ' GLY . . . -88.04 120.72 29.67 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.347 -0.846 . . . . 0.0 109.31 179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.418 ' C ' ' O ' ' A' ' 104' ' ' ALA . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 121.26 0.552 . . . . 0.0 109.544 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 49.2 m -133.7 127.16 32.28 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.304 -0.873 . . . . 0.0 109.559 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.44 ' N ' ' CD1' ' A' ' 3' ' ' TYR . 16.1 m-85 -90.69 137.61 32.22 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.281 -0.887 . . . . 0.0 109.361 179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.962 HG23 ' HB3' ' A' ' 30' ' ' GLU . 2.0 m -139.19 110.62 7.01 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.226 -0.921 . . . . 0.0 109.646 -179.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.706 HG23 ' O ' ' A' ' 5' ' ' VAL . 26.8 m -96.49 109.14 22.41 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 O-C-N 121.244 -0.91 . . . . 0.0 109.466 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -86.75 137.9 32.06 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.182 -0.949 . . . . 0.0 109.43 179.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.734 ' HB2' ' HE3' ' A' ' 97' ' ' MET . 0.1 OUTLIER -98.47 80.27 2.59 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.0 109.1 179.606 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.468 ' O ' ' ND2' ' A' ' 34' ' ' ASN . . . 134.48 79.94 0.13 Allowed Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.444 -1.463 . . . . 0.0 109.444 -179.802 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 2.4 p -52.58 -88.59 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.251 -1.147 . . . . 0.0 109.563 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -172.38 37.03 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.274 -0.891 . . . . 0.0 109.555 -179.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -128.21 20.37 6.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.223 -0.923 . . . . 0.0 109.435 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.432 ' HA2' ' CE ' ' A' ' 35' ' ' LYS . . . 73.02 37.41 56.3 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.455 ' O ' ' HA2' ' A' ' 8' ' ' GLY . 74.7 mt -139.89 139.38 36.22 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.295 -1.121 . . . . 0.0 109.442 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.793 HD22 ' CE1' ' A' ' 39' ' ' HIS . 17.0 mt -101.25 114.31 28.17 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.204 -0.935 . . . . 0.0 109.561 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 14' ' ' LEU . 15.0 m -157.59 157.65 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -0.892 . . . . 0.0 109.378 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -81.82 147.09 29.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.199 -0.938 . . . . 0.0 109.614 -179.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.496 ' HA ' ' HA ' ' A' ' 18' ' ' PRO . 14.2 mm-40 -139.61 107.01 7.06 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.251 -0.905 . . . . 0.0 109.424 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.496 ' HA ' ' HA ' ' A' ' 17' ' ' GLU . 34.7 Cg_endo -78.1 176.19 44.15 Favored 'Cis proline' 0 C--N 1.312 -1.374 0 C-N-CA 123.761 -1.349 . . . . 0.0 110.675 0.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -69.07 -61.05 1.95 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.335 -0.853 . . . . 0.0 109.298 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 6.5 tttp -82.03 174.72 10.97 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.242 -0.912 . . . . 0.0 109.198 179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.519 ' CD2' HG13 ' A' ' 29' ' ' VAL . 5.2 tp -158.95 104.73 1.74 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.12 -0.988 . . . . 0.0 110.083 -179.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . 0.475 ' HA ' ' HB ' ' A' ' 102' ' ' THR . 32.1 m -87.01 90.09 8.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.188 -0.945 . . . . 0.0 108.477 179.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.688 ' CD1' HD13 ' A' ' 101' ' ' ILE . 1.0 OUTLIER -99.7 163.43 2.83 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 121.316 -0.865 . . . . 0.0 110.348 -178.999 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.607 ' HB3' ' HD2' ' A' ' 25' ' ' PRO . 14.1 mmtt -88.03 166.74 22.6 Favored Pre-proline 0 C--N 1.301 -1.526 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 178.732 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PRO . . . . . 0.873 ' HA ' ' HB3' ' A' ' 80' ' ' ALA . 31.4 Cg_endo -73.09 88.86 0.92 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 121.693 1.596 . . . . 0.0 110.017 -179.677 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 77' ' ' PRO . . . 125.59 -3.13 8.15 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 -179.504 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.485 ' OD2' ' CG ' ' A' ' 24' ' ' LYS . 62.6 m-20 -62.47 -168.51 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -1.145 . . . . 0.0 109.566 -179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 19.2 m -129.33 130.63 46.35 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.278 -0.889 . . . . 0.0 109.369 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.091 HG21 HD11 ' A' ' 101' ' ' ILE . 3.3 t -121.42 115.91 48.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.251 -0.905 . . . . 0.0 109.346 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.962 ' HB3' HG23 ' A' ' 4' ' ' THR . 2.0 mm-40 -99.58 132.92 44.6 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.27 -0.893 . . . . 0.0 109.635 -179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.6 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -131.7 94.41 3.51 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -179.968 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . 0.582 ' HA ' ' CB ' ' A' ' 71' ' ' SER . 0.4 OUTLIER -96.58 179.68 4.91 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.343 -0.848 . . . . 0.0 110.663 -178.35 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASN . . . . . 0.575 ' ND2' ' HB3' ' A' ' 37' ' ' PRO . 1.7 p-10 -107.87 155.05 20.7 Favored 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.47 -0.768 . . . . 0.0 109.469 -178.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.468 ' ND2' ' O ' ' A' ' 8' ' ' GLY . 53.2 t30 -151.19 -58.52 0.16 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.985 -1.072 . . . . 0.0 110.009 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.691 ' HB3' HD21 ' A' ' 14' ' ' LEU . 0.0 OUTLIER -60.72 -147.78 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.27 -0.894 . . . . 0.0 109.124 -179.345 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.431 ' N ' ' HD3' ' A' ' 35' ' ' LYS . 65.4 t -68.05 112.35 10.46 Favored Pre-proline 0 N--CA 1.494 1.734 0 O-C-N 121.371 -0.831 . . . . 0.0 109.382 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.575 ' HB3' ' ND2' ' A' ' 33' ' ' ASN . 37.5 Cg_endo -82.01 175.33 9.32 Favored 'Trans proline' 0 C--N 1.314 -1.277 0 C-N-CA 122.807 2.338 . . . . 0.0 110.636 -179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.552 ' O ' ' CG ' ' A' ' 39' ' ' HIS . 37.8 Cg_endo -84.57 -156.09 1.13 Allowed 'Cis proline' 0 C--N 1.311 -1.404 0 C-N-CA 123.631 -1.404 . . . . 0.0 109.86 -1.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.793 ' CE1' HD22 ' A' ' 14' ' ' LEU . 86.0 m-70 -160.44 143.27 13.27 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.961 -1.087 . . . . 0.0 109.708 179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.485 ' OD1' ' N ' ' A' ' 41' ' ' VAL . 63.7 t-20 -113.58 147.42 38.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.278 -0.889 . . . . 0.0 109.201 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.485 ' N ' ' OD1' ' A' ' 40' ' ' ASN . 18.8 t -128.6 118.58 47.88 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.277 -0.889 . . . . 0.0 109.182 -179.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.894 HG12 ' CB ' ' A' ' 60' ' ' SER . 0.0 OUTLIER -153.04 175.59 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.294 -0.879 . . . . 0.0 109.379 -179.804 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.65 ' N ' ' CD1' ' A' ' 43' ' ' PHE . 0.2 OUTLIER -130.03 135.0 47.77 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.194 -0.941 . . . . 0.0 109.538 -179.471 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -59.6 130.49 47.09 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.238 -0.914 . . . . 0.0 109.353 179.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -81.87 1.99 32.44 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.245 -0.909 . . . . 0.0 109.904 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.45 ' C ' HD12 ' A' ' 47' ' ' LEU . . . -103.64 5.73 36.64 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.204 -0.935 . . . . 0.0 109.611 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.45 HD12 ' C ' ' A' ' 46' ' ' ALA . 3.6 mp -131.21 57.1 1.77 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.137 -0.977 . . . . 0.0 109.672 -179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.413 ' OD1' ' N ' ' A' ' 48' ' ' ASN . 0.7 OUTLIER -114.44 156.18 44.87 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.217 -0.927 . . . . 0.0 109.274 179.744 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.464 ' HG2' ' HG2' ' A' ' 81' ' ' PRO . 36.2 Cg_endo -79.38 -40.36 0.26 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 C-N-CA 122.67 2.247 . . . . 0.0 110.907 -179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ALA . . . . . 0.501 ' O ' ' C ' ' A' ' 51' ' ' LYS . . . -106.5 28.9 7.37 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.07 -1.019 . . . . 0.0 109.788 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.501 ' C ' ' O ' ' A' ' 50' ' ' ALA . 0.0 OUTLIER 32.5 45.88 0.06 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.186 0.517 . . . . 0.0 110.316 179.652 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.2 m -100.56 111.93 24.24 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.17 -0.957 . . . . 0.0 109.783 -179.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -70.76 -28.3 64.58 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.94 . . . . 0.0 108.982 179.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . 0.478 ' HA ' ' HB2' ' A' ' 57' ' ' LYS . 2.1 t0 -68.17 -23.85 64.9 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.375 -0.828 . . . . 0.0 109.435 179.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.455 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 17.8 tp -56.11 -61.09 2.62 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.277 -0.889 . . . . 0.0 109.532 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.747 ' HB1' ' OG ' ' A' ' 60' ' ' SER . . . -66.61 -23.98 66.26 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.297 -0.877 . . . . 0.0 109.649 -179.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.478 ' HB2' ' HA ' ' A' ' 54' ' ' ASP . 0.0 OUTLIER -45.65 -64.58 0.7 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 109.52 -179.932 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -81.98 -23.07 36.26 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.249 -0.907 . . . . 0.0 109.538 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.686 HD21 ' CZ ' ' A' ' 76' ' ' PHE . 4.7 tp -72.65 -58.07 3.65 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.268 -0.895 . . . . 0.0 109.498 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . 0.894 ' CB ' HG12 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -79.67 133.52 36.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.306 -0.871 . . . . 0.0 110.021 -179.153 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.428 ' ND1' ' C ' ' A' ' 61' ' ' HIS . 16.2 p80 -107.34 149.98 27.22 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.384 -0.822 . . . . 0.0 108.941 179.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.428 ' O ' ' CB ' ' A' ' 63' ' ' GLN . 0.0 OUTLIER -99.59 174.5 6.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.096 -1.003 . . . . 0.0 109.461 -179.785 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.428 ' CB ' ' O ' ' A' ' 62' ' ' LYS . 0.0 OUTLIER 70.27 126.73 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.315 -0.866 . . . . 0.0 109.42 179.908 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.0 mp -70.67 163.97 25.99 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.268 -0.895 . . . . 0.0 109.528 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 4.9 mt -83.25 160.71 21.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.279 -0.888 . . . . 0.0 109.126 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -132.26 9.29 4.4 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.116 -0.99 . . . . 0.0 109.81 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.503 ' HB3' ' HB2' ' A' ' 70' ' ' GLN . 9.0 t -124.66 138.31 30.99 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.18 -0.95 . . . . 0.0 109.143 179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.522 ' HA ' ' OD1' ' A' ' 33' ' ' ASN . 36.7 Cg_endo -79.3 105.72 1.93 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.538 2.159 . . . . 0.0 110.967 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.515 ' N ' ' OD1' ' A' ' 33' ' ' ASN . . . 92.75 39.09 5.34 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLN . . . . . 0.503 ' HB2' ' HB3' ' A' ' 67' ' ' SER . 9.3 mt-30 -153.11 82.04 1.2 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.232 -1.158 . . . . 0.0 109.177 179.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.6 ' CB ' ' O ' ' A' ' 31' ' ' PHE . 3.2 p -99.08 -169.21 1.73 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.164 -0.96 . . . . 0.0 109.457 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . 0.47 HG23 ' O ' ' A' ' 72' ' ' THR . 4.1 t -102.75 125.16 49.39 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 178.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 16.0 p -78.98 93.84 5.16 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.072 -1.018 . . . . 0.0 109.443 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' THR . . . . . 0.533 ' HG1' ' HE1' ' A' ' 31' ' ' PHE . 4.6 m -72.36 97.96 2.13 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.367 -0.833 . . . . 0.0 109.409 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.451 ' O ' ' C ' ' A' ' 76' ' ' PHE . 11.2 m -78.56 89.07 4.49 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 1.03 ' CZ ' HD12 ' A' ' 101' ' ' ILE . 9.9 m-85 -40.46 150.26 0.28 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.744 -0.598 . . . . 0.0 109.459 -179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 76' ' ' PHE . 34.8 Cg_endo -77.53 168.27 22.95 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.846 2.364 . . . . 0.0 111.434 -179.049 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.489 ' HA ' ' O ' ' A' ' 25' ' ' PRO . . . -83.46 5.45 23.75 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 81' ' ' PRO . 1.8 m-20 -99.19 -7.21 26.87 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.179 -0.951 . . . . 0.0 109.113 179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.873 ' HB3' ' HA ' ' A' ' 25' ' ' PRO . . . -38.59 99.11 0.18 Allowed Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.593 -0.692 . . . . 0.0 109.462 179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.464 ' HG2' ' HG2' ' A' ' 49' ' ' PRO . 34.8 Cg_endo -77.25 141.47 20.55 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 C-N-CA 122.425 2.083 . . . . 0.0 110.629 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . 0.828 ' HB2' ' O ' ' A' ' 104' ' ' ALA . . . -43.5 132.01 4.84 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.409 -0.807 . . . . 0.0 109.358 179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . 0.401 ' HA3' ' HB3' ' A' ' 49' ' ' PRO . . . 158.29 148.78 5.27 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.342 -1.503 . . . . 0.0 109.342 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 6.8 tt0 -89.46 117.7 28.57 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.154 -1.204 . . . . 0.0 109.893 -179.63 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' TYR . . . . . 0.462 ' O ' ' HB3' ' A' ' 100' ' ' LYS . 60.9 m-85 -84.02 -166.69 1.49 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.244 -0.91 . . . . 0.0 108.934 179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' THR . . . . . 0.46 ' HA ' ' HG2' ' A' ' 100' ' ' LYS . 39.2 m -166.59 105.72 0.62 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.897 -1.127 . . . . 0.0 110.836 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.561 ' CE2' ' HA3' ' A' ' 99' ' ' GLY . 0.4 OUTLIER -104.75 165.67 10.91 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 178.26 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' TYR . . . . . 0.426 ' N ' ' CD1' ' A' ' 88' ' ' TYR . 29.7 p90 -157.22 -166.62 2.1 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 120.786 -1.197 . . . . 0.0 110.561 -179.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' CYS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 97' ' ' MET . 0.5 OUTLIER -130.28 126.85 38.28 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.811 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.625 ' N ' ' CD ' ' A' ' 91' ' ' PRO . 6.0 tp10 -67.94 -43.25 36.46 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.89 . . . . 0.0 111.514 -179.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.625 ' CD ' ' N ' ' A' ' 90' ' ' GLU . 34.4 Cg_endo -76.59 -53.83 0.07 OUTLIER 'Trans proline' 0 C--N 1.314 -1.257 0 C-N-CA 121.968 1.779 . . . . 0.0 111.205 -178.695 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.592 ' CE1' ' CE1' ' A' ' 39' ' ' HIS . 34.8 m80 -89.78 30.34 1.06 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.016 -1.052 . . . . 0.0 109.614 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ARG . . . . . . . . . . . . . 8.6 ttt-85 -60.26 91.99 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.228 -0.92 . . . . 0.0 109.283 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 137.74 -15.82 3.56 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.166 -1.574 . . . . 0.0 109.166 -179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . 0.419 ' O ' ' O ' ' A' ' 14' ' ' LEU . . . -91.32 37.19 0.94 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.353 -1.086 . . . . 0.0 109.493 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 67.08 23.02 72.84 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 110.016 -1.234 . . . . 0.0 110.016 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' MET . . . . . 0.734 ' HE3' ' HB2' ' A' ' 7' ' ' LEU . 0.8 OUTLIER -91.26 53.57 2.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.063 -1.257 . . . . 0.0 109.299 179.791 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . . . . . . . . . 11.3 t -137.26 118.43 17.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.273 -0.892 . . . . 0.0 109.445 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.561 ' HA3' ' CE2' ' A' ' 87' ' ' PHE . . . -127.32 172.47 18.69 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 85' ' ' TYR . 35.7 mttt -145.84 135.86 23.64 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.26 -1.141 . . . . 0.0 109.649 -179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 1.091 HD11 HG21 ' A' ' 29' ' ' VAL . 0.3 OUTLIER -87.36 140.69 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.957 . . . . 0.0 108.878 179.661 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.475 ' HB ' ' HA ' ' A' ' 22' ' ' THR . 0.3 OUTLIER -115.77 95.55 5.18 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.331 -0.856 . . . . 0.0 108.883 179.305 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' VAL . . . . . 0.643 HG22 ' CD1' ' A' ' 23' ' ' ILE . 12.5 t -99.77 150.42 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.146 -0.971 . . . . 0.0 109.597 -179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.828 ' O ' ' HB2' ' A' ' 82' ' ' ALA . . . -89.67 -34.27 16.33 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.221 -0.924 . . . . 0.0 109.492 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 CA-C-O 117.983 -1.454 . . . . 0.0 109.49 179.973 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ' CU' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_